Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chemical synaptic transmission (GO:0007268),0.5606025744423607,2.6428589959848385,0.0,0.0,0.0,103/284,15.12%,KCND2;NRXN1;GRID2;GRM5;GRIA3;KCNQ3;NLGN1;GRIK5;GRIK2;GRID1;ASIC2;SYT1;SYT5;DLG2;GLRA3;GABRG3;CHRM2;GABRB1;HTR2C;RIT2;AMPH;ERC2;DLGAP1;GRIN2B;CDH8;SNAP25;GRIA4;HCRTR1;GABRB3;SNPH;DLGAP2;RIMS1;PTPRN2;HTR3A;GAD2;CACNA1B;PCDHB5;PNOC;CDK5;GLRA1;GRIN2A;GABRB2;APBA2;GABRA2;PLP1;CACNA1A;GABBR2;GRIA1;CAMK4;SYN1;CHRM3;MTNR1B;CACNB3;SNCG;CNP;SLC1A2;NPTX2;RAPSN;GRM1;NPY;GRIK1;HOMER1;CACNB4;STXBP2;SLC12A5;CACNA1E;HTR4;GRIA2;GRM7;TSPOAP1;SLC6A2;SLC6A5;SYN2;GABRA3;GABRA1;MINK1;PDLIM4;KIF5A;PENK;RAB3A;LIN7C;SLC17A6;CBLN1;MBP;NAAA;DTNA;HTR1D;PRKAR1B;DLG4;SLC12A4;NLGN2;UTS2;PPFIA3;SLC1A3;PTCHD1;NOVA1;GABRE;KCNC4;SCN2B;APOE;GRM4;UNC13A;HTR1F
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5728443195003544,2.611788167256767,0.0,0.0,0.0,84/224,15.12%,KCND2;NRXN1;GRM5;GRIA3;KCNQ3;NLGN1;GRIK2;ASIC2;SYT1;SYT5;DLG2;GLRA3;GABRG3;CHRM2;GABRB1;HTR2C;RIT2;AMPH;DLGAP1;GRIN2B;SNAP25;GRIA4;HCRTR1;GABRB3;HTR3A;GAD2;CACNA1B;PCDHB5;PNOC;CDK5;GLRA1;GRIN2A;GABRB2;APBA2;GABRA2;PLP1;CACNA1A;GABBR2;GRIA1;CAMK4;SYN1;CHRM3;MTNR1B;CACNB3;SNCG;CNP;SLC1A2;NPTX2;RAPSN;GRM1;NPY;GRIK1;HOMER1;CACNB4;SLC12A5;CACNA1E;HTR4;GRIA2;GRM7;SLC6A2;SLC6A5;SYN2;GABRA3;GABRA1;MINK1;KIF5A;PENK;CBLN1;MBP;DTNA;HTR1D;PRKAR1B;DLG4;SLC12A4;NLGN2;UTS2;SLC1A3;PTCHD1;NOVA1;GABRE;KCNC4;SCN2B;GRM4;HTR1F
prerank,neurotransmitter secretion (GO:0007269),0.6918115657901038,2.488262926291381,0.0,0.0,0.0,22/44,18.01%,NRXN1;SYT1;PCLO;RIMS2;SNAP25;SNPH;RIMS1;PTPRN2;GAD2;CDK5;SYN1;STXBP2;SYN2;RAB3A;LIN7C;NAAA;PPFIA3;GRM4;UNC13A;SNAPIN;GAD1;SLC32A1
prerank,signal release from synapse (GO:0099643),0.6834936418175875,2.4384718362405415,0.0,0.0,0.0,21/43,18.01%,NRXN1;SYT1;PCLO;SNAP25;SNPH;RIMS1;PTPRN2;GAD2;CDK5;SYN1;STXBP2;SYN2;RAB3A;LIN7C;NAAA;PPFIA3;GRM4;UNC13A;SNAPIN;GAD1;SLC32A1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5569646446746138,2.4031085519847903,0.0,0.0,0.0,59/159,11.60%,KIRREL3;PTPRD;GRID2;CDH18;LRRC4C;IL1RAPL1;TENM4;ROBO2;NLGN1;UNC5D;L1CAM;LRFN5;CNTN6;CNTN4;DSCAML1;CDH8;TENM1;PCDHGB4;CDH20;CDH9;CDH10;DSCAM;ADGRL3;ROBO1;IGSF11;TENM3;PCDHB5;CD177;NTNG1;MMP24;CLDN18;PTPRT;IGSF21;CEACAM5;DCHS1;CDH19;TENM2;CXADR;CLDN14;CDH12;NECTIN3;MYPN;CLDN11;SDK1;VSTM2L;CDH7;SLITRK1;EMB;CNTN2;CDH17;PTPRS;CDH24;CDHR3;MAG;LRFN4;LRRC4B;CBLN1;CELSR2;CDH2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.557058302405927,2.3345668495523473,0.0,0.0,0.0,43/107,15.07%,GRID2;GRM5;LRRC4C;NRG3;NLGN1;GRIK5;GRIK2;GRID1;SYT1;DGKI;DLGAP1;ATP1A2;RIMS2;CNTNAP4;DLGAP2;RIMS1;TMEM108;GRM8;PSMC5;CACNA1B;CDK5;CLN3;NPTXR;CACNA1A;SYN1;SLC8A2;NPTX2;GRM1;GRIK1;HOMER1;GRM7;MCTP2;CLSTN2;CDH2;SLC8A3;DLG4;DLGAP3;BDNF;NLGN2;CACNG5;BEGAIN;GRM4;UNC13A
prerank,regulation of cell junction assembly (GO:1901888),-0.7422041138047935,-2.3306618617364325,0.0,0.0,0.0,16/27,15.35%,TJP1;PRKCH;RAPGEF2;CLDN5;CBFB;F11R;PDLIM5;RAP1A;MEF2C;SETD5;RAP1B;ROCK1;OCLN;RAPGEF1;FLOT1;ROCK2
prerank,regulation of endothelial cell migration (GO:0010594),-0.5942790171154009,-2.3110140625656657,0.0,0.0,0.0,47/85,22.67%,FOXP1;TEK;DAB2IP;PTPRM;SP100;NRP2;ACVRL1;BMPER;ETS1;RAC1;RHOJ;BMPR2;THBS1;KDR;ANXA3;PRKD2;ABL1;SLIT2;PTK2;FGF1;BMP4;PRKD1;FLT4;SCARB1;ADAMTS9;RRAS;BCAR1;PIK3CD;AKT1;EDN1;BCAS3;RIN2;FGF2;CEACAM1;PRCP;PIK3CB;ROCK2;SMOC2;ANGPT1;SASH1;EPHA2;ITGB3;NF1;NR2F2;DLL4;PTK2B;PTN
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.6158578301574772,2.3021369556856444,0.0,9.37111795630116e-05,0.001,29/57,14.09%,GRIA3;NLGN1;DLG2;LRRC7;DLGAP1;GRIN2B;GRIA4;DLGAP2;OPRM1;LYNX1;GRIN2A;SHANK1;NPTXR;GRIA1;CACNG8;NPTX2;CAMK2B;NETO1;CACNG3;GRIA2;MINK1;CACNG2;CACNG4;PRRT1;DLG4;DLGAP3;NLGN2;CACNG5;BEGAIN
prerank,neurotransmitter transport (GO:0006836),0.5893921034618047,2.285724806949726,0.0,0.0001639945642352703,0.002,35/73,18.01%,NRXN1;SYT1;ATP1A2;SNAP25;PPFIA2;SNPH;RIMS1;PTPRN2;SLC22A1;GAD2;SLC6A15;GABRA2;SYN1;SLC1A2;STXBP2;SLC29A4;TSPOAP1;SLC6A2;SYN2;SLC28A2;RAB3A;LIN7C;SLC17A6;NAAA;GLS2;GLS;PPFIA3;SLC1A3;GRM4;UNC13A;SNAPIN;SLC6A4;GAD1;PPFIA4;SLC32A1
prerank,glutamate receptor signaling pathway (GO:0007215),0.6800800046516977,2.2842030794681194,0.0,0.00014577294598690693,0.002,15/37,8.89%,GRID2;GRM5;GRIA3;GRIK2;GRIN2B;GRIA4;GRM8;GRIN2A;CLN3;GRM1;GRIK1;HOMER1;TRPM1;GRIA2;GRM7
prerank,establishment of endothelial barrier (GO:0061028),-0.7163009894083161,-2.2768488436297463,0.0,0.0,0.0,15/29,11.03%,TJP1;RAPGEF2;PECAM1;F11R;RAB1A;ICAM1;MSN;AFDN;PDE2A;ROBO4;RAP1A;EZR;TJP2;RAP1B;RAPGEF1
prerank,presynapse assembly (GO:0099054),0.8192858365746551,2.250356191064008,0.0,0.0005903804312469732,0.009,5/16,0.55%,PTPRD;IL1RAPL1;NLGN1;PCLO;LRRTM3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.6050363476067228,-2.23863220941074,0.0,0.0009538841744713178,0.003,31/67,15.35%,FLT1;DAB2IP;WASF2;NRP2;DOCK1;ABI1;RAC1;CLEC14A;ELMO1;CRK;PAK2;KDR;PRKD2;NCK1;PXN;PIK3R1;PTK2;MAPKAPK2;ROCK1;PRKD1;SHB;FLT4;BCAR1;VEGFC;NCK2;RHOA;NCF2;PIK3CB;ELMO2;NCKAP1;ROCK2
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.56849440011221,-2.217145145152087,0.0,0.0007631073395770543,0.003,35/84,16.14%,FOXP1;TEK;NRP2;NOS3;ETS1;RAC1;BMPR2;THBS1;TMSB4X;KDR;ANXA3;PLCG1;PRKD2;SP1;ABL1;FGF1;BMP4;PRKD1;AKT3;FLT4;SCARB1;RRAS;BCAR1;PIK3CD;AKT1;EDN1;BCAS3;RIN2;FGF2;CD40;PIK3CB;ROCK2;SMOC2;LGMN;ANGPT1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6414158431672197,2.205833314785214,0.0,0.0012523221268875187,0.02,13/37,6.66%,PTPRD;GRID2;IL1RAPL1;TENM4;NLGN1;TENM1;TENM3;IGSF21;CEACAM5;DCHS1;TENM2;CXADR;NECTIN3
prerank,neuron cell-cell adhesion (GO:0007158),0.8427457242665143,2.2049847266449616,0.0,0.0011479619496468922,0.02,7/14,4.93%,NRXN3;NRXN1;NLGN1;NCAM2;CNTN4;ASTN2;ASTN1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6162456588613745,2.1937266667863273,0.0,0.0012614966479636178,0.022,24/46,15.07%,NRXN1;GRM5;NLGN1;SYT1;DGKI;ATP1A2;GRM8;CDK5;CLN3;CACNG8;GRM1;ATAD1;GRIK1;HOMER1;CACNG3;GRM7;CACNG2;CACNG4;CDH2;CCL2;NLGN2;CACNG5;GRM4;UNC13A
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6418131328408827,2.1507006974782845,0.0,0.0023896350788567963,0.046,15/35,10.12%,CDH18;NLGN1;CDH8;PCDHGB4;CDH20;CDH9;CDH10;PCDHB5;DCHS1;CDH19;CDH12;CDH7;CDH17;CDH24;CDHR3
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.5336390643441623,-2.1435121737006484,0.0,0.002331716870929888,0.011,29/87,12.22%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;GCNT2;F11R;ID1;SMURF1;TGFBR3;ADAM9;TGFBR2;CBL;PXN;ITGB5;TGFB2;PTK2;PTPRK;CDH5;JUN;SMAD1;SMAD2;SMAD4;SMAD7;USP15;RHOA
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.5394641067197649,-2.1411278836879197,0.0,0.001998614460797047,0.011,42/92,17.07%,FOXP1;TEK;RREB1;NRP2;DOCK1;ETS1;RAC1;PRKCE;BMPR2;THBS1;KDR;ANXA3;MTOR;PLCG1;PRKD2;ADAM9;ABL1;TGFB2;FGF1;BMP4;PPM1F;PRKD1;FLT4;PLCG2;SCARB1;RRAS;BCAR1;PIK3CD;FGF7;AKT1;EDN1;BCAS3;RIN2;FGF2;PIK3CB;MAP4K4;ROCK2;SMOC2;ANGPT1;RAB11A;CTSH;HDAC6
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.7651889504136652,-2.1299117318241527,0.0,0.0022257297404330747,0.014,9/17,12.19%,PBX1;CREBBP;MAML2;KAT2B;NOTCH3;PLXND1;MAML1;NOTCH4;NOTCH1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.49947658572327575,-2.127876912876354,0.0,0.0021197426099362616,0.015,40/128,12.22%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;BMPR2;SMURF2;GCNT2;BMP5;F11R;RNF111;ID1;SMURF1;TGFBR3;ADAM9;TGFBR2;BMP6;CBL;PXN;ITGB5;PDCD4;HIVEP1;TGFB2;PTK2;BMP4;PTPRK;CDH5;JUN;SMAD1;SMAD2;ACVR2A;SMAD4;RGMB;SMAD7;USP15;HFE;RHOA
prerank,regulation of cation channel activity (GO:2001257),0.5242397554935007,2.1264183225892532,0.0,0.0027113767953564688,0.055,39/89,17.85%,GRIA3;FGF14;NLGN1;DLG2;LRRC7;ANK3;GRIN2B;GRIA4;FGF12;OPRM1;GRIN2A;SHANK1;HPCA;GRIA1;CALM2;CACNB3;CACNG8;CAMK2B;HOMER1;NETO1;CACNG3;CACNB4;GRIA2;STAC;MINK1;CACNG2;CACNG4;PRRT1;HRC;DLG4;NLGN2;CACNG5;KCNS2;SHISA9;SELENON;NEFL;EPO;CACNB1;CNIH2
prerank,regulation of cation transmembrane transport (GO:1904062),0.6368419719872479,2.1259942771012716,0.0,0.00254191574564669,0.055,12/29,8.20%,KCNIP4;DPP10;KCNIP1;FGF12;DPP6;ATP2B4;KCNN2;CD63;WNK3;CACNA1D;HOMER1;SCN5A
prerank,regulation of synapse assembly (GO:0051963),0.6067773393850492,2.1170493273078925,0.0,0.0027010869403456287,0.06,19/46,13.34%,PTPRD;NRXN1;GRID2;IL1RAPL1;ROBO2;NLGN1;LRFN5;IL1RAPL2;MUSK;EPHB1;SYNDIG1;MDGA1;SLITRK1;SLIT1;LRFN4;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,neuropeptide signaling pathway (GO:0007218),0.5627356432185399,2.112709704019293,0.0,0.0027696859737512316,0.066,16/58,11.23%,GLRA3;HCRTR1;OPRM1;SORCS1;SORCS3;NXPH3;PNOC;GLRA1;GPR37;CPE;NXPH4;NPY;KISS1R;SORL1;PENK;NMUR2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.5052598152979632,-2.0974803181696933,0.0,0.0045786440374623255,0.034,35/112,12.80%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;LIMS1;GCNT2;F11R;ID1;NR3C1;SMURF1;TGFBR3;PDE3A;ADAM9;TGFBR2;CBL;PXN;ITGB5;PDE2A;TGFB2;PTK2;PTPRK;MEF2C;CDH5;JUN;SMAD1;SMAD2;SMAD4;SMAD7;USP15;RHOA;WWOX
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.6347415604807569,-2.0966331904504485,0.0,0.004162403670420296,0.034,16/33,14.15%,TJP1;SEMA6A;KLF4;BMPER;RHOJ;KLF2;THBS1;JAK1;FGF1;SMAD1;CEMIP2;ADAMTS9;FGF2;S100A1;CEACAM1;PIK3CB
prerank,calcium ion transport into cytosol (GO:0060402),0.7020843866668824,2.0933850321925664,0.0,0.003659668170302874,0.092,10/21,11.92%,GRIN2B;MS4A1;ATP2B4;CACNA2D1;GRIN2A;CACNB3;RYR2;TRPM1;ADRA1A;SLC8A1
prerank,positive regulation of nervous system development (GO:0051962),0.6079958596426989,2.09237804797712,0.0,0.003575081500328893,0.094,14/42,13.34%,PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;OPRM1;MME;EPHB1;SYNDIG1;GPER1;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6283476816384305,2.0917595470351027,0.0,0.003436076583977092,0.095,10/33,4.29%,GRID2;LRRC4C;NRG3;NLGN1;GRIK5;GRIK2;GRID1;PSMC5;CACNA1B;CACNA1A
prerank,protein localization to cell-cell junction (GO:0150105),-0.777800510103381,-2.079375995801123,0.0,0.00582929217732472,0.049,11/15,16.15%,TJP1;MPP7;F11R;JAK1;PAK2;CGNL1;LSR;CDH5;TJP2;ACTB;ARHGEF18
prerank,regulation of potassium ion transport (GO:0043266),0.6264864260646529,2.066241006871549,0.0,0.005337277636020615,0.152,10/31,9.30%,KCNIP4;DPP10;KCNIP1;ANK3;DPP6;KCNA5;KCNN2;CD63;CACNA1D;ADRA2A
prerank,Notch signaling pathway (GO:0007219),-0.5668686464242587,-2.0657228672825823,0.0,0.006554896378418286,0.06,27/59,17.95%,PBX1;ZNF423;CREBBP;MAML2;GMDS;KAT2B;DTX3L;NOTCH3;HES1;JAG2;PSEN2;SORBS2;PLXND1;MAML1;NOTCH2;ADAM10;MIB1;NOTCH4;PSEN1;GALNT11;NOTCH1;DTX3;JAG1;NLE1;APH1A;HEY1;HEY2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6662568089331896,-2.0568694649109736,0.0,0.006995150612789664,0.07,21/26,29.65%,ANKRD17;KMT2E;DDX3X;EGFR;PLCB1;CCND3;CDK10;AKT1;RGCC;RPTOR;UBE2E2;LSM11;ANXA1;LSM10;CCND1;MTBP;TFDP1;ADAM17;FGF10;RDX;CCND2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.808905755379594,-2.0553597084302293,0.0,0.006698386647398587,0.071,9/14,11.47%,GHR;LYN;PTPN1;PXN;PIK3R1;PTK2;STAT6;SOCS2;JAK2
prerank,regulation of DNA binding (GO:0051101),-0.5902460999341868,-2.051496376228192,0.0,0.007074640960662273,0.078,21/44,20.11%,LEF1;SP100;SMO;HES1;NFKBIA;ZBTB7A;NGF;JUN;HJURP;DOT1L;JAK2;MAPK8;FOXC1;ILRUN;IGF1;SKI;SUMO1;TFAP4;CEBPG;TXN;PPARG
prerank,positive regulation of synapse assembly (GO:0051965),0.6502326417721039,2.047734187469985,0.0,0.006759428125871142,0.196,11/27,13.34%,PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;EPHB1;SYNDIG1;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,sprouting angiogenesis (GO:0002040),-0.570197380919305,-2.0382984398586377,0.0,0.008079960066109986,0.095,29/51,24.90%,TEK;ENG;ACVRL1;RSPO3;ADGRA2;BMPER;PARVA;THBS1;KDR;RNF213;OTULIN;SLIT2;BMP4;FLT4;RAMP2;AKT1;VEGFC;NAXE;FGF2;JMJD6;ANGPT1;PIK3R3;SEMA3E;PTK2B;RECK;ESM1;E2F7;SEMA5A;EGR3
prerank,potassium ion transport (GO:0006813),0.47649776023275325,2.0300321174398164,0.0,0.008746376759214415,0.252,20/120,5.25%,KCND2;KCNC2;KCNQ3;HCN1;SLC24A4;SLC24A2;KCNMA1;ATP1A2;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;KCNH4;SLC9A7;KCNH5;KCNN2;KCNA2;SLC9A9
prerank,receptor clustering (GO:0043113),0.6409453593237836,2.0172920758248876,0.0,0.010102065156892652,0.289,6/27,3.18%,NRXN1;MAGI2;NLGN1;DLG2;LRRC7;MUSK
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5697342907273476,-2.0163881171216946,0.0,0.011022661571668561,0.133,30/48,30.81%,JCAD;NOS3;ETS1;RHOJ;THBS1;TMSB4X;KDR;PLCG1;PRKD2;SP1;PIK3C2A;PRKD1;AKT3;AKT1;MAP3K3;FGF2;CD40;ANGPT1;ANXA1;GATA2;HDAC7;MAP2K3;HMGB1;ADAM17;HMOX1;ANGPT4;FGF18;FOXC2;MAPK14;TGFB1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5906152374825042,-2.013012365912434,0.0,0.011245792372714485,0.141,17/42,14.75%,UTRN;TEK;FERMT2;RAC1;LIMS1;GSK3B;CCL25;KDR;PTPRJ;ABL1;ROCK1;PPM1F;RRAS;RIN2;MYOC;CDK6;MAP4K4
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6312485068873595,-2.0111697683813734,0.0,0.01093787186727111,0.144,13/30,9.39%,TJP1;PECAM1;CLDN5;ITGB1;JAM2;ESAM;F11R;LSR;SLC12A2;CDH5;TJP2;MFSD2A;OCLN
prerank,positive regulation of synaptic transmission (GO:0050806),0.5110211636780797,2.009185857712214,0.0,0.011075940569120564,0.319,25/72,13.44%,NRXN1;NLGN1;GRIK2;SYT1;MPP2;SLC24A2;GRIN2B;RIMS2;RIMS1;ADCY8;GRIN2A;CACNG8;SLC8A2;CACNG3;GPER1;CACNG2;PRKCZ;ADRA1A;CACNG4;CLSTN2;SLC8A3;DLG4;CCL2;NLGN2;CACNG5
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.5285156301531035,-2.0026972094307256,0.0,0.011749430466503851,0.161,37/66,28.04%,RB1;DCUN1D3;KLF4;PKD2;ANKRD17;KMT2E;DDX3X;EGFR;DLG1;PLCB1;CCND3;PSME2;FAM107A;AKT1;RGCC;RPTOR;CDC73;UBE2E2;LSM11;CDK6;ANXA1;LSM10;CDK2AP2;PSME1;CCND1;PTEN;CDKN2C;FHL1;E2F7;TFDP1;INO80;ADAM17;APC;FGF10;KIF14;CDKN2B;RDX
prerank,axon development (GO:0061564),0.5187822394601072,1.9986622462914372,0.0,0.012973792192834718,0.372,30/78,10.41%,CTNNA2;L1CAM;DCC;ANK3;CNTN4;DSCAML1;SHTN1;CDK5;NTNG2;NTNG1;PLPPR4;PLP1;NRCAM;ATL1;PAX2;PAK3;MAP1S;FGFR2;SLITRK1;MAPT;POU4F1;RTN4;NEFH;S100A6;GRM7;SPTBN4;SLITRK4;MAP1B;CCK;RAB3A
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5974657842874156,-1.9937744308560983,0.0,0.012891889145885082,0.186,15/38,15.15%,SP100;NOS3;GSK3B;THBS1;BMP5;DDX3X;TNFSF10;ICAM1;FAS;ARHGEF2;CASP8;CFLAR;GPX1;TNFAIP3;FEM1B
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.5018329282931814,-1.9936185862110656,0.0,0.012331372226498775,0.186,34/100,14.48%,FLT1;TEK;DAB2IP;IGF1R;GAB1;ROR1;INSR;LYN;PDGFD;KDR;EGFR;PIP4K2A;CBL;PIK3R1;TGFB2;NEDD4;PTK2;PIP4K2B;STAMBP;PIP5K1B;MAPK1;HAX1;IER3;WNT16;PIK3CD;JAK2;MAZ;FGF2;CEACAM1;PTPN13;MYOC;HGF;PIK3CB;PIK3IP1
prerank,negative regulation of DNA binding (GO:0043392),-0.6411704627411132,-1.9824940976231058,0.0,0.0145732304433118,0.22,13/28,17.95%,LEF1;SP100;SMO;NFKBIA;JUN;SIN3A;JAK2;ILRUN;MAD2L2;SUMO1;TFAP4;HEY1;HEY2
prerank,synapse assembly (GO:0007416),0.5157547351039616,1.9816424238376367,0.0,0.016071467295056492,0.443,19/67,9.50%,KIRREL3;NRXN1;GRID2;NLGN1;LRRTM3;GABRB3;DSCAM;ADGRL3;DNER;PCDHB5;CDK5;GABRB2;GABRA2;NRCAM;GPM6A;SDK1;SLITRK1;POU4F1;GABRA1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.6623033281379773,-1.9799932173267378,0.0,0.01449903945196403,0.226,10/23,12.29%,ENG;SMURF2;ITGA3;TGFBR3;NREP;SMAD2;SMAD4;LATS2;SMAD7;LTBP4
prerank,regulation of cellular component biogenesis (GO:0044087),-0.6006346572916271,-1.979927426605165,0.0,0.013941384088426951,0.226,22/39,23.60%,TJP1;DAB2IP;RAPGEF2;SNCAIP;TIE1;MSN;IRGM;RAP1A;EZR;RAP1B;ROCK1;SPTY2D1;HJURP;RAPGEF1;NOTCH1;HCFC1;ROCK2;NCLN;CCL19;PTPN11;HSP90AA1;GFAP
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.7624567422149853,-1.979693184316726,0.0,0.013425036529596323,0.226,7/14,11.79%,NOS3;ACE;ECE1;ENPEP;EDN1;EDN3;AGTR1
prerank,neuronal action potential (GO:0019228),0.6527524600084735,1.9786144674650383,0.0,0.01619587696447635,0.458,8/22,9.96%,ANK3;SCN8A;SCN1A;SCN3A;KCNA2;SCN2A;SCN5A;GPER1
prerank,regulation of NMDA receptor activity (GO:2000310),0.590223392335121,1.9697081208020744,0.0,0.017908206414491517,0.492,11/32,8.83%,GRIA3;NLGN1;DLG2;LRRC7;GRIN2B;GRIA4;OPRM1;GRIN2A;GRIA1;CAMK2B;GRIA2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.6337085189016337,-1.9672763955384178,0.0,0.016624838469357254,0.285,10/29,11.47%,GHR;PKD2;IL15;IFNAR1;NMI;STAT6;STAMBP;SOCS2;STAT2;JAK2
prerank,synaptic vesicle exocytosis (GO:0016079),0.5693479825281441,1.9633087132604583,0.0,0.018515515316885358,0.515,10/40,6.17%,SYT1;PCLO;SYT5;RIMS2;SNAP25;SNPH;RIMS1;CDK5;STX2;PRRT2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.6164399206330651,-1.962647340515384,0.001841620626151013,0.0172357002559645,0.302,17/32,21.75%,JCAD;KLF4;RHOJ;THBS1;KDR;MEOX2;PIK3C2A;AKT3;STARD13;MAP3K3;NOTCH1;RHOA;FGF2;ANXA1;GATA2;DLL4;HDAC7
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.7024765435520665,-1.942113264771213,0.0,0.022723640778516727,0.38,11/19,14.75%,TEK;FERMT2;RAC1;LIMS1;KDR;PTPRJ;ABL1;ROCK1;PPM1F;MYOC;MAP4K4
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7065575946252602,1.941129821810642,0.002352941176470588,0.02418919822470237,0.617,6/15,8.89%,GRM5;GRM8;GRM1;HOMER1;TRPM1;GRM7
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6407162953064015,-1.9399844710993626,0.0018832391713747645,0.022688083805704893,0.389,11/24,13.13%,SEC31A;SEC24B;ACE;SEC24A;ABCB9;SEC24D;TAP2;SEC13;BCAP31;HFE;PDIA3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.5989140666247645,-1.9347156299043864,0.0,0.024006085057528163,0.412,11/30,12.29%,ENG;XIAP;SMURF2;ITGA3;TGFBR3;NREP;SMAD2;SMAD4;LATS2;SMAD7;LTBP4
prerank,blood vessel morphogenesis (GO:0048514),-0.5372807724752344,-1.9178983256120765,0.0,0.02994618196219046,0.485,20/54,12.04%,FLT1;ENG;CAV1;LRP5;ID1;TBX1;KDR;SOX17;TGFBR3;TGFBR2;HES1;RASIP1;COL4A1;FLT4;RAMP2;LAMA1;CUL7;SMAD7;ADM;RASA1
prerank,synapse organization (GO:0050808),0.4501767994614784,1.9160036330006047,0.0,0.032699522202062986,0.732,38/125,11.77%,KIRREL3;PTPRD;NRXN1;GRM5;LRRC4C;NLGN1;L1CAM;LRFN5;ANK3;ARHGAP39;CTNND2;PPFIA2;WNT7B;DSCAM;ADGRL3;DNER;PCDHB5;CDK5;MUSK;NTNG1;NRCAM;CACNB3;SNCG;PAK3;SLC8A2;GPM6A;SDK1;CACNB4;SLITRK1;CNTN2;MAPT;POU4F1;PTPRS;LRFN4;LRRC4B;CBLN1;CDH2;SLC8A3
prerank,endothelial cell proliferation (GO:0001935),-0.7146282536890287,-1.9151291383107718,0.0,0.030000592467686153,0.498,8/17,7.34%,TEK;ACVRL1;BMPER;CD34;BMPR2;DLG1;BMP4;ERN1
prerank,sodium ion export across plasma membrane (GO:0036376),0.7230779001562359,1.9143239533487122,0.004640371229698376,0.0324516302404382,0.742,5/13,8.71%,ATP1A2;ATP12A;SLC4A4;ATP1B1;ATP4A
prerank,synaptic membrane adhesion (GO:0099560),0.7167009542320059,1.912762788387005,0.0021551724137931034,0.032180419061938186,0.75,8/14,10.45%,PTPRD;LRRC4C;LRFN5;NTNG1;SLITRK1;PTPRS;LRFN4;LRRC4B
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.5647543667061182,-1.9126689356110134,0.0,0.030051893801439234,0.509,21/39,24.42%,TEK;THBS1;KDR;ICAM1;PLCG1;GAS6;PDCD4;CDH5;RAMP2;RGCC;ANO6;ITGA4;ECSCR;CD40;TNFAIP3;ANGPT1;GATA2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,protein localization to synapse (GO:0035418),0.7481375696840931,1.9110153935668865,0.0023752969121140144,0.031906053552884256,0.752,6/12,13.34%,NRXN1;NLGN1;PCLO;SHANK1;DLG4;NLGN2
prerank,tight junction assembly (GO:0120192),-0.5366487582369905,-1.9107056721286804,0.0,0.03002968697409704,0.517,14/49,9.78%,PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;LSR;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2
prerank,central nervous system neuron differentiation (GO:0021953),0.5855615300385203,1.9104517983953104,0.0,0.031309664912377015,0.755,14/33,10.91%,GRID2;MDGA2;SPOCK1;CHD5;LHX1;TOX;MDGA1;MAP2;PROX1;NPY;NTRK2;MAPT;FAIM2;CBLN1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.7020311856191437,-1.9021370034739078,0.0018083182640144665,0.03213083535061281,0.558,9/15,12.22%,SORBS1;ITGB1;FAM171A1;ITGB5;CUL3;PDLIM1;TNFAIP1;PHACTR1;RHOA
prerank,stress fiber assembly (GO:0043149),-0.7020311856191437,-1.9021370034739078,0.0018083182640144665,0.03213083535061281,0.558,9/15,12.22%,SORBS1;ITGB1;FAM171A1;ITGB5;CUL3;PDLIM1;TNFAIP1;PHACTR1;RHOA
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.7036894530241237,-1.9008332975926427,0.0,0.031861361998580424,0.565,9/15,15.65%,THBS1;TMSB4X;PRKD2;FGF1;PRKD1;NOTCH1;FGF2;SMOC2;LGMN
prerank,apical junction assembly (GO:0043297),-0.5216730351841004,-1.8948157693304104,0.0017699115044247787,0.03418084958522222,0.602,17/53,14.01%,CTNNA1;PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2;RHOA;RHOC;PKN2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.45474275747422943,-1.8942324566228108,0.0,0.033843500304006756,0.604,48/122,21.66%,SORBS1;INSR;KLF4;THBS1;STN1;EIF3E;METTL14;DDX3X;KDR;MTOR;PRKD2;NIBAN1;EGFR;PLD1;EIF3C;NFKB1;IRS1;TGFB2;UPF3B;SAMD4A;ABCB10;LDB1;NAMPT;RPL26;AKT1;ZCCHC4;RGCC;EEF2;JAK2;FGF2;DNA2;CTC1;LARP4B;HGF;RPS4X;SMOC2;RPL5;METTL5;IGF1;NLRC5;CCL19;NOD2;SOX4;PRKDC;FGFR4;IGF2;RBM3;PDGFRB
prerank,secondary palate development (GO:0062009),-0.7358947608986144,-1.8911579607299032,0.0,0.03412785601997382,0.614,7/14,13.26%,LEF1;TGFBR3;TGFBR2;TGFB2;SMAD2;SMAD4;WNT11
prerank,synaptic vesicle cycle (GO:0099504),0.5721391064155201,1.889385035550641,0.0,0.03932417024504692,0.839,8/30,10.73%,NLGN1;PCLO;SNAP25;RIMS1;CDK5;SYNDIG1;RAB3A;SLC17A6
prerank,sensory perception of chemical stimulus (GO:0007606),0.6931734114761612,1.8885920468955835,0.002277904328018223,0.03873635707013615,0.842,6/15,16.21%,SLC24A4;GNAL;BBS4;UBR3;ADCY3;MKKS
prerank,regulation of gastrulation (GO:0010470),0.7070120749206096,1.8863259004326873,0.0021321961620469083,0.03878471444164143,0.847,5/14,6.40%,TENM4;LHX1;OSR1;PHLDB1;PHLDB2
prerank,endothelial cell development (GO:0001885),-0.6099003869474615,-1.8852696416786985,0.0,0.03620323192412072,0.643,11/25,11.76%,RAPGEF2;PECAM1;ICAM1;MSN;PDE2A;ROBO4;RAP1A;EZR;RAP1B;RAPGEF1;COL15A1
prerank,bicellular tight junction assembly (GO:0070830),-0.534360928014626,-1.8824729282777608,0.0,0.03688352141289095,0.661,13/46,9.78%,PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2
prerank,sensory perception of smell (GO:0007608),0.7551183115235091,1.877485565393332,0.0,0.04159862117187344,0.87,5/11,16.21%,SLC24A4;BBS4;UBR3;ADCY3;MKKS
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.4693971965356169,-1.8745757658543423,0.0,0.040020740475596624,0.697,52/91,31.94%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;SRPRA;RPL26;RPS11;SRP9;RPL13;RPL38;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;SRP14;SIL1;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;RPS2;RPL39;RPS26;RPS15A;SEC61A1;RPL15;RPL34;RPLP2;RPL18;RPL19;RPS13;RPL8;SEC63
prerank,regulation of angiogenesis (GO:0045765),-0.42574958503898874,-1.8737319604184466,0.0,0.0395101589947685,0.702,66/192,20.79%,FLT1;TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;SP100;ITGB1;GAB1;COL4A2;NOS3;TIE1;ADGRA2;KLF4;BMPER;ETS1;CD34;RHOJ;THBS1;KDR;ANXA3;PLCG1;PRKD2;SP1;TGFB2;FGF1;ISM1;CDH5;PLXND1;ROCK1;HSPG2;PRKD1;CEMIP2;RRAS;PIK3CD;RAMP2;VEGFC;PIK3R6;RGCC;STAB1;NAXE;FGF2;MTDH;CEACAM1;ECSCR;CD40;MECP2;AGO2;TNFAIP3;FOXC1;ROCK2;SMOC2;FOXO4;NPR1;HIPK1;GTF2I;CTSH;CTNNB1;SASH1;SEMA3E;GATA2;EPHA2;PPARG;F3;BRCA1;NF1
prerank,positive regulation of cell communication (GO:0010647),0.5827215801218029,1.8727988870995855,0.0,0.04318523524862118,0.886,9/28,12.36%,GRIK2;SYT1;ANK3;RIMS2;RIMS1;CARTPT;HOMER1;CLSTN2;DLG4
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5268311263551733,-1.8724349156388882,0.0,0.0393730914569012,0.707,24/54,16.67%,TEK;ACVRL1;FERMT2;RAC1;LIMS1;CORO1C;THBS1;KDR;PTPRJ;ABL1;MACF1;PTK2;ROCK1;PPM1F;LDB1;FAM107A;BCAS3;RHOA;LIMCH1;DUSP3;MYOC;MAP4K4;ROCK2;SLK
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6245106535781567,-1.8721228620322077,0.0017793594306049821,0.03879128976183359,0.71,13/24,14.75%,TEK;FERMT2;RAC1;LIMS1;KDR;PTPRJ;PIK3R1;ABL1;ROCK1;PPM1F;DUSP3;MYOC;MAP4K4
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.5784982126475771,-1.8705339515942772,0.0019455252918287938,0.03888213587368801,0.716,23/33,29.65%,ANKRD17;KMT2E;DDX3X;EGFR;PLCB1;CCND3;STXBP4;PLCG2;AKT1;RGCC;RPTOR;CDC73;UBE2E2;LSM11;ANXA1;LSM10;CCND1;TFDP1;CRNN;ADAM17;FGF10;RDX;CCND2
prerank,epithelial to mesenchymal transition (GO:0001837),-0.5408909389497611,-1.8686427830728256,0.0,0.038714979027875886,0.722,22/47,20.86%,LEF1;ENG;LIMS1;GSK3B;LOXL3;TGFBR3;TGFB2;ROCK1;HNRNPAB;TASOR;CUL7;NOTCH4;NOTCH1;FOXF2;HGF;ROCK2;BMP7;CTNNB1;HEY1;HEY2;AKNA;TRIM28
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.7439770347010666,-1.866864632157957,0.0018214936247723133,0.0387538825393053,0.727,4/12,7.28%,IGF1R;INSR;IRGM;BNIP3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.6353115745592055,-1.8622077546932048,0.0017667844522968198,0.04052784813074291,0.748,8/21,17.13%,DAB2IP;CD2AP;CGNL1;SLIT2;TGFB2;STAMBP;SPRY4;ARHGAP12
prerank,calcium ion import into cytosol (GO:1902656),0.6844167439349992,1.8619641584459878,0.00228310502283105,0.047520285357476,0.909,7/15,11.92%,SLC24A2;MS4A1;ATP2B4;CACNA2D1;SLC8A2;SLC8A3;SLC8A1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.4956299540043874,-1.8607895608724285,0.0,0.04041109307697356,0.753,23/72,14.15%,FLT1;TEK;IGF1R;GAB1;ROR1;INSR;LYN;PDGFD;KDR;CBL;PIK3R1;TGFB2;NEDD4;PTK2;HAX1;WNT16;PIK3CD;JAK2;MAZ;FGF2;MYOC;HGF;PIK3CB
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5895996744860088,-1.8602986520532943,0.0,0.03989826645813364,0.754,15/30,23.21%,NOS3;GSK3B;BMP5;DDX3X;TNFSF10;ICAM1;FAS;ARHGEF2;CASP8;CFLAR;GPX1;TNFAIP3;BRCA1;SERPINE1;RIPK1
prerank,sodium ion transmembrane transport (GO:0035725),0.47012809392654853,1.8602489029511249,0.0,0.047245343096506506,0.912,22/84,9.20%,ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;SCN8A;SCN1B;SCN1A;ATP12A;SLC6A15;SLC9A7;SLC4A4;SCN3A;ATP1B1;SLC6A11;SLC9A9;SCN2A;SLC8A2;SCN5A;ATP4A;SLC6A2;SLC6A5
prerank,mesenchymal cell differentiation (GO:0048762),-0.5281170753228205,-1.860104441714123,0.0,0.0393347146854718,0.756,24/51,20.86%,LEF1;ENG;LIMS1;GSK3B;FBXL17;LOXL3;TGFBR3;LRP6;TGFB2;MEF2C;ROCK1;HNRNPAB;CUL7;NOTCH4;NOTCH1;FOXF2;HGF;FOXC1;ROCK2;BMP7;CTNNB1;HEY2;AKNA;TRIM28
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5793377702861231,-1.8556133005095363,0.0,0.04140311547764791,0.776,21/34,25.52%,FLT1;DAB2IP;SEMA6A;GAB1;KDR;PRKD2;ERN1;MAPKAPK2;PRKD1;FLT4;RAMP2;VEGFC;NOTCH1;FOXC1;ANXA1;DLL4;MAP2K3;RELA;EGR3;PIK3CA;MT1G
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7756120801632725,-1.854559742030387,0.0,0.041413076674123174,0.783,6/11,7.60%,TJP1;RAPGEF2;F11R;RAB1A;AFDN;TJP2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5760466081772119,1.8541192219393223,0.002398081534772182,0.049067173619192876,0.927,13/26,13.34%,NRXN1;NLGN1;RIMS2;RIMS1;TMEM108;SHANK1;SLC8A2;MTMR2;PRKCZ;CBLN1;SLC8A3;DLG4;NLGN2
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.6961777761184287,-1.8539468173379583,0.0017513134851138354,0.040962198572699345,0.785,10/14,22.62%,SEC31A;SEC24B;RAB1A;SEC24A;SEC24D;SEC13;SEC23B;TBC1D20;SEC24C;SAR1A
prerank,positive regulation of cell motility (GO:2000147),-0.41547868504157204,-1.851509566493286,0.0,0.04192779026772233,0.794,76/205,22.76%,FLT1;TJP1;LEF1;IGF1R;ITGA6;SEMA6A;PECAM1;SEMA3C;ITGB1;PODXL;FERMT2;INSR;CAV1;DAB2;CBLL1;NTN1;PDGFD;SEMA7A;THBS1;GCNT2;ATM;SPOCK2;SYNE2;KDR;SMO;EGFR;ADAM9;PTK2;FGF1;CDH5;PPM1F;FAM107A;MYLK;BCAR1;PIK3CD;ADAM10;EDN1;MAZ;TWIST2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;ACTN4;NEDD9;WNT11;MYOC;RHOC;HGF;NUMB;MAP4K4;ROCK2;VSIR;CAVIN1;SEMA5B;PIK3R3;IGF1;RIPOR1;CTSH;SEMA4A;SEMA3E;CCL19;WASHC1;CXCL12;F3;FERMT3;LAMB1;SEMA4G;SH3RF2;ROR2;PDGFRB;SPAG9;LAMC2;PTK2B;CCN1;MIEN1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.5647860543901324,-1.8504931990366327,0.0018450184501845018,0.041801324267943085,0.798,17/33,24.42%,TEK;CAST;KDR;ICAM1;PPARA;GAS6;CDH5;YAP1;RAMP2;TNFAIP3;ANGPT1;GATA2;TCF7L2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,regulation of epithelial cell migration (GO:0010632),-0.5205774470425689,-1.8473905893902685,0.0017699115044247787,0.04290915040572617,0.811,16/51,8.99%,PTPRG;DAB2IP;RREB1;DOCK1;BMPER;RHOJ;PRKCE;BMPR2;CORO1C;MCC;PLCG1;TGFB2;MACF1;PTK2;PPM1F;PLCG2
prerank,artery morphogenesis (GO:0048844),-0.5821071612320761,-1.8447740980248413,0.0034662045060658577,0.043796617473037924,0.819,21/30,28.96%,ENG;PKD2;BMPR2;TBX1;HES1;TGFB2;BMP4;TBX2;ADAMTS9;SMAD7;NOTCH1;JAG1;HEY2;NF1;PDGFRB;FOXF1;GJA5;LRP1;STRA6;TGFBR1;LRP2
prerank,hemopoiesis (GO:0030097),-0.46380873814915036,-1.8433180490128254,0.0,0.04396951813753504,0.824,29/87,14.85%,MECOM;FLT1;TEK;KITLG;ETV6;ZBTB16;SNRK;CD34;CDK13;KDR;KAT6A;TGFBR3;TGFBR2;TET2;TGFB2;BMP4;NOTCH2;FLT4;RRAS;TAL1;TP53;FUT10;NOTCH4;PRRC2C;ZFPM1;ASH2L;MKNK2;ATF4;JAG1
prerank,positive regulation of glucose import (GO:0046326),-0.634920035448894,-1.8399352719911606,0.0018281535648994515,0.045150517591642375,0.836,9/21,16.38%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;OCLN;AKT1;CREBL2;IGF1
prerank,neuron projection morphogenesis (GO:0048812),0.427092796727529,1.8377787471273637,0.0,0.05708436875076409,0.949,48/137,13.12%,CNTNAP2;NLGN1;CTNNA2;DCC;ANK3;CNTN4;DSCAML1;CTNND2;DOCK10;EPB41L3;SHTN1;CDK5;EPHB1;NTNG2;NTNG1;PLPPR4;SHANK1;NBL1;NRCAM;TNIK;ATL1;DCDC2;IMPACT;PAX2;PAK3;MAP2;MAP1S;GPM6A;PAK1;FGFR2;SLITRK1;NYAP2;POU4F1;NEFH;S100A6;MINK1;SPTBN4;CPNE1;SLITRK4;MAP1B;CCK;RAB3A;SRGAP2;CELSR2;LLGL1;DLG4;SGK1;BDNF
prerank,BMP signaling pathway (GO:0030509),-0.4988904467515851,-1.832073003377387,0.0,0.04934760795931617,0.867,20/62,11.78%,ENG;ACVRL1;USP9X;BMPR2;BMP5;SMURF1;TGFBR3;BMP6;PDCD4;HIVEP1;TGFB2;BMP4;SMAD1;SMAD2;ACVR2A;SMAD4;RGMB;SMAD7;USP15;HFE
prerank,potassium ion transmembrane transport (GO:0071805),0.42544585925219164,1.827277642342383,0.0,0.06279247187187073,0.967,34/135,15.24%,KCND2;KCNC2;KCNQ3;HCN1;SLC24A4;SLC24A2;ATP1A2;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;ATP12A;KCNH4;SLC9A7;KCNH5;KCNN2;KCNA2;ATP1B1;SLC9A9;SLC12A5;ATP4A;KCNJ6;KCNN3;KCND1;SLC12A4;SLC1A3;KCNS2;KCNC4;KCNK12;KCNK10;KCNA4;KCNK9
prerank,positive regulation of vasculogenesis (GO:2001214),-0.7686640716625908,-1.8263942872242693,0.0019267822736030828,0.052376912852788726,0.885,7/10,12.66%,RAPGEF2;CD34;KDR;RAP1A;RRAS;RIN2;CEACAM1
prerank,sodium ion transport (GO:0006814),0.45774998689997415,1.8236775803865224,0.0,0.06367088956434369,0.974,27/85,15.61%,ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;SCN8A;SLC5A12;SCN1B;SCN1A;CATSPER4;SLC6A15;SLC4A4;SCN3A;ATP1B1;SLC6A11;SCN2A;SLC8A2;SCN5A;SLC6A2;SLC6A5;SLC8A3;SLC8A1;SGK1;SCN2B;ASIC1;SLC4A11;SLC6A4
prerank,neuromuscular process controlling balance (GO:0050885),0.6963240879558664,1.8233336716657034,0.019522776572668113,0.06258568063672561,0.974,4/12,3.86%,NRXN1;PCDH15;SHANK1;CLN3
prerank,regulation of sodium ion transport (GO:0002028),0.5456112568448707,1.8230356506441387,0.004819277108433735,0.06153076050107342,0.975,13/34,9.74%,NKAIN2;ANK3;FGF12;SCN1B;ATP2B4;NKAIN3;PKP2;NKAIN4;GPD1L;WNK2;WNK3;SCN5A;SPTBN4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5286730130429711,-1.8221221674841412,0.0,0.05506901472917996,0.903,16/43,16.77%,FOXP1;THBS1;LDLRAP1;MMP2;IL6R;BMP4;ERN1;JUN;AKT1;EDN1;FGF2;P2RY6;IGFBP5;HTR1B;IGF1;DNMT1
prerank,positive regulation of protein modification process (GO:0031401),-0.4123930130272116,-1.8213289482796915,0.0,0.054726766558883845,0.903,59/203,13.69%,TEK;PECAM1;ENG;TRABD2B;PPP2R5A;DYRK1A;INSR;DAB2;RAC1;FAM20A;LYN;RAB3GAP1;DVL3;APP;ATG7;RALBP1;LIMK2;RAMP1;TBX1;LRRK2;ATG10;DDX3X;ALG10B;KDR;NIBAN1;SLCO3A1;EGFR;ACE;TFRC;GAS6;ABL1;FAS;IL34;CCND3;PTK2;IRGM;PRKCD;FGF1;SPPL3;BMP4;CDH5;NOS1AP;FLT4;ACVR2A;ASPSCR1;FGF7;AKT1;VEGFC;AXIN2;RAB3GAP2;ILK;FGF2;LIMCH1;CSNK1D;KAT5;FLOT1;CHP1;CD40;HGF
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.5731547375643756,-1.8207387515632993,0.0,0.054320708447670986,0.905,10/33,9.23%,PTPRG;DAB2IP;PTPRM;SP100;ACVRL1;CORO1C;THBS1;MCC;SLIT2;ADAMTS9
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.7201767803807575,-1.820655181751019,0.0,0.05354469832698998,0.905,5/12,13.05%,FOXP1;DAB2;HDAC1;ZBTB7A;PIAS2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.5026597492049042,-1.8194119012212235,0.0,0.05350708035954603,0.905,32/54,30.81%,ACVRL1;NOS3;ETS1;THBS1;TMSB4X;KDR;PLCG1;PRKD2;SP1;MEF2C;PRKD1;AKT3;AKT1;RGCC;FGF2;PRCP;CD40;MECP2;ANGPT1;GATA2;EPHA2;PPARG;NF1;MAP2K3;GADD45A;HMGB1;ADAM17;ANGPT4;FGF18;JUP;MAPK14;TGFB1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4903973694399488,-1.8174634638882834,0.0,0.05423008177086936,0.914,21/67,13.67%,UTRN;RREB1;DOCK1;RSU1;FERMT2;RAC1;LIMS2;LIMS1;GSK3B;VIT;CRK;CCL25;ABL1;PPM1F;FBLN2;FLNA;ILK;JAK2;NEDD9;MYOC;CDK6
prerank,regulation of presynapse organization (GO:0099174),0.6428632608990033,1.8167841966028673,0.0022371364653243847,0.0628351480350678,0.979,8/18,10.45%,PTPRD;IL1RAPL1;LRFN5;IL1RAPL2;MDGA1;SLITRK1;LRFN4;LRRC4B
prerank,regulation of presynapse assembly (GO:1905606),0.6428632608990033,1.8167841966028673,0.0022371364653243847,0.0628351480350678,0.979,8/18,10.45%,PTPRD;IL1RAPL1;LRFN5;IL1RAPL2;MDGA1;SLITRK1;LRFN4;LRRC4B
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.4798300283392468,-1.8146216951008867,0.0017094017094017094,0.05573471185632412,0.923,28/72,17.77%,AKAP13;BCR;HEG1;EPS8;RAC1;ARHGEF3;NET1;ARHGEF28;STARD8;ITGA3;RALBP1;F11R;SCAI;EPS8L2;RASIP1;ABL1;CUL3;ARHGDIA;PRAG1;ARHGEF2;RAF1;STARD13;TNFAIP1;MYOC;ARHGEF18;KCTD10;ARHGAP35;ADGRG1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6891727889069618,-1.8144820872226664,0.001876172607879925,0.05511903689242372,0.923,6/15,5.93%,IGF1R;DYRK1A;KDR;EGFR;BMX;ABL1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.5207215399172125,-1.8134282411094906,0.0018867924528301887,0.05514722374010179,0.924,24/47,27.56%,RREB1;ZBTB16;LRP5;SOX13;TRPM4;SIX1;NAPEPLD;PPARD;AKT1;LPL;TMEM64;CREBL2;BMP7;CARM1;CMKLR1;PPARG;AAMDC;CREB1;SYAP1;PIM1;BMP2;ZFP36L1;FRZB;HNRNPU
prerank,receptor signaling pathway via STAT (GO:0097696),-0.6041927572757861,-1.8124178160377782,0.001893939393939394,0.0551244643983951,0.925,9/25,11.47%,GHR;PKD2;IFNAR1;NMI;STAT6;STAMBP;SOCS2;STAT2;JAK2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7329597402623862,-1.810918661127133,0.0035842293906810036,0.05551523308048656,0.929,7/11,9.84%,IGF1R;GHR;GIGYF2;PIK3R1;IRS1;PLCB1;AKT1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.5255280502109351,-1.8108465566080334,0.0,0.054868722172580923,0.929,21/46,23.26%,PIEZO2;F11R;NFKB1;PDE2A;FAS;BNIP3;IRF1;CASP8;CRADD;CD40;MAPK8;TNFRSF1A;MAP2K4;CASP8AP2;MAP3K14;CHEK1;PIEZO1;CASP2;LTBR;GADD45A;CASP1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6433429672847389,-1.8107838316887754,0.0017793594306049821,0.05422247931847085,0.929,10/19,19.29%,TJP1;PRKCH;CLDN5;CBFB;F11R;ROCK1;OCLN;ROCK2;IKBKB;EPHA2
prerank,positive regulation of angiogenesis (GO:0045766),-0.4446847257527723,-1.8100366908985916,0.0,0.05405343655337467,0.93,32/108,14.23%,FLT1;TJP1;TEK;ITGB1;GAB1;NOS3;TIE1;KLF4;BMPER;ETS1;CD34;THBS1;JAK1;KDR;ANXA3;PLCG1;PRKD2;SP1;FGF1;CDH5;SMAD1;PRKD1;RRAS;PIK3CD;RAMP2;VEGFC;PIK3R6;FGF2;MTDH;S100A1;CD40;AGO2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4720860087486696,1.8094079559302538,0.0,0.06710781337989703,0.983,30/75,12.35%,CTNNA2;DCC;ANK3;CNTN4;DSCAML1;SHTN1;CDK5;NTNG2;NTNG1;PLPPR4;NRCAM;ATL1;DCDC2;PAX2;PAK3;MAP2;MAP1S;FGFR2;SLITRK1;POU4F1;NEFH;S100A6;MINK1;SPTBN4;SLITRK4;MAP1B;CCK;RAB3A;CELSR2;LLGL1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5842471828539364,-1.808219508694238,0.0035587188612099642,0.05479927191613003,0.934,10/25,12.19%,ZNF423;ENG;ACVRL1;BMPR2;BMP4;CDH5;SMAD2;ACVR2A;SMAD4;NOTCH1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7501081521919966,-1.806747117777472,0.0018083182640144665,0.055433854301796585,0.937,3/11,1.78%,MECOM;ETV6;CD34
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3734940930028736,-1.8050058224211738,0.0,0.055945881461763554,0.94,159/476,22.69%,MECOM;LEF1;RREB1;SMARCA2;FLI1;ZBTB16;NFIB;SP100;ZNF423;ACVRL1;FOXO1;AFAP1L2;CREBBP;NSD1;DYRK1A;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;LRP5;ESR1;MLLT3;ZFHX3;KLF2;DVL3;RXRA;TRIM56;NFATC1;PRDM16;RNF111;BICRA;TEAD1;KMT2E;ARID1B;TBX1;DTX3L;MITF;MAP3K5;KAT6A;SOX17;EGFR;CD38;NAA16;SP1;FZD4;CRLF3;CTCF;HDAC1;NFKB1;HES1;PPARA;SIX1;SMARCC1;RYBP;TASP1;FOXO3;DNM2;LRP6;PLCB1;NSD3;MED1;BMP4;CREB3L2;MEF2C;JUN;SMAD2;ZFP90;ACTA2;SETD3;MDFIC;HNRNPAB;YAP1;CDH1;PPARD;PHF5A;IRF1;GLI3;PICALM;SMAD4;SP3;FGF7;TAL1;AKT1;GLIS2;NAA15;ELF2;TP53;NOTCH4;ETS2;MED13;KDM3A;RGMB;ILK;SMARCC2;PSEN1;MAZ;ARHGEF11;MED17;YAF2;NOTCH1;FOXF2;FGF2;RPS6KA1;HDAC4;KAT5;WNT11;RHOG;FBXW11;XPC;SMARCD3;ZIC3;ATF4;NR1D2;HCFC1;TCF3;FOXC1;MRPL12;TADA3;JMJD6;TRIM16;MAD2L2;CREBL2;PCBD2;BMP7;IGF1;SIX4;RARA;CTNNB1;GPATCH3;TFAP4;HEY1;HEY2;WBP2;ZIC1;CITED2;RNF10;EDRF1;IKBKB;SOX4;NCOA6;RNF4;TCF4;TBL1X;PPARG;BRCA1;NR2F2;TRIM28;FOXL2;BLM;CAND2;CREB1;MAP2K3;ELF4;NOS1;ATAD2;RELA;MYOCD;KCNH2
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.4607765090395624,-1.80496547589991,0.0,0.05532528211933643,0.94,29/85,16.38%,DAB2IP;AKAP13;BCR;EPS8;LYN;ARHGEF28;STARD8;EPS8L2;SHOC2;TGFB2;STAMBP;ARHGDIA;NGF;PLCE1;DENND3;NOTCH2;ARHGEF2;RAF1;ARHGAP17;STARD13;GABARAP;RAPGEF1;JAK2;NOTCH1;SPRY4;GRB2;DENND4C;ARHGEF18;IGF1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6839475037188574,-1.8046486699461126,0.005504587155963303,0.0549437284495479,0.942,8/14,13.55%,THBS1;PLCG1;PDCD4;RGCC;ANO6;ITGA4;ECSCR;CD40
prerank,mesoderm formation (GO:0001707),-0.6447434211726029,-1.804085735770512,0.0,0.054822459453723646,0.945,8/17,20.64%,ITGB1;BMPR2;ITGA3;ITGB4;SMAD2;KDM6B;ITGA2;ITGB3
prerank,regulation of autophagosome assembly (GO:2000785),-0.5535478838577937,-1.8026017361700728,0.0,0.055230259174753084,0.945,16/33,23.45%,RAB3GAP1;MTMR3;LRRK2;PIP4K2A;PIP4K2B;RAB5A;TBC1D14;SCFD1;CHMP4B;CHMP4A;RAB3GAP2;PHF23;IFT20;TBC1D12;SEC22B;RALB
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6447962410741294,-1.800951826281427,0.0,0.05578777141604979,0.95,8/18,12.19%,ENG;ACVRL1;NOS3;TGFBR2;TGFB2;BMP4;TBX2;NOTCH1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.5839939176155657,-1.799312164569612,0.007326007326007326,0.056332755292373554,0.951,16/27,24.82%,ACVRL1;BMPR2;ATM;PRKD2;PARP4;DACH1;HMBOX1;RGCC;FGF2;HGF;SMOC2;TERF2;FGFR4;PDGFRB;SMG6;PINX1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.48408103502349625,1.798461824246325,0.0,0.07350600801389783,0.99,20/57,15.12%,CHRM2;GNAI2;OPRM1;GRM8;ADCY8;GNAI1;GNAL;CHRM3;GPR37;GNAT3;MTNR1A;HTR4;ADCY7;GRM7;ADRA2A;HTR1D;GABBR1;ADCY3;GRM4;HTR1F
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.7400865893289407,1.797010127957755,0.011286681715575621,0.07315946596502895,0.99,7/10,18.60%,GABRG3;GABRB2;GABRA2;GABRA3;GABRA1;GABRE;GABRA5
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6318366968181841,-1.796708623566376,0.0036968576709796672,0.057317840172676514,0.956,12/19,26.17%,CBFB;ELF1;KLF4;IFIH1;LIFR;IRAK1;IRAK2;MAVS;MAPK7;TAF9;DHX9;PARP9
prerank,receptor internalization (GO:0031623),-0.5181620703920298,-1.7933839877373694,0.0,0.05907792535516865,0.966,18/44,14.62%,ITGB1;CALCRL;CAV1;DNM3;RAMP1;LDLRAP1;TFRC;DNM2;NEDD4;RAB5A;PICALM;RAMP2;ADM;CEACAM1;LMBRD1;ACKR3;SAG;GRB2
prerank,regulation of glucose import (GO:0046324),-0.5640269831845005,-1.790670448018018,0.0018050541516245488,0.06021912266662406,0.971,11/30,16.38%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;GRB10;GSK3A;OCLN;AKT1;CREBL2;IGF1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.573490093384501,-1.7902703196196008,0.0,0.059872471911619055,0.971,14/26,27.14%,DAB2IP;IQGAP1;PLCG1;EGFR;PTPN12;MED1;DUSP3;ZPR1;FOXC1;DUSP22;PTPN11;SYAP1;ZFP36L1;SNAI2
prerank,Ras protein signal transduction (GO:0007265),-0.4277920467312829,-1.787992071451846,0.0,0.060994466078251076,0.971,63/137,20.86%,RREB1;RAPGEF2;GNB1;RB1;EPS8;BRAP;RAC1;ARHGEF3;NTN1;ELMO1;PLEKHG5;PLD1;EPS8L2;ARHGAP5;GNA12;SHOC2;PHACTR4;RAP1A;ARHGDIA;JUN;PLCE1;PLK2;RAP1B;ROCK1;RASGRP2;PRKD1;RRAS;RASSF1;TP53;GRAP;RAPGEF1;ARHGAP1;AGTR1;ARHGEF11;GDI1;RHOA;FGF2;RTKN;TAX1BP3;RHOG;CDC42EP3;KSR1;GRB2;NCKAP1;ROCK2;RERG;IGF1;DNMT1;RIPOR1;DBNL;ARHGAP29;ADGRG1;RAP2A;CFL1;WASF1;RRAS2;RAP2C;KRAS;NRAS;RGL2;CDC42EP1;NF1;TRIM28
prerank,actomyosin structure organization (GO:0031032),-0.46527757880705994,-1.7876981262667875,0.0,0.060673727420407185,0.972,24/75,12.81%,TJP1;FRMD6;PGM5;SORBS1;ITGB1;MYH9;FAM171A1;F11R;ITGB5;TMOD3;CUL3;CDC42BPA;MYO18A;EPB41L2;ROCK1;PDLIM1;CSRP2;EPB41L5;TNFAIP1;PHACTR1;FRMD5;RHOA;LMOD1;TPM1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6306630081948051,1.78733590176208,0.006622516556291391,0.0791976606281902,0.992,8/18,10.73%,GRID2;GRIK5;GRIK2;GRID1;CDH8;GRIK1;GRIA2;SLC17A6
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.6083428058902377,1.787038056575841,0.004694835680751174,0.07804990418551601,0.992,8/18,13.34%,NRXN1;NLGN1;RIMS2;RIMS1;SHANK1;PRKCZ;DLG4;NLGN2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.6204740958689425,-1.7859008134167669,0.0035650623885918,0.06137979694896688,0.975,15/20,30.39%,ENG;ACVRL1;TGFBR3;PDCD4;TGFB2;BMP4;NOTCH1;HEY1;HEY2;TBX3;HAS2;BMP2;SNAI2;TGFBR1;SPRY1
prerank,protein targeting to ER (GO:0045047),-0.4385174480953539,-1.7857180522294507,0.0,0.06086502182674717,0.976,54/99,31.12%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;SRPRA;RPL26;CHMP4B;CHMP4A;RPS11;SRP9;RPL13;RPL38;SGTA;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;SRP14;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;ZFAND2A;RPS2;RPL39;RPS26;RPS15A;SEC61A1;RPL15;RPL34;RPLP2;RPL18;RPL19;RPS13;RPL8
prerank,regulation of Notch signaling pathway (GO:0008593),-0.4632272452539879,-1.7826503620153933,0.0,0.06255403701975173,0.98,32/76,21.16%,CREBBP;NOS3;ZMIZ1;MAML2;KAT2B;EGFR;IL6ST;NOTCH3;JAG2;ZBTB7A;TGFB2;PRAG1;AAK1;MAML1;TSPAN14;ARRDC1;YAP1;AKT1;NOTCH4;MFNG;GALNT11;TSPAN5;NOTCH1;TCIM;JAG1;CCN3;HEY1;NOD2;GATA2;RITA1;WWP2;DLL4
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.48015881324361925,1.781081634259482,0.0021929824561403508,0.08118296428143243,0.993,20/59,8.83%,KIRREL3;ROBO2;L1CAM;CNTN6;CNTN4;DSCAML1;DSCAM;ROBO1;IGSF11;TENM3;PTPRT;IGSF21;CEACAM5;NECTIN3;MYPN;SDK1;VSTM2L;EMB;CNTN2;CDH17
prerank,inorganic cation transmembrane transport (GO:0098662),0.3780004684509959,1.7807790985542187,0.0,0.0801182935511429,0.993,65/268,15.69%,TRPM3;KCND2;KCNC2;KCNQ3;ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;KCNA6;KCNH8;KCNQ5;SCN8A;KCNH7;SCN1B;RYR3;KCNA5;SCN1A;ATP12A;ATP2B4;SLC6A15;KCNH4;SLC9A7;KCNH5;SLC4A4;KCNN2;SCN3A;CACNA1A;KCNA2;ATP1B1;SLC46A1;SLC6A11;SLC9A9;SCN2A;CACNA1D;SLC8A2;UCP3;TMCO1;SLC36A2;TRPM1;ATP6V0C;SCN5A;ATP4A;SLC6A2;SLC6A5;SLC39A2;KCNN3;P2RX3;SLC8A3;SLC8A1;KCND1;SLC1A3;CACNA2D4;SLC39A7;KCNS2;KCNC4;KCNK12;SCN2B;ASIC1;KCNK10;KCNA4;KCNK9;SLC4A11;SLC6A4;ATP6V0D1
prerank,membrane depolarization (GO:0051899),0.546555598139247,1.7800108117251408,0.0,0.07927497235132967,0.994,13/32,11.00%,SCN8A;SCN1B;CACNA1B;SCN1A;SCN3A;CACNA1A;SCN2A;CACNB3;CACNB4;CACNA1E;SCN5A;CACNG2;CACNG4
prerank,regulation of vasculogenesis (GO:2001212),-0.6770907111496917,-1.7791024811107647,0.00186219739292365,0.06458149151605812,0.981,9/14,17.95%,RAPGEF2;CD34;KDR;RAP1A;RRAS;RIN2;CEACAM1;HEY1;HEY2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7684587590743109,-1.7780364645423974,0.0016806722689075631,0.06480053158575153,0.981,5/10,11.47%,GHR;LYN;PTPN1;STAT6;JAK2
prerank,cytoplasmic translation (GO:0002181),-0.44535521637867326,-1.7753295753022569,0.0,0.06616115449072349,0.982,51/91,31.12%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;RPL26;RPS11;RPL13;RPL38;DRG1;RPL27;RWDD1;RPS16;RPS4X;GSPT1;RPL10;RPL7A;RPL5;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;EIF3I;RPS2;RPL39;RPS26;RPS15A;RPL15;RPL34;RPL22L1;RPL18;RPL19;RPS13;EIF4A2;RPL8
prerank,negative regulation of angiogenesis (GO:0016525),-0.4548757828657878,-1.7746874104021682,0.0,0.06598634053989821,0.983,27/84,17.12%,TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;COL4A2;KLF4;KLF2;THBS1;SLC12A2;TGFB2;ISM1;ROCK1;HSPG2;ADAMTS9;RGCC;STAB1;NAXE;ECSCR;MECP2;PIK3CB;FOXC1;ROCK2;FOXO4;NPR1;GTF2I;CTNNB1
prerank,positive regulation of cell migration (GO:0030335),-0.3878859166294041,-1.772791492426475,0.0,0.06691389438783263,0.987,89/253,22.06%,FLT1;TJP1;LEF1;DAB2IP;IGF1R;RREB1;ITGA6;RAPGEF2;SEMA6A;PECAM1;SEMA3C;DOCK1;ITGB1;GAB1;PODXL;FERMT2;INSR;CAV1;DAB2;PRKCE;BMPR2;CBLL1;SMURF2;PDGFD;SEMA7A;THBS1;GCNT2;ATM;SYNE2;KDR;MTOR;PLCG1;SMO;EGFR;ADAM9;NIPBL;TGFB2;PTK2;FGF1;CDH5;PPM1F;ARHGEF2;PLCG2;FAM107A;MYLK;BCAR1;PIK3CD;ADAM10;EDN1;MAZ;TWIST2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;ACTN4;NEDD9;WNT11;MYOC;RHOC;HGF;AGO2;NUMB;MAP4K4;ROCK2;VSIR;SEMA5B;PIK3R3;IGF1;RAB11A;RIPOR1;CTSH;HDAC6;SEMA4A;SEMA3E;WASHC1;PTPRC;CXCL12;F3;FERMT3;LAMB1;SEMA4G;SH3RF2;ROR2;PDGFRB;SPAG9;LAMC2;SYDE1;PTK2B
prerank,lipid modification (GO:0030258),0.5168720039293082,1.769898460395661,0.0021645021645021645,0.08550300198259896,0.996,15/37,16.66%,DGKK;DGKI;DGKQ;PLPPR4;PLPPR1;PLPP2;PLA2G7;SGPP1;PLPP4;PLPPR5;ALOX12;MBOAT7;ALOX5;CYP1A1;MBOAT2
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.6451159326220554,-1.7672221464758395,0.010657193605683837,0.07078309745948702,0.989,10/17,21.48%,CLDN5;F11R;CDH5;ROCK1;PPP1R12A;ROCK2;TNFRSF1A;IKBKB;VCL;S1PR3
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.5151739365286078,-1.766154761460278,0.0,0.07085996724644075,0.989,23/44,27.32%,TNRC6B;ZC3HAV1;METTL14;GIGYF2;FTO;PUM1;ROCK1;POLR2G;CELF1;AGO2;RC3H1;BTG2;ROCK2;MOV10;TNRC6A;TOB1;METTL16;RBM24;CNOT8;ZFP36L1;NANOS1;CNOT1;PABPC1
prerank,endocardial cushion development (GO:0003197),-0.6090183284362448,-1.7655782899787191,0.0017857142857142857,0.07059942745395262,0.99,8/21,12.19%,ENG;ACVRL1;NOS3;BMPR2;TGFB2;BMP4;TBX2;NOTCH1
prerank,blood vessel diameter maintenance (GO:0097746),-0.5461331530412441,-1.7635803634387366,0.0017513134851138354,0.07173446720167478,0.991,17/34,26.88%,NOS3;EDNRA;KLF2;ACE;ECE1;ROCK1;SCPEP1;EDN1;EDN3;AGTR1;ROCK2;NPR1;KCNMB2;GCLC;NOS1;ACE2;ADCY6
prerank,dendrite self-avoidance (GO:0070593),0.6392731299208602,1.762529474635527,0.0064516129032258064,0.09062022210807033,0.998,8/16,8.42%,CNTN6;CNTN4;DSCAML1;DSCAM;MYPN;VSTM2L;EMB;CNTN2
prerank,endothelial tube morphogenesis (GO:0061154),-0.7381106838226337,-1.7615844551905635,0.0019083969465648854,0.07255407899898506,0.992,6/10,17.12%,ACVRL1;PRKD2;BMP4;STARD13;RHOA;CTNNB1
prerank,regulation of tube diameter (GO:0035296),-0.7007349137159495,-1.7600052566387618,0.007079646017699115,0.07270331744334117,0.993,10/13,26.88%,NOS3;ACE;ROCK1;SCPEP1;AGTR1;ROCK2;NPR1;GCLC;ACE2;ADCY6
prerank,vascular process in circulatory system (GO:0003018),-0.7007349137159495,-1.7600052566387618,0.007079646017699115,0.07270331744334117,0.993,10/13,26.88%,NOS3;ACE;ROCK1;SCPEP1;AGTR1;ROCK2;NPR1;GCLC;ACE2;ADCY6
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7183472753090184,-1.7565531937823247,0.007168458781362007,0.07533679816395093,0.994,6/11,13.82%,RSPO3;DAB2;MLLT3;NKD1;CSNK1D;PLEKHA4
prerank,nervous system development (GO:0007399),0.35617715932415017,1.7545361378321693,0.0,0.09636632965063027,0.999,102/429,13.66%,LSAMP;KIRREL3;RBFOX1;NRXN1;ROBO2;NLGN1;NRG1;L1CAM;NAV3;ASIC2;ERBB4;MYT1L;CHRM2;CNTN6;IL1RAPL2;CNTN4;DSCAML1;ADAM23;TENM1;ADAM22;SCN8A;FGF12;SH3GL2;DSCAM;ADGRL3;APC2;MOBP;CYP46A1;ROBO1;NPAS1;SPOCK1;GPM6B;DNER;PCDHB5;KALRN;CDK5;ZEB2;LHX1;VLDLR;EPHB1;APBA2;TYRO3;SRRM4;NBL1;NRCAM;GFRA1;NELL1;DCHS1;PCDHA4;CHRM3;LIMK1;SCN2A;ATXN10;DPYSL5;EFNB3;NFASC;PTPRZ1;CYP51A1;MAP1S;PROX1;HPCAL4;TMOD2;PCDHA5;GSN;GPM6A;GRIK1;SCRG1;SDK1;MSI1;SLITRK1;AHI1;LRCH4;NCAN;ACVR1B;POU4F1;FGF5;KLK6;NRSN1;VEGFA;DCX;DPF1;POU3F3;SDHA;HAPLN2;RBFOX3;MOG;CBLN1;MBP;ALDH1A2;NMUR2;ARNT2;CDH2;DLG4;ESS2;FZD9;GDF11;FKTN;BDNF;RPS6KA6;NLGN2;SCD5;CAPG
prerank,regulation of interleukin-8 production (GO:0032677),-0.4674651464914101,-1.7528177166362087,0.0,0.07751444493977638,0.994,39/69,37.60%,AFAP1L2;KLF4;NOD1;TMSB4X;RAB1A;PRKD2;LBP;ANXA4;ANXA1;MAVS;HYAL2;NOD2;PTPRC;F3;RELA;SERPINE1;RIPK1;ARRB1;HSPA1B;HMGB1;F2R;LGALS9;CACTIN;DDIT3;STAT3;TLR6;TLR1;C5AR2;NOS2;TLR5;CD14;PARK7;CD74;TLR2;CD33;TLR8;MAPKBP1;SYK;CRP
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6767143620981289,-1.7527052910494543,0.00718132854578097,0.0769410291054387,0.994,6/14,12.22%,KLF4;THBS1;MEOX2;STARD13;NOTCH1;RHOA
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.41338629844663105,-1.7502528012585299,0.0,0.07856435504826924,0.997,57/132,27.44%,ZBTB20;FOXO1;INSR;DAPK1;SH3BP4;GSK3B;PTPN1;APP;ZC3HAV1;DTX3L;LRRK2;MSN;VGLL4;ADAM9;PPARA;TNFRSF1B;IRS1;FOXO3;IRGM;PRKCD;BNIP3;EZR;PIK3C2A;SNX9;PLK2;ROCK1;PRKD1;GSK3A;PRKAA1;PFKFB3;PSEN1;TRIM14;MTDH;KAT5;PIK3CB;RC3H1;IGF1;MOV10;ARNT;RNF152;DAGLB;ORMDL3;AMER1;HSP90AA1;ATF6;PFKFB4;TRIM68;HMGB1;PNPLA2;PLEKHF1;CNOT8;TPCN1;DXO;VPS35;CNOT1;TRIM6;PFKFB2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.6598958732321273,-1.748906062400029,0.0018552875695732839,0.07925256804940828,0.998,8/15,12.53%,TJP1;KLF4;BMPER;JAK1;FGF1;SMAD1;FGF2;S100A1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.59435862063993,1.7487484992392361,0.0063025210084033615,0.09978044267689729,1.0,10/21,18.82%,GCK;PGLS;H6PD;TKT;RPIA;HK1;PGD;PGM2;PGM2L1;HK3
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.44336087786775313,-1.74836058409002,0.0017793594306049821,0.07916142229520591,0.998,51/87,32.77%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;RPL26;RPS11;SRP9;RPL13;RPL38;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;SRP14;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;RPS2;RPL39;RPS26;RPS15A;SEC61A1;RPL15;RPL34;RPLP2;RPL18;RPL19;RPS13;RPL8;SEC63;RPL41
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4612966690248412,-1.746019496410525,0.0,0.08052847822773244,0.999,29/74,23.21%,ITGA6;NOS3;EYA4;MCL1;GSK3B;THBS1;BMP5;DDX3X;TNFSF10;ICAM1;FAS;BMP4;BIRC6;ARHGEF2;SH3RF1;CASP8;CFLAR;AKT1;GPX1;TNFAIP3;IGF1;ZMYND11;TCF7L2;BRCA1;TERT;MAPK7;RELA;SERPINE1;RIPK1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.539270311628527,-1.745679104817874,0.0018552875695732839,0.08004004383755939,0.999,11/35,11.85%,TJP1;TEK;ESAM;BAIAP2L1;F11R;ABL1;ARHGDIA;NOTCH2;HAX1;BCAS3;ABI3
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5358170378488911,-1.743498032800424,0.003738317757009346,0.08147293066660903,0.999,17/34,22.06%,FLT1;TEK;DAB2IP;PIK3R1;IRS1;AMBRA1;PTK2;PRKD1;FGF2;PIK3IP1;TNFAIP8L3;PIK3R3;CCL19;WASHC1;NOD2;PDGFRB;PTK2B
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.548471053544031,-1.7408945811490564,0.003629764065335753,0.08319989743999827,0.999,12/34,13.32%,RREB1;DOCK1;FERMT2;RAC1;LIMS2;LIMS1;CRK;ABL1;FLNA;ILK;NEDD9;MYOC
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.47896908005247224,-1.738640141951374,0.0,0.08448838561322812,1.0,26/59,23.73%,LEF1;CBFB;TNRC6B;MED15;MED26;MITF;NFKB1;MED1;JUN;TP53;MED13;MED17;MECP2;CCNC;MOV10;CTNNB1;PPM1D;TNRC6A;CCND1;MED10;TCF7L2;PTEN;TRIM28;MED27;RELA;MED20
prerank,myeloid cell development (GO:0061515),-0.6292043360457333,-1.7384648057151257,0.0036900369003690036,0.08393138238982054,1.0,6/18,8.14%,FOXP1;ALAS1;ANXA2;APP;MED1;ABCB10
prerank,calcium ion import across plasma membrane (GO:0098703),0.6484267928441642,1.7358716899920699,0.011494252873563218,0.11139520000177931,1.0,6/14,11.92%,SLC24A2;ATP2B4;CACNA2D1;SLC8A2;SLC8A3;SLC8A1
prerank,receptor metabolic process (GO:0043112),-0.4861192533253168,-1.7353245364189278,0.0,0.08582372518278523,1.0,31/53,30.85%,ITGB1;CALCRL;CAV1;DNM3;RAMP1;LDLRAP1;SMURF1;TFRC;DNM2;NEDD4;PICALM;RAMP2;ADM;ACKR3;REP15;GRB2;LGMN;AP2M1;SNX25;KIF16B;ARFGEF2;BECN1;GRK3;LRP1;FCER1G;GRK4;PHETA2;CD9;RAB31;TGFB1;LILRB1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4785430735974626,-1.7335849071692637,0.0017730496453900709,0.08672140532424724,1.0,15/56,11.78%,RBPMS;ENG;ACVRL1;BMPER;DAB2;BMPR2;BMP5;BMP6;LDLRAD4;TGFB2;BMP4;ACVR2A;SMAD4;SMAD7;HFE
prerank,embryonic limb morphogenesis (GO:0030326),-0.5341367819959258,-1.733329792019094,0.0036496350364963502,0.08629217795937329,1.0,11/34,9.09%,MBNL1;MAP3K20;CREBBP;NIPBL;HDAC1;RARG;LRP6;TGFB2;ECE1;TBX2;GLI3
prerank,clathrin-dependent endocytosis (GO:0072583),-0.5684383053492722,-1.7332535269348681,0.0,0.08570825952842287,1.0,12/26,13.60%,FCHO2;FNBP1L;AP2B1;AP2A2;AP2S1;ITSN1;GPR107;PICALM;GAK;FCHSD2;ITSN2;LMBRD1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.5952715353719662,-1.7331688338176356,0.0035778175313059034,0.0851235221312987,1.0,9/23,11.10%,LYN;THBS1;BMP5;MSN;IL34;SLIT2;PTK2;MAPK1;STK10
prerank,regulation of monooxygenase activity (GO:0032768),-0.5821509754750137,-1.7325559746389334,0.010771992818671455,0.0851341625715651,1.0,9/23,9.84%,NOS3;CAV1;NOSTRIN;EGFR;DNM2;CYGB;WASL;NOS1AP;AKT1
prerank,response to laminar fluid shear stress (GO:0034616),-0.7335913873042399,-1.7319916564049875,0.005385996409335727,0.08491787488084196,1.0,6/10,22.38%,KLF4;KLF2;SMAD7;SMAD6;MAPK7;NFE2L2
prerank,axonogenesis (GO:0007409),0.3744129823606416,1.7315366104532748,0.0,0.11410046044975171,1.0,61/237,10.41%,NRXN3;NRXN1;ROBO2;UNC5D;CTNNA2;L1CAM;DAB1;DCC;ANK3;NCAM1;CNTN6;CNTN4;DSCAML1;EPHA6;ENAH;DSCAM;SCN1B;ROBO1;SHTN1;CDK5;VLDLR;EPHB1;NTNG2;NTNG1;PLPPR4;NRCAM;TNR;DOK5;UNC5C;ATL1;GFRA1;SEMA6D;EPHA5;EFNA3;EFNB3;SEMA3B;DOK6;PAX2;PAK3;GPC1;MAP1S;MYPN;SHC3;FGFR2;VSTM2L;SLITRK1;EMB;CNTN2;POU4F1;NEFH;S100A6;SHC1;SPTBN2;SPTBN4;SLITRK4;SLIT3;SLIT1;KIF5A;MAP1B;CCK;RAB3A
prerank,mesenchyme morphogenesis (GO:0072132),-0.6233360438155506,-1.7297545911638923,0.003472222222222222,0.08634853050137282,1.0,7/17,12.19%,ENG;ACVRL1;NOS3;TGFB2;SMAD2;TBX2;NOTCH1
prerank,regulation of actin filament-based movement (GO:1903115),0.7129055715326147,1.7296507547065163,0.020454545454545454,0.11428707751154092,1.0,5/10,12.08%,PDE4B;PDPN;STC1;SCN5A;SRI
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.557549863635848,-1.728888378375488,0.005703422053231939,0.08632044982416781,1.0,8/24,9.84%,SORBS1;INSR;GSK3B;PPP1R3B;IRS1;PPP1R3C;GSK3A;AKT1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4607385457382578,-1.7276869023658818,0.0,0.08681309507057146,1.0,27/70,16.68%,WASF2;DOCK1;MYO10;ABI1;RAC1;LYN;PRKCE;ELMO1;CRK;PLCG1;YES1;NCK1;PIK3R1;ABL1;PTK2;PRKCD;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;GRB2;ELMO2;NCKAP1;ARPC4;FYN
prerank,cellular response to BMP stimulus (GO:0071773),-0.4678753110909646,-1.7267245450813975,0.0,0.08724095562608353,1.0,20/66,11.78%,ENG;ACVRL1;USP9X;BMPR2;BMP5;SMURF1;TGFBR3;BMP6;PDCD4;HIVEP1;TGFB2;BMP4;SMAD1;SMAD2;ACVR2A;SMAD4;RGMB;SMAD7;USP15;HFE
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5926802609838658,-1.726313273411896,0.009124087591240875,0.08705498157463609,1.0,6/21,3.24%,FOXP1;PRKCH;CBFB;ELF1;LYN;SLC39A10
prerank,neuron differentiation (GO:0030182),0.3885586858856645,1.7245256350675042,0.0,0.11795067864145001,1.0,28/165,9.25%,PTPRD;IL1RAPL1;TENM4;PHOX2A;MYT1L;TENM1;ATP8A2;SNPH;WNT7B;IRX4;NIF3L1;SPOCK1;TENM3;ATP2B2;FUT9;CDK5;LHX1;ITM2C;TENM2;EPHA5;RUNX2;NTRK2;IRX3;ADNP2;INSM1;ACSL3;LMX1B;VEGFA
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5894750633807447,1.7242489819990854,0.008928571428571428,0.11641237327889188,1.0,8/21,12.82%,ATP1A2;AKAP6;CALM2;RYR2;SLC8A1;SRI;HRC;CASQ1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5699368671493964,-1.722651480449417,0.0056925996204933585,0.08979229695690004,1.0,13/24,24.42%,TEK;KDR;ICAM1;GAS6;CDH5;RAMP2;TNFAIP3;ANGPT1;GATA2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,positive regulation of vascular permeability (GO:0043117),-0.692235092953744,-1.721731683994904,0.00546448087431694,0.0899176111523698,1.0,9/12,18.49%,TJP1;PDE3A;BMP6;PDE2A;TJP2;OCLN;FGFBP3;ANGPT1;TRPV4
prerank,cellular response to growth factor stimulus (GO:0071363),-0.40021245807865174,-1.720178223946476,0.0,0.09097873391551253,1.0,65/151,24.99%,FLT1;DAB2IP;RAPGEF2;SEMA6A;ACVRL1;KLF4;BMPR2;LIMS1;IQGAP1;TBX1;NR3C1;KDR;PLCG1;PRKD2;EGFR;EMD;PTPN12;PDE3A;TGFBR2;BMP6;DSTYK;PDE2A;MED1;BMP4;RAP1A;ERN1;MEF2C;MAPKAPK2;PRKD1;FLT4;ACVR2A;SMAD4;MTSS2;BCAR1;RAMP2;AKT1;RAPGEF1;EHD1;SMAD7;NOTCH1;WWOX;DUSP3;ZPR1;HGF;HAS1;FOXC1;LGMN;BMP7;ANXA1;CTNNB1;HYAL2;DUSP22;SMAD9;DLL4;PTPN11;MAP2K3;MAPK7;NOS1;RELA;SYAP1;HAS2;ADAMTS7;ACVR2B;EGR3;BMP2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.6134724514626695,-1.7193024418331317,0.012797074954296161,0.09119501358834482,1.0,5/19,5.38%,KLF4;SLCO1C1;KLF2;APP;NFKB1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.6187345203911739,-1.717571122739605,0.005263157894736842,0.09210357889907228,1.0,10/19,15.99%,TJP1;BMP6;AFDN;PPM1F;DENND6A;NOTCH4;RGCC;NOTCH1;FLOT1;MAD2L2
prerank,regulation of ion transport (GO:0043269),0.4341689634872884,1.7165588885038177,0.0,0.1227616452275452,1.0,13/76,4.61%,NKAIN2;SYT1;SYT5;ANK3;CA2;KCNA5;STC1;KCNJ3;NKAIN3;SYT12;SYT11;NKAIN4;KCNA2
prerank,myelination in peripheral nervous system (GO:0022011),-0.6723479541776993,-1.7151281633561035,0.003472222222222222,0.09385311815679223,1.0,9/13,20.79%,PARD3;ADGRG6;CNTNAP1;DICER1;MYOC;ARHGEF10;SKI;SOD1;NF1
prerank,regulation of GTPase activity (GO:0043087),-0.3966346509383214,-1.7141126362277348,0.0,0.09426089478227206,1.0,49/177,13.86%,DAB2IP;DOCK9;CHN2;PRKG1;ITGA6;RAPGEF2;RSU1;ITGB1;FGD5;FERMT2;FGD6;RAB3GAP1;LIMS1;SH3BP4;NET1;GSK3B;DVL3;RALBP1;F11R;LRCH1;PKP4;CRK;CCL25;LRRK2;AFDN;RASIP1;CHN1;PTK2;RAP1A;SNX9;PLXND1;TGM2;USP6NL;AGRN;RASGRP2;EPHA4;TBC1D30;PLXNA4;PICALM;RASA4;RAB3GAP2;RAPGEF1;ARAP1;BCAS3;ARFGEF1;WNT11;CD40;LARS1;GPR137B
prerank,protein-containing complex assembly (GO:0065003),-0.3752108274594583,-1.7140862377558008,0.0,0.09365978227649362,1.0,95/259,23.81%,LEF1;FBXL7;SLC2A1;PARD3;MNAT1;SEC31A;CREBBP;SEC24B;FERMT2;CSNK1A1;CD2AP;CTSC;GSK3B;TRAPPC3;TRAPPC9;RANBP9;TEAD1;SH3PXD2B;LRRK2;MITF;RAB1A;HDAC1;HES1;RBX1;AFDN;SEC24A;TRRAP;FAS;KPNA3;CUL3;SEC16B;SNX9;WASL;SEC24D;KLHL12;SEC13;YAP1;SCFD1;AFG3L2;PICALM;DET1;OCLN;CASP8;ADAM10;SAMM50;TP53;AXIN2;HFE;ANO6;CDC73;PPP6R3;CDC123;CSNK1D;KAT5;ASH2L;CD40;TCF7L1;CTSZ;TBC1D20;PEX14;TUBGCP4;TNFRSF1A;F5;TFG;CTNNB1;TFAP4;DBNL;FANCC;DNAJB12;IKBKG;VAMP3;WASF1;MDN1;MAGI1;TCF7L2;AP2M1;CXCL12;FERMT3;TERT;MDM2;BLM;CAND2;VAMP2;PTK2B;PREB;SEC24C;AMER1;SEC22B;PPIH;TSPAN33;BET1;RIPK1;NDUFAF1;CD247;RBBP5
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.45516387213429177,-1.7133207553173646,0.0,0.09386753918293975,1.0,27/71,16.68%,WASF2;DOCK1;MYO10;ABI1;RAC1;LYN;PRKCE;ELMO1;CRK;PLCG1;YES1;NCK1;PIK3R1;ABL1;PTK2;PRKCD;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;GRB2;ELMO2;NCKAP1;ARPC4;FYN
prerank,positive regulation of lipid transport (GO:0032370),0.679503359887403,1.7132768939806815,0.019522776572668113,0.12424782534286845,1.0,5/12,14.63%,ABCA12;PRELID1;TRIAP1;SPP1;APOE
prerank,cell differentiation in hindbrain (GO:0021533),0.6736132188940966,1.712103192332235,0.01569506726457399,0.12363367981514543,1.0,6/11,13.25%,GRID2;LHX1;PROX1;FAIM2;CBLN1;KNDC1
prerank,cardiac muscle cell contraction (GO:0086003),0.5909795513348464,1.7105864216554525,0.01126126126126126,0.12358450640699575,1.0,8/19,8.20%,FGF12;SCN1B;SCN1A;CACNA2D1;PKP2;CACNA1D;GSN;SCN5A
prerank,monocarboxylic acid transport (GO:0015718),-0.4784113042392713,-1.7105349976964819,0.005319148936170213,0.09610383057798527,1.0,15/51,12.66%,ABCC4;ABCG2;ATP8B1;SLCO2A1;SLCO1C1;RXRA;SLCO3A1;SLC16A12;SLC5A6;SLC16A9;SLC16A1;SLCO2B1;SLC16A6;SLC27A4;CEACAM1
prerank,regulation of defense response (GO:0031347),-0.4553049961695641,-1.7100210241711657,0.0017574692442882249,0.09608135399686267,1.0,31/76,25.01%,FOXP1;IL1R1;XIAP;CASP12;SEMA7A;TMSB4X;BIRC3;SAMHD1;IRF1;CELF1;CASP8;AREL1;JAK2;AGTR1;MGLL;USP18;NR1D2;N4BP1;ANXA1;ZMPSTE24;ERAP1;NOD2;DAGLB;TKFC;BCL6;AKNA;RELA;CASP1;SHPK;ACE2;BRD4
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.6942499948331662,1.7094136791312433,0.01141552511415525,0.12317321459724763,1.0,7/10,14.09%,DLGAP1;DLGAP2;NPTXR;NPTX2;DLGAP3;CACNG5;BEGAIN
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5478819950672367,1.7083612600927889,0.0023584905660377358,0.12260670941066767,1.0,6/27,3.42%,SYT1;SYT5;RIMS2;RIMS1;SYT12;SYT11
prerank,regulation of catecholamine secretion (GO:0050433),0.5337051180745643,1.7083000211766264,0.0066815144766146995,0.12107977616275639,1.0,10/29,16.94%,SYT1;SYT5;SYT12;SYT11;KCNA2;CHGA;SYT4;FGF20;SYT3;SYT9
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4486223597652424,-1.7081417670260615,0.0017889087656529517,0.09735716469307258,1.0,29/76,18.97%,NFAT5;NR3C2;NOD1;UACA;LIMS1;TMSB4X;APP;DDX3X;EGFR;NFKBIA;DLG1;NMI;PDCD4;RASSF2;EZR;PPM1B;ILK;RHOA;IRAK1;ACTN4;TCIM;IFI35;CCN3;C1QTNF3;BMP7;SASH1;RPS3;CCL19;NOD2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.4275311663352888,-1.7065196873516058,0.0,0.09817436487733372,1.0,34/95,20.87%,ENG;CREBBP;CAV1;DAB2;SMURF2;IL17RD;THBS1;ITGA3;PRDM16;RNF111;SPRED2;SMURF1;TGFBR3;TGFBR2;NREP;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD2;SMAD4;LATS2;SMAD7;LTBP4;SMAD6;SKI;GIPC1;CITED2;PMEPA1;HTRA3;DAND5;SNX25;STRAP
prerank,regulation of developmental growth (GO:0048638),-0.545785025624318,-1.7051455867375396,0.0036101083032490976,0.09904067667371115,1.0,15/29,18.06%,GHR;INSR;GSK3B;APP;NIPBL;SIX1;ABL1;DNM2;PLCB1;MFSD2A;LATS2;SIN3A;IGF1;SIX4;SOD1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.6486990852637464,-1.7038548765685164,0.014234875444839857,0.09972464259819602,1.0,9/15,24.96%,GSK3B;YWHAE;EMD;GAS6;TP53;TPR;XPO4;TCF7L2;RAPGEF3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6707911724097388,-1.702262466160419,0.014109347442680775,0.10086583235120708,1.0,6/13,11.47%,RBPMS;DAB2;BMP6;BMP4;SMAD4;JAK2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5108436409170448,-1.7002664573049822,0.010434782608695653,0.102370933832445,1.0,14/35,18.85%,UBR5;ZMIZ1;NR3C2;ESR1;RBFOX2;NR3C1;NEDD4;MED1;YAP1;KDM3A;NCOA4;TADA3;WBP2;PMEPA1
prerank,sulfur compound transport (GO:0072348),-0.5515513817320858,-1.7001288374901584,0.0018484288354898336,0.10182295192229357,1.0,8/27,10.75%,ABCG2;SLC6A6;SLC26A7;SLC13A4;SLC5A6;SLC19A2;LRRC8D;SLC25A11
prerank,plasma membrane tubulation (GO:0097320),-0.6592264678039607,-1.6972148398911366,0.007246376811594203,0.10439108900227284,1.0,6/13,10.04%,CAVIN2;FNBP1L;EHD2;SNX9;BIN3;CHMP4A
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.6068758969740339,-1.6955988448455173,0.01651376146788991,0.10555492323738452,1.0,8/18,19.79%,ABL1;RFK;EDN1;EDN3;AGTR1;SIRT3;NOD2;POR
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.7260438763980621,-1.6945107369539536,0.01098901098901099,0.10584216745381099,1.0,8/10,23.46%,RXRA;TBX1;RARG;ACTN4;RARA;PPARG;RARB;RXRG
prerank,regulation of cardiac muscle contraction (GO:0055117),0.51194534218268,1.6941814266833835,0.006787330316742082,0.13480779140046323,1.0,11/34,12.08%,PDE4B;STC1;ATP1B1;CHGA;CALM2;RNF207;RYR2;SCN5A;ADRA1A;SLC8A1;SRI
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.3880277192729286,-1.6939706133120196,0.0,0.10577515623581947,1.0,58/186,16.35%,NXN;DAB2IP;TRABD2B;CSNK1A1;CAV1;DAB2;MLLT3;FZD6;GSK3B;DVL3;MCC;NFATC1;PSMA2;IGFBP4;ZNRF3;SOX13;SOX17;EMD;KREMEN1;VGLL4;RNF213;FZD4;LIMD1;HDAC1;FRMD8;RBX1;STK3;RNF43;CUL3;LRP6;NKD1;PSME2;KLHL12;CTNND1;GRB10;PSMB4;GLI3;GSK3A;LATS2;UBAC2;AXIN2;HMGXB4;WWOX;DKK2;TMEM64;NOTUM;TAX1BP3;WNT11;APCDD1;PSMC2;LMBR1L;TMEM170B;PSMB2;FUZ;RUVBL2;PSMB1;MAD2L2;HIC1
prerank,positive regulation of neuron migration (GO:2001224),-0.6945005945508959,-1.6938730519846223,0.0037174721189591076,0.10520674117926967,1.0,5/11,8.57%,DAB2IP;RAPGEF2;SEMA6A;NIPBL;ARHGEF2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.594741936627633,-1.6934460649600183,0.0106951871657754,0.10496750746924881,1.0,11/18,26.25%,FLT1;PLCG1;SP1;MEF2C;AKT3;FGF2;ITGA4;PPARG;IGF2;HMGB1;ADAM17
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.4881029563654467,-1.6931883692353036,0.0017825311942959,0.1046672907585509,1.0,24/46,26.64%,UBR5;GSK3B;YWHAE;EMD;GAS6;PIK3R1;NEDD4;PRKCD;CDH1;TP53;FLNA;PSEN1;ZPR1;TPR;XPO4;MAVS;ZIC1;HYAL2;TCF7L2;TRIM28;KHDRBS1;DHX9;RAPGEF3;RAN
prerank,action potential (GO:0001508),0.4804079691420372,1.691742522034526,0.00425531914893617,0.135989338650478,1.0,12/44,12.08%,KCND2;ANK3;SCN8A;SCN1A;AKAP6;CLN3;SCN3A;KCNA2;SCN2A;SCN5A;GPER1;SRI
prerank,negative regulation of binding (GO:0051100),-0.4448897769405488,-1.6903427641825834,0.0017699115044247787,0.10723247928015063,1.0,29/81,19.98%,LEF1;SP100;CAV1;DAB2;BTAF1;GSK3B;LRRK2;SMO;NFKBIA;PRKCD;JUN;ROCK1;NES;WAPL;AKT1;JAK2;ZFPM1;ARHGAP28;ACTB;MAPK8;ILRUN;CTSZ;MITD1;PEX14;SUMO1;TFAP4;PLN;TFIP11;CTNNBIP1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6418632686450678,-1.689277674122885,0.003683241252302026,0.10696849281622803,1.0,4/14,12.52%,ABCG2;SLCO2B1;BLVRA;HMOX2
prerank,heme catabolic process (GO:0042167),-0.6418632686450678,-1.689277674122885,0.003683241252302026,0.10696849281622803,1.0,4/14,12.52%,ABCG2;SLCO2B1;BLVRA;HMOX2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.5730198325204439,-1.6892092850726739,0.0108499095840868,0.10635906079524363,1.0,8/22,14.93%,DAB2IP;MFHAS1;LYN;WDFY1;LBP;FLOT1;TNFAIP3;IFI35
prerank,heart morphogenesis (GO:0003007),-0.4775180025321429,-1.6888269432661172,0.0052173913043478265,0.10619910475780672,1.0,17/50,17.95%,ENG;ACVRL1;NOS3;INSR;TBX1;SOX17;TGFBR3;NIPBL;HES1;TGFB2;PTK2;TBX2;ZFPM1;NOTCH1;FLRT2;HEY1;HEY2
prerank,chloride transmembrane transport (GO:1902476),0.47427283484829413,1.6888190863855306,0.0022675736961451248,0.13748141772371494,1.0,15/48,14.23%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;ANO4;SLC12A5;GABRA3;GABRA1;SLC12A4;SLC1A3;GABRE
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.44049013864860387,-1.687954282494617,0.0017574692442882249,0.10651899318803346,1.0,24/75,18.35%,TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;COL4A2;KLF4;THBS1;TGFB2;ISM1;ROCK1;HSPG2;RGCC;STAB1;NAXE;ECSCR;MECP2;FOXC1;ROCK2;FOXO4;NPR1;GTF2I;CTNNB1;SEMA3E
prerank,response to lipid (GO:0033993),-0.4176343165589102,-1.6878267969864997,0.0,0.1059615914292235,1.0,33/105,17.12%,FOXP1;FOXO1;PELI1;NOS3;SRR;ESR1;ACER2;ASXL1;RXRA;IFNAR1;HNRNPA0;PPARA;RARG;STRN3;GGT5;FOXO3;ALPL;GCH1;LBP;RBP4;MAPKAPK2;PPARD;SOCS2;JAK2;IRAK1;RPS6KA3;TRIM16;SMAD6;TAB2;RARA;ANXA1;CTSH;CTNNB1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4878326233073857,-1.6873396801751137,0.0054249547920434,0.10578404138448387,1.0,12/45,11.78%,RBPMS;ENG;ACVRL1;DAB2;BMPR2;BMP5;BMP6;TGFB2;BMP4;ACVR2A;SMAD4;HFE
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.6624255932481917,-1.6868757900511133,0.005376344086021506,0.10568431012396505,1.0,6/13,7.18%,ABHD2;NR3C2;ESR1;NR3C1;MED1;BMP4
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.49104130263793877,-1.6867317128655201,0.005154639175257732,0.105194422017831,1.0,14/43,12.27%,NFIB;KLF4;ETS1;TEAD1;NFATC4;NR3C1;PPARA;FOXO3;TGFB2;BMP4;JUN;PPARD;TP53;FGF2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3465906717043832,-1.6861791933644623,0.0,0.105166665416026,1.0,168/572,21.31%,FOXP1;KLF12;DAB2IP;KLF7;RREB1;FOXP2;SMARCA2;ETV6;ZBTB16;NFIB;SP100;MEF2A;CREBBP;NSD1;RB1;CBFB;ZEB1;KLF4;CAV1;USP9X;DAB2;ESR1;NEDD4L;MIER1;CUX1;ZFHX3;NRIP1;PRDM5;SMURF2;KLF2;IRF2;RXRA;PRDM16;WWC2;NFATC4;ID1;MITF;NR3C1;THRB;SOX13;NFIX;ZHX2;ZNF148;CTCF;NIPBL;BMP6;HDAC1;NFKB1;HES1;PPARA;RARG;RPS14;DLG1;ZBTB7A;FOXO3;PDE2A;HIVEP1;NEDD4;MED1;SPEN;GTF2IRD1;BMP4;MAX;MEF2C;EZR;SKIL;JUN;ZBTB4;SMAD2;ZFP90;PHF21A;TBX2;SUV39H1;DACH1;YAP1;LDB1;PRDM2;PPARD;GLI3;ZNF25;USP2;SMAD4;CTBP2;UBE2D3;GLIS2;TP53;FRK;KLF10;EDN1;HMBOX1;PER3;NOTCH4;ETS2;DICER1;NFIC;SIN3A;FNIP2;PSEN1;MAZ;SMAD7;ZFPM1;PRDM6;CHD3;NOTCH1;MTDH;CDC73;RTF1;HDAC4;SFPQ;LRRFIP1;WWOX;KAT5;ZHX1;MECP2;ATF4;MZF1;RPL10;KMT5A;NR1D2;HCFC1;TCF3;FOXC1;PHF6;BCOR;NR2C1;DR1;TPR;MIER2;MAD2L2;TAF7;TRPS1;HIC1;SKI;ORC2;SUMO1;RARA;ZNF692;ARID5B;TAF3;IGBP1;HDAC10;HEY1;HEY2;MIER3;VPS72;ELK4;KDM1B;CITED2;NCOA5;RNF2;CCND1;DUSP22;LIN37;ATRX;RITA1;TCF7L2;TBL1X;PPARG;WWP2;PRDM1;BCL6;RARB;NR2F2;IGF2;GLIS1;DLL4;MDM2;NKAP
prerank,regulation of protein import into nucleus (GO:0042306),-0.5115605449497034,-1.686109341321381,0.0018181818181818182,0.10462603261043296,1.0,17/36,20.86%,UBR5;PIK3R1;PRKCD;BMP4;MDFIC;CDH1;FLNA;PSEN1;CHP1;UFM1;ZPR1;RAB23;TPR;MAVS;ZIC1;HYAL2;TRIM28
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.4785181455925687,-1.6849670673378812,0.0055147058823529415,0.10520824832851093,1.0,15/45,11.38%,GAB1;IQGAP1;RPS6KA5;PLCG1;EGFR;SLC30A10;CBL;PIK3R1;PTK2;PIK3C2A;PLCE1;BCAR1;AKT1;NCK2;BRAF
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5777996369144813,-1.684684385460903,0.007380073800738007,0.10493093504608184,1.0,10/22,16.38%,MEF2A;IL6ST;ROCK1;SMAD4;LMCD1;EDN1;PDE9A;NOTCH1;ROCK2;IGF1
prerank,I-kappaB phosphorylation (GO:0007252),-0.7270123652212735,-1.684680043645034,0.003676470588235294,0.10432788369524229,1.0,2/10,1.49%,DAB2IP;ERC1
prerank,regulation of dopamine secretion (GO:0014059),0.5534260485615403,1.684339593133758,0.0044943820224719105,0.14110092306802657,1.0,10/25,19.27%,SYT1;SYT5;SYT12;SYT11;KCNA2;SYT4;FGF20;SYT3;SYT9;SYT17
prerank,collagen fibril organization (GO:0030199),-0.42839166391915984,-1.684121106156742,0.0035335689045936395,0.1042404625862256,1.0,26/88,11.76%,TLL1;COL8A1;ITGA6;COL12A1;COL4A2;COL25A1;PLOD1;PLOD2;ADAMTS2;COL4A6;P3H2;COL5A1;ITGB4;LOXL3;LAMA3;COL4A5;COL4A1;TGFB2;COL8A2;COL5A2;COLGALT2;LOXL1;DST;P4HA1;COL6A3;COL15A1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6510263089550892,1.6838634625568483,0.011682242990654205,0.14000681612342483,1.0,4/12,6.37%,ANK3;ATP1B1;WNK2;WNK3
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5969955991200435,-1.6794598705586994,0.01125703564727955,0.10864162635607416,1.0,10/18,15.01%,CTNNA1;MFHAS1;GSK3B;MDFIC;LATS2;SIN3A;CHP1;UFM1;RAB23;ILRUN
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.3515986319437059,-1.6792552873264555,0.0,0.10827214117464269,1.0,135/417,21.81%,FOXP1;MECOM;LEF1;DAB2IP;FOXP2;SMARCA2;ZBTB16;ATP8B1;WWP1;ZNF423;FOXO1;ZHX3;RB1;ZEB1;KAT6B;KLF4;CBFA2T3;BTAF1;FOXN3;PRDM5;SMURF2;LIMS1;RBFOX2;SPINDOC;PRDM16;RPS6KA5;UIMC1;ID1;NR3C1;SOX13;KAT6A;RCOR1;LOXL3;PSPC1;CD38;ZHX2;CDKN1B;VGLL4;ZNF148;ELK3;CTCF;NIPBL;LIMD1;HDAC1;HES1;GAS6;ZBTB7A;PDCD4;PLCB1;SPEN;BMP4;PTPRK;MIDEAS;JUN;ZBTB4;SMAD2;PBXIP1;TBX2;SUV39H1;PPM1F;DACH1;MDFIC;NAB1;SMARCE1;LDB1;PPARD;IRF1;GLI3;SMAD4;CTBP2;SP3;GLIS2;TP53;EHMT1;KLF10;HMBOX1;SMARCC2;SIN3A;SOX7;SCMH1;TWIST2;YAF2;NOTCH1;HDAC4;SFPQ;PA2G4;KAT5;WNT11;CIC;FBXW11;ZHX1;MECP2;KMT5A;SAMD1;NR1D2;DAP;BCOR;PHC1;PEX14;TAF7;BMP7;SUMO1;SIX4;RARA;ARID5B;HDAC6;ZBTB14;CTNNB1;TFAP4;HDAC10;PATZ1;HEY1;ZMYND11;HEY2;CITED2;BAP1;PIAS4;SCML4;TCF7L2;NONO;TIMELESS;PPARG;WWP2;BCL6;BRCA1;NR2F2;TRIM28;FOXL2;MDM2;NKAP;NACC1;CBFA2T2;GCLC;PHC3;TSHZ3
prerank,cell-substrate junction assembly (GO:0007044),-0.5222805631402654,-1.6787580780025901,0.005385996409335727,0.10819976070426342,1.0,9/33,8.83%,ITGA6;SORBS1;THSD1;BCR;FERMT2;ITGB4;LAMA3;PTPRK;DST
prerank,epithelial tube morphogenesis (GO:0060562),-0.5236558006077073,-1.6774766044247584,0.009633911368015413,0.10909450737305486,1.0,11/32,7.35%,ACVRL1;PODXL;PKD2;PRKD2;SOX17;HES1;RASIP1;COL4A1;SLIT2;BMP4;MEF2C
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.632831095689021,-1.6767323064061281,0.02018348623853211,0.10922327088131577,1.0,7/15,16.38%,MEF2A;IL6ST;ROCK1;EDN1;PDE9A;ROCK2;IGF1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.4187747190093529,-1.6766519502588437,0.0,0.10873928250418889,1.0,38/101,22.46%,KLF4;THBS1;ATG7;EIF3E;METTL14;ATG10;DDX3X;MTOR;NIBAN1;MSN;PLD1;VGLL4;EIF3C;NFKBIA;UPF3B;SAMD4A;EZR;ASPH;ASPSCR1;CASP8;RPL26;AKT1;ZCCHC4;PERP;EEF2;AGTR1;FBXW11;LARP4B;RPS4X;RPL5;METTL5;SOX4;PRKDC;FGFR4;RBM3;OGT;AMER1;HSP90AA1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.4337536197074409,-1.673941219872635,0.0017761989342806395,0.11106985398569322,1.0,24/80,14.71%,XIAP;KLF4;DAPK1;NOD1;UACA;THBS1;MAP3K5;DDX3X;TNFSF10;YWHAE;GAS6;NGF;DNAJB6;PPM1F;RAF1;ARL6IP5;SH3RF1;AKT1;BCAP31;SOX7;RPS6KA1;HGF;RPS6KA3;GPX1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5469088373429926,-1.6718123239688092,0.005649717514124294,0.1131386555644341,1.0,12/27,22.06%,FLT1;TEK;IRS1;AMBRA1;PTK2;PRKD1;FGF2;TNFAIP8L3;CCL19;NOD2;PDGFRB;PTK2B
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.49746081956131327,-1.671318469448318,0.011049723756906077,0.11309748451231667,1.0,17/39,15.43%,CREBBP;NOS3;ZMIZ1;MAML2;KAT2B;IL6ST;JAG2;TGFB2;AAK1;MAML1;TSPAN14;YAP1;NOTCH4;TSPAN5;NOTCH1;JAG1;CCN3
prerank,circulatory system development (GO:0072359),-0.40581418119543944,-1.6688356790402659,0.0,0.11524295795792937,1.0,45/118,19.09%,NXN;TEK;ACVRL1;MEF2A;AKAP13;HEG1;PKD2;KAT2B;MICAL2;SH3PXD2B;TBX1;SOX17;CDKN1B;PDLIM5;TGFBR2;TGFB2;SMYD4;RBP4;MTHFD1;ECE1;MEF2C;WDR11;CDH5;PLCE1;HSPG2;PDLIM1;KDM6A;FLT4;PCSK5;CASP8;RAMP2;KDM6B;NOTCH4;ZFPM1;NOTCH1;PDLIM3;RBM20;FOXC1;BCOR;TAB2;HEY1;HEY2;CITED2;SOX4;NCOA6
prerank,clathrin coat assembly (GO:0048268),-0.6348865367402383,-1.6686726613927603,0.017341040462427744,0.11478748126774202,1.0,6/15,9.18%,HIP1;FCHO2;EPS15;AP2S1;PIK3C2A;PICALM
prerank,positive regulation of vasculature development (GO:1904018),-0.41811570625643796,-1.6680795076714532,0.0017482517482517483,0.11483337184865404,1.0,39/94,25.22%,FLT1;TEK;ITGB1;GAB1;NOS3;TIE1;ETS1;CD34;THBS1;KDR;ANXA3;PLCG1;PRKD2;SP1;FGF1;CDH5;PRKD1;RRAS;PIK3CD;RAMP2;VEGFC;PIK3R6;FGF2;MTDH;CD40;AGO2;SMOC2;HIPK1;CTSH;SASH1;GATA2;F3;BRCA1;SERPINE1;CYP1B1;PTGIS;SEMA5A;RAPGEF3;TNFSF12
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.39252631381196634,-1.6670368265308282,0.0,0.1153320383431704,1.0,47/140,17.59%,CHN2;ARHGAP31;AKAP13;BCR;CD2AP;RAC1;RHOJ;ARHGEF3;NET1;STARD8;RALBP1;MCF2L;ARHGAP10;CGNL1;ARAP3;PLEKHG5;ARHGAP5;RASGRF2;CHN1;ARHGEF12;SLIT2;RHOQ;ARHGDIA;PLCE1;TGM2;ITSN1;ARHGEF2;ARHGAP17;SOS2;STARD13;ARAP1;ARHGAP1;ARHGEF11;RHOA;ARHGAP28;FAM13A;RHOC;RHOG;TRIO;ARHGAP22;ABR;ARHGEF18;DEPDC7;PREX1;ARHGAP12;ARHGAP29;ARHGAP35
prerank,pharyngeal system development (GO:0060037),-0.635949069409802,-1.6645347069151906,0.017271157167530225,0.1175817861060835,1.0,8/15,16.90%,BMPR2;BMP5;TBX1;HES1;TGFB2;BMP4;BMP7;SIX4
prerank,limb development (GO:0060173),-0.5404579355337926,-1.6634472006247498,0.008818342151675485,0.11832180117863167,1.0,8/28,12.31%,MAP3K20;KAT2B;SMOC1;ZNRF3;KREMEN1;GLI3;PCSK5;COMP
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.47625698634602487,-1.6604251256715654,0.01054481546572935,0.12128479130066723,1.0,27/49,36.91%,AFAP1L2;NOD1;RAB1A;PRKD2;LBP;MAVS;HYAL2;NOD2;F3;RELA;SERPINE1;RIPK1;HSPA1B;HMGB1;F2R;LGALS9;DDIT3;STAT3;TLR1;NOS2;TLR5;CD14;PARK7;CD74;TLR2;TLR8;SYK
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.5745003647545806,-1.6601550158459455,0.01090909090909091,0.1209776852664561,1.0,11/21,26.50%,CSNK1A1;CAV1;GSK3B;DVL3;LRP6;CTNNB1;AMER1;PPP1CA;FZD5;FZD1;APC
prerank,aorta morphogenesis (GO:0035909),-0.5977266278065096,-1.6599005109461387,0.007054673721340388,0.12070012117179038,1.0,11/17,21.66%,ENG;ACVRL1;TBX1;TBX2;ADAMTS9;MYLK;JAG1;HEY1;HEY2;DLL4;PDGFRB
prerank,positive regulation of GTPase activity (GO:0043547),-0.38171425527544534,-1.6594995889305475,0.0017152658662092624,0.12046475399251179,1.0,76/188,25.65%,DOCK9;ITGA6;TBC1D4;RAPGEF2;RSU1;ITGB1;BCR;FERMT2;RALGAPA1;RAB3GAP1;LIMS1;NET1;CORO1C;GSK3B;DVL3;RALBP1;F11R;PKP4;CCL25;TBC1D1;AFDN;TBC1D2B;ARHGEF15;RAP1A;TBC1D8B;SNX9;TGM2;USP6NL;SIPA1L3;AGRN;RASGRP2;TBC1D30;TBC1D14;PICALM;MTSS2;TBC1D22B;RAPGEF1;ARAP1;TBC1D22A;BCAS3;SLC27A4;TAX1BP3;WNT11;ARHGEF10;RHOG;CD40;LARS1;MAP4K4;TBC1D20;ARHGAP22;ABR;ALS2;ARHGAP29;CCL19;TBC1D8;NDEL1;EPHA2;TBC1D17;TBC1D25;ARHGAP42;NF1;ARHGEF5;ASAP3;SYDE1;SNX13;TBC1D12;EVI5;ARHGAP11A;PIP5K1A;SNX18;ADRB1;PLXNB1;RAPGEF3;FZD10;SIPA1;SIPA1L1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5950931517717597,-1.6583500691121509,0.0111731843575419,0.12118405443881766,1.0,10/18,21.75%,JCAD;RHOJ;KDR;PIK3C2A;AKT3;MAP3K3;FGF2;ANXA1;GATA2;HDAC7
prerank,RNA destabilization (GO:0050779),-0.5920512945661214,-1.6582805322649474,0.017985611510791366,0.1206306585266789,1.0,10/18,26.53%,METTL14;GIGYF2;FTO;PUM1;ROCK1;CELF1;ROCK2;METTL16;RBM24;DXO
prerank,regulation of cellular component size (GO:0032535),-0.5210779951092861,-1.6576319276426155,0.01079136690647482,0.12084469697295518,1.0,19/30,28.88%,RIN3;EPS8;RAC1;MTOR;MSN;RARG;EZR;PICALM;RPTOR;LARS1;PEX11A;AP2M1;PTEN;VAV2;MTPN;PPP1CA;RAB22A;RDX;PEX11B
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.4335793244489745,-1.6574483543830538,0.0,0.12042707409419709,1.0,31/75,26.25%,TEK;JCAD;NRP2;BMPR2;KDR;PLCG1;PRKD2;SP1;BMP4;PRKD1;AKT3;FLT4;PIK3CD;AKT1;VEGFC;AGTR1;FGF2;ITGA4;ARNT;GATA2;NRAS;F3;ITGB3;IGF2;SEMA5A;HMGB1;EGR3;BMP2;THBS4;TNFSF12;ADAM17
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4017688353372842,-1.6563595304892602,0.0,0.12113849677004594,1.0,58/110,31.12%,RPS21;EIF3E;RPL37;RPL31;RPL9;RPS14;UPF3B;RPSA;UPF2;RPL3;RPLP1;RPL26;RPS11;HELZ2;RPL13;RPL38;RPL27;RPS16;RPS4X;GSPT1;RPL10;RPL7A;RPL5;RPS27;RPL27A;RPS3;CTIF;RPL36A;RPL35A;PPP2CA;DCP1A;RNPS1;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;SMG6;RPS17;RPS2;RPL39;RPS26;RPS15A;RPL15;RPL34;PABPC1;SMG1;RPLP2;RPL18;RPL19;RPS13;RPL8
prerank,neuron projection organization (GO:0106027),-0.611527528314311,-1.6561201274585156,0.011363636363636364,0.12076173648806884,1.0,6/15,15.65%,INSR;GSK3B;APP;PSEN1;DCTN1;LGMN
prerank,positive regulation of protein metabolic process (GO:0051247),-0.4131876396366103,-1.656066336362499,0.0016891891891891893,0.12019889736820664,1.0,40/110,23.53%,DAB2IP;WWP1;FOXO1;KLF4;NEDD4L;SMURF2;KLF2;GSK3B;APP;ATG7;RANBP9;RAB7A;RAB1A;SMURF1;TIPARP;CDKN1B;NFKBIA;NEDD4;NKD1;PLK2;ABCB10;LDB1;GSK3A;AKT1;AREL1;PSEN1;AGTR1;MAPK8;TNFAIP3;ROCK2;PAEP;OAZ2;GPC3;WWP2;HUWE1;MAPK7;HACE1;SEC22B;MTPN;FZR1
prerank,negative regulation of MAPK cascade (GO:0043409),-0.4229068976019507,-1.6558439447773712,0.0,0.11983681513341644,1.0,31/87,20.79%,DAB2IP;SEMA6A;FOXO1;CAV1;LYN;PTPN1;RANBP9;SPRED2;PTPRJ;DLG1;PPEF2;PRKCD;BMP4;EZR;SMAD4;PEBP1;STK38;TIMP3;CNKSR3;DUSP3;SPRY4;PIK3CB;ABCA7;BMP7;IGBP1;CDK5RAP3;HYAL2;PTPRC;UCHL1;PTEN;NF1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3920556533065686,-1.655258524062448,0.0,0.11981035841323488,1.0,48/136,24.19%,DAB2IP;SP100;RB1;KLF4;PKD2;ESR1;CD200;FZD6;TMSB4X;ID1;SIK1;TAX1BP1;HES1;GAS6;NFKBIA;OTULIN;ANXA4;GLIS2;FLNA;NFKBIL1;SMAD7;IRAK1;HDAC4;CHP1;TNFAIP3;DAP;PEX14;MAD2L2;MTURN;BMP7;SUMO1;IRAK2;TAF3;NLRC5;CDK5RAP3;CEBPG;CMKLR1;RNF2;USP7;TCF7L2;CTNNBIP1;WWP2;KEAP1;SFRP4;PIM1;CYP1B1;ARRB1;PTGIS
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6758361466750259,-1.6542347726278352,0.012477718360071301,0.12050736737487647,1.0,3/11,2.75%,CD34;CD200;THBS1
prerank,regulation of peptide hormone secretion (GO:0090276),0.43479158454139843,1.6536397506435405,0.002304147465437788,0.17632215562485817,1.0,20/67,18.05%,KCNC2;HTR2C;SNAP25;GIP;GCK;KCNA5;CACNA1A;MTNR1B;CACNA1D;ADRA2C;CACNA1E;GIPR;ADRA2A;EIPR1;CCL5;ALOX5;SLC8B1;GLP1R;ABCC8;KCNG2
prerank,regulation of nervous system process (GO:0031644),0.571060289566671,1.6534416546448174,0.022779043280182234,0.1744190861738882,1.0,11/18,14.09%,HTR2C;DLGAP1;DLGAP2;TMEM108;NPTXR;SLC8A2;NPTX2;SLC8A3;DLGAP3;CACNG5;BEGAIN
prerank,regulation of protein export from nucleus (GO:0046825),-0.5652108598568563,-1.6531842722002112,0.01436265709156194,0.1211665556255274,1.0,10/23,19.87%,SP100;PTPN14;GSK3B;YWHAE;EMD;GAS6;TP53;TPR;XPO4;TCF7L2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5460944460346417,-1.6530017481130748,0.012302284710017574,0.1207574146827476,1.0,11/24,9.29%,SEMA3C;NRP2;ENG;BMPR2;PARVA;TBX1;TGFBR2;TGFB2;BMP4;TBX2;SMAD4
prerank,positive regulation of sodium ion transport (GO:0010765),0.6469590967101737,1.651903729046657,0.013921113689095127,0.17467763870545364,1.0,6/12,8.20%,ANK3;SCN1B;PKP2;GPD1L;WNK3;SCN5A
prerank,long-term memory (GO:0007616),0.5646756038920561,1.6508051601729248,0.01627906976744186,0.17415836852222796,1.0,8/19,14.63%,RASGRF1;SHANK1;CAMK4;SLC2A4;CPEB3;SGK1;LDLR;APOE
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5313013920070587,-1.6504760019960443,0.005128205128205128,0.12322155954281662,1.0,5/26,5.93%,FOXP1;DAB2;HDAC1;STRN3;ZBTB7A
prerank,Rho protein signal transduction (GO:0007266),-0.46152588225093716,-1.6500861205392474,0.0017452006980802793,0.12309386100180832,1.0,24/53,18.28%,EPS8;RHOJ;ARHGEF3;NTN1;PLEKHG5;EPS8L2;ARHGAP5;GNA12;PHACTR4;ARHGDIA;ROCK1;ARHGAP1;AGTR1;ARHGEF11;RHOA;RTKN;TAX1BP3;RHOG;CDC42EP3;ROCK2;RIPOR1;ARHGAP29;ADGRG1;CFL1
prerank,regulation of hydrolase activity (GO:0051336),-0.4387434857918894,-1.6492677182827433,0.0,0.12356375223374869,1.0,28/71,22.47%,DAB2IP;CHN2;PRKG1;FGD5;FGD6;CAV1;RAB3GAP1;RALBP1;CRK;RASIP1;CHN1;PTK2;PLXND1;EPHA4;PLXNA4;RAB3GAP2;PAFAH1B1;FBXW11;GPR137B;ARHGAP12;CDK5RAP3;SOD1;WRN;NF1;ARHGEF5;VAV2;NOS1;EPHB3
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.45308132225181336,1.6489989141313202,0.00228310502283105,0.17492499263290484,1.0,16/53,17.27%,CHRM2;HTR2C;OPRM1;CNR1;CHRM3;MTNR1B;MTNR1A;NPY;HTR4;ADRB3;TSHR;HTR1D;CCL2;HTR1F;HRH1;HRH2
prerank,presynapse organization (GO:0099172),0.676254923236535,1.6483942387461903,0.018306636155606407,0.1736985184500194,1.0,2/10,0.55%,NLGN1;LRRTM3
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.32772026774773505,-1.6472318408360584,0.0,0.12524044980249133,1.0,278/834,25.06%,LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;SMARCA2;ITGA6;NFIB;ENG;ERG;ACVRL1;FOXO1;MEF2A;CREBBP;MLLT10;MRTFB;SENP1;NFAT5;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;PKD2;DAB2;LRP5;ESR1;BMPR2;TCF12;ASXL1;ZFHX3;NRIP1;MAML2;KLF2;IRF2;CDK13;DVL3;RXRA;APP;KAT2B;NFATC1;BMP5;ATM;RPS6KA5;FOSL2;RNF111;LMO2;TEAD1;MICAL2;ZSCAN21;TBX1;MITF;NR3C1;THRB;DDX3X;KANSL3;NFIX;KAT6A;PRKD2;PLAGL1;SOX17;CDK12;EGFR;NOTCH3;RTRAF;SP1;CRLF3;ELK3;BMP6;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;TET2;NCK1;NFKBIA;PIK3R1;ABL1;FOXO3;LMO7;HIVEP1;LRP6;TGFB2;RHOQ;MED1;AATF;STAT6;PRPF6;E2F4;FGF1;GABPB2;BMP4;MAX;MEF2C;JUN;WASL;SMAD1;SMAD2;PLXND1;AGRN;MAML1;SETD3;PRKD1;ARHGEF2;ATAD2B;YAP1;LDB1;PRDM2;PPARD;IRF1;GLI3;ACVR2A;HAX1;SMAD4;AKIRIN2;NAMPT;CTBP2;SP3;TAL1;GLIS2;TP53;KDM6B;BCLAF3;KLF10;EDN1;DOT1L;NOTCH4;MED13;NCK2;POGZ;HELZ2;NFIC;PPP1R12A;RGCC;SIN3A;SMAD7;ZFPM1;BCAS3;MED17;NOTCH1;FOXF2;FOXJ3;FGF2;CDC73;RPS6KA1;HDAC4;SFPQ;TCEA1;GABPB1;WWOX;KAT5;EIF5A;CREBRF;CD40;HGF;PLSCR1;SMARCD3;ZIC3;ATF4;MZF1;AGO2;GRHL1;RPS6KA3;NR1D2;HCFC1;JAG1;TCF3;FOXC1;MYBL2;ZNF462;JMJD6;KMT2C;DR1;RUVBL2;ETV1;TNFRSF1A;FOXO4;TAF7;IGF1;SKI;CCNC;GCN1;RARA;CTNNB1;NLRC5;ARNT;CEBPG;MAVS;HEY1;HEY2;THAP3;NRF1;WBP2;ELK4;KDM1B;IKBKG;EPAS1;HLF;ZNF507;CITED2;RNF10;IKBKB;HYAL2;NOD2;GATA2;SOX4;NCOA6;RNF4;PRKDC;ATRX;SMAD9;MED10;TCF4;TCF7L2;SS18;TBL1X;PPARG;RARB;LPIN2;CKAP2;BRCA1;AKNA;NR2F2;IGF2;GLIS1;OGT;PCGF5;TERT;PBX2;CAPRIN2;TET3;CREB1;ELF4;MAPK7;NOS1;NFE2L2;GABPA;CCN1;ATAD2;RELA;MYOCD;YY1;SERPINE1;GLMP;TBX3;USP16;ATF6;RIPK1;RXRG;CRTC1;RFXANK;PCBP1;SUPT4H1;CEBPA;FZD5;ARRB1;SSBP4;THRAP3;ATF5;CCNK;E2F7;E2F3;TAF9;SMARCB1;TFDP1;HMGB1;GPS2;DHX9;INO80;BMP2;BRD4;IRF7;APBB1
prerank,cilium movement (GO:0003341),0.4639741840234253,1.6469686069664071,0.009501187648456057,0.17382678379101218,1.0,18/47,18.48%,TEKT1;TTC29;ADCY10;CFAP54;CCDC63;ODAD2;DNAAF5;DNAAF1;ROPN1L;DNAI4;CFAP70;GAS8;SPAG17;ODAD1;CABYR;DNAAF2;CAMSAP3;ODAD3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.32955042198772727,-1.6467907575214584,0.0,0.1252376081705565,1.0,241/807,21.82%,FOXP1;MECOM;KLF12;LEF1;DAB2IP;KLF7;RREB1;FOXP2;SMARCA2;ETV6;ZBTB16;ATP8B1;SP100;WWP1;ZNF423;FOXO1;MEF2A;ZHX3;CREBBP;NSD1;RB1;CBFB;ZEB1;KAT6B;KLF4;CAV1;USP9X;CBFA2T3;DAB2;ESR1;NEDD4L;BTAF1;MIER1;CUX1;FOXN3;ZFHX3;NRIP1;PRDM5;SMURF2;LIMS1;RBFOX2;KLF2;IRF2;RXRA;SPINDOC;PRDM16;RPS6KA5;UIMC1;WWC2;ID1;MITF;NR3C1;THRB;KDM2A;SOX13;NFIX;KAT6A;RCOR1;LOXL3;PSPC1;CD38;ZHX2;CDKN1B;VGLL4;ZNF148;ELK3;CTCF;NIPBL;LIMD1;BMP6;HDAC1;NFKB1;HES1;PPARA;RARG;GAS6;RPS14;DLG1;ZBTB7A;FOXO3;PDE2A;PDCD4;HIVEP1;PLCB1;MED1;SPEN;GTF2IRD1;BMP4;MAX;PTPRK;MEF2C;EZR;MIDEAS;SKIL;JUN;ZBTB4;SMAD2;ZFP90;PHF21A;PBXIP1;TBX2;SUV39H1;PPM1F;DACH1;MDFIC;NAB1;SMARCE1;YAP1;LDB1;PRDM2;PPARD;IRF1;GLI3;ZNF25;USP2;SMAD4;CTBP2;SP3;UBE2D3;GLIS2;TP53;FLNA;EHMT1;FRK;KLF10;EDN1;HMBOX1;PER3;NOTCH4;ETS2;DICER1;NFIC;SMARCC2;SIN3A;FNIP2;PSEN1;SOX7;MAZ;SMAD7;ZFPM1;PRDM6;SCMH1;CHD3;TWIST2;YAF2;NOTCH1;MTDH;CDC73;RTF1;HDAC4;SFPQ;PA2G4;LRRFIP1;WWOX;KAT5;WNT11;CIC;FBXW11;ZHX1;MECP2;ATF4;MZF1;RPL10;KMT5A;SAMD1;NR1D2;HCFC1;TCF3;FOXC1;PHF6;DAP;BCOR;NR2C1;NAB2;PHC1;DR1;PEX14;TPR;MIER2;MAD2L2;TAF7;TRPS1;BMP7;HIC1;SKI;ORC2;SUMO1;SIX4;RARA;ZNF692;ARID5B;HDAC6;ZBTB14;CTNNB1;TAF3;IGBP1;TFAP4;HDAC10;PATZ1;HEY1;ZMYND11;HEY2;MIER3;VPS72;ELK4;KDM1B;CITED2;NCOA5;RNF2;BAP1;CCND1;DUSP22;LIN37;PIAS4;RITA1;SCML4;TCF7L2;NONO;TIMELESS;TBL1X;PPARG;WWP2;PRDM1;BCL6;RARB;BRCA1;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;DLL4;MDM2;NKAP;NACC1;CBFA2T2;HSF4;GCLC;PHC3;TSHZ3;CREB1
prerank,regulation of regulated secretory pathway (GO:1903305),0.49691851852102886,1.6451299862878186,0.004434589800443459,0.17427647062215582,1.0,14/34,17.39%,SYT1;SYT5;RIMS2;RIMS1;RAB15;SYT12;SYT11;SYN1;RAB3A;SYT4;SYT3;SNAPIN;SYT9;RIMS3
prerank,response to histamine (GO:0034776),0.6715090167468838,1.6447586878093035,0.030878859857482184,0.17288671394047164,1.0,3/10,3.54%,GABRB1;GABRB3;GABRB2
prerank,Wnt signaling pathway (GO:0016055),-0.4159668161243585,-1.6430828314824661,0.0016806722689075631,0.12951827322428477,1.0,38/92,26.76%,LEF1;NXN;FERMT2;CSNK1A1;LRP5;FZD6;GSK3B;DVL3;LRRK2;DDX3X;CSNK1G3;FZD4;RBX1;RARG;LRP6;KLHL12;PLCG2;WNT16;VPS26A;CSNK1G1;WNT11;TCF7L1;USP34;CTNNB1;TCF7L2;PTEN;AMER1;FZD7;SFRP4;FZD5;PLPP3;FZD10;WNT2B;WNT5B;FZD1;APC;VPS35;FRZB
prerank,protein K48-linked ubiquitination (GO:0070936),-0.4585365151574251,-1.642630035780109,0.003656307129798903,0.12940580800715118,1.0,36/54,37.74%,PELI1;UBR5;NEDD4L;ZNRF1;UBE2K;DTX3L;RBX1;CUL3;RNF115;UBE2D3;UBE2E2;TNFAIP3;KLHL3;RNF152;RNF4;UBE2R2;RNF216;HACE1;RNF146;FBXO38;ARIH2;RNF34;RNF187;CDC34;UBE2H;TRIM32;UBE2A;IFI27;UBE2T;TOPORS;UBE2G2;UBE2C;ITCH;UBE3A;KBTBD7;RNF5
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5015483717520502,-1.6418975986354254,0.019400352733686066,0.12972230452451994,1.0,15/35,18.35%,SEMA6A;SEMA3C;NRP2;RAC1;SEMA7A;ARHGDIA;PLXND1;PLXNA4;FLNA;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.3816542951420284,-1.6414556294847995,0.0,0.12963359875574856,1.0,50/153,16.81%,PRKCH;DYRK1A;CSNK1A1;PRKCE;TLK2;GSK3B;ATM;MARK1;RPS6KA5;PAK2;LRRK2;NEK6;MTOR;PRKD2;TLK1;CSNK1G3;TGFBR2;RICTOR;GAS6;MAST4;MAST2;PRKCD;ERN1;MAPKAPK2;PLK2;MAPK1;ROCK1;PRKD1;AKT3;LATS2;CLSPN;AKT1;STK32C;IKBKE;STK38;RPS6KA1;CSNK1G1;CSNK1D;ULK2;MKNK2;MAPK8;PKN2;RPS6KA3;MARK2;PKN3;ROCK2;MAPK12;SRPK2;MARK3;HIPK1
prerank,membrane depolarization during action potential (GO:0086010),0.5229366935275532,1.6410801680042748,0.013157894736842105,0.17597517811478766,1.0,12/26,17.93%,ATP1A2;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;CACNA1D;SCN5A;SLC8A1;SCN2B;CACNA1G;CACNA1I
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5832477417204939,-1.6407143236830646,0.018083182640144666,0.12981657033684657,1.0,10/19,18.14%,CYTH3;PARD3;MSN;CYTH1;EZR;MYO18A;SIPA1L3;RHOA;GOLPH3;RAP2A
prerank,positive regulation of protein catabolic process (GO:0045732),-0.4300959834694745,-1.6399161326774405,0.0017452006980802793,0.1301971308860575,1.0,22/84,10.67%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;CDKN1B;MSN;VGLL4;ADAM9;TNFRSF1B;NEDD4;NKD1;EZR;SNX9;PLK2;GSK3A;AREL1
prerank,heart trabecula morphogenesis (GO:0061384),-0.5813217507922331,-1.6397181362383713,0.018456375838926176,0.12982159419165604,1.0,11/18,17.91%,TEK;ENG;ADGRG6;BMP5;TGFBR3;TGFB2;RBP4;S1PR1;NOTCH1;BMP7;HEY1
prerank,cell junction assembly (GO:0034329),0.3956619924078702,1.6390619468681213,0.004484304932735426,0.17668631746739122,1.0,29/100,10.12%,KIRREL3;NRXN1;CDH18;NLGN1;CDH8;CTNND2;CDH20;CDH9;CDH10;DSCAM;ADGRL3;DNER;PCDHB5;CDK5;NRCAM;PKP2;DCHS1;CDH19;FLNC;FLCN;CDH12;FSCN1;GPM6A;SDK1;CDH7;SLITRK1;POU4F1;CDH24;CDHR3
prerank,regulation of inflammatory response (GO:0050727),-0.375189292567539,-1.63801475102592,0.0016750418760469012,0.13133112159205104,1.0,66/190,25.01%,FOXP1;TEK;IL1R1;XIAP;RB1;KLF4;ETS1;MFHAS1;CASP12;CD200;SEMA7A;TMSB4X;APP;IL15;BIRC3;PPARA;TNFRSF1B;NFKBIA;OTULIN;NMI;PDE2A;PDCD4;PRKCD;NAPEPLD;CDH5;PPARD;CELF1;FEM1A;AREL1;JAK2;AGTR1;MGLL;USP18;LPL;IL17RA;NR1D2;TNFAIP3;IFI35;CCN3;C1QTNF3;IL16;TNFRSF1A;ANXA1;VAMP3;HYAL2;NOD2;DAGLB;PPARG;BCL6;AKNA;LPCAT3;VAMP2;GPR4;MAPK7;RELA;SERPINE1;RIPK1;CASP1;CEBPA;PTGIS;SHPK;ACE2;DDT;GPS2;DHX9;BRD4
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5359268283705072,-1.6375084388367132,0.02010968921389397,0.13126024352346224,1.0,10/26,16.38%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;OCLN;AKT1;BRAF;CREBL2;IGF1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5594799100273142,-1.6360642567011021,0.016885553470919325,0.1325424218536888,1.0,10/21,16.77%,LDLRAP1;MMP2;ERN1;JUN;FGF2;P2RY6;IGFBP5;HTR1B;IGF1;DNMT1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.4240445324063013,-1.6358192028889258,0.005208333333333333,0.13226048079186092,1.0,29/75,22.61%,DAB2IP;RB1;HEG1;LRP5;LYN;PTPN1;PTPRJ;CDKN1B;RASIP1;ABL1;LRP6;PRKCD;BMP4;LATS2;AKT1;STK38;SPRY4;PIK3CB;PKIG;BMP7;TFAP4;CDK5RAP3;HYAL2;UCHL1;PTEN;NF1;NR2F2;GADD45A;MYOCD
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.571768739816813,1.635656938406108,0.010869565217391304,0.17925134885638383,1.0,9/18,13.44%,NRXN1;NLGN1;CACNG8;CACNG3;CACNG2;CACNG4;CCL2;NLGN2;CACNG5
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4944275831092561,-1.6353332248993966,0.009416195856873822,0.13224342214329712,1.0,17/37,20.17%,PRKG1;LDLRAP1;MMP2;CDKN1B;PDCD4;ERN1;MEF2C;JUN;FGF2;TPM1;P2RY6;IGFBP5;HTR1B;IGF1;DNMT1;PPARG;PTEN
prerank,regulation of exocytosis (GO:0017157),0.45676972562642765,1.635123609840517,0.008888888888888889,0.1780701827911231,1.0,8/46,5.59%,IL1RAPL1;STXBP5L;SYT1;RIMS2;CADPS;RAB15;RAB3C;RAB27B
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.6199198218226945,-1.634709615540726,0.0149812734082397,0.13235142920789533,1.0,7/15,11.65%,PRKCE;LDLRAP1;PPARA;IRS1;PPARD;AKT1;ADM
prerank,renal filtration (GO:0097205),-0.693932130262938,-1.633821287013977,0.016423357664233577,0.13295590914216215,1.0,5/10,10.92%,CD34;XPNPEP3;ITGA3;TBC1D8B;MCAM
prerank,regulation of BMP signaling pathway (GO:0030510),-0.4272467860285626,-1.6337281077677637,0.005253940455341506,0.1325026719051751,1.0,20/73,12.19%,ZNF423;ENG;ACVRL1;XIAP;BMPER;CRIM1;BMPR2;SMURF2;ITGA3;SMURF1;BMP4;SKIL;CDH5;SMAD1;SMAD2;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.37592364590048655,-1.6333880720125382,0.0,0.13231676161124606,1.0,77/168,27.32%,PAN3;TUT7;TENT4B;ATM;CNOT4;RPS21;EIF3E;RPL37;RPL31;RPL9;RPS14;UPF3B;XRN1;RPSA;SAMD4A;UPF2;POLR2G;RPL3;RPLP1;RPL26;RPS11;HELZ2;XRN2;TUT4;RPL13;RPL38;RPL27;RPS16;RPS4X;TENT2;PARN;GSPT1;RPL10;PDE12;RPL7A;RC3H1;RPL5;EXOSC8;RPS27;RPL27A;RPS3;CTIF;RPL36A;RPL35A;PPP2CA;EXOSC5;PELO;DCP1A;RNPS1;RPL37A;RPL32;DIS3L2;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;THRAP3;SMG6;CNOT2;RPS17;EXOSC7;RPS2;CNOT8;ZFP36L1;RPL39;RPS26;RPS15A;DXO;RPL15;RPL34;CNOT1;PABPC1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.3123916151062545,-1.6301109488812666,0.0,0.1359480188072543,1.0,522/1668,25.06%,FOXP1;MECOM;KLF12;LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;FOXP2;SMARCA2;FLI1;ETV6;BAZ2B;ITGA6;ZBTB16;NFIB;SP100;TEF;ENG;ERG;MNAT1;ZBTB20;ACVRL1;FOXO1;MEF2A;ZHX3;CREBBP;MLLT10;NSD1;MRTFB;RB1;CBFB;SENP1;ZEB1;NFAT5;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;CAV1;USP9X;CHD1;PKD2;DAB2;LRP5;NR3C2;DACH2;PKNOX2;ESR1;NEDD4L;VGLL3;MIER1;CUX1;BMPR2;TCF12;ASXL1;HIVEP2;ZFHX3;TEAD4;TNRC6B;NRIP1;PRDM5;MED15;SMURF2;ZNF260;MED26;MAML2;KLF2;CHD2;IRF2;CDK13;DVL3;RXRA;PRRX1;APP;KLF3;TRAK1;KAT2B;NFATC1;BMP5;ATM;TBX15;PRDM16;DEK;RPS6KA5;FOSL2;RNF111;LMO2;TEAD1;CRK;WWC2;NFATC4;ZSCAN21;ARID1B;ID1;TBX1;MITF;NR3C1;THRB;DDX3X;KDM2A;ZBTB37;KANSL3;SOX13;NFIX;KAT6A;PBX3;PRKD2;PLAGL1;RCOR1;SOX17;CDK12;EGFR;MKX;ZHX2;ZBTB46;RTRAF;SP1;ZNF148;CRLF3;ELK3;CTCF;NIPBL;MGA;BMP6;HDAC1;NFKB1;HES1;LHX6;PPARA;MEOX2;RARG;SIX1;UBP1;TET2;SMARCC1;NCK1;NFKBIA;PIK3R1;RPS14;DLG1;PHF20;ABL1;ZBTB7A;FOXO3;ZIC4;PDE2A;LMO7;IKZF2;HIVEP1;HOXB6;LRP6;BBX;RHOQ;FUS;MED1;AATF;STAT6;NFYC;PRPF6;E2F4;BAZ1A;FGF1;SPEN;BRD2;GTF2IRD1;GABPB2;BMP4;CREB3L2;MAX;MEF2C;EZR;MIDEAS;SKIL;ZNF182;JUN;ZBTB4;WASL;SMAD1;SMAD2;ZFP90;TSHZ2;SRCAP;AGRN;PHF21A;TBX2;SUV39H1;MAML1;SETD3;DACH1;PRKD1;ARHGEF2;BACH2;ANXA4;ATAD2B;SMARCE1;ZBTB39;YAP1;NOP2;LDB1;PRDM2;PPARD;EBF1;IRF1;GLI3;ZNF25;ACVR2A;USP2;HAX1;SMAD4;AKIRIN2;RBBP8;ZIC5;HSF5;NAMPT;CTBP2;HOXC6;SP3;PHF20L1;UBE2D3;TAL1;GLIS2;ELF2;TP53;ZBTB40;FRK;KDM6B;BCLAF3;KLF10;EDN1;HMBOX1;DOT1L;MAMLD1;PER3;NOTCH4;ETS2;MED13;NCK2;KDM3A;POGZ;DICER1;HELZ2;STAT2;NFIC;PPP1R12A;RGCC;SMARCC2;SIN3A;PRRX2;GMEB1;FNIP2;PSEN1;JMJD1C;ZBTB7C;MAZ;SMAD7;ZFPM1;PRDM6;BCAS3;CHD3;TWIST2;HR;MED17;ZSCAN25;NOTCH1;FOXF2;FOXJ3;FGF2;MTDH;CDC73;SP140;RTF1;RPS6KA1;HDAC4;SFPQ;ZNF394;TCEA1;GABPB1;LRRFIP1;WWOX;TIAL1;KAT5;PROX2;PIAS2;ZBTB6;KLF9;EIF5A;CREBRF;CIC;CD40;HGF;ZHX1;PLSCR1;TFCP2L1;SMARCD3;DBX2;MECP2;ZIC3;ATF4;KDM7A;PGBD1;MZF1;ARID3B;AGO2;RPL10;KMT5A;GRHL1;ZBTB25;RPS6KA3;NR1D2;HCFC1;ZBTB34;HIF3A;JAG1;TCF3;TCF7L1;FOXC1;MYBL2;PHF6;MED29;ZKSCAN1;BCOR;TADA3;ZNF32;NR2C1;ZNF462;JMJD6;KMT2C;SMAD6;DR1;RUVBL2;TPR;BRWD3;ETV1;MIER2;TNFRSF1A;FOXO4;MAD2L2;CC2D1B;ZFP1;TAF7;TRPS1;HIC1;IGF1;SKI;CCNC;MOV10;ORC2;ZNF235;SUMO1;KDM5B;SIX4;RARA;MAMSTR;ZNF692;HOXA2;ARID5B;ZNF691;ZBTB14;CTNNB1;FOXQ1;ZBTB8A;TAF3;IGBP1;TFAP4;ZXDB;ZNF250;HDAC10;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;MAVS;HEY1;ZFP28;HEY2;TSHZ1;THAP3;ZSCAN12;NRF1;WBP2;MIER3;VPS72;ELK4;KDM1B;HOXB9;ZIC1;IKBKG;ZBTB12;EPAS1;HLF;ZNF507;CITED2;RNF10;NCOA5;IKBKB;HYAL2;PCGF3;NOD2;GATA2;RNF2;PPM1D;SOX4;ZFX;NCOA6;TNRC6A;CCND1;DUSP22;LIN37;RNF4;PRKDC;ATRX;SMAD9;PIAS4;RITA1;MED10;TCF4;TCF7L2;SS18;TBL1X;PPARG;WWP2;PRDM1;PTEN;BCL6;RARB;ELOC;LPIN2;CKAP2;BRCA1;ZSCAN26;BAZ1B;AKNA;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;MED27;OGT;DLL4;PCGF5;MDM2;NKAP;NACC1;TOX4;PBX2;HSF4;CAPRIN2;TET3;TSHZ3;CREB1;ZSCAN18;ELF4;MAPK7;NOS1;AASS;NFE2L2;GADD45A;GABPA;MCPH1;CCN1;ATAD2;RELA;MYOCD;YY1;SERPINE1;KDM3B;GLMP;TBX3;SUDS3;USP16;ATF6;RIPK1;MSX1;ZKSCAN8;RXRG;CRTC1;RFXANK;PCBP1;AEBP2;MED20;SUPT4H1;CEBPA;FZD5;ARRB1;BEND3;SSBP4;ZNF697;THRAP3;TRIB3;KLF16;ATF5;ZFP3;ACVR2B;CCNK;E2F7;ZFHX4;GMEB2;CNOT2;ARID3A;E2F3;TAF9;SMARCB1;ZNF276;TFDP1;TLE6;ZKSCAN4;HMGB1;RBAK;GPS2;EGR3;SP110;DHX9;INO80;BMP2;BRD4;IRF7;APBB1
prerank,response to ethanol (GO:0045471),0.6048720691625986,1.6282648212744195,0.010845986984815618,0.1861528192513117,1.0,5/14,13.89%,GRIN2B;GLRA1;GRIN2A;ADCY7;GRIN3A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.6318677003430972,1.6280553854322868,0.025974025974025976,0.18452805029889477,1.0,4/12,1.29%,SYT1;SYT5;RIMS2;RIMS1
prerank,translation (GO:0006412),-0.36021852743095145,-1.6279615467422737,0.0017699115044247787,0.1379313739330141,1.0,95/208,30.55%,YARS1;WARS2;RRBP1;RPS21;RPL37;RPL31;RPL9;RPS14;FARS2;RPSA;PTCD3;RPL3;RPLP1;MRPL32;MRPL47;RPL26;RPS11;EEF2;RPL13;MRPS18A;RPL38;DRG1;RPL27;RWDD1;RPS16;LARS1;RPS4X;MRPL2;GSPT1;AGO2;RPL10;MRPS24;RPL7A;AIMP2;HARS2;N6AMT1;DARS2;RPL5;MRPL24;RPS27;RPL27A;MRPL57;RPS3;NDUFA7;RPL36A;RPL35A;FARSA;MRPS14;RPL37A;IARS2;ABCE1;MRPS21;MRPL35;GFM2;RPL32;WARS1;RPS7;RPS15;MRPL34;RPS8;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;RPS23;MRPS2;SRBD1;NOA1;RPS17;MRPS28;RPS2;MRPL43;TUFM;EEF1B2;RPL39;MRPL11;RPS26;TNIP1;RPS15A;TRMT112;RPL15;RPL34;EEF1G;RPL22L1;GATB;RPLP2;RPL18;MRPS17;RPL19;EEF1D;RPS13;COPS5
prerank,protein phosphorylation (GO:0006468),-0.3344653112758719,-1.625739192864309,0.0,0.14024585758226993,1.0,134/478,17.01%,FLT1;GRK5;TEK;PRKCH;DAB2IP;IGF1R;PRKG1;SNRK;MAP3K20;ERG;ACVRL1;BCR;DYRK1A;ERC1;INSR;ABI1;CSNK1A1;NEK7;DAPK1;FAM20A;LYN;PRKCE;BMPR2;TLK2;GSK3B;CDK13;PRKACB;APP;ATM;JAK1;MARK1;RPS6KA5;LIMK2;PAK2;SIK1;LRRK2;MAP3K5;MAP4K3;NEK6;KDR;MTOR;CDK17;PRKD2;MERTK;CDK12;EGFR;TLK1;CSNK1G3;TGFBR3;TGFBR2;RICTOR;GAS6;STK3;STK24;BMX;ABL1;MAST4;MAST2;TGFB2;PTK2;PRKCD;BRD2;BMP4;CDK10;ERN1;MAPKAPK2;PRAG1;CDC42BPA;SMAD2;AAK1;PLK2;MAPK1;ROCK1;MAML1;BIRC6;EPHA4;PRKD1;AKT3;YWHAZ;FLT4;PXK;GSK3A;ACVR2A;LATS2;CLSPN;PIK3CD;ADAM10;AKT1;MAP3K3;SIK3;FRK;TAOK3;PRKAA1;WNK4;STK10;ILK;STK32C;FNIP2;IKBKE;BRAF;JAK2;SMAD7;USP15;ABI3;STK38;PKDCC;IRAK1;RPS6KA1;CSNK1G1;CSNK1D;CLK3;WNT11;CSK;ULK2;CDK6;MKNK2;MAPK8;PKN2;RPS6KA3;MAP4K4;MARK2;LIPE;GMFB;PKN3;ROCK2;NUAK1;MAPK12;SRPK2;SLK;FYN;MARK3;HIPK1;RARA;CDC42BPB
prerank,regulation of cell migration (GO:0030334),-0.34216534363068357,-1.6256339799850696,0.0,0.13980941323145843,1.0,140/382,22.81%,FLT1;TJP1;LEF1;IGF1R;ITGA6;SEMA6A;PECAM1;CLDN5;SEMA3C;ENG;ITGB1;ACVRL1;PODXL;FERMT2;INSR;CAV1;DAB2;RAC1;CBLL1;CORO1C;PDGFD;SEMA7A;THBS1;TMSB4X;GCNT2;ATM;MITF;ARID2;SYNE2;KDR;PTPRJ;SCAI;SMO;EGFR;ACE;ADAM9;LDLRAD4;GNA12;AFDN;TCAF1;STK24;FOXO3;LMO4;SLIT2;ROBO4;MACF1;PTK2;FGF1;NKD1;PTPRK;CDH5;PLXND1;ROCK1;PPM1F;EPHA4;DACH1;PLXNA4;LDB1;CDH1;FAM107A;MYLK;BCAR1;PIK3CD;ADAM10;FGF7;AKT1;FLNA;EDN1;ZMYND8;LMNA;MAZ;SMAD7;PHACTR1;FRMD5;TWIST2;ABI3;NOTCH1;RHOA;FGF2;SEMA3G;LIMCH1;SEMA6B;CEACAM1;SEMA4C;TPM1;ACTN4;DUSP3;NEDD9;WNT11;MYOC;RHOC;HGF;NUMB;MAP4K4;JAG1;IGFBP5;MIF;TBCCD1;ROCK2;FUZ;VSIR;SEMA5B;PIK3R3;IGF1;SLK;RIPOR1;ANXA1;CTSH;TMSB10;ADARB1;SEMA4A;RAP2A;SASH1;SEMA3E;WASHC1;CITED2;DUSP22;RAP2C;CXCL12;PTEN;F3;FERMT3;SPATA13;NF1;LAMB1;SEMA4G;VCL;AMOTL2;SH3RF2;ROR2;PDGFRB;SPAG9;LAMC2;PTK2B;HACE1;SERPINE2;CCN1;RECK;MIEN1;SERPINE1
prerank,purine-containing compound salvage (GO:0043101),-0.6557478644892263,-1.624358499126816,0.01971326164874552,0.14082948596548095,1.0,9/12,31.66%,ADK;AMPD2;HPRT1;AMPD3;ADA;PNP;GMPR2;APRT;DCK
prerank,regulation of chromatin organization (GO:1902275),-0.6366394901883169,-1.6241751344185298,0.01289134438305709,0.14042157589856738,1.0,9/14,27.56%,MLLT3;TLK2;TLK1;METTL4;SETD5;HPF1;IGF2;ALKBH4;HNRNPU
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3401508516140676,-1.6239478970768073,0.0,0.14012585699170965,1.0,112/390,17.15%,PTPRG;FLT1;TEK;IGF1R;RAPGEF2;GHR;SORBS1;WASF2;NRP2;DOCK1;FOXO1;GAB1;COL4A2;TIE1;ROR1;INSR;ABI1;ANKS1A;RAC1;LYN;RBFOX2;ARHGEF28;COL4A6;PDGFD;GSK3B;ELMO1;CRK;PAK2;NFATC4;SPRED2;KDR;PRKD2;MERTK;PTPRJ;MMP2;EGFR;GIGYF2;YES1;AP2B1;CEP57;AP2A2;CBL;NCK1;PXN;PIK3R1;IRS1;PSEN2;SHOC2;CHN1;PLCB1;DDIT4;RHOQ;PTK2;AP2S1;FGF1;PIK3C2A;MAPKAPK2;NGF;WASL;ITSN1;HNRNPM;MAPK1;ROCK1;EPHA4;POLR2G;PRKD1;GRB10;SHB;FLT4;GSK3A;ZNF106;NAMPT;GRB14;BCAR1;FGF7;AKT1;MPZL1;VEGFC;SOCS2;FRK;NCK2;RAPGEF1;PSEN1;JAK2;HNRNPF;RASA1;RHOA;FGF2;ACTB;TIAL1;ATP6V1E1;NEDD9;HGF;NCF2;PIK3CB;GRB2;ELMO2;NCKAP1;HNRNPA1;FOXC1;FLRT2;ROCK2;FOXO4;ANGPTL1;ANGPT1;PIK3R3;ARPC4;IGF1;FYN;UBASH3B;PLAT;APH1A
prerank,Rap protein signal transduction (GO:0032486),-0.6928169329933417,-1.623695949797948,0.01048951048951049,0.13988677592941928,1.0,9/10,27.59%,RAPGEF2;RAP1A;PLK2;RAP1B;RAPGEF1;RAP2A;RAP2C;RAPGEF3;RAP2B
prerank,positive regulation of hydrolase activity (GO:0051345),-0.38547682590933036,-1.6236518514542702,0.0,0.13934792711471675,1.0,55/137,25.12%,DOCK9;ITGA6;RAPGEF2;RSU1;ITGB1;FERMT2;RAB3GAP1;CD200;LIMS1;NET1;GSK3B;DVL3;RALBP1;F11R;PKP4;CCL25;AFDN;RAP1A;SNX9;TGM2;USP6NL;AGRN;RASGRP2;TBC1D30;PICALM;RAPGEF1;ARAP1;BCAS3;RHOA;MTCL1;WNT11;RHOC;CD40;LARS1;MAPK8;MAP4K4;MAPK12;TBC1D20;CTSH;ALS2;WRN;RPS3;CCL19;NDEL1;NF1;ASAP3;SNX13;EVI5;ARHGAP11A;SNX18;ADRB1;PLXNB1;RAPGEF3;BMP2;FZD10
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.6550770035138348,-1.6232556692727376,0.016697588126159554,0.1392966048762419,1.0,4/12,7.34%,DAB2IP;PTPN1;PIK3R1;ERN1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.33604510039731955,-1.623191693169501,0.0,0.13880751502460775,1.0,153/497,21.81%,FOXP1;MECOM;LEF1;DAB2IP;FOXP2;SMARCA2;ZBTB16;ATP8B1;WWP1;ZNF423;ACVRL1;FOXO1;ZHX3;RB1;ZEB1;KAT6B;KLF4;CBFA2T3;DAPK1;BTAF1;FOXN3;BMPR2;PRDM5;SMURF2;LIMS1;RBFOX2;GSK3B;SPINDOC;PRDM16;RPS6KA5;RNF139;UIMC1;ID1;NR3C1;DDX3X;SOX13;KAT6A;RCOR1;LOXL3;GIGYF2;PSPC1;CD38;ZHX2;CDKN1B;VGLL4;ZNF148;ELK3;CTCF;NIPBL;LIMD1;HDAC1;LARP1;HES1;GAS6;ZBTB7A;PDCD4;PLCB1;SPEN;BMP4;PTPRK;SAMD4A;MIDEAS;JUN;ZBTB4;SMAD2;PBXIP1;TBX2;SUV39H1;PPM1F;DACH1;MDFIC;NAB1;SMARCE1;LDB1;PPARD;IRF1;GLI3;GSK3A;SMAD4;CTBP2;SP3;WAPL;GLIS2;TP53;EHMT1;KLF10;HMBOX1;SMARCC2;SIN3A;SOX7;SCMH1;TWIST2;YAF2;PDS5A;NOTCH1;HDAC4;SFPQ;PA2G4;KAT5;WNT11;CIC;FBXW11;ZHX1;MECP2;KMT5A;SAMD1;NR1D2;IGFBP5;DAP;SYNCRIP;BCOR;BTG2;PHC1;PEX14;TAF7;BMP7;SUMO1;SIX4;RARA;ARID5B;HDAC6;ZBTB14;CTNNB1;TFAP4;HDAC10;PATZ1;HEY1;ZMYND11;HEY2;RPS3;CITED2;BAP1;PIAS4;SCML4;TCF7L2;NONO;TIMELESS;CAPRIN1;PPARG;WWP2;BCL6;BRCA1;TOB1;NR2F2;TRIM28;FOXL2;MDM2;NKAP;NACC1;CBFA2T2;GCLC;PHC3;TSHZ3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.4354649402395385,-1.6228869454082224,0.00186219739292365,0.13860988057157275,1.0,19/67,12.16%,FLT1;TEK;IGF1R;GHR;DYRK1A;INSR;ABI1;LYN;IL15;KDR;EGFR;BMX;ABL1;PTK2;EPHA4;FLT4;JAK2;ABI3;PKDCC
prerank,embryonic organ development (GO:0048568),-0.44111602828070906,-1.6220986818083645,0.005128205128205128,0.13909221070749264,1.0,27/61,21.46%,PBX1;KITLG;TEAD4;TEAD1;KDR;PBX3;SOX17;TGFBR2;TGFB2;RBP4;TBX2;NES;GLI3;PCSK5;MFSD2A;TAL1;ZFPM1;PKDCC;ATF4;RPL10;ERCC3;TBC1D23;HEY1;HEY2;COL13A1;RARB;PBX2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.49954049070273404,-1.6218592945683525,0.012152777777777778,0.13878421034714641,1.0,19/33,30.81%,ACVRL1;KLF4;THBS1;MEOX2;MEF2C;STARD13;RGCC;NOTCH1;RHOA;FGF2;MECP2;PPARG;DLL4;GADD45A;HMGB1;HDAC5;ANGPT4;JUP;TGFB1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.47486336575445337,-1.620289843635458,0.01107011070110701,0.1401657902652895,1.0,16/44,14.71%,CAST;XIAP;KLF4;THBS1;DDX3X;YWHAE;GAS6;NGF;DNAJB6;RAF1;SH3RF1;AKT1;RPS6KA1;HGF;RPS6KA3;GPX1
prerank,response to gamma radiation (GO:0010332),-0.5331278713246635,-1.6200629145771146,0.016423357664233577,0.13984020506735073,1.0,13/24,21.28%,MAP3K20;DCUN1D3;TLK2;ATM;YAP1;RPL26;TP53;PRKAA1;TRIM13;FANCD2;WRN;LIG4;MDM2
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5614307925297122,-1.62000239868087,0.008695652173913044,0.13932442677291723,1.0,9/22,21.82%,SORBS1;ZBTB20;MTOR;PPARA;PPARD;AKT1;CREBL2;PPARG;CREB1
prerank,positive regulation of phosphorylation (GO:0042327),-0.358414050417095,-1.6185476691735978,0.0,0.14066611959537034,1.0,85/240,23.45%,FLT1;TEK;IGF1R;ITGA6;PECAM1;ENG;ZBTB20;TIE1;ROR1;INSR;DAB2;RAC1;FAM20A;LYN;THBS1;DVL3;APP;RALBP1;LIMK2;TBX1;LRRK2;KDR;NIBAN1;MERTK;SLCO3A1;EGFR;TFRC;GAS6;ABL1;DSTYK;FAS;LMO4;IL34;CCND3;PTK2;IRGM;FGF1;BMP4;MRE11;EPHA4;FLT4;ACVR2A;FGF7;AKT1;VEGFC;AXIN2;PRKAA1;ILK;PFKFB3;PSEN1;FGF2;LIMCH1;CSNK1D;FLOT1;CD40;HGF;PTGES3;MIF;ROCK2;ANGPT1;PELI2;PIK3R3;IGF1;ARNT;MAVS;RAP2A;AKTIP;CCND1;BRAT1;EPHA2;KRAS;FGFR4;ITGB3;IGF2;P2RY1;ROR2;PDGFRB;EPHB6;CCN1;HSP90AA1;EPHB3;PFKFB4;RIPK1;FZD7;RALB
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.4591066332556577,-1.6185387899537855,0.008976660682226212,0.14009947620500687,1.0,17/50,14.71%,XIAP;KLF4;THBS1;PAK2;DDX3X;YWHAE;GAS6;NGF;DNAJB6;RAF1;CAAP1;SH3RF1;AKT1;RPS6KA1;HGF;RPS6KA3;GPX1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.386557786167909,-1.6180781257456995,0.0017421602787456446,0.14008838245973912,1.0,59/138,28.94%,MNAT1;CREBBP;NR3C2;ESR1;TEAD4;MED26;MAML2;RXRA;KAT2B;TEAD1;NR3C1;THRB;NOTCH3;HDAC1;PPARA;RARG;MED1;MAML1;POLR2G;NOTCH2;YAP1;PPARD;GTF2E1;GTF2E2;ERCC2;TAF11;NOTCH4;MAZ;MED17;NOTCH1;TAF8;ERCC3;NR1D2;NR2C1;DR1;TAF7;RARA;TAF3;HDAC10;TBL1X;PPARG;RARB;MED27;HDAC7;TAF4B;TAF13;RXRG;POLR2C;E2F3;TAF9;TAF15;POLR2L;POLR2H;HDAC5;GTF2H3;MAML3;E2F2;CCNH;RORC
prerank,presynaptic endocytosis (GO:0140238),0.5330159470852912,1.617908218769132,0.01805869074492099,0.19738859137728126,1.0,6/24,6.00%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.5151925074608382,-1.6172630797694687,0.013011152416356878,0.14047739412429214,1.0,12/27,26.66%,FBXL12;FBXL17;SIK1;FBXL3;USP2;TP53;PER3;RBM4B;CRTC1;PPP1CA;FBXL22;CRY2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5193151542899197,-1.6158838044338333,0.00927643784786642,0.1416294532248498,1.0,15/27,32.99%,TNRC6B;EGFR;LIMD1;BMP4;PUM1;TP53;AGO2;WTIP;RIPK1;AJUBA;DHX9;FXR1;TGFB1;STAT3;PUM2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4964372500173294,-1.6132262497926129,0.008912655971479501,0.1443086852962848,1.0,13/35,17.59%,DAB2IP;HEG1;ITGA3;SCAI;RASIP1;CUL3;TGFB2;STAMBP;TNFAIP1;MYOC;SPRY4;KCTD10;ARHGAP35
prerank,vascular transport (GO:0010232),-0.4150439139811101,-1.612427492284348,0.0,0.1446660992358891,1.0,25/81,11.66%,ABCC4;ABCG2;SLC6A6;SLC2A1;INSR;SLCO1C1;SLC7A1;SLC7A5;SLCO3A1;SLC16A12;SLC12A2;ABCC9;TFRC;SLC5A6;SLC38A5;SLC22A5;SLC16A1;SLC44A1;SLC1A5;ATP2A3;SLCO2B1;SLC13A3;MFSD2A;SLC2A13;SLC27A4
prerank,DNA double-strand break processing (GO:0000729),-0.5800624951659097,-1.6120935353232673,0.018018018018018018,0.14447559988579864,1.0,9/18,21.31%,ATM;MRE11;RBBP8;DNA2;KAT5;UBE2V2;SMARCAD1;BRCA1;BLM
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.6493983947646192,-1.6107926349641508,0.017374517374517374,0.14552326262237525,1.0,5/13,8.91%,NFIB;NFATC4;PPARA;BMP4;PPARD
prerank,muscle tissue development (GO:0060537),-0.6384175789541015,-1.609876959088362,0.027422303473491772,0.14612203663738582,1.0,5/13,8.49%,PGM5;ENG;SMO;BMP4;CSRP2
prerank,lipid phosphorylation (GO:0046834),0.6552716614709212,1.6098244037913545,0.027210884353741496,0.2079384137946397,1.0,3/10,1.83%,DGKK;DGKI;DGKQ
prerank,Notch signaling involved in heart development (GO:0061314),-0.6540452013161168,-1.6094957801108518,0.025380710659898477,0.14610762356581847,1.0,8/11,27.14%,NOTCH2;GALNT11;NOTCH1;JAG1;HEY1;HEY2;DLL4;SNAI2
prerank,photoperiodism (GO:0009648),-0.5060045367132451,-1.6093997087475527,0.018148820326678767,0.14566109432981544,1.0,12/28,26.66%,FBXL12;FBXL17;SIK1;FBXL3;USP2;TP53;PER3;RBM4B;CRTC1;PPP1CA;FBXL22;CRY2
prerank,granulocyte differentiation (GO:0030851),-0.5730676575948055,-1.6093767037331146,0.01757469244288225,0.14513885898259304,1.0,7/18,16.92%,LEF1;CBFA2T3;RXRA;DEK;TAL1;LBR;RARA
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6201665921381381,-1.609091695568033,0.01263537906137184,0.1449953241536169,1.0,7/13,15.77%,SP100;MDFIC;NUP153;CHP1;UFM1;RAB23;TPR
prerank,phosphorylation (GO:0016310),-0.34067396235247693,-1.6082616801785212,0.0,0.14549127578499976,1.0,106/384,15.37%,GRK5;PRKCH;PRKG1;SNRK;MAP3K20;ERG;ACVRL1;BCR;DYRK1A;INSR;CSNK1A1;NEK7;DAPK1;FAM20A;LYN;PRKCE;BMPR2;TLK2;GSK3B;CDK13;PRKACB;APP;ATM;JAK1;MARK1;RPS6KA5;LIMK2;PAK2;PANK2;SIK1;LRRK2;MAP3K5;MAP4K3;NEK6;MTOR;CDK17;PRKD2;MERTK;CDK12;TLK1;TGFBR2;LIMD1;GAS6;STK3;STK24;BMX;ABL1;MAST2;TGFB2;PRKCD;BRD2;CDK10;ERN1;MAPKAPK2;PRAG1;CDC42BPA;AAK1;PLK2;MAPK1;ROCK1;MAML1;BIRC6;PRKD1;AKT3;YWHAZ;PXK;GSK3A;ACVR2A;LATS2;PIK3CD;ADAM10;AKT1;DGKA;SIK3;FRK;DGKZ;TAOK3;PRKAA1;WNK4;STK10;ILK;FNIP2;IKBKE;BRAF;JAK2;STK38;IRAK1;CSNK1D;CLK3;WNT11;CSK;CDK6;PNKP;MKNK2;AGK;MAPK8;PKN2;PIK3CB;GK5;MAP4K4;MARK2;LIPE;GMFB;PKN3;ROCK2;NUAK1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.43586438321930504,-1.607700145972153,0.011884550084889643,0.14573882671807165,1.0,16/66,13.67%,DAB2IP;PTPRM;NFIB;CAV1;THBS1;MCC;TGFBR3;TGFB2;MED1;AQP11;PTPRK;RGCC;CDC73;CEACAM1;KLF9;CDK6
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.43768680754331046,-1.6076317605687647,0.005208333333333333,0.1452876457821831,1.0,25/64,22.06%,UTRN;ACER2;CORO1C;GSK3B;THBS1;CCL25;MACF1;PTK2;ROCK1;LDB1;RASA1;RHOA;LIMCH1;DUSP3;MYOC;CDK6;PIK3CB;MAP4K4;JAG1;ROCK2;SLK;SEMA3E;NF1;VCL;PTK2B
prerank,membrane assembly (GO:0071709),0.48617370368641977,1.6073443022063598,0.015659955257270694,0.20943596712518883,1.0,6/34,3.52%,PTPRD;NRXN1;IL1RAPL1;NLGN1;ANK3;STX2
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5156710712450978,-1.6069452029577067,0.014336917562724014,0.1456117541854537,1.0,11/28,19.26%,FOXP1;XIAP;BIRC3;SAMHD1;CD55;IRF1;CASP8;N4BP1;ZMPSTE24;ERAP1;TKFC
prerank,transport across blood-brain barrier (GO:0150104),-0.4115232158603214,-1.6065378287348733,0.0,0.14557554019827668,1.0,25/83,11.66%,ABCC4;ABCG2;SLC6A6;SLC2A1;INSR;SLCO1C1;SLC7A1;SLC7A5;SLCO3A1;SLC16A12;SLC12A2;ABCC9;TFRC;SLC5A6;SLC38A5;SLC22A5;SLC16A1;SLC44A1;SLC1A5;ATP2A3;SLCO2B1;SLC13A3;MFSD2A;SLC2A13;SLC27A4
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.4434757121159173,-1.606439510003821,0.0036496350364963502,0.14516864560274859,1.0,32/56,31.34%,RB1;ANKRD17;KMT2E;DDX3X;EGFR;CUL3;PLCB1;CCND3;AKT1;RGCC;CDC16;RPTOR;NSMCE2;UBE2E2;LSM11;MECP2;RAB11A;ANXA1;LSM10;CCND1;CDC25A;TFDP1;BRD4;ANAPC7;DTL;ADAM17;FGF10;RDX;ANAPC11;CCND2;STOX1;ANAPC5
prerank,integrin-mediated signaling pathway (GO:0007229),-0.42281736579141865,-1.606084549338726,0.0017094017094017094,0.14504798752640083,1.0,22/73,13.20%,DOCK1;ITGB1;FERMT2;MYH9;DAB2;ITGBL1;SEMA7A;ITGB4;ADAM9;LAMA3;ITGB5;ABL1;CUL3;PTK2;PRKD1;DST;BCAR1;ADAM10;ILK;LAMA5;CEACAM1;NEDD9
prerank,myeloid cell differentiation (GO:0030099),-0.4657941951204675,-1.6059012153198815,0.005504587155963303,0.14474654442992585,1.0,12/47,11.57%,ZBTB16;SNRK;MFHAS1;LYN;KMT2E;KAT6A;TET2;RPS14;ACIN1;TAL1;JAK2;ZFPM1
prerank,generation of neurons (GO:0048699),0.35857566155283394,1.6045256463551123,0.0,0.2117235422103034,1.0,44/190,14.87%,PTPRD;IL1RAPL1;TAFA1;MYT1L;SNPH;WNT7B;IRX4;ADGRL3;NIF3L1;SPOCK1;DNER;ATP2B2;ASTN2;FUT9;CDK5;LHX1;CDKL5;NRCAM;ITM2C;ASTN1;MDGA1;DCDC2;RUNX2;GPM6A;NTRK2;IRX3;ADNP2;INSM1;MAPT;ACSL3;LMX1B;DCX;MAP1B;CCK;AUTS2;HMGB2;WNT6;FZD3;NRBP2;TUBGCP2;BRSK2;RNF112;WNT4;RACGAP1
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.5150872323820431,-1.6033043718191928,0.00922509225092251,0.14784371097661067,1.0,14/29,26.46%,LEF1;CREBBP;HDAC1;TRRAP;AXIN2;CDC73;KAT5;ASH2L;TCF7L1;CTNNB1;TCF7L2;TERT;RBBP5;LEO1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.3402005546879509,-1.6030031293548457,0.0,0.14754832272879473,1.0,117/348,22.46%,TEK;RBPMS;RAPGEF2;GHR;PECAM1;ENG;ACVRL1;INSR;CAV1;DAB2;RAC1;FAM20A;LYN;BMPR2;PDGFD;IQGAP1;DVL3;UBE2K;APP;RALBP1;BMP5;RPS6KA5;LIMK2;PAK2;TBX1;LRRK2;IL15;DDX3X;KDR;PRKD2;NIBAN1;PTPRJ;SLCO3A1;EGFR;TFRC;BMP6;IL6R;GAS6;MRNIP;ABL1;FAS;IL34;CCND3;TGFB2;PTK2;IRGM;RASSF2;FGF1;BMP4;RAP1A;SNX9;NGF;MRE11;MAPK1;MMD;PRKD1;ARHGEF2;RAF1;FLT4;PLCG2;ACVR2A;HAX1;SMAD4;CSPG4;FGF7;AKT1;VEGFC;TP53;AXIN2;ILK;FNIP2;BRAF;JAK2;HFE;RPTOR;FGF2;LIMCH1;CSNK1D;MTCP1;FLOT1;CD40;HGF;MIF;ROCK2;MAD2L2;CREBL2;ANGPT1;PELI2;PIK3R3;BMP7;IGF1;TAB2;HDAC6;ALS2;MAVS;CACUL1;RAP2A;CCL19;CENPE;AKTIP;CCND1;BRAT1;PTPRC;RAP2C;TXN;KRAS;ITGB3;IGF2;PTPN11;P2RY1;CAPRIN2;MAP2K3;NOS1;PTK2B;TTK;CCN1;HSP90AA1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.480741919945349,-1.602961681725485,0.014209591474245116,0.14705655255802427,1.0,11/38,11.47%,INSR;KLF4;CAV1;PKD2;CD34;RAC1;KLF2;NOS1AP;AKT1;EDN1;JAK2
prerank,regulation of transferase activity (GO:0051338),-0.5932330717151227,-1.6027108487681136,0.025735294117647058,0.1468039520859191,1.0,11/17,29.78%,ATM;PARP4;LDB1;FEM1A;HMBOX1;FEM1B;NLRC5;SMG6;PINX1;BAG5;EMP2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.5219510715162493,-1.6025269582076371,0.02333931777378815,0.1465015910961705,1.0,7/26,10.40%,INSR;KLF4;PKD2;KLF2;NOS1AP;AKT1;EDN1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.46582304445784195,-1.6023480737209859,0.008787346221441126,0.14622015696025772,1.0,16/47,14.08%,RREB1;DOCK1;FERMT2;RAC1;LIMS2;LIMS1;CORO1C;CRK;ABL1;PTK2;FLNA;ILK;ACTN4;NEDD9;MYOC;SPRY4
prerank,small GTPase mediated signal transduction (GO:0007264),-0.3980405652284262,-1.6012088790471894,0.005366726296958855,0.14711479590454346,1.0,42/103,21.36%,RAPGEF5;RREB1;ARHGAP31;RAPGEF2;GNB1;BCR;RB1;BRAP;RAC1;NTN1;RALBP1;PLD1;SHOC2;JUN;PLCE1;PLK2;RASGRP2;PRKD1;PLD2;RRAS;RASSF1;TP53;GRAP;ARHGAP1;RIN2;FGF2;CHP1;KSR1;GRB2;RERG;ABR;ARHGEF18;IGF1;DNMT1;RGL1;RRAS2;KRAS;NRAS;RGL2;NF1;TRIM28;NUCB2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4207106912181261,-1.6008754589658167,0.008741258741258742,0.14697243122279968,1.0,27/73,16.68%,WASF2;DOCK1;MYO10;ABI1;RAC1;LYN;PRKCE;ELMO1;CRK;PLCG1;YES1;NCK1;PIK3R1;ABL1;PTK2;PRKCD;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;GRB2;ELMO2;NCKAP1;ARPC4;FYN
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.31342996104364235,-1.6004137262928133,0.0,0.14705309678298192,1.0,352/1082,25.06%,MECOM;LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;SMARCA2;FLI1;ITGA6;ZBTB16;NFIB;SP100;ZNF423;ENG;ERG;ACVRL1;FOXO1;MEF2A;AFAP1L2;CREBBP;MLLT10;NSD1;MRTFB;SENP1;NFAT5;DYRK1A;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;PKD2;DAB2;LRP5;ESR1;BMPR2;TCF12;ASXL1;MLLT3;ZFHX3;NRIP1;MAML2;KLF2;IRF2;DVL3;RXRA;APP;TRIM56;KAT2B;NFATC1;BMP5;ATM;PRDM16;RPS6KA5;FOSL2;RNF111;LMO2;BICRA;TEAD1;KMT2E;ZSCAN21;ARID1B;TBX1;DTX3L;MITF;NR3C1;THRB;MAP3K5;DDX3X;KANSL3;NFIX;MTOR;KAT6A;PRKD2;PLAGL1;SOX17;EGFR;CD38;NAA16;RTRAF;SP1;FZD4;CRLF3;ELK3;CTCF;BMP6;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;TET2;SMARCC1;RYBP;NCK1;TASP1;NFKBIA;PIK3R1;WDR75;ABL1;FOXO3;DNM2;LMO7;HIVEP1;LRP6;PLCB1;RHOQ;NSD3;MED1;AATF;STAT6;PRPF6;E2F4;FGF1;GABPB2;BMP4;CREB3L2;MAX;MEF2C;JUN;WASL;SMAD1;SMAD2;ZFP90;ACTA2;AGRN;MAML1;SETD3;PRKD1;MDFIC;ARHGEF2;ATAD2B;HNRNPAB;YAP1;LDB1;PRDM2;CDH1;PPARD;PHF5A;IRF1;GLI3;ACVR2A;PICALM;DDX39B;HAX1;SMAD4;AKIRIN2;NAMPT;CTBP2;SP3;FGF7;TAL1;AKT1;GLIS2;NAA15;ELF2;TP53;KDM6B;BCLAF3;KLF10;EDN1;DOT1L;NOTCH4;ETS2;MED13;NCK2;KDM3A;POGZ;HELZ2;RGMB;NFIC;PPP1R12A;RGCC;ILK;SMARCC2;SIN3A;PSEN1;MAZ;SMAD7;ZFPM1;BCAS3;RPTOR;ICE1;ARHGEF11;MED17;YAF2;NOTCH1;FOXF2;FOXJ3;FGF2;RPS6KA1;HDAC4;SFPQ;TCEA1;GABPB1;WWOX;KAT5;EIF5A;WNT11;CREBRF;ZPR1;RHOG;FBXW11;CD40;HGF;XPC;PLSCR1;SMARCD3;ZIC3;ATF4;MZF1;AGO2;GRHL1;RPS6KA3;NR1D2;HCFC1;JAG1;TCF3;FOXC1;MYBL2;MRPL12;TADA3;ZNF462;JMJD6;TRIM16;KMT2C;DR1;RUVBL2;ETV1;TNFRSF1A;FOXO4;MAD2L2;CREBL2;PCBD2;TAF7;THOC1;BMP7;IGF1;SKI;CCNC;SIX4;RARA;CTNNB1;GPATCH3;TFAP4;NLRC5;ARNT;CEBPG;MAVS;HEY1;HEY2;THAP3;NRF1;WBP2;ELK4;KDM1B;ZIC1;IKBKG;EPAS1;HLF;ZNF507;CITED2;RNF10;EDRF1;IKBKB;HYAL2;NOD2;GATA2;SOX4;NCOA6;RNF4;PRKDC;ATRX;ELOF1;MED10;TCF4;TCF7L2;SS18;TBL1X;PPARG;RARB;LPIN2;CKAP2;BRCA1;AKNA;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;OGT;PCGF5;BLM;PBX2;CAND2;CAPRIN2;TET3;CREB1;CHEK1;MAP2K3;ELF4;MAPK7;NOS1;UBTF;NFE2L2;GABPA;CCN1;ATAD2;RELA;MYOCD;KCNH2;YY1;SERPINE1;GLMP;TBX3;USP16;ATF6;RIPK1;EIF2AK3;FZD7;RXRG;CRTC1;RFXANK;PCBP1;SUPT4H1;CEBPA;FZD5;ARRB1;SSBP4;THRAP3;ATF5;SERTAD2;CCNK;E2F7;E2F3;TAF9;SMARCB1;TFDP1;TAF15;HMGB1;GPS2;FANK1;DHX9;INO80;BMP2;BRD4;IRF7;APBB1
prerank,regulation of T cell cytokine production (GO:0002724),-0.6167936801124314,-1.5998955959778882,0.013675213675213675,0.14722073239618194,1.0,7/15,24.76%,TRPM4;TNFRSF1B;CD55;SMAD7;HFE;FZD5;MAP3K7
prerank,positive regulation of cartilage development (GO:0061036),-0.5790236919542702,-1.5992254416566436,0.023985239852398525,0.14755245165251632,1.0,5/17,12.16%,ZBTB16;ACVRL1;BMPR2;BMP4;PKDCC
prerank,neuron development (GO:0048666),0.37172342799003305,1.5990843921968563,0.0,0.2180705540104331,1.0,32/141,9.80%,CNTNAP2;TENM4;NLGN1;L1CAM;RASGRF1;MYT1L;PPP1R9A;CNTN4;BLK;TENM1;ATP8A2;SH3GL2;TMEM108;GPM6B;TENM3;CDK5;SRRM4;PLP1;TENM2;EPHA5;ATXN10;MAP2;NPY;GPM6A;NTRK2;INSM1;MAPT;POU4F1;ARL3;DCX;ZFYVE27;STMN2
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.4791269358086324,-1.5988462564924963,0.01384083044982699,0.1474883358110616,1.0,14/39,15.99%,PODXL;KLF4;BMP6;PPARA;PTK2;FXYD5;PPM1F;CDH1;AKT1;NOTCH4;RGCC;NOTCH1;JAG1;MAD2L2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5418392344034706,-1.598404809952998,0.02146690518783542,0.1475158513065321,1.0,8/24,8.07%,PECAM1;ITGB1;F11R;ICAM1;NT5E;MSN;EZR;ROCK1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.33021832011238167,-1.5982292402286178,0.0,0.14723429348244427,1.0,141/509,18.97%,FLT1;HIP1;TEK;VWF;DAB2IP;IGF1R;KITLG;JCAD;RAPGEF2;ENG;ITGB1;PELI1;GAB1;AKAP13;FERMT2;NFAT5;ROR1;INSR;CAV1;RAC1;TAB3;NR3C2;MFHAS1;ESR1;LYN;MIER1;ANKRD17;NOD1;LIMS1;TRAF5;PDGFD;THBS1;IQGAP1;GCNT2;TRIM25;APP;ADRA1B;TBX1;DDX3X;PLEKHG5;RPL37;NEK6;KDR;TNFSF10;PRKD2;PTPRJ;EGFR;BIRC3;TFRC;RICTOR;CBL;GAS6;PIK3R1;IRS1;NMI;PDCD4;TGFB2;NEDD4;PTK2;FGF1;PUM1;PLK2;TGM2;SEC13;ROCK1;MIOS;PRKD1;NOS1AP;FLT4;PLCG2;HAX1;ALPK1;WNT16;CASP8;PIK3CD;CFLAR;FGF7;MAP3K3;TP53;FLNA;THEM4;BCAP31;DDX60;ILK;IKBKE;TRIM14;JAK2;MAZ;ADGRV1;USP15;RPTOR;RHOA;FGF2;IRAK1;MTDH;ACTN4;TCIM;WNT11;MYOC;RHOC;RHOG;CD40;LARS1;HGF;KSR1;PIK3CB;GRB2;IFI35;BBC3;IAPP;CGAS;TNFRSF19;MIF;ROCK2;GAB2;TNFRSF1A;TNFAIP8L3;ANGPT1;PELI2;BCL2L11;IGF1;TAB2;TFG;TRIM13;MIB2;FYN;GSDME;VAPA;GOLPH3;CDK5RAP3;MAVS;SASH1;RPS3;IKBKG;CCL19;LURAP1;MAP3K14;EDAR;SIAH1;IKBKB;NOD2
prerank,regulation of secretion (GO:0051046),0.6155444170851363,1.5981330530725164,0.030303030303030304,0.21752110376978617,1.0,7/13,15.40%,NRG1;POFUT2;ACSL3;OAS2;GPLD1;SGK1;MYO6
prerank,receptor catabolic process (GO:0032801),-0.5317161673111509,-1.5974442686298198,0.012797074954296161,0.14770155286131678,1.0,13/24,23.00%,ZNRF3;SMURF1;AP2B1;AP2A2;RNF43;NEDD4;AP2S1;MYLIP;LGMN;AP2M1;SNX25;KIF16B;BECN1
prerank,positive regulation of cell differentiation (GO:0045597),-0.35383856839195016,-1.5968367951934859,0.0,0.14787234245102174,1.0,68/237,16.38%,LEF1;PRKCH;KITLG;CTNNA1;SLC6A6;RAPGEF2;ZBTB16;ACVRL1;MEF2A;ZHX3;ZEB1;FERMT2;BOC;CD34;DAB2;LRP5;BMPR2;GCNT2;KDR;MTOR;IL6ST;TRPM4;TGFBR2;BMP6;IL6R;NFKB1;ABL1;PLCB1;TGFB2;BLOC1S5;BMP4;RAP1A;MEF2C;CDON;NGF;SMAD2;MMD;BNIP2;PRKD1;ARHGEF2;YAP1;PPARD;ACVR2A;SMAD4;RRAS;AKT1;AXIN2;RGCC;SIN3A;EDN3;AGTR1;RIN2;PKDCC;RHOA;RPS6KA1;PA2G4;CEACAM1;LPL;TMEM64;HGF;RPS6KA3;SMYD1;TCF3;FOXC1;MAPK12;CREBL2;BMP7;IGF1
prerank,copper ion homeostasis (GO:0055070),-0.5687679125570544,-1.5961677321781067,0.031078610603290677,0.14823067951277963,1.0,4/17,4.50%,XIAP;APP;ATOX1;SLC31A1
prerank,homologous chromosome segregation (GO:0045143),0.5413993994011945,1.5948689494775614,0.019823788546255508,0.22057428107667384,1.0,4/20,3.69%,SYCP1;MAJIN;ZCWPW1;FMN2
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.5555302081391597,-1.5947453494358224,0.013816925734024179,0.14952246393074345,1.0,11/21,17.95%,NOS3;SRGN;TRPM4;GAS6;ASPN;ROCK1;NOTCH1;BCOR;ROCK2;HEY1;HEY2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.4424302464374787,-1.594683335649086,0.007259528130671506,0.14908261341082252,1.0,25/60,23.73%,LEF1;CBFB;TNRC6B;MED15;MED26;NFKB1;MED1;TP53;MED13;MED17;MECP2;CCNC;MOV10;CTNNB1;HEY2;PPM1D;TNRC6A;CCND1;MED10;TCF7L2;PTEN;TRIM28;MED27;RELA;MED20
prerank,negative regulation of vascular permeability (GO:0043116),-0.6279901217668674,-1.5946557689312295,0.039285714285714285,0.14863249773125806,1.0,9/12,16.14%,CLDN5;FERMT2;PTPRJ;PDE3A;PDE2A;SLIT2;RAMP2;CEACAM1;ANGPT1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.604720877635514,-1.5937727055886544,0.021359223300970873,0.14917374718259468,1.0,5/15,9.48%,LEF1;CHD1;SP1;JUN;TAF11
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.4804816664120379,-1.593623705553527,0.0149812734082397,0.14882359573927503,1.0,14/39,12.27%,ENG;TIE1;PKD2;LRP5;KDR;TGFBR2;SIX1;RASIP1;COL4A1;LRP6;SLIT2;BMP4;NOTCH4;FGF2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5850584016352828,-1.5935344883942613,0.013513513513513514,0.1484362598419519,1.0,5/17,8.91%,CAV1;ADIPOR2;PANK2;PPARA;PPARD
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5227662095122639,-1.5926285174435435,0.01981981981981982,0.14903398628452563,1.0,7/25,10.40%,INSR;KLF4;PKD2;KLF2;NOS1AP;AKT1;EDN1
prerank,cellular component maintenance (GO:0043954),-0.6345661718531618,-1.5908247203816535,0.01639344262295082,0.15078144391791978,1.0,3/12,2.92%,IGF1R;INSR;ITGA3
prerank,inhibitory synapse assembly (GO:1904862),0.6302045251114663,1.590387243499751,0.04387990762124711,0.22550514078997633,1.0,4/11,9.50%,GABRB3;GABRB2;GABRA2;GABRA1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.5100798826206197,-1.5900955164310664,0.013157894736842105,0.1512320201909526,1.0,13/29,22.06%,FLT1;TEK;IRS1;AMBRA1;PTK2;PRKD1;DGKZ;FGF2;TNFAIP8L3;CCL19;NOD2;PDGFRB;PTK2B
prerank,erythrocyte development (GO:0048821),-0.6700935373493149,-1.5892108352662364,0.01971326164874552,0.15195298935855722,1.0,4/10,8.14%,ALAS1;ZBTB7A;MED1;ABCB10
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.4913069614454177,-1.5891324136001097,0.007272727272727273,0.15157024862109553,1.0,19/33,32.81%,RB1;DCUN1D3;KLF4;PKD2;DLG1;FAM107A;CDC73;CDK6;CDK2AP2;PTEN;CDKN2C;FHL1;E2F7;PLK3;APC;CDKN2B;JADE1;WEE1;CDK4
prerank,extracellular matrix organization (GO:0030198),-0.3470413275180478,-1.588641553002286,0.0,0.1517117749851806,1.0,82/276,15.88%,VWF;TLL1;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;COL12A1;ITGB1;JAM2;BSG;COL4A2;COL25A1;PLOD1;PLOD2;ADAMTS2;COL4A6;THBS1;ITGA3;APP;F11R;VIT;SPOCK2;SH3PXD2B;ITGA1;SMOC1;KDR;P3H2;COL5A1;ICAM1;ITGB4;HTRA1;MMP2;LOXL3;LAMA3;LAMA4;GAS6;ITGB5;COL4A5;COL4A1;TGFB2;COL8A2;COL5A2;SLC39A8;AGRN;HSPG2;COLGALT2;LOXL1;DST;CDH1;ADAMTS9;CAPN2;ADAM10;ADAMTS4;LAMA1;ADAMTS10;BGN;FBLN5;ADAMTS5;P4HA1;ADAMTS20;COL6A3;ADAMTS17;COL15A1;LAMA5;FGF2;COMP;THSD4;LAMC3;LCP1;NID1;FLOT1;ITGA4;COL26A1;ICAM2;HAS1;FLRT2;EXOC8;SMOC2;ITGA2;COL6A2
prerank,sodium-independent organic anion transport (GO:0043252),-0.6675258515261541,-1.588046556014663,0.025362318840579712,0.1519296870501411,1.0,7/10,29.04%,SLCO2A1;SLCO1C1;SLCO3A1;SLCO2B1;SLCO4A1;SLCO1B1;SLC16A2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5214933490835418,-1.5865697636442795,0.009191176470588236,0.153353742635207,1.0,11/26,18.97%,TAB3;NOD1;IFIH1;ALPK1;CASP8;IRAK1;TNFAIP3;TAB2;IRAK2;IKBKG;NOD2
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.5907366470416814,-1.584440498765423,0.021778584392014518,0.1558693688405682,1.0,5/16,10.04%,CREBBP;KAT2B;NAA16;NAA80;NAA15
prerank,regulation of glycolytic process (GO:0006110),-0.41904741372772325,-1.5836677203676877,0.01060070671378092,0.156351931331292,1.0,20/68,17.86%,ZBTB20;INSR;CBFA2T3;APP;NUP42;RAE1;RANBP2;PPARA;ZBTB7A;NUP98;SEC13;PRKAA1;PFKFB3;PSEN1;NUP153;HDAC4;TPR;IGF1;ARNT;NUP214
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.45301480390440524,-1.5834091464954987,0.012195121951219513,0.15613600116268517,1.0,15/44,20.79%,DAB2IP;LYN;PTPN1;PTPRJ;PDCD4;PRKCD;BMP4;STK38;SPRY4;PIK3CB;BMP7;CDK5RAP3;HYAL2;UCHL1;NF1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3709850315082165,-1.5826419944682435,0.003401360544217687,0.15661869683700494,1.0,46/161,15.99%,DAB2IP;CSNK1A1;CAV1;DAB2;MLLT3;FZD6;GSK3B;DVL3;MCC;PSMA2;IGFBP4;ZNRF3;SOX13;SOX17;EMD;KREMEN1;FZD4;LIMD1;HDAC1;FRMD8;RBX1;STK3;CUL3;LRP6;NKD1;PSME2;KLHL12;CTNND1;PSMB4;GLI3;GSK3A;LATS2;UBAC2;AXIN2;DKK2;TMEM64;NOTUM;WNT11;PSMC2;LMBR1L;TMEM170B;PSMB2;FUZ;RUVBL2;PSMB1;MAD2L2
prerank,canonical Wnt signaling pathway (GO:0060070),-0.42384559936254534,-1.5826318648887603,0.008445945945945946,0.1561253603355439,1.0,30/68,26.76%,LEF1;CSNK1A1;CAV1;LRP5;FZD6;GSK3B;DVL3;LRRK2;FZD4;RARG;LRP6;RAB5A;WNT16;WNT11;TCF7L1;CTNNB1;TCF7L2;PTEN;AMER1;FZD7;SFRP4;PPP1CA;FZD5;PLPP3;FZD10;WNT2B;WNT5B;FZD1;APC;FRZB
prerank,endothelial cell differentiation (GO:0045446),-0.6297501474310893,-1.581981249726136,0.017889087656529516,0.15634885690080372,1.0,6/12,14.85%,ACVRL1;TIE1;BMPR2;KDR;KDM6B;JAG1
prerank,macrophage activation (GO:0042116),-0.48702418928946145,-1.5818538977556498,0.015332197614991482,0.15598934844369775,1.0,9/34,14.93%,FOXP1;APP;DYSF;NMI;LBP;CD93;PLCG2;JAK2;IFI35
prerank,aortic valve development (GO:0003176),-0.48016003991416,-1.5804249759854447,0.01718213058419244,0.15754205076077107,1.0,17/34,17.95%,ELN;RB1;NOS3;TIE1;BMPR2;NFATC1;TNFRSF1B;SLIT2;BMP4;ROCK1;NOTCH1;JAG1;ROCK2;SMAD6;TNFRSF1A;HEY1;HEY2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.6367259919778476,-1.58037763325854,0.022058823529411766,0.1571061782607466,1.0,5/12,9.09%,GMDS;CSGALNACT1;GFPT2;FUT8;SLC35A3
prerank,long-term synaptic potentiation (GO:0060291),0.5223504682022655,1.5801620259766243,0.02591792656587473,0.2409564323043863,1.0,7/21,11.77%,MPP2;SLC24A2;GRIN2B;GRIN2A;SLC8A2;PRKCZ;SLC8A3
prerank,positive regulation of catabolic process (GO:0009896),-0.42905569768824314,-1.5800510439012194,0.0051635111876075735,0.15699628523676465,1.0,28/65,26.50%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;CDKN1B;NEDD4;NKD1;PLK2;GSK3A;AREL1;TNFAIP3;VSIR;OAZ2;GPC3;WWP2;HUWE1;HACE1;SEC22B;FZR1;TNFSF12;DTL;APC
prerank,positive regulation of blood coagulation (GO:0030194),-0.5754741692125148,-1.5799785901274868,0.0325497287522604,0.15657327378107772,1.0,9/17,26.84%,ST3GAL4;THBS1;ENPP4;ANO6;F3;SERPINE1;HPSE;DMTN;F2R
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.33928161550739067,-1.5795332612243353,0.0,0.15666750089709502,1.0,123/306,27.65%,MEF2A;ST3GAL4;EXT1;ALAS1;RBMS1;RRBP1;ATM;RPS21;THRB;RPL37;RPL31;TOP3A;RPL9;RPS14;RPSA;MRE11;POLR2G;MCM9;ST3GAL2;RPL3;RPLP1;MRPL32;RBBP8;CLSPN;RPL26;MCM4;PWP1;RPS11;TAF1B;ORC5;EEF2;POLD3;RPL13;MRPS18A;RPA3;DNA2;KAT5;RPL38;REV1;DRG1;RPA1;RPL27;RPS16;TBRG1;RPS4X;GSPT1;AGO2;RPL10;B4GALT5;RPL7A;GAL3ST2;HARS2;RPL5;TOP1MT;CREBL2;ORC2;MRPL24;RPS27;POLE2;PTMS;RPL27A;GOLPH3;WRN;RPS3;LARGE1;ORC4;RPA2;RPL36A;RPL35A;MRPS14;TIMELESS;RNPS1;RPL37A;BRCA1;MRPS21;MRPL35;TERT;RPL32;BLM;WARS1;RFC4;CHEK1;PTMA;RPS7;RPS15;MCM3;TOP1;MRPL34;RPS8;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;MED20;RPS23;POLR2C;SRBD1;RPS17;POLR2L;POLA2;RPS2;MRPL43;MLF1;POLR2H;TUFM;MCM7;EEF1B2;RPL39;MRPL11;RPS26;TNIP1;RPS15A;MMS19;RPL15;RPL34;MCM5;EEF1G;MCM10;POLL;EXO1
prerank,negative regulation of apoptotic process (GO:0043066),-0.327239409127488,-1.5794362484010427,0.0,0.15631802551196422,1.0,117/444,17.30%,TJP1;LEF1;GRK5;TEK;PRKCH;IGF1R;ITGB1;FOXO1;XIAP;RB1;ERC1;KLF4;CAV1;MCL1;DAB2;TNFAIP8;GSK3B;THBS1;ARHGAP10;PAK2;NFATC4;TBX1;DDX3X;KDR;YWHAE;MERTK;EGFR;IL6ST;BIRC3;TFRC;CD38;NAA16;TAX1BP1;RNF213;SLC30A10;HDAC1;NFKB1;SIX1;CBL;GAS6;NFKBIA;PIK3R1;DSTYK;PSEN2;FAS;PTK2;MED1;AATF;PRKCD;BMP4;BNIP3;MEF2C;ARHGDIA;NGF;RNF144B;MYO18A;PLK2;MRE11;DNAJB6;MAPK1;BIRC6;NOTCH2;BNIP2;ANXA4;RAF1;YAP1;YWHAZ;FLT4;SH3RF1;HAX1;ADAM10;CFLAR;AKT1;NAA15;SOCS2;TP53;FLNA;PRKAA1;AREL1;PSEN1;BRAF;MAZ;RASA1;NOTCH1;SON;IRAK1;COMP;MTDH;RPS6KA1;SFPQ;PA2G4;CAT;TCIM;WNT11;UFM1;BABAM2;HGF;MAPK8;RPL10;RPS6KA3;ZFAND6;GPX1;MAP4K4;MIF;PRDM9;SMAD6;LGMN;ANGPT1;IGF1;SIX4;ANXA1;CTSH;CTNNB1;FOXQ1;IGBP1;API5;PPIF
prerank,response to interferon-beta (GO:0035456),-0.5273749479333888,-1.579015691872961,0.023575638506876228,0.15630613947467628,1.0,12/22,30.71%,UBE2K;IRGM;IRF1;IKBKE;IFITM3;PLSCR1;IFNAR2;IFITM2;TRIM6;BST2;CDC34;SHFL
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.41397188332984286,-1.5788511527464044,0.0017241379310344827,0.15606197322846124,1.0,31/88,25.22%,TEK;PTPRM;NRP2;ACVRL1;TIE1;CAV1;BMPR2;THBS1;KDR;PRKD2;BMP4;PRKD1;AKT3;FLT4;PIK3CD;AKT1;VEGFC;RGCC;FGF2;ANGPT1;ARNT;NRAS;F3;ITGB3;NF1;NR2F2;SEMA5A;EGR3;BMP2;THBS4;TNFSF12
prerank,regulation of intracellular signal transduction (GO:1902531),-0.3305903114726905,-1.5786877792562701,0.0,0.15577466970194861,1.0,137/420,22.02%,SGMS1;TEK;VWF;DAB2IP;CHN2;ARHGAP31;MOB3B;AKAP13;PPP1R13B;XIAP;BCR;RAC1;RHOJ;ARHGEF3;LYN;NET1;TRAF5;STARD8;TMSB4X;RALBP1;ATM;MCF2L;ARHGAP10;CRK;PAK2;WWC2;LRRK2;ARAP3;PLEKHG5;MTOR;KAT6A;PRKD2;EGFR;BIRC3;PIP4K2A;TOP3A;RICTOR;HDAC1;ARHGAP5;RASGRF2;GNA12;NFKBIA;DLG1;PHF20;STK3;PDE2A;CHN1;ARHGEF12;DDIT4;PAK1IP1;RHOQ;PIP4K2B;RASSF2;FGF1;PIP5K1B;EZR;ARHGDIA;MRE11;ITSN1;MAPK1;ARHGEF2;NOP2;PLCG2;USP2;IER3;RRAS;RBBP8;TAF11;ARHGAP17;SOS2;STARD13;AKT1;TP53;EHMT1;TAOK3;PRKAA1;ARAP1;ARHGAP1;CHD3;TTI1;ARHGEF11;RHOA;ARHGAP28;CEACAM1;RPA3;DNA2;KAT5;PTPN13;RPA1;FAM13A;MYOC;RHOC;RHOG;KMT5A;TRIO;ZFAND6;MAP4K4;NUAK1;RPL5;ARHGAP22;CASTOR1;ABR;ARHGEF18;DEPDC7;TAF7;PREX1;HIPK1;ARHGAP12;TAF3;ARHGAP29;ARHGAP35;CMKLR1;WRN;IKBKG;RPA2;PRKAB1;ITFG2;ARHGAP26;VRK2;USP7;BOP1;FAM13B;TMEM127;PRDM1;PTEN;BRCA1;ARHGEF5;RRS1;MDM2;BLM;NRK;VAV2;ARHGEF1;RFC4;TAF4B;CHEK1;SYDE1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5901321806975189,-1.5782748738485404,0.02154398563734291,0.1558294350754163,1.0,10/15,28.84%,TMSB4X;KDR;PRKD2;PRKD1;FGF2;SMOC2;LGMN;SEMA5A;MET;FGF18
prerank,regulation of leukocyte activation (GO:0002694),-0.6073694200907039,-1.5761668262331017,0.018726591760299626,0.15826603966529826,1.0,7/14,15.33%,MFHAS1;LYN;CD200;MYO18A;PLSCR1;GPR137B;MIF
prerank,atrial septum morphogenesis (GO:0060413),-0.6702000717331065,-1.5760558914065037,0.031192660550458717,0.15793021570497906,1.0,6/10,19.06%,BMPR2;TGFB2;NOTCH2;ZFPM1;HEY2;SOX4
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5805112253723945,1.5757949990113642,0.035164835164835165,0.24644360496381773,1.0,7/15,15.56%,MELTF;PDPN;DDR2;FSCN1;CST3;DDR1;CLASP2
prerank,negative regulation of programmed cell death (GO:0043069),-0.33270836128347725,-1.5741814094562874,0.0,0.15985534033001353,1.0,96/355,17.30%,MECOM;TJP1;LEF1;GRK5;TEK;IGF1R;FOXO1;XIAP;ERC1;MCL1;DAB2;TNFAIP8;GSK3B;THBS1;ARHGAP10;PAK2;RAB7A;DDX3X;KDR;EGFR;IL6ST;BIRC3;TFRC;CD38;NAA16;TAX1BP1;HDAC1;NFKB1;CBL;GAS6;NFKBIA;PIK3R1;DSTYK;PSEN2;FAS;PTK2;MED1;AATF;BMP4;BNIP3;ARHGDIA;NGF;RNF144B;MYO18A;PLK2;MRE11;BIRC6;NOTCH2;BNIP2;ANXA4;RAF1;YWHAZ;FLT4;SH3RF1;HAX1;ADAM10;CFLAR;AKT1;NAA15;SOCS2;TP53;FLNA;PRKAA1;AREL1;PSEN1;BRAF;RASA1;SON;IRAK1;COMP;TM7SF3;MTDH;RPS6KA1;PA2G4;CAT;TCIM;WNT11;UFM1;BABAM2;HGF;MAPK8;RPL10;RPS6KA3;ZFAND6;MAP4K4;MIF;PRDM9;SMAD6;ANGPT1;IGF1;SIX4;ANXA1;CTSH;CTNNB1;API5;PPIF
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.42802531780676206,-1.5731443460664072,0.005319148936170213,0.16050051120140035,1.0,32/65,30.81%,CAV1;SMURF2;IL17RD;PRDM16;SPRED2;SMURF1;TGFBR2;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD2;SMAD7;SMAD6;SKI;NRROS;PMEPA1;HTRA3;DAND5;SNX25;STRAP;MTMR4;FBN1;ADAM17;EMILIN1;TGFBR1;ADAMTSL2;BAMBI;LTBP1;SPRY1;TGFB1
prerank,cellular response to cadmium ion (GO:0071276),-0.525634430961526,-1.5724903116106919,0.025500910746812388,0.16089843153590178,1.0,14/24,25.53%,EGFR;JUN;MAPK1;AKT1;MAPK8;SUMO1;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B
prerank,positive regulation of wound healing (GO:0090303),-0.47130528299140056,-1.5712972033442967,0.016304347826086956,0.1620251760687406,1.0,12/36,11.88%,RREB1;ITGB1;ST3GAL4;FERMT2;PRKCE;THBS1;MTOR;PTK2;ENPP4;OCLN;MYLK;ARFGEF1
prerank,embryonic hemopoiesis (GO:0035162),-0.6388976611953325,-1.5708341591837702,0.02181818181818182,0.16216625286370331,1.0,6/12,14.04%,KITLG;KDR;TGFBR2;TAL1;ZFPM1;ATF4
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6338445180744485,-1.570416720453105,0.03272727272727273,0.16222350695532708,1.0,8/11,23.08%,CD34;ADIPOR2;KDR;MCAM;PRCP;GATA2;ITGB3;HPSE
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5658006102763041,-1.5703156618543488,0.022452504317789293,0.16185120787396923,1.0,8/18,17.27%,ANKRD17;RNF125;BIRC3;PUM1;SEC14L1;DDX60;USP15;GPATCH3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.5702128259885838,1.5693662763382348,0.024719101123595506,0.2557395606382916,1.0,5/15,13.34%,NLGN1;CNTNAP4;CLN3;ADRA1A;NLGN2
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.42147423562374875,-1.569343490753464,0.01060070671378092,0.16271379800827407,1.0,31/66,29.47%,UBR5;FERMT2;LIMK2;DTX3L;TFRC;PIK3R1;PRKCD;TCP1;YAP1;CDH1;AKT1;FLNA;PSEN1;ZPR1;TPR;CDK5RAP3;MAVS;ZIC1;HYAL2;ORMDL3;TRIM28;TERT;EIF2AK3;PINX1;CCT5;CCT2;PARP9;RAN;NMD3;JUP;LARP7
prerank,actin filament organization (GO:0007015),-0.3661241832782524,-1.5686840576774252,0.0035087719298245615,0.1630349480724085,1.0,44/151,17.13%,HIP1;SHROOM4;MYO1D;EPS8;ABI1;BAIAP2L1;CD2AP;RAC1;SHROOM3;TPM3;RHOBTB1;CORO1C;PLS3;SVIL;ELMO1;RND3;CGNL1;DLG1;TMOD3;WASL;MYO1F;BIN3;ARHGEF2;SHROOM1;ARHGAP17;BCAR1;NEBL;FLNA;SHROOM2;FAT1;RHOA;ACTN1;LCP1;LMOD1;TPM1;NEDD9;RHOC;RHOG;ELMO2;HIP1R;MAD2L2;ARPC4;CORO7;ARHGAP12
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.49824447803998595,-1.5682236349061787,0.028119507908611598,0.16313174998504573,1.0,10/29,16.11%,SORBS1;ZBTB20;MTOR;PPARA;ELOVL5;SCARB1;MFSD2A;AKT1;CHP1;CREBL2
prerank,cellular response to reactive oxygen species (GO:0034614),-0.4271868522281933,-1.5680223204261228,0.007104795737122558,0.16291680495853245,1.0,26/59,24.02%,PKD2;NET1;MAP3K5;EGFR;PXN;ABL1;PRKCD;PTPRK;JUN;MAPK1;ANKZF1;AKT1;TPM1;MAPK8;TNFAIP3;AGAP3;ANXA1;HDAC6;PPIF;RPS3;ERCC6L2;MAPK7;NFE2L2;RELA;RIPK1;CYP1B1
prerank,regulation of cell cycle (GO:0051726),-0.34152957183912963,-1.5675471390534945,0.0,0.16305215258747527,1.0,96/271,26.54%,MECOM;GRK5;APBB2;DAB2IP;TTC28;MAP3K20;PPP1R13B;XIAP;AFAP1L2;RB1;DCUN1D3;NEK7;PKD2;ANKRD17;THBS1;IQGAP1;FBXL12;LIN52;KAT2B;ATM;FBXL17;SIK1;NEK6;PLAGL1;FBXL3;BIRC3;CDKN1B;CRLF3;ABL1;PDCD4;PHACTR4;LRP6;TGFB2;RNF40;CDC14A;BMP4;PTPRK;CDK10;ERN1;PUM1;JUN;UHRF2;NOTCH2;IRF1;RASSF1;ADAM10;TP53;RGCC;NOTCH1;SON;CDC123;CDK6;TBRG1;NUDT6;RNF167;HCFC1;MYBL2;MIF;MAPK12;FOXO4;BMP7;SRPK2;RARA;TFAP4;ADARB1;CDK5RAP3;RAD23A;CITED2;BAP1;CCND1;PTPRC;LIN37;BOP1;TCF7L2;CDK11B;BRCA1;PES1;MDM2;CDKN2C;CHEK1;CDC25A;GADD45A;TBX3;MAEA;BMP2;APBB1;FBXL22;SIPA1;MLF1;DTL;RPS15A;NUPR2;CDKN3;APC;GAS2L1;FGF10
prerank,peptide biosynthetic process (GO:0043043),-0.3628221052523161,-1.5664541896258815,0.0018115942028985507,0.16407580959305426,1.0,68/153,31.12%,RRBP1;RPS21;RPL37;RPL31;RPL9;RPS14;GGT5;RPSA;PCSK5;RPL3;RPLP1;MRPL32;RPL26;RPS11;RPL13;MRPS18A;RPL38;RPL27;RPS16;RPS4X;GSPT1;AGO2;RPL10;RPL7A;HARS2;RPL5;MRPL24;RPS27;RPL27A;RPS3;RPL36A;RPL35A;MRPS14;RPL37A;MRPS21;MRPL35;RPL32;WARS1;RPS7;RPS15;MRPL34;RPS8;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;RPS23;SRBD1;RPS17;RPS2;MRPL43;RPL39;MRPL11;RPS26;TNIP1;RPS15A;RPL15;RPL34;RPLP2;RPL18;MRPS17;RPL19;RPS13;COPS5;RPL8
prerank,cardiac muscle cell action potential (GO:0086001),0.47743595391761584,1.56626965851502,0.022727272727272728,0.2592997015469602,1.0,9/30,8.20%,ATP1A2;FGF12;SCN1B;SCN1A;CACNA2D1;PKP2;ATP1B1;CACNA1D;SCN5A
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5802983978716081,-1.5656377884748296,0.019855595667870037,0.1646153570101775,1.0,5/16,12.29%,ST3GAL4;NFAT5;ETS1;RHOA;IRAK1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.4774608955038897,-1.565620843241483,0.018315018315018316,0.16413339938254506,1.0,21/34,35.49%,RB1;INSR;LRP5;CUL3;EDN1;RGCC;CDC16;EDN3;NSMCE2;IGF1;IGF2;PDGFRB;ANAPC7;BTC;ANAPC11;ANAPC5;AURKA;PHIP;IL1A;ESPL1;DRD3
prerank,positive regulation of axon extension (GO:0045773),0.5276008490647204,1.5637225366579206,0.031818181818181815,0.26166912487888266,1.0,9/22,9.71%,L1CAM;DSCAM;SHTN1;CDKL5;LIMK1;MEGF8;MAPT;VEGFA;ZFYVE27
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.530989564584623,-1.5603874864847183,0.026168224299065422,0.17085636217438063,1.0,9/23,17.56%,ZBTB20;INSR;APP;NFKB1;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,regulation of vasculature development (GO:1901342),-0.5104047883687717,-1.5596548489817617,0.029616724738675958,0.17134013193576692,1.0,13/26,29.78%,SP100;ADGRA2;BMPER;ETS1;PLXND1;FGF2;CTNNB1;EPHA2;NF1;WARS1;TSPAN12;HMOX1;EMP2
prerank,vasoconstriction (GO:0042310),-0.6437605198704138,-1.559263710562809,0.029411764705882353,0.1713754781320625,1.0,5/11,11.69%,EDNRA;PIK3C2A;ACTA2;EDN1;EDN3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.299144022824915,-1.5584033920330667,0.0,0.1720674171358769,1.0,512/1646,25.19%,FOXP1;MECOM;KLF12;LEF1;PBX1;APBB2;DAB2IP;KLF7;NFIA;RREB1;FOXP2;SMARCA2;FLI1;ETV6;BAZ2B;ZBTB16;ATP8B1;NFIB;SP100;WWP1;ZNF423;TEF;ENG;ERG;MNAT1;ZBTB20;ACVRL1;FOXO1;MEF2A;ZHX3;AFAP1L2;CREBBP;NSD1;RB1;BNC2;CBFB;ZEB1;NFAT5;DYRK1A;ZMIZ1;KAT6B;ELF1;ERC1;INSR;KLF4;ETS1;CHD1;CBFA2T3;LRP5;NR3C2;DACH2;PKNOX2;ESR1;VGLL3;BTAF1;CUX1;FOXN3;TCF12;HIVEP2;MLLT3;ZFHX3;TEAD4;PRDM5;SMURF2;ZNF260;LIMS1;RBFOX2;MED26;KLF2;CHD2;IRF2;ZNF326;DVL3;RXRA;PRRX1;KLF3;TRIM56;TRAK1;NFATC1;TBX15;SPINDOC;PRDM16;DEK;RPS6KA5;FOSL2;RNF111;BICRA;TEAD1;CRK;UIMC1;WWC2;KMT2E;NFATC4;ZSCAN21;ARID1B;ID1;TBX1;DTX3L;MITF;NR3C1;MAP3K5;KDM2A;ZBTB37;SOX13;NFIX;KAT6A;CDK17;PBX3;PLAGL1;RCOR1;SOX17;EGFR;LOXL3;MKX;PSPC1;CD38;ZHX2;CDKN1B;NAA16;ZBTB46;VGLL4;SP1;FZD4;ZNF148;CRLF3;VSX1;ELK3;METTL4;CTCF;NIPBL;LIMD1;MGA;HDAC1;NFKB1;HES1;LHX6;PPARA;MEOX2;SIX1;UBP1;SMARCC1;RYBP;GAS6;TASP1;PHF20;ABL1;ZBTB7A;FOXO3;ZIC4;DNM2;TRRAP;IKZF2;PDCD4;HIVEP1;HOXB6;LRP6;PLCB1;BBX;NSD3;FUS;MED1;AATF;STAT6;NFYC;E2F4;BAZ1A;SPEN;BRD2;GTF2IRD1;BMP4;CREB3L2;MAX;PTPRK;MEF2C;SETD5;MIDEAS;SLC39A8;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;ZFP90;ASCC1;ACTA2;TSHZ2;SRCAP;PBXIP1;TBX2;SUV39H1;PPM1F;SETD3;DACH1;MDFIC;BACH2;ANXA4;HNRNPAB;NAB1;SMARCE1;ZBTB39;YAP1;NOP2;LDB1;PRDM2;CDH1;PPARD;PHF5A;EBF1;IRF1;GLI3;ZNF25;PICALM;SMAD4;RBBP8;ZIC5;GPBP1;SPTY2D1;HSF5;CTBP2;HOXC6;SP3;USP13;PHF20L1;FGF7;TAL1;AKT1;GLIS2;NAA15;ELF2;TP53;ZBTB40;EHMT1;KLF10;HMBOX1;MAMLD1;NOTCH4;ETS2;MED13;KDM3A;HMG20A;RGMB;STAT2;NFIC;ILK;SMARCC2;SIN3A;PRRX2;GMEB1;PSEN1;SOX7;JMJD1C;ZBTB7C;MAZ;SMAD7;SCMH1;CHD3;TWIST2;HR;ARHGEF11;MED17;YAF2;ZSCAN25;NOTCH1;FOXF2;FOXJ3;FGF2;MTDH;SP140;RPS6KA1;HDAC4;SFPQ;PA2G4;ZNF394;OGG1;LRRFIP1;TIAL1;KAT5;PROX2;PIAS2;ZBTB6;TCIM;KLF9;WNT11;CREBRF;RHOG;CIC;FBXW11;TAF5L;XPC;ZHX1;TFCP2L1;SMARCD3;DBX2;MECP2;ZIC3;ATF4;KDM7A;PGBD1;MZF1;ARID3B;GPBP1L1;KMT5A;SAMD1;GRHL1;ZBTB25;RPS6KA3;NR1D2;HCFC1;ZBTB34;HIF3A;TCF3;TCF7L1;POLR3F;FOXC1;MYBL2;PHF6;DAP;MRPL12;MED29;ZKSCAN1;BCOR;TADA3;ZNF32;NR2C1;JMJD6;TRIM16;NAB2;SMAD6;PHC1;RUVBL2;PEX14;BRWD3;UBE2L3;ETV1;FOXO4;MAD2L2;CC2D1B;CREBL2;PCBD2;ZFP1;TAF7;THOC1;TRPS1;BMP7;HIC1;IGF1;CCNC;ZNF235;SUMO1;KDM5B;SIX4;RARA;MAMSTR;ZNF692;HOXA2;ARID5B;HDAC6;ZNF691;ZBTB14;CTNNB1;FOXQ1;HINT1;ZBTB8A;GPATCH3;TFAP4;ZXDB;ZNF250;HDAC10;ZNF83;ARNT;PATZ1;CEBPG;HEY1;ZMYND11;ZFP28;HEY2;TSHZ1;CARM1;ZSCAN12;NRF1;WBP2;ELK4;HOXB9;WTIP;ZIC1;ZBTB12;EPAS1;HLF;CITED2;RNF10;EDRF1;IKBKB;PCGF3;GATA2;BAP1;SOX4;ZFX;NCOA6;PPP2CA;RNF4;UTP4;ATRX;SMAD9;PIAS4;SCML4;TCF4;TCF7L2;NONO;TIMELESS;TBL1X;CDK11B;PPARG;WWP2;PRDM1;BCL6;ELOC;BRCA1;ZSCAN26;BAZ1B;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;MED27;OGT;SRSF10;PCGF5;MDM2;BLM;NKAP;NACC1;TOX4;PBX2;CDK14;CBFA2T2;HSF4;CAND2;GCLC;PHC3;TSHZ3;CREB1;ZSCAN18;MAP2K3;ELF4;NOS1;NFE2L2;GABPA;ATAD2;RELA;MYOCD;KCNH2;YY1;TULP3;ZNHIT3;KDM3B;TBX3;SUDS3;USP16;ATF6;MSX1;ZKSCAN8;TCEA2;FZD7;RXRG;RFXANK;MYCBP;RBM15;AJUBA;AEBP2;MED20;SUPT4H1;CEBPA;ARRB1;ZNF697;THRAP3;CDK18;TRIB3;KLF16;ATF5;ZFP3;ACVR2B;CCNK;E2F7;ZFHX4;GMEB2;CNOT2;ARID3A;E2F3;SMARCB1;ZNF276;MBTD1;TFDP1;TAF15;ZKSCAN4;HMGB1;RBAK;GCFC2;KHDRBS1;SETDB2;EGR3;FANK1;SP110;DHX9;BMP2;BRD4;IRF7;APBB1;POLR2L;HIC2;EID2B;FOXF1
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.36560854408413407,-1.5572768099793777,0.00528169014084507,0.1732397500517016,1.0,50/150,23.17%,HIP1;TEK;IGF1R;KITLG;ENG;ITGB1;GAB1;FERMT2;INSR;RAC1;MFHAS1;ESR1;THBS1;GCNT2;PTPRJ;EGFR;RICTOR;GAS6;PIK3R1;IRS1;PTK2;FGF1;HAX1;PIK3CD;FGF7;THEM4;MAZ;FGF2;MTDH;MYOC;RHOG;HGF;PIK3CB;GRB2;IAPP;GAB2;TNFAIP8L3;ANGPT1;FYN;CCL19;TXN;TCF7L2;F3;FGFR4;IGF2;PTPN11;PDGFRB;HSP90AA1;HPSE;FRS2
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.4175159552386967,-1.556978542551302,0.007352941176470588,0.17314837602599245,1.0,29/64,28.73%,MNAT1;MLLT3;CDK13;SETD2;CDK12;IWS1;EAF1;POLR2G;ERCC2;CDC73;RTF1;TCEA1;MLLT1;ERCC3;NELFB;ELOF1;ADRM1;ELOC;TCEA2;SUPT4H1;POLR2C;CCNK;POLR1E;POLR2L;POLR2H;LEO1;GTF2H3;CCNH;ELP2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.6189704044388632,-1.5562482084787925,0.033210332103321034,0.17366712546104426,1.0,8/12,29.30%,LMO2;THRB;MED1;KLF9;CTSH;GAS2L1;RDX;BRD8
prerank,positive regulation of neuron differentiation (GO:0045666),0.4450800651252568,1.5551612205721757,0.01348314606741573,0.27453882740724145,1.0,12/40,9.77%,BRINP3;BEND6;NBL1;NRCAM;VWC2;BRINP1;HOXD3;IMPACT;PROX1;BRINP2;ADRA2C;CPNE1
prerank,regulation of stress fiber assembly (GO:0051492),-0.40450027289190943,-1.554811632424986,0.0050335570469798654,0.17531584499063996,1.0,28/74,16.65%,TJP1;WASF2;FERMT2;RAC1;F11R;PAK2;CGNL1;PXN;PIK3R1;ABL1;ARHGEF15;PPFIA1;ROCK1;PPM1F;RGCC;ARAP1;RHOA;ARHGAP28;LIMCH1;TPM1;WNT11;MYOC;RHOC;ARHGEF10;SORBS3;ROCK2;ARHGEF18;ALMS1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.477811264417428,-1.5545794098029504,0.017391304347826087,0.17510320865491133,1.0,18/36,24.96%,DAB2IP;PTPRM;SP100;ACVRL1;THBS1;SLIT2;MEF2C;ADAMTS9;RGCC;NOTCH1;FGF2;MECP2;PPARG;NR2F2;DLL4;GADD45A;HMGB1;ADGRB1
prerank,T-helper cell differentiation (GO:0042093),-0.5911853007590763,-1.554229528999735,0.0260707635009311,0.17517528063497315,1.0,2/14,0.16%,FOXP1;LEF1
prerank,amino acid import (GO:0043090),-0.5449813815679329,-1.5539506468738777,0.03398926654740608,0.17507214534731474,1.0,5/21,2.55%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SH3BP4
prerank,positive regulation of chemotaxis (GO:0050921),-0.442933123333779,-1.5536810116627873,0.017271157167530225,0.17500669147725087,1.0,20/43,28.28%,THBS1;TMSB4X;KDR;PRKD2;IL6R;STX3;PPM1F;PRKD1;EDN3;FGF2;SMOC2;LGMN;CCL19;F3;PDGFRB;PTN;SEMA5A;ADAM17;MET;TREM2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.503816675812479,-1.5530446471666781,0.024263431542461005,0.17535940463245972,1.0,11/27,13.32%,TJP1;WASF2;SHANK3;F11R;PAK2;CGNL1;PIK3R1;PPFIA1;ARAP1;ARHGAP28;MYOC
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6307218072269827,-1.5525508999417632,0.029684601113172542,0.17554049366493038,1.0,8/11,32.99%,LIMD1;PUM1;WTIP;AJUBA;DHX9;FXR1;STAT3;PUM2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.35917406437231153,-1.5521341939177271,0.007246376811594203,0.17569112910609289,1.0,54/166,21.66%,SORBS1;INSR;KLF4;PKD2;KLF2;THBS1;STN1;EIF3E;METTL14;DDX3X;MTOR;PRKD2;NIBAN1;EGFR;PLD1;SP1;EIF3C;ELOVL5;IRS1;UPF3B;SAMD4A;ABCB10;NOS1AP;LDB1;SCARB1;MFSD2A;RPL26;AKT1;ZCCHC4;EDN1;RGCC;EEF2;FGF2;STARD4;DNA2;CHP1;CTC1;LARP4B;HGF;RPS4X;SMOC2;RPL5;METTL5;IGF1;ARNT;GIPC1;CCL19;STAR;SOX4;PRKDC;FGFR4;IGF2;RBM3;PDGFRB
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.49117192574538227,-1.5517526201087093,0.025167785234899327,0.1756649638035998,1.0,9/28,20.17%,DAB2IP;CTSC;RNF139;SMURF1;PTK2;ECSCR;PSMC2;CDK5RAP3;PTEN
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.47160850315487346,-1.5505253365012506,0.017513134851138354,0.1768194262264246,1.0,17/36,22.46%,NOS3;CAV1;NOSTRIN;EGFR;DNM2;GCH1;CYGB;WASL;NOS1AP;SCARB1;AKT1;S100A1;PIK3CB;TERF2;TERT;GLA;HSP90AA1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.4795665615720983,-1.549932841765494,0.024778761061946902,0.1772092674384595,1.0,18/31,32.81%,RB1;DCUN1D3;KLF4;PKD2;DLG1;FAM107A;CDC73;CDK6;CDK2AP2;PTEN;CDKN2C;FHL1;E2F7;APC;CDKN2B;JADE1;WEE1;CDK4
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.6529138334875146,-1.549441642978334,0.0421792618629174,0.17738611800692336,1.0,7/10,21.16%,BMP5;PHACTR4;LRP6;NOTCH1;BMP7;ARHGAP12;DLL4
prerank,insulin receptor signaling pathway (GO:0008286),-0.41169664872243494,-1.548666698155971,0.007285974499089253,0.1779496744854185,1.0,21/69,16.18%,IGF1R;SORBS1;FOXO1;GAB1;INSR;GSK3B;PIK3R1;IRS1;RHOQ;PIK3C2A;GRB10;GSK3A;ZNF106;NAMPT;GRB14;BCAR1;AKT1;ATP6V1E1;GRB2;FOXO4;PIK3R3
prerank,cytoskeleton organization (GO:0007010),-0.3800404239173443,-1.5485235604794787,0.008710801393728223,0.1776753802858052,1.0,38/114,18.40%,SEMA6A;FGD5;FGD6;RAC1;PDZD8;RHOBTB1;RANBP9;MARK1;ARHGAP10;RND3;MICAL2;ARAP3;DIAPH1;LIMD1;ZMYM6;CNTNAP1;MAST4;MAST2;PLCE1;PPP2R3C;SIPA1L3;PLD2;DST;LRCH3;CECR2;RHOA;ZMYM4;TPM1;NEDD9;RHOC;RHOG;TNFAIP3;BRWD3;FMNL2;CDC42BPB;CAPZB;CFL1;WTIP
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.6010700561053242,-1.5482046992010752,0.043052837573385516,0.17760440602979843,1.0,5/13,15.93%,ALG14;ALG12;ALG8;ALG11;ALG13
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5229841317646392,1.5469927989506955,0.024229074889867842,0.2875725942433329,1.0,6/20,12.17%,ATP1A2;ATP1B1;CALM2;RYR2;SLC8A1;HRC
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.656801090069213,-1.5459413763478334,0.03867403314917127,0.1803936888896605,1.0,2/10,0.62%,DAB2IP;SEMA6A
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.44569142311302024,-1.5453354813637816,0.026833631484794274,0.18083852616193138,1.0,17/47,19.68%,DAB2IP;IGF1R;FOXO1;MID1;EGFR;TGFBR3;FAS;TGFB2;MAPK1;ARL6IP5;TAOK3;SEMA4C;MAP4K4;IGBP1;RAP2A;NOD2;KLHDC10
prerank,positive regulation of gene expression (GO:0010628),-0.3233289558113447,-1.5451241218897174,0.0,0.18058777996695197,1.0,134/442,21.16%,LEF1;CLDN5;UBR5;NOS3;DYRK1A;KLF4;ETS1;CD34;TNRC6B;LIMS1;MED26;GSK3B;THBS1;TENT4B;APP;KAT2B;ATM;DEK;EIF3E;METTL14;MITF;IL15;DDX3X;MTOR;NIBAN1;SMO;EGFR;TFRC;MSN;PLD1;SP1;CTCF;EIF3C;BMP6;AFDN;GAS6;PIK3R1;PDE2A;UPF3B;MED1;SEC16B;FGF1;BMP4;ERN1;MEF2C;SAMD4A;EZR;CDH5;NGF;SMAD1;ACTA2;MAPK1;ROCK1;PPM1F;RAB27A;NOS1AP;YAP1;PLCG2;CELF1;GSK3A;SF3B1;OCLN;WNT16;PIK3CD;TENT4A;RPL26;FGF7;RAMP2;AKT1;MYOM1;TP53;ZCCHC4;PRKAA1;TAF1B;RGCC;PSEN1;BRAF;EEF2;MAZ;HFE;NOTCH1;FGF2;ACTB;FLOT1;WNT11;ZPR1;LARP4B;TAF1C;PLSCR1;MAPK8;RPS4X;ATF4;PIK3CB;AGO2;RBM20;FAM98A;HCFC1;AGPAT1;MIF;ROCK2;TADA3;C1QTNF3;RPL5;VSIR;TERF2;ANGPT1;PIK3R3;METTL5;BMP7;IGF1;MOV10;SRPK2;DNMT1;CTSH;FUBP1;HEY1;HEY2;SOD1;RPS3;WBP2;LURAP1;CITED2;GATA2;SOX4;TNRC6A;PRKAB1;PRKDC;KRAS;F3;FGFR4;BRCA1;BAZ1B;RBM3;DLL4
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.46197100573178457,1.5448330083290835,0.022988505747126436,0.28939183638802524,1.0,7/34,3.70%,GRID2;MPP2;GABRG3;GRIN2B;GLRA1;GRIN2A;GABRA2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6381720293532684,-1.544571500300126,0.035580524344569285,0.18087995259106535,1.0,5/11,14.15%,SEMA6A;KLF2;THBS1;ADAMTS9;PIK3CB
prerank,regulation of neuron projection development (GO:0010975),0.3462628051391779,1.543012625605407,0.0,0.2902732812550875,1.0,35/163,10.54%,MAGI2;CSMD3;LRRC4C;IL1RAPL1;CTNNA2;LRRC7;DCC;RIT2;PPFIA2;SCN1B;CCDC88A;SPOCK1;TENM3;FUT9;CDK5;CDKL5;TOX;NTNG2;NTNG1;ITM2C;KIDINS220;NDRG4;NCS1;PAK3;CAMK2B;NTRK2;PAK1;TANC2;PLA2G3;TSKU;PLPPR5;PTPRS;STMN2;MAG;ABI2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.42997103223873334,1.5425072053663478,0.013605442176870748,0.28892965120636466,1.0,12/47,12.71%,VTN;SPOCK3;SPOCK1;SERPIND1;SORL1;TIMP1;ANXA8;ANXA8L1;SERPINA2;SERPING1;PCID2;FETUB
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5576774955464028,1.5420510795099676,0.04856512141280353,0.2872842515876575,1.0,6/16,8.51%,GPR137C;PIP4P1;RRAGA;FLCN;KLHL22;SEH1L
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.45258634569047684,-1.541826293467671,0.01773049645390071,0.1846485287454255,1.0,15/40,17.12%,LEF1;FERMT2;DAB2;GCNT2;MTOR;TGFBR2;TGFB2;SMAD2;SMAD4;AXIN2;RGCC;NOTCH1;JAG1;FOXC1;CTNNB1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.466695824100234,-1.5399763722753221,0.017699115044247787,0.18694358446983286,1.0,7/36,3.40%,GULP1;DOCK1;MYH9;RAC1;RHOBTB1;THBS1;ELMO1
prerank,positive regulation of hemostasis (GO:1900048),-0.6620615117723975,-1.53948995463175,0.02702702702702703,0.18667944876347817,1.0,7/10,26.84%,ST3GAL4;THBS1;ENPP4;SERPINE1;HPSE;DMTN;F2R
prerank,positive regulation of coagulation (GO:0050820),-0.6620615117723975,-1.53948995463175,0.02702702702702703,0.18667944876347817,1.0,7/10,26.84%,ST3GAL4;THBS1;ENPP4;SERPINE1;HPSE;DMTN;F2R
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.4111001542495401,-1.539107089247734,0.014652014652014652,0.18679968246147707,1.0,25/62,26.61%,NUP42;RAE1;RANBP2;LIMD1;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;NUP214;IPO8;WTIP;TNRC6A;PPARG;NUP188;AJUBA;POLR2C;DHX9;POLR2L;FXR1;POLR2H;NUP88
prerank,regulation of humoral immune response (GO:0002920),0.4351972799096131,1.5383093455901404,0.013986013986013986,0.29218741860248904,1.0,11/44,13.37%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;CPN1;SERPING1;CLU;GATA6
prerank,phospholipid translocation (GO:0045332),-0.49522242767733937,-1.5374325252528163,0.028169014084507043,0.18860804038922133,1.0,10/28,16.71%,ATP10A;ATP8B1;PLSCR4;PLSCR2;MFSD2A;ATP10B;ANO6;PLSCR1;ABCA7;ATP9B
prerank,positive regulation of binding (GO:0051099),-0.40070404648193914,-1.537319394757288,0.008547008547008548,0.18828206089949243,1.0,46/84,29.99%,RAPGEF2;CLDN5;CAV1;GSK3B;APP;DTX3L;LRRK2;HES1;STK3;SPPL3;BMP4;NGF;DPH3;HMBOX1;PSEN1;HFE;FLOT1;FOXC1;HIP1R;IGF1;SKI;MARK3;RARA;CEBPG;AKTIP;CLN5;TXN;TCF7L2;PPARG;TERT;CAPRIN2;RALB;TRIB3;HMGB1;DHX9;BMP2;LRP1;PARP9;RAN;NMD3;MET;STMN1;PLAUR;KDM4D;MED25;BAMBI
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6145343300810229,1.5370767125941354,0.0598669623059867,0.292056097284768,1.0,4/10,12.08%,PDE4B;CACNA2D1;CACNB3;SRI
prerank,negative regulation of potassium ion transport (GO:0043267),-0.5971718905047275,-1.5370196227096946,0.03484320557491289,0.1882749578631388,1.0,8/13,28.55%,CAV1;NEDD4L;CASQ2;NOS1;PTK2B;KCNH2;CAB39;ACTN2
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5151262349431435,-1.5344699771332246,0.02982456140350877,0.19180195632038027,1.0,11/24,16.15%,TJP1;WASF2;F11R;PAK2;CGNL1;PIK3R1;PPFIA1;ARAP1;ARHGAP28;MYOC;ARHGEF18
prerank,response to molecule of bacterial origin (GO:0002237),-0.40752492029440746,-1.5344526455657628,0.0071301247771836,0.1913070593400187,1.0,16/69,16.41%,FOXP1;PELI1;NOS3;SRR;IFNAR1;HNRNPA0;GGT5;GCH1;LBP;MAPKAPK2;JAK2;IRAK1;RPS6KA3;TNFAIP3;SMAD6;TAB2
prerank,pulmonary valve development (GO:0003177),-0.548715209224529,-1.534076921289076,0.033391915641476276,0.19136437224810457,1.0,14/18,17.95%,NOS3;BMPR2;NFATC1;TNFRSF1B;SLIT2;TGFB2;BMP4;NOTCH2;NOTCH1;JAG1;SMAD6;TNFRSF1A;HEY1;HEY2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6068274138872626,-1.5340124562676734,0.040780141843971635,0.19094917169181935,1.0,8/13,21.16%,ENG;KDR;TGFBR2;COL4A1;NOTCH4;CTNNB1;SEMA3E;DLL4
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.6273687708912551,-1.533567424028273,0.04316546762589928,0.191038078848353,1.0,7/11,24.87%,RESF1;TASOR;TPR;DNMT1;PPHLN1;TRIM28;SETDB2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5137047616412187,1.5334721837956313,0.03218390804597701,0.29679680643921513,1.0,7/22,12.08%,PDE4B;STAC2;HPCA;CACNB3;CACNB4;STAC;SRI
prerank,regulation of endocytosis (GO:0030100),-0.415564300114267,-1.533326014685635,0.02146690518783542,0.19083511353205695,1.0,24/61,20.15%,HIP1;RUFY1;DAB2;NEDD4L;CBLL1;PTPN1;STON1;RAB5B;ABL1;AP2S1;ROCK1;RAB5A;PRKD1;PICALM;RAB4B;SNX12;FLOT1;HIP1R;ABCA7;ZFYVE16;STON2;CCL19;GPC3;RUFY2
prerank,sensory perception (GO:0007600),0.4408396300931661,1.5330565095440292,0.013636363636363636,0.2951957280458138,1.0,15/45,18.13%,PCDH15;OPRM1;MME;PNOC;GNAL;KCNA2;TTC8;BBS4;PENK;CCL2;WHRN;NTSR2;CLRN1;RETREG1;TRPV2
prerank,positive regulation of cellular component organization (GO:0051130),-0.37876473821985496,-1.5328882731875835,0.013986013986013986,0.19104351219035234,1.0,32/107,18.45%,ATP10A;DAB2IP;IGF1R;SHANK3;RB1;TRABD2B;ASAP1;INSR;MPP7;DAB2;NEDD4L;CBLL1;GSK3B;TFRC;TGFB2;SPIDR;BNIP3;CDH5;TAL1;FNIP2;DCTN1;ICE1;FLOT1;RHOC;ABCB7;SLF2;GPX1;BCL2L11;BMP7;SUMO1;RPS3;CCL19
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.403009868058797,-1.5324235706189702,0.0016835016835016834,0.19122010546685075,1.0,24/78,14.87%,SPTBN1;PRKCH;SORBS1;ITGB1;PPP2R5A;DAB2;PRKCE;ITGA3;PTPN9;LDLRAP1;EGFR;PIK3R1;DLG1;STX3;RHOQ;PPFIA1;STX8;PICALM;AKT1;ABI3;ACTB;RHOG;NUMB;STAC3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5029494689704611,-1.5317792285562697,0.02717391304347826,0.19173582005362508,1.0,7/26,14.93%,CAV1;MFHAS1;DDX3X;WDFY1;LBP;FLOT1;IFI35
prerank,regulation of insulin secretion (GO:0050796),0.3722773098280474,1.531055802799878,0.006756756756756757,0.2963436440586079,1.0,31/101,18.05%,KCNC2;ABCA12;BLK;SNAP25;GIP;GCK;NR1D1;KCNA5;CACNA1A;MTNR1B;EPHA5;CHGA;TRH;CACNA1D;ADRA2C;CACNA1E;GIPR;ADRA2A;GPER1;EIPR1;CCL5;NLGN2;GLUD1;BRSK2;MCU;BMP8A;ALOX5;SLC8B1;GLP1R;ABCC8;KCNG2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.40797629212640296,-1.5302407284912782,0.00859106529209622,0.19357828672755534,1.0,32/72,25.97%,CBFB;ELF1;PTPN1;JAK1;BIRC3;TAX1BP1;GAS6;OTULIN;LIFR;CASP8;CFLAR;JAK2;IRAK1;USP18;TNFAIP3;AGPAT1;TNFRSF1A;SUMO1;HIPK1;IRAK2;IKBKG;IKBKB;IFNGR2;PTPRC;VRK2;ABCE1;PTPN11;IFNAR2;RIPK1;IL7;PTPN2;TRIM44
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5654761454099487,1.5301693857511285,0.05088495575221239,0.29561849894826625,1.0,5/14,9.75%,ANK3;ATP1B1;WNK2;WNK3;TESC
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.48232004263189737,-1.5299346365376612,0.03636363636363636,0.1935133324018781,1.0,9/29,11.88%,TJP1;SHANK3;LIMA1;KANK3;SLIT2;PRKCD;KANK4;SMAD4;ARFGEF1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5911145624985785,-1.5294285400879577,0.03597122302158273,0.1937962030150481,1.0,8/13,26.25%,PLCG1;SP1;AKT3;FGF2;ITGA4;IGF2;HMGB1;ADAM17
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.41765867361539516,-1.5287035696360212,0.005272407732864675,0.19441404403924945,1.0,22/63,23.21%,ITGA6;SP100;CAV1;THBS1;PAK2;TNFSF10;FAS;BMP4;BIRC6;SH3RF1;CASP8;CFLAR;WWOX;FEM1B;IGF1;ZMYND11;HYAL2;TCF7L2;G0S2;LTBR;RELA;RIPK1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.49487205180866073,-1.5282050433753431,0.034420289855072464,0.1946863337975497,1.0,10/27,11.66%,PTPN1;PIP4K2A;NCK1;IRS1;PIP4K2B;PRKCD;GRB10;GSK3A;GRB14;SLC27A4
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.43722225450728974,-1.5273299876773596,0.01916376306620209,0.19553621488057307,1.0,19/50,18.97%,NFAT5;NR3C2;NOD1;LIMS1;APP;DDX3X;EGFR;NMI;PDCD4;ILK;RHOA;IRAK1;ACTN4;TCIM;IFI35;SASH1;RPS3;CCL19;NOD2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4847187818231767,-1.526037303878254,0.02992957746478873,0.19694578661577883,1.0,10/28,11.66%,PTPN1;PIP4K2A;NCK1;IRS1;PIP4K2B;PRKCD;GRB10;GSK3A;GRB14;SLC27A4
prerank,positive regulation of programmed cell death (GO:0043068),-0.331044997314279,-1.5258257587373865,0.0,0.19672987120824162,1.0,91/272,25.06%,UNC13B;DAB2IP;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;DCUN1D3;ARHGEF3;DAPK1;TNFAIP8;NET1;ATG7;ATM;MCF2L;LRRK2;UTP11;MAP3K5;DDX3X;PLEKHG5;TNFSF10;RASGRF2;RARG;RBM5;RYBP;STK3;ABL1;FOXO3;PSEN2;DNM2;FAS;ARHGEF12;SLIT2;RASSF2;BMP4;BNIP3;NGF;JUN;TGM2;ITSN1;ARHGEF2;ARL6IP5;LATS2;SOS2;CASP8;TP53;CRADD;PSEN1;SLC27A4;ARHGEF11;ANO6;CTNNBL1;STPG1;MAPK8;ATF4;TRIO;ERCC3;IAPP;HIP1R;ABR;ARHGEF18;BCL2L11;PREX1;HDAC6;CTNNB1;APH1A;TFAP4;SOD1;SIAH1;SOX4;RNPS1;BCL6;NF1;ARHGEF5;FOXL2;PNMA2;VAV2;ARHGEF1;CASP2;PHLDA3;GADD45A;SUDS3;ATF6;RIPK1;SFRP4;CYP1B1;CALHM2;HMGB1;FANK1;BMP2;APBB1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4930867511855028,-1.5250462982732875,0.02640845070422535,0.19733862820585737,1.0,9/28,17.78%,DAB2IP;DDX3X;ZDHHC3;NGF;CASP8;CRADD;GABARAP;TNFRSF1A;CASP8AP2
prerank,erythrocyte differentiation (GO:0030218),-0.44689943179517233,-1.5248095791123022,0.022222222222222223,0.197218865169773,1.0,15/44,18.25%,ALAS1;MFHAS1;LYN;KMT2E;TGFBR3;RPS14;MED1;ACIN1;ABCB10;TAL1;JAK2;ZFPM1;CDK5RAP3;CEBPG;FLVCR1
prerank,Golgi to endosome transport (GO:0006895),-0.5578638877639508,-1.5240944576560627,0.039285714285714285,0.19779676171937716,1.0,7/16,22.11%,VPS13A;EPS15;VPS13C;WIPI1;CORO7;AP4M1;KIF16B
prerank,histone lysine demethylation (GO:0070076),-0.506406219638918,-1.5229781064404793,0.038128249566724434,0.19893509816193536,1.0,14/25,31.74%,KDM2A;KDM6A;KDM6B;KDM3A;JMJD1C;HR;RIOX2;KDM7A;KDM5B;KDM1B;KDM3B;KDM4D;RIOX1;KDM4A
prerank,microtubule-based transport (GO:0099111),0.5958029937947257,1.522480386997964,0.05502392344497608,0.30856787056831775,1.0,8/12,21.02%,ADCY10;ROPN1L;DYNC1I1;HTT;SPAG17;CABYR;DNAAF2;DYNC1I2
prerank,response to ionizing radiation (GO:0010212),-0.4033293901198135,-1.52002009303236,0.012433392539964476,0.20313049763961302,1.0,28/70,22.73%,DCUN1D3;NET1;ATM;UIMC1;MRNIP;XRCC4;SPIDR;INIP;NABP1;TP53;PRKAA1;INTS3;KAT5;BABAM2;NHEJ1;RNF168;GRB2;TRIM13;ANXA1;RFWD3;FANCD2;BRCC3;BRAT1;LIG4;BRCA1;BLM;GADD45A;INTS7
prerank,spinal cord development (GO:0021510),-0.6192077166910583,-1.5194168305252895,0.03512014787430684,0.2036657440833399,1.0,6/12,20.79%,PKD2;VIT;LOXL3;ZPR1;SOX4;NF1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6391088526042201,1.5180944726613885,0.052060737527114966,0.31504022434165485,1.0,7/10,18.85%,GALNT13;GALNT16;MGAT5B;GALNT3;GALNT2;POGLUT1;POGLUT2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.5435467190032528,-1.5175853828257633,0.03577817531305903,0.2061861103502475,1.0,10/18,33.07%,NR3C1;FAM107A;KLF9;UBE2L3;BCL2L11;ANXA1;ZFP36L1;HNRNPU;SSTR2;AQP1
prerank,regulation of JUN kinase activity (GO:0043506),-0.4691934434003908,-1.5173199828411785,0.022263450834879406,0.20609442110791068,1.0,13/33,25.12%,DAB2IP;DVL3;MAP3K5;PPEF2;PDCD4;EDN1;TAOK3;SASH1;RPS3;ARHGEF5;MAP3K7;AIDA;FZD10
prerank,hemidesmosome assembly (GO:0031581),-0.628661720440042,-1.517270645007327,0.0325497287522604,0.20563563424289094,1.0,4/11,8.83%,ITGA6;ITGB4;LAMA3;DST
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5483075987722251,-1.5171923633626463,0.03852889667250438,0.20523758919908897,1.0,12/17,34.50%,BMP4;NOTCH2;GALNT11;NOTCH1;JAG1;HEY1;HEY2;DLL4;BMP2;SNAI2;TGFB1;BMPR1A
prerank,regulation of cellular response to heat (GO:1900034),-0.39046168269862125,-1.5167442807519904,0.011428571428571429,0.20543056701302906,1.0,22/77,15.77%,CREBBP;CD34;GSK3B;ATM;NUP42;MTOR;YWHAE;RAE1;CAMK2G;RANBP2;DNAJC7;NUP98;MAPKAPK2;SEC13;DNAJB6;MAPK1;RPTOR;NUP153;RPA3;RPA1;PTGES3;TPR
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5381224423886097,-1.5165229143141636,0.05303030303030303,0.20523197307796087,1.0,6/18,11.09%,DNAJC13;DAB2;MSN;EZR;MAPK1;SNX12
prerank,peptidyl-lysine modification (GO:0018205),-0.38012686250412286,-1.5152362091922973,0.01054481546572935,0.2068117486119586,1.0,32/99,22.99%,SENP1;PLOD1;PLOD2;IFIH1;KAT2B;NUP42;RAE1;LOXL3;TRPM4;RANBP2;UBA2;SIRT5;NUP98;LOXL1;NSMCE2;NUP153;HDAC4;KAT5;PIAS2;SIRT3;TPR;SENP2;SUMO1;HDAC6;HDAC10;NUP214;PIAS4;CTH;TRIM28;LOX;NUP188;SENP6
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6329078191959239,-1.513984353282952,0.05328596802841918,0.20814908910205937,1.0,8/11,30.81%,TGFBR3;TGFBR2;TGFB2;SMAD7;USP15;BMP2;TGFBR1;TGFB1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4079584104037889,-1.513249490868125,0.011029411764705883,0.20875246580260468,1.0,27/62,28.73%,MNAT1;MLLT3;CDK13;SETD2;CDK12;IWS1;EAF1;POLR2G;ERCC2;CDC73;RTF1;TCEA1;MLLT1;ERCC3;NELFB;ELOF1;ADRM1;ELOC;SUPT4H1;POLR2C;CCNK;POLR2L;POLR2H;LEO1;GTF2H3;CCNH;ELP2
prerank,positive regulation of response to external stimulus (GO:0032103),-0.36482654749241344,-1.5129745811992992,0.006622516556291391,0.20872008326832203,1.0,44/128,28.28%,ETS1;ANKRD17;THBS1;APP;IL15;BMP6;SCARF1;NFKBIA;NMI;PDE2A;PDCD4;STX3;PUM1;NAPEPLD;PPM1F;AKIRIN2;FEM1A;DDX60;USP15;AGTR1;LPL;IL17RA;PLSCR1;POLR3F;IFI35;IL16;TNFRSF1A;GBP5;SASH1;CCL19;HYAL2;PDGFRB;GPR4;PTN;SERPINE1;RIPK1;CEBPA;DDT;DHX9;TNIP1;GPSM3;OASL;RIOK3;TREM2
prerank,axonemal dynein complex assembly (GO:0070286),0.4724451094507734,1.512851297980914,0.03879310344827586,0.32373055994765704,1.0,11/27,18.48%,DNAAF3;SPAG1;CCDC63;ODAD2;DNAAF5;DNAAF1;DNAI4;ODAD1;DNAAF2;LRRC49;ODAD3
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3847974983374029,-1.5127479323543962,0.008880994671403197,0.2085794852348561,1.0,27/82,16.46%,ZHX3;FERMT2;CRIM1;LRP5;BMPR2;SMOC1;IL6ST;TRPM4;LIMD1;BMP6;IL6R;PTK2;BMP4;MEF2C;PRKD1;YAP1;ACVR2A;TWIST2;NOTCH1;TMEM64;CDK6;HGF;ATF4;SMAD6;BMP7;IGF1;SKI
prerank,regulation of fat cell differentiation (GO:0045598),-0.3945136851100996,-1.5125806476281118,0.009174311926605505,0.2083028667932166,1.0,30/74,26.76%,ZBTB16;FOXO1;FERMT2;LRP5;ASXL1;TRPM4;FTO;YAP1;PPARD;AKT1;ANKRD26;ZFPM1;LPL;TMEM64;TRIO;TAF8;CREBL2;CARM1;CMKLR1;GATA2;PPARG;AAMDC;CREB1;SYAP1;TRIB3;GPS2;PTPRQ;BMP2;ZFP36L1;FRZB
prerank,response to reactive oxygen species (GO:0000302),-0.4225453454371239,-1.5124649283893266,0.03165735567970205,0.20792930576887997,1.0,21/54,20.81%,PKD2;EGFR;ADAM9;PXN;STK24;PTPRK;JUN;MAPK1;AKT1;TPM1;CAT;TXNRD2;MAPK8;GPX1;AGAP3;FYN;SOD1;RPS3;HYAL2;COA8;ERCC6L2
prerank,cellular response to oxidative stress (GO:0034599),-0.3661005738007566,-1.5124568608525144,0.00530035335689046,0.2074152324847931,1.0,40/118,22.38%,FOXO1;PKD2;DAPK1;LRRK2;EGFR;PXN;ABL1;FOXO3;PYROXD1;PRKCD;PTPRK;JUN;MAPK1;PRKD1;WNT16;AKT1;TP53;PRKAA1;ERO1A;TPM1;CAT;NCF2;TXNRD2;MAPK8;ATF4;MSRA;GPX1;AGAP3;NOX4;FANCC;ARNT;CCS;SOD1;RPS3;VRK2;ERCC6L2;TXNRD1;KEAP1;SLC25A24;NFE2L2
prerank,embryonic digit morphogenesis (GO:0042733),-0.5454692531956082,-1.5123778162328725,0.04409171075837742,0.20702048037318455,1.0,6/18,9.09%,MAP3K20;CREBBP;HDAC1;ECE1;TBX2;GLI3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.48483194620238423,-1.511836634885976,0.02276707530647986,0.20734545671024554,1.0,10/29,15.88%,TUT7;PUM1;SMAD1;SMAD2;ZC3H7B;SNIP1;DICER1;TUT4;AGO2;PUS10
prerank,positive regulation of signaling (GO:0023056),0.4488249232560642,1.5112594614348136,0.02197802197802198,0.3245832893605025,1.0,9/37,12.36%,GRIK2;SYT1;RIMS2;RIMS1;CARTPT;HOMER1;CLSTN2;INPP5F;DLG4
prerank,regulation of store-operated calcium entry (GO:2001256),0.6266497153380965,1.5109683154095932,0.04185022026431718,0.32275692094493913,1.0,6/10,19.45%,EFHB;HOMER1;CASQ1;SLC8B1;GRAMD2A;CD84
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.4324506248546448,-1.5105169075351756,0.018281535648994516,0.20882762085265413,1.0,12/46,12.95%,DAB2IP;SEMA6A;LYN;PTPN1;RANBP9;SPRED2;DLG1;EZR;SMAD4;TIMP3;CNKSR3;DUSP3
prerank,cholesterol biosynthetic process (GO:0006695),0.4657460470193118,1.5105154344763059,0.03669724770642202,0.32135186815424704,1.0,12/31,13.87%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;SC5D;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,regulation of cellular component organization (GO:0051128),-0.3633834321201428,-1.5101274709171824,0.003418803418803419,0.2089429246405991,1.0,50/135,20.63%,HIP1;TJP1;DAB2IP;RAPGEF2;SNCAIP;RUFY1;MLLT3;NET1;PTPN1;STON1;MTOR;TFRC;METTL4;RAB5B;ABL1;NEDD4;IRGM;AP2S1;RAP1A;SETD5;PLCE1;RAP1B;ROCK1;RASGRP2;RAB5A;PICALM;FAM107A;RAB4B;BCAR1;SOCS2;HJURP;RAPGEF1;SNX12;AGTR1;RPTOR;ARHGEF11;LTBP4;CEACAM1;HCFC1;HIP1R;ROCK2;MAD2L2;NCLN;ZFYVE16;STON2;BAP1;SLITRK2;CDK11B;RUFY2;DCUN1D5
prerank,regulation of cell killing (GO:0031341),-0.5652645947883082,-1.509819060066227,0.04035087719298246,0.2089139151518607,1.0,8/16,23.43%,RAC1;CR1L;ICAM1;TGFB2;CD55;MAPK8;CFH;FZD7
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3806852597071565,-1.508795568746109,0.012367491166077738,0.20999479546817096,1.0,20/86,12.19%,RBPMS;ZNF423;ENG;ACVRL1;CREBBP;DAB2;BMPR2;THBS1;BMP5;RNF111;BMP6;TGFB2;BMP4;CDH5;SMAD2;ACVR2A;SMAD4;JAK2;HFE;NOTCH1
prerank,ncRNA processing (GO:0034470),-0.34069204856274915,-1.5086849239361853,0.0034782608695652175,0.20960263698798598,1.0,86/200,30.40%,INTS8;TUT7;UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;FARS2;RPF1;DDX10;SMAD1;SMAD2;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;DICER1;EXOSC3;XRN2;TUT4;RPL13;INTS3;UTP3;RPL38;RRP1;RPL27;RPS16;AGO2;RPL10;RPL7A;RPL5;PUS10;INTS9;DCAF13;EXOSC8;UTP14A;RPS27;RPL27A;WDR74;RPL36A;MDN1;RPL35A;UTP4;EXOSC5;BOP1;RPL37A;TRPT1;PES1;DROSHA;RPL32;EBNA1BP2;RPS7;RPS15;INTS7;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS17;NOL8;EXOSC7;WDR46;RPS2;RPP30;RPL39;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RPLP2;INTS5;UTP20;RPL18;INTS12;SSB;RPL19;FCF1
prerank,cellular potassium ion homeostasis (GO:0030007),0.5851147954830906,1.508449266006694,0.053738317757009345,0.32322816127758547,1.0,5/13,8.71%,KCNMA1;ATP1A2;ATP12A;ATP1B1;ATP4A
prerank,positive regulation of cytokinesis (GO:0032467),-0.4737639482554301,-1.5082534412087232,0.028368794326241134,0.2098234977601299,1.0,9/32,17.76%,PRKCE;SVIL;PKP4;CUL3;CDC14A;KIF23;RHOA;PKN2;GIPC1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.46521853932504,1.5076995832984763,0.04405286343612335,0.3222277070355465,1.0,11/31,19.27%,SYT1;SYT5;SYT12;SYT11;ADRA2A;SYT4;SYT3;SYT9;CACNA1G;CACNA1I;SYT17
prerank,cellular response to increased oxygen levels (GO:0036295),-0.606510793704838,-1.507621056444342,0.04684684684684685,0.21021967112525558,1.0,4/11,6.09%,FOXO1;CAV1;ATG7;FAS
prerank,positive regulation of biosynthetic process (GO:0009891),-0.44642617458849765,-1.5067809196423299,0.03103448275862069,0.2110275798280236,1.0,19/40,31.57%,SORBS1;ZBTB20;MTOR;PPARA;BMP4;RAB27A;PLCG2;AKT1;RGCC;CREBL2;CREB1;MTPN;ADGRB1;SLC5A3;F2R;LARP6;RUNX1;TGFB1;TLR6
prerank,positive regulation of cell division (GO:0051781),-0.4540503244005308,-1.5066426438423401,0.026785714285714284,0.2107506613853724,1.0,10/38,14.01%,PRKCE;SVIL;PKP4;CUL3;FGF1;CDC14A;TAL1;KIF23;RHOA;PKN2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6450278345190471,-1.5053852865179653,0.05565217391304348,0.21228147006752998,1.0,6/10,15.99%,BMP6;PPM1F;NOTCH4;RGCC;NOTCH1;MAD2L2
prerank,positive regulation of protein binding (GO:0032092),-0.42308874533017243,-1.5047364371225032,0.0196078431372549,0.21276903677701434,1.0,28/56,27.52%,RAPGEF2;CLDN5;CAV1;GSK3B;APP;DTX3L;LRRK2;STK3;ABL1;SPPL3;BMP4;PSEN1;HFE;FLOT1;HIP1R;PPP2CB;MARK3;AKTIP;PPP2CA;TCF7L2;TERT;CAPRIN2;RALB;TRIB3;BMP2;LRP1;RAN;NMD3
prerank,organic hydroxy compound transport (GO:0015850),-0.4486838278530867,-1.5044624256574677,0.027874564459930314,0.21269171233852766,1.0,8/36,8.86%,ABCC4;ATP8B1;SLCO1C1;RXRA;RALBP1;RBP4;SLC16A1;SLCO2B1
prerank,somite development (GO:0061053),-0.6126851131605953,-1.503301364219297,0.0570902394106814,0.2138835543372522,1.0,4/11,7.19%,SMO;LOXL3;MEOX2;MTHFD1
prerank,nuclear export (GO:0051168),-0.393243668222643,-1.5031097716649064,0.007194244604316547,0.21368526854528286,1.0,34/80,26.64%,SRSF11;NUP42;SMURF1;RAE1;CSE1L;SARNP;THOC2;XPO7;UPF3B;THOC7;DDX39B;DHX38;NUP153;SLU7;CHP1;HNRNPA1;TPR;THOC3;THOC1;LSG1;XPO4;NUP214;WASHC4;PHAX;SRRM1;RITA1;RNPS1;SRSF3;NUP188;POLDIP3;NXF1;NEMF;ATXN1;RAN
prerank,positive regulation of glycolytic process (GO:0045821),-0.5280523290346167,-1.5029697042187162,0.039399624765478425,0.212931173371826,1.0,8/20,17.56%,ZBTB20;INSR;APP;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5280523290346167,-1.5029697042187162,0.039399624765478425,0.212931173371826,1.0,8/20,17.56%,ZBTB20;INSR;APP;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,adipose tissue development (GO:0060612),-0.626613660545631,-1.5029642752350114,0.05405405405405406,0.2124405036674506,1.0,5/11,17.05%,LRP5;SH3PXD2B;NAMPT;DGAT2;ARID5B
prerank,supramolecular fiber organization (GO:0097435),-0.3203664551587011,-1.502600476459699,0.0,0.21250068048538284,1.0,83/333,17.15%,HIP1;TLL1;COL8A1;ITGA6;PGM5;SHROOM4;COL12A1;COL4A2;SNCAIP;MYO1D;COL25A1;CLIP1;USP9X;CD2AP;RAC1;SHROOM3;PLOD1;TPM3;PLOD2;ADAMTS2;RHOBTB1;CORO1C;COL4A6;APP;ELMO1;RND3;CGNL1;P3H2;COL5A1;ITGB4;LOXL3;LAMA3;COL4A5;DLG1;TMOD3;COL4A1;TGFB2;COL8A2;COL5A2;MYH11;MYO1F;BIN3;DNAJB6;HSPG2;COLGALT2;LOXL1;TSPAN14;ARHGEF2;DST;SHROOM1;ARHGAP17;BCAR1;ADAM10;SHROOM2;FBLN5;P4HA1;COL6A3;FAT1;DCTN1;COL15A1;TSPAN5;RHOA;ACTN1;LMOD1;TPM1;SLAIN2;CHP1;RHOC;RHOG;COL26A1;ELMO2;H3-3A;IAPP;HIP1R;COL6A2;TUBGCP4;MAD2L2;CORO7;SLK;TUBGCP5;COLGALT1;ARHGAP12;APH1A
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5431597926643242,1.502337596877158,0.04967602591792657,0.3310873642379393,1.0,5/16,12.17%,ATP1A2;CALM2;RYR2;SLC8A1;HRC
prerank,negative regulation of cell differentiation (GO:0045596),-0.34413617129777274,-1.501633730982717,0.0035398230088495575,0.21354978599732347,1.0,64/181,25.21%,DAB2IP;ZBTB16;FOXO1;RB1;FERMT2;CRIM1;CAV1;LRP5;ASXL1;IL17RD;BMP5;SPRED2;TBX1;METTL14;COL5A1;EGFR;TRPM4;LIMD1;HES1;PPARA;LDLRAD4;NFKBIA;PDCD4;MED1;SUZ12;COL5A2;BMP4;YAP1;NOTCH4;ANKRD26;SMAD7;ZFPM1;ADGRV1;TWIST2;NOTCH1;CDC73;TMEM64;CDK6;TRIO;JAG1;SMAD6;MAD2L2;BMP7;SKI;HEY1;NELFB;GATA2;PPP2CA;PPARG;PTEN;ITGB3;IGF2;PTPN11;HDAC7;USH2A;PTK2B;MYOCD;TBX3;ADAMTS7;TRIB3;NEPRO;GPS2;EID2B;GDF10
prerank,body fluid secretion (GO:0007589),0.5444846437047159,1.5012711426133847,0.0702576112412178,0.3309034746196987,1.0,3/15,9.25%,ERBB4;SLC22A4;VEGFA
prerank,heart development (GO:0007507),-0.35188673127057685,-1.5010112062786154,0.005263157894736842,0.21400001501614072,1.0,45/150,16.41%,TEK;ACVRL1;MEF2A;AKAP13;HEG1;INSR;PKD2;BMPR2;KAT2B;BMP5;MICAL2;SH3PXD2B;TBX1;SOX17;CDKN1B;TGFBR3;PDLIM5;TGFBR2;NIPBL;TGFB2;SMYD4;PTK2;RBP4;BMP4;MTHFD1;ECE1;MEF2C;WDR11;PLCE1;TBX2;PDLIM1;KDM6A;PCSK5;CASP8;RAMP2;KDM6B;ZFPM1;NOTCH1;PDLIM3;RBM20;FOXC1;FLRT2;BCOR;BMP7;TAB2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5306830124792183,-1.500616947750155,0.052158273381294966,0.2141428823743327,1.0,7/18,17.78%,ITGB1;JAM2;SLC39A8;ROCK1;ITGA4;VCAM1;GOLPH3
prerank,glycerolipid catabolic process (GO:0046503),-0.5368633482331945,-1.5000829657766066,0.04395604395604396,0.2145239232314932,1.0,6/19,13.54%,GPCPD1;ABHD2;PLA2G4A;GDPD1;MGLL;GDPD3
prerank,alpha-amino acid metabolic process (GO:1901605),0.4285707879163891,1.4998665006680858,0.022172949002217297,0.33132368460999106,1.0,15/45,14.38%,SLC25A13;ASNS;DDAH2;OAT;GADL1;GNMT;PYCR2;RIMKLA;ASPA;DPEP1;THAP4;GLS2;GLS;GLUD1;GPT2
prerank,positive regulation of protein import (GO:1904591),-0.46805254932952584,-1.4996910222651807,0.038869257950530034,0.2146708515924959,1.0,13/30,20.86%,UBR5;PIK3R1;PRKCD;CDH1;FLNA;PSEN1;ZPR1;TPR;MAVS;ZIC1;HYAL2;ARHGEF5;TRIM28
prerank,purine nucleotide catabolic process (GO:0006195),-0.5911765833731553,-1.4988207552490265,0.057034220532319393,0.21548273217324962,1.0,8/13,27.28%,NT5C2;NT5E;NT5C1A;GPX1;HINT1;GDA;NT5C;PNP
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5909307347922886,-1.4982631986400694,0.04380952380952381,0.21593210209050015,1.0,3/12,9.84%,PPP1R3B;PPP1R3C;AKT1
prerank,chloride transport (GO:0006821),0.3804244635867124,1.4981236058121423,0.02320185614849188,0.33277826296294505,1.0,18/74,14.48%,GLRA3;GABRG3;GABRB1;GABRB3;CLCNKA;ANO3;GLRA1;GABRB2;GABRA2;ANO4;CLCN2;SLC12A5;GABRA3;GABRA1;SLC12A4;SLC1A3;GABRE;SLC26A8
prerank,response to thyroid hormone (GO:0097066),-0.5848045180216267,-1.497584799412101,0.04727272727272727,0.2165627642990417,1.0,9/13,33.15%,LMO2;THRB;MED1;KLF9;CTSH;GAS2L1;RDX;BRD8;HPN
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.44549092188685424,-1.4973129165944394,0.03860294117647059,0.21654424900558156,1.0,13/39,15.65%,DAB2IP;EPS15;ITGA1;PTPRJ;EGFR;PTPN12;CBL;EPS15L1;RNF115;PTPN3;DUSP3;GRB2;LGMN
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.37246801064681573,-1.497065623453511,0.008849557522123894,0.21638155917011867,1.0,44/108,23.64%,NXN;RSPO3;CBFB;TRABD2B;ESR1;ITGA3;APP;NFATC1;LRRK2;EMD;KREMEN1;VGLL4;OTULIN;RNF43;MACF1;NKD1;MDFIC;GRB10;CCNY;HMGXB4;PSEN1;SOX7;CDC73;WWOX;NOTUM;TAX1BP3;APCDD1;TCF7L1;TNFAIP3;DAAM2;HIC1;SKI;SENP2;CTNNB1;PPP2CA;CTNNBIP1;GPC3;TERT;CDK14;AMER1;RSPO2;FZD7;SFRP4;PPP1CA
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.4851879371200724,-1.4963933358456465,0.04693140794223827,0.21694513084611874,1.0,10/27,15.76%,CREBBP;KAT6B;KAT2B;KAT6A;PHF20;TRRAP;SGF29;PHF20L1;KAT5;RUVBL2
prerank,amide transport (GO:0042886),-0.4992259932677992,-1.49605201450172,0.03710575139146568,0.21695223718728293,1.0,9/26,7.90%,ABCG2;CERT1;PLTP;SLC25A32;SLC5A6;SLC38A5;AQP11;ABCB9;TAP2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.42089826563113447,-1.4953020047002956,0.022108843537414966,0.2175352960889348,1.0,13/52,9.84%,SPTBN1;PRKCH;SORBS1;ITGB1;PRKCE;ITGA3;PTPN9;EGFR;PIK3R1;DLG1;STX3;EPB41L2;AKT1
prerank,cell-cell junction organization (GO:0045216),0.375207528533228,1.49503516020975,0.011363636363636364,0.3365168458107747,1.0,24/79,11.60%,CDH18;CADM2;CDH8;CTNND2;CDH20;CDH9;CDH10;CD177;PKP2;DCHS1;CDH19;CXADR;FLCN;CDH12;ANG;FSCN1;NECTIN3;SDK1;CDH7;CDH17;CDH24;CDHR3;CSF1R;CDH2
prerank,iron ion transmembrane transport (GO:0034755),-0.6403495750881606,-1.4947680499664595,0.04679376083188908,0.21783272394081238,1.0,5/10,16.78%,SLC40A1;SCARA5;SLC39A8;ABCB7;SLC25A28
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5523963536041123,-1.494259876827328,0.05872193436960276,0.21819281940538426,1.0,9/16,24.99%,ENG;BMPR2;TGFB2;NOTCH2;ZFPM1;NOTCH1;HEY2;DLL4;BMP2
prerank,regulation of lymphocyte migration (GO:2000401),-0.6401887916773706,-1.4942340490428796,0.04044117647058824,0.2177411223954528,1.0,5/10,11.10%,JAM2;MSN;WASL;AKT1;STK10
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4315469928058925,1.4939792485693684,0.04215456674473068,0.33633220007919123,1.0,11/39,7.32%,FGF14;ANK3;HECW1;FGF12;SCN1B;OSR1;GPD1L;WNK2;HECW2;WNK3;NETO1
prerank,neuron migration (GO:0001764),0.416348033738804,1.493425930217779,0.022779043280182234,0.3350360713631209,1.0,18/48,11.65%,ADGRL3;SPOCK1;DNER;ASTN2;CDK5;CDKL5;NRCAM;ASTN1;MDGA1;DCDC2;GPM6A;NTRK2;SOX1;VEGFA;DCX;MAP1B;CCK;AUTS2
prerank,regulation of protein neddylation (GO:2000434),-0.6154508740026151,-1.4932726360865731,0.058823529411764705,0.2188298659084041,1.0,6/10,20.63%,DCUN1D3;COPS9;RPL5;DCUN1D2;EPAS1;DCUN1D5
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5972372677719772,-1.49316456590308,0.054820415879017016,0.21846838153497639,1.0,5/12,14.98%,PRKG1;DOCK4;MEF2C;TPM1;IGFBP5
prerank,endochondral bone morphogenesis (GO:0060350),-0.6036735442468998,-1.491999931222938,0.04488330341113106,0.21981586664861488,1.0,6/11,19.96%,BMPR2;BMP4;MEF2C;FOXC1;TRPV4;COL13A1
prerank,external encapsulating structure organization (GO:0045229),-0.3340133196396946,-1.4919084690377815,0.0034542314335060447,0.21949119440270784,1.0,55/205,12.36%,VWF;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;ITGB1;JAM2;BSG;COL4A2;ADAMTS2;COL4A6;THBS1;ITGA3;APP;F11R;VIT;SPOCK2;ITGA1;SMOC1;KDR;COL5A1;ICAM1;ITGB4;MMP2;LAMA3;LAMA4;ITGB5;COL4A5;COL4A1;COL8A2;COL5A2;SLC39A8;HRNR;AGRN;HSPG2;LOXL1;CDH1;ADAMTS9;ADAMTS4;LAMA1;ADAMTS10;BGN;FBLN5;ADAMTS5;ADAMTS20;COL6A3;ADAMTS17;COL15A1;LAMA5;FGF2;COMP;THSD4;LAMC3
prerank,receptor-mediated endocytosis (GO:0006898),-0.3561392621564589,-1.49185182573379,0.0035971223021582736,0.21907611648271738,1.0,38/132,15.35%,FCHO2;ITGB1;DNAJC13;CALCRL;INSR;CAV1;DAB2;DNM3;EPS15;FNBP1L;RAMP1;LDLRAP1;TFRC;AP2B1;SCARF1;AP2A2;DNM2;LRP6;NEDD4;AP2S1;PI4KB;SNX9;HSPG2;GPR107;SCARB1;PICALM;IGF2R;RAMP2;GAK;STAB1;FCHSD2;ADM;AP1G1;LMBRD1;ACKR3;GRB2;LMBR1L;HIP1R
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.4748274399760254,-1.4917188796536651,0.03914590747330961,0.2187774889647054,1.0,12/28,20.86%,UBR5;PIK3R1;PRKCD;CDH1;FLNA;PSEN1;ZPR1;TPR;MAVS;ZIC1;HYAL2;TRIM28
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.43530358638641914,-1.4909617553471968,0.02112676056338028,0.21966059060125123,1.0,16/43,21.29%,SORBS1;PTPN1;PIP4K2A;NCK1;IRS1;PIP4K2B;PRKCD;GRB10;GSK3A;GRB14;SLC27A4;TNS2;GKAP1;IGF2;OGT;PTPN11
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.6321904848306439,-1.4905201630227713,0.0600375234521576,0.21986103428270296,1.0,6/10,18.94%,DDX39B;WDR76;FEM1B;THOC1;RFWD3;RPA2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5796344186955443,-1.4898596595473916,0.05693950177935943,0.22036218208636726,1.0,3/13,6.52%,DAB2IP;PTPN1;NEDD4
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5626617169918962,-1.4897432409033244,0.03389830508474576,0.22006902808532028,1.0,10/15,27.32%,TNRC6B;TENT4B;POLR2G;TENT4A;AGO2;BTG2;TNRC6A;TOB1;CNOT1;PABPC1
prerank,protein hydroxylation (GO:0018126),-0.5625464136726304,-1.4892470844264956,0.04744525547445255,0.22032387520283167,1.0,5/15,9.07%,PLOD1;PLOD2;P3H2;OGFOD1;ASPH
prerank,negative regulation of TOR signaling (GO:0032007),-0.4472509292781097,-1.4882561749657213,0.03867403314917127,0.22143679200438166,1.0,14/36,20.40%,SH3BP4;SESN1;ATM;DDIT4;GSK3A;UBR2;PRKAA1;KPTN;CASTOR1;UBR1;RNF152;ITFG2;TMEM127;AKT1S1
prerank,vacuolar acidification (GO:0007035),0.5000891079643142,1.487856970024313,0.05286343612334802,0.3440677780092862,1.0,7/21,11.39%,TMEM9;CLN3;GRN;CCDC115;ATP6V0D2;ATP6V0A2;DMXL2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5585354344235357,-1.4874872949782045,0.06283662477558348,0.22227404803445616,1.0,8/15,25.77%,RSPO3;ZNRF3;RNF213;CSNK1D;DAAM2;GPC3;SFRP4;WNT5B
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.5319916731015706,-1.4871595072181807,0.03731343283582089,0.22231973045716463,1.0,8/18,26.25%,LYN;MTUS1;IL6R;SLIT2;EDN3;PTK2B;PTN;ADAM17
prerank,gene silencing by miRNA (GO:0035195),-0.4655971485912937,-1.4866715517947673,0.03345070422535211,0.22262070334710737,1.0,15/32,27.03%,TNRC6B;LIMD1;PUM1;ZC3H7B;SNIP1;NOTCH4;DICER1;AGO2;MOV10;WTIP;TNRC6A;AJUBA;CNOT8;RAN;CNOT1
prerank,regulation of complement activation (GO:0030449),0.4395501528179067,1.4864211282497732,0.026570048309178744,0.3447498482819482,1.0,10/40,13.30%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;CPN1;SERPING1;CLU
prerank,endothelial cell migration (GO:0043542),-0.4429925566053463,-1.4862176000337917,0.03063063063063063,0.22285591766040472,1.0,18/37,25.35%,NOS3;ADGRA2;MYH9;ID1;PLEKHG5;PXN;ABL1;CDH5;PLXND1;STARD13;RHOA;CCN3;LGALS8;GIPC1;CYP1B1;EGR3;TNFSF12;PIK3CA
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.31802202120613937,-1.48593665579225,0.0,0.22286368160124162,1.0,111/348,22.40%,LEF1;CLDN5;RESF1;UBR5;NOS3;INSR;KLF4;ETS1;CD34;TNRC6B;LIMS1;MED26;KLF2;GSK3B;ANXA2;PTPN1;APP;ATM;DTX3L;MITF;DDX3X;MTOR;SMO;TFRC;MSN;SP1;CTCF;BMP6;AFDN;GAS6;PDE2A;MED1;SEC16B;FGF1;BMP4;ECE1;MEF2C;EZR;CDH5;NGF;SMAD1;ACTA2;MAPK1;ROCK1;PPM1F;RAB27A;NOS1AP;YAP1;PLCG2;CELF1;GSK3A;OCLN;WNT16;PIK3CD;FGF7;RAMP2;AKT1;MYOM1;TASOR;TP53;PRKAA1;RGCC;PSEN1;BRAF;MAZ;HFE;NOTCH1;FGF2;WNT11;ZPR1;PLSCR1;MAPK8;ATF4;PIK3CB;AGO2;FAM98A;HCFC1;ROCK2;TADA3;RPL5;VSIR;TERF2;ANGPT1;PIK3R3;BMP7;IGF1;MOV10;SRPK2;DNMT1;CTSH;FUBP1;PPHLN1;HEY1;HEY2;RPS3;CITED2;VAMP3;GATA2;TNRC6A;PRKAB1;KRAS;F3;FGFR4;BRCA1;TRIM28;DLL4;WARS1;MAPK7;RPS7;NFE2L2;GABPA
prerank,transcription by RNA polymerase II (GO:0006366),-0.3200044188734667,-1.4854769238256087,0.0016806722689075631,0.22309175315573923,1.0,98/305,24.63%,RREB1;MNAT1;INTS8;CREBBP;CBFB;NR3C2;ESR1;MLLT3;TEAD4;MED26;MAML2;CDK13;RXRA;PRRX1;KAT2B;SETD2;DEK;TEAD1;NR3C1;THRB;NFIX;CDK12;NOTCH3;SP1;HDAC1;NFKB1;PPARA;RARG;RPRD2;IWS1;MED1;EAF1;MAML1;POLR2G;NOTCH2;NABP1;YAP1;PPARD;GTF2E1;GTF2E2;ERCC2;TAF11;CPSF7;NOTCH4;NFIC;MAZ;ICE1;MED17;NOTCH1;INTS3;CDC73;SNAPC1;RTF1;TCEA1;LSM11;TAF5L;TAF1C;MLLT1;SNRPE;ATF4;TAF8;ERCC3;NR1D2;NR2C1;PIR;INTS9;TAF7;GTF2I;RARA;TAF3;HDAC10;LSM10;NELFB;PHAX;HSF2BP;FIP1L1;ELOF1;ADRM1;TBL1X;PPARG;RARB;ELOC;MED27;HDAC7;TAF4B;INTS7;SNAPC3;TAF13;RXRG;MED20;SUPT4H1;POLR2C;CCNK;GMEB2;E2F3;TAF9;TFDP1;TAF15
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.39867887595380025,-1.4853483715261735,0.021937842778793418,0.2228178808481316,1.0,19/65,15.35%,HIP1;DAB2IP;AFAP1L2;EPS15;ITGA1;PTPRJ;EGFR;PTPN12;CBL;EPS15L1;RNF115;RHBDF2;AKT1;ARAP1;PTPN3;CEACAM1;DUSP3;GRB2;HIP1R
prerank,negative regulation of growth (GO:0045926),-0.36013645759904717,-1.4852977895172195,0.0035778175313059034,0.22244801105101863,1.0,47/121,25.55%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;DDX3X;PTPRJ;SOX17;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;NOTCH2;SMAD4;TP53;DCBLD2;NOTCH1;WNT11;ST7L;CCN3;RERG;NPR1;OSGIN2;HYAL2;PPP2CA;BCL6;CDKN2C;CAPRIN2;FHL1;MSX1;SERTAD2;HSPA1B;GNG4;APBB1;SIPA1;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B;SERTAD3
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5346289802197529,1.4851885601649768,0.060324825986078884,0.34498793193458216,1.0,6/17,17.93%,NLGN1;RAB15;RAB3A;SYT4;CACNA1G;CACNA1I
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5348456769895492,-1.4850680945642403,0.045207956600361664,0.22237346885648995,1.0,9/18,17.59%,HEG1;ITGA3;SCAI;RASIP1;CUL3;TNFAIP1;MYOC;KCTD10;ARHGAP35
prerank,regulation of response to stress (GO:0080134),0.6173696190108275,1.4845767918901278,0.0625,0.3437654055499736,1.0,3/10,8.60%,OPRM1;ADCY8;CORO2B
prerank,vasculogenesis (GO:0001570),-0.4676802933393986,-1.484258325571309,0.03910614525139665,0.22317295336464163,1.0,12/32,12.19%,ENG;CAV1;KDR;SOX17;TGFBR3;TGFBR2;RASIP1;RAMP2;CUL7;ADM;RASA1;NOTCH1
prerank,cellular response to leucine (GO:0071233),-0.6260739704897098,-1.4839183031167658,0.05197132616487455,0.22276843082941852,1.0,6/10,18.69%,SESN1;MTOR;UBR2;RPTOR;LARS1;UBR1
prerank,response to leucine (GO:0043201),-0.6260739704897098,-1.4839183031167658,0.05197132616487455,0.22276843082941852,1.0,6/10,18.69%,SESN1;MTOR;UBR2;RPTOR;LARS1;UBR1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4845262622223854,-1.4833671090173703,0.05565529622980251,0.22324598087626776,1.0,14/26,25.53%,SLC39A10;SLC30A10;SLC39A8;SLC30A5;SLC39A6;SLC30A1;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B
prerank,hippo signaling (GO:0035329),-0.48951584198293546,-1.4831212859169773,0.023214285714285715,0.22315681694319942,1.0,9/26,11.87%,TJP1;TEAD4;TEAD1;YWHAE;STK3;TJP2;YAP1;LATS2;SAV1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.620495143559186,-1.482734476139957,0.06386861313868614,0.2233005244100727,1.0,3/10,8.04%,LYN;FAS;MAPK1
prerank,metal ion export (GO:0070839),0.45399873657421885,1.482462759911789,0.032036613272311214,0.3458959391866131,1.0,7/31,8.71%,ATP1A2;KCNA5;ATP12A;ATP2B4;SLC4A4;ATP1B1;ATP4A
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5189188108971696,-1.481736449429463,0.043875685557586835,0.22452714019186676,1.0,13/21,27.98%,CAV1;NCK1;DDIT4;RASSF2;PPM1F;NCK2;SMAD7;CNKSR3;PTEN;GADD45A;INPP5J;DMTN;NLRP2B
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.4643166350175802,-1.4814226595506184,0.030249110320284697,0.22449844473952796,1.0,14/32,28.28%,ZBTB20;INSR;TMSB4X;APP;PPARA;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT;PFKFB4;BEND3;PFKFB2;TREM2
prerank,response to cytokine (GO:0034097),-0.3521767574364453,-1.4811735682200877,0.003527336860670194,0.22442095478017499,1.0,35/141,13.89%,LEF1;IL1R1;OSMR;SP100;NFAT5;PTPN14;MCL1;APP;TRIM56;SETD2;PTPN9;LDLRAP1;MAP4K3;IL6ST;PTPN12;ADAM9;IL6R;GGT5;GCH1;MAPKAPK2;LIFR;HAX1;CASP8;ADAM10;IKBKE;JAK2;IFITM3;TIMP3;RHOA;IRAK1;HDAC4;PTPN13;CD40;PLSCR1;MAPK8
prerank,central nervous system myelination (GO:0022010),0.5820395403055069,1.4811290291717538,0.06306306306306306,0.34627336749147586,1.0,6/11,16.50%,TENM4;MYRF;PLP1;ABCA2;CLU;B4GALT6
prerank,plasma membrane organization (GO:0007009),-0.40018296382276053,-1.4807860007043703,0.008992805755395683,0.224574300328339,1.0,19/61,16.51%,SPTBN1;PLSCR4;MYOF;MYH9;CAVIN2;FNBP1L;A4GALT;COL5A1;PLSCR2;EHD2;DYSF;AHNAK2;SNX9;BIN3;CHMP4A;ANO6;PLSCR1;ABCA7;TLCD1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.3987193169717349,1.4796165297835029,0.029612756264236904,0.3471684647801256,1.0,11/54,6.43%,KCNIP4;DPP10;KCNIP1;KCNMA1;DPP6;KCNJ3;AKAP6;KCNN2;GABBR2;CD63;CACNA1D
prerank,regulation of protein binding (GO:0043393),-0.3643587412754697,-1.4796131187008401,0.010186757215619695,0.2259636602010736,1.0,45/114,26.64%,RAPGEF2;CLDN5;CAV1;DAB2;GSK3B;APP;CRK;DTX3L;LRRK2;LDLRAP1;STK3;PRKCD;SPPL3;BMP4;ROCK1;NES;AKT1;PSEN1;ZFPM1;HFE;HDAC4;ACTB;FLOT1;MAPK8;BTBD1;MARK2;HIP1R;CTSZ;MITD1;PEX14;MARK3;AKTIP;PPP2CA;TFIP11;TCF7L2;CTNNBIP1;TERT;CAPRIN2;RALB;PPP1CA;TRIB3;BMP2;LRP1;HDAC5;RAN
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.372752260810196,-1.4793927058703282,0.01303538175046555,0.22588895356560268,1.0,29/94,17.21%,DAB2IP;ITPR1;PPP1R13B;MCL1;ATM;MAP3K5;DDX3X;FHIT;TNFRSF1B;STK24;ABL1;CUL3;PRKCD;BNIP3;ERN1;CUL2;PPM1F;ATP2A3;ARL6IP5;TP53;FNIP2;IKBKE;ERO1A;ATF4;DNAJC10;BBC3;BCL2L11;HIC1;HINT1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.41609912832050006,-1.4787179470165777,0.013157894736842105,0.22651515638017622,1.0,17/50,16.38%,IGF1R;PLCB4;PLCB3;PIK3R1;IRS1;PLCB1;PI4KB;EZR;PIK3C2A;NGF;PLCE1;PIK3CD;RHOA;PIK3CB;GAB2;TNFAIP8L3;IGF1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.567530113570706,1.4768723568029143,0.049217002237136466,0.3507934837083674,1.0,4/12,9.46%,DGKQ;H6PD;CLCN2;ABCA2
prerank,positive regulation of cell adhesion (GO:0045785),-0.3856239548713268,-1.47647713071978,0.012131715771230503,0.2296689580783457,1.0,20/74,12.81%,RSU1;RAC1;ZFHX3;LIMS1;ATM;VIT;PRKD2;PTPRJ;ADAM9;AFDN;STX3;TGFB2;TGM2;PPM1F;EPHA4;FBLN2;JAK2;SMAD7;FRMD5;TPM1
prerank,peptidyl-serine modification (GO:0018209),-0.3399791536696204,-1.476390116617012,0.0053285968028419185,0.22933468464715479,1.0,55/166,19.55%,PRKCH;DYRK1A;CSNK1A1;PRKCE;TLK2;GSK3B;ATM;MARK1;RPS6KA5;PAK2;LRRK2;NEK6;MTOR;PRKD2;TLK1;CSNK1G3;TGFBR2;RICTOR;GAS6;MAST4;MAST2;PRKCD;MAPKAPK2;PLK2;MAPK1;ROCK1;PRKD1;AKT3;LATS2;CLSPN;AKT1;STK32C;IKBKE;STK38;RPS6KA1;CSNK1G1;CSNK1D;ULK2;MKNK2;MAPK8;PKN2;RPS6KA3;MARK2;PKN3;ROCK2;MAPK12;SRPK2;MARK3;HIPK1;HPF1;IKBKB;GALNT1;VRK2;POGLUT3;PRKDC
prerank,positive regulation of innate immune response (GO:0045089),-0.47097419441504446,-1.4762860724682043,0.03626943005181347,0.22905001493606852,1.0,16/30,31.52%,UBE2K;NMI;LBP;AKIRIN2;PLSCR1;POLR3F;IFI35;NLRC5;GBP5;MAVS;DHX9;TRIM6;RIOK3;SPI1;PLA2G5;TRIM62
prerank,synaptic vesicle membrane organization (GO:0048499),0.5212421034052754,1.4757992168070466,0.06221198156682028,0.35060906836506067,1.0,5/17,12.46%,SNAP25;STX2;PRRT2;SYP;SYNGR1
prerank,postsynaptic membrane organization (GO:0001941),0.5233563733341443,1.4756645779360684,0.057736720554272515,0.3485401185201879,1.0,6/17,14.63%,NRXN1;NLGN1;MUSK;DLG4;NLGN2;APOE
prerank,regulation of protein phosphorylation (GO:0001932),-0.32447586633155745,-1.4751002971511213,0.004830917874396135,0.23042849077424776,1.0,87/256,24.16%,TEK;DAB2IP;PECAM1;ENG;NSD1;PPP2R5A;INSR;BMPER;DAB2;RAC1;FAM20A;LYN;CORO1C;DVL3;APP;RALBP1;LIMK2;TBX1;LRRK2;KDR;NIBAN1;SLCO3A1;EGFR;TFRC;GAS6;ABL1;FAS;IL34;LRP6;SLIT2;CCND3;PTK2;IRGM;FGF1;BMP4;CDH5;PLCE1;FLT4;ACVR2A;OCLN;FGF7;AKT1;VEGFC;AXIN2;STAT2;ILK;FNIP2;FGF2;LIMCH1;CSNK1D;PTPN13;FLOT1;CHP1;CD40;HGF;ATF4;TRAF3IP1;DNAJC10;ROCK2;ANGPT1;PELI2;PIK3R3;BMP7;FYN;CDK5RAP3;MAVS;SOD1;RAP2A;AKTIP;CCND1;BRAT1;PPP2CA;PRKDC;KRAS;PTEN;ITGB3;IGF2;P2RY1;WARS1;CCN1;HSP90AA1;RIPK1;EIF2AK3;RALB;PLPP3;ARRB1;PPP2R5E
prerank,regulation of multicellular organism growth (GO:0040014),-0.5654114442055483,-1.474858286077633,0.060658578856152515,0.23038802509956305,1.0,5/15,18.06%,GHR;APP;MFSD2A;IGF1;SOD1
prerank,negative regulation of blood pressure (GO:0045776),-0.5832218144458725,-1.4740334641307105,0.04882154882154882,0.23127101411679907,1.0,8/13,35.49%,NOS3;BMPR2;SCPEP1;PRCP;NOS1;APLN;NOS2;DRD3
prerank,amino sugar metabolic process (GO:0006040),-0.617741314445222,-1.473621358596581,0.06007067137809187,0.2315077555244376,1.0,5/10,9.09%,ST3GAL1;ST6GAL1;CSGALNACT1;GFPT2;SLC35A3
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6347314027598021,-1.4728608561692076,0.06111111111111111,0.2323264397272767,1.0,4/10,9.84%,CD200;LRCH1;WASL;AKT1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5208609963211257,1.4727291441563601,0.0539906103286385,0.35257269457590396,1.0,8/18,16.82%,ADCY10;AQP4;DNAAF1;NEK10;ROPN1L;SPAG17;CABYR;DNAAF2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.529815935585817,-1.4721411443977526,0.054003724394785846,0.23300157885027872,1.0,11/18,36.42%,CD34;CD200;TGFB2;SMAD4;LGALS9;LRRC32;LTBP1;LILRB1;HIF1A;SMAD3;ITGB6
prerank,negative regulation of hippo signaling (GO:0035331),-0.5933129226140472,-1.471875770651368,0.061946902654867256,0.23298522010821432,1.0,7/12,23.63%,WWC2;VGLL4;LIMD1;MARK3;WTIP;MAP2K3;AJUBA
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.5277367663925981,-1.471810960951068,0.04735883424408015,0.2325871121123604,1.0,10/20,23.21%,PELI1;BIRC3;CASP8;CFLAR;FLOT1;ASAH1;PDCD6IP;OGT;HSP90AA1;RIPK1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.5110486327053763,-1.4711336524685386,0.05486725663716814,0.23324964456913935,1.0,10/21,16.67%,CORO1C;MACF1;PTK2;ROCK1;LDB1;RHOA;LIMCH1;DUSP3;ROCK2;SLK
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.565763056401205,1.470952317151776,0.06950672645739911,0.35401550904323,1.0,3/12,6.17%,SNAP25;STX2;PRRT2
prerank,regulation of response to external stimulus (GO:0032101),-0.3588434690492002,-1.4707288893075896,0.016891891891891893,0.2335265800825286,1.0,32/121,20.85%,FOXP1;IL1R1;XIAP;ADGRA2;CAV1;CASP12;SEMA7A;TMSB4X;BIRC3;STK24;SAMHD1;CD55;IRF1;NMT1;CELF1;CASP8;AREL1;JAK2;AGTR1;MGLL;USP18;SAG;NR1D2;N4BP1;ANXA1;ZMPSTE24;ERAP1;NOD2;DAGLB;TKFC;BCL6;AKNA
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.38036663473501703,-1.4676362044316333,0.023853211009174313,0.2382119639655039,1.0,21/74,17.12%,LEF1;DAB2IP;FERMT2;DAB2;IL17RD;GCNT2;BMP5;SPRED2;MTOR;TGFBR2;LDLRAD4;TGFB2;SMAD2;SMAD4;AXIN2;RGCC;SMAD7;FOXC1;MAD2L2;MCRIP1;CTNNB1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.4297160187718169,-1.4675348941887632,0.03333333333333333,0.2378951874632205,1.0,15/43,17.81%,CTNNA1;FERMT2;MFHAS1;GSK3B;LIMK2;DTX3L;TFRC;BMP4;YAP1;LATS2;AKT1;SIN3A;ILRUN;TPR;CDK5RAP3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.5414219713972085,-1.4665174403612118,0.05730129390018484,0.23915127249634588,1.0,8/16,16.74%,MEF2A;IL6ST;ROCK1;EDN1;PDE9A;ROCK2;IGF1;TRPC3
prerank,hepaticobiliary system development (GO:0061008),-0.5066502355744805,-1.4665070719444404,0.059027777777777776,0.2386778160564674,1.0,11/20,23.86%,PKD2;LSR;TGFBR3;NIPBL;PRKCSH;ARID5B;CDK5RAP3;CEBPG;CITED2;NF1;CEBPA
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5976667350555165,-1.4664662441996672,0.07321428571428572,0.23825820415577054,1.0,6/11,28.55%,CAV1;NEDD4L;CASQ2;KCNH2;CAB39;ACTN2
prerank,response to ketone (GO:1901654),-0.49171754391095146,-1.4663173565571819,0.05263157894736842,0.23801644301329525,1.0,7/24,8.80%,ABHD2;CAV1;THBS1;TGFBR3;SLIT2;TGFB2;YAP1
prerank,negative regulation of protein kinase activity (GO:0006469),-0.37511923071870507,-1.4661559543405758,0.014652014652014652,0.23781444041914188,1.0,30/88,22.39%,PTPRB;DAB2IP;RB1;CAV1;LRP5;CORO1C;PTPN1;CEP85;PAK2;CDKN1B;RTRAF;ABL1;LRP6;PPM1F;SH3BP5L;PRKRIP1;AKT1;CEACAM1;DUSP3;CHP1;TAF7;UBASH3B;ADARB1;CDK5RAP3;HYAL2;PTPRC;AKT1S1;NF1;WARS1;GADD45A
prerank,positive regulation of autophagy (GO:0010508),-0.3767655578331821,-1.4661245943359071,0.014414414414414415,0.23738623416450913,1.0,34/81,26.11%,FOXO1;DAPK1;GNAI3;SH3BP4;GSK3B;SESN1;LRRK2;KDR;LARP1;FOXO3;IRGM;BNIP3;PIK3C2A;PLK2;ROCK1;PRKD1;GSK3A;PRKAA1;TRIM14;MTDH;KAT5;PIK3CB;TRIM13;IKBKG;RNF152;ORMDL3;ATF6;TRIM68;HMGB1;MAP3K7;PLEKHF1;PLK3;EIF2AK4;TPCN1
prerank,synaptic vesicle recycling (GO:0036465),0.45191870213848734,1.466124215396449,0.05592841163310962,0.36284842939979883,1.0,6/31,6.00%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG
prerank,negative regulation of glycolytic process (GO:0045820),-0.6143821387182695,-1.465823886151539,0.05734767025089606,0.23687930962164094,1.0,3/10,12.48%,CBFA2T3;PPARA;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6143821387182695,-1.465823886151539,0.05734767025089606,0.23687930962164094,1.0,3/10,12.48%,CBFA2T3;PPARA;HDAC4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5238153518162453,-1.4658068695294082,0.05516014234875445,0.2364350650303826,1.0,9/20,14.53%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;PKDCC;CSK;NUMB
prerank,negative regulation of cellular process (GO:0048523),-0.30180085132815265,-1.4650349643613008,0.0,0.23736425648044826,1.0,187/521,27.13%,APBB2;DAB2IP;SMARCA2;IGFBP7;RAPGEF2;SP100;ACVRL1;JAM2;PPP1R13B;RB1;PODXL;FERMT2;NOS3;DCUN1D3;PTPN14;KLF4;ETS1;ABI1;PKD2;CBFA2T3;CD34;MYH9;LYN;BMPR2;PDS5B;CBLL1;CD200;SH3BP4;BTG3;APP;KAT2B;BMP5;RNF139;ITGA1;TBX1;ARID2;DDX3X;P3H2;THAP12;PTPRJ;SOX17;CDKN1B;TGFBR3;VGLL4;CRLF3;CTCF;DYSF;TNFRSF1B;RARG;RBM5;NCK1;NMI;PDCD4;SLIT2;TGFB2;SUZ12;AQP11;BMP4;BNIP3;PTPRK;CDK10;ARHGDIA;NGF;PLXND1;PLXNA4;PRKD1;RAF1;IRF1;CELF1;SMAD4;WNT16;CTBP2;ADAM10;VPS13C;CHMP4B;TP53;FRK;UBR2;KLF10;NOTCH4;AXIN2;NCK2;RGCC;LMNA;SOX7;TXNIP;JAK2;ZBTB7C;DCBLD2;RASA1;NOTCH1;FGF2;RAD18;ACTN1;CDC73;CTTNBP2NL;WNT11;CCN5;CDK6;TBRG1;PLSCR1;ST7L;PDE12;NUDT6;RNF167;IFI35;BTG2;MIF;ATG5;CCN3;FUZ;SMAD6;FOXO4;RERG;ANGPT1;BMP7;SKI;NPR1;GSDME;NOX4;PIP4P2;CTNNB1;TFAP4;ADARB1;OSGIN2;TNS2;ADGRG1;VAMP3;TES;HYAL2;BAP1;PPM1D;SOX4;PPP2CA;TGFBI;TMEM127;PTEN;BCL6;TOB1;LPCAT3;DLL4;BLM;WARS1;CDKN2C;ROR2;CAPRIN2;DIS3L2;NOS1;PTK2B;CCN1;FHL1;MYOCD;PARP16;BECN1;TXNDC12;MSX1;EIF2AK3;SFRP4;COPS8;CEBPA;CYP1B1;ATF5;SERTAD2;E2F7;SEMA5A;HSPA1B;PINX1;GNG4;PLXNB1;ADGRB1;BMP2;PLPP1;APBB1;SIPA1;SERTAD3;PTPN2;TPTE;NUPR2;CDKN3;APC;VPS35;EMILIN1;FRZB;RND1;F2R;FABP3;CGREF1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.4044328945853743,-1.4645441128047234,0.021897810218978103,0.23769210205634683,1.0,16/56,12.16%,FLT1;TEK;DYRK1A;INSR;ABI1;LYN;KDR;EGFR;ABL1;PTK2;TPST2;EPHA4;FLT4;JAK2;ABI3;PKDCC
prerank,regulation of microglial cell activation (GO:1903978),0.553082073068964,1.4644169971306018,0.06387665198237885,0.3640854253558185,1.0,5/15,13.15%,NR1D1;SYT11;SPHK1;GRN;LDLR
prerank,calcium ion transmembrane transport (GO:0070588),0.3648185438879711,1.4638832595070363,0.023148148148148147,0.36288195866756556,1.0,16/86,8.06%,TRPM3;SLC24A4;SLC24A2;GRIN2B;SLC25A23;RYR3;PHB2;ATP2B4;CACNA2D1;GRIN2A;CACNA1A;CACNB3;CACNA1D;SLC8A2;TMCO1;TRPM1
prerank,extracellular structure organization (GO:0043062),-0.3295989298231722,-1.4637355052919858,0.0035026269702276708,0.23854113530733637,1.0,54/204,12.36%,VWF;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;ITGB1;JAM2;BSG;COL4A2;ADAMTS2;COL4A6;THBS1;ITGA3;APP;F11R;VIT;SPOCK2;ITGA1;SMOC1;KDR;COL5A1;ICAM1;ITGB4;MMP2;LAMA3;LAMA4;ITGB5;COL4A5;COL4A1;COL8A2;COL5A2;SLC39A8;AGRN;HSPG2;LOXL1;CDH1;ADAMTS9;ADAMTS4;LAMA1;ADAMTS10;BGN;FBLN5;ADAMTS5;ADAMTS20;COL6A3;ADAMTS17;COL15A1;LAMA5;FGF2;COMP;THSD4;LAMC3
prerank,regulation of RNA metabolic process (GO:0051252),-0.40736155778371286,-1.4632474471081298,0.02112676056338028,0.23890855849252027,1.0,18/59,14.58%,MBNL1;MBNL2;ZNF326;MITF;AHNAK;METTL4;TNFRSF1B;NOVA2;FUS;MED1;AHNAK2;CELF1;HNRNPF;RASA1;SON;CLK3;RBM20;RC3H1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.31612314161704297,-1.4619960641722949,0.0016474464579901153,0.24058443969300544,1.0,76/327,16.35%,APBB2;NFIA;RREB1;SMARCA2;ZNF423;ENG;ACVRL1;CREBBP;NSD1;RB1;BNC2;ZMIZ1;KAT6B;ERC1;INSR;ESR1;FOXN3;ZFHX3;IRF2;RPS6KA5;WWC2;ZSCAN21;MITF;NR3C1;SOX13;SOX17;PSPC1;SP1;VSX1;LIMD1;SIX1;RYBP;ABL1;DNM2;TRRAP;NSD3;FUS;NFYC;GTF2IRD1;MEF2C;SLC39A8;ZBTB4;ASCC1;NAB1;LDB1;PRDM2;GPBP1;SPTY2D1;SP3;USP13;TP53;HMG20A;PRRX2;SOX7;JMJD1C;CHD3;YAF2;NOTCH1;SFPQ;OGG1;ACTN4;TAF5L;ATF4;MZF1;GPBP1L1;NR1D2;HCFC1;TCF3;TCF7L1;FOXC1;MYBL2;NAB2;UBE2L3;FOXO4;CREBL2;HIC1
prerank,organelle fission (GO:0048285),-0.5047061762019873,-1.461599784384,0.03345724907063197,0.2407436441609922,1.0,6/24,6.71%,DNM3;CORO1C;TMCC1;MIEF1;DNM2;SEC16B
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3238232394557911,-1.461255438610696,0.0033500837520938024,0.24088704448915443,1.0,69/248,16.07%,DAB2IP;XIAP;UBR5;ADGRA2;CSNK1A1;CAV1;DAB2;MLLT3;SMURF2;FZD6;GSK3B;DVL3;MCC;PSMA2;LRRK2;IGFBP4;DDX3X;ZNRF3;SOX13;SOX17;EGFR;EMD;KREMEN1;CSNK1G3;TRPM4;FZD4;LIMD1;HDAC1;FRMD8;NFKB1;RBX1;STK3;OTULIN;LRRK1;CUL3;LRP6;NKD1;PSME2;KLHL12;CTNND1;PSMB4;GLI3;GSK3A;LATS2;PPM1B;UBAC2;AXIN2;CCNY;ILK;PSEN1;SOX7;CSNK1G1;DKK2;CSNK1D;TMEM64;NOTUM;WNT11;PLEKHA4;PSMC2;LMBR1L;TMEM170B;LYPD6;USP34;PSMB2;FUZ;RUVBL2;PSMB1;MAD2L2;DAAM2
prerank,regulation of dendrite extension (GO:1903859),0.5118691966509922,1.4594811456228773,0.03648068669527897,0.3704982457788935,1.0,10/18,20.23%,SYT1;RIMS2;RIMS1;CPNE9;RNF157;SYT4;SYT3;UNC13A;SYT17;CPNE5
prerank,regulation of immune effector process (GO:0002697),0.42657478017852174,1.459148721409382,0.031026252983293555,0.36880555334687454,1.0,10/41,13.30%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;CPN1;SERPING1;CLU
prerank,telomere organization (GO:0032200),-0.42163333549824417,-1.4588320562409045,0.0325497287522604,0.24453249808100436,1.0,19/43,21.31%,SP100;STN1;ATM;MRE11;DOT1L;POLD3;RPA3;DNA2;RPA1;CTC1;PTGES3;H3-3A;TERF2;WRN;RPA2;PRKDC;DCLRE1B;TERT;BLM
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.39911256523829525,-1.458688900458321,0.017605633802816902,0.24430264442571945,1.0,20/59,24.76%,DAB2IP;ERC1;TAB3;BIRC3;NFKBIA;ROCK1;AKT1;NFKBIL1;ROCK2;TNFRSF1A;TAB2;IRAK2;IKBKG;MAP3K14;IKBKB;TBKBP1;NKIRAS2;RELA;RIPK1;MAP3K7
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6045437225111502,1.4585865263789737,0.07929515418502203,0.3676545150201208,1.0,4/10,13.32%,QDPR;ASRGL1;THAP4;PCBD1
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5220428216841101,-1.457901782397438,0.049723756906077346,0.24505397550963542,1.0,10/19,19.06%,BMPR2;TGFBR2;TGFB2;SMAD4;ZFPM1;NOTCH1;SMAD6;HEY1;HEY2;SOX4
prerank,cellular protein modification process (GO:0006464),-0.2861776514899613,-1.4578032878875162,0.0,0.24471362288981333,1.0,227/982,17.01%,PTPRG;PTPRB;GRK5;PRKCH;PTPRM;PRKG1;FBXL7;IGFBP7;ZBTB16;ST3GAL6;KLHL5;SNRK;MAP3K20;ERG;ACVRL1;BCR;DCAF10;ST3GAL4;ST3GAL1;PPP2R5A;DCUN1D3;PTPN14;DYRK1A;INSR;PPM1H;CSNK1A1;NEK7;PTP4A2;DAPK1;FAM20A;LYN;PRKCE;BMPR2;PLOD2;TLK2;ST8SIA4;GSK3B;THBS1;CDK13;PRKACB;FBXL12;GCNT2;MTMR3;PTPN1;APP;ATG7;ZDHHC6;ATM;JAK1;MARK1;RPS6KA5;ZC3HAV1;PSMA2;LIMK2;PAK2;SIK1;LRRK2;ATG10;IGFBP4;MAN2A1;MAP3K5;PTPN9;MAP4K3;RAB1A;ALG10B;NEK6;MTOR;CUL9;CDK17;TIPARP;PRKD2;MERTK;PTPRJ;PARP4;CDK12;FBXL3;TLK1;DAD1;YES1;PTPN12;CSNK1G3;RAB2A;TGFBR2;B3GNT2;RBX1;PIGT;GAS6;STK3;STK24;BMX;ABL1;PPEF2;MAST2;LMO7;CUL3;DCAF5;TGFB2;SIRT5;PRKCD;PPM1L;PARP14;BRD2;BMP4;OGFOD1;ILKAP;PTPRK;CDK10;ERN1;PSME2;MAPKAPK2;PRAG1;CDC42BPA;AAK1;PLK2;PDIA6;TGM2;MAPK1;ROCK1;MTMR6;PHKA2;CUL2;PPM1F;MAML1;NAA80;SETD3;BIRC6;LOXL1;WSB2;RAB5A;PRKD1;AKT3;SPSB1;YWHAZ;PSMB4;ST3GAL2;PXK;GSK3A;ACVR2A;LATS2;PPM1B;PIK3CD;ADAM10;UBE2D3;AKT1;FEM1A;UBA7;SOCS2;FUT10;SIK3;CUL7;FRK;TAOK3;PRKAA1;FBXW8;WIPI1;WNK4;PPP1R12A;UBLCP1;STK10;ILK;KLHL13;FNIP2;PTPN3;IKBKE;ITIH2;BRAF;ERO1A;JAK2;STK38;IRAK1;LRRC41;UBE2E2;CSNK1D;PRKCSH;PTPN13;CTTNBP2NL;CLK3;ANO8;CCDC8;NOTUM;WNT11;FEM1C;CSK;MSLN;ASB1;SIRT3;FBXW11;CDK6;KLHL25;MKNK2;MAPK8;PKN2;BTBD1;B4GALT5;MSRA;PSMC2;MAP4K4;MARK2;HIF3A;LIPE;IGFBP5;SERPINC1;GMFB;PTAR1;FEM1B;PKN3;UBE2M;ROCK2;NUAK1;ATG5;ERCC8;PSMB2;ABCA7;UBE2L3;PSMB1;F5;DCAF13;PPP2CB;SRPK2;RAB11A;FYN;MARK3;HIPK1;RARA;PLAT;ANXA1;CDC42BPB
prerank,regulation of hemopoiesis (GO:1903706),-0.6196818937289728,-1.456779635443662,0.06028368794326241,0.24593938086834896,1.0,2/10,1.23%,CREBBP;CBFB
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.443065735356364,-1.4566016606303602,0.04070796460176991,0.2457960245149157,1.0,17/36,25.25%,LEF1;GNB1;TNRC6B;FZD6;NFATC1;FZD4;PLCB3;PLCB1;WNT11;AGO2;MOV10;CTNNB1;TNRC6A;TCF7L2;FZD5;MAP3K7;GNG2
prerank,pentose-phosphate shunt (GO:0006098),0.5965846990878338,1.45633403389753,0.0779510022271715,0.37027221727762666,1.0,6/11,17.50%,PGLS;H6PD;TKT;RPIA;PGD;PGM2
prerank,modification-dependent protein catabolic process (GO:0019941),-0.33220202580933256,-1.4559342337938508,0.005253940455341506,0.24652855935042248,1.0,91/193,35.76%,FBXL7;NEDD4L;SMURF2;UBE2K;TRIM25;CNOT4;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;RNF213;RBX1;CBL;RNF43;UBE4B;CUL3;NEDD4;RNF40;RNF144B;BIRC6;ARRDC1;SPSB1;TRIP12;MIB1;FEM1A;AREL1;NTAN1;CDC16;ANAPC16;ATXN3;UBR4;FEM1C;UBE4A;KLHL25;RNF168;PSMC2;RC3H1;RNF167;MYLIP;UBE2L3;KCTD10;KLHL3;SIAH1;ADRM1;BUB1B;HERPUD1;ELOC;UBE2R2;MDM2;BUB3;KEAP1;NDFIP2;HACE1;FZR1;ARRB1;RCHY1;RNF146;TRPC4AP;ANAPC7;DTL;ARIH2;RNF34;RNF114;UBE2I;UBA1;RNF14;ANAPC11;CDC34;UBE2H;TRIM32;ANAPC10;ANAPC5;PSMD13;RNF11;PLK1;RNF19A;RBBP6;AURKA;FBXL14;UBE2A;RNF20;TOLLIP;KLHL15;WDR81;TOPORS;RNF185;UBE2G2;CDC20;NEDD8;OS9
prerank,positive regulation of kinase activity (GO:0033674),-0.3584821486116429,-1.4555167023403894,0.017035775127768313,0.24670817258172464,1.0,23/107,8.85%,FLT1;TEK;IGF1R;RAPGEF2;TIE1;ROR1;INSR;IQGAP1;KDR;MERTK;EGFR;GAS6;MRNIP;DSTYK;LMO4;PTK2;RASSF2;RAP1A;SNX9;MRE11;EPHA4;MMD;FLT4
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.45378287557803443,1.4552026969451455,0.06220095693779904,0.3703670058644651,1.0,10/30,8.20%,FGF12;SCN1B;KCNA5;SCN1A;CACNA2D1;PKP2;GPD1L;CACNA1D;RYR2;SCN5A
prerank,gene expression (GO:0010467),-0.30730886057372364,-1.4547378222570906,0.0,0.2476422425036318,1.0,132/348,27.03%,RBPMS;MEF2A;SRSF11;RBMS1;RRBP1;NUP42;RPS21;THRB;RPL37;RAE1;SARNP;RPL31;RANBP2;THOC2;RPL9;RBM5;TASP1;RPS14;UPF3B;THOC7;NUP98;RPSA;RBMS2;UPF2;SEC13;AGFG1;TSPAN14;POLR2G;DDX39B;RPL3;RPLP1;MRPL32;RPL26;NOL9;PWP1;RPS11;TAF1B;HNRNPUL1;RBM39;DHX38;HNRNPF;XRN2;TSPAN5;TSPAN17;NUP153;RPL13;SLU7;MRPS18A;RPL38;DRG1;RPL27;RPS16;APOBEC1;MCM3AP;RPS4X;GSPT1;AGO2;RPL10;RPL7A;SYNCRIP;HARS2;TPR;RPL5;THOC3;CREBL2;THOC1;MRPL24;NOX4;RPS27;ADARB1;RPL27A;GOLPH3;NUP214;NXT1;RPS3;RPL36A;RPL35A;FIP1L1;TFIP11;SRRM1;MRPS14;RNPS1;GLE1;RPL37A;SRSF3;MRPS21;DROSHA;MRPL35;RBM3;RPL32;WARS1;RBM6;PTMA;RPS7;NUP188;RPS15;TSPAN33;MRPL34;RPS8;ALKBH5;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;MED20;RPS23;POLR2C;POLDIP3;SMG6;NXF1;SRBD1;RPS17;POLR2L;RPS2;MRPL43;MLF1;POLR2H;ATXN1;RPL39;MRPL11;RPS26;TNIP1;RPS15A;HNRNPL;HNRNPD;NUP88;MMS19;RPL15;RPL34
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.4104173696000919,-1.4544845000221094,0.025951557093425604,0.24763552146301002,1.0,13/52,9.84%,SPTBN1;PRKCH;SORBS1;ITGB1;PRKCE;ITGA3;PTPN9;EGFR;PIK3R1;DLG1;STX3;CNST;AKT1
prerank,positive regulation of dendrite extension (GO:1903861),0.5179888419280421,1.4544008385794438,0.043478260869565216,0.3698087869018991,1.0,10/17,20.23%,SYT1;RIMS2;RIMS1;CPNE9;RNF157;SYT4;SYT3;UNC13A;SYT17;CPNE5
prerank,neurotransmitter uptake (GO:0001504),0.5673412469695616,1.453616852260116,0.07456140350877193,0.3692534822410305,1.0,4/12,13.81%,ATP1A2;SNAP25;SLC29A4;SLC1A3
prerank,regulation of apoptotic process (GO:0042981),-0.2921707767570292,-1.4535203489167798,0.0,0.24875963090045392,1.0,163/676,17.32%,HIP1;TJP1;LEF1;UNC13B;GRK5;TEK;DAB2IP;IGF1R;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;PPP1R13B;XIAP;CREBBP;DCUN1D3;ERC1;MCL1;DAB2;ARHGEF3;DAPK1;ACER2;TNFAIP8;NET1;GSK3B;THBS1;ATG7;ATM;MCF2L;ARHGAP10;PAK2;UTP11;MAP3K5;DDX3X;PLEKHG5;KDR;TNFSF10;EGFR;IL6ST;BIRC3;TFRC;CD38;NAA16;TAX1BP1;IER3IP1;HDAC1;NFKB1;RASGRF2;RARG;CBL;RBM5;RYBP;GAS6;NFKBIA;PIK3R1;STK3;ABL1;ZBTB7A;FOXO3;DSTYK;PSEN2;DNM2;FAS;ARHGEF12;SLIT2;PTK2;MED1;AATF;RASSF2;STEAP3;BMP4;BNIP3;MEF2C;ARHGDIA;NGF;JUN;RNF144B;MYO18A;PLK2;TGM2;MRE11;ITSN1;BIRC6;NOTCH2;BNIP2;ARHGEF2;ANXA4;RAF1;YWHAZ;FLT4;ARL6IP5;SH3RF1;HAX1;LATS2;SOS2;CASP8;BCAR1;ADAM10;CFLAR;AKT1;NAA15;SOCS2;TP53;FLNA;CRADD;PRKAA1;AREL1;PERP;PSEN1;BRAF;JAK2;SLC27A4;ARHGEF11;ANO6;RASA1;SON;IRAK1;COMP;ACTN1;MTDH;RPS6KA1;PA2G4;CTNNBL1;ACTN4;CAT;NDRG1;RTKN;TCIM;WNT11;UFM1;STPG1;BABAM2;HGF;MAPK8;ATF4;RPL10;TRIO;RPS6KA3;SPTLC1;ZFAND6;ERCC3;MAP4K4;IAPP;MIF;HIP1R;PRDM9;SMAD6;ABR;ANGPT1;ARHGEF18;BCL2L11;IGF1;PREX1;SLK;SIX4;ANXA1;CTSH;CTNNB1;APH1A;API5;PPIF;TFAP4
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5546908686540927,-1.4530155014002861,0.0782608695652174,0.24913602434910292,1.0,5/15,6.37%,EDA;ANKRD11;TBX1;HDAC1;LRP6
prerank,regulation of cell population proliferation (GO:0042127),-0.2942398891262776,-1.4529133864327568,0.0,0.24883066941964585,1.0,231/691,27.22%,FLT1;TJP1;LEF1;GRK5;DAB2IP;IGF1R;SMARCA2;KITLG;IGFBP7;OSMR;RAPGEF2;ELN;CLDN5;ENG;ACVRL1;XIAP;NOS3;PTPN14;INSR;KLF4;ETS1;ABI1;PKD2;CBFA2T3;LRP5;LYN;ACER2;BMPR2;PDS5B;CD200;LIMS1;SH3BP4;RBFOX2;BTG3;PDGFD;THBS1;CDK13;GCNT2;APP;KAT2B;BMP5;RNF139;ITGA1;TBX1;ARID2;IL15;KDR;P3H2;THAP12;PTPRJ;EGFR;IL6ST;TFRC;CDKN1B;TRPM4;TGFBR2;CTCF;BMP6;HDAC1;IL6R;HES1;JAG2;RARG;SIX1;RBM5;IRS1;NMI;STX3;IL34;CUL3;DNAJA2;TGFB2;PTK2;STAT6;AQP11;FGF1;BMP4;STAMBP;PTPRK;CDK10;NGF;JUN;TBX2;BIRC6;ARHGEF2;RAF1;YAP1;NOP2;FLT4;IRF1;LIFR;CELF1;NAMPT;CTBP2;ADAM10;FGF7;AKT1;VEGFC;TP53;FRK;KLF10;EDN1;DOT1L;AXIN2;PTGFR;NCK2;STAT2;RGCC;LMNA;SOX7;JAK2;ZBTB7C;MAZ;EDN3;ACER3;AGTR1;NOTCH1;RHOA;FGF2;CDC73;HDAC4;CDC123;ASH2L;RHOG;CDK6;TBRG1;KSR1;RPS4X;MECP2;NUDT6;FAM98A;COPS9;JAG1;IFI35;BTG2;NUAK1;GAB2;FUZ;SMAD6;LGMN;FOXO4;RERG;IGF1;SKI;SRPK2;COX17;GSDME;NOX4;SIX4;RARA;CTSH;CTNNB1;TFAP4;ADARB1;TNS2;ADGRG1;CACUL1;CLCF1;TNFSF13;TBC1D8;TES;BAP1;PPM1D;SOX4;DUSP22;PRKDC;TCF7L2;TIMELESS;KRAS;TMEM127;PTEN;BCL6;ECRG4;FGFR4;PRC1;IL13RA1;TOB1;IGF2;DLL4;MDM2;NACC1;S1PR3;WARS1;CDKN2C;ROR2;PDGFRB;DIS3L2;LAMC2;PTK2B;TTK;RELA;MYOCD;PTN;ESM1;TBX3;HAS2;CEP131;SFRP4;COPS8;CEBPA;CYP1B1;ATF5;E2F7;HSPA1B;ACE2;PINX1;IL7;MVD;ADGRB1;BMP2;PLPP1;CDCA7;PTPN2;CNOT8;ZFP36L1;ADAM17;TBX6;RPS15A;TPTE;NUPR2;CDKN3;TNFRSF9;APC;FGF10;FRZB;F2R;KIF14;FABP3;CGREF1;HILPDA;IL12RB2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4241253644802765,-1.4524925988938047,0.029143897996357013,0.24908738702190675,1.0,12/43,14.62%,DAB2IP;EPS15;RAB7A;ITGA1;PTPRJ;EGFR;CBL;EPS15L1;RNF115;PTPN3;DUSP3;GRB2
prerank,dopamine metabolic process (GO:0042417),-0.5251900552868325,-1.452227442980593,0.05545286506469501,0.2490288349955043,1.0,4/18,10.24%,SNCAIP;TGFB2;GCH1;MAOA
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5294548196745552,-1.4512952289428573,0.0481283422459893,0.250208046196199,1.0,5/17,11.65%,TEK;BAIAP2L1;ABL1;HAX1;BCAS3
prerank,positive regulation of cell projection organization (GO:0031346),0.3422284132019278,1.4512303367243944,0.015765765765765764,0.37216658240340283,1.0,22/115,9.80%,PTPRD;MAGI2;IL1RAPL1;ROBO2;LRRC7;GRIP1;RIT2;SCN1B;ROBO1;TENM3;FUT9;CDKL5;TOX;KIDINS220;NDRG4;CAMK2B;NTRK2;CARMIL1;PLA2G3;SLITRK1;PLPPR5;STMN2
prerank,protein modification by small protein conjugation (GO:0032446),-0.3058212873850756,-1.4502657278331297,0.0016474464579901153,0.251529473380656,1.0,110/361,22.54%,FBXL7;WWP1;DCUN1D3;USP9X;BRAP;NEDD4L;CBLL1;SMURF2;IFIH1;UBE2K;ATG7;NUP42;CNOT4;RNF139;RNF111;FBXL17;DTX3L;ATG10;ZNRF3;SMURF1;CUL9;RAE1;FBXL3;TRPM4;RNF213;RANBP2;UBA2;RBX1;CBL;OTULIN;RNF43;LMO7;CUL3;NEDD4;RNF40;NUP98;CUL2;BIRC6;UHRF2;PDZRN3;ARRDC1;SPSB1;UBE2J2;DET1;UBE2D3;MIB1;UBA7;CUL7;UBR2;RNF25;FBXW8;AREL1;TNFAIP1;KLHL13;TRIM14;CDC16;NSMCE2;TSPAN17;NUP153;RAD18;CDC73;RTF1;ANAPC16;PIAS2;UFM1;ASB1;FBXW11;KLHL25;RNF168;MYLIP;DTX3;HIF3A;VCPIP1;UBE2M;UBE2V2;PEX14;TPR;UBE2L3;DCUN1D2;HERC2;TRIM13;MIB2;SUMO1;RFWD3;KCTD10;CDK5RAP3;NUP214;KLHL3;SDE2;EPAS1;UBR1;RNF152;USP7;PRKDC;PIAS4;TRIM47;WWP2;ELOC;HUWE1;BRCA1;DCUN1D5;TRIM28;UBE2R2;MDM2;CAND2;KEAP1;MOCS3;HACE1;NFE2L2;NUP188
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.6084644736370491,-1.450031371294605,0.08052434456928839,0.25143239492776026,1.0,3/10,12.16%,ZBTB16;ACVRL1;PKDCC
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.49700236796971425,-1.4499626963513377,0.06216696269982238,0.2510798574183124,1.0,4/21,4.26%,FOXP1;PRKCH;SLC39A10;PRKD2
prerank,organic anion transport (GO:0015711),-0.3822931007275526,-1.4499293300295146,0.0196078431372549,0.2506338267883031,1.0,15/76,9.97%,ABCC4;ABCG2;SLC26A7;LRRC8C;SLCO2A1;SLCO1C1;SLC4A10;SLCO3A1;CA4;ABCC6;SLC39A8;LRRC8D;SLCO2B1;SLC35A3;SLC52A1
prerank,zinc ion homeostasis (GO:0055069),-0.4635662422487626,-1.4498445369197357,0.06405693950177936,0.2502793044544782,1.0,14/28,25.53%,SLC39A10;SLC30A10;SLC39A8;SLC30A5;SLC39A6;SLC30A1;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.33896155572526127,-1.4497837895582348,0.001736111111111111,0.24990675217806277,1.0,66/166,28.41%,MNAT1;CREBBP;NR3C2;ESR1;TEAD4;MED26;MAML2;RXRA;KAT2B;TEAD1;NR3C1;THRB;NOTCH3;HDAC1;PPARA;RARG;MED1;MAML1;POLR2G;NOTCH2;YAP1;PPARD;GTF2E1;GTF2E2;ERCC2;TAF11;NOTCH4;TAF1B;BRF1;MAZ;MED17;NOTCH1;TAF1C;TAF8;ERCC3;NR1D2;NR2C1;CAVIN1;TAF7;RARA;TAF3;HDAC10;NCOA6;TBL1X;PPARG;RARB;MED27;HDAC7;TAF4B;UBTF;TAF1D;TAF13;RXRG;POLR2C;E2F3;TAF9;TAF15;POLR1E;POLR2L;POLR2H;HDAC5;RSF1;GTF2H3;MAML3;E2F2;CCNH
prerank,regulation of cholesterol storage (GO:0010885),-0.5526783939373411,-1.4496152550206265,0.05301645338208409,0.24972905303820575,1.0,6/15,20.11%,PPARA;PPARD;SCARB1;EHD1;LPL;PPARG
prerank,positive regulation of apoptotic process (GO:0043065),-0.31216757418306795,-1.4496086970424882,0.0,0.24925518386735526,1.0,96/293,25.06%,UNC13B;DAB2IP;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;DCUN1D3;ARHGEF3;DAPK1;TNFAIP8;NET1;ATG7;ATM;MCF2L;SIK1;UTP11;MAP3K5;DDX3X;PLEKHG5;TNFSF10;RASGRF2;RARG;RBM5;RYBP;STK3;ABL1;FOXO3;PSEN2;DNM2;FAS;ARHGEF12;SLIT2;TGFB2;RASSF2;BMP4;BNIP3;NGF;JUN;TGM2;ITSN1;ARHGEF2;ARL6IP5;LATS2;SOS2;CASP8;TP53;CRADD;TPD52L1;PSEN1;SLC27A4;ARHGEF11;ANO6;CTNNBL1;STPG1;MAPK8;ATF4;TRIO;ERCC3;IAPP;HIP1R;ABR;ARHGEF18;BCL2L11;SRPK2;PREX1;CTNNB1;APH1A;TFAP4;SOD1;RPS3;SIAH1;SOX4;RNPS1;BCL6;NF1;ARHGEF5;FOXL2;PNMA2;VAV2;ARHGEF1;CASP2;PHLDA3;GADD45A;SUDS3;TRIM39;ATF6;RIPK1;SFRP4;CYP1B1;PTGIS;CALHM2;HMGB1;FANK1;BMP2;APBB1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4709590179140455,-1.4495362481631586,0.05574912891986063,0.24889632318124325,1.0,12/26,24.04%,SETD2;KMT5B;TET2;SETD5;SUV39H1;SETD3;PRDM9;ANTKMT;WDR82;OGT;TET3;BEND3
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.409642892200051,-1.4493180555542673,0.039655172413793106,0.24881290316789464,1.0,23/51,24.99%,BMPER;CRIM1;BMPR2;SMURF2;SMURF1;SKIL;SMAD1;GREM2;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1;SMAD6;SKI;HTRA3;SMAD9;DAND5;PPARG;CHRDL1;ACVR2B;FBN1;BMP2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3810642872363899,-1.4490846281799337,0.02112676056338028,0.24881618745719009,1.0,29/76,24.52%,CSNK1A1;CBFA2T3;DAB2;GSK3B;RNF139;LRRK2;SMURF1;RBX1;PTK2;RNF144B;HECTD1;GSK3A;DET1;GABARAP;SMAD7;CSNK1D;ZER1;ZYG11B;SUMO1;CDK5RAP3;RAD23A;PTEN;MDM2;SH3RF2;KEAP1;CEBPA;RCHY1;TRIB3;HSPA1B
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4567175342811344,-1.4483625344671334,0.04195804195804196,0.24962424301123984,1.0,11/32,21.82%,SORBS1;ZBTB20;ADIPOR2;MTOR;PPARA;AKT1;CEACAM1;ASAH1;CREBL2;STAR;CREB1
prerank,regulation of MAP kinase activity (GO:0043405),-0.3629554085451871,-1.4478481758488764,0.02054794520547945,0.2500132811976478,1.0,25/92,14.15%,FLT1;DAB2IP;LYN;PDGFD;PTPN1;LRRK2;PTPRJ;CDK12;EGFR;PPEF2;IL34;PRKCD;FGF1;BMP4;EDN1;TPD52L1;PIK3R6;EDN3;STK38;FGF2;IRAK1;CD40;KSR1;SPRY4;PIK3CB
prerank,telomere maintenance (GO:0000723),-0.4083599218796391,-1.4475647065670538,0.027522935779816515,0.2500190672885084,1.0,20/50,21.31%,SP100;STN1;ATM;SMC5;MRE11;NSMCE2;POLD3;RPA3;DNA2;RPA1;CTC1;PTGES3;TERF2;TEP1;WRN;RPA2;PRKDC;DCLRE1B;TERT;BLM
prerank,cholesterol metabolic process (GO:0008203),0.3702531678058874,1.447298637261207,0.02745995423340961,0.3787454461013568,1.0,22/68,15.42%,IDI2;AKR1D1;CYP46A1;INSIG1;PIP4P1;SULT2B1;LSS;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;TSKU;CYP27A1;CYP11B1;OSBPL5;FDFT1;DHCR24;ABCA5;IDI1;APOE;CLN8
prerank,positive regulation of cell junction assembly (GO:1901890),0.39206194612225903,1.4472044141914047,0.02511415525114155,0.3765926354708521,1.0,15/56,13.34%,CNTNAP2;PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;EPHB1;SYNDIG1;NPHP4;IRX3;VEGFA;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3196244520913557,-1.4459385838853709,0.0033112582781456954,0.25232796778031163,1.0,63/245,16.73%,FLT1;TEK;DAB2IP;IGF1R;JCAD;RAPGEF2;FERMT2;ROR1;INSR;BMPER;MFHAS1;PDGFD;SEMA7A;IQGAP1;GCNT2;APP;ADRA1B;TBX1;CCL25;LRRK2;KDR;ICAM1;PRKD2;PTPRJ;MID1;EGFR;SLC30A10;GAS6;DSTYK;IL34;TGFB2;FGF1;RAP1A;ROCK1;NOTCH2;FLT4;ARL6IP5;PLCG2;EDN1;TAOK3;HTR2A;TPD52L1;PIK3R6;BRAF;EDN3;NOTCH1;FGF2;IRAK1;SEMA4C;CD40;ACKR3;KSR1;P2RY6;IAPP;MIF;ROCK2;ABCA7;TNFAIP8L3;MTURN;ANGPT1;PELI2;IGF1;GSDME
prerank,cellular response to dsRNA (GO:0071359),-0.5476710129588506,-1.4459090649572561,0.0798611111111111,0.25192051331769605,1.0,9/15,28.25%,CAV1;IFIH1;FLOT1;PDE12;CGAS;MAVS;RALB;DHX9;RIOK3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3786551458823032,-1.4456988664663388,0.015306122448979591,0.2517874565211455,1.0,23/73,23.39%,HIP1;SENP1;ACER2;NOD1;CASP12;TNFSF10;FAS;NGF;ATP2A3;CASP8;CFLAR;CRADD;JAK2;BBC3;DAP;HIP1R;CASP8AP2;PPARG;F3;CASP2;RIPK1;CASP1;EIF2AK3
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.39620033629329154,-1.4452579804580092,0.02664298401420959,0.25206937009263286,1.0,19/62,16.58%,ZBTB16;CREBBP;CBFB;LYN;TNRC6B;THBS1;KAT2B;CNOT4;KMT2E;HDAC1;MEF2C;SIN3A;ZFPM1;CDC73;ASH2L;CDK6;H3-3A;KMT2C;MOV10
prerank,regulation of dendritic spine development (GO:0060998),0.4986226332855344,1.4447625110443467,0.06398104265402843,0.37967373631989837,1.0,9/19,14.63%,NLGN1;PPFIA2;SHANK1;CAMK2B;TANC2;PTPRS;CPEB3;GRIN3A;APOE
prerank,atrial septum development (GO:0003283),-0.5695097695804014,-1.44158032656272,0.06491228070175438,0.25791278699044934,1.0,7/13,26.07%,BMPR2;TGFB2;NOTCH2;ZFPM1;HEY2;DAND5;GJA5
prerank,positive regulation of cell death (GO:0010942),-0.3919755181310554,-1.4413822116493238,0.0353356890459364,0.2577599148218265,1.0,13/59,10.55%,SLC6A6;ACER2;GSK3B;LRRK2;MAP3K5;CDKN1B;RARG;DDIT4;BMP4;BNIP3;CELF1;PICALM;AXIN2
prerank,cellular response to cytokine stimulus (GO:0071345),-0.3023741230043158,-1.4413323649210315,0.001658374792703151,0.25736972662019447,1.0,155/416,29.63%,LEF1;DAB2IP;IL1R1;OSMR;ST3GAL6;GHR;ITGB1;FOXO1;ZEB1;NFAT5;PTPN14;MCL1;DAPK1;GSK3B;UBE2K;JAK1;LRCH1;CRK;CCL25;PTPN9;LDLRAP1;IFNAR1;ICAM1;PTPRJ;MMP2;SLC12A2;IL6ST;CDKN1B;PTPN12;IL6R;NFKB1;TNFRSF1B;CBL;GAS6;PIK3R1;FOXO3;PDE2A;STX3;IL34;STAT6;IRGM;LBP;GBP6;GRB10;ARHGEF2;YWHAZ;GREM2;IRF1;LIFR;GSK3A;S1PR1;HAX1;PIK3CD;AKT1;SOCS2;TP53;MAOA;IL4R;STAT2;RAPGEF1;JAK2;RHOA;LAMA5;FGF2;IRAK1;PTPN13;GBP4;CSK;CD40;HGF;MAPK8;PIK3CB;PDE12;ZFAND6;RC3H1;GRB2;FOXC1;SYNCRIP;GAB2;USP10;ASAH1;TPR;IL16;TNFRSF1A;BCL2L11;VCAM1;FYN;GSDME;IRAK2;ANXA1;GBP5;IL10RB;IL20RB;RPS3;CCL19;CLCF1;IKBKB;HYAL2;CCND1;IFNGR2;CXCL12;BCL6;F3;BRCA1;IL13RA1;INPP5D;PTPN11;ITGAM;IFNAR2;IL3RA;NFE2L2;HSP90AA1;RELA;RIPK1;CASP1;RPL13A;HAS2;MAPK11;PIM1;GBP3;CEBPA;ADAMTS7;PTGIS;SHPK;IL7;DHX9;ERBIN;PIK3CA;MT1X;LCN2;PTPN2;CRNN;IFITM2;ZFP36L1;LGALS9;IL12RB2;BAG4;TRIM6;HNRNPU;IL22;CXCL10;HMOX1;PTPN18;DUSP1;RORC;PLP2;IL2RA;AXL;HYAL3;CACTIN;WNK1;IL2RG;BIRC5;IFNLR1;SHMT1
prerank,regulation of signal transduction (GO:0009966),-0.3306752498998996,-1.4409838967162893,0.003389830508474576,0.2575334461531361,1.0,51/190,16.88%,GRK5;IGFBP7;SP100;CREBBP;RSPO3;CBFB;RGS3;ELF1;BRAP;ESR1;RGS5;GIT2;ITGA3;PTPN1;APP;CRK;FBXL17;LRRK2;IGFBP4;ZDHHC3;NCK1;PXN;RGS12;PLCB1;CD55;WDR11;PRAG1;TMEM204;PLCE1;PRKD1;MDFIC;LIFR;SOCS2;NCK2;MFNG;ILK;GALNT11;IRAK1;MGLL;CSK;PLSCR1;TCF7L1;IGFBP5;FUZ;CASTOR1;NCLN;FYN;UBASH3B;SENP2;IRAK2;KIF26A
prerank,adherens junction organization (GO:0034332),0.4001235717523962,1.4404320639097945,0.03870967741935484,0.38711570853789257,1.0,16/48,10.12%,CDH18;CADM2;CDH8;CDH20;CDH9;CDH10;INAVA;DCHS1;CDH19;CDH12;ANG;NECTIN3;CDH7;CDH17;CDH24;CDHR3
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5046608998824339,-1.4402565598894708,0.05871559633027523,0.2583794159086404,1.0,8/20,13.55%,THBS1;PLCG1;PDCD4;RGCC;ANO6;ITGA4;ECSCR;CD40
prerank,regulation of AMPA receptor activity (GO:2000311),0.47529043742271676,1.4396841094183326,0.053691275167785234,0.3863391943989338,1.0,13/25,19.35%,NLGN1;SHANK1;CACNG8;CACNG3;MINK1;CACNG2;CACNG4;PRRT1;NLGN2;CACNG5;SHISA9;CNIH2;NLGN3
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2956385870949825,-1.439242602377241,0.0,0.25962982247623745,1.0,155/532,23.92%,IL1R1;OSMR;GHR;SP100;ITGB1;FOXO1;PELI1;EDA;ZEB1;MCL1;TAB3;NOD1;LIMS1;TRAF5;TMSB4X;IRF2;ANXA2;TRIM25;JAK1;ADIPOR2;RPS6KA5;PSMA2;CRK;PAK2;CCL25;IL15;IFNAR1;ICAM1;PTPRJ;MID1;MMP2;CAMK2G;IL6ST;BIRC3;CDKN1B;MSN;IL6R;NFKB1;RBX1;TNFRSF1B;CBL;NFKBIA;PIK3R1;IRS1;SAMHD1;FOXO3;PDCD4;STX3;IL34;PLCB1;STAT6;PRKCD;LBP;TCP1;PSME2;RAP1B;TXNDC17;GRB10;YAP1;YWHAZ;PSMB4;GREM2;IRF1;LIFR;S1PR1;SMAD4;PIK3CD;AKT1;MAP3K3;SOCS2;TP53;MAOA;IL4R;STAT2;RAPGEF1;ILK;JAK2;HNRNPF;IFITM3;LAMA5;FGF2;IRAK1;CEACAM1;LCP1;ACTN4;IL17RA;EIF5A;CSK;FBXW11;CD40;MAP3K8;ACKR3;HGF;PIK3CB;PSMC2;GRB2;TALDO1;FOXC1;IFI35;IL17RE;MIF;GAB2;PSMB2;IL16;PSMB1;TNFRSF1A;PELI2;BCL2L11;TAB2;VCAM1;TNFRSF11B;FYN;IRAK2;ANXA1;PSMA8;IL10RB;SOD1;IL20RB;CFL1;IKBKG;CCL19;MAP3K14;CLCF1;EDAR;TNFSF13;IKBKB;NOD2;PSME1;CCND1;IFNGR2;CXCL12;TNFRSF25;BCL6;F3;PSMD4;IL13RA1;INPP5D;PTPN11;TNFSF8;PSMA7;ITGAM;PTK2B;LTBR;IFNAR2;IL3RA;HSP90AA1;RELA;FCGR1A;RIPK1;CASP1;PITPNA;PIM1;PSMD5;CEBPA;TRIM68
prerank,axoneme assembly (GO:0035082),0.4475303887436496,1.4388603293375501,0.056155507559395246,0.38593785012613574,1.0,10/30,16.82%,DNAAF3;CFAP74;SPAG1;DNAAF1;DCX;DNAI4;FOXJ1;GAS8;SPAG17;DNAAF2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6046731246818995,-1.4381227513858839,0.08639705882352941,0.2611141030044831,1.0,3/10,14.93%,WDFY1;LBP;IFI35
prerank,striated muscle tissue development (GO:0014706),-0.4535740825702487,-1.4370124884664426,0.05391304347826087,0.2626349425403084,1.0,10/29,9.75%,PGM5;CAV1;BMPR2;SVIL;BMP5;SIX1;RBP4;MEF2C;TBX2;CFLAR
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.36786775515704595,-1.4367664382182914,0.02717391304347826,0.26260582733381804,1.0,26/87,15.35%,EPS8;ESAM;RAC1;RHOBTB1;IQGAP1;F11R;RND3;CRK;MTOR;RICTOR;ABL1;RHOQ;PRKCD;CDK10;EZR;ARHGDIA;ROCK1;NOTCH2;FAM107A;ARHGAP17;ABI3;RHOA;RHOC;RHOG;HIP1R;ROCK2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.44819988217919765,1.4365815965938908,0.04716981132075472,0.38868292394257714,1.0,13/28,19.91%,MAP2;MAP1S;MAPT;STMN2;MAP1B;MAPRE3;STMN4;MAPRE1;CLASP2;SKA3;CAMSAP3;MAP1A;STMN3
prerank,negative regulation of GTPase activity (GO:0034260),-0.49363164079306465,-1.4359087177042698,0.05217391304347826,0.2636184763758904,1.0,8/22,11.88%,DAB2IP;SH3BP4;F11R;LRCH1;LRRK2;RASA4;BCAS3;ARFGEF1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3698760899600943,1.4358229769103217,0.024390243902439025,0.3880563111360676,1.0,16/76,11.23%,GRM5;CHRM2;HTR2C;OPRM1;CALCA;PTGER3;GRM1;HOMER1;TRHR;C3AR1;ADRA2A;GPR65;ADRA1D;ADRA1A;TACR1;NMUR2
prerank,response to estrogen (GO:0043627),-0.4511940012694048,-1.4358128265669523,0.05172413793103448,0.2632975619008457,1.0,11/31,23.81%,CAV1;ESR1;TRIM25;NCOA4;BCAS3;ASH2L;RARA;WBP2;CITED2;BRCA1;RBBP5
prerank,aortic valve morphogenesis (GO:0003180),-0.4484146230266488,-1.4357775149166503,0.05132743362831858,0.26291758338979926,1.0,14/30,17.95%,ELN;RB1;NOS3;TIE1;NFATC1;SLIT2;BMP4;ROCK1;NOTCH1;JAG1;ROCK2;SMAD6;HEY1;HEY2
prerank,protein localization to chromatin (GO:0071168),-0.5226529031938394,-1.4353856045014224,0.06338028169014084,0.26312403557913544,1.0,9/18,17.79%,ESR1;NIPBL;MRNIP;SGF29;MCM9;WAPL;TASOR;RUVBL2;PPHLN1
prerank,regulation of hippo signaling (GO:0035330),-0.5197922217367983,-1.4347587307563228,0.07081174438687392,0.26367135934630037,1.0,8/17,23.63%,MOB3B;WWC2;VGLL4;LIMD1;MARK3;WTIP;MAP2K3;AJUBA
prerank,regulation of interleukin-1 production (GO:0032652),-0.5424705191216617,-1.434695442681289,0.06996587030716724,0.263315809447115,1.0,6/15,26.84%,FOXP1;GAS6;CEACAM1;ANXA1;HMGB1;F2R
prerank,sterol biosynthetic process (GO:0016126),0.4415450653101685,1.433958720302213,0.053864168618266976,0.390049357136145,1.0,12/33,13.87%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;SC5D;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,regulation of vasoconstriction (GO:0019229),-0.46892935718730133,-1.4337872245581191,0.06964285714285715,0.2645484775231774,1.0,8/27,11.79%,CAV1;BMPR2;ADRA1B;ACE;TRPM4;ECE1;ADM;AGTR1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.43589760364343844,-1.4336921611614983,0.04440497335701599,0.26423395145397177,1.0,18/35,31.42%,ETS1;LYN;FOXO3;MED1;ABCB10;LDB1;ACVR2A;TAL1;ZFPM1;CDK6;ARNT;PRKDC;MAPK11;HSPA1B;ZFP36L1;SPI1;MAPK14;STAT3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5202176234771618,-1.4331333197000486,0.07342657342657342,0.26472720681063455,1.0,8/16,21.21%,GCH1;NOS1AP;SCARB1;AKT1;S100A1;PIK3CB;TERF2;TERT
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5396055432276373,-1.433071436033349,0.0633147113594041,0.2643677408341119,1.0,6/16,9.64%,PDGFD;PTPN1;PTPRJ;ABL1;PIK3C2A;BCAR1
prerank,manganese ion transport (GO:0006828),-0.5613855141831655,-1.4319638349315769,0.06766917293233082,0.26579517281905274,1.0,5/14,16.74%,SLC30A10;TRPC4;SLC39A8;TRPC6;TRPC3
prerank,positive regulation of signal transduction (GO:0009967),-0.3184770856340169,-1.4315210781831726,0.001658374792703151,0.26607784199583806,1.0,85/238,24.99%,TEK;VWF;DAB2IP;JCAD;SORBS1;SHANK3;CREBBP;RSPO3;NOS3;ZMIZ1;PKD2;LIMS2;ASXL1;LIMS1;MAML2;KLF2;KAT2B;TTC23;LRRK2;PRKD2;SMO;LOXL3;IL6ST;BMP6;JAG2;GAS6;PIK3R1;IRS1;DSTYK;FAS;TGFB2;MACF1;FGF1;ERN1;AAK1;MAML1;TSPAN14;GRB10;YAP1;CTBP2;FLNA;CRADD;NOTCH4;TPD52L1;ILK;JAK2;TSPAN5;NOTCH1;CDC73;P2RY6;JAG1;TNFAIP3;AGPAT1;FGFBP3;CCN3;TRIM16;SMOC2;IGF1;SKI;ARNT;SASH1;RPS3;CITED2;NOD2;PTPRC;KIF7;GKAP1;PTEN;F3;ITGB3;IGF2;DLL4;TERT;PTPN11;TUBD1;PTK2B;ESM1;TRIM39;RSPO2;PTGIS;NEPRO;SMARCB1;GPS2;IL7;BMP2
prerank,protein acetylation (GO:0006473),-0.4583202894507548,-1.431325145472598,0.04980842911877394,0.26594086014849005,1.0,8/30,12.91%,FOXO1;CREBBP;KAT2B;KAT6A;NAA16;NAA80;NAA15;KAT5
prerank,endodermal cell differentiation (GO:0035987),-0.44772668572453833,-1.4310527853484583,0.03780718336483932,0.26593382323141795,1.0,10/31,13.40%,COL8A1;COL12A1;COL4A2;SETD2;MMP2;LAMA3;ITGB5;CDC73;RTF1;ITGA4
prerank,cellular senescence (GO:0090398),-0.4603867570573362,-1.431016385164002,0.066543438077634,0.26552553392336353,1.0,18/27,41.97%,KAT6A;SMC5;PRKCD;TBX2;NSMCE2;TERF2;ECRG4;TBX3;CDKN2B;SPI1;MAPK14;MAPKAPK5;HMGA1;CDKN1A;MAP2K1;SIRT1;SMC6;PML
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5699600961639161,-1.4305471039973423,0.07326007326007326,0.26590398303168783,1.0,6/13,17.95%,TMSB4X;SIN3A;PSEN1;MAD2L2;HEY1;HEY2
prerank,protein deacetylation (GO:0006476),-0.42509888038682325,-1.429971945992249,0.050788091068301226,0.26643696223918567,1.0,18/41,23.74%,MIER1;PRDM5;RCOR1;HDAC1;SIRT5;MIDEAS;FLNA;SIN3A;HDAC4;SIRT3;MIER2;HDAC6;HDAC10;MIER3;TBL1X;HDAC7;SUDS3;MORF4L1
prerank,organelle organization (GO:0006996),-0.30302719425152685,-1.4298718368163204,0.0016420361247947454,0.2661720204481029,1.0,99/388,18.40%,SEMA6A;ATP8B1;FGD5;SEC31A;NOS3;FGD6;CSNK1A1;CAV1;PKD2;ALAS1;PEX1;PDZD8;RAB3GAP1;COG1;DYM;EPS15;TMCC1;RANBP9;MARK1;ARHGAP10;FNBP1L;RAB7A;MICAL2;LRRK2;ARAP3;SYNE1;DIAPH1;RAB1A;GOLPH3L;RAB2A;LIMD1;ZMYM6;CNTNAP1;MAST4;MAST2;ATL2;TOR1B;SIRT5;SEC16B;ABCD3;WASL;PLCE1;MYO18A;USP6NL;SIPA1L3;PEX7;CEP78;PYROXD2;PRKD1;PLD2;DST;HAX1;VPS13C;CHMP4B;CHMP4A;CECR2;CUL7;TMEM135;FBXW8;AGTPBP1;GAK;BCAS3;ARFGEF1;MTX1;FAM174B;ZMYM4;GABPB1;TPM1;CSNK1D;MIEF2;CHMP2B;NEDD9;SIRT3;MCOLN1;AFG1L;TRAPPC12;HCFC1;RAB32;TNFAIP3;PI4K2B;VPS13D;TBC1D20;PEX14;BRWD3;FMNL2;CHMP5;CDC42BPB;LMAN2;FANCG;TMED5;ZFYVE16;VAPA;CAPZB;GOLPH3;PEX11A;NRF1;CFL1;TJAP1;WTIP
prerank,regulation of cellular pH (GO:0030641),0.4383155218106783,1.4293896374369524,0.06,0.3982409064135976,1.0,7/29,5.56%,CA2;SLC9A7;SLC4A4;SLC4A5;CLN3;SLC9A9;SLC4A2
prerank,inorganic anion transmembrane transport (GO:0098661),0.38226828096265586,1.429356323431087,0.03755868544600939,0.3959870628459273,1.0,13/63,9.50%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;SLC25A3;ANO4;SLC12A5;GABRA3;GABRA1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.48262892641798033,-1.429098398496934,0.08378870673952642,0.26707856463557283,1.0,10/23,25.12%,DAB2IP;DVL3;MAP3K5;EDN1;TAOK3;SASH1;RPS3;ARHGEF5;MAP3K7;FZD10
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5676711787997328,-1.428360712349661,0.08644067796610169,0.26790999902359797,1.0,7/13,31.26%,CBFB;TGFBR2;GLI3;NKAP;PNP;RUNX1;SHH
prerank,regulation of ossification (GO:0030278),-0.42776057838586984,-1.428222487903093,0.05862646566164154,0.26768199402830034,1.0,12/36,17.52%,ZBTB16;BMPR2;SGMS2;LRP6;TGFB2;BMP4;MEF2C;S1PR1;NOTCH1;NOTUM;SMAD6;ANKH
prerank,regulation of actin filament polymerization (GO:0030833),-0.3781121765276584,-1.427804925599628,0.037037037037037035,0.2679630822609321,1.0,25/69,22.89%,KANK3;ESAM;BAIAP2L1;PRKCE;NCK1;SLIT2;PRKCD;SNX9;KANK4;HAX1;NCK2;FCHSD2;ARFGEF1;RASA1;ARHGAP28;LMOD1;CDC42EP3;NCKAP1;HIP1R;GBA2;DBNL;FCHSD1;CDC42EP1;PTK2B;MTPN
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.45339569127763757,1.4272503667317702,0.06306306306306306,0.39862762919166966,1.0,5/25,3.46%,GRID2;MPP2;GRIN2B;GLRA1;GRIN2A
prerank,negative regulation of response to stimulus (GO:0048585),-0.3902571115035012,-1.4272371923358518,0.024691358024691357,0.26842870653136625,1.0,16/60,16.88%,KLF7;KLF4;BRAP;CD34;LYN;PTPN1;SLC30A10;SLIT2;AQP11;AKT3;VPS13C;MAP3K3;CDK6;TERF2;UBASH3B;KIF26A
prerank,copper ion transport (GO:0006825),-0.5811388007656412,-1.4269465660244662,0.08241758241758242,0.2684308162742654,1.0,8/11,34.81%,ATOX1;SLC31A1;STEAP3;COX17;STEAP2;ATP7B;STEAP4;CUTC
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5237229198978838,-1.4265814273345443,0.0743362831858407,0.26870020666240035,1.0,6/16,13.27%,BMPR2;ACE;PLCB3;GSK3A;ADM;PRCP
prerank,COPII-coated vesicle budding (GO:0090114),-0.3777555523350143,-1.4265806125724354,0.02857142857142857,0.26823267456258143,1.0,26/68,22.93%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;SEC23B;CTSZ;TBC1D20;F5;TFG;VAPA;PREB;SEC24C;SEC22B;SAR1A;BET1
prerank,entry into host (GO:0044409),-0.5534835067102652,-1.4259622324654844,0.07509157509157509,0.2688632694676224,1.0,6/13,17.12%,CBLL1;CBL;CTNND1;CDH1;GRB2;CTNNB1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3796749019258389,-1.425945490772329,0.039783001808318265,0.2684303187003537,1.0,21/67,19.31%,ATP8B1;MYO10;PODXL;CAV1;RAC1;PLD1;TBC1D1;TBC1D2B;IFT140;USP6NL;RAB5A;TBC1D14;TBC1D22B;TBC1D22A;DYNC2LI1;ATG5;TBC1D20;CAPZB;TBC1D8;EPHA2;TBC1D17
prerank,blood circulation (GO:0008015),-0.4025717706261425,-1.4257148267626838,0.053763440860215055,0.26841028824056923,1.0,21/49,21.72%,ELN;ACVRL1;MYOF;NOS3;ACE;MEOX2;ROCK1;SCPEP1;EDN3;AGTR1;GPX1;ROCK2;F5;NPR1;GUCY1A1;SOD1;PLN;TBC1D8;CXCL12;DLL4;GCLC
prerank,negative regulation of mitochondrion organization (GO:0010823),0.43121620650387665,1.425350009029601,0.04680851063829787,0.4005815130206368,1.0,13/33,16.23%,OMA1;MPV17L;PSMD10;PRELID1;FLCN;TRIAP1;MAPT;TMEM14A;GHITM;FZD9;CLU;ADCK1;SLC35F6
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3723509496167884,-1.4250215751563273,0.030303030303030304,0.26915431789665684,1.0,32/78,26.36%,CSNK1A1;CAV1;CBFA2T3;DAB2;GSK3B;LRRK2;RBX1;RNF144B;HECTD1;GSK3A;DET1;BCAP31;GABARAP;SMAD7;CSNK1D;SGTA;ZER1;ZYG11B;SUMO1;RAD23A;HERPUD1;MDM2;SH3RF2;KEAP1;NFE2L2;FZR1;CEBPA;RCHY1;TRIB3;HSPA1B;PLK3;ARIH2
prerank,regulation of microtubule depolymerization (GO:0031114),0.4549223571119021,1.4243805046993674,0.05,0.40085959171848107,1.0,9/25,17.71%,NAV3;APC2;MAP1S;STMN2;MAP1B;HDGFL3;CLASP2;CAMSAP3;MAP1A
prerank,negative regulation of macrophage activation (GO:0043031),0.5120691568181046,1.4238194984824384,0.07172131147540983,0.3998262875855539,1.0,7/16,19.12%,LRFN5;NR1D1;SYT11;GRN;LDLR;FCGR2B;CX3CL1
prerank,pore complex assembly (GO:0046931),-0.5043321501949226,-1.4234709829224774,0.09363295880149813,0.27151367959105255,1.0,7/19,15.77%,AFDN;AHCTF1;NUP98;ADAM10;ANO6;NUP153;TPR
prerank,cellular response to hexose stimulus (GO:0071331),-0.48275604873597855,-1.4231958001711207,0.04727272727272727,0.27151262323457986,1.0,6/23,10.64%,UNC13B;IGF1R;ZBTB20;GAS6;ERN1;PRKAA1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3552211894518213,-1.4228869567097213,0.02120141342756184,0.27161920512585347,1.0,38/100,24.54%,EIF3H;CSNK1A1;CBFA2T3;DAB2;TLK2;GSK3B;LRRK2;FHIT;RBX1;GNA12;RYBP;RNF144B;HECTD1;GSK3A;DET1;GABARAP;SMAD7;HFE;FOXF2;CSNK1D;ZER1;N4BP1;ZYG11B;SUMO1;GIPC1;RAD23A;USP7;HERPUD1;OGT;MDM2;SH3RF2;KEAP1;TRIM39;CEBPA;RCHY1;TRIB3;HSPA1B;TAF9
prerank,vasculature development (GO:0001944),-0.5151461782215321,-1.4228173186306707,0.08483754512635379,0.27127369503372933,1.0,11/16,29.92%,ACVRL1;BMPR2;CDH5;FLT4;NOTCH4;PDGFRB;ACVR2B;FOXF1;PIK3CA;STRA6;APLNR
prerank,rRNA metabolic process (GO:0016072),-0.32790538556382015,-1.4223103702331288,0.005016722408026756,0.27174151665443835,1.0,69/160,30.40%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;RPF1;DDX10;XRN1;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;EXOSC3;XRN2;RPL13;UTP3;RPL38;RRP1;RPL27;RPS16;RPL10;RPL7A;RPL5;DCAF13;EXOSC8;UTP14A;RPS27;RPL27A;WDR74;RPL36A;MDN1;RPL35A;UTP4;EXOSC5;BOP1;RPL37A;PES1;RPL32;EBNA1BP2;RPS7;RPS15;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS17;NOL8;EXOSC7;WDR46;RPS2;RPL39;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RPLP2;UTP20;RPL18;RPL19;FCF1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.573752950357596,-1.4220597096783019,0.09391304347826086,0.271676702337398,1.0,6/12,24.99%,HES1;EPHA4;NOTCH1;CLCF1;SERPINE2;BMP2
prerank,cellular response to fluid shear stress (GO:0071498),-0.5625334734392616,-1.4218461214093725,0.09945750452079566,0.2716186550277881,1.0,7/12,23.34%,KLF4;PKD2;KLF2;MEF2C;MAPK7;NFE2L2;HAS2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4179143334403022,1.4212557934475494,0.0515695067264574,0.4036965162159064,1.0,17/37,19.91%,TRIM36;BICD1;PHLDB1;PHLDB2;CYLD;MAPT;STMN2;MAPRE3;TPPP;STMN4;MAPRE1;CLASP2;SKA3;CAMSAP3;MAP6;MAP6D1;STMN3
prerank,anion transport (GO:0006820),-0.43805506849940146,-1.4207795773973286,0.05415162454873646,0.2729328316927932,1.0,8/33,9.05%,ABCG2;SLC26A7;LRRC8C;SLC13A4;LRRC8D;SLCO2B1;SLC17A5;SLC13A3
prerank,apoptotic process (GO:0006915),-0.3228805617131978,-1.4204649336346105,0.005208333333333333,0.273044589109636,1.0,73/203,25.63%,HIP1;ZBTB16;SEMA6A;FOXO1;DAPK1;PRKCE;YARS1;CASP12;APP;ELMO1;TBX1;MAGI3;MTOR;PLAGL1;KREMEN1;TGFBR2;NFKBIA;STK3;FAS;PDCD4;DDIT4;PRKCD;BNIP3;RFK;NOTCH2;BNIP2;RAF1;PPARD;IRF1;IER3;ERCC2;CASP8;CFLAR;AKT1;TNFAIP1;JAK2;PLSCR1;ERCC3;NCKAP1;BBC3;DAP;IAPP;FEM1B;TNFRSF19;BCL2L11;THOC1;PAEP;IKBKG;SIAH1;RNF152;BRAT1;PPP2CA;CDK11B;TNFRSF25;LIG4;OGT;MDM2;CHEK1;CASP2;PTK2B;GADD45A;BIK;RIPK1;CASP1;AKAP1;AHCYL1;MAP3K7;TNFSF12;PLK3;PIK3CA;FXR1;MAGEH1;DMPK
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4289632192533428,1.4201329832425016,0.05869074492099323,0.4038887945179734,1.0,7/32,6.03%,PTPRD;IL1RAPL1;ADGRB3;HECW1;CDKL5;TNIK;HECW2
prerank,neuron projection development (GO:0031175),0.32205911987786856,1.4198164149670218,0.0048543689320388345,0.4023259187401689,1.0,36/168,9.80%,CNTNAP2;NLGN1;L1CAM;RASGRF1;PPP1R9A;CNTN4;BLK;CTNND2;SH3GL2;TMEM108;GPM6B;DOCK10;EPB41L3;SHTN1;CDK5;EPHB1;SHANK1;PLP1;NBL1;TNIK;ATXN10;PAK3;MAP2;MAP1S;NPY;GPM6A;PAK1;NYAP2;MAPT;POU4F1;NEFH;TSKU;GRM7;MINK1;ZFYVE27;STMN2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.4441949067220391,1.4196011682110534,0.06944444444444445,0.4005152638447006,1.0,11/30,13.87%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.46029560197942143,-1.419366330876892,0.062388591800356503,0.2744972629854049,1.0,11/27,24.76%,MAP3K20;MAP3K5;NFKB1;MAPK1;FBXW11;MAP3K8;MAPK8;IKBKG;IKBKB;MAPK11;MAP3K7
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.5030226903885758,-1.4192936700569359,0.0583804143126177,0.27415097012119444,1.0,11/20,30.81%,ADAM9;NFKB1;PSEN2;ADAM10;PSEN1;APH1A;RELA;ADAM17;RHBDD1;MBTPS1;TGFB1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.47274401390351156,-1.4192422523803372,0.07220216606498195,0.2737777360892474,1.0,11/23,22.61%,UACA;TMSB4X;DDX3X;NMI;PPM1B;IFI35;CCN3;C1QTNF3;BMP7;HDAC7;RELA
prerank,regulation of mRNA stability (GO:0043488),-0.33397223146382826,-1.418575353494961,0.015202702702702704,0.2745458958211233,1.0,56/145,28.54%,PSMA2;METTL14;GIGYF2;LARP1;FUS;PRKCD;FTO;XRN1;SAMD4A;PUM1;PSME2;MAPKAPK2;ROCK1;YWHAZ;EXOSC2;PSMB4;EXOSC1;CELF1;AKT1;AXIN2;EXOSC3;SERBP1;PARN;PDE12;PSMC2;RC3H1;ROCK2;ZC3H14;PSMB2;PSMB1;EXOSC8;PSMA8;NUP214;TNFSF13;PSME1;EXOSC5;DCP1A;PSMD4;PSMA7;METTL16;RBM24;PSMD5;THRAP3;TAF15;CARHSP1;EXOSC7;FXR1;IGF2BP2;ZFP36L1;PSMB10;HNRNPD;PSMA3;PABPC1;HNRNPU;TENT5C;SET
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.35722610498589435,-1.418136241152303,0.028192371475953566,0.2749104969178592,1.0,27/98,14.96%,SPTBN1;PRKCH;SORBS1;ITGB1;PPP1R13B;PRKCE;ITGA3;PTPN9;YWHAE;EGFR;MIEF1;PIK3R1;TCAF1;DLG1;STX3;YWHAZ;NMT1;CASP8;AKT1;TP53;MTCL1;MIEF2;CHP1;RHOG;MAPK8;STAC3;BBC3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.450341031544198,-1.4173711750159967,0.06702898550724638,0.27580756586259003,1.0,13/28,24.76%,TAB3;NOD1;OTULIN;IRGM;CASP8;IRAK1;TNFAIP3;TAB2;IRAK2;IKBKG;NOD2;RELA;MAP3K7
prerank,positive regulation of translation (GO:0045727),-0.3596071095736349,-1.416540247694762,0.0196078431372549,0.27686273325251964,1.0,37/94,26.86%,THBS1;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;PLD1;EIF3C;LARP1;UPF3B;SAMD4A;POLR2G;RPL26;ZCCHC4;EEF2;CDC123;EIF5A;EIF5AL1;LARP4B;RPS4X;AGO2;RPUSD4;MRPS27;RPL5;METTL5;MPV17L2;UQCC2;SOX4;PRKDC;RBM3;USP16;POLDIP3;KHDRBS1;DHX9;FXR1;HNRNPD;LARP6
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5676723744483221,-1.416486575883623,0.08633093525179857,0.2764923627925125,1.0,2/12,1.54%,FOXP1;KLF4
prerank,muscle organ development (GO:0007517),-0.3921493603186544,-1.4163973462150266,0.025594149908592323,0.27619175630393766,1.0,20/54,25.68%,UTRN;MEF2A;TCF12;TEAD4;CHD2;TBX1;MKX;EMD;MEF2C;COL6A3;MAPK12;IGF1;LARGE1;SMTN;ITGA7;FHL1;EGR3;FXR1;POU6F1;ITGA11
prerank,cation transport (GO:0006812),0.31591003532314915,1.415654112042483,0.00975609756097561,0.40735883287741176,1.0,29/166,9.62%,TRPM3;KCNMA1;ATP1A2;KCNA6;SLC22A4;SCN8A;SLC22A1;SLC5A12;KCNA5;SCN1A;CATSPER4;KCNJ3;KCNH4;SLC4A4;KCNN2;CLN3;SCN3A;SLC7A8;KCNA2;ATP1B1;SCN2A;SLC8A2;SLC36A2;TRPM1;SCN5A;SLC29A4;KCNJ6;PANX2;SLC7A6
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.45198378734056677,-1.4151470215049824,0.06394316163410302,0.2780831547197123,1.0,10/30,15.96%,ACVRL1;BMPR2;TENT4B;STN1;XRN1;DACH1;TP53;CTC1;HNRNPA1;TERF2
prerank,Golgi localization (GO:0051645),-0.5835832269836614,-1.41500292810717,0.0843585237258348,0.2778982561626439,1.0,5/11,16.94%,ARCN1;COPG1;YWHAZ;TBCCD1;RIPOR1
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.3027997251913079,-1.4143967289924761,0.001597444089456869,0.2784937014485506,1.0,135/336,29.66%,FOXP1;SUSD6;MNAT1;FOXO1;XIAP;UBR5;MCL1;LYN;ACER2;PDS5B;TLK2;ATM;DTX3L;RNF169;PARP4;SMC5;NIPBL;KMT5B;TNFRSF1B;MRNIP;ABL1;SAMHD1;TRRAP;AATF;SPIDR;MAPKAPK2;ZBTB4;MRE11;STXBP4;SUV39H1;INIP;NABP1;MCM9;YAP1;TRIP12;RBBP8;UBA7;TP53;ZBTB40;WDR76;TAOK3;DOT1L;NSMCE3;FNIP2;PSEN1;IKBKE;ENDOV;PDS5A;RAD18;INTS3;OGG1;UBE2E2;RPA1;ASH2L;BABAM2;PNKP;XPC;RNF168;SLF2;ERCC3;GRB2;VCPIP1;CGAS;BTG2;ERCC8;MAPK12;USP10;BCL2L11;HIC1;HERC2;SUMO1;POLE2;RFWD3;FANCC;FANCG;HPF1;WRN;RPS3;IKBKG;AKTIP;NCOA6;CCND1;BRAT1;EPHA2;PRKDC;RAD54L;TIMELESS;BCL6;NSMCE4A;FANCL;BRCA1;DCUN1D5;CBX1;BAZ1B;TRIM28;CHRNA4;BLM;RFC4;CHEK1;CASP2;PWWP3A;GADD45A;YY1;USP16;RBM24;RBBP5;SETD7;MSH3;CCNK;TAF9;LIG1;INO80;IRF7;APBB1;PLK3;DTL;MCM7;NUPR2;APC;MMS19;GTF2H3;MCM10;EXO1;ZBTB38;ALKBH7;GNL1;XRCC2;APLF;UBA1;HINFP;RAD51AP1;BOD1L1;FBXO31;TDP1;CHD1L
prerank,histone mRNA catabolic process (GO:0071044),-0.536596910192088,-1.4137926491921362,0.06989247311827956,0.27914883340810465,1.0,6/15,13.97%,TUT7;TENT4B;ATM;XRN1;TUT4;TENT2
prerank,myelin assembly (GO:0032288),0.5684243147744141,1.4135964397376268,0.14545454545454545,0.4098625035840869,1.0,6/10,17.29%,TENM4;EPB41L3;GPC1;ABCA2;TPPP;NCMAP
prerank,regulation of gene expression (GO:0010468),-0.2814028995751976,-1.413386174061736,0.0,0.2793983544804268,1.0,241/903,21.31%,FOXP1;LEF1;MBNL1;APBB2;NFIA;RREB1;SMARCA2;MBNL2;CLDN5;ZNF423;ENG;ACVRL1;AFF1;CREBBP;NSD1;RB1;BNC2;UBR5;NOS3;KAT6B;ERC1;INSR;KLF4;ETS1;CD34;ESR1;LYN;FOXN3;ZFHX3;TNRC6B;PRDM5;SLC7A5;LIMS1;MED26;GSK3B;IRF2;ZNF326;GCNT2;APP;ATM;RPS6KA5;WWC2;ZSCAN21;MITF;NR3C1;DDX3X;SOX13;AHNAK;KDR;MTOR;TIPARP;SOX17;SMO;HMG20B;PSPC1;TFRC;MSN;SP1;ZNF148;VSX1;METTL4;CTCF;LIMD1;BMP6;HDAC1;LARP1;NFKB1;SIX1;AFDN;RYBP;GAS6;ABL1;PDE2A;NOVA2;DNM2;TRRAP;TGFB2;NSD3;FUS;MED1;AHNAK2;SEC16B;NFYC;PARP14;FGF1;GTF2IRD1;BMP4;MEF2C;PUM1;EZR;SLC39A8;CDH5;NGF;ZBTB4;SMAD1;ASCC1;ACTA2;ZC3H7B;MAPK1;ROCK1;KDM6A;PPM1F;RAB27A;NOTCH2;NOS1AP;HNRNPAB;NAB1;YAP1;LDB1;PRDM2;CDH1;PLCG2;CELF1;GSK3A;PICALM;OCLN;WNT16;GPBP1;SPTY2D1;CASP8;SP3;PIK3CD;USP13;ADAM10;FGF7;RAMP2;AKT1;MYOM1;TP53;KDM6B;PRKAA1;POGZ;HMG20A;DICER1;RGCC;SNX12;PRRX2;PSEN1;SOX7;BRAF;TRIM14;JMJD1C;MAZ;PRDM6;HNRNPF;EDN3;CHD3;HFE;YAF2;NOTCH1;SON;FGF2;HDAC4;SFPQ;OGG1;CLK3;WNT11;ZPR1;TAF5L;CDK6;PLSCR1;MAPK8;MECP2;ATF4;MARF1;MZF1;PIK3CB;AGO2;GPBP1L1;RBM20;ICOSLG;RC3H1;FAM98A;NR1D2;HCFC1;GPX1;TCF3;TCF7L1;FOXC1;MYBL2;MIF;ROCK2;TADA3;ZNF462;PRDM9;NAB2;LGMN;RPL5;UBE2L3;VSIR;FOXO4;TERF2;CREBL2;ANGPT1;PIK3R3;BMP7;HIC1;IGF1;MOV10;SRPK2;DNMT1;CTSH;HDAC6;HINT1;HDAC10;PATZ1;FUBP1;HEY1;HEY2;CARM1;RPS3;WTIP;ZNF507;CITED2;GATA2;SOX4;TNRC6A;PPP2CA;PRKAB1;PTPRC;CAVIN4;UTP4;ATRX;NONO;KRAS;CDK11B;WWP2;PRDM1;BCL6;F3;FGFR4;BRCA1;PTBP3;ZSCAN26;TOB1;IGF2;DLL4;SRSF10;TERT;TRA2B;NKAP
prerank,phospholipid dephosphorylation (GO:0046839),0.4173518868185932,1.413164242282675,0.05,0.40853311069296383,1.0,13/37,12.19%,PIP4P1;PLPPR4;PLPPR1;PLPP2;SGPP1;MTMR2;PLPP4;MTMR10;MTMR11;PLPPR5;MTMR7;OCRL;INPP5F
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5440116506492474,-1.4125103681545166,0.08585858585858586,0.28058608979204314,1.0,6/14,14.92%,GAB1;KDR;FLT4;PIK3CD;VEGFC;FOXC1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5600782461741606,-1.4125006589907843,0.08905380333951762,0.2801425027894367,1.0,9/13,37.20%,NAMPT;NAXE;NUDT12;NAPRT;PARP16;PTGIS;PARP9;NAXD;NNMT
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5453878591494105,1.4124156344277048,0.09782608695652174,0.4080941656162304,1.0,6/13,12.17%,ANK3;CALM2;IRX3;SLC8A1;SRI;HRC
prerank,ribosome biogenesis (GO:0042254),-0.3212487423046034,-1.4114204304643612,0.006791171477079796,0.2814771704296526,1.0,80/187,31.12%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;PAK1IP1;RPF1;DDX10;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;EXOSC3;XRN2;RPL13;UTP3;RPL38;RRP1;RPL27;NIP7;RPS16;RPL10;RPL7A;RPL5;DCAF13;EXOSC8;UTP14A;RPS27;LSG1;RPL27A;WDR74;RPL36A;MDN1;RPL35A;DDX31;UTP4;EXOSC5;BOP1;RPL37A;PES1;ABCE1;RRS1;RPL32;EBNA1BP2;RPS7;RPS15;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;NOP16;RPS17;NOL8;GLUL;EXOSC7;WDR46;RPS2;RPL39;NAF1;RAN;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RPLP2;UTP20;RPL18;RPL19;FCF1;DHX29;RPL8
prerank,heterochromatin organization (GO:0070828),-0.5501380986140123,-1.411391176484943,0.09272727272727273,0.28103990453826583,1.0,2/14,3.23%,MECOM;PRDM16
prerank,chromatin organization (GO:0006325),-0.3373418497081062,-1.4109571539941583,0.019197207678883072,0.2813621401957682,1.0,43/132,24.98%,MECOM;SMARCA2;BAZ2B;RB1;CHD1;ESR1;KAT2B;SETD2;PRDM16;HDAC1;SMARCC1;ZBTB7A;BAZ1A;SETD5;SUV39H1;KDM6A;SMARCE1;EHMT1;KDM6B;HMG20A;SMARCC2;HDAC4;HMGN3;MCM3AP;SMARCD3;HCFC1;TCF7L1;DR1;RUVBL2;KDM5B;HDAC10;HMGN2;SMARCAD1;ATRX;BAZ1B;PWWP3A;TOP1;NPM3;SUPT4H1;SETD7;SMARCB1;SETDB2;INO80
prerank,regulation of gene silencing by RNA (GO:0060966),-0.39604133491777416,-1.4106978106005463,0.04725897920604915,0.2809330559784537,1.0,19/50,26.61%,NUP42;RAE1;RANBP2;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;NUP214;IPO8;TNRC6A;NUP188;POLR2C;POLR2L;POLR2H;NUP88
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.39604133491777416,-1.4106978106005463,0.04725897920604915,0.2809330559784537,1.0,19/50,26.61%,NUP42;RAE1;RANBP2;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;NUP214;IPO8;TNRC6A;NUP188;POLR2C;POLR2L;POLR2H;NUP88
prerank,response to nutrient levels (GO:0031667),-0.5088231955872957,-1.410168939042661,0.09786476868327403,0.2813858788060432,1.0,5/17,14.04%,MTOR;FAM107A;PRKAA1;RPTOR;ATF4
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.5551189125312266,-1.4100940936906288,0.09278350515463918,0.2810611352674699,1.0,11/13,35.75%,IFIH1;GAS6;AGPAT1;MAVS;TAF9;IL7;DHX9;TRIM44;AXL;TSLP;CD74
prerank,Golgi organization (GO:0007030),-0.35058290542671555,-1.4100487854941202,0.03019538188277087,0.28068107096829914,1.0,36/112,22.93%,ATP8B1;VTI1A;CSNK1A1;COG1;DYM;LRRK2;SYNE1;RAB1A;GOLPH3L;RAB2A;ATL2;SEC16B;MYO18A;USP6NL;PRKD1;YWHAZ;CUL7;FBXW8;GAK;BCAS3;ARFGEF1;FAM174B;CSNK1D;TRAPPC12;VCPIP1;PI4K2B;TBC1D20;LMAN2;TMED5;GOLPH3;TJAP1;GORASP2;HUWE1;HACE1;SEC22B;BET1
prerank,focal adhesion assembly (GO:0048041),-0.49004306447144574,-1.408699372982265,0.08944543828264759,0.2827542042333405,1.0,6/21,12.34%,SORBS1;THSD1;BCR;FERMT2;PTPRK;ACTN1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.40473626809266955,1.4081460265395866,0.06605922551252848,0.41624508838390867,1.0,9/41,7.41%,SLC24A2;HTR2C;GRIN2B;RYR3;ATP2B4;CACNA2D1;GRIN2A;SLC8A2;RYR2
prerank,regulation of protein kinase activity (GO:0045859),-0.3485599443311646,-1.4080701097862234,0.024054982817869417,0.28337593473355777,1.0,36/106,22.42%,RAPGEF2;RB1;IQGAP1;CEP85;PAK2;RTRAF;GAS6;MRNIP;LRP6;PTK2;RASSF2;RAP1A;SNX9;PLCE1;PPM1F;MMD;PRKRIP1;AKT1;CEACAM1;CHP1;TAF7;TAB2;UBASH3B;ALS2;CACUL1;SOD1;CCL19;CENPE;PTPRC;RAP2C;AKT1S1;NF1;WARS1;MAP2K3;PTK2B;CCN1
prerank,response to interferon-alpha (GO:0035455),-0.5235415620352054,-1.4075263997262342,0.0905587668593449,0.28387094269299373,1.0,9/16,29.08%,IFNAR1;GAS6;IFITM3;PDE12;TPR;IFNAR2;IFITM2;BST2;AXL
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5671386837198936,-1.4074008202711135,0.08112874779541446,0.28366305698650157,1.0,6/12,15.43%,BMP5;SLIT2;PLCB1;WASL;AKT1;CCN3
prerank,mitochondrion transport along microtubule (GO:0047497),0.5474616477207754,1.4071863648068708,0.08983451536643026,0.4160827302586608,1.0,7/13,24.88%,SYBU;MAP1S;MAPT;NEFL;RHOT1;UBB;SPAST
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4425063620549269,-1.4067144902436601,0.059931506849315065,0.2844604821446746,1.0,16/32,25.94%,FOXN3;ATM;UIMC1;MRNIP;MRE11;CLSPN;TAOK3;BABAM2;CDK5RAP3;BRCC3;BRCA1;BLM;CHEK1;TRIM39;FZR1;DTL
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.44401550343152396,1.406676534733863,0.08293838862559241,0.4150250327671665,1.0,13/29,16.35%,GRIK2;CLN3;SLC8A2;SYP;CAMK2B;NETO1;RAB3A;DLG4;SYNGR1;PPFIA3;APOE;NCDN;SHISA9
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3797808980749858,-1.4063978328873137,0.04056437389770723,0.284703146950932,1.0,31/61,27.27%,USP9X;EYA4;UIMC1;PRKD2;EGFR;MRE11;PPP1R10;RGCC;OTUD4;FGF2;BABAM2;HGF;MECP2;RNF168;ERCC8;SMOC2;CEBPG;BRCC3;WRN;RPS3;USP7;ATRX;FGFR4;BRCA1;TRIM28;PDGFRB;HMGB1;DHX9;ERCC6;FGF10;STPG4
prerank,cell differentiation in spinal cord (GO:0021515),0.577725908512242,1.4063448218274979,0.1016548463356974,0.4136718798274415,1.0,3/10,5.07%,MDGA2;LHX1;MDGA1
prerank,protein kinase A signaling (GO:0010737),-0.5637975587318694,-1.4062506221740878,0.09040590405904059,0.2845217635905746,1.0,4/12,12.71%,PRKACB;EZR;MYOM1;LCP1
prerank,negative regulation of developmental process (GO:0051093),-0.37151494555760883,-1.4062368766344338,0.02443280977312391,0.2840936076188806,1.0,23/69,17.95%,KLF7;NFIB;NOS3;TBX1;TFRC;GAS6;ARHGEF15;SUZ12;BMP4;BNIP3;ROCK1;TBX2;NOTCH4;NOTCH1;WNT11;CDK6;RC3H1;FOXC1;MIF;ROCK2;FUZ;HEY1;HEY2
prerank,sensory perception of taste (GO:0050909),0.5727498109758612,1.4051621860930517,0.09859154929577464,0.4142274678750301,1.0,3/10,14.60%,ASIC2;GNAT3;ASIC1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.46793565164170303,1.4044256061312645,0.08647450110864745,0.4137652640576821,1.0,4/21,5.87%,NUDT19;LPIN1;HAO1;CYP26B1
prerank,COPII vesicle coating (GO:0048208),-0.3776354284409442,-1.4036080426310769,0.0421455938697318,0.28750069018565516,1.0,19/61,16.42%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;CTSZ;TBC1D20;F5;TFG
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3776354284409442,-1.4036080426310769,0.0421455938697318,0.28750069018565516,1.0,19/61,16.42%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;CTSZ;TBC1D20;F5;TFG
prerank,vesicle coating (GO:0006901),-0.3776354284409442,-1.4036080426310769,0.0421455938697318,0.28750069018565516,1.0,19/61,16.42%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;CTSZ;TBC1D20;F5;TFG
prerank,positive regulation of catalytic activity (GO:0043085),-0.4302297217186256,-1.4032441372701099,0.0546448087431694,0.28776683564668054,1.0,17/37,25.67%,CAV1;ABL1;PSEN2;PHACTR4;XRCC4;PSEN1;BCAS3;MAPK8;NHEJ1;APH1A;SOD1;WRN;NOD2;FGFR4;IGF2;MSH3;SLC5A3
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5557326217808598,-1.402884432165903,0.08378870673952642,0.28807302069033797,1.0,4/13,14.45%,KPNA4;RANBP2;KPNA3;KPNA1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5370906247147886,1.402862287294196,0.11926605504587157,0.4152932399789849,1.0,4/13,17.93%,SYT1;SYT4;CACNA1G;CACNA1I
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5878287632426347,-1.4027217574433624,0.07196969696969698,0.28791684703737475,1.0,6/11,32.98%,MFHAS1;LYN;TNFAIP3;TREM2;TLR6;TLR1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.5518026602226421,-1.4025449422109921,0.10223048327137546,0.28781212929219196,1.0,4/12,8.04%,LYN;IL34;PTK2;MAPK1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.4623459086229279,-1.4023629515364715,0.06810035842293907,0.2876873971147384,1.0,9/25,17.95%,NSD1;RB1;ZBTB7A;DOT1L;SIN3A;MAD2L2;IGF1;HEY1;HEY2
prerank,negative regulation of organelle assembly (GO:1902116),-0.42962191217085177,-1.4021311342668923,0.07231040564373897,0.2876077608906491,1.0,10/35,10.04%,KAT2B;LIMK2;LRRK2;CDK10;TBC1D30;YAP1;SCFD1;SMAD4;CHMP4B;CHMP4A
prerank,nucleotide catabolic process (GO:0009166),-0.5189069533044669,-1.4019994876183037,0.09225092250922509,0.2873803009761818,1.0,13/16,42.83%,NT5C2;NT5E;SAMHD1;NT5C1A;GPX1;GDA;NT5C;PNP;DERA;VCP;NUDT15;NUDT3;XDH
prerank,defense response to tumor cell (GO:0002357),-0.5974547193331478,-1.4010528359659318,0.10144927536231885,0.28868869115538953,1.0,3/10,11.85%,KLF4;DAPK1;ABI3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.3495439405440657,-1.4008266807052172,0.021660649819494584,0.28856133659523425,1.0,27/101,13.55%,FLT1;DAB2IP;RAPGEF2;FERMT2;PKD2;PDGFD;LRRK2;DDX3X;EGFR;IL34;CCND3;IRGM;FGF1;AKT1;EDN1;TPD52L1;CCNY;PIK3R6;RGCC;EDN3;RPTOR;RHOA;FGF2;IRAK1;MTCP1;TCIM;CD40
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.5597279868163025,-1.400103433869305,0.09363957597173145,0.2893771670960702,1.0,7/12,24.95%,CAV1;IFIH1;FLOT1;CGAS;MAVS;RALB;DHX9
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.46648431390181794,-1.3994512469556324,0.060550458715596334,0.29012188125737465,1.0,9/24,18.97%,TAB3;NOD1;CASP8;IRAK1;TNFAIP3;TAB2;IRAK2;IKBKG;NOD2
prerank,smooth muscle cell differentiation (GO:0051145),-0.5544121672920025,-1.398757301855905,0.08976660682226212,0.29086423872829514,1.0,7/12,22.61%,MRTFB;BMP4;MEF2C;TMEM204;HEY1;HEY2;MYOCD
prerank,leukocyte tethering or rolling (GO:0050901),-0.5019402116751097,-1.3976693929343371,0.0922242314647378,0.2924320553749415,1.0,6/17,17.78%,ITGB1;JAM2;ROCK1;ITGA4;VCAM1;GOLPH3
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5556438575815685,-1.3968349357499037,0.09205776173285199,0.2934673309850875,1.0,7/12,31.65%,HES1;NOTCH1;JAG1;NELFB;HNRNPU;N4BP2L2;TCF15
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.36888979122061405,-1.3963712272092188,0.037996545768566495,0.29388245071249874,1.0,30/72,27.03%,SP100;ACER2;ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;TP53;CRADD;RGCC;KAT5;NDRG1;BTG2;USP10;TFAP4;CARM1;SOX4;ATRX;MDM2;CASP2;GADD45A;E2F7;CNOT2;ARID3A;TFDP1;PLK3;CNOT8;CNOT1
prerank,regulation of biomineral tissue development (GO:0070167),-0.4548855260142677,-1.3960661997421364,0.06394316163410302,0.2939463075256048,1.0,11/26,17.95%,NOS3;SGMS2;GAS6;ROCK1;S1PR1;NOTCH1;NOTUM;ROCK2;ANKH;HEY1;HEY2
prerank,myeloid leukocyte differentiation (GO:0002573),-0.37394242566618424,-1.396065728421562,0.057660626029654036,0.29348485335366503,1.0,27/65,31.27%,FOXP1;LEF1;CBFA2T3;MYH9;RXRA;DEK;IL15;TGFBR2;BMP4;CASP8;PIK3CD;GAB2;PIR;RARA;CCL19;EPHA2;PPARG;CEBPA;MT1G;LGALS9;GLO1;TREM2;SPI1;BATF2;RUNX1;MAPK14;SBNO2
prerank,regulation of receptor internalization (GO:0002090),0.4162925399579102,1.3959214353252845,0.05580357142857143,0.4298936244277667,1.0,10/35,13.03%,MAGI2;ANKRD13B;WDR54;CD63;MTMR2;ATAD1;AHI1;VEGFA;DLG4;RSPO1
prerank,negative regulation of calcium ion transport (GO:0051926),0.5146346493668768,1.3958198649531741,0.09307359307359307,0.42790732443486984,1.0,4/15,9.30%,ATP1A2;STC1;TRIM27;ADRA2A
prerank,regulation of secretion by cell (GO:1903530),0.3800202853927706,1.395090044773423,0.04285714285714286,0.42738350061080066,1.0,10/54,12.35%,STXBP5L;SYT1;RIMS2;RIMS1;RAB15;SYN1;RAB3C;RAB3A;MCTP2;LLGL1
prerank,superoxide metabolic process (GO:0006801),-0.44636858372172283,-1.394220916603675,0.07380073800738007,0.29632805593900197,1.0,9/29,18.06%,SH3PXD2A;NOS3;SH3PXD2B;NCF2;PREX1;NOX4;NRROS;CCS;SOD1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4318824079741411,-1.393825635822376,0.0776173285198556,0.29661468774248956,1.0,17/31,32.86%,CRIM1;LRP5;TRPM4;LIMD1;TWIST2;NOTCH1;TMEM64;CDK6;SMAD6;SKI;PPARG;HDAC7;GDF10;SUFU;BAMBI;RIOX1;PTCH1
prerank,T cell homeostasis (GO:0043029),-0.5808538700513678,-1.393824282086788,0.0994671403197158,0.29615122729289195,1.0,3/10,9.84%,FAS;PPP2R3C;AKT1
prerank,protein sumoylation (GO:0016925),-0.3945407584517821,-1.3937385447503918,0.059149722735674676,0.29587175547506916,1.0,18/49,26.61%,IFIH1;NUP42;RAE1;TRPM4;RANBP2;UBA2;NUP98;NSMCE2;NUP153;PIAS2;TPR;SUMO1;NUP214;PIAS4;TRIM28;NUP188;SAE1;NUP88
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.42905557585395737,1.3932500102882954,0.05203619909502263,0.42945842838100196,1.0,12/31,16.83%,DSCAML1;COL2A1;OSR1;HOXD3;MEGF8;FGFR2;HOXA4;EIF4A3;HOXA9;PDGFRA;TWIST1;HOXD4
prerank,regulation of fibroblast migration (GO:0010762),-0.49896456945366263,-1.393183510800818,0.07875457875457875,0.2964806726871319,1.0,9/20,14.73%,ITGB1;RAC1;PRKCE;CORO1C;THBS1;GNA12;PTK2;FGF2;HAS1
prerank,axon guidance (GO:0007411),0.3077480682832757,1.3928519885638133,0.011574074074074073,0.4282219298648936,1.0,42/201,10.15%,NRXN3;NRXN1;ROBO2;UNC5D;L1CAM;DAB1;DCC;NCAM1;CNTN6;CNTN4;DSCAML1;EPHA6;ENAH;DSCAM;SCN1B;ROBO1;LHX1;VLDLR;EPHB1;TNR;DOK5;UNC5C;GFRA1;SEMA6D;EPHA5;EFNA3;EFNB3;SEMA3B;DOK6;GPC1;MYPN;SHC3;VSTM2L;EMB;CNTN2;SHC1;VEGFA;SPTBN2;SPTBN4;SLIT3;SLIT1;KIF5A
prerank,positive regulation of protein acetylation (GO:1901985),-0.567296983986501,-1.3925524361851167,0.0856610800744879,0.29724197888787407,1.0,8/12,30.00%,DDX3X;DIP2B;PRKAA1;KAT5;RAPGEF3;DIP2A;CEP295;FAM161A
prerank,mRNA destabilization (GO:0061157),-0.41680512116050805,-1.392106694653848,0.06909090909090909,0.29754471530889787,1.0,17/38,27.03%,TUT7;METTL14;GIGYF2;FTO;PUM1;ROCK1;CELF1;TUT4;PDE12;RC3H1;ROCK2;MOV10;DIS3L2;METTL16;RBM24;ZFP36L1;CNOT1
prerank,regulation of dendrite development (GO:0050773),0.4023702496206421,1.3918134479016235,0.056818181818181816,0.428353801782526,1.0,8/37,6.03%,CSMD3;ADGRB3;DCC;HECW1;CDKL5;VLDLR;TNIK;HECW2
prerank,motile cilium assembly (GO:0044458),0.5451207050105156,1.3916491614407935,0.1070615034168565,0.4265900235100365,1.0,4/12,11.37%,DNAAF3;BBOF1;DNAAF1;BBS5
prerank,myoblast fusion (GO:0007520),0.5325640550494718,1.390629620420868,0.12095032397408208,0.42678877751469707,1.0,4/12,6.52%,ADAM12;ADGRB3;ADAMTS15;CD81
prerank,detection of calcium ion (GO:0005513),0.5400071379242445,1.3903822497124219,0.08624708624708624,0.4251202927988164,1.0,3/13,7.41%,SYT1;CALM2;RYR2
prerank,protein import into mitochondrial matrix (GO:0030150),-0.5084059528335216,-1.390237928560013,0.0933572710951526,0.300687954036447,1.0,10/18,36.31%,TOMM40;TIMM17B;DNAJC19;TOMM40L;TIMM50;TOMM20;TOMM70;DNLZ;TIMM23;PAM16
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5579591858168891,-1.3899791725011845,0.11754068716094032,0.30072059950727037,1.0,7/12,24.87%,RESF1;TASOR;APOBEC1;DNMT1;PPHLN1;TRIM28;SETDB2
prerank,protein autophosphorylation (GO:0046777),-0.3236136275592771,-1.3896183301900746,0.012612612612612612,0.30098903505069613,1.0,34/157,11.47%,FLT1;GRK5;TEK;IGF1R;DYRK1A;INSR;DAPK1;LYN;GSK3B;ATM;PAK2;SIK1;LRRK2;NEK6;KDR;MTOR;PRKD2;CDK12;EGFR;STK24;BMX;ABL1;PTK2;ERN1;MAPKAPK2;AAK1;EPHA4;PRKD1;FLT4;AKT1;MAP3K3;TAOK3;STK10;JAK2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.32720072795375676,-1.389230634394731,0.020905923344947737,0.30122720121977575,1.0,68/158,32.10%,PELI1;AKAP13;ROR1;TAB3;MIER1;ANKRD17;NOD1;TRAF5;TRIM25;PLEKHG5;NEK6;TNFSF10;BIRC3;TFRC;PLK2;PRKD1;ALPK1;CASP8;CFLAR;MAP3K3;FLNA;IKBKE;TRIM14;RHOA;IRAK1;MTDH;RHOC;CD40;TNFRSF19;TNFRSF1A;PELI2;TAB2;TFG;TRIM13;MIB2;VAPA;MAVS;IKBKG;CCL19;LURAP1;MAP3K14;EDAR;IKBKB;NOD2;TMEM9B;LTBR;NDFIP2;RELA;RIPK1;CASP1;TRIM68;MAP3K7;BRD4;F2R;SLC20A1;LGALS9;TRIM6;TIFA;HMOX1;BST2;RNF31;EEF1D;TRIM32;TICAM1;TRIM62;TLR6;TNIP2;LPAR1
prerank,cardiac ventricle development (GO:0003231),-0.4876748776957255,-1.3884347665362187,0.08318264014466546,0.30225635240628285,1.0,11/20,26.96%,ENG;HES1;PDE2A;HECTD1;NOTCH1;HEY1;HEY2;DAND5;DLL4;GJA5;STRA6
prerank,regulation of striated muscle contraction (GO:0006942),0.44976724779711347,1.3876124636934972,0.0763888888888889,0.4296723510427091,1.0,7/27,12.61%,ATP1A2;CALM2;RNF207;RYR2;SLC8A3;SRI;MYL2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5694412674414732,1.3876099748404027,0.1252847380410023,0.42752726917878026,1.0,5/10,19.33%,LAPTM4B;TSKU;GATA6;HSP90AB1;CD24
prerank,positive regulation of inflammatory response (GO:0050729),-0.35364492462539826,-1.3875127632948894,0.03418803418803419,0.30345256861104475,1.0,25/86,24.95%,OSMR;ETS1;APP;IL15;IL6ST;NFKBIA;NMI;PDE2A;PDCD4;LBP;NAPEPLD;FEM1A;AGTR1;LPL;IL17RA;IFI35;IL16;TNFRSF1A;HYAL2;GPR4;SERPINE1;RIPK1;CEBPA;DDT;DHX9
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5720411848072859,-1.3870525485296032,0.09655172413793103,0.30384605475607107,1.0,8/11,30.85%,MERTK;GAS6;CCL19;NOD2;CXCL12;IRF7;AXL;LILRB1
prerank,excitatory postsynaptic potential (GO:0060079),0.46973838413917474,1.3869150403344546,0.08108108108108109,0.42713648889775474,1.0,4/19,3.46%,GRID2;MPP2;GRIN2B;GRIN2A
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3267229037497036,1.3868143904382089,0.02102803738317757,0.42529798227865695,1.0,26/124,9.80%,CNTNAP2;NLGN1;L1CAM;RASGRF1;PPP1R9A;CNTN4;BLK;SH3GL2;TMEM108;GPM6B;CDK5;TTC29;PLP1;PLEK;ATXN10;MAP2;TSGA10IP;NPY;GPM6A;CARMIL1;MAPT;POU4F1;CATIP;KIFAP3;ZFYVE27;STMN2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.502446554006417,-1.3867742763413817,0.09479553903345725,0.3039164711301254,1.0,5/17,12.95%,PTPRJ;EZR;DGKZ;CEACAM1;DUSP3
prerank,regulation of actomyosin structure organization (GO:0110020),-0.5519826089400548,-1.386478901916011,0.10497237569060773,0.30402173036396407,1.0,6/13,20.98%,AKAP13;RAC1;ROCK1;ROCK2;ALMS1;ASAP3
prerank,regulation of cellular catabolic process (GO:0031329),-0.3711368950671536,-1.3860704109567583,0.04092526690391459,0.3042569638095027,1.0,22/62,24.23%,ITPR1;DAPK1;ACER2;MTMR3;ATM;LRRK2;PIP4K2A;ABL1;PIP4K2B;ROCK1;USP13;RPTOR;GPR137B;USP10;HDAC6;RAB39B;DRAM2;WDR41;KEAP1;MTMR4;TPCN2;TRIB3
prerank,rRNA processing (GO:0006364),-0.3165395881498304,-1.385805704315001,0.013888888888888888,0.3042914788425449,1.0,72/172,30.40%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;RPF1;RRP15;DDX10;NOP2;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;EXOSC3;XRN2;RPL13;UTP3;RPL38;RRP1;RPL27;RPS16;RPL10;RPL7A;RPL5;DCAF13;EXOSC8;UTP14A;RPS27;RPL27A;WDR74;RPL36A;MDN1;RPL35A;UTP4;EXOSC5;PRKDC;BOP1;RPL37A;PES1;RPL32;EBNA1BP2;RPS7;RPS15;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS17;NOL8;EXOSC7;WDR46;RPS2;RPL39;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RIOK3;RPLP2;UTP20;RPL18;RPL19;FCF1
prerank,steroid metabolic process (GO:0008202),0.3549702885180134,1.3857363484876886,0.04608294930875576,0.42575250869465625,1.0,15/72,12.34%,AKR1D1;CYP46A1;AKR1C1;CYP24A1;SULT2B1;CYP26B1;LSS;HSD17B7;CYP51A1;HSD17B14;CYP27A1;GC;CYP11B1;FDFT1;DHCR24
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3406985877969849,-1.3854043130863851,0.01217391304347826,0.3045953803140058,1.0,33/108,23.39%,HIP1;SENP1;DAPK1;ACER2;NOD1;CASP12;UACA;MAP3K5;DDX3X;TNFSF10;FAS;NGF;PPM1F;ATP2A3;ARL6IP5;CASP8;CFLAR;CRADD;BCAP31;SOX7;JAK2;BBC3;DAP;HIP1R;CASP8AP2;RPS3;PPARG;F3;FOXL2;CASP2;RIPK1;CASP1;EIF2AK3
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5865993946994006,-1.385157128049514,0.09838998211091235,0.3046060451288409,1.0,3/10,12.91%,CREBBP;KAT2B;KAT5
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4579719883294465,1.3843533574164026,0.09135802469135802,0.4268103235309,1.0,8/22,9.80%,MAGI2;SH3GL2;TMEM108;KIDINS220;NTRK2;MAPT;ACAP2;STMN2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.44912166778586854,-1.3839196860610423,0.0692167577413479,0.30652251298077104,1.0,9/28,14.96%,DAB2IP;ITPR1;MAP3K5;ERN1;ATP2A3;ERO1A;ATF4;DNAJC10;BBC3
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.45756801413676873,-1.3837653986666225,0.08035714285714286,0.30636617425174695,1.0,8/25,15.33%,ITGA6;THBS1;APP;EGFR;ILK;PSEN1;PTGES3;MIF
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.47541552944857196,1.3836665580309104,0.09803921568627451,0.42622267242095163,1.0,4/19,6.81%,PTPRD;IL1RAPL1;CDKL5;CAMK2B
prerank,filopodium assembly (GO:0046847),-0.5076465268525145,-1.383355565838382,0.10476190476190476,0.30662269556601657,1.0,4/16,7.39%,FGD5;FGD6;DNM3;EZR
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.49339105494072855,-1.3829619972674136,0.09025270758122744,0.30693808854430477,1.0,3/19,0.62%,DAB2IP;JCAD;SEMA6A
prerank,thymus development (GO:0048538),-0.5432571314804132,-1.3827780805116583,0.10740740740740741,0.3068490731316435,1.0,8/13,31.26%,TBX1;HES1;SIX1;SOD1;EPHB3;FGF10;TGFBR1;SHH
prerank,peroxisome organization (GO:0007031),-0.45252141588382155,-1.382595384441118,0.09043478260869565,0.30671428658360095,1.0,12/25,31.64%,PEX1;SEC16B;ABCD3;PEX7;TMEM135;PEX14;PEX11A;PEX3;PEX6;PEX11B;PEX19;LONP2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5265725364909507,-1.382446848991755,0.10707803992740472,0.3065396819876833,1.0,6/13,20.89%,SORBS1;INSR;IRS1;AKT1;IGF1;IGF2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.45412285482936193,1.3819743567982594,0.08237986270022883,0.42809268422393787,1.0,15/23,24.34%,CCDC88A;TUBA1C;KIF5A;DYNC1I1;KIF1C;HOOK1;TUBB;MAP6;MAP6D1;HOOK3;DYNC1I2;CCDC88C;F8A1;KIF5C;KIF1B
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.46772694926034936,-1.381881599145704,0.08981001727115717,0.30721286204577,1.0,8/24,14.53%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;GDI1;NUMB
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.438939768647712,1.3818256708602847,0.07311827956989247,0.4263573462179227,1.0,11/29,17.17%,HSD17B12;ACSBG1;HACD1;ACLY;ACACA;ACSL3;ACSL6;TECR;SCD5;HACD2;SCD
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.5866557219638933,-1.3817070032525594,0.10076045627376426,0.3070514009223619,1.0,4/10,16.50%,ST3GAL1;ST6GAL1;GNPDA2;GNE
prerank,regulation of acrosome reaction (GO:0060046),0.5688928081699964,1.3815459098706206,0.11674008810572688,0.4249824519908433,1.0,2/10,3.88%,GLRA1;SPINK13
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.44947355932145,-1.381122360558632,0.07944732297063903,0.3076817521409642,1.0,8/28,11.47%,RAC1;ADIPOR2;MITF;TNFRSF1B;MED1;SIRT5;NOS1AP;JAK2
prerank,regulation of kinase activity (GO:0043549),-0.3506901265414681,-1.381061750983959,0.034904013961605584,0.3073372923017168,1.0,18/89,8.88%,FLT1;TEK;IGF1R;RB1;TIE1;ROR1;INSR;KDR;MERTK;EGFR;CDKN1B;DSTYK;LMO4;PLCE1;MRE11;EPHA4;FLT4;LDB1
prerank,chromatin remodeling (GO:0006338),-0.34708406304534273,-1.3810468756661325,0.03395585738539898,0.30691211431649346,1.0,35/100,26.75%,SMARCA2;BAZ2B;RB1;ESR1;KAT2B;ARID1B;HDAC1;SMARCC1;ZBTB7A;BAZ1A;SRCAP;KDM6A;SMARCE1;CECR2;KDM6B;SMARCC2;CHD3;HDAC4;ACTB;SMARCD3;HCFC1;DR1;RUVBL2;KDM5B;INO80B;SMARCAD1;ATRX;BAZ1B;TOP1;NPM3;SMARCB1;INO80;ERCC6;HDAC5;RSF1
prerank,actin filament bundle assembly (GO:0051017),-0.4237186307815817,-1.3806528469089847,0.08614232209737828,0.30723802492011393,1.0,10/33,13.20%,LIMA1;EPS8;BAIAP2L1;PLS3;EZR;SHROOM1;FAM107A;SHROOM2;LCP1;NEDD9
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.356817722282489,-1.3804870607319053,0.03374777975133215,0.30716302459135714,1.0,27/80,16.85%,THBS1;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;PLD1;SP1;EIF3C;UPF3B;PRKCD;SAMD4A;EPHA4;GSK3A;PICALM;RPL26;ZCCHC4;SLC2A13;EEF2;SIRT3;LARP4B;RPS4X;ROCK2;RPL5;TNFRSF1A;METTL5;SMPD2
prerank,muscle tissue morphogenesis (GO:0060415),-0.5101606375707322,-1.3800433856759573,0.09719626168224299,0.307551941173788,1.0,7/16,17.95%,TBX1;TGFBR3;BMP4;MYLK;ZFPM1;NOTCH1;HEY2
prerank,positive regulation of secretion by cell (GO:1903532),-0.36447920081041374,-1.3792962896945073,0.04712041884816754,0.30853877337471075,1.0,17/70,11.69%,UNC13B;CD2AP;GOLPH3L;SLC12A2;ADAM9;IER3IP1;BMP6;RAB2B;TGFB2;EZR;MYO18A;RAB27A;RAB5A;MYOM1;EDN1;RGCC;EDN3
prerank,response to progesterone (GO:0032570),-0.4978407771845361,-1.3787861122475722,0.09386281588447654,0.3090999867756672,1.0,5/18,8.80%,ABHD2;CAV1;THBS1;TGFB2;YAP1
prerank,RNA 3'-end processing (GO:0031123),-0.3701419990385,-1.3787259659395599,0.036231884057971016,0.3087532295928761,1.0,21/69,20.23%,SRSF11;TUT7;TENT4B;SARNP;THOC2;RPRD2;UPF3B;THOC7;DDX39B;TENT4A;CPSF7;DHX38;TUT4;SLU7;TENT2;THOC3;THOC1;FIP1L1;SRRM1;RNPS1;SRSF3
prerank,regulation of monocyte differentiation (GO:0045655),-0.530551668869705,-1.3784818136998385,0.10507246376811594,0.3087273411387524,1.0,7/14,26.06%,FOXP1;IL34;ACIN1;CDK6;CTNNBIP1;IRF7;ZFP36L1
prerank,cellular protein catabolic process (GO:0044257),-0.38054707997135173,-1.3784221596820756,0.04363636363636364,0.3083727655396729,1.0,22/59,24.07%,DAB2IP;CTSC;RAB7A;AP2B1;AP2A2;AP2S1;BNIP3;DENND3;CASP8;CAPN2;AFG1L;MYLIP;MAGEC2;CTSZ;LGMN;CTSH;AP2M1;MDM2;CTSF;CTSO;RIPK1;ADAMTS7
prerank,positive regulation of receptor internalization (GO:0002092),0.45964041912932363,1.3782759862385912,0.09885057471264368,0.4307328999584177,1.0,5/22,9.25%,MAGI2;CD63;ATAD1;AHI1;VEGFA
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5234089970985416,-1.378268346381309,0.0998185117967332,0.30817493379483085,1.0,5/15,15.35%,DAB2;WASL;AAK1;PIK3CB;HIP1R
prerank,regulation of organelle assembly (GO:1902115),-0.36174244449115506,-1.3767454994378252,0.04189435336976321,0.3106955756577947,1.0,26/72,22.99%,MTMR3;STX18;MSN;TBC1D1;TBC1D2B;IFT140;EZR;PLK2;USP6NL;RAB5A;TBC1D14;TBC1D22B;TBC1D22A;DYNC2LI1;TRAPPC12;ATG5;TBC1D20;ALMS1;TBC1D8;TBC1D17;RNF4;PDCD6IP;IFT20;TBC1D12;EVI5;SENP6
prerank,positive regulation of vacuole organization (GO:0044090),-0.5894536949938384,-1.3763553426154778,0.11498257839721254,0.3109755926832817,1.0,5/10,11.00%,RAB3GAP1;ANXA2;PIP4K2A;PIP4K2B;RAB3GAP2
prerank,negative regulation of cell aging (GO:0090344),-0.5055353332779469,-1.3762274103259549,0.1105072463768116,0.31078975129470776,1.0,7/16,21.21%,SLC30A10;AKT3;MAP3K3;CDK6;MIF;TERF2;TERT
prerank,heart contraction (GO:0060047),0.3941247777719773,1.3759988294411496,0.07472527472527472,0.43397022514433586,1.0,11/41,14.50%,SGCZ;ATP1A2;SCN1B;ATP1B1;RYR2;SCN5A;TNNC1;SLC8A1;MYL2;TNNI2;SCN2B
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5270645139551982,1.375777892211877,0.1252847380410023,0.4324326808019891,1.0,8/13,16.35%,GRIK2;CLN3;SLC8A2;SYP;RAB3A;SYNGR1;PPFIA3;SHISA9
prerank,negative regulation of signal transduction (GO:0009968),-0.301376094524196,-1.375513029607642,0.00676818950930626,0.3116692992037018,1.0,71/249,20.17%,NXN;DAB2IP;SEMA6A;RB1;TRABD2B;BRAP;LYN;ASXL1;NTN1;THBS1;PTPN1;NFATC1;BMP5;LRRK2;PTPRJ;EGFR;NOTCH3;PIP4K2A;PTPN12;VGLL4;NCK1;IRS1;ZBTB7A;RNF43;PHACTR4;HERC4;PALM;DDIT4;NEDD4;PIP4K2B;PRKCD;NKD1;ARRDC1;GRB10;GLI3;GSK3A;GRB14;AKT1;GLIS2;NFKBIL1;HMGXB4;MOSMO;MAZ;OTUD4;SLC27A4;FGF2;WWOX;TCIM;NOTUM;TAX1BP3;APCDD1;SPRY4;PIK3CB;TNFAIP3;IGFBP5;LGMN;GPR108;HIC1;UBASH3B;KIF26A;TNS2;HEY1;SIAH1;GATA2;PTPRC;RITA1;KIF7;CTNNBIP1;GPC3;WWP2;PTEN
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.47360243860110374,-1.3753135977094926,0.0965391621129326,0.31156864503663734,1.0,10/20,21.05%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,organic acid transport (GO:0015849),-0.34305589147183113,-1.3750168553732338,0.03716814159292035,0.3116914159810489,1.0,23/94,13.79%,ABCC4;ABCG2;SLC6A6;SLC26A7;ATP8B1;SLCO1C1;SLC7A1;RXRA;SLC25A32;SLC5A6;SLC38A5;SLC16A1;SLC1A5;LRRC8D;SLCO2B1;PPARD;SLC13A3;MFSD2A;SLC25A11;SLC27A4;CEACAM1;SLC7A7;SFXN5
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5415276408076339,-1.3748642024298923,0.10971223021582734,0.31151675505328125,1.0,3/13,5.48%,NOS3;TMSB4X;PPARA
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5254234108500736,-1.374092299629955,0.10387323943661972,0.3125087707768919,1.0,9/15,30.24%,EHD2;ADAM9;EHD1;FLOT1;CD53;RAPGEF3;ADGRB1;TREM2;MAPK14
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.452378182369574,-1.3739479425475185,0.07942238267148015,0.3123408337928266,1.0,15/25,33.46%,CDK13;CDK12;EAF1;LDB1;CDC73;RNF168;ZMYND11;NELFB;SUPT4H1;BRD4;LEO1;HNRNPU;LARP7;NELFA;NELFCD
prerank,water transport (GO:0006833),0.5366680023521845,1.372793771855091,0.12747252747252746,0.43750964924615177,1.0,2/12,4.58%,PDPN;AQP4
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.4756152785087352,1.3725874847516102,0.07875894988066826,0.4358867727519058,1.0,9/17,20.73%,GGA3;NTRK2;SORL1;RTN4;CLU;APOE;RTN3;HAP1;RTN1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.5764194984455129,-1.372565977646857,0.11387900355871886,0.3145137287280575,1.0,2/10,14.02%,GNB1;SAG
prerank,cellular response to ionizing radiation (GO:0071479),-0.3902973666446313,-1.372219258409254,0.06216696269982238,0.3146793284769704,1.0,23/47,30.42%,MAP3K20;NET1;TLK2;ATM;NIPBL;SPIDR;YAP1;RPL26;TP53;GRB2;WRN;LIG4;MDM2;BLM;GADD45A;INTS7;INO80;TMEM109;KDM4D;RAD51AP1;SWI5;MAPK14;EEF1D
prerank,cellular response to chemical stress (GO:0062197),-0.34613829265084317,-1.3717599245818148,0.02411873840445269,0.3151227796475681,1.0,31/96,22.38%,FOXO1;CAV1;PKD2;ATG7;ATM;LRRK2;DDX3X;ABL1;FOXO3;FAS;PYROXD1;LRRC8D;PRKD1;PRKAA1;ERO1A;CAT;NCF2;TXNRD2;ATF4;MSRA;GPX1;NOX4;FANCC;CCS;SOD1;TRPV4;VRK2;TXNRD1;KEAP1;SLC25A24;NFE2L2
prerank,dorsal/ventral pattern formation (GO:0009953),0.468692369567263,1.3715145151012378,0.08387096774193549,0.4362102142710307,1.0,5/20,8.72%,DSCAML1;LHX1;NBL1;FBXL15;LMX1B
prerank,T cell differentiation (GO:0030217),-0.40791436967426803,-1.371314680204579,0.0718132854578097,0.3155078891178965,1.0,24/40,40.89%,SOX13;JAG2;GLI3;PIK3CD;NHEJ1;LMBR1L;ANXA1;SOX4;PTPRC;LIG4;DLL4;PTPN2;ZFP36L1;ADAM17;FCER1G;SPI1;SHH;LFNG;ZAP70;GATA3;GPR89A;GPR89B;LCK;CD28
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.42355770123240594,-1.3712022954748073,0.07705779334500876,0.3152504489907375,1.0,10/35,21.16%,FLT1;PTPRM;CAV1;THBS1;MEF2C;RGCC;PPARG;NF1;NR2F2;DLL4
prerank,protein deacylation (GO:0035601),-0.463364781147128,-1.3709735886824619,0.0875,0.31524701978472863,1.0,15/23,29.05%,HDAC1;SIRT5;SIN3A;HDAC4;ABHD17A;NOTUM;SIRT3;ABHD17C;HDAC6;HDAC10;HDAC7;LYPLA1;HDAC5;ABHD10;PPT1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.44304674450695014,-1.3701785894137997,0.07777777777777778,0.3161177652089443,1.0,16/31,36.31%,PEX1;PEX7;TOMM40;TIMM17B;PEX14;DNAJC19;TOMM40L;TIMM50;PEX6;TOMM20;TOMM70;AIFM1;PEX26;DNLZ;TIMM23;PAM16
prerank,regulation of lipid catabolic process (GO:0050994),0.47238656290912634,1.3695943180618009,0.11502347417840375,0.43872130930385533,1.0,5/19,15.14%,PDE3B;BSCL2;TYSND1;ADRA2A;APOC1
prerank,negative regulation of histone methylation (GO:0031061),-0.5752708103391049,-1.3689229698447607,0.11029411764705882,0.31801080131818166,1.0,6/10,30.94%,BCOR;DNMT1;BRCA1;AASS;WDR5;DNMT3B
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5060671452700998,-1.3688901870103012,0.1056338028169014,0.317619674362803,1.0,8/16,20.15%,IGF1R;INSR;OGFOD1;BNIP3;GSPT1;HDAC6;TBC1D25;GLE1
prerank,response to lipopolysaccharide (GO:0032496),-0.3229271658401484,-1.368583712774488,0.026455026455026454,0.3178099378577638,1.0,29/138,16.45%,FOXP1;DAB2IP;PELI1;NOS3;SRR;IFNAR1;ADAM9;HNRNPA0;NFKB1;TNFRSF1B;GGT5;PDCD4;GCH1;IRGM;LBP;MEF2C;MAPKAPK2;SCARB1;NFKBIL1;JAK2;RHOA;IRAK1;CDC73;MAPK8;RPS6KA3;TNFAIP3;SMAD6;TAB2;CHMP5
prerank,negative regulation of peptidase activity (GO:0010466),0.3817011231990198,1.368568815240954,0.05309734513274336,0.43914099978555715,1.0,10/47,13.78%,VTN;SPOCK3;SPOCK1;ECM1;SERPIND1;TIMP1;SERPINA2;SERPING1;FETUB;CST3
prerank,outer dynein arm assembly (GO:0036158),0.5187827726832324,1.3684518856777268,0.1146067415730337,0.4374044879635472,1.0,7/14,18.48%,CCDC63;ODAD2;DNAAF5;DNAAF1;ODAD1;LRRC49;ODAD3
prerank,mitochondrion distribution (GO:0048311),-0.5468493064048037,-1.3677335487866518,0.11559633027522936,0.31899089399010744,1.0,3/12,3.71%,MEF2A;TRAK1;LRRK2
prerank,protein monoubiquitination (GO:0006513),-0.40770694809845964,-1.3670700379971454,0.0631768953068592,0.3198191229966581,1.0,13/36,21.22%,TRIM25;DTX3L;RBX1;CUL3;RNF40;KLHL12;UBE2D3;RAD18;CDC73;OBI1;HUWE1;FANCL;UBE2R2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.36809250915005787,-1.366861159579475,0.05110732538330494,0.3197601445051566,1.0,28/63,27.03%,ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;TP53;CRADD;RGCC;BTG2;RFWD3;CARM1;SDE2;RPA2;SOX4;CCND1;PRKDC;MDM2;CASP2;GADD45A;E2F7;CNOT2;ARID3A;TFDP1;PLK3;CNOT8;CNOT1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4586620057267878,-1.366274624357812,0.08545454545454545,0.3204198090965423,1.0,12/25,28.04%,ZNF326;SETD5;EAF1;LDB1;DDX39B;THOC1;ZMYND11;TCEA2;SUPT4H1;CCNK;ERCC6;HTATSF1
prerank,regulation of JNK cascade (GO:0046328),-0.34113060301804593,-1.3662467673104892,0.03541315345699832,0.32000866426755725,1.0,35/101,24.93%,MECOM;DAB2IP;IGF1R;MFHAS1;TRAF5;APP;MAP3K5;EGFR;TGFBR3;PLCB1;RASSF2;FLT4;SH3RF1;WNT16;TAOK3;TPD52L1;DUSP3;MAP4K4;TNFRSF19;MTURN;ZMYND11;RAP2A;CCL19;EDAR;NOD2;DUSP22;SH3RF2;PTK2B;LTBR;GADD45A;RIPK1;FZD7;HMGB1;GPS2;AIDA
prerank,DNA conformation change (GO:0071103),-0.5011210100379386,-1.3658832402670837,0.11009174311926606,0.3202861732148501,1.0,8/17,24.66%,KAT6A;TOP3A;ABL1;TOP3B;ERCC3;TOP1MT;TOP1;HMGB1
prerank,regulation of urine volume (GO:0035809),-0.5837092270726709,-1.365749985792339,0.10477941176470588,0.32007149890669395,1.0,7/10,41.33%,ADM;NPR1;HYAL2;HAS2;ADCY6;TFAP2B;NPR3
prerank,regulation of autophagy (GO:0010506),-0.3052570502790072,-1.365739585697502,0.017064846416382253,0.31964094925201425,1.0,70/216,24.66%,ITPR1;FOXO1;MCL1;TAB3;DAPK1;ACER2;SH3BP4;TLK2;GSK3B;MTMR3;ATM;LRRK2;EXOC4;MTOR;PIP4K2A;RASIP1;ABL1;FOXO3;NEDD4;PIP4K2B;IRGM;BNIP3;ERN1;PIK3C2A;PLK2;ROCK1;PRKD1;TBC1D14;DAPL1;GSK3A;HAX1;USP13;AKT1;PRKAA1;TRIM14;RPTOR;VPS26A;MTDH;KAT5;ATP6V1E1;HGF;GPR137B;MAPK8;PIK3CB;DAP;EXOC8;USP10;TAB2;HDAC6;RAB39B;ATP6V0A1;WASHC1;RNF152;DRAM2;PRKAB1;UCHL1;WDR41;ORMDL3;CTSA;KEAP1;MTMR4;ATP6V1H;ATF6;GFAP;TPCN2;FZD5;TRIM68;TRIB3;RHEB;HMGB1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4277034333605508,-1.3654159748797863,0.07192982456140351,0.3198115124482901,1.0,11/31,15.35%,PPP1R13B;GSK3B;YWHAE;YWHAZ;NMT1;GSK3A;CASP8;TP53;MAPK8;BBC3;HIP1R
prerank,histone mRNA metabolic process (GO:0008334),-0.4386383178864144,-1.364889039909762,0.07454545454545454,0.3203629669226301,1.0,9/27,18.08%,TUT7;TENT4B;ATM;XRN1;TUT4;LSM11;TENT2;SNRPE;LSM10
prerank,regulation of muscle cell differentiation (GO:0051147),-0.42473395019485444,-1.3648077825640899,0.08801498127340825,0.32005598461178303,1.0,14/31,23.50%,CTNNA1;MEF2A;BOC;ABL1;MEF2C;CDON;BNIP2;TCF3;MAPK12;CTNNB1;IGF2;SPAG9;MYOCD;MAPK11
prerank,protein-DNA complex disassembly (GO:0032986),-0.5061386392047927,-1.3644678120495557,0.11047619047619048,0.3202790564710071,1.0,5/16,13.91%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5361741532408425,-1.364211241252514,0.1170018281535649,0.3202972881355296,1.0,6/12,20.89%,SORBS1;INSR;IRS1;AKT1;IGF1;IGF2
prerank,limb morphogenesis (GO:0035108),-0.47647765831387706,-1.3638700451951409,0.10196779964221825,0.32052833718264057,1.0,6/20,9.13%,MBNL1;NIPBL;LRP6;TGFB2;GLI3;PCSK5
prerank,endoderm formation (GO:0001706),-0.415152149661421,-1.3636362373816946,0.08,0.3204729292232233,1.0,8/35,5.76%,COL8A1;COL12A1;COL4A2;SETD2;SOX17;MMP2;LAMA3;ITGB5
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5332510840199649,-1.3634401872727828,0.1092896174863388,0.3203873521772667,1.0,5/13,13.52%,GFPT2;GNPDA2;SLC35A3;GNPNAT1;UAP1
prerank,melanosome transport (GO:0032402),0.4690166240723313,1.3630078578091667,0.11136363636363636,0.44678709033602104,1.0,9/18,16.60%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,pigment granule transport (GO:0051904),0.4690166240723313,1.3630078578091667,0.11136363636363636,0.44678709033602104,1.0,9/18,16.60%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,cellular glucan metabolic process (GO:0006073),-0.5612342993258469,-1.3626660051783621,0.12050359712230216,0.3213939494814873,1.0,4/11,13.72%,GBE1;GSK3B;PPP1R3C;PHKB
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3842503131260823,-1.3625820714679138,0.05321100917431193,0.32109386707317866,1.0,27/55,31.23%,DAB2IP;CAV1;PAK2;TNFSF10;FAS;TP53;CRADD;TPD52L1;BCAP31;WWOX;BBC3;BCL2L11;GSDME;RPS3;SIAH1;HYAL2;G0S2;LTBR;BECN1;TRIM39;RIPK1;TNFSF12;TNFRSF12A;TGFBR1;DDIT3;PMAIP1;ING5
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.43762588264565205,-1.362478333253475,0.08247422680412371,0.3208443598613275,1.0,9/26,21.21%,GCH1;NOS1AP;SCARB1;AKT1;S100A1;PIK3CB;TERF2;POR;TERT
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.30977848329635943,-1.362227497208638,0.015332197614991482,0.3208687204759501,1.0,44/182,16.77%,FOXP1;CLDN5;ENG;ACVRL1;RB1;RIN3;KLF4;CD34;ESR1;TNRC6B;SLC7A5;APP;KDR;TIPARP;SMO;ZNF148;HDAC1;NFKB1;TGFB2;PARP14;BMP4;MEF2C;NOTCH2;YAP1;CELF1;PICALM;OCLN;ADAM10;PRKAA1;DICER1;SNX12;PSEN1;NOTCH1;FGF2;APOBEC1;MECP2;AGO2;MIF;ROCK2;LGMN;TERF2;IGF1;MOV10;DNMT1
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.3235721426792286,-1.3620901262066314,0.024305555555555556,0.32067513439719886,1.0,56/144,25.30%,PPP1R13B;UBR5;GSK3B;YWHAE;EMD;MIEF1;GAS6;PIK3R1;TCAF1;HPS4;SEC16B;PRKCD;YWHAZ;CDH1;NMT1;GSK3A;UBE2J2;CASP8;UBE2D3;TP53;FLNA;PSEN1;BCAS3;ICE1;MTCL1;MIEF2;CHP1;ZPR1;MAPK8;BBC3;TPR;UBE2L3;FYN;RIPOR1;XPO4;MAVS;PCM1;ZIC1;OAZ2;HYAL2;BAP1;NPEPPS;TCF7L2;PPP3CC;HUWE1;TRIM28;VAMP2;ITGAM;PCNT;SAR1A;CEP131;FZD5;TFDP1;SAE1;RAPGEF3;PLK3
prerank,modulation by host of symbiont process (GO:0051851),-0.4301381704848552,-1.3607344382429405,0.07532956685499058,0.3228152777672112,1.0,7/31,9.48%,LEF1;CHD1;SP1;HDAC1;NAPEPLD;JUN;TAF11
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5370304944416743,1.359561978650244,0.12581344902386118,0.45336446368807964,1.0,4/12,8.11%,TMEM9;CLN3;GRN;CCDC115
prerank,muscle cell migration (GO:0014812),-0.5727568623654996,-1.359009805073806,0.10124333925399645,0.32562779392970875,1.0,6/10,25.21%,SIX1;ROCK1;CCN3;PLAT;ITGB3;THBS4
prerank,nucleosome disassembly (GO:0006337),-0.520065103856358,-1.3582238217149005,0.13051823416506717,0.3262283876691907,1.0,5/14,13.91%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3
prerank,chromatin disassembly (GO:0031498),-0.520065103856358,-1.3582238217149005,0.13051823416506717,0.3262283876691907,1.0,5/14,13.91%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3
prerank,histone H3-K9 demethylation (GO:0033169),-0.5690355714956326,-1.3581640444980851,0.1268939393939394,0.32590207044583536,1.0,7/11,31.74%,KDM3A;JMJD1C;HR;KDM7A;KDM3B;KDM4D;KDM4A
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.44570744305556786,-1.3581041404945386,0.0829103214890017,0.32556962788019117,1.0,6/25,7.91%,CAV1;FAM20A;CNNM2;TMTC2;TRPM7;CNNM4
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.36061941336824843,-1.3572234721913048,0.04655493482309125,0.32682396224801,1.0,14/70,11.47%,DAB2IP;MCL1;GSK3B;DDX3X;IL6R;TNFRSF1B;FAS;TGFB2;NGF;GSK3A;CASP8;CRADD;GABARAP;JAK2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3910042578628928,-1.3569383083753523,0.06725663716814159,0.3269326327346406,1.0,16/46,18.28%,ANXA2;JAK1;PAK2;MSN;PDCD4;PLCB1;TCP1;PSME2;RAP1B;JAK2;HNRNPF;LCP1;TALDO1;MIF;SOD1;CFL1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.31875726778010965,-1.3568832086605511,0.022058823529411766,0.3265704039114816,1.0,47/151,22.10%,SGMS1;CERT1;ST3GAL4;ALAS1;ACER2;DEGS2;SGMS2;PLA2G4A;PRKD3;PRKD2;GSTT1;SPNS2;LPCAT1;ELOVL5;CERS4;GCH1;PPM1L;PAM;SLC44A1;PRKD1;STARD7;ST3GAL2;PCSK5;MFSD2A;GSTM2;ACER3;TYW1;MOCS2;B4GALT5;SPTLC1;GAL3ST2;CEPT1;CERS5;PCTP;ESD;VAPA;GOLPH3;HPGDS;LARGE1;DEGS1;ELOVL7;CDO1;LPIN2;GSTO2;LPCAT3;LCAT;MOCS3
prerank,intracellular pH reduction (GO:0051452),0.4058467300850054,1.3568676438412255,0.0967741935483871,0.4580746628085489,1.0,12/33,19.06%,TMEM9;ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V1G2;DMXL2;RAB39A;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.466827115157237,-1.3565276843527219,0.09461966604823747,0.3267734643403172,1.0,8/21,18.01%,MYH9;ADAM9;PSEN2;SPPL3;ADAM10;PSEN1;APH1A;ERAP1
prerank,neuromuscular process (GO:0050905),0.4855153887015131,1.3560198053177845,0.1074561403508772,0.4581062570489213,1.0,4/16,6.17%,NRXN1;SHANK1;CLN3;PRRT2
prerank,embryonic digestive tract development (GO:0048566),-0.4899400552606933,-1.355882355461008,0.09532374100719425,0.3275883377633844,1.0,9/18,26.96%,NIPBL;TGFB2;GLI3;PCSK5;PKDCC;RARB;FOXF1;RBPMS2;STRA6
prerank,protein localization to membrane (GO:0072657),0.3021879142096559,1.3557788619021078,0.012345679012345678,0.4567491296491281,1.0,37/187,11.34%,KCNIP4;NRXN1;MAGI2;NLGN1;ABCA12;DLG2;LRRC7;DPP10;MAP7;ANK3;DPP6;CYP46A1;ANK1;RAB15;EPB41L3;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CPE;CACNB3;WNK3;CD81;MYO5A;HGS;ARL3;ZFYVE27;SPTBN4;TESC;C2CD5;RAB3A;LIN7C;TSPAN32;PPIL2;NKD2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3983240073314558,-1.3554666258283612,0.0846286701208981,0.3279114052263401,1.0,17/42,25.60%,SMARCA2;ARID1B;HDAC1;SMARCC1;SRCAP;SMARCE1;SPTY2D1;CECR2;SMARCC2;CHD3;ACTB;INO80B;VPS72;SMARCAD1;SMARCB1;INO80;ERCC6
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4602884645915809,1.3552908948637092,0.1111111111111111,0.4558902462022447,1.0,5/20,9.78%,AKR1D1;CYP46A1;AKR1C1;TSPOAP1;CYP11B1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3889902849628393,-1.3548614472165899,0.06980802792321117,0.32864593816700716,1.0,12/43,9.17%,ZHX3;FERMT2;LRP5;BMPR2;IL6ST;BMP6;IL6R;BMP4;MEF2C;PRKD1;YAP1;ACVR2A
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.3069286179417888,-1.3547894394871796,0.013675213675213675,0.32834639278518435,1.0,65/190,23.63%,DAB2IP;ITPR1;CAV1;MCL1;CD2AP;ESR1;LYN;UACA;SH3BP4;THBS1;TMSB4X;CGNL1;WWC2;DDX3X;PTPRJ;VGLL4;PDE3A;LIMD1;PPARA;PPEF2;NMI;PDE2A;SLIT2;DDIT4;STAMBP;GSK3A;PPM1B;CASP8;AKT1;UBR2;THEM4;PRKAA1;PEBP1;DUSP3;PIK3CB;PIK3IP1;TRIM59;TNFAIP3;IFI35;CCN3;ABCA7;USP10;C1QTNF3;BMP7;MARK3;ARHGAP12;PPIF;ZMYND11;WTIP;UBR1;HYAL2;EPHA2;TMEM127;PTEN;HERPUD1;AKT1S1;NF1;MDM2;HDAC7;MAP2K3;PHLDA3;RELA;TRIM39;RIPK1;AJUBA
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3074614814464724,-1.3546993493169686,0.015957446808510637,0.3280615457052597,1.0,43/173,17.73%,SPTBN1;SPTAN1;SEC31A;SEC24B;VTI1A;COG5;CTSC;COG1;TRAPPC3;ARCN1;RAB1A;PROS1;RAB2A;IER3IP1;GAS6;SEC24A;ATL2;CUL3;SEC16B;CD55;SEC24D;KLHL12;SEC13;COPG1;SCFD1;BET1L;KDELR3;BCAP31;COPA;DCTN1;DCTN3;COPE;TRAPPC12;ERGIC2;USE1;CTSZ;TBC1D20;F5;TFG;LMAN2;TMED5;VAPA;CAPZB
prerank,response to prostaglandin E (GO:0034695),-0.5704117655788173,-1.3524489809899958,0.11347517730496454,0.3320348651780978,1.0,5/10,26.88%,GNB1;TGFBR3;CCL19;GNG2;ADCY6
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5611599784015042,-1.3520560028848099,0.13711151736745886,0.3323375723911335,1.0,5/10,31.29%,ACADL;ACAD11;ACADVL;IVD;ACADS
prerank,plasma membrane invagination (GO:0099024),-0.4297581972467942,-1.351227305626561,0.08411214953271028,0.3334464568662318,1.0,11/29,24.25%,GULP1;DOCK1;MYH9;ELMO1;SNX9;RHOA;ARHGAP12;ITGAM;FCGR1A;ALKBH4;SNX18
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3532109550950128,-1.351153550613833,0.059931506849315065,0.33312172160845016,1.0,25/79,20.11%,DAB2IP;BMPER;CRIM1;BMPR2;SMURF2;THBS1;PTPN1;SMURF1;SLIT2;NEDD4;SKIL;SMAD1;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1;FGF2;SPRY4;SMAD6;SKI;HTRA3;SMAD9;DAND5;PPARG
prerank,cellular response to starvation (GO:0009267),-0.3185085335036398,-1.351153549549043,0.034050179211469536,0.33267033716182626,1.0,43/147,19.30%,FOXO1;BMPR2;SESN1;MTMR3;ATG7;SIK1;LRRK2;MAP3K5;MTOR;MAP1LC3B;PPARA;STK24;FOXO3;FAS;SEC13;MAPK1;MIOS;PRKD1;DAPL1;MFSD2A;TP53;KLF10;PRKAA1;WIPI1;GABARAP;RPTOR;ATP6V1E1;LARS1;KPTN;MAPK8;ATF4;ZFYVE1;HNRNPA1;DAP;NUAK1;ATG5;CASTOR1;GCN1;RIPOR1;LAMP2;WRN;RNF152;ITFG2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.5438523231751554,-1.3511034853910275,0.10909090909090909,0.33232515751684905,1.0,9/12,32.19%,TP53;RFWD3;SDE2;RPA2;CCND1;PRKDC;PLK3;FBXO31;RPS27L
prerank,steroid catabolic process (GO:0006706),0.5493502788415928,1.350622276886222,0.13901345291479822,0.46560753585894,1.0,3/10,13.06%,CYP24A1;HSD17B14;SPP1
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.4354457129527428,-1.3503928477202867,0.08719851576994433,0.3333644725203707,1.0,6/26,9.03%,ST3GAL6;ST3GAL4;ST3GAL1;B3GNT2;B4GALT4;ST3GAL2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.564381668337329,-1.350229633882345,0.11458333333333333,0.3332304038450895,1.0,7/11,36.17%,CBFB;VSIR;HMGB1;LGALS9;RUNX1;TWSG1;CD274
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2813899230141046,-1.3500556761185718,0.004807692307692308,0.33313097809254383,1.0,115/423,23.40%,FOXP1;FLT1;TJP1;LEF1;GRK5;PRKCH;IGF1R;KITLG;OSMR;CLDN5;INSR;LRP5;LYN;ACER2;PDGFD;THBS1;CDK13;GCNT2;BMP5;TBX1;IL15;KDR;EGFR;IL6ST;TGFBR3;TRPM4;TGFBR2;BMP6;HDAC1;IL6R;HES1;GAS6;IRS1;STX3;IL34;CUL3;DNAJA2;TGFB2;PTK2;AQP11;FGF1;BMP4;STAMBP;MEF2C;TBX2;YAP1;NOP2;FLT4;NES;LIFR;NAMPT;ADAM10;FGF7;AKT1;MAP3K3;VEGFC;EDN1;DOT1L;PTGFR;MAZ;EDN3;ACER3;NOTCH1;FGF2;HDAC4;SAAL1;CDC123;ASH2L;RHOG;CDK6;RPS4X;MECP2;FAM98A;COPS9;MIF;GAB2;LGMN;IGF1;SRPK2;COX17;RARA;CTSH;CACUL1;CLCF1;TNFSF13;TBC1D8;NOD2;SOX4;PTPRC;TCF7L2;KRAS;PTEN;LIG4;FGFR4;PRC1;IL13RA1;IGF2;LAMB1;DLL4;TERT;MDM2;NACC1;S1PR3;PDGFRB;LAMC2;PTK2B;TTK;CCN1;RELA;PTN;ESM1;TBX3;HPSE;HAS2;CEP131
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.4061921054072203,-1.3499807847988203,0.08047945205479452,0.33281956041715266,1.0,12/38,18.16%,ANKRD17;BMP6;NMI;PUM1;AKIRIN2;DDX60;USP15;PLSCR1;POLR3F;IFI35;GBP5;SASH1
prerank,positive regulation of nervous system process (GO:0031646),0.47748119174648496,1.3499002394167496,0.1291759465478842,0.4652075890762469,1.0,5/18,2.82%,TENM4;MYRF;RIMS2;RIMS1;CARTPT
prerank,smooth muscle contraction (GO:0006939),-0.5200062347475704,-1.3492380582647032,0.10657193605683836,0.3338714273538883,1.0,9/14,23.84%,EDNRA;MYH11;PIK3C2A;ACTA2;ROCK1;MYLK;ROCK2;SMTN;TPCN2
prerank,sulfation (GO:0051923),0.551758500242173,1.348970380692478,0.12121212121212122,0.4654671443106948,1.0,2/11,4.15%,HS3ST5;SULT2B1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.4233964680411353,-1.348790359628694,0.09323583180987204,0.33427003671410727,1.0,10/29,20.17%,DAB2IP;IL17RD;BMP5;SPRED2;LDLRAD4;SMAD7;FUZ;MAD2L2;PPP2CA;PTEN
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3140394681248349,-1.348561791940625,0.032467532467532464,0.3343078462980013,1.0,33/149,18.97%,PRKCH;EDA;ERC1;ROR1;CAV1;TAB3;NOD1;TRAF5;TRIM25;APP;RPS6KA5;PRKD2;SLCO3A1;TFRC;NFKB1;NFKBIA;ZBTB7A;PRKD1;ARHGEF2;CFLAR;RNF25;TRIM14;IRAK1;MTDH;FLOT1;CD40;TAB2;TRIM13;IRAK2;RPS3;IKBKG;IKBKB;NOD2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4739841589457333,-1.348550219287409,0.08752327746741155,0.33388074362128584,1.0,8/20,23.26%,ENTPD1;APP;NT5E;TXNIP;ANO6;PSTPIP1;TXN;CASP1
prerank,protein-containing complex subunit organization (GO:0043933),-0.33504121783096813,-1.3479252475924544,0.04569420035149385,0.3345531950100313,1.0,38/109,23.77%,SLC2A1;PARD3;MNAT1;CREBBP;CD2AP;RANBP9;TEAD1;MITF;HES1;FAS;KPNA3;NUP98;SNX9;WASL;YAP1;AFG3L2;PICALM;DET1;OCLN;TP53;HFE;CD40;PEX14;TPR;TUBGCP4;TFAP4;FANCC;IKBKG;VAMP3;WASF1;MDN1;MAGI1;MDM2;VAMP2;PTK2B;PPIH;NDUFAF1;CD247
prerank,regulation of calcium ion transport (GO:0051924),0.36317883908859977,1.347877351491321,0.06338028169014084,0.4660437805804566,1.0,15/54,12.82%,STC1;CACNA2D1;BCL2;EFHB;WNK3;CACNA1D;CAMK2B;HOMER1;PLPP4;ADRA2A;LILRA5;SRI;HRC;CCL5;CASQ1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.3747123288859058,-1.3469002672661885,0.08035714285714286,0.33614250026848,1.0,25/58,25.60%,ATM;UIMC1;KDM2A;SMC5;ZBTB7A;XRCC4;MRE11;NSMCE2;KAT5;BABAM2;NHEJ1;RNF168;UBE2V2;ERCC8;HERC2;SUMO1;BRCC3;PRKDC;PIAS4;LIG4;BRCA1;DCLRE1B;HMGB1;DCLRE1A;ERCC6
prerank,activation of GTPase activity (GO:0090630),-0.3441860828750266,-1.3468781125569853,0.05025125628140704,0.33573840091440876,1.0,33/89,22.98%,TBC1D4;BCR;RALGAPA1;CORO1C;TBC1D1;TBC1D2B;ARHGEF15;TBC1D8B;USP6NL;SIPA1L3;TBC1D30;TBC1D14;MTSS2;TBC1D22B;TBC1D22A;BCAS3;SLC27A4;TAX1BP3;ARHGEF10;RHOG;ARHGAP22;ABR;ARHGAP29;TBC1D8;EPHA2;TBC1D17;TBC1D25;ARHGAP42;ARHGEF5;SYDE1;TBC1D12;EVI5;PIP5K1A
prerank,negative regulation of cellular senescence (GO:2000773),-0.5223487453025217,-1.3467625395467513,0.1322463768115942,0.33554537619267755,1.0,6/13,21.21%,SLC30A10;AKT3;MAP3K3;CDK6;TERF2;TERT
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4250174117966764,1.3459253490853051,0.10816777041942605,0.46890127875632953,1.0,7/27,7.22%,IL1RAPL1;CTNNA2;CCDC88A;NTNG2;NTNG1;NCS1;HOMER1
prerank,response to estradiol (GO:0032355),-0.4210671437092455,-1.345650689949969,0.10674157303370786,0.33735703637135606,1.0,10/31,17.12%,ESR1;NRIP1;EGFR;STRN3;GGT5;SOCS2;KAT5;RUVBL2;ANXA1;CTNNB1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.37531503649168424,-1.3451735783443388,0.06172839506172839,0.33782109954432815,1.0,22/54,24.96%,NXN;DCUN1D3;CAV1;IVNS1ABP;AKT1;SMAD7;SPOPL;CHP1;COPS9;TNFAIP3;N4BP1;RPL5;SENP2;CTNNB1;RPS3;SOX4;OGT;SH3RF2;ARRB1;HSPA1B;PINX1;ADGRB1
prerank,protein ADP-ribosylation (GO:0006471),-0.44247522661269084,-1.3450491958236355,0.08517887563884156,0.33764294860402255,1.0,12/28,26.17%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;HPF1;ART3;PARP16;PARP6;PARP9
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.5566700079846187,-1.344164065759454,0.12982456140350876,0.3389375782286589,1.0,10/11,43.71%,TENT4B;EXOSC2;EXOSC3;PARN;EXOSC5;LARP7;EXOSC4;FBL;FBLL1;DKC1
prerank,urogenital system development (GO:0001655),0.5235146955826744,1.344144339456299,0.14864864864864866,0.47134604632656896,1.0,3/11,6.07%,LHX1;OSR1;PAX2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5156752418166143,1.3439636472663241,0.11777301927194861,0.4697201882278106,1.0,4/12,10.48%,ATIC;PAICS;ADSS2;ADSS1
prerank,negative regulation of gene expression (GO:0010629),-0.290013443006695,-1.3438904603436996,0.011363636363636364,0.3389670313536648,1.0,99/302,27.43%,FOXP1;CLDN5;ENG;ACVRL1;RB1;KLF4;CD34;DAPK1;ESR1;TNRC6B;SLC7A5;APP;KAT2B;RPS6KA5;RNF139;DDX3X;KDR;SRGN;TIPARP;SMO;GIGYF2;ZNF148;HDAC1;LARP1;NFKB1;TGFB2;SUZ12;PARP14;BMP4;ERN1;MEF2C;SAMD4A;NOTCH2;YAP1;CELF1;PICALM;OCLN;ADAM10;TASOR;PRKAA1;DICER1;RGCC;SNX12;PSEN1;NOTCH1;FGF2;ASB1;MECP2;AGO2;H3-3A;IGFBP5;N4BP1;SYNCRIP;BTG2;MIF;ROCK2;LGMN;TERF2;IGF1;MOV10;DNMT1;PPHLN1;HEY2;RPS3;CITED2;NUDT12;GATA2;PPM1D;TNRC6A;CAPRIN1;WWP2;PTBP3;TOB1;DLL4;TERT;DIS3L2;METTL16;NDFIP2;YY1;RPL13A;MRPL13;EIF2AK3;AEBP2;HSPA1B;SETDB2;BMP2;DIP2A;FXR1;IGF2BP2;CNOT8;PARP9;RPS26;DXO;EMILIN1;NANOS1;LGALS9;CNOT1;SLC24A3;TRIM6
prerank,protein autoprocessing (GO:0016540),0.48531690927128796,1.3434041583151666,0.11564625850340136,0.46902728120535986,1.0,5/17,16.86%,OMA1;MYRF;KLK6;HTRA2;CASP4
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.35156024411803255,-1.3427963306373576,0.050966608084358524,0.34062275607920045,1.0,26/70,22.47%,TEK;RB1;FERMT2;PARVB;RAC1;PARVA;NTN4;PXN;PIK3R1;MEF2C;SIPA1L3;ILK;RHOA;LAMA5;ACTN1;LAMC3;ITGA4;ATF4;ATRNL1;VAMP3;EPHA2;FERMT3;ITGB3;LAMB1;USH2A;EPHB3
prerank,positive regulation of nuclear division (GO:0051785),-0.4414583565807587,-1.3424624773884282,0.09345794392523364,0.3407807842306502,1.0,13/25,35.49%,INSR;LRP5;EDN1;RGCC;EDN3;IGF1;IGF2;PDGFRB;BTC;AURKA;PHIP;IL1A;DRD3
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4710783437599063,-1.3421029842077148,0.11599297012302284,0.3410138018342283,1.0,7/21,15.43%,RBPMS;DAB2;BMP6;BMP4;SMAD4;JAK2;CCN3
prerank,ameboidal-type cell migration (GO:0001667),-0.3765811571813494,-1.3413246064817492,0.08633093525179857,0.34215657990185383,1.0,22/51,21.39%,SEMA6A;SEMA3C;CORO1C;SEMA7A;TBX1;PHACTR4;PDLIM1;AKT1;SEMA3G;SEMA6B;SEMA4C;PDXDC1;ITGA4;PKN2;PKN3;CCN3;SEMA5B;SEMA4A;SEMA3E;GPC3;SEMA4G;AMOTL2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5150364842632713,-1.3413066521861166,0.13457943925233645,0.34174540495850986,1.0,4/14,10.54%,ZEB1;CAV1;SPRED2;NOTCH4
prerank,mesonephric tubule development (GO:0072164),0.4859085701161855,1.3410177123072344,0.1297539149888143,0.473019445758364,1.0,6/15,7.53%,ROBO2;LHX1;NPNT;OSR1;WT1;FGFR2
prerank,GPI anchor metabolic process (GO:0006505),0.4315550905119301,1.3408406402129351,0.1004566210045662,0.4714773638616912,1.0,7/26,12.14%,PGAP1;DPM1;PIGP;MPPE1;PIGB;PGAP3;GPLD1
prerank,regulation of hormone secretion (GO:0046883),-0.5078646434473364,-1.3407285106419604,0.12252252252252252,0.34244692226820694,1.0,9/15,38.27%,EDN1;EDN3;ANXA1;VAMP3;VAMP2;NMB;IL11;LIF;SNX6
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5645991233913712,-1.3406625636771037,0.13660245183887915,0.3421331248482524,1.0,4/11,9.60%,PELI1;BIRC3;ARHGEF2;CASP8
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.5264181283931445,-1.340631793040989,0.14010507880910683,0.3417435717984624,1.0,6/12,20.77%,SRR;MTHFD1;SERINC3;SERINC5;SEPHS2;CTH
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.29895753341439946,-1.3403533868623967,0.020168067226890758,0.3418288620067098,1.0,62/214,22.42%,TEK;DAB2IP;RAPGEF2;SEMA6A;FERMT2;ROR1;BMPER;MFHAS1;LYN;PDGFD;SEMA7A;GCNT2;PTPN1;APP;RANBP9;SPRED2;CCL25;KDR;ICAM1;PRKD2;EGFR;TGFBR3;SLC30A10;GAS6;DLG1;DSTYK;RAP1A;EZR;NOTCH2;YWHAZ;FLT4;SMAD4;RRAS;HTR2A;BRAF;TIMP3;NOTCH1;FGF2;CNKSR3;CEACAM1;DUSP3;ACKR3;P2RY6;MIF;ABCA7;TNFAIP8L3;MTURN;ANGPT1;CCL19;NOD2;EPHA2;PTPRC;PTEN;FGFR4;ARHGEF5;PTPN11;P2RY1;ROR2;PDGFRB;PTK2B;APIP;CCN1
prerank,regulation of cell development (GO:0060284),-0.41029152078055625,-1.3398842596448182,0.09523809523809523,0.3423605698087265,1.0,9/36,17.95%,FOXO1;ADGRA2;HES1;NOTCH2;YAP1;AKT1;CTNNB1;HEY1;HEY2
prerank,plasma membrane repair (GO:0001778),-0.5223719184288853,-1.3398440307942692,0.11270125223613596,0.34198716776843135,1.0,4/13,6.64%,MYOF;MYH9;DYSF;AHNAK2
prerank,endomembrane system organization (GO:0010256),-0.3085392007657409,-1.3396019295925905,0.0297723292469352,0.3419525721077413,1.0,47/178,18.82%,SPTBN1;ATP8B1;SEC31A;MYOF;DNAJC13;CSNK1A1;COG1;DYM;TMCC1;A4GALT;LRRK2;SYNE1;RAB1A;SRGN;GOLPH3L;RAB2A;DYSF;ATL2;TOR1B;SEC16B;ALS2CL;MYO18A;USP6NL;PRKD1;REEP3;CUL7;FBXW8;GAK;BCAS3;ARFGEF1;FAM174B;CSNK1D;CHMP2B;TRAPPC12;EXOC8;PI4K2B;TBC1D20;SUN1;TLCD1;LMAN2;ALS2;TMED5;VAPA;GOLPH3;WASHC4;TJAP1;AKTIP
prerank,substrate-dependent cell migration (GO:0006929),-0.5206829451387622,-1.3392628631903465,0.10695187165775401,0.34211653387128643,1.0,6/14,19.32%,ANKS1A;CD2AP;NTN1;VEGFC;ITGA2;PTPRC
prerank,regulation of cellular senescence (GO:2000772),-0.43039863552451224,-1.338817640340389,0.09769094138543517,0.3425608668331256,1.0,10/28,15.96%,NEK6;SLC30A10;AKT3;YPEL3;MAP3K3;ABI3;CDK6;CGAS;NUAK1;TERF2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4244116119909521,1.3387800346044048,0.10849056603773585,0.47464632694470005,1.0,7/29,13.72%,SYCP1;MAJIN;ZCWPW1;REC8;SYCP2;RAD21;SIRT7
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.43672066270134763,-1.3384262705180239,0.10326086956521739,0.34292816534365744,1.0,10/25,24.52%,ETS1;FOXO3;MED1;ABCB10;ACVR2A;TAL1;ARNT;PRKDC;MAPK11;HSPA1B
prerank,cellular response to gamma radiation (GO:0071480),-0.4806294938036887,-1.3384168780739532,0.11313868613138686,0.3425053749641417,1.0,6/17,10.11%,MAP3K20;TLK2;ATM;YAP1;RPL26;TP53
prerank,negative regulation of cellular protein localization (GO:1903828),-0.4045254365804668,-1.3383399506413618,0.0931098696461825,0.34218898005290604,1.0,10/34,15.35%,CTNNA1;MFHAS1;NEDD4L;GSK3B;PICALM;LATS2;SIN3A;TAX1BP3;ILRUN;ROCK2
prerank,steroid biosynthetic process (GO:0006694),0.3546227656642752,1.3378120147999595,0.0735632183908046,0.47502554293632987,1.0,12/56,13.40%,AKR1D1;CYP46A1;INSIG1;LSS;CYP51A1;SC5D;OSBPL6;SQLE;CYP27A1;CYP11B1;FDFT1;OSBPL9
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.3959450952461115,-1.3374842352732565,0.06260869565217392,0.3433637953718382,1.0,15/42,14.15%,RSU1;RAC1;LIMS1;CORO1C;GCNT2;VIT;FZD4;PTK2;PPM1F;FBLN2;JAK2;NOTCH1;RHOA;ATXN3;PIK3CB
prerank,negative regulation of cell population proliferation (GO:0008285),-0.28541357409128315,-1.3374784818439713,0.009508716323296355,0.342930591859611,1.0,113/351,25.03%,DAB2IP;SMARCA2;IGFBP7;RAPGEF2;ACVRL1;NOS3;PTPN14;KLF4;ETS1;ABI1;PKD2;CBFA2T3;LYN;BMPR2;PDS5B;CD200;SH3BP4;BTG3;APP;MCC;KAT2B;BMP5;RNF139;ITGA1;ARID2;P3H2;THAP12;PTPRJ;EMD;CDKN1B;TGFBR3;VGLL4;CTCF;HES1;RARG;RBM5;NMI;TGFB2;RBP4;AQP11;BMP4;PTPRK;CDK10;NGF;RAF1;IRF1;CELF1;CTBP2;TP53;FRK;KLF10;AXIN2;NCK2;RGCC;LMNA;SOX7;JAK2;ZBTB7C;NOTCH1;CDC73;CDK6;TBRG1;NUDT6;TNFAIP3;IFI35;IGFBP5;BTG2;CCN3;FUZ;SMAD6;FOXO4;RERG;SKI;GSDME;NOX4;CTNNB1;TFAP4;ADARB1;TNS2;ADGRG1;TES;GATA2;BAP1;PPM1D;SOX4;TMEM127;CTNNBIP1;PPARG;PTEN;NF1;TOB1;DLL4;WARS1;CDKN2C;ROR2;DIS3L2;PTK2B;MYOCD;TBX3;SFRP4;COPS8;CEBPA;CYP1B1;ATF5;E2F7;HSPA1B;E2F3;TFDP1;PINX1;PLXNB1;ADGRB1;BMP2;PLPP1
prerank,positive regulation of defense response (GO:0031349),-0.34360922770488345,-1.3372556016161954,0.06357388316151202,0.34291644379370434,1.0,30/89,28.25%,ETS1;APP;IL15;NFKBIA;NMI;PDE2A;PDCD4;MEF2C;NAPEPLD;AKIRIN2;FEM1A;AGTR1;LPL;IL17RA;PLSCR1;POLR3F;IFI35;IL16;TNFRSF1A;GBP5;HYAL2;GPR4;SERPINE1;RIPK1;CEBPA;DDT;DHX9;TNIP1;GPSM3;RIOK3
prerank,positive regulation of transport (GO:0051050),-0.3402907277113765,-1.3371215623825383,0.05776173285198556,0.3427451929244508,1.0,22/85,20.09%,DAB2;NEDD4L;CBLL1;GSK3B;ANXA2;RXRA;IL15;MERTK;GAS6;RAB27A;GSK3A;ACTB;FLOT1;CHP1;HIP1R;ABCA7;ANXA1;LMAN2;TULP1;CCL19;GATA2;GPC3
prerank,mitochondrial genome maintenance (GO:0000002),-0.5485371722719767,-1.3370043877024642,0.12522045855379188,0.3425335132153379,1.0,3/11,8.59%,MEF2A;TOP3A;AKT3
prerank,regulation of cytoskeleton organization (GO:0051493),-0.32900083250183354,-1.3361267366915928,0.04448398576512456,0.3438309588751171,1.0,32/108,15.35%,TJP1;RAC1;RHOBTB1;GSK3B;IQGAP1;F11R;RND3;CRK;PAK2;DIAPH1;MTOR;RICTOR;ABL1;RHOQ;PTK2;PRKCD;CDK10;EZR;MAPK1;ROCK1;FAM107A;ARHGAP17;CAPN2;PRKAA1;RHOA;RHOC;RHOG;TRAF3IP1;SORBS3;MARK2;HIP1R;ROCK2
prerank,actin filament bundle organization (GO:0061572),-0.41215673594150154,-1.3360985738129847,0.1070110701107011,0.3434374365193963,1.0,10/33,13.20%,LIMA1;EPS8;BAIAP2L1;PLS3;EZR;SHROOM1;FAM107A;SHROOM2;LCP1;NEDD9
prerank,mammary gland development (GO:0030879),0.4476841251883803,1.3359194225824802,0.10779816513761468,0.4776185992310252,1.0,3/21,1.29%,NRG1;ERBB4;WNT7B
prerank,response to glucocorticoid (GO:0051384),-0.43860270009592667,-1.3357404423761887,0.11070780399274047,0.34371585708030505,1.0,10/26,27.56%,NR3C1;ADAM9;SLIT2;FAM107A;UBE2L3;BCL2L11;ANXA1;PDCD7;ZFP36L1;HNRNPU
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.33959514823420045,-1.335519539988472,0.059027777777777776,0.3437138245996956,1.0,38/93,25.77%,NSD1;CAV1;APP;PRKD2;EGFR;TFRC;GAS6;NCK1;DDIT4;IRGM;RASSF2;NGF;PPM1F;PRKD1;RAF1;HAX1;AKT1;NCK2;FNIP2;BRAF;SMAD7;RPTOR;CNKSR3;MTCP1;MIF;MAD2L2;CREBL2;HDAC6;TXN;PTEN;CAPRIN2;NOS1;HSP90AA1;AKAP9;SH2D3C;INPP5J;RAPGEF3;DMTN
prerank,cellular copper ion homeostasis (GO:0006878),-0.50228764406481,-1.3350286025585012,0.13711151736745886,0.3442332052629367,1.0,3/14,4.50%,APP;ATOX1;SLC31A1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5421011719549809,-1.3343390946378328,0.13211009174311927,0.34515357947086145,1.0,2/12,0.62%,DAB2IP;SEMA6A
prerank,stress-activated MAPK cascade (GO:0051403),-0.36030433051919136,-1.3341482854391276,0.06294964028776978,0.3451335214098592,1.0,25/61,27.01%,MAP3K20;TAB3;NOD1;MAP3K5;MAP4K3;NFKB1;MAPK1;IRAK1;FBXW11;MAP3K8;MAPK8;TNFRSF19;MAP2K4;TAB2;IRAK2;IKBKG;IKBKB;NOD2;MAP2K3;MAPK11;SH2D3C;MAP3K7;GPS2;ZFP36L1;LGALS9
prerank,cellular metal ion homeostasis (GO:0006875),0.32216268100365136,1.3338348420036124,0.03773584905660377,0.4806777145126499,1.0,19/102,12.59%,SLC24A4;SLC24A2;HTR2C;KCNMA1;ATP1A2;STC1;ATP12A;ATP2B4;ATP2B2;ATP1B1;SLC8A2;RYR2;TMCO1;ATP4A;CCL13;ATP13A2;SLC8A3;SLC8A1;CCL5
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.3111516254214265,-1.3331512634889255,0.03664921465968586,0.3467429653858105,1.0,44/150,20.79%,DAB2IP;PARD3;ENG;RB1;CAV1;LYN;CORO1C;CEP85;PAK2;SPRED2;LRRK2;NIBAN1;RTRAF;LDLRAD4;NCK1;PPEF2;LRP6;SLIT2;DDIT4;PRKCD;RASSF2;PPM1F;PRKRIP1;OCLN;AKT1;NCK2;SMAD7;CNKSR3;CEACAM1;PTPN13;CHP1;TRAF3IP1;DNAJC10;SMAD6;TAF7;UBASH3B;CDK5RAP3;PMEPA1;PTPRC;PRKDC;PTEN;SNX25;AKT1S1;NF1
prerank,positive regulation of cellular process (GO:0048522),-0.2718154808866209,-1.3329180353321934,0.0,0.34679689394718083,1.0,157/565,23.43%,FLT1;TJP1;LEF1;GRK5;IGF1R;KITLG;OSMR;SLC6A6;CLDN5;PARD3;INSR;ETS1;CAV1;RAC1;LRP5;LYN;ACER2;ANKRD17;ZFHX3;PDGFD;THBS1;CDK13;GCNT2;BMP5;ATM;TBX1;IL15;DDX3X;KDR;PRKD2;MERTK;PTPRJ;EGFR;IL6ST;CDKN1B;SMC5;TRPM4;TGFBR2;BMP6;HDAC1;IL6R;HES1;TNFRSF1B;GAS6;IRS1;STX3;IL34;CUL3;DNAJA2;LRP6;TGFB2;PTK2;PRKCD;LBP;AQP11;FGF1;BMP4;STAMBP;TGM2;TBX2;RAB27A;EPHA4;NOP2;FLT4;EXOSC2;LIFR;CELF1;MFSD2A;NAMPT;ADAM10;FGF7;TAL1;ACACB;AKT1;VEGFC;EDN1;DOT1L;AXIN2;PRKAA1;PTGFR;DICER1;LMNA;MAZ;EDN3;ACER3;FRMD5;RPTOR;NOTCH1;FGF2;RAD18;RPS6KA1;HDAC4;PA2G4;TPM1;CDC123;ACTN4;FLOT1;ASH2L;RHOG;MAPK8;RPS4X;MECP2;RPS6KA3;FAM98A;COPS9;HCFC1;H3-3A;AGPAT1;GAB2;N6AMT1;ABCA7;LGMN;IGF1;TRIM13;SRPK2;COX17;TRPC3;RARA;CTSH;LMAN2;TULP1;ADGRG1;CACUL1;RAD23A;CLCF1;TNFSF13;CITED2;TBC1D8;RNF10;GATA2;SOX4;CCND1;BRAT1;KRAS;CXCL12;PTEN;NSMCE4A;FGFR4;PRC1;IL13RA1;IGF2;MDM2;NACC1;S1PR3;PDGFRB;CHEK1;LAMC2;PTK2B;TTK;RELA;PTN;ESM1;MTPN;TBX3;HAS2;CEP131;FZD7
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.30179498761528134,-1.3328576718220226,0.02564102564102564,0.34646654953669637,1.0,45/199,17.95%,PTPRG;DAB2IP;KLF7;NFIB;ZNF423;RB1;NOS3;BMPR2;IL17RD;CORO1C;GSK3B;MCC;BMP5;RPS6KA5;WWC2;ID1;SPRED2;IL15;SRGN;EGFR;LDLRAD4;LAMA4;GAS6;NOVA2;BMP4;MEF2C;RAB11FIP3;ROCK1;GSK3A;ADAMTS5;RGCC;SMAD7;ADM;NOTCH1;WNT11;ASB1;ATF4;N4BP1;ROCK2;SMAD6;MAD2L2;PCTP;PAEP;HEY1;HEY2
prerank,negative regulation of synaptic transmission (GO:0050805),0.44611905010656216,1.332574454362747,0.11818181818181818,0.48177897655808316,1.0,6/23,11.23%,SLC24A2;SYT11;MTMR2;ATAD1;CBLN1;PRRT1
prerank,mitochondrion localization (GO:0051646),-0.47780858228230505,-1.3323098588271742,0.12825278810408922,0.34708488178224034,1.0,4/19,3.71%,MEF2A;TRAK1;MARK1;LRRK2
prerank,transcription preinitiation complex assembly (GO:0070897),-0.5305000749701172,-1.3322570479149975,0.14107142857142857,0.346767888593925,1.0,5/12,16.25%,TAF11;TAF1B;BDP1;DR1;TAF7
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4901244506890813,-1.332078039893646,0.11007462686567164,0.346659115461723,1.0,5/16,7.51%,RREB1;SOX13;SIX1;FTO;NAPEPLD
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5684406790796015,-1.3319776316403742,0.11387900355871886,0.34636594246358515,1.0,3/10,9.09%,BMP4;IRF1;GLI3
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.32967900276713435,-1.3317495414415643,0.05565217391304348,0.34636059632837723,1.0,22/113,10.05%,TEK;RREB1;NRP2;BMPR2;BMP5;TBX1;KDR;PRKD2;EGFR;BMP6;FGF1;BMP4;STXBP4;NOTCH2;PRKD1;AKT3;YAP1;FLT4;PIK3CD;FGF7;AKT1;VEGFC
prerank,regulation of protein kinase B signaling (GO:0051896),-0.3038183762332437,-1.3314336113178231,0.02413793103448276,0.3465586948772343,1.0,57/193,23.17%,HIP1;TEK;IGF1R;KITLG;ENG;ITGB1;GAB1;FERMT2;INSR;RAC1;MFHAS1;ESR1;THBS1;GCNT2;PTPRJ;EGFR;RICTOR;PPARA;GAS6;PIK3R1;IRS1;PTK2;FGF1;HAX1;RRAS;PIK3CD;FGF7;AKT1;THEM4;MAZ;FGF2;MTDH;MYOC;RHOG;HGF;PIK3CB;GRB2;IAPP;GAB2;TNFAIP8L3;ANGPT1;FYN;CCL19;HYAL2;EPHA2;TXN;TCF7L2;PTEN;F3;FGFR4;IGF2;PTPN11;PDGFRB;PHLDA3;HSP90AA1;HPSE;FRS2
prerank,positive regulation of vasoconstriction (GO:0045907),-0.531863853638038,-1.331308188283399,0.1371841155234657,0.3463579434348685,1.0,3/13,4.94%,CAV1;ADRA1B;TRPM4
prerank,lipid droplet formation (GO:0140042),0.550981602922938,1.330975842980971,0.15566037735849056,0.483660968570871,1.0,4/10,17.76%,BSCL2;SQLE;AUP1;CDS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4883669625525372,-1.3297244102139378,0.14234234234234233,0.34861494415864425,1.0,9/17,35.34%,JAK1;IRS1;SOCS2;IL7;IL2RG;BRWD1;STAT3;TSLP;IL7R
prerank,cellular response to interleukin-7 (GO:0098761),-0.4883669625525372,-1.3297244102139378,0.14234234234234233,0.34861494415864425,1.0,9/17,35.34%,JAK1;IRS1;SOCS2;IL7;IL2RG;BRWD1;STAT3;TSLP;IL7R
prerank,regulation of lipid kinase activity (GO:0043550),-0.547378236295481,-1.329706816166295,0.13818181818181818,0.3482147405293942,1.0,3/11,5.82%,RB1;PPP2R5A;PIK3R1
prerank,synaptic vesicle endocytosis (GO:0048488),0.40469767363889486,1.32939348728944,0.10262008733624454,0.4856525498608111,1.0,7/33,6.12%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG;DNM1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.404623378582094,-1.329199216338082,0.1026936026936027,0.3487308217658345,1.0,18/36,29.08%,UBE2K;GAS6;IRGM;PARP14;EDN1;AGPAT1;NLRC5;MAVS;RIPK1;CASP1;HSPA1B;IL7;TRIM44;PARP9;ADAM17;CD300LF;TRIM6;AXL
prerank,double-strand break repair (GO:0006302),-0.30935979154030085,-1.3287710894694675,0.02218430034129693,0.3491597632234812,1.0,70/158,32.37%,ATM;UIMC1;DTX3L;KDM2A;SMC5;SAMHD1;ZFYVE26;XRCC4;SPIDR;MMS22L;MRE11;NABP1;MCM9;RBBP8;TENT4A;RAD54B;NSMCE2;SFPQ;RPA3;DNA2;KAT5;RPA1;BABAM2;MAPK8;NHEJ1;RNF168;UBE2V2;PALB2;MAD2L2;HERC2;SUMO1;RFWD3;HPF1;BRCC3;WRN;RPA2;BAP1;SMARCAD1;PRKDC;PIAS4;LIG4;BRCA1;RAD51AP2;BAZ1B;DCLRE1B;BLM;YY1;MORF4L1;HMGB1;INO80;DCLRE1A;APBB1;PARP9;TRIP13;POLL;XRCC2;AP5Z1;APLF;KDM4D;RAD51AP1;MDC1;TDP1;SWI5;RAD51D;HUS1B;CYREN;KDM4A;RMI1;MEIOB;PARP3
prerank,protein acylation (GO:0043543),-0.39460228114168916,-1.3286342617741291,0.08759124087591241,0.34901284203719096,1.0,7/38,8.25%,FOXO1;CREBBP;KAT2B;ZDHHC6;KAT6A;ZDHHC3;NAA80
prerank,negative regulation of cytokine production (GO:0001818),-0.3104337668324349,-1.3278984409238996,0.03773584905660377,0.35001919462749276,1.0,37/163,18.05%,LEF1;KLF4;CD34;RAC1;CD200;THBS1;TMSB4X;IFIH1;TRIM25;RPS6KA5;SRGN;RNF125;TAX1BP1;PPARA;GAS6;PDCD4;EZR;ANXA4;UBA7;RGCC;IKBKE;ZFPM1;CEACAM1;KAT5;ASB1;TRAF3IP1;TNFAIP3;N4BP1;ILRUN;C1QTNF3;VSIR;RARA;ANXA1;GPATCH3;NLRC5;MAVS;CMKLR1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.45670752549382726,-1.327011344829728,0.11262798634812286,0.3513461496963445,1.0,11/20,30.97%,RPS6KA5;DIP2B;PRKAA1;RUVBL2;SOX4;BRCA1;NOS1;ARRB1;DIP2A;GLYR1;RPS6KA4
prerank,negative regulation of neuron projection development (GO:0010977),0.35189679925842965,1.327003155416796,0.08120649651972157,0.4897663777711919,1.0,16/56,15.52%,NLGN1;DCC;SPOCK1;ITM2C;EFNB3;RTN4;TSKU;PTPRS;STMN2;MAG;OMG;PAQR3;NGEF;DENND5A;APOE;PTPRO
prerank,RNA stabilization (GO:0043489),-0.4118516027947354,-1.3268160564303075,0.10669077757685352,0.35133626431464465,1.0,14/33,28.15%,LARP1;FUS;AXIN2;TENT2;PARN;TRDMT1;PHAX;RBM24;THRAP3;TAF15;NAF1;PABPC1;HNRNPU;TENT5C
prerank,nucleic acid metabolic process (GO:0090304),-0.3508193350200438,-1.3268074981624338,0.06293706293706294,0.35091404114169933,1.0,26/69,27.56%,RBFOX2;METTL14;NT5E;HNRNPA0;HNRNPR;HNRNPM;POLR2G;HNRNPA3;WTAP;HNRNPF;XRN2;DNA2;PDE12;HNRNPA1;WRN;WDR74;PCBP1;POLR2C;POLR2L;POLR2H;HNRNPL;HNRNPD;DXO;RAN;MMS19;HNRNPU
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.4185877890862276,-1.3265670109410859,0.10634328358208955,0.35094258773630366,1.0,18/29,36.91%,DCUN1D3;DTX3L;ABL1;FEM1A;SMAD7;MAGEC2;FEM1B;UBE2L3;DCUN1D2;DCUN1D5;TRIB3;RPS2;BAG5;PLK1;PARK7;BMI1;TOPORS;FBXO5
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.5373086006373483,-1.3263366234470708,0.1456140350877193,0.3509899757851859,1.0,6/11,30.81%,MEF2C;MYOCD;FRS2;FZD7;BMP2;TGFB1
prerank,histone deacetylation (GO:0016575),-0.3876106987656558,-1.3258583936404467,0.08797127468581688,0.35147641103308497,1.0,17/43,23.74%,MIER1;PRDM5;RCOR1;HDAC1;MIDEAS;SIN3A;HDAC4;SFPQ;MIER2;HDAC6;HDAC10;MIER3;ELK4;SMARCAD1;TBL1X;SUDS3;MORF4L1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.5293341697611806,-1.3257525074522103,0.14893617021276595,0.35128563186335815,1.0,6/12,27.56%,CDYL;PCGF3;BRCA1;PCGF5;RBM15;HNRNPU
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4561282943573124,1.3253190012769611,0.12100456621004566,0.49203768268580605,1.0,6/20,11.92%,KCNMA1;ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.41708907532198675,-1.324882622221661,0.12478031634446397,0.35254302944691057,1.0,8/30,10.98%,FLT1;MLLT3;KDR;ACE;BMP4;FLT4;TP53;PRRC2C
prerank,negative regulation of cell death (GO:0060548),-0.3373643993311638,-1.3247330229517764,0.06972477064220184,0.35238590692623034,1.0,26/88,16.68%,MECOM;FERMT2;CD34;CD200;GSK3B;LRRK2;INPP5A;TNFRSF1B;NCK1;BMP4;BNIP3;PRKD1;WNT16;AKT1;CHMP4B;CHMP4A;FGF2;RAD18;TM7SF3;WNT11;CCN5;PDE12;ATG5;CCN3;BMP7;FYN
prerank,ERBB signaling pathway (GO:0038127),-0.3574997301149246,-1.3244847307526113,0.07156308851224105,0.3525189391774026,1.0,17/64,11.38%,GAB1;IQGAP1;RPS6KA5;PLCG1;EGFR;PTPN12;SLC30A10;CBL;PIK3R1;PTK2;PIK3C2A;PLCE1;MAPK1;BCAR1;AKT1;NCK2;BRAF
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.47698801172688043,-1.32435792239111,0.13859649122807016,0.35236223281331636,1.0,8/17,19.68%,LYN;MID1;TGFB2;ARL6IP5;TAOK3;SEMA4C;NOD2;KLHDC10
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4433523916334515,-1.3238739042749126,0.12172284644194757,0.3529590190481511,1.0,11/22,28.90%,ERI3;RPS21;EXOSC2;NOL9;EXOSC3;EXOSC8;PES1;RRS1;EXOSC7;WDR12;UTP20
prerank,stem cell differentiation (GO:0048863),-0.3878443340430339,-1.3238242708410142,0.09473684210526316,0.3526195732995738,1.0,14/39,19.32%,MLLT3;SETD2;FBXL17;ACE;LRP6;TGFB2;MEF2C;PUM1;TP53;LMBR1L;FOXO4;METTL5;NELFB;PTPRC
prerank,regulation of innate immune response (GO:0045088),-0.36664658068880057,-1.3238097949726504,0.08317929759704251,0.35221861415499006,1.0,28/57,32.73%,XIAP;PTPN1;BIRC3;SAMHD1;NMI;IRF1;AKIRIN2;CASP8;USP18;PLSCR1;POLR3F;TNFAIP3;IFI35;N4BP1;GBP5;ERAP1;TKFC;ABCE1;PTPN11;IFNAR2;DHX9;PARP9;RIOK3;TREM2;CACTIN;LRP8;FGR;TRAFD1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.47099349318068884,-1.3224226945585527,0.13532513181019332,0.35466744608017275,1.0,5/20,12.38%,LYN;PRKCE;LBP;IRAK1;MTDH
prerank,muscle contraction (GO:0006936),-0.3180357564231168,-1.32144304885992,0.043795620437956206,0.3562442539905742,1.0,35/126,22.03%,UTRN;SORBS1;MYOF;GJC1;EDNRA;TPM3;ITGA1;EMD;DYSF;PXN;ITGB5;TMOD3;SNTB1;MYH11;ACTA2;ROCK1;ASPH;MYLK;CHRNB1;MYOM1;ARHGEF11;LMOD1;TPM1;SORBS3;ROCK2;SSPN;CALD1;CASQ2;MYL6;MYL12B;SMTN;GAMT;VCL;SNTA1;NOS1
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.3435477120756374,-1.3209036388104716,0.07207207207207207,0.3568932209637741,1.0,29/80,25.90%,XIAP;DCUN1D3;CAV1;LRRK2;BIRC3;RBX1;CUL3;GSK3A;FAM107A;NSMCE3;SMAD7;MAGEC2;FANCM;UBE2L3;DCUN1D2;ANGPT1;SENP2;CDK5RAP3;PHF23;HUWE1;BRCA1;DCUN1D5;NDFIP2;AMER1;RCHY1;TRIB3;FANCI;RPS2;PEF1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.49666579458806503,-1.3206629029474406,0.14285714285714285,0.3569077843700731,1.0,5/16,12.16%,RB1;PDS5B;NIPBL;POGZ;PDS5A
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5222703509265895,-1.320607272355865,0.1393596986817326,0.35660783647709937,1.0,4/13,7.51%,RREB1;SOX13;SIX1;NAPEPLD
prerank,calcium ion import (GO:0070509),0.412529122676084,1.3186636526955688,0.12470588235294118,0.5072378756151703,1.0,10/28,17.93%,MS4A1;SLC25A23;CACNA1B;CACNA1A;CACNA1D;CACNA1E;SLC8A1;MCU;CACNA1G;CACNA1I
prerank,regulation of neuron death (GO:1901214),0.32752912528724815,1.3178269901091662,0.057649667405764965,0.5071916784177511,1.0,22/82,15.00%,GRID2;DCC;GRIN2B;CDK5;EPHB1;EGR1;CHGA;NAE1;SNCG;SORL1;MAPT;FAIM2;KIR3DL2;TRIM2;ATP13A2;DHCR24;HTRA2;CCL5;CLU;SIGMAR1;LANCL1;GRM4
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.49801704271901404,-1.317715934481029,0.16225749559082892,0.362050490519734,1.0,4/14,11.75%,ANKRD17;PUM1;DDX60;USP15
prerank,inositol phosphate metabolic process (GO:0043647),-0.37388403090401184,-1.3169596002801878,0.10088495575221239,0.36309104648774326,1.0,12/46,12.27%,PLCB4;INPP1;PLCG1;INPP5A;PLCB3;PLCB1;MINPP1;PLCE1;PLCG2;ITPKB;INPP4A;FGF2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3963573574226479,-1.3167643833981375,0.09352517985611511,0.3630702345307698,1.0,15/37,23.28%,CAV1;NCK1;TP53;BCAP31;SFPQ;EIF5A;BBC3;BCL2L11;GSDME;SOD1;RPS3;SIAH1;RPS7;BECN1;MSX1
prerank,regulation of translational initiation (GO:0006446),-0.35672494710441055,-1.3162986938330477,0.06976744186046512,0.3635304618956073,1.0,35/63,36.89%,EIF3H;EIF4H;EIF3E;DDX3X;LARP1;NCK1;EIF3B;POLR2G;EIF2B2;NCK2;CDC123;KLHL25;ATF4;AGO2;TPR;CTIF;GLE1;EIF2AK3;KHDRBS1;EIF2AK4;EIF5B;DNAJC3;MTIF2;EIF4G3;BOLL;EIF4A2;CEBPB;ATF3;EIF2B5;PAIP2B;MIF4GD;ALKBH1;EIF4EBP1;EIF4EBP3;PAIP2
prerank,regulation of DNA repair (GO:0006282),-0.38381439737738726,-1.3159075952397623,0.09195402298850575,0.3638494563291709,1.0,17/44,20.86%,UBR5;EYA4;DEK;UIMC1;EGFR;TRIP12;AXIN2;BABAM2;RNF168;UBE2V2;ERCC8;CEBPG;BRCC3;RPS3;USP1;BRCA1;TRIM28
prerank,sensory perception of light stimulus (GO:0050953),0.32416528180197185,1.3158017611326487,0.05803571428571429,0.5104950791272946,1.0,11/87,6.07%,PCDH15;COL2A1;EML2;COL1A1;CABP4;GRM8;RP2;FSCN2;OAT;EFEMP1;PAX2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.5063307632758491,-1.315613111989353,0.14389799635701275,0.3639892825952391,1.0,3/14,5.78%,PKD2;TMSB4X;NFKBIA
prerank,cardiac muscle contraction (GO:0060048),0.39268277664797613,1.3156068107425025,0.11920529801324503,0.5089408634368587,1.0,10/34,14.50%,ATP1A2;SCN1B;ATP1B1;GSN;RYR2;SCN5A;TNNC1;SLC8A1;TNNI2;SCN2B
prerank,diacylglycerol metabolic process (GO:0046339),0.43264508520997375,1.3155196529919233,0.12854030501089325,0.5071267391614065,1.0,6/23,12.65%,DGKK;DGKI;DGKQ;ANG;PGS1;MOGAT1
prerank,lipid transport (GO:0006869),-0.32727671337009606,-1.3151373266353716,0.05964912280701754,0.3645342870942563,1.0,36/97,26.99%,ABCC4;PITPNC1;ATP8B1;CERT1;PLTP;SLCO2A1;SLCO1C1;RXRA;SLCO3A1;SPNS2;LBP;ABCD3;SLCO2B1;PPARD;SCARB1;MFSD2A;ABCA9;SLC27A4;CEACAM1;ABCA7;TNFAIP8L3;MFSD2B;PCTP;ACSL1;PRELID2;GLTP;OSBPL2;ABCA6;PITPNA;SLC10A3;PEX3;SLC27A3;ABCG4;STARD5;SLCO1B1;FABP3
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.2832918003334694,-1.31466770872988,0.011235955056179775,0.36503655354830483,1.0,67/308,18.51%,LEF1;PRKCH;IGF1R;RREB1;ZBTB16;GHR;FERMT2;CAV1;DAB2;BMPR2;SMURF2;GCNT2;ADRA1B;ADIPOR2;PRDM16;IL15;SHLD1;MTOR;SMO;TFRC;TRPM4;TGFBR2;KMT5B;SIX1;GAS6;PLCB1;TGFB2;MED1;STAT6;LBP;BMP4;SMAD2;RBM19;UCP2;ROCK1;GRB10;SMAD4;ACADL;PIK3CD;EHMT1;KDM6B;IL4R;AXIN2;KDM3A;RGCC;JAK2;FGF2;FLOT1;AGO2;B4GALT5;FOXC1;AGPAT1;MIF;ABCA7;TRIM16;C1QTNF3;MAD2L2;NPR1;ALMS1;SIX4;CTNNB1;ACSL1;CMKLR1;SOD1;CFL1;EPAS1;LURAP1
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.3364397230066422,-1.3146396009368433,0.06296296296296296,0.3646519148577341,1.0,28/85,20.92%,DAB2IP;ACVRL1;TIE1;LIMS1;MCC;BMP5;TBX1;EGFR;TGFBR3;BMP6;TGFB2;AQP11;FGF1;BMP4;PRKD1;YAP1;FGF7;FGF2;CDC73;CDK6;GPX1;ANGPT1;IGF1;SIX4;NOD2;PRKDC;TCF7L2;LAMB1
prerank,glial cell differentiation (GO:0010001),0.40955378571851053,1.3145468344794562,0.11363636363636363,0.5076692129541129,1.0,9/28,12.81%,MYRF;CDK5;MMP24;PTPRZ1;PAX2;GPC1;CDH2;SLC8A3;TPPP
prerank,alcohol catabolic process (GO:0046164),0.5444172655225111,1.3144975817277806,0.15513126491646778,0.5057618600146013,1.0,4/10,14.63%,AKR1D1;CYP46A1;CYP27A1;APOE
prerank,autophagosome assembly (GO:0000045),-0.3709250392744738,-1.3144512423023755,0.08396946564885496,0.364595728909037,1.0,22/52,27.26%,ATG7;RAB7A;RAB1A;SMURF1;MAP1LC3B;AMBRA1;IRGM;WIPI1;GABARAP;ULK2;RAB23;ATG5;STX12;EMC6;WDR45B;ATG16L2;BECN1;ATG2A;RAB19;ATG2B;UBXN2A;ATG3
prerank,pyroptosis (GO:0070269),-0.4955467311167331,-1.3143144922961345,0.14056939501779359,0.3644403150878758,1.0,7/15,29.62%,CASP8;GSDME;APIP;CASP1;DHX9;TREM2;NLRC4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.2812391419632785,-1.314260043280973,0.014331210191082803,0.3641066358362522,1.0,80/366,16.35%,APBB2;NFIA;RREB1;SMARCA2;ZNF423;ENG;ACVRL1;CREBBP;NSD1;RB1;BNC2;KAT6B;ERC1;INSR;ESR1;FOXN3;ANKRD17;ZFHX3;IRF2;APP;RPS6KA5;WWC2;ZSCAN21;MITF;NR3C1;SOX13;SOX17;PSPC1;SP1;VSX1;LIMD1;SIX1;RYBP;ABL1;FOXO3;DNM2;TRRAP;NSD3;FUS;NFYC;GTF2IRD1;MEF2C;SLC39A8;ZBTB4;ASCC1;NAB1;LDB1;PRDM2;GPBP1;SPTY2D1;SP3;USP13;TP53;HMG20A;ORC5;PRRX2;SOX7;JMJD1C;CHD3;YAF2;NOTCH1;SFPQ;OGG1;OBI1;TAF5L;ATF4;MZF1;RPL10;GPBP1L1;NR1D2;HCFC1;TCF3;TCF7L1;FOXC1;MYBL2;NAB2;UBE2L3;FOXO4;CREBL2;HIC1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.32593160035955765,-1.31388514034745,0.05317324185248713,0.36444170444601287,1.0,33/113,18.94%,UNC13B;DAB2IP;FERMT2;TRABD2B;ASAP1;MPP7;ESR1;GSK3B;ATM;DDX3X;TFRC;RBX1;RASIP1;SPIDR;CDH5;RAP1B;ERCC2;TAL1;TP53;FNIP2;ICE1;LCP1;RPA3;RPA1;RHOC;SLF2;ERCC3;PSMC2;BCL2L11;SUMO1;GBP5;RPS3;RPA2
prerank,embryonic skeletal system development (GO:0048706),0.3890601678706016,1.3138680627363517,0.12051282051282051,0.5053750576004966,1.0,12/35,16.83%,DSCAML1;COL1A1;OSR1;HOXD3;UCMA;DEAF1;MEGF8;SLC2A10;HOXA4;HOXA9;PDGFRA;HOXD4
prerank,regulation of intracellular pH (GO:0051453),0.39005348021152875,1.3137570855184253,0.08602150537634409,0.5037080025044721,1.0,7/34,5.56%,CA2;SLC9A7;SLC4A4;SLC4A5;CLN3;SLC9A9;SLC4A2
prerank,miRNA metabolic process (GO:0010586),-0.45768640982789166,-1.3127572782556458,0.14031971580817051,0.36624125844168454,1.0,12/20,35.42%,TUT7;TENT4B;DICER1;TUT4;PARN;AGO2;DROSHA;DIS3L2;RAN;SND1;TARBP2;DGCR8
prerank,sulfate transport (GO:0008272),-0.5022673286400424,-1.3126517060952767,0.12637362637362637,0.3660252873821017,1.0,5/14,16.49%,SLC26A7;SLC26A2;SLC13A4;SLC25A11;SLC26A11
prerank,response to exogenous dsRNA (GO:0043330),-0.47155419381035524,-1.3126099388524932,0.148014440433213,0.3656867505534343,1.0,10/18,31.57%,CAV1;IFIH1;FLOT1;CGAS;MAVS;SLC3A2;RALB;DHX9;TICAM1;RFTN1
prerank,negative regulation of secretion (GO:0051048),0.5405847486806076,1.31253935467733,0.16079295154185022,0.5048543490989158,1.0,2/10,5.24%,NRG1;PTGER3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.338179502306756,-1.31172803009156,0.06104129263913824,0.3670215441392624,1.0,33/87,27.78%,FBXL7;RB1;DCUN1D3;KLF4;PKD2;PSMA2;RBX1;DLG1;PSME2;PSMB4;FAM107A;RGCC;CDC73;CDK6;PSMC2;PSMB2;PSMB1;PSMA8;CDK2AP2;PSME1;PTEN;PSMD4;CDKN2C;PSMA7;FHL1;PSMD5;E2F7;PINX1;ZFP36L1;PSMB10;APC;PSMA3;CDKN2B
prerank,regulation of neuron differentiation (GO:0045664),0.33232543037408596,1.311628631039751,0.07090464547677261,0.5052065615071429,1.0,13/76,7.41%,BRINP3;NLGN1;CNTN4;YWHAG;BEND6;NBL1;NRCAM;VWC2;BRINP1;HOXD3;IMPACT;BRINP2;ADRA2C
prerank,regulation of cell size (GO:0008361),-0.43155898876970805,-1.311579982662783,0.13786764705882354,0.36682360618369947,1.0,13/23,22.89%,RAC1;MTOR;MSN;RARG;EZR;EDN1;RPTOR;RHOA;LARS1;PTEN;AKT1S1;VAV2;MTPN
prerank,cell-cell junction assembly (GO:0007043),0.3509704402671278,1.3115692097302898,0.09656652360515021,0.5033822795940694,1.0,21/63,11.60%,CDH18;CDH8;CTNND2;CDH20;CDH9;CDH10;EPB41L3;PKP2;DCHS1;CDH19;FLCN;CDH12;FSCN1;CLDN11;CDH7;GJB2;CDH24;CDHR3;GJB6;PATJ;CDH2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.46681855566174313,-1.3112433721186034,0.14209591474245115,0.36708188417011944,1.0,14/19,49.60%,PRKCE;NMI;LBP;IRAK1;ITGAM;LGALS9;PIK3AP1;CD14;TNIP3;TLR4;TICAM2;SCIMP;RAB11FIP2;LY96
prerank,cytosolic transport (GO:0016482),-0.32818478521761457,-1.3103425281688834,0.048507462686567165,0.3685040200992477,1.0,32/108,23.00%,VPS13A;MYO1D;VTI1A;ERC1;EPS15;RAB7A;TMEM87B;HEATR5A;VPS54;RAB5A;STX8;VPS13C;BET1L;GAK;DCTN1;VPS26A;ANKFY1;AP1G1;VPS52;TBC1D23;CORO7;AP4M1;ANKRD27;WASHC1;VAMP3;AKTIP;TBC1D17;CLN5;SPAG9;KIF16B;EVI5;BECN1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.4555083376316158,-1.3101899190688215,0.12208258527827648,0.3684258671593423,1.0,9/21,24.73%,THBS1;MTUS1;IL34;PTK2;MAPK1;MIF;CMKLR1;PTK2B;DDT
prerank,cellular response to hydroxyurea (GO:0072711),-0.5539108209833861,-1.3100065555604354,0.1586998087954111,0.3683267776452451,1.0,7/10,21.31%,DDI2;SPIDR;RTF2;NSMCE3;ATRX;TIMELESS;BLM
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.40448625412391237,-1.3097581549723967,0.12006861063464837,0.3683258731321144,1.0,13/33,22.61%,KLF4;ETS1;TEAD1;NR3C1;FOXO3;TGFB2;JUN;TP53;FGF2;GATA2;PPARG;TERT;RELA
prerank,proton transmembrane transport (GO:1902600),0.39233101671498205,1.3097394012715167,0.107981220657277,0.5060385393437868,1.0,7/36,8.71%,ATP1A2;ATP12A;SLC46A1;UCP3;SLC36A2;ATP6V0C;ATP4A
prerank,membrane lipid biosynthetic process (GO:0046467),-0.3608426966400961,-1.3097099416000795,0.07942238267148015,0.367984808513799,1.0,14/58,9.03%,SGMS1;CERT1;ST3GAL4;ACER2;DEGS2;SGMS2;PRKD3;PRKD2;SPNS2;ELOVL5;CERS4;PPM1L;PRKD1;ST3GAL2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.307221051073829,-1.3094738114825646,0.03345070422535211,0.36803392135508256,1.0,58/148,27.65%,PPP1R13B;ATM;RPL37;MTOR;KAT6A;PIP4K2A;TOP3A;RICTOR;HDAC1;PHF20;PAK1IP1;PIP4K2B;MRE11;NOP2;USP2;RBBP8;TAF11;AKT1;TP53;EHMT1;PRKAA1;CHD3;RPA3;DNA2;KAT5;RPA1;KMT5A;NUAK1;RPL5;TAF7;HIPK1;TAF3;CDK5RAP3;WRN;RPA2;PRKAB1;USP7;BOP1;PRDM1;BRCA1;RRS1;MDM2;BLM;RFC4;TAF4B;CHEK1;RPS15;TAF13;MAPK11;CCNG1;TAF9;TAF15;PLK3;PPP1R13L;PRR5;RNF34;PPP2R5C;EXO1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5022319712666026,-1.3093456104613725,0.16176470588235295,0.3678561783449579,1.0,6/13,19.30%,SESN1;ATM;KPTN;CASTOR1;RNF152;ITFG2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3978715774476588,-1.3087201954543333,0.11010830324909747,0.3687077296087365,1.0,14/36,21.87%,DAB2IP;MGA;RYBP;SUZ12;MAX;RBBP8;EHMT1;YAF2;PHC1;FOXO4;RNF2;BRCA1;PHC3;CHEK1
prerank,cell projection assembly (GO:0030031),-0.4525599360410052,-1.3085615695534283,0.13358070500927643,0.36860002007254206,1.0,7/22,14.72%,PARVB;RAC1;RHOJ;PARVA;RHOQ;RHOG;NCKAP1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5034308305598162,-1.3083910454336871,0.14774774774774774,0.36852697861527645,1.0,4/13,12.29%,NFAT5;ETS1;RHOA;IRAK1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.378512547925342,-1.3080660721549713,0.12915129151291513,0.3687246188623042,1.0,10/45,14.33%,DYRK1A;EGFR;NFKB1;PIK3R1;WDR75;BMP4;ERN1;TP53;ZPR1;RBM20
prerank,cellular response to ATP (GO:0071318),0.49756671026956506,1.3079733655847214,0.15419501133786848,0.5087864353729049,1.0,4/14,14.11%,RYR3;CIB2;P2RX3;TAF1
prerank,regulation of MAPK cascade (GO:0043408),-0.3043749085843703,-1.3058667193568256,0.058823529411764705,0.3728059995813254,1.0,40/157,16.73%,FLT1;TEK;DAB2IP;IGF1R;JCAD;ROR1;INSR;CAV1;LYN;IQGAP1;ADRA1B;PAK2;TBX1;KDR;PTPRJ;EGFR;TGFBR3;STK3;PPEF2;FAS;MAPK1;ROCK1;YWHAZ;FLT4;PLCG2;RRAS;TAOK3;PEBP1;FGF2;CEACAM1;DUSP3;MYOC;KSR1;MAP4K4;IAPP;ROCK2;ABCA7;PELI2;IGF1;GSDME
prerank,mitochondrion disassembly (GO:0061726),-0.39683101497796236,-1.3058488666107368,0.12177121771217712,0.3723957853030206,1.0,16/34,27.26%,ATG7;MAP1LC3B;AMBRA1;BNIP3;WIPI1;GABARAP;FUNDC1;ULK2;MARK2;ATG5;WDR45B;BECN1;ATG2A;FUNDC2;ATG2B;ATG3
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.37917895136746216,-1.3054385883310802,0.1125,0.3727713825490933,1.0,14/42,21.49%,YARS1;WARS2;NARS2;CARS2;FARS2;TARS3;LARS1;AIMP2;HARS2;DARS2;VARS2;FARSA;IARS2;WARS1
prerank,lysine catabolic process (GO:0006554),-0.523007300604434,-1.3053514136335205,0.15716753022452504,0.3720653452742376,1.0,5/12,22.34%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,lysine metabolic process (GO:0006553),-0.523007300604434,-1.3053514136335205,0.15716753022452504,0.3720653452742376,1.0,5/12,22.34%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,positive regulation of macroautophagy (GO:0016239),-0.37284410947206525,-1.3047056344813959,0.09490333919156414,0.37301286321663685,1.0,14/48,18.43%,RAB3GAP1;GNAI3;SESN1;KDR;PIP4K2A;LARP1;PIP4K2B;IRGM;BNIP3;RAB3GAP2;SPTLC1;VPS13D;TRIM13;IKBKG
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.32409935524616157,-1.3039435612942472,0.058925476603119586,0.37420720519073397,1.0,32/104,20.87%,BMPER;CRIM1;CAV1;BMPR2;SMURF2;IL17RD;PRDM16;SPRED2;SMURF1;TGFBR2;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD1;SMAD2;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1;CCN3;SMAD6;SKI;PMEPA1;HTRA3;SMAD9;DAND5;PPARG;SNX25;STRAP
prerank,cellular protein metabolic process (GO:0044267),-0.27338540734194305,-1.3038964128058923,0.011363636363636364,0.3738737362022132,1.0,151/396,30.55%,DAB2IP;IGFBP7;ST3GAL6;ST3GAL1;PLOD2;MSRB3;ST8SIA4;APP;RRBP1;RPS21;IGFBP4;RPL37;PARP4;MMP2;RPL31;YES1;CSNK1G3;RPL9;GAS6;RPS14;ABL1;PSEN2;SPPL3;BMP4;RPSA;PDIA6;PHKA2;DENND3;AFG3L2;PCSK5;RPL3;RPLP1;MRPL32;RPL26;ADAM10;UBE2D3;LMCD1;UBA7;RPS11;FDX1;PSEN1;ITIH2;ERO1A;GALNT11;STK38;RPL13;MRPS18A;PRKCSH;RPL38;ANO8;NOTUM;FDXR;MSLN;RPL27;RPS16;RPS4X;GSPT1;AGO2;RPL10;RPL7A;MSRA;IGFBP5;SERPINC1;MAGEC2;UBE2M;HARS2;LGMN;RPL5;UBE2L3;F5;IGF1;MRPL24;RPS27;PLAT;CTSH;APH1A;RPL27A;RPS3;RPL36A;RPL35A;BAP1;CLN5;PRKDC;MRPS14;GPC3;WWP2;RPL37A;MRPS21;MFGE8;IGF2;LAMB1;MRPL35;RPL32;UBL4A;LOX;WARS1;RPS7;CCN1;CHRDL1;KTN1;RPS15;MRPL34;RPS8;RPL28;RIPK1;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;RPS23;MSRB2;STOML2;FBN1;SRBD1;RPS17;PNPLA2;RPS2;MRPL43;SEC11A;RABGGTB;ADAM17;RPL39;MRPL11;RPS26;TNIP1;RPS15A;RPL15;RPL34;TMEM132A;DNAJC3;ATG3;MANBA;PAPPA;IGFALS;SCG3;RPLP2;UBE2I;LIPT1;DUSP12;YME1L1;RPL18;MRPS17;MBTPS1;CDC34;LTBP1;RPL19;AHSG;RPS13;COPS5
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.36047750863654743,-1.3007314623677215,0.09236234458259325,0.37986329829795235,1.0,23/57,27.64%,PAK1IP1;RPL26;RPL38;NIP7;RPS16;TGS1;RPL5;WDR74;RPL35A;DDX31;BOP1;PES1;RRS1;EBNA1BP2;RPS7;RPS15;NOP16;RPS17;GLUL;NAF1;BYSL;EMG1;WDR12
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5137269117578088,-1.3002982948015158,0.1552901023890785,0.38033352526183206,1.0,8/13,27.32%,TNRC6B;POLR2G;AGO2;BTG2;TNRC6A;TOB1;CNOT1;PABPC1
prerank,regulation of myoblast fusion (GO:1901739),-0.5408547441579575,-1.2995813625366048,0.16083916083916083,0.3812615289276681,1.0,7/11,30.24%,EHD2;CFLAR;EHD1;FLOT1;CD53;ADGRB1;MAPK14
prerank,dendritic spine morphogenesis (GO:0060997),0.48008479770236634,1.2994205838940784,0.15151515151515152,0.5292930917071808,1.0,5/15,6.15%,CTNND2;DOCK10;EPHB1;SHANK1;PAK3
prerank,axonal fasciculation (GO:0007413),0.5027551830438177,1.298772339739694,0.17142857142857143,0.528959084879876,1.0,4/12,8.64%,CNTN4;NRCAM;MEGF8;RTN4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3624025914953092,-1.2985528939502633,0.08996539792387544,0.38289920281485745,1.0,23/54,27.03%,ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;TP53;CRADD;RGCC;BTG2;CARM1;SOX4;MDM2;CASP2;GADD45A;E2F7;CNOT2;ARID3A;TFDP1;PLK3;CNOT8;CNOT1
prerank,regulation of actin filament-based process (GO:0032970),-0.34879181650134816,-1.2985086583967036,0.07468123861566485,0.38253846687606,1.0,21/70,15.35%,RAC1;RHOBTB1;IQGAP1;F11R;RND3;CRK;MTOR;RICTOR;ABL1;RHOQ;PRKCD;CDK10;EZR;ROCK1;FAM107A;ARHGAP17;RHOA;RHOC;RHOG;HIP1R;ROCK2
prerank,artery development (GO:0060840),-0.4369538283532394,-1.298290842775205,0.13214285714285715,0.38255791316604376,1.0,9/23,11.55%,ENG;ACVRL1;PKD2;BMPR2;TBX1;HES1;PDE2A;HECTD1;SMAD7
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5044982455610771,-1.2980799283462465,0.13736263736263737,0.3825655653947022,1.0,6/13,22.56%,LRRK2;SCFD1;CHMP4B;CHMP4A;PHF23;SEC22B
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.49737897833910066,-1.2979033897244583,0.15236427320490367,0.3825086541754258,1.0,3/13,10.15%,PKD2;NFKBIA;FLNA
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.35832651304386487,-1.2978494704537127,0.08056042031523643,0.38218226627216495,1.0,29/57,32.44%,FOXN3;ATM;UIMC1;MRNIP;MRE11;CLSPN;TP53;TAOK3;BABAM2;RFWD3;FANCD2;CDK5RAP3;BRCC3;SDE2;RPA2;CCND1;PRKDC;BRCA1;BLM;CHEK1;TRIM39;FZR1;DTL;RINT1;FBXO31;MDC1;HUS1B;RPS27L;PLK1
prerank,purine nucleotide metabolic process (GO:0006163),-0.43175453550285714,-1.2973782824857039,0.1413427561837456,0.38269672086679657,1.0,11/24,27.28%,NT5C2;FHIT;NT5E;MTHFD1;NT5C1A;GPX1;HPRT1;GDA;PRPS2;NT5C;PNP
prerank,histone modification (GO:0016570),-0.31845521121750175,-1.2970493598461994,0.05087719298245614,0.3829190764076171,1.0,32/109,20.76%,CREBBP;NSD1;KAT6B;EYA4;MIER1;PRDM5;RPS6KA5;KAT6A;RCOR1;HDAC1;PHF20;TRRAP;NSD3;PRKCD;MIDEAS;SGF29;PHF20L1;EHMT1;SIN3A;HDAC4;KAT5;PHC1;RUVBL2;MIER2;HDAC6;HDAC10;CARM1;MIER3;TBL1X;HUWE1;ATXN7;BAZ1B
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.45443300794419955,-1.2967231502100849,0.1268939393939394,0.383136540733995,1.0,12/19,32.44%,CHMP4B;DRG1;CHMP2B;TPR;CHMP5;PDCD6IP;HSPA1B;CHMP3;HNRNPU;CCSAP;CHMP1A;PLK1
prerank,positive regulation of exocytosis (GO:0045921),0.3834647520628883,1.2960148779210776,0.11538461538461539,0.5343119512315821,1.0,13/35,19.83%,CADPS;RAB15;SMPD3;RAB27B;HGS;TSG101;ATP13A2;RAB3A;SDC4;CLASP2;CHMP2A;VPS4B;EXPH5
prerank,actin filament-based transport (GO:0099515),-0.4374233217410354,-1.2960063310754364,0.14726027397260275,0.38420675130743126,1.0,6/21,12.83%,MYO1D;FNBP1L;SYNE2;WASL;MYO1F;ACTN4
prerank,regulation of neuron apoptotic process (GO:0043523),0.3161749033913808,1.2955195465012226,0.061124694376528114,0.5336647019514464,1.0,28/96,17.26%,GRID2;CDK5;BCL2;TYRO3;CLN3;PTPRZ1;NAE1;NTRK2;VSTM2L;GRN;PLA2G3;POU4F1;BACE1;FAIM2;TRIM2;MAG;FZD9;NRBP2;CCL2;BDNF;FGF20;SIGMAR1;APOE;LANCL1;GRM4;ADAM8;MSH2;RETREG1
prerank,positive regulation of axonogenesis (GO:0050772),0.36872004536846936,1.2954357891826305,0.11512415349887133,0.5318907058255967,1.0,13/43,13.54%,ROBO2;L1CAM;ROBO1;SHTN1;CDKL5;LIMK1;NTRK2;SLITRK1;MAPT;ZFYVE27;PLXNA2;BDNF;PLXNA1
prerank,ion homeostasis (GO:0050801),0.39671770289316416,1.2952895458695357,0.14380530973451328,0.5302549108598184,1.0,7/30,7.87%,UNC80;SLC4A4;SLC4A5;WNK2;SLC4A2;WNK3;SLC12A5
prerank,rRNA 3'-end processing (GO:0031125),-0.5388590486493227,-1.2947821257320848,0.16279069767441862,0.3863861001920725,1.0,5/10,16.26%,ERI3;RPS21;EXOSC2;EXOSC3;EXOSC8
prerank,regulation of cellular component movement (GO:0051270),-0.36483685998488896,-1.2945004901901878,0.09683098591549295,0.38647661435334246,1.0,19/49,17.28%,SP100;ETS1;LYN;DIAPH1;EGFR;TGFBR3;ABL1;PRAG1;ROCK1;RAF1;ARAP1;RHOA;ACTN1;ACTN4;CDK6;PKN2;ROCK2;HDAC6;IGBP1
prerank,regulation of defense response to virus by host (GO:0050691),-0.4029407952684762,-1.2938007916402754,0.13285457809694792,0.38754660609533886,1.0,16/30,30.85%,DTX3L;SIN3A;TNFAIP3;CGAS;MAVS;ZDHHC1;RNF216;HSP90AA1;DHX9;EIF2AK4;TRIM44;PARP9;TRIM6;TOMM70;IFNLR1;LILRB1
prerank,cGMP-mediated signaling (GO:0019934),0.49747697128697066,1.2933852880124541,0.15454545454545454,0.5333028685947248,1.0,2/13,0.78%,KCNC2;HTR2C
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.45827104593175344,-1.2931441183290708,0.15263157894736842,0.3884457370278198,1.0,7/20,14.53%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;NUMB
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.4961572405870056,-1.29215014822374,0.14416058394160583,0.3900171711830001,1.0,4/15,12.71%,PRKCH;NFKB1;AGTR1;LPL
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.44666660007475967,-1.2921150853653736,0.1412639405204461,0.3896540802724202,1.0,10/22,26.46%,CDK13;CDK12;DDX39B;CDC73;THOC1;SUPT4H1;CCNK;BRD4;ERCC6;LEO1
prerank,ventricular septum morphogenesis (GO:0060412),-0.4187142005224697,-1.2920306197907634,0.1319073083778966,0.389372843211118,1.0,15/27,19.06%,BMPR2;TGFBR3;TGFBR2;HES1;SLIT2;TGFB2;BMP4;SMAD4;SMAD7;ZFPM1;NOTCH1;HEY1;HEY2;CITED2;SOX4
prerank,positive regulation of cell cycle (GO:0045787),-0.3495457081941601,-1.2915264852375272,0.11808118081180811,0.3899984352907027,1.0,30/62,27.05%,PKD2;ANKRD17;APP;EGFR;CDKN1B;LRP6;CCND3;TGFB2;USP2;TAL1;AKT1;CCNY;RGCC;DUSP3;PKN2;HCFC1;SMOC2;LGMN;SRPK2;RARA;RAD23A;CITED2;CCND1;MDM2;CHEK1;TBX3;CCNYL1;ADAM17;RPS15A;USP19
prerank,neural crest cell migration (GO:0001755),-0.3877677091105893,-1.291204603026983,0.12190812720848057,0.3903006757864412,1.0,12/36,18.35%,SEMA6A;SEMA3C;CORO1C;SEMA7A;TBX1;PHACTR4;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,regulation of cellular response to stress (GO:0080135),-0.31436535770114893,-1.2911665369772283,0.0575139146567718,0.38992449009511215,1.0,28/115,15.77%,CREBBP;MCL1;GSK3B;ATM;NUP42;NEK6;MTOR;YWHAE;RAE1;CAMK2G;RANBP2;ABL1;DNAJC7;NUP98;MAPKAPK2;SEC13;DNAJB6;MAPK1;IER3;RPTOR;NUP153;RPA3;RPA1;ATF4;PTGES3;ROCK2;NUAK1;TPR
prerank,cellular sodium ion homeostasis (GO:0006883),0.48256415777356043,1.291151830697203,0.1643192488262911,0.5369714241837249,1.0,5/15,11.92%,ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.47522807766949954,-1.2907463454653352,0.15198618307426598,0.39033559777909205,1.0,7/18,15.35%,TEK;CDH5;RAP1B;ROCK1;BCAS3;ARFGEF1;ROCK2
prerank,apical protein localization (GO:0045176),-0.5512363237865741,-1.290740193213222,0.16785714285714284,0.3899041128483032,1.0,4/10,12.61%,ATP8B1;SHROOM3;SHROOM2;ACTB
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.37644358668597167,-1.2907267911811353,0.12686567164179105,0.38948797416104103,1.0,15/48,13.32%,RREB1;DOCK1;FERMT2;RAC1;CUX1;LIMS2;LIMS1;CRK;ABL1;FLNA;CUL7;FBXW8;ILK;NEDD9;MYOC
prerank,histone H3-K4 methylation (GO:0051568),-0.4191614253537563,-1.2907146593531134,0.14864864864864866,0.389094307212903,1.0,12/26,24.04%,TET2;KDM6A;ASH2L;PRDM9;KMT2C;WDR82;WDR5B;OGT;TET3;WDR5;RBBP5;BEND3
prerank,quinone biosynthetic process (GO:1901663),-0.4906296073631067,-1.2905063906692085,0.17017543859649123,0.3891116156489379,1.0,6/14,19.31%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,B cell receptor signaling pathway (GO:0050853),0.39302811768324913,1.2903802366996842,0.14317673378076062,0.5369551945613658,1.0,5/32,3.49%,BLK;MS4A1;BLNK;NFATC2;BCL2
prerank,regulation of protein ubiquitination (GO:0031396),-0.3204257281057961,-1.2900609666191616,0.08,0.389628743325568,1.0,39/108,24.96%,NXN;XIAP;CAV1;LRRK2;IVNS1ABP;BIRC3;CUL3;GSK3A;FAM107A;AKT1;NSMCE3;SMAD7;SPOPL;FOXF2;CHP1;TNFAIP3;N4BP1;UBE2L3;ANGPT1;SENP2;CDK5RAP3;SASH1;RPS3;WASHC1;SOX4;PHF23;HUWE1;BRCA1;OGT;SH3RF2;NDFIP2;AMER1;HSP90AA1;ARRB1;RCHY1;HSPA1B;FANCI;PINX1;ADGRB1
prerank,cellular response to interleukin-6 (GO:0071354),-0.4255362797376511,-1.2896259721773797,0.12932604735883424,0.390130401136042,1.0,9/26,11.47%,ST3GAL6;JAK1;IL6ST;IL6R;NFKB1;CBL;YAP1;SMAD4;JAK2
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5319003495641158,-1.28962509497021,0.1813285457809695,0.3896934814106824,1.0,3/10,6.37%,CD200;BMP5;SLIT2
prerank,positive regulation of protein processing (GO:0010954),0.4444260255378022,1.2892601045654544,0.1486810551558753,0.5378653179806225,1.0,7/19,16.65%,MELTF;CLEC3B;GSN;PLGRKT;NKD2;ADAM8;KLKB1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.45500166429639555,-1.2891872209558715,0.15789473684210525,0.3900797456196041,1.0,7/19,11.69%,NFAT5;NFATC1;NFATC4;INPP5A;PLCE1;EDN1;EDN3
prerank,positive regulation of chromatin organization (GO:1905269),-0.5163208200315713,-1.2887651371621371,0.17582417582417584,0.39053786139292734,1.0,6/12,19.63%,MIER1;TAL1;SIN3A;H3-3A;TERF2;ATRX
prerank,protein localization to organelle (GO:0033365),-0.30639605991728214,-1.2887358833020546,0.059130434782608696,0.39014895309264713,1.0,41/133,21.65%,ZNF423;APP;LRRK2;DDX3X;YWHAE;EMD;SIX1;ZBTB7A;TOR1B;CEP250;IFT140;BMP4;CNTLN;UBE2J2;UBAC2;CROCC;GAK;LMNA;EHD1;WDR35;TSPAN17;CSNK1D;RPA1;SGTA;LMBRD1;TRAM2;ABCA7;BMP7;RAB11A;SIX4;RIPOR1;LAMP2;TULP1;GBP5;VAPA;RPA2;DCP1A;WDR83OS;MDM2;IFT20;VAMP2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.319144912061954,-1.288649756450774,0.06228956228956229,0.3899145606063764,1.0,45/114,27.42%,EDA;LIMS1;TRAF5;TMSB4X;PSMA2;BIRC3;TNFRSF1B;NFKBIA;FOXO3;PSME2;TXNDC17;PSMB4;TP53;ILK;JAK2;ACTN4;EIF5A;CD40;PSMC2;PSMB2;PSMB1;TNFRSF1A;TNFRSF11B;PSMA8;MAP3K14;EDAR;TNFSF13;IKBKB;PSME1;TNFRSF25;PSMD4;TNFSF8;PSMA7;PTK2B;LTBR;RELA;RIPK1;PSMD5;TNFSF12;ADAM17;PSMB10;TNFRSF9;TNFRSF12A;PSMA3;BAG4
prerank,positive regulation of JNK cascade (GO:0046330),-0.3472488726250575,-1.2885862103287191,0.09859154929577464,0.3896039548512906,1.0,25/70,24.66%,DAB2IP;MFHAS1;TRAF5;APP;MAP3K5;PLCB1;RASSF2;FLT4;SH3RF1;WNT16;TAOK3;TPD52L1;TNFRSF19;MTURN;CCL19;EDAR;NOD2;DUSP22;SH3RF2;PTK2B;LTBR;GADD45A;RIPK1;FZD7;HMGB1
prerank,cell chemotaxis (GO:0060326),-0.3510968823789293,-1.2882229077568625,0.10296684118673648,0.3899072536676398,1.0,21/60,24.90%,LEF1;PARVA;DOCK4;CCL25;PLEKHG5;PRKCD;CCR9;BCAR1;AGTR1;RHOG;ACKR3;HGF;ELMO2;CCN3;HOXB9;EPHA2;CXCL12;PDGFRB;PIP5K1A;SEMA5A;EGR3
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.44621250323393247,1.2877792839871316,0.15436241610738255,0.5399533265846591,1.0,8/17,17.51%,ATP1A2;SCN1B;CACNA2D1;CACNA1D;SCN5A;SLC8A1;SCN2B;CACNA1G
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3361948322705662,-1.2877436832496005,0.09269162210338681,0.39042114154942437,1.0,20/76,19.46%,DAB2IP;KLF4;CD200;TMSB4X;TAX1BP1;NFKBIA;OTULIN;ANXA4;NFKBIL1;IRAK1;CHP1;TNFAIP3;DAP;MTURN;BMP7;IRAK2;NLRC5;CDK5RAP3;CMKLR1;USP7
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4677216492900502,-1.287461084503185,0.14156079854809436,0.39060388489598324,1.0,11/17,17.95%,NOS3;NFATC1;SLIT2;TGFB2;BMP4;NOTCH2;NOTCH1;JAG1;SMAD6;HEY1;HEY2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5373270545678828,-1.287287826401134,0.16666666666666666,0.39053156963457086,1.0,3/10,5.09%,LRP5;TBX1;TGFBR2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.40595102696685714,1.2872018266697325,0.14285714285714285,0.5395701600141688,1.0,6/27,9.70%,AK9;AK7;TYMS;AK5;AK6;NME2
prerank,cellular response to interleukin-12 (GO:0071349),-0.3690113961430357,-1.2869406619439427,0.09430604982206406,0.3908480345522276,1.0,16/48,18.28%,ANXA2;JAK1;PAK2;MSN;PDCD4;PLCB1;TCP1;PSME2;RAP1B;JAK2;HNRNPF;LCP1;TALDO1;MIF;SOD1;CFL1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.40232711837539836,1.2867642308873943,0.13616071428571427,0.5387379355820114,1.0,7/27,12.34%,LPIN1;ETNK1;PLA2G3;PLA2G4E;PLA2G6;NAAA;CHKA
prerank,regulation of exosomal secretion (GO:1903541),0.4399784260859232,1.2867528174853655,0.14541387024608501,0.5367862814796945,1.0,8/19,18.93%,ATP9A;SMPD3;HGS;TSG101;ATP13A2;SDC4;CHMP2A;VPS4B
prerank,protein heterooligomerization (GO:0051291),0.4536464992635475,1.2862068507782212,0.14666666666666667,0.5361826394519844,1.0,2/17,0.90%,KCNC2;GRIN2B
prerank,response to peptide hormone (GO:0043434),-0.377500911620565,-1.2860607576744492,0.12815884476534295,0.39226483977134374,1.0,14/43,21.82%,CAV1;TGFBR3;IRS1;STAT6;ROCK1;AKT1;EIF2B2;STAT2;IGFBP5;ROCK2;TRIM16;ANXA1;OGT;CREB1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.382108822884408,-1.2858957707075425,0.11913357400722022,0.39219797375465276,1.0,10/37,11.82%,PARD3;UBE2K;APP;SPRED2;PPEF2;DDIT4;IRGM;MAPK1;SMAD7;RPTOR
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.34238598176410645,-1.2855085063531386,0.0989399293286219,0.3925664720922425,1.0,22/73,20.36%,KITLG;CBFB;TCF12;PSMA2;LMO2;METTL14;ABL1;PSME2;YAP1;LDB1;PSMB4;TAL1;PSMC2;TCF3;FOXC1;PSMB2;PSMB1;PSMA8;PSME1;GATA2;PRKDC;PSMD4
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.29660074433921235,-1.2854113561752523,0.046052631578947366,0.39230667383791396,1.0,62/175,26.87%,DAB2IP;EDA;LIMS1;TRAF5;TMSB4X;PSMA2;CCL25;BIRC3;TNFRSF1B;NFKBIA;FOXO3;PSME2;TXNDC17;ARHGEF2;PSMB4;AKT1;TP53;ILK;JAK2;ACTN4;EIF5A;CD40;ZFAND6;PSMC2;PSMB2;ASAH1;PSMB1;TNFRSF1A;TNFRSF11B;GSDME;PSMA8;RPS3;CCL19;MAP3K14;EDAR;TNFSF13;IKBKB;HYAL2;PSME1;TNFRSF25;PSMD4;BRCA1;TNFSF8;PSMA7;PTK2B;LTBR;NFE2L2;RELA;RIPK1;HAS2;PSMD5;GBP3;ADAMTS7;DHX9;ERBIN;TNFSF12;ZFP36L1;ADAM17;PSMB10;TNFRSF9;TNFRSF12A;PSMA3
prerank,gas transport (GO:0015669),0.5176699765596937,1.2852075021015277,0.17990654205607476,0.5368713477164936,1.0,2/10,3.98%,CA2;NGB
prerank,regulation of acute inflammatory response (GO:0002673),-0.4707908862619548,-1.2850697118272991,0.14285714285714285,0.3925983485762547,1.0,2/18,4.57%,OSMR;IL6ST
prerank,recombinational repair (GO:0000725),-0.33468204383869743,-1.284893328743396,0.10296684118673648,0.39248508416175476,1.0,36/77,33.67%,SMC5;SAMHD1;ZFYVE26;SPIDR;MMS22L;MRE11;NABP1;MCM9;RBBP8;RAD54B;NSMCE2;SFPQ;RPA3;RPA1;PALB2;RFWD3;WRN;RPA2;BRCA1;RAD51AP2;BLM;YY1;MORF4L1;INO80;POLL;XRCC2;AP5Z1;KDM4D;RAD51AP1;SWI5;RAD51D;HUS1B;RMI1;MEIOB;RAD50;FAN1
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.34768837019355314,-1.2848770423434706,0.10142348754448399,0.39207479137773443,1.0,17/66,13.55%,FLT1;DAB2IP;PDGFD;DVL3;LRRK2;MAP3K5;EGFR;IL34;FGF1;EDN1;TAOK3;TPD52L1;PIK3R6;EDN3;FGF2;IRAK1;CD40
prerank,error-prone translesion synthesis (GO:0042276),-0.4433981052385576,-1.2848527515818438,0.1441947565543071,0.3916850122759736,1.0,8/21,23.23%,RPA3;REV1;RPA1;MAD2L2;POLE2;RPA2;RFC4;RFC1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.429425663160116,1.28466966449859,0.14578587699316628,0.5364154462480354,1.0,10/19,20.73%,GGA3;NTRK2;SORL1;RTN4;CLU;APOE;RTN3;FLOT2;HAP1;RTN1
prerank,polyol metabolic process (GO:0019751),-0.36349480890400293,-1.2845232096572503,0.13157894736842105,0.3919453056723533,1.0,11/46,10.99%,PLCB4;INPP1;PLCG1;INPP5A;PLCB3;PLCB1;MINPP1;PLCE1;PLCG2;ITPKB;INPP4A
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5350731317236718,1.284294322820503,0.19333333333333333,0.5355334928402593,1.0,4/10,11.43%,ENPP2;PLA2G7;PLA2G6;LIPC
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4125136127236695,-1.2838748612599105,0.13414634146341464,0.39290524087285833,1.0,8/27,20.64%,PRKCH;NFKB1;PPARA;NFKBIA;AGTR1;LPL;PPARG;ITGB3
prerank,regulation of osteoclast differentiation (GO:0045670),0.38070141627456844,1.2834145117059266,0.13501144164759726,0.5359389893864934,1.0,7/33,15.02%,BGLAP;CARTPT;CAMK4;POU4F1;TMEM178A;TCTA;IL23A
prerank,cellular response to nutrient levels (GO:0031669),-0.3463117544104415,-1.2833253684887915,0.09057971014492754,0.3935950177648391,1.0,19/62,18.18%,FOXO1;BMPR2;ATG7;LRRK2;MTOR;MAP1LC3B;PPARA;STK24;MFSD2A;FAM107A;KLF10;PRKAA1;WIPI1;RPTOR;LPL;ZFYVE1;RIPOR1;LAMP2;WRN
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4592533971529217,1.282423520570782,0.16,0.5367701937717666,1.0,9/17,25.59%,BCL2;GGCT;FZD9;CLU;MFF;FIS1;DNM1L;SFN;BOK
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5379744713025646,-1.282389125529814,0.1936619718309859,0.3950516886842988,1.0,7/11,26.17%,TIPARP;PARP4;PARP14;PARP11;PARP16;PARP6;PARP9
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5162786638159877,1.2820335588147078,0.17792792792792791,0.5358422101941702,1.0,4/10,6.03%,ATP1A2;HECW1;OSR1;HECW2
prerank,striated muscle contraction (GO:0006941),0.34980733081131943,1.281909597230734,0.09480812641083522,0.5342366864530804,1.0,13/53,14.50%,SMPX;ATP1A2;SCN1B;STAC2;ATP1B1;RYR2;SCN5A;STAC;TNNC1;DTNA;SLC8A1;TNNI2;SCN2B
prerank,bile acid and bile salt transport (GO:0015721),-0.41879893546507,-1.2818088616636805,0.14716312056737588,0.3958518328652319,1.0,4/24,2.90%,ABCC4;ATP8B1;SLCO1C1;RXRA
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4286406498355938,1.2816373151339155,0.16589861751152074,0.5330479315903225,1.0,6/20,14.53%,BICD1;PLEK;RPGRIP1L;RNF157;CCL5;MRAP2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3375957852099584,-1.2813057358502644,0.08303249097472924,0.39649020185092704,1.0,23/69,21.66%,IGF1R;PLCB4;PLCB3;PIK3R1;IRS1;PLCB1;PI4KB;EZR;PIK3C2A;NGF;PLCE1;PIK3CD;AKT1;EDN1;HTR2A;RHOA;PIK3CB;GAB2;IGF1;PTEN;NF1;OGT;PDGFRB
prerank,RNA processing (GO:0006396),-0.2922112442087181,-1.2810722028098371,0.045454545454545456,0.39649611769463516,1.0,54/176,21.55%,MBNL1;RBPMS;SRSF11;TUT7;TENT4B;RBMS1;PRPF3;SMU1;CDK12;IVNS1ABP;RSRC1;HNRNPA0;PPIG;RBM5;HNRNPR;FUS;PRPF6;RBMS2;CELF1;DDX39B;SF3B1;TENT4A;NOL9;DICER1;HNRNPUL1;RBM39;HNRNPF;XRN2;TUT4;SON;SFPQ;SLU7;APOBEC1;TENT2;YJU2;SCNM1;SF3A1;SYNCRIP;THOC1;SRPK2;ADARB1;USB1;ZMAT5;PPP2CA;TFIP11;SRRM1;NONO;RNPS1;TSEN34;DROSHA;RBM3;FASTKD5;LSM3;RBM6
prerank,establishment of protein localization to membrane (GO:0090150),-0.34717249006577877,-1.2807827013816107,0.0936936936936937,0.396685299677011,1.0,33/66,36.63%,PARD3;RAB3GAP1;ZDHHC6;ZDHHC3;EGFR;AFDN;COX18;AQP11;RAB3GAP2;BRAF;RAB11A;ZDHHC1;GORASP2;REEP1;ZDHHC4;ZDHHC12;RAB3IP;ATG3;VPS37B;RTP4;RFTN1;GOLGA7B;ZDHHC9;SEC63;NPC1;ZDHHC22;RAB10;SYNE3;NCF1;VPS37C;ICMT;YIF1B;RABGEF1
prerank,skeletal muscle organ development (GO:0060538),-0.41222934606393524,-1.280767781917987,0.13989637305699482,0.3962859965078791,1.0,13/26,28.65%,CAV1;SVIL;SIX1;MEF2C;CFLAR;SIX4;MYL6;LARGE1;FOXL2;FXR1;DISP1;STRA6;MSC
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.4578915598170834,-1.280529449047744,0.16856060606060605,0.396350304477494,1.0,5/18,14.93%,DYSF;NMI;LBP;PLCG2;IFI35
prerank,positive regulation of ion transport (GO:0043270),0.35654766968157237,1.2801118964684106,0.10368663594470046,0.5352058899558612,1.0,11/48,12.59%,ANK3;SCN1B;PKP2;GPD1L;WNK3;CACNA1D;PLA2G3;SCN5A;ADRA2A;LILRA5;CCL5
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.32262400642231753,-1.279964364583231,0.08919382504288165,0.39711613267126916,1.0,27/94,19.01%,IL1R1;PELI1;TAB3;NOD1;RPS6KA5;PSMA2;NFKB1;RBX1;NFKBIA;PLCB1;PSME2;PSMB4;MAP3K3;IRAK1;FBXW11;MAP3K8;PSMC2;PSMB2;PSMB1;PELI2;TAB2;IRAK2;PSMA8;IKBKG;IKBKB;NOD2;PSME1
prerank,homeostasis of number of cells (GO:0048872),-0.5157046882931389,-1.2799580782621238,0.1847246891651865,0.3967024564317977,1.0,7/12,26.84%,NOS3;NAPEPLD;NOTCH1;CCN3;LPCAT3;OCIAD2;F2R
prerank,histone acetylation (GO:0016573),-0.3381108302131795,-1.2799042223351658,0.09636363636363636,0.3963794395997817,1.0,24/69,25.06%,LEF1;CREBBP;KAT6B;KAT2B;KAT6A;EP400;PHF20;TRRAP;SGF29;PHF20L1;KAT5;TAF5L;ZZZ3;TADA3;TRIM16;DR1;RUVBL2;JADE2;WDR5;MORF4L1;BEND3;TAF9;MAP3K7;APBB1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3654905673926234,-1.279716776406801,0.10734463276836158,0.39632473521186606,1.0,16/48,22.01%,MCL1;ATM;TNFRSF1B;ABL1;DDIT4;TP53;FNIP2;IKBKE;BCL2L11;HIC1;HIPK1;EPHA2;PRKDC;BRCA1;CASP2;PHLDA3
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.37664638188616184,-1.279713148503127,0.11206896551724138,0.3959049932657662,1.0,17/43,23.53%,FOXN3;ATM;UIMC1;MRNIP;MRE11;NABP1;CLSPN;TAOK3;INTS3;BABAM2;CDK5RAP3;BRCC3;BRCA1;BLM;CHEK1;TRIM39;FZR1
prerank,cytosolic calcium ion transport (GO:0060401),0.3965360070521977,1.2794807834246118,0.1486810551558753,0.534885135942564,1.0,8/28,11.92%,SLC25A23;CACNA2D1;CACNB3;SLC8A2;RYR2;TRPM1;ADRA1A;SLC8A1
prerank,cellular response to glucose stimulus (GO:0071333),-0.41219222318788373,-1.2791191316428965,0.12522686025408347,0.39668918260596814,1.0,6/30,10.64%,UNC13B;IGF1R;ZBTB20;GAS6;ERN1;PRKAA1
prerank,atrioventricular valve development (GO:0003171),-0.49069216449183406,-1.279001889512342,0.18181818181818182,0.396525698294211,1.0,5/14,12.19%,BMPR2;TGFBR2;TGFB2;ZFPM1;NOTCH1
prerank,ubiquinone metabolic process (GO:0006743),-0.4704767862853654,-1.2785113510030255,0.17993079584775087,0.39709600717991284,1.0,6/15,19.31%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.3655158222370039,-1.2783929428655199,0.1054481546572935,0.39691734470507484,1.0,20/46,22.47%,TEK;FERMT2;PARVB;RAC1;PARVA;NTN4;PXN;PIK3R1;ILK;RHOA;LAMA5;LAMC3;ITGA4;ATRNL1;VAMP3;FERMT3;ITGB3;LAMB1;USH2A;EPHB3
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5209769192529301,-1.2782735185450766,0.17625899280575538,0.3967349557089564,1.0,6/11,24.04%,TET2;PRDM9;WDR82;OGT;TET3;BEND3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5015209852578,-1.2780459194008291,0.18262411347517732,0.39590052492679817,1.0,4/12,11.85%,RB1;CUL3;CDC16;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5015209852578,-1.2780459194008291,0.18262411347517732,0.39590052492679817,1.0,4/12,11.85%,RB1;CUL3;CDC16;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5015209852578,-1.2780459194008291,0.18262411347517732,0.39590052492679817,1.0,4/12,11.85%,RB1;CUL3;CDC16;NSMCE2
prerank,purine-containing compound catabolic process (GO:0072523),-0.5027964306823715,-1.2775779064301296,0.1648148148148148,0.39639277781885773,1.0,7/13,27.28%,NT5C2;NT5E;NT5C1A;GPX1;GDA;NT5C;PNP
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.34376465395249267,-1.27698587863663,0.09532710280373832,0.3971634271045272,1.0,18/59,17.01%,DYRK1A;GSK3B;LRRK2;PRKD2;TGFBR2;PRKCD;CDK10;CDC42BPA;MAPK1;ROCK1;PRKD1;GSK3A;AKT1;MAPK8;MARK2;ROCK2;HIPK1;CDC42BPB
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3210600377842451,-1.2768970424367456,0.06261510128913444,0.39696424395339774,1.0,32/96,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.43656022381133663,-1.2761821499213102,0.14028776978417265,0.39798564244822554,1.0,5/22,12.27%,FLT1;ESR1;PLCG1;AGTR1;FGF2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.5398541271470513,-1.275996570726524,0.16425992779783394,0.3979585752563223,1.0,4/10,15.57%,PRKCH;MED1;FOXC1;TRIM16
prerank,peripheral nervous system development (GO:0007422),0.41262482913133636,1.2759863456723008,0.1475,0.5424337519366329,1.0,4/23,6.31%,ASIC2;SCN8A;NFASC;GPC1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4617317281064697,-1.275643299144321,0.15591397849462366,0.3983347015195679,1.0,4/17,7.66%,XIAP;ITGA3;SLIT2;TMEM204
prerank,nucleotide-excision repair (GO:0006289),-0.31578266792487264,-1.2750751897439325,0.09106529209621993,0.3991045962339525,1.0,40/101,31.32%,MNAT1;RNF111;RBX1;POLR2G;ERCC2;TP53;POLD3;TCEA1;OGG1;RPA3;ATXN3;RPA1;PNKP;XPC;ERCC3;ERCC8;FANCC;CETN2;RAD23A;RPA2;USP7;LIG4;COPS7A;RFC4;RFC1;COPS8;POLR2C;COPS4;LIG1;POLR2L;ERCC6;POLR2H;MMS19;GTF2H3;POLL;CCNH;PPIE;CHD1L;COPS5;HUS1B
prerank,regulation of cell adhesion (GO:0030155),-0.3054125620635184,-1.2741431627270177,0.07256637168141593,0.4006923043434149,1.0,38/129,22.47%,RSU1;ACVRL1;PODXL;LYN;ZFHX3;CBLL1;ATM;PKP4;PRKD2;PTPRJ;ABL1;STX3;PTK2;CYTH1;ARHGDIA;PLXND1;TGM2;ROCK1;EPHA4;PLXNA4;ADAM10;PPP1R12A;FRMD5;RASA1;TPM1;ATXN3;ROCK2;NUAK1;ANGPT1;ADGRG1;PPP2CA;EPHA2;TGFBI;CXCL12;PTPN11;GPR4;PTK2B;EPHB3
prerank,sulfur compound biosynthetic process (GO:0044272),-0.3080949326028094,-1.2735572292831838,0.06303236797274275,0.40149052554857656,1.0,31/104,22.21%,ST3GAL6;ST3GAL4;ST3GAL1;SLC26A2;CSGALNACT1;GSTT1;B3GNT2;CHST15;GGT5;B4GALT4;SLC10A7;DSE;ST3GAL2;CHST11;CSPG4;GSTM2;BGN;MAT2B;B4GALT5;ANGPT1;ESD;HPGDS;MAT2A;B4GALT1;CDO1;CHST7;GSTO2;CTH;CHPF2;GCLC;METTL16
prerank,carboxylic acid metabolic process (GO:0019752),-0.3889012807145814,-1.273034763383207,0.13503649635036497,0.4022248771060819,1.0,5/33,3.70%,SLC2A1;ST3GAL1;ST6GAL1;PLA2G4A;CSGALNACT1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.3569702615829718,-1.2728117771602836,0.12897526501766785,0.4022906931936297,1.0,19/52,23.66%,SEC31A;PDIA5;ERN1;PDIA6;KLHDC3;GSK3A;SRPRA;CUL7;KDELR3;WIPI1;LMNA;DCTN1;EXTL3;ACADVL;DNAJB9;PREB;PARP16;FKBP14;TLN1
prerank,regulation of phospholipase C activity (GO:1900274),-0.4777655920626279,-1.2727222116723085,0.16873889875666073,0.40204616345684413,1.0,4/15,5.93%,FLT1;ESR1;PLCG1;ABL1
prerank,mitotic recombination (GO:0006312),-0.47332176208169385,-1.2724486728029683,0.16967509025270758,0.40217804682638997,1.0,11/15,42.06%,SMC5;DMC1;RAD54B;NSMCE2;TEP1;MSH3;RAD51D;RAD50;RAD52;SMC6;ERCC1
prerank,odontogenesis (GO:0042476),-0.39292795819052545,-1.27234634734008,0.14482758620689656,0.40196376291848485,1.0,14/35,24.99%,EDA;ANKRD11;TBX1;HDAC1;LRP6;TGFB2;BMP4;AXIN2;FOXC1;BCOR;TUFT1;LAMB1;MSX1;BMP2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.41725918660513384,1.27224692012556,0.14705882352941177,0.5507468717017195,1.0,7/23,16.64%,FADS1;ACSBG1;ALOX12;ACOT7;ALOX5;CYP1A1;ASAH2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.44326732096507304,-1.2722258866578269,0.1510791366906475,0.4018023654216667,1.0,8/21,20.46%,SLC30A10;PPARA;SIRT5;AATF;ABCB7;HDAC6;COA8;BRCA1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.40018973274502684,-1.272150680583568,0.12585034013605442,0.40152043645077995,1.0,13/32,20.17%,ACVRL1;ACER2;CORO1C;THBS1;FAM107A;BCAS3;RASA1;MYOC;MAP4K4;JAG1;SEMA3E;DUSP22;PTEN
prerank,smooth muscle tissue development (GO:0048745),-0.539399381932558,-1.272073253714823,0.1857638888888889,0.40128069215340234,1.0,9/10,33.81%,ENG;SMO;BMP4;MYLK;NF1;STRA6;SHH;PTCH1;EFEMP2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4174080662995729,1.2715356426458786,0.15317286652078774,0.550660372369667,1.0,10/22,20.72%,STAC2;AKAP6;ATP1B1;CALM2;RYR2;STAC;CASQ1;HTT;HAP1;VMP1
prerank,cellular glucose homeostasis (GO:0001678),-0.3754149687169973,-1.2711150071724917,0.1303538175046555,0.40296195331926804,1.0,9/41,10.64%,UNC13B;IGF1R;ZBTB20;FOXO1;GAS6;PIK3R1;ERN1;LRRC8D;PRKAA1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.38616833944725526,-1.271098232103738,0.1288135593220339,0.402572591247053,1.0,7/36,11.50%,SGMS1;DAB2IP;RB1;FAS;CRADD;TPD52L1;MAZ
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5187601581829691,-1.2709048035765673,0.19494584837545126,0.40255851359399014,1.0,5/11,12.19%,FOXO1;GSK3A;SMAD4;LMNA;NOTCH1
prerank,membrane organization (GO:0061024),-0.2818495354397102,-1.2699750985022484,0.034545454545454546,0.4040354105280276,1.0,68/227,21.65%,SPTBN1;HIP1;FCHO2;MYOF;CERT1;DAB2;DNM3;CORO1C;EPS15;TMCC1;FNBP1L;STX18;A4GALT;LDLRAP1;EGFR;TFRC;EMD;FZD4;AP2B1;AP2A2;DYSF;CBL;DNM2;TOR1B;COX18;RABEP1;AP2S1;EPS15L1;PIK3C2A;SNX9;WASL;AAK1;ITSN1;AGFG1;RAB5A;PICALM;IGF2R;REEP3;CHRNB1;CHMP4B;CHMP4A;ATP10B;GAK;ACTB;CHP1;CHMP2B;GRB2;HIP1R;MITD1;SUN1;ARPC4;CHMP5;TLCD1;REPS1;MOSPD3;VAPA;STON2;VAMP3;GLTP;AP2M1;HUWE1;M6PR;PDCD6IP;OSBPL2;LPCAT3;REEP1;RABIF;VAMP2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.503576324886363,1.269945533544282,0.185589519650655,0.55313416930828,1.0,2/12,3.86%,B3GALT1;B3GALT5
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5245705277359328,-1.2698955119547433,0.18853974121996303,0.40379428506318893,1.0,3/10,12.97%,THBS1;AKT1;CTTNBP2NL
prerank,regulation of spindle assembly (GO:0090169),-0.41718057087517524,-1.2696027507247645,0.14018691588785046,0.4040149424251347,1.0,14/25,32.44%,CHMP4B;DRG1;CHMP2B;TPR;CHMP5;RNF4;PDCD6IP;SENP6;HSPA1B;CHMP3;HNRNPU;CCSAP;CHMP1A;PLK1
prerank,fatty acid biosynthetic process (GO:0006633),0.3383685171214879,1.2694152927311555,0.1048951048951049,0.5525211147035164,1.0,19/63,17.17%,FADS1;ACSBG1;HACD1;ELOVL4;ACLY;ACACA;OXSM;ALOX12;LIPC;TECR;OLAH;ACOT7;SCD5;NDUFAB1;ALOX5;CYP1A1;HACD2;ASAH2;SCD
prerank,regulation of smooth muscle cell migration (GO:0014910),0.43529425837482744,1.2691274751502453,0.15570175438596492,0.551363391172665,1.0,6/20,12.59%,VTN;IGFBP3;NDRG4;SORL1;PDGFA;CCL5
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.28420191811423345,-1.2686651618405702,0.04560810810810811,0.4055895533220117,1.0,68/234,24.95%,PRKCH;EDA;ERC1;ROR1;CAV1;TAB3;ESR1;NOD1;CD200;TRAF5;TRIM25;APP;RPS6KA5;ANXA3;PRKD2;SLCO3A1;SMO;TFRC;FZD4;NFKB1;NFKBIA;STK3;ZBTB7A;LRP6;PRKD1;ARHGEF2;PLCG2;CFLAR;AKT1;RNF25;EDN1;RGCC;IKBKE;TRIM14;IRAK1;MTDH;HDAC4;FLOT1;CD40;TCF3;ADCY1;TAB2;TRIM13;IRAK2;ARID5B;CTNNB1;CEBPG;MAVS;RPS3;IKBKG;IKBKB;NOD2;PPARG;PTEN;ARHGEF5;RELA;MYOCD;MTPN;RIPK1;CRTC1;TRIM68;PLPP3;HSPA1B;SMARCB1;TFDP1;MAP3K7;FANK1;DHX9
prerank,keratan sulfate metabolic process (GO:0042339),-0.39389073770235666,-1.2682917838533032,0.15185185185185185,0.4059395790187353,1.0,6/31,9.03%,ST3GAL6;ST3GAL4;ST3GAL1;B3GNT2;B4GALT4;ST3GAL2
prerank,blood vessel endothelial cell migration (GO:0043534),-0.43465027994441263,-1.2679542562997679,0.1602112676056338,0.4061865408074416,1.0,8/22,16.18%,MYH9;ID1;KDR;SLIT2;CDH5;AKT1;FGF2;PIK3R3
prerank,positive regulation of locomotion (GO:0040017),-0.4116794847332208,-1.2675441514281303,0.14972273567467653,0.4066161965048382,1.0,11/27,30.90%,NTN1;THBS1;SPOCK2;STX3;PPM1F;CAVIN1;CCL19;PDGFRB;TREM2;TGFB1;TRIM32
prerank,mitotic sister chromatid segregation (GO:0000070),-0.3191170941814928,-1.267263005732041,0.0941385435168739,0.40677573336877815,1.0,50/98,36.37%,RB1;PDS5B;NIPBL;CUL3;WRAP73;SMC4;TENT4A;CHMP4B;CHMP4A;POGZ;KIF23;PDS5A;CHMP2B;KMT5A;CHMP5;RAB11A;DSN1;CENPE;PRC1;PDCD6IP;RRS1;NCAPD2;DIS3L2;MCPH1;BECN1;NCAPH;KIF18B;EML4;NCAPH2;PINX1;INO80;RAN;CHMP3;KIF14;SPDL1;TUBG2;CDCA8;SET;TTN;CHMP6;CHMP1A;NUDC;PLK1;BOD1;PSRC1;MIS12;ESPL1;CSNK2A1;CSNK2A2;CHMP1B
prerank,positive regulation of embryonic development (GO:0040019),0.43362620673746205,1.2672248545291334,0.15299334811529933,0.5543924199535446,1.0,3/19,4.20%,TENM4;LHX1;OSR1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4925560843205038,1.2670758431551334,0.19815668202764977,0.55287204691388,1.0,4/12,19.15%,IL12RB1;IL23A;ZBTB1;PRKCQ
prerank,protein insertion into membrane (GO:0051205),-0.3910885704343336,-1.2663118354343734,0.14285714285714285,0.4083763628390081,1.0,11/32,21.65%,APP;EGFR;EMD;COX18;UBE2J2;SGTA;TRAM2;VAPA;WDR83OS;REEP1;VAMP2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.37756102576928907,-1.2662442003904693,0.11895910780669144,0.40810625833159764,1.0,14/39,18.75%,EFR3B;PIP4K2A;PIK3R1;PIP4K2B;PI4KB;PIK3C2A;ITPKB;PIK3CD;TTC7A;SOCS2;PIK3CB;PI4K2B;PIK3R3;TMEM150A
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5176228421788938,1.2661045553298165,0.19098712446351931,0.5534855991804623,1.0,6/10,21.60%,HSF1;CPEB1;CPEB3;DHX36;PAF1;NCBP2
prerank,cellular calcium ion homeostasis (GO:0006874),0.2941190061553054,1.2658878497265078,0.06280193236714976,0.5521539722739955,1.0,25/133,12.59%,SLC24A4;SLC24A2;HTR2C;HCRTR1;STC1;ATP2B4;ATP2B2;ADCY8;CALCA;BCL2;CLN3;ATP1B1;SLC8A2;SELENOK;RYR2;TMCO1;CCL13;GPER1;TMEM178A;ATP13A2;SLC8A3;SLC8A1;HRC;FZD9;CCL5
prerank,negative regulation of cellular component movement (GO:0051271),-0.47450499587702466,-1.26565484653368,0.162748643761302,0.4089076040502202,1.0,5/15,12.34%,SP100;CRK;TGFBR3;FRMD5;ACTN1
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.3609258576387566,-1.2652722671073706,0.13080895008605853,0.4093123926393934,1.0,15/49,16.58%,CBFB;TNRC6B;THBS1;KAT2B;CNOT4;KMT2E;HDAC1;MEF2C;SIN3A;ZFPM1;ASH2L;H3-3A;KMT2C;MTURN;MOV10
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.39574702129488193,-1.265149853401391,0.15441176470588236,0.4087395335077947,1.0,14/32,31.36%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;NUP88;RAN;SSB;NUP35
prerank,tRNA export from nucleus (GO:0006409),-0.39574702129488193,-1.265149853401391,0.15441176470588236,0.4087395335077947,1.0,14/32,31.36%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;NUP88;RAN;SSB;NUP35
prerank,histone lysine methylation (GO:0034968),-0.38919162402262397,-1.2649598701858589,0.14893617021276595,0.4087206070639463,1.0,15/33,26.63%,PRDM5;SUV39H1;KDM6A;SETD3;DOT1L;ASH2L;SMYD1;N6AMT1;PRDM9;WDR82;WDR5B;WDR5;RBBP5;SETDB2;TRMT112
prerank,ventricular septum development (GO:0003281),-0.3796359865112701,-1.264919142612452,0.13427561837455831,0.40838342956107515,1.0,17/37,19.74%,BMPR2;TGFBR3;TGFBR2;HES1;PDE2A;SLIT2;TGFB2;HECTD1;SMAD4;SMAD7;ZFPM1;NOTCH1;HEY1;HEY2;CITED2;SOX4;DAND5
prerank,regulation of necroptotic process (GO:0060544),-0.436270334852785,-1.2647723973863314,0.16725352112676056,0.4082414044329643,1.0,10/23,23.21%,PELI1;BIRC3;ARHGEF2;CASP8;CFLAR;FLOT1;PDCD6IP;OGT;HSP90AA1;RIPK1
prerank,peptide catabolic process (GO:0043171),-0.42528077986409474,-1.264717637012659,0.1710758377425044,0.4079395432792693,1.0,9/23,19.22%,CPQ;ACE;GGT5;ECE1;ENPEP;XPNPEP1;CTSH;ERAP1;NPEPPS
prerank,protein K63-linked ubiquitination (GO:0070534),-0.37152065608788665,-1.2646799512461608,0.13562386980108498,0.40759503554684307,1.0,12/41,20.14%,PELI1;TRAF5;TRIM56;NEDD4;RNF115;HECTD1;UBE2E2;RNF168;UBE2V2;RNF152;RNF4;WWP2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4200713235954672,1.2646193256815568,0.16166281755196305,0.5537172915347985,1.0,6/21,17.24%,NAV3;APC2;STMN2;HDGFL3;CLASP2;CAMSAP3
prerank,bile acid metabolic process (GO:0008206),0.39489823684860964,1.2644886365807502,0.15402298850574714,0.5521485012038254,1.0,5/27,8.86%,AKR1D1;CYP46A1;AKR1C1;OSBPL6;CYP27A1
prerank,Rac protein signal transduction (GO:0016601),-0.4561149226507777,-1.2644125364844938,0.18265682656826568,0.4077371845810869,1.0,8/18,22.30%,EPS8;RAC1;ELMO1;RHOG;NCKAP1;DBNL;WASF1;HACE1
prerank,macrophage activation involved in immune response (GO:0002281),-0.4901511601174896,-1.2640358653942374,0.1935483870967742,0.40810148325333995,1.0,5/13,14.93%,DYSF;NMI;LBP;PLCG2;IFI35
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4405904164972286,1.2637161047354912,0.14847161572052403,0.5522002730378939,1.0,4/18,8.00%,SLC25A13;ASNS;GADL1;ASPA
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5370740364676555,-1.2636391522546606,0.17765567765567766,0.4084754902166343,1.0,4/10,18.97%,KDR;NAMPT;JAK2;NOD2
prerank,calcium ion transport (GO:0006816),0.30646685854879196,1.262999353968864,0.08775981524249422,0.5521541847808356,1.0,20/113,8.06%,TRPM3;SLC24A4;SLC24A2;MS4A1;RYR3;CACNA1B;ATP2B4;ATP2B2;CACNA2D1;CACNA1A;CACNB3;CACNG8;CACNA1D;SLC8A2;SELENOK;RYR2;TMCO1;CACNG3;CACNA1E;TRPM1
prerank,negative regulation of cell cycle process (GO:0010948),-0.3410815406913284,-1.2626292137007518,0.11403508771929824,0.4102720471316451,1.0,22/61,24.58%,DAB2IP;MGA;RYBP;SUZ12;BMP4;MAX;RBBP8;WAPL;EHMT1;PPP1R10;YAF2;PHC1;FOXO4;TERF2;BMP7;RNF2;BRCA1;PHC3;CHEK1;TOM1L2;E2F7;TFDP1
prerank,positive regulation of cell growth (GO:0030307),0.31240990434209936,1.2624244336886228,0.08275862068965517,0.5519007908684294,1.0,20/96,11.31%,L1CAM;SYT1;RIMS2;RIMS1;CXCL16;SHTN1;CDKL5;AKAP6;BCL2;PSMD10;LIMK1;EXOSC9;SPHK1;CPNE9;ADNP2;KLHL22;MAPT;ZFYVE27;RNF157;SYT4
prerank,neutral amino acid transport (GO:0015804),-0.40761289179659965,-1.2609073293968085,0.1490125673249551,0.41344112092692215,1.0,11/28,23.45%,SLC6A6;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC43A1;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC38A6
prerank,ureteric bud development (GO:0001657),0.4385127380598767,1.2608631399672272,0.18468468468468469,0.554017663373115,1.0,6/17,7.53%,ROBO2;LHX1;NPNT;OSR1;WT1;FGFR2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2864025814435664,-1.2608215599270634,0.05254237288135593,0.41322340625324905,1.0,53/208,18.97%,DAB2IP;PELI1;AKAP13;ROR1;TAB3;ESR1;MIER1;ANKRD17;NOD1;TRAF5;TRIM25;PLEKHG5;NEK6;TNFSF10;BIRC3;TFRC;PLK2;PRKD1;PLCG2;ALPK1;PPM1B;CASP8;CFLAR;MAP3K3;FLNA;IKBKE;TRIM14;RHOA;IRAK1;MTDH;RHOC;CD40;ZFAND6;TRIM59;TNFAIP3;TNFRSF19;USP10;TNFRSF1A;PELI2;TAB2;TFG;TRIM13;MIB2;VAPA;MAVS;ZMYND11;IKBKG;CCL19;LURAP1;MAP3K14;EDAR;IKBKB;NOD2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4192543522331691,1.2606663479288989,0.17324561403508773,0.5526934931274617,1.0,6/22,12.48%,TAFA1;TOX;PTPRZ1;PROX1;INSM1;FZD9
prerank,response to organophosphorus (GO:0046683),0.45643389238959686,1.2592674428237796,0.16738197424892703,0.5544481289259304,1.0,3/16,5.28%,DGKQ;AKR1C1;TYMS
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.31272487422921375,-1.2591269231257478,0.09506398537477148,0.41637516113336953,1.0,30/107,20.26%,DAB2IP;ITPR1;GSK3B;THBS1;RNF139;ATG10;MAP3K5;NIBAN1;RASGRF2;NCK1;PIK3R1;CREB3L2;ERN1;JUN;ATP2A3;TP53;BCAP31;ERO1A;FLOT1;PDIA3;UFM1;ATF4;DNAJC10;BBC3;BCL2L11;CDK5RAP3;DNAJB12;DNAJB9;GORASP2;HERPUD1
prerank,central nervous system development (GO:0007417),0.2704982058299745,1.259119533622035,0.03640776699029126,0.5529983879203606,1.0,49/250,13.66%,CNTNAP2;ROBO2;ASIC2;CNTN6;IL1RAPL2;CNTN4;GRIN2B;DSCAML1;ADAM23;MYRF;ADAM22;SH3GL2;ADGRL3;NPAS1;SPOCK1;DNER;CDK5;GRIN2A;NRCAM;POMK;MEIS1;NDRG4;MEIS3;MDGA1;PITPNM1;SMG9;PTPRZ1;MAP1S;PROX1;HPCAL4;GSN;GRIK1;AHI1;NCAN;KLK6;DCX;POU3F3;HAPLN2;MOG;MBP;NMUR2;ARNT2;CDH2;SLC8A3;PBX4;TPPP;RPS6KA6;TUBGCP2;CAPG
prerank,positive regulation of behavior (GO:0048520),0.5205835294582104,1.2589528646258785,0.21397379912663755,0.5516212391381762,1.0,3/10,10.12%,NLGN1;NR4A3;SGIP1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4634823602752016,-1.2588244219703155,0.1853932584269663,0.41658794335397675,1.0,9/17,36.26%,KLF4;TMSB4X;ANXA4;ANXA1;ARRB1;CACTIN;TLR6;CD33;MAPKBP1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.451921610645853,-1.2584063992112053,0.18467583497053044,0.4170666119653714,1.0,7/17,25.58%,ALG14;ALG12;ALG8;DOLPP1;ALG13;MVD;DOLK
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3434357275231041,-1.2581477663110785,0.1113013698630137,0.4171290071907146,1.0,19/61,17.77%,AKAP13;RAC1;ARHGEF3;LYN;NET1;F11R;SHOC2;PRAG1;NGF;NOTCH2;RAPGEF1;JAK2;NOTCH1;PIK3CB;GRB2;MAP4K4;IGF1;ALS2;ADGRG1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.3634875745748367,1.2580123431934294,0.14988814317673377,0.5523120428969666,1.0,10/41,12.02%,ANK3;KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;KCNJ6;STAC;KCNN3;GABBR1
prerank,protein ubiquitination (GO:0016567),-0.25772308120775483,-1.2579873606752952,0.014263074484944533,0.41703310481208417,1.0,157/471,27.43%,FBXL7;WWP1;PELI1;UBR5;CBFB;USP9X;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;FBXL12;UBE2K;TRIM25;CNOT4;RNF139;PSMA2;RNF111;FBXL17;DTX3L;ZNRF3;SMURF1;CUL9;RNF125;FBXL3;RNF213;RBX1;CBL;OTULIN;RNF43;LMO7;UBE4B;CUL3;NEDD4;RNF40;PSME2;RNF115;RNF144B;KLHL12;CUL2;BIRC6;UHRF2;PDZRN3;ARRDC1;SPSB1;PSMB4;SH3RF1;TRIP12;UBE2J2;DET1;ZNRF2;UBE2D3;MIB1;TPP2;CUL7;UBR2;RNF25;FBXW8;AREL1;TNFAIP1;KLHL13;TRIM14;RMND5A;CDC16;HERC6;TSPAN17;RAD18;CDC73;RTF1;ANAPC16;UBE2E2;OBI1;UBE4A;ASB1;FBXW11;KLHL25;RNF168;PSMC2;RC3H1;RNF167;MYLIP;DTX3;HIF3A;VCPIP1;UBE2V2;ERCC8;PSMB2;PHC1;PEX14;UBE2L3;PSMB1;PELI2;HERC2;TRIM13;MIB2;CTNNB1;RFWD3;KCTD10;PSMA8;SPOP;SASH1;KLHL3;SDE2;EPAS1;RNF10;UBR1;SIAH1;RNF152;AKTIP;PSME1;TRIM3;NPEPPS;RNF4;USP7;PRKDC;TRIM47;WWP2;ELOC;PSMD4;HUWE1;FANCL;BRCA1;UBE2R2;MDM2;SH3RF2;CAND2;PSMA7;KEAP1;HACE1;NFE2L2;TRIM39;PSMD5;THOP1;TRIM68;ARRB1;RCHY1;TRIM7;RNF146;FBXO32;TRPC4AP;RNF38;FBXL22;FBXO17;ANAPC7;FBXO40;DTL;TRIM44;PSMB10;ARIH2;LEO1;RNF122;RNF103-CHMP3;PSMA3;RNF34;RNF103;ATG3;TRIM6
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.37902085200789565,-1.2577866954865515,0.13217391304347825,0.41699308956593195,1.0,13/39,14.85%,ACER2;CORO1C;THBS1;GCNT2;FZD4;RASA1;NOTCH1;RHOA;ACTN4;MYOC;SPRY4;MAP4K4;JAG1
prerank,positive regulation of exosomal secretion (GO:1903543),0.453086795330222,1.257779627706521,0.17913832199546487,0.5511404161072574,1.0,7/15,18.93%,SMPD3;HGS;TSG101;ATP13A2;SDC4;CHMP2A;VPS4B
prerank,tRNA transport (GO:0051031),-0.38625741075395126,-1.2575758616129158,0.15384615384615385,0.4170398430719789,1.0,15/35,31.36%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;NUP88;RAN;TOMM20;SSB;NUP35
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4649135538806308,-1.2574463501433606,0.16460176991150444,0.41690296286117756,1.0,4/17,3.37%,RAPGEF2;AKAP13;ADRA1B;ADCY9
prerank,regulation of cytokinesis (GO:0032465),-0.3276970565516182,-1.2572894900696794,0.09734513274336283,0.41682317398573054,1.0,24/78,25.30%,PRKCE;SVIL;SETD2;PKP4;AHCTF1;ZFYVE26;CUL3;CDC14A;RAB11FIP3;PLK2;BIRC6;KLHL13;KIF23;RHOA;PKN2;RAB11A;GIPC1;PLK4;CETN2;PRC1;KIF13A;BECN1;E2F7;PLK3
prerank,response to hydrogen peroxide (GO:0042542),-0.3618374845011087,-1.2552864751825177,0.12014787430683918,0.4206338980967861,1.0,21/45,24.02%,NET1;MAP3K5;ADAM9;STK24;ABL1;PRKCD;ANKZF1;CAT;GPX1;TNFAIP3;FYN;ANXA1;HDAC6;PPIF;SOD1;RPS3;MAPK7;NFE2L2;RELA;RIPK1;CYP1B1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3254935750914011,-1.254864288329762,0.0905861456483126,0.4211471113890752,1.0,29/85,24.52%,DAB2IP;CSNK1A1;CBFA2T3;DAB2;GSK3B;LRRK2;RBX1;RNF144B;HECTD1;GSK3A;DET1;USP13;GABARAP;SMAD7;CSNK1D;ATXN3;ECSCR;ZER1;PSMC2;ZYG11B;SUMO1;RAD23A;MDM2;SH3RF2;KEAP1;CEBPA;RCHY1;TRIB3;HSPA1B
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.3289597089125407,-1.2542193837145545,0.10357142857142858,0.42204804829911313,1.0,27/76,24.76%,XIAP;DCUN1D3;CAV1;LRRK2;BIRC3;UBA2;CUL3;GSK3A;FAM107A;NSMCE3;SMAD7;HDAC4;UBE2L3;DCUN1D2;ANGPT1;SENP2;CDK5RAP3;PIAS4;PHF23;HUWE1;BRCA1;DCUN1D5;NDFIP2;AMER1;RCHY1;SAE1;FANCI
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.33187397942760943,-1.2541939896565062,0.1111111111111111,0.42168817764302713,1.0,28/73,26.59%,KAT2B;DEK;CTCF;SUZ12;SF3B1;TASOR;TAF1B;HDAC4;ACTB;TAF1C;MECP2;GPX1;H3-3A;DNMT1;HDAC6;PPHLN1;WBP2;KDM1B;PPM1D;BAZ1B;IGF2;TAF1D;AEBP2;POLR1E;POLR2L;ERCC6;POLR2H;HDAC5
prerank,regulation of axon extension (GO:0030516),0.3665471563447081,1.2539514252314947,0.12473572938689217,0.5595903173900271,1.0,14/37,14.63%,L1CAM;SHTN1;CDKL5;NRCAM;LIMK1;MAP2;MAPT;RTN4;PTPRS;ZFYVE27;MAG;TRIM46;OLFM1;APOE
prerank,regulation of translation (GO:0006417),-0.2877305255079775,-1.253190932678882,0.06872852233676977,0.4233575634414519,1.0,63/173,27.10%,EIF3H;DAPK1;THBS1;EIF4H;APP;RNF139;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;GIGYF2;PLD1;EIF3C;LARP1;FOXO3;UPF3B;LTN1;EIF3B;OGFOD1;SAMD4A;RPL26;EIF2B2;ZCCHC4;EEF2;RPS6KA1;LARP4B;KLHL25;RPS4X;GSPT1;RPL10;RPS6KA3;IGFBP5;SYNCRIP;BTG2;RPL5;METTL5;RPS3;CTIF;RBM4B;SOX4;PRKDC;CAPRIN1;GLE1;TOB1;RBM3;MTPN;RPL13A;MRPL13;EIF2AK3;MTG2;POLDIP3;NEMF;DHX9;FXR1;IGF2BP2;EIF2AK4;CNOT8;HNRNPD;NANOS1;LARP6;CNOT1;EIF5B
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5055973824281997,-1.253150264515776,0.17122040072859745,0.42302533237025086,1.0,4/12,15.57%,ASXL1;KLF2;CTBP2;TRIM16
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3859485370075565,-1.2531286199313294,0.1586452762923351,0.42264761543389634,1.0,15/33,26.42%,IGF1R;PIK3R1;IRS1;PIK3C2A;PIK3CD;AKT1;EDN1;HTR2A;PIK3CB;IGF1;PTEN;NF1;PIK3CA;ZFP36L1;TPTE
prerank,autophagy of peroxisome (GO:0030242),-0.5061910706372078,-1.253034879421969,0.19962335216572505,0.4224269182285791,1.0,2/12,4.77%,ATM;MAP1LC3B
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.3050581923477899,-1.2526998130396605,0.06666666666666667,0.4228067612293451,1.0,46/124,26.87%,LEF1;GNB1;RAC1;TNRC6B;SMURF2;FZD6;DVL3;NFATC1;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;PLCB3;PLCB1;AP2S1;PSME2;PSMB4;RHOA;WNT11;AGO2;PSMC2;PSMB2;PSMB1;MOV10;CTNNB1;PSMA8;PSME1;TNRC6A;TCF7L2;AP2M1;PSMD4;ROR2;PSMA7;FZD7;SFRP4;PSMD5;FZD5;MAP3K7;FZD10;GNG2;PSMB10;FZD1;FRZB;PSMA3
prerank,V(D)J recombination (GO:0033151),-0.5123089981384974,-1.2517222705684308,0.1978798586572438,0.4244193391900623,1.0,6/11,24.66%,XRCC4;TCF3;PRKDC;LIG4;LIG1;HMGB1
prerank,neutrophil activation (GO:0042119),-0.5005627982900547,-1.2513765734962565,0.20287253141831238,0.4246814932270736,1.0,4/12,16.59%,KMT2E;IL15;PRKCD;PREX1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.3427787177743644,-1.250483309463895,0.1168141592920354,0.4261588373506322,1.0,21/53,26.54%,EYA4;ATM;UIMC1;SPRED2;EGFR;PRKCD;BABAM2;RNF168;ERCC8;HIC1;CEBPG;BRCC3;RPS3;NSMCE4A;BRCA1;TRIM28;MSX1;DHX9;FXR1;ERCC6;FGF10
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2859113261343928,1.2498949970923603,0.07517084282460136,0.5684394591561496,1.0,30/152,12.02%,ADGRB3;GNAO1;CHRM2;GNAI2;ADGRL3;GRM8;ADCY8;GNAI1;CALCA;GNAL;ADGRG4;CNR1;PTGER3;GPR37;GNAT3;MTNR1A;CACNA1D;PF4;GIPR;ADCY7;ADRB3;ADRA2A;GPR65;TSHR;GPER1;LGR5;VIPR2;ADRA1D;HTR1D;GABBR1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.47413420658972427,-1.2497704093564028,0.21299638989169675,0.42723433543171263,1.0,2/14,2.95%,DAB2IP;PTPN1
prerank,eosinophil chemotaxis (GO:0048245),0.4687742834405537,1.2494716577788556,0.19870410367170627,0.5659345921782403,1.0,5/14,19.12%,CCL13;CCL5;CCL2;CCL7;CX3CL1
prerank,eosinophil migration (GO:0072677),0.4687742834405537,1.2494716577788556,0.19870410367170627,0.5659345921782403,1.0,5/14,19.12%,CCL13;CCL5;CCL2;CCL7;CX3CL1
prerank,membrane protein proteolysis (GO:0033619),-0.3809825505918759,-1.2493588791227843,0.15412844036697249,0.42772077264985964,1.0,11/37,18.01%,MYH9;ADAM9;NFKB1;PSEN2;SPPL3;AFG3L2;ADAM10;PSEN1;CTSH;APH1A;ERAP1
prerank,"phototransduction, visible light (GO:0007603)",-0.4735094018291317,-1.249350537910127,0.18330308529945555,0.4273159450973971,1.0,8/14,46.73%,GNB1;SAG;GNA11;PDE6G;PDE6B;RP1;GNAQ;RHO
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3433613699832381,-1.2493375746710351,0.11895910780669144,0.4269246321411029,1.0,13/57,11.35%,DAPK1;NOD1;UACA;MAP3K5;DDX3X;TNFSF10;PPM1F;ARL6IP5;ASPH;CASP8;PERP;BCAP31;SOX7
prerank,nuclear pore complex assembly (GO:0051292),-0.5195698840508121,-1.248788703123779,0.19607843137254902,0.4276955161097265,1.0,4/10,15.77%,AHCTF1;NUP98;NUP153;TPR
prerank,glycine transport (GO:0015816),0.5060421191372287,1.2482741749188613,0.1822429906542056,0.5673702424865059,1.0,3/10,9.20%,SLC7A8;SLC36A2;SLC6A5
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.31406199154182435,-1.248090417384997,0.10583941605839416,0.42875397637057544,1.0,30/91,25.64%,ABCG2;APP;ATOX1;SLC39A10;SLC40A1;SLC31A1;TFRC;SLC30A10;BMP6;SCARA5;SLC39A8;SMAD4;HFE;HMOX2;ABCB7;SLC30A5;SLC39A6;SOD1;FLVCR1;SLC30A1;GLRX3;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B;LCN2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.4292025249425306,-1.2475022228263584,0.17428087986463622,0.4296671821797557,1.0,6/21,14.09%,PAN3;TUT7;CNOT4;SAMD4A;TUT4;PARN
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.44471300784948137,1.2469674619417157,0.16404494382022472,0.5690336291307743,1.0,6/18,11.47%,HSD17B12;ACSBG1;HACD1;ACSL3;ACSL6;TECR
prerank,NAD biosynthetic process (GO:0009435),-0.4378136425427742,-1.2464427269647484,0.1724770642201835,0.4315618781313577,1.0,12/20,37.20%,NAMPT;NADSYN1;NAXE;NUDT12;NAPRT;KYNU;PARP16;PTGIS;PARP9;NAXD;NMNAT3;NNMT
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3628034170780576,-1.246381333745399,0.1512455516014235,0.43126184470153345,1.0,10/45,11.47%,SP100;IRF2;TRIM25;JAK1;ICAM1;MID1;CAMK2G;PRKCD;IRF1;JAK2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.39694137389192785,-1.2460640013532447,0.19217081850533807,0.4315446522575761,1.0,6/30,7.55%,AKAP13;RAC1;ARHGEF3;NET1;F11R;PRAG1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.4963533452485191,1.2459381065283546,0.19696969696969696,0.5701020551626272,1.0,3/11,11.43%,PLA2G7;PLA2G3;LIPC
prerank,regulation of TORC1 signaling (GO:1903432),0.37955490878518117,1.2458636028948595,0.15973741794310722,0.5684724394606716,1.0,8/33,8.51%,DGKQ;GPR137C;PIP4P1;RRAGA;STK11;FLCN;KLHL22;SEH1L
prerank,cellular response to UV-A (GO:0071492),0.5038224773076341,1.2456981539391356,0.20674157303370785,0.5670753890195456,1.0,4/11,13.12%,MME;CERS1;TIMP1;PPID
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.47409298066996153,-1.245376952466662,0.1962962962962963,0.43258016436497493,1.0,7/14,23.01%,KMT2E;SMAD4;PRDM9;DNMT1;CTNNB1;BRCA1;WDR5
prerank,regulation of cartilage development (GO:0061035),-0.443335903506217,-1.2447972768428501,0.17259786476868327,0.43342833026582156,1.0,5/18,16.33%,ZBTB16;BMPR2;BMP4;WNT11;TRPS1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.3595958210716803,-1.2447127717801119,0.15356489945155394,0.43321830333335776,1.0,16/46,25.53%,PLA2G4A;LPCAT1;PLD1;PLD2;DGKA;AGPAT4;DGKZ;ACP6;AGPAT3;AGPAT1;PLA2G12A;LCLAT1;DDHD2;GPD1;DGKH;DGKE
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5300303790858294,-1.2446617268779192,0.2147887323943662,0.43290679327826487,1.0,2/10,9.06%,CBFB;SH3RF1
prerank,positive regulation of ATPase activity (GO:0032781),0.3593897860317375,1.2445344550181963,0.15258215962441316,0.5683591993794064,1.0,14/41,20.89%,PFN2;DNAJB11;ATP1B1;UHRF1;PFN1;DNAJC24;RYR2;MSH2;MYL4;DNAJB2;DNAJB1;VMP1;ATP1B2;CHTOP
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.518811232119375,1.2440512362793932,0.21710526315789475,0.5678376863854265,1.0,2/10,2.53%,UBE2J1;INSIG1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4855612255672813,1.2438295497794791,0.21365638766519823,0.5666095229550987,1.0,7/12,19.04%,BICD1;NINL;BBS4;KIF3A;CEP19;HOOK3;CCDC120
prerank,regulation of synapse organization (GO:0050807),0.39535250719947845,1.2437267076072187,0.17932489451476794,0.5651056097003536,1.0,7/26,9.85%,IL1RAPL1;CTNNA2;CDKL5;CLN3;MDGA1;CAMK2B;SLITRK4
prerank,respiratory chain complex IV assembly (GO:0008535),-0.42927136385402276,-1.243640453993946,0.17712177121771217,0.43457153248186964,1.0,7/21,19.59%,COX16;COX18;SCO1;COX17;COA6;COX10;COA8
prerank,ncRNA export from nucleus (GO:0097064),-0.38215415839743583,-1.2434718400874047,0.14656771799628943,0.43451040634005816,1.0,15/36,31.36%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;PHAX;NUP188;NUP88;RAN;SSB;NUP35
prerank,ubiquinone biosynthetic process (GO:0006744),-0.4616094766736798,-1.2430803774806733,0.21061946902654868,0.43494358927642474,1.0,6/15,19.31%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,negative regulation of cell growth (GO:0030308),-0.29929520953348876,-1.2427062514929337,0.08333333333333333,0.4353232905579704,1.0,41/121,25.55%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;DDX3X;PTPRJ;SOX17;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;DIP2B;GSK3A;SMAD4;TP53;DCBLD2;SEMA3G;WNT11;ULK2;ST7L;CCN3;RERG;NPR1;OSGIN2;HYAL2;PPP2CA;BCL6;CDKN2C;CAPRIN2;FHL1;MSX1;SERTAD2;HSPA1B;GNG4;APBB1;SIPA1;SERTAD3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.44352639076958167,-1.242587841456122,0.2018348623853211,0.435168970566226,1.0,5/17,11.55%,PARD3;SPRED2;PPEF2;DDIT4;SMAD7
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.3035861611774643,-1.2425031828302455,0.09490333919156414,0.4349199095488871,1.0,36/118,18.40%,SP100;SHANK3;FERMT2;ADGRA2;BMPER;ETS1;NEDD4L;PDZD8;GSK3B;KIF13B;PAK2;TBX1;LRRK2;PDLIM5;ZMYM6;CHN1;NEDD4;MEF2C;PLXND1;EPHA4;FLT4;STAT2;ABI3;FGF2;ZMYM4;CEACAM1;RC3H1;MARK2;TNFAIP3;FMNL2;CTNNB1;ARHGAP35;CAPZB;RAP2A;CFL1;WTIP
prerank,positive regulation of neurogenesis (GO:0050769),0.3206347828869661,1.2419730048615403,0.1278538812785388,0.5680854218098057,1.0,14/68,13.54%,PTPRD;IL1RAPL1;ROBO2;OPRM1;MME;ROBO1;CDKL5;NTRK2;SLITRK1;VEGFA;GPER1;FZD3;PLXNA2;PLXNA1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5100150407100952,-1.2417732523647942,0.20522388059701493,0.436069368482772,1.0,3/11,10.11%,EGFR;BMP4;TP53
prerank,protein modification by small protein removal (GO:0070646),-0.27203085760115514,-1.2415897390433857,0.050243111831442464,0.43604083189064735,1.0,91/252,27.05%,SENP1;USP9X;ESR1;ASXL1;SMURF2;IFIH1;KAT2B;PSMA2;UIMC1;USP24;BIRC3;NFKBIA;TRRAP;STAMBP;PSME2;SMAD1;SMAD2;JOSD1;PSMB4;USP2;SMAD4;CLSPN;USP13;TP53;OTUD1;USP40;INO80E;SMAD7;OTUD4;USP15;INO80D;RHOA;USP18;ACTB;ATXN3;BABAM2;PSMC2;HCFC1;TNFAIP3;VCPIP1;USP34;TADA3;PSMB2;USP10;PSMB1;FOXO4;SENP2;INO80B;PSMA8;BRCC3;RAD23A;KDM1B;IKBKG;PSME1;BAP1;USP7;JOSD2;ADRM1;UCHL1;PTEN;USP1;PSMD4;BRCA1;ATXN7;COPS7A;EIF3F;OGT;MDM2;PSMA7;CDC25A;KEAP1;YY1;MBD6;SENP6;BECN1;SUDS3;USP16;RIPK1;STAM2;COPS8;PSMD5;USP12;COPS4;MAP3K7;INO80;PSMB10;TNIP1;APC;TOMM20;PSMA3;USP19
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3960908820538339,1.2407184573307029,0.17548076923076922,0.5696667353781094,1.0,6/27,8.20%,PDE4B;CTNNA3;STC1;PKP2;RYR2;SCN5A
prerank,establishment of melanosome localization (GO:0032401),0.4270340832325285,1.240701066272787,0.19114219114219114,0.5679316253352176,1.0,9/19,16.60%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,reverse cholesterol transport (GO:0043691),0.47657396326721446,1.240358319582121,0.2100456621004566,0.5670472233411997,1.0,5/13,14.63%,APOM;LIPC;ABCA5;CLU;APOE
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.36190857492584383,-1.240285082666021,0.1413427561837456,0.43849743773592076,1.0,16/44,15.35%,FERMT2;RAC1;PXN;ABL1;ARHGEF15;PPM1F;RGCC;RHOA;LIMCH1;TPM1;WNT11;MYOC;RHOC;ARHGEF10;SORBS3;ROCK2
prerank,negative regulation of DNA replication (GO:0008156),0.4796078133499279,1.2401117938445705,0.21149425287356322,0.5660073757623671,1.0,4/13,11.19%,GMNN;GTPBP4;TERF1;ATR
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.5254115516963729,-1.2396908465741476,0.2018867924528302,0.43936970137812853,1.0,4/10,14.26%,SETD2;SETD3;EHMT1;KMT5A
prerank,aminoglycan biosynthetic process (GO:0006023),0.3445943422072366,1.2392384748904985,0.14855875831485588,0.566549939398841,1.0,10/49,7.93%,GPC5;B3GALT1;HS3ST6;HS3ST5;B3GALT5;HS6ST2;GPC1;GALNT5;B4GALT7;HS3ST2
prerank,negative regulation of cell migration (GO:0030336),-0.29791271633559646,-1.23913739256395,0.08602150537634409,0.44009465537405257,1.0,44/137,21.11%,PTPRG;DAB2IP;CLDN5;ENG;ACVRL1;RAC1;CORO1C;MCC;MITF;ARID2;PTPRJ;SCAI;LDLRAD4;AFDN;TCAF1;STK24;FOXO3;SLIT2;PTPRK;EPHA4;DACH1;CDH1;ZMYND8;SMAD7;FGF2;LIMCH1;TPM1;DUSP3;WNT11;HAS1;JAG1;IGFBP5;MIF;FUZ;ADARB1;ADGRG1;RAP2A;CITED2;HYAL2;DUSP22;RAP2C;PTEN;NF1;VCL
prerank,protein localization to plasma membrane (GO:0072659),0.29160343731926874,1.2391011926826616,0.0776255707762557,0.5651556377184888,1.0,29/129,11.34%,KCNIP4;ABCA12;DPP10;MAP7;ANK3;DPP6;CCDC88A;ANK1;RAB15;EPB41L3;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CACNB3;WNK3;CD81;NECTIN3;MYO5A;ZFYVE27;SPTBN4;TESC;C2CD5;RAB3A;TSPAN32;PPIL2;NKD2
prerank,cellular response to interferon-beta (GO:0035458),-0.46935348028302026,-1.2388559147690357,0.18265682656826568,0.4402363506868271,1.0,7/14,35.23%,UBE2K;IRGM;IRF1;IFITM2;TRIM6;CDC34;UBE2G2
prerank,protein-containing complex disassembly (GO:0032984),-0.3447520054948698,-1.2387192499360014,0.14620938628158844,0.44011073136355927,1.0,17/54,26.83%,CSNK1A1;CAV1;LIX1L;GSK3B;DVL3;MAP1LC3B;LRP6;TECPR1;GABARAP;CTNNB1;LAMP2;AMER1;PPP1CA;FZD5;FZD1;APC;CHMP3
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5189255526204976,-1.23857039407138,0.21402877697841727,0.4400089328250718,1.0,2/10,5.58%,TRPM4;TNFRSF1B
prerank,protein glycosylation (GO:0006486),-0.30036405831247426,-1.238160813624984,0.09352517985611511,0.4404825143447552,1.0,24/125,10.84%,ST3GAL6;EOGT;ST3GAL4;ST3GAL1;PLOD1;PLOD2;ST8SIA4;GCNT2;TRAK1;GALNT10;ALG10B;MAN1C1;DAD1;MGAT4B;B3GNT2;GFPT2;TET2;FUT8;AQP11;SLC39A8;ST3GAL2;FUT10;ALG12;ALG8
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4966197572219166,-1.2378183673915282,0.2018018018018018,0.4408573393281675,1.0,4/11,20.12%,ATG7;ATG10;WIPI1;WDR45B
prerank,cellular response to virus (GO:0098586),-0.3928106925201985,-1.2377839785002478,0.1657754010695187,0.4405150940463476,1.0,15/30,30.24%,IFIH1;DDX3X;IRGM;EIF5A;LGALS8;GSDME;CCL19;HSP90AA1;MAPK11;VWCE;LGALS9;CXCL10;RIOK3;TOMM70;MAPK14
prerank,positive regulation of secretion (GO:0051047),0.5002088929429209,1.2372724509033428,0.22119815668202766,0.5682467156604627,1.0,3/11,12.14%,TRH;ACSL3;GPLD1
prerank,microvillus organization (GO:0032528),-0.4855777958890009,-1.2361318990909138,0.21323529411764705,0.44361083419650366,1.0,8/13,19.61%,RAPGEF2;RAP1A;EZR;FXYD5;RAP1B;MAP4K4;RAP2A;RAP2C
prerank,positive regulation of transferase activity (GO:0051347),-0.2942792573049881,-1.2360783906003654,0.08775137111517367,0.44330115461521025,1.0,42/142,22.47%,FLT1;TEK;IGF1R;TIE1;DCUN1D3;ROR1;INSR;KLF4;NEK7;CD200;DTX3L;KDR;MERTK;EGFR;DSTYK;LMO4;TCP1;MRE11;MAPK1;EPHA4;FLT4;GSK3A;HMBOX1;PNKP;PARN;PTGES3;MAGEC2;UBE2L3;DCUN1D2;CTNNB1;SERINC1;SERINC5;EPHA2;FGFR4;DCUN1D5;IGF2;ROR2;PDGFRB;RFC4;EPHB6;HSP90AA1;EPHB3
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.47340542769667465,1.2359545070349176,0.20964360587002095,0.5701497398503914,1.0,5/14,9.70%,AK7;AK3;AK5;ENPP3;NME2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.490236090394764,-1.2354923801044688,0.23357664233576642,0.4441726346515579,1.0,5/12,15.49%,RANBP9;ROCK1;PICALM;ROCK2;ABCA7
prerank,synaptonemal complex organization (GO:0070193),0.4569505793215367,1.2354546453136395,0.2009132420091324,0.5680011730299892,1.0,4/15,13.00%,SYCP1;REC8;SYCP2;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.4569505793215367,1.2354546453136395,0.2009132420091324,0.5680011730299892,1.0,4/15,13.00%,SYCP1;REC8;SYCP2;RAD21
prerank,mRNA transport (GO:0051028),-0.308206823544805,-1.2347377778236268,0.09259259259259259,0.44543679649123413,1.0,32/101,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,negative regulation of phosphorylation (GO:0042326),-0.31655909127153775,-1.2345606817700074,0.12371134020618557,0.44536510443776817,1.0,25/85,21.55%,DAB2IP;CBFA2T3;LYN;CORO1C;LRRK2;NIBAN1;CDKN1B;PPARA;LRP6;SLIT2;BMP4;ROCK1;PRKRIP1;OCLN;HDAC4;PTPN13;CHP1;TRAF3IP1;DNAJC10;BMP7;CDK5RAP3;PRKDC;PTEN;WARS1;CDKN2C
prerank,secretion (GO:0046903),0.4665380939420537,1.234014745868283,0.1976470588235294,0.5702006259627764,1.0,2/14,1.29%,SLC22A4;RIMS1
prerank,regulation of endocytic recycling (GO:2001135),0.49317638312475803,1.233631183998822,0.22489082969432314,0.5695481520568442,1.0,6/11,12.19%,ATP9A;PLA2G3;SORL1;PLA2G4E;EIPR1;INPP5F
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.4452573298917708,-1.233571891050862,0.21102661596958175,0.44706109658390947,1.0,4/18,10.11%,ESR1;EGFR;BMP4;TP53
prerank,response to interleukin-1 (GO:0070555),-0.3225867593878132,-1.2334826727148327,0.10771992818671454,0.4468122501034692,1.0,22/73,24.54%,DAB2IP;IL1R1;APP;CCL25;NFKB1;IRAK1;HDAC4;CD40;RC3H1;USP10;IRAK2;ANXA1;IGBP1;CCL19;HYAL2;RELA;HAS2;MAPK11;GBP3;ADAMTS7;PTGIS;TAF9
prerank,positive regulation of organelle organization (GO:0010638),-0.37672151505925267,-1.2327703887186439,0.16785714285714284,0.4479228927489755,1.0,14/32,31.44%,RAB3GAP1;GSK3B;ANXA2;STX18;IRGM;RAB3GAP2;SORBS3;ANXA1;LIG4;KATNBL1;DOC2B;TREM2;SYNJ1;PLA2G5
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.43729673474246444,-1.2326994526623558,0.21033210332103322,0.4476552981617911,1.0,6/18,15.56%,ASH1L;SETD2;SUV39H1;SETD3;EHMT1;PRDM9
prerank,mitotic cell cycle phase transition (GO:0044772),-0.27870441241475885,-1.232473889162182,0.06934306569343066,0.44773987589310915,1.0,73/203,29.15%,FBXL7;MNAT1;RB1;EPS8;FBXL12;FBXL17;PPP1R12B;YWHAE;FBXL3;CDKN1B;CRLF3;CEP57;DNM2;CUL3;PLCB1;CCND3;CEP250;MAX;PLK2;CUL2;CEP78;PPP2R2D;NES;LATS2;HAUS8;CHMP4B;TPD52L1;CCNY;PPP1R12A;CDC16;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;FBXW11;CDK6;GSPT1;CEP41;ALMS1;PLK4;PCM1;CACUL1;CETN2;CNTRL;CEP152;CCND1;TACC3;CDK14;CDKN2C;ODF2;CDC25A;HSP90AA1;PCNT;CEP131;AKAP9;AJUBA;CCNG1;CCNE2;E2F3;KHDRBS1;FBXL22;PLK3;ANAPC7;CDKN3;CCNJ;DYNLL1;ARPP19;CDKN2B;CCNH;HAUS1;BORA;HINFP
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.5035780322566167,-1.23216479678401,0.20550458715596331,0.44797607989460686,1.0,5/11,17.32%,SP100;TP53;KAT5;MAD2L2;TFAP4
prerank,response to hydroxyurea (GO:0072710),-0.5085657929268785,-1.2310501332368549,0.22309197651663404,0.45002910130285084,1.0,7/11,21.31%,DDI2;SPIDR;RTF2;NSMCE3;ATRX;TIMELESS;BLM
prerank,positive regulation of type I interferon production (GO:0032481),-0.32236192813168396,-1.2300327380881038,0.11805555555555555,0.451781292244865,1.0,38/73,37.30%,CREBBP;IFIH1;TRIM56;SETD2;DDX3X;NFKB1;STAT6;MRE11;IRF1;IRAK1;LRRFIP1;FLOT1;POLR3F;CGAS;CTNNB1;MAVS;PRKDC;PTPN11;HSP90AA1;RELA;DHX9;IRF7;POLR2L;POLR2H;POLR3GL;RIOK3;TOMM70;POLR3K;IRF5;POLR2E;CD14;POLR3A;TBK1;TLR2;TLR8;GAPDH;G3BP1;NFKB2
prerank,methylguanosine-cap decapping (GO:0110156),0.5084297168223146,1.2296703106799616,0.2288888888888889,0.5784737322508945,1.0,2/10,3.94%,PATL2;DCPS
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.30231097412199837,-1.229597749733672,0.12095400340715502,0.45229123018175904,1.0,34/112,24.95%,FOXP1;CD34;THBS1;IFIH1;APP;PTPRJ;FRMD8;GAS6;LBP;MAPKAPK2;ARHGEF2;PLCG2;NFKBIL1;DICER1;PSEN1;JAK2;LPL;TNFAIP3;ILRUN;MIF;VSIR;IGF1;RARA;MAVS;CCL19;NOD2;PTPRC;PTPN11;ARFGEF2;RIPK1;FZD5;HMGB1;DDT;DHX9
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.47167848482335883,-1.2294735415651135,0.21354166666666666,0.45215390251382703,1.0,2/14,4.57%,OSMR;IL6ST
prerank,protein deubiquitination (GO:0016579),-0.271463299834831,-1.2294550066912122,0.042692939244663386,0.45175369746379557,1.0,79/242,23.87%,USP9X;ESR1;ASXL1;SMURF2;IFIH1;KAT2B;PSMA2;UIMC1;USP24;BIRC3;NFKBIA;OTULIN;TRRAP;MINDY1;STAMBP;PSME2;SMAD1;SMAD2;JOSD1;PSMB4;USP2;SMAD4;CLSPN;USP13;TP53;OTUD1;USP40;INO80E;SMAD7;OTUD4;USP15;INO80D;RHOA;USP18;ACTB;ATXN3;BABAM2;PSMC2;HCFC1;TNFAIP3;VCPIP1;USP34;TADA3;PSMB2;USP10;PSMB1;FOXO4;INO80B;PSMA8;BRCC3;RAD23A;KDM1B;IKBKG;PSME1;BAP1;USP7;JOSD2;ADRM1;UCHL1;PTEN;USP1;PSMD4;BRCA1;ATXN7;EIF3F;OGT;MDM2;PSMA7;CDC25A;KEAP1;YY1;MBD6;BECN1;SUDS3;USP16;RIPK1;STAM2;PSMD5;USP12
prerank,negative regulation of lipid catabolic process (GO:0050995),0.43348069223217167,1.2291671155193173,0.20919540229885059,0.5780966456343144,1.0,6/17,15.14%,PDE3B;BSCL2;SORL1;ADRA2A;GPLD1;APOC1
prerank,sphingoid metabolic process (GO:0046519),0.4901759988198983,1.2289461582687289,0.21460176991150443,0.5769594706928003,1.0,6/12,16.64%,PLPP2;SPHK1;SGPP1;SPHK2;NAAA;ASAH2
prerank,mRNA export from nucleus (GO:0006406),-0.3049403089179723,-1.2288202760074092,0.1141804788213628,0.4527758044052889,1.0,33/102,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;IWS1;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5005364536008594,-1.2287959915696463,0.2088495575221239,0.45238914506217354,1.0,4/11,8.96%,MAP3K5;STK24;PRKCD;ARL6IP5
prerank,nucleosome organization (GO:0034728),-0.33932365893344435,-1.2286719283966376,0.14608695652173914,0.45223888625247044,1.0,16/55,19.63%,KAT6B;SETD2;ARID2;CTCF;SMARCC1;BRD2;SRCAP;SMARCE1;SPTY2D1;SMARCC2;MCM3AP;SMARCD3;H3-3A;PRDM9;VPS72;ATRX
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.43503055614308284,-1.2282794812932813,0.19464285714285715,0.45263745827619695,1.0,4/20,3.37%,RAPGEF2;AKAP13;ADRA1B;ADCY9
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.39538271805744873,-1.228255180618688,0.19089316987740806,0.4522641609729462,1.0,10/26,18.59%,ST3GAL4;ST3GAL2;ALG8;ALG11;B4GALT5;GK5;GAL3ST2;GOLPH3;GBGT1;LARGE1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.26231979127432253,-1.2281442861068121,0.03980099502487562,0.4520611541209728,1.0,122/341,29.34%,FBXL7;WWP1;PELI1;USP9X;NEDD4L;ZNRF1;SMURF2;UBE2K;TRIM25;CNOT4;PSMA2;RNF111;FBXL17;DTX3L;ZNRF3;SMURF1;RNF125;RNF213;RBX1;CBL;RNF43;UBE4B;CUL3;NEDD4;RNF40;PSME2;RNF115;RNF144B;BIRC6;ARRDC1;SPSB1;PSMB4;TRIP12;GSK3A;UBE2D3;MIB1;FEM1A;AREL1;NTAN1;TNFAIP1;RMND5A;CDC16;SPOPL;ARMC8;ANAPC16;KAT5;ATXN3;UBR4;FEM1C;UBE4A;FBXW11;KLHL25;APPBP2;RNF168;PSMC2;RC3H1;RNF167;MYLIP;TNFAIP3;FEM1B;ERCC8;PSMB2;UBE2L3;PSMB1;AGAP3;TRIM13;CTNNB1;KCTD10;UBXN11;PSMA8;SPOP;KLHL3;RAD23A;SIAH1;PSME1;TRIM3;RNF4;ADRM1;BUB1B;UCHL1;TBL1X;WWP2;HERPUD1;ELOC;PSMD4;HUWE1;UBE2R2;MDM2;BUB3;PSMA7;KEAP1;NDFIP2;RNF216;HACE1;NFE2L2;FZR1;PSMD5;ARRB1;RCHY1;RNF146;TRPC4AP;MAEA;FBXL22;ZFAND2A;ANAPC7;DTL;PSMB10;ARIH2;RNF122;UBXN2A;PSMA3;KIF14;RNF34;PPP2R5C;RNF114;VPS37B;UBE2I;UBA1;ATE1;RNF14;RNF187;ANAPC11
prerank,protein localization to cell junction (GO:1902414),-0.4152817623576008,-1.227887797094356,0.18134715025906736,0.4521659063436503,1.0,7/22,7.60%,TJP1;FERMT2;HEG1;JAK1;PAK2;CGNL1;TJP2
prerank,DNA biosynthetic process (GO:0071897),0.4416401998923081,1.2272455412932908,0.20134228187919462,0.5797983628385942,1.0,5/16,14.05%,WRNIP1;TYMS;POLD4;POLA1;PPIA
prerank,positive regulation of developmental growth (GO:0048639),0.33975830136674734,1.2267522370245498,0.16326530612244897,0.5794911921817512,1.0,15/49,15.07%,L1CAM;SYT1;RIMS2;RIMS1;SHTN1;CDKL5;LIMK1;CPNE9;MAPT;ZFYVE27;RNF157;SYT4;BDNF;SYT3;UNC13A
prerank,amino sugar biosynthetic process (GO:0046349),-0.49790484727277995,-1.2263202881979443,0.21641791044776118,0.4552759804033389,1.0,4/12,13.52%,GFPT2;GNPDA2;GNPNAT1;UAP1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5186868255169609,-1.2262713036198645,0.21052631578947367,0.45495836345021734,1.0,6/11,17.00%,RAPGEF2;LYN;MEF2C;PIK3CD;PIK3CB;ANXA1
prerank,motor neuron axon guidance (GO:0008045),-0.46773038213177087,-1.225982850348789,0.20072992700729927,0.4551759104625866,1.0,6/15,13.44%,RAC1;NTN1;CHN1;SLIT2;EPHA4;RHOG
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.42227888873697206,-1.2255244290422866,0.18867924528301888,0.45571371892189527,1.0,3/21,4.16%,MFHAS1;GSK3B;YWHAE
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.26784985306473846,-1.2255236763878172,0.057724957555178265,0.45528217183958286,1.0,64/259,19.61%,ABCC4;ABLIM1;RAPGEF2;ITGB1;EXOC6;FGD5;ASAP1;FGD6;PARVB;CD2AP;RAC1;DNM3;PARVA;NTN1;FNBP1L;EXOC4;RAB1A;EHD2;PTPDC1;SSX2IP;CEP250;IFT140;CDC14A;RAP1A;WDR11;EZR;RAB11FIP3;FXYD5;RAP1B;EXOC2;S1PR1;MYLK;PDE6D;FLNA;EMP1;EHD1;WDR35;GALNT11;ANO6;RAB8B;NOTCH1;IFT52;CFAP44;RAB23;TRAF3IP1;CEP41;MAP4K4;EXOC8;FUZ;DZIP1L;VSTM5;NUDCD3;EHD4;RAB11A;HDAC6;CFAP298;GOLPH3;PLK4;PCM1;RAP2A;TMEM17;KIF3B;IFT43;RAP2C
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.4640119804544297,-1.2254224914521012,0.19030520646319568,0.4550848737014154,1.0,12/15,47.14%,IL17RA;GBP5;NOD2;STAT3;TICAM1;TLR6;HIF1A;CARD9;TLR4;TNF;IL6;MYD88
prerank,gland development (GO:0048732),-0.3350505501765343,-1.2252126272595143,0.15344827586206897,0.4551019263260245,1.0,27/59,28.59%,CAV1;PKD2;LSR;TBX1;MSN;TGFBR3;HES1;SIX1;EZR;NOTCH4;PRKCSH;WNT11;ANXA1;ARID5B;ARHGAP35;CDK5RAP3;CEBPG;SOD1;CITED2;NF1;EPHB3;TBX3;CEBPA;FGF10;STRA6;MET;TGFBR1
prerank,positive regulation of phagocytosis (GO:0050766),-0.3514209200889149,-1.2251880840576441,0.1621129326047359,0.4547334298175618,1.0,20/47,31.44%,IL15;MERTK;PTPRJ;GAS6;MYO18A;RAB27A;ANO6;ABCA7;LMAN2;TULP1;GATA2;PTPRC;IL15RA;CD300LF;FCER1G;TREM2;IL2RG;AHSG;RAB31;PLA2G5
prerank,eye development (GO:0001654),-0.34326399519551976,-1.2249985733052815,0.14154411764705882,0.4547375834208587,1.0,17/54,16.81%,PBX1;RAB3GAP1;SH3PXD2B;SMOC1;COL5A1;PBX3;NIPBL;TGFB2;RBP4;COL5A2;SIPA1L3;LAMA1;SHROOM2;FOXC1;SKI;FREM2;HIPK1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.41008390982950854,-1.2248622183607876,0.19072164948453607,0.4546050747228112,1.0,19/26,45.32%,IL6ST;FLT4;ATF4;ARNT;BRCA1;HPSE;EIF2AK3;CYP1B1;TGFB1;SULF1;IL1A;SARS1;HIF1A;RORA;GATA4;ISL1;CCBE1;NODAL;IL6
prerank,regulation of axon guidance (GO:1902667),0.500207334767886,1.2246188510496043,0.2040358744394619,0.5834848502841281,1.0,5/10,24.18%,VEGFA;ZSWIM5;YTHDF1;ZSWIM8;MYCBP2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5060623091683547,-1.2243874623362305,0.22522522522522523,0.45526322806895486,1.0,3/11,5.09%,LRP5;TBX1;TGFBR2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4538421508441072,-1.2242944188845772,0.21920289855072464,0.4550299708715727,1.0,7/17,20.17%,PRKG1;CDKN1B;PDCD4;MEF2C;TPM1;PPARG;PTEN
prerank,embryonic appendage morphogenesis (GO:0035113),-0.4847305508891767,-1.2240642010051614,0.2206405693950178,0.4551545598571017,1.0,3/12,6.51%,MBNL1;LRP6;TGFB2
prerank,cortical cytoskeleton organization (GO:0030865),-0.35929149394207893,-1.223584239905593,0.1686143572621035,0.4557470495786737,1.0,17/41,18.83%,RAC1;RHOBTB1;RND3;DLG1;RHOQ;EZR;PPP2R3C;ROCK1;RHOA;LCP1;RHOC;RHOG;NCKAP1;ROCK2;FMNL2;TRPV4;IKBKB
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5007152121964724,-1.2235808933628516,0.23185840707964603,0.45532787121974594,1.0,2/12,2.03%,FOXP1;LYN
prerank,carboxylic acid transport (GO:0046942),-0.3399981050805101,-1.2233779393152764,0.13523131672597866,0.4553588560614606,1.0,19/55,24.20%,SLC6A6;SLC7A1;SLC7A5;SLC16A12;SLC38A5;SLC16A9;SLC16A1;SLC1A5;SLC17A5;SLC13A3;SLC16A6;SLC36A4;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC38A6;SLC16A13
prerank,regulation of phosphorylation (GO:0042325),-0.2957417418648926,-1.2222908599547588,0.09531772575250837,0.4573523310932704,1.0,32/120,19.24%,ITGA6;LYN;CORO1C;THBS1;APP;NUP42;RAE1;EGFR;CDKN1B;RANBP2;ZBTB7A;PTK2;NUP98;BMP4;CDH5;SEC13;ROCK1;PRKRIP1;LDB1;STAT2;ILK;FNIP2;PSEN1;NUP153;PTGES3;MIF;TPR;BMP7;NLRC5;NUP214;IKBKB;PPP2CA
prerank,neuron fate commitment (GO:0048663),0.45013645615751885,1.2221510868684888,0.22115384615384615,0.588233416358528,1.0,2/14,8.54%,MYT1L;POU4F1
prerank,mesenchyme development (GO:0060485),-0.4590622761210408,-1.2221466229122777,0.22058823529411764,0.457265958171229,1.0,8/15,28.59%,PKD2;BMPR2;BMP4;WNT11;BMP7;BMP2;FOXF1;TGFBR1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.48548001984832434,-1.2220113068551364,0.22072936660268713,0.45711912601739324,1.0,5/13,18.97%,KDR;NAMPT;EDN1;JAK2;NOD2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3846050509177082,1.2218831014325877,0.1792452830188679,0.5871956374018834,1.0,5/27,9.50%,HTR2C;CALCA;GRM1;C3AR1;GPR65
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3732135862712128,1.2217806747411126,0.1842696629213483,0.585732467314311,1.0,10/32,18.37%,NAV3;EML2;APC2;MAP2;STMN2;HDGFL3;MAPRE1;CLASP2;CAMSAP3;TUBB4A
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4773917973005532,-1.2214658192037497,0.21851851851851853,0.4579178426355586,1.0,7/13,22.38%,CAV1;USP13;BCAP31;ATXN3;SGTA;HERPUD1;NFE2L2
prerank,myoblast differentiation (GO:0045445),-0.46284553577498166,-1.2213071804855216,0.2210144927536232,0.4578276246300527,1.0,8/14,19.87%,MBNL1;RB1;PLEKHM3;JAG1;MAPK12;IGF1;EPAS1;TCF7L2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.49765058896327397,-1.2212383354157428,0.2281639928698752,0.45756214781023974,1.0,6/12,19.32%,CBFB;ELF1;LYN;ELF2;RC3H1;PTPRC
prerank,positive regulation of isotype switching (GO:0045830),-0.46878525202382,-1.2210840478521805,0.21195652173913043,0.45749729748417656,1.0,7/15,18.58%,SHLD1;TFRC;KMT5B;CD40;MAD2L2;CLCF1;TNFSF13
prerank,RNA export from nucleus (GO:0006405),-0.3055201105632805,-1.220685426911341,0.10223048327137546,0.45793539047549553,1.0,33/100,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;HNRNPA1;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,purine ribonucleotide transport (GO:0015868),-0.45987493411786,-1.2205010819550628,0.21554770318021202,0.45788213393534916,1.0,4/16,7.79%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4046015324394152,-1.2202818156188977,0.18647166361974407,0.45796478152999,1.0,13/24,23.50%,CTNNA1;MEF2A;BOC;ABL1;MEF2C;CDON;BNIP2;TCF3;MAPK12;CTNNB1;SPAG9;MYOCD;MAPK11
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.34632342981409736,-1.2202010177480993,0.17010309278350516,0.4576956895385029,1.0,19/51,27.81%,THBS1;IL6R;GAS6;MOSPD2;IL34;PTK2;MAPK1;VEGFC;EDN3;ANO6;LGMN;CMKLR1;CXCL12;PTN;SERPINE1;HMGB1;ADAM17;LGALS9;CXCL10
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.4355311411242002,-1.220094205374404,0.22321428571428573,0.4575638285661396,1.0,11/20,30.01%,TNRC6B;LIMD1;CELF1;AGO2;MOV10;WTIP;TNRC6A;AJUBA;CNOT8;CNOT1;HELZ
prerank,autophagosome organization (GO:1905037),-0.349716765790735,-1.2200512219785529,0.16153846153846155,0.4572426125806512,1.0,21/50,27.26%,ATG7;RAB7A;RAB1A;MAP1LC3B;AMBRA1;IRGM;WIPI1;GABARAP;ULK2;RAB23;ATG5;STX12;EMC6;WDR45B;ATG16L2;BECN1;ATG2A;RAB19;ATG2B;UBXN2A;ATG3
prerank,protein localization to mitochondrion (GO:0070585),-0.5037569346512204,-1.219718897944385,0.22202486678507993,0.4575385006733635,1.0,3/11,9.84%,LRRK2;COX18;AKT1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3837612576857367,-1.219572876657975,0.16967509025270758,0.4574835553512495,1.0,12/30,24.54%,EIF3H;TLK2;FHIT;RYBP;HFE;SGTA;N4BP1;GIPC1;USP7;OGT;TRIM39;TAF9
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.38944009620161657,-1.2187837884785302,0.19653179190751446,0.45876632193151284,1.0,10/26,15.65%,APP;HES1;CUL3;USP2;TAL1;PPP1R10;DUSP3;PKN2;SMOC2;LGMN
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5091771162911072,-1.2187216561089929,0.216696269982238,0.45848742034727097,1.0,6/10,31.81%,PARD3;PRKD3;DGKH;PLPP1;F2R;DGKD
prerank,negative regulation of translation (GO:0017148),-0.3122327257739303,-1.2186328937567283,0.12903225806451613,0.45825709339102255,1.0,32/87,27.03%,DAPK1;RNF139;EIF3E;METTL14;DDX3X;GIGYF2;LARP1;FTO;SAMD4A;PUM1;ROCK1;CELF1;AGO2;IGFBP5;SYNCRIP;BTG2;ROCK2;TPR;RPS3;CAPRIN1;TOB1;METTL16;RPL13A;RBM24;MRPL13;EIF2AK3;FXR1;IGF2BP2;EIF2AK4;CNOT8;NANOS1;CNOT1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.44398362879902975,-1.218313499725218,0.20105820105820105,0.4585869900392329,1.0,3/17,6.51%,PODXL;ADAM9;TGFB2
prerank,positive regulation of cytokine production (GO:0001819),-0.2653643682277002,-1.2181015211686066,0.06199021207177814,0.4586576984046705,1.0,116/292,34.60%,FOXP1;SPTBN1;IL1R1;AFAP1L2;CREBBP;CD34;NOD1;CD200;SLC7A5;IFIH1;APP;IL15;RAB1A;PRKD2;IL6ST;IL6R;NFKB1;PLCB1;STAT6;LBP;MRE11;ARHGEF2;FLT4;IRF1;PLCG2;PIK3CD;RGCC;ZFPM1;IRAK1;LPL;LRRFIP1;FLOT1;IL17RA;CD40;ATF4;POLR3F;AGPAT1;CGAS;MIF;ROCK2;C1QTNF3;IL16;RARA;ANXA1;CTNNB1;ARNT;GBP5;PAEP;CEBPG;MAVS;SOD1;RPS3;CCL19;LURAP1;HYAL2;NOD2;PTPRC;PRKDC;F3;BRCA1;PTPN11;RELA;SERPINE1;HPSE;RIPK1;EIF2AK3;MAPK11;CD276;FZD5;CYP1B1;STOML2;HSPA1B;HMGB1;MAP3K7;IL7;DHX9;IRF7;POLR2L;POLR2H;ADAM17;F2R;LGALS9;POLR3GL;HILPDA;IL12RB2;PNP;FCER1G;TRIM6;HMOX1;POLR3K;RUNX1;MAPK14;DDIT3;TNFRSF14;TGFB1;LILRB1;STAT3;TICAM1;TLR6;RFTN1;SULF1;IRF5;CEBPB;FGR;TLR1;NOS2;RAB7B;TLR5;POLR2E;CD14;IL1A;TSLP;NLRP3;POLR3A;PARK7;TBK1
prerank,response to glucose (GO:0009749),-0.35500784398124746,-1.2179779074533346,0.18861209964412812,0.45850383345632545,1.0,9/46,12.71%,UNC13B;IGF1R;ZBTB20;THBS1;GAS6;ERN1;EIF2B2;PRKAA1;LPL
prerank,icosanoid secretion (GO:0032309),-0.48705434405104997,-1.2179506470468406,0.24107142857142858,0.45813886077837307,1.0,2/12,4.51%,ABCC4;ACE
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.4399506131611089,-1.2171772081129033,0.23134328358208955,0.45936261448631965,1.0,6/18,20.79%,DAB2IP;EMD;TP53;CDC73;SKI;NF1
prerank,protein transport (GO:0015031),-0.26053117340131215,-1.2168131564121023,0.04965753424657534,0.4597436109436023,1.0,94/332,22.66%,SPTBN1;TBC1D4;SEC31A;RUFY1;CALCRL;MYH9;ARF3;RAMP1;RAB7A;ARCN1;RAB1A;GOLPH3L;TLK1;TFRC;SCAMP2;SYNRG;TBC1D1;RAB5B;DNM2;STX3;TBC1D2B;MACF1;TANGO6;STEAP3;MON1A;TBC1D8B;WDR11;SNX9;SLC10A7;USP6NL;SEC13;COPG1;RAB5A;TBC1D30;ARRDC1;ARHGEF2;STX8;TBC1D14;SCFD1;ARL6IP5;TVP23A;RAMP2;TBC1D22B;COPA;RAB3GAP2;ARHGAP1;EHD1;TXNIP;TBC1D22A;HFE;VPS26A;RAB8B;ARL4A;GOLGA4;SLU7;ATP6V1E1;CHMP2B;MCOLN1;VPS45;REP15;RAB23;RAB24;RAB32;TOM1;SNX8;HERC2;SIL1;AP4M1;HDAC6;LAMP2;TMED5;GOLPH3;FAM91A1;ATP6V0A1;STX12;TBC1D8;VPS26C;SCAMP1;AP3B1;KIF3B;TBC1D17;TBC1D25;PPARG;ARL5C;KIF13A;CTSA;VAMP2;SNX13;PREB;TBC1D12;ATP6V1H;EVI5;SAR1A;ARL4C
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.3524878218007881,-1.2167683689747608,0.15985130111524162,0.4594344109100755,1.0,20/48,25.92%,ZMIZ1;KAT2B;DEK;ARID1B;ATAD2B;SF3B1;TAF1B;ACTB;TAF1C;WBP2;ELOF1;BAZ1B;CHEK1;ATAD2;TAF1D;SERTAD2;POLR1E;POLR2L;ERCC6;POLR2H
prerank,UV protection (GO:0009650),-0.5106247407779867,-1.215754613579667,0.22935779816513763,0.46132619748707077,1.0,6/10,32.94%,ERCC2;CAT;GPX1;SDF4;MFAP4;SCARA3
prerank,regulation of type I interferon production (GO:0032479),-0.3143104784035807,-1.2156636594537014,0.14361702127659576,0.4611370228213535,1.0,30/84,25.92%,CREBBP;IFIH1;TRIM25;TRIM56;RNF125;TAX1BP1;NFKB1;STAT6;MRE11;IRF1;UBA7;IKBKE;IRAK1;LRRFIP1;TRAF3IP1;POLR3F;TNFAIP3;ILRUN;CGAS;CTNNB1;GPATCH3;NLRC5;MAVS;PRKDC;RNF216;RELA;DHX9;IRF7;POLR2L;POLR2H
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.4606925890706485,-1.2152166517278555,0.20869565217391303,0.46169387847771737,1.0,8/15,32.49%,NR3C1;FAM107A;UBE2L3;BCL2L11;ANXA1;ZFP36L1;HNRNPU;SSTR2
prerank,positive regulation of phospholipid transport (GO:2001140),0.5121207024790604,1.2147650786984947,0.23129251700680273,0.6035385833420853,1.0,3/10,14.63%,PRELID1;TRIAP1;APOE
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.34248691860678976,1.21448732842156,0.15825688073394495,0.602528532984753,1.0,11/44,12.02%,KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;ATP1B1;WNK2;WNK3;KCNJ6;KCNN3;GABBR1
prerank,serine family amino acid metabolic process (GO:0009069),-0.4441548221712436,-1.2144646687102745,0.209009009009009,0.4629181331620751,1.0,6/16,21.72%,SRR;MTHFD1;CDO1;SEPHS2;CTH;GCLC
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.43823814049508136,-1.2143818276232927,0.2113970588235294,0.4626688960209322,1.0,7/18,11.47%,JAK1;IL6ST;IL6R;CBL;YAP1;SMAD4;JAK2
prerank,oligodendrocyte differentiation (GO:0048709),0.4195669442581346,1.2142814774494026,0.22602739726027396,0.6013210744563062,1.0,7/19,17.61%,MYRF;CDK5;PTPRZ1;SLC8A3;TPPP;EIF2B1;SOX9
prerank,transition metal ion transport (GO:0000041),-0.3704671810374328,-1.213806354362156,0.19349005424954793,0.46354832559702885,1.0,10/35,16.74%,ATOX1;SLC31A1;TFRC;SLC30A10;TRPC4;SLC39A8;TRPC6;SLC30A5;COX17;TRPC3
prerank,cation transmembrane transport (GO:0098655),0.3400778349929975,1.213531147794313,0.1714922048997773,0.6016181229023253,1.0,11/44,11.71%,TRPM3;ASIC2;ATP1A2;SLC7A8;ATP1B1;MFSD12;TRPM1;SLC29A4;SLC6A5;ATP13A2;P2RX3
prerank,positive regulation of neuron projection development (GO:0010976),0.302655723726078,1.2134306183385783,0.14216867469879518,0.6001075972023697,1.0,15/85,9.80%,MAGI2;LRRC7;RIT2;SCN1B;TENM3;FUT9;TOX;VLDLR;KIDINS220;NDRG4;CAMK2B;NTRK2;PLA2G3;PLPPR5;STMN2
prerank,endoplasmic reticulum organization (GO:0007029),-0.3165454660704788,-1.2133595649350541,0.1637323943661972,0.4640940167412936,1.0,22/72,21.65%,SEC31A;APP;TMCC1;STX18;LRRK2;EMD;ATL2;TOR1B;SEC16B;UBE2J2;REEP3;GAK;SGTA;VCPIP1;TRAM2;LMAN2;MOSPD3;VAPA;WDR83OS;LPCAT3;REEP1;VAMP2
prerank,regulation of RNA splicing (GO:0043484),-0.3250147627247828,-1.2127982156340607,0.16179001721170397,0.4649751766832006,1.0,25/69,22.21%,MBNL1;MBNL2;DYRK1A;ZNF326;AHNAK;METTL4;PIK3R1;FUS;AHNAK2;ERN1;CELF1;RBM39;HNRNPF;SON;CLK3;ZPR1;RBM20;JMJD6;SRPK2;SRSF3;PTBP3;SRSF10;TRA2B;CWC22;METTL16
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.5012060394451333,-1.2127567131530217,0.24118738404452691,0.46465335596345075,1.0,4/11,13.52%,GFPT2;GNPDA2;GNPNAT1;UAP1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5033775002530234,-1.2126733195005026,0.21693121693121692,0.46445445654264056,1.0,3/10,15.35%,IL15;ROCK1;ROCK2
prerank,retrograde axonal transport (GO:0008090),0.44035611401386604,1.2124990507627906,0.22632794457274827,0.6008874916755425,1.0,7/16,19.24%,DLG2;TMEM108;KIF5A;KIF1C;NEFL;MAP1A;HAP1
prerank,histone H3 acetylation (GO:0043966),-0.3551618771081549,-1.2110335167867774,0.1713221601489758,0.46771054090647507,1.0,14/40,24.76%,LEF1;KAT6B;KAT2B;KAT6A;SGF29;LDB1;TAF5L;TADA3;TRIM16;DR1;JADE2;WDR5;TAF9;MAP3K7
prerank,cellular response to retinoic acid (GO:0071300),0.3423580878412897,1.2109936000815695,0.18082788671023964,0.6032307798757206,1.0,9/42,12.41%,BRINP3;WNT7B;BRINP1;PAX2;BRINP2;ADNP2;TESC;WNT6;HTRA2
prerank,regulation of cell death (GO:0010941),-0.306685662597748,-1.2109015003327788,0.14762741652021089,0.4675818107651523,1.0,37/94,26.56%,FERMT2;ACER2;LRRK2;CDKN1B;TNFRSF1B;NCK1;BMP4;BNIP3;PRKD1;CELF1;WNT16;CHMP4B;AXIN2;ACER3;FGF2;RAD18;CHP1;WNT11;CCN5;PDE12;ATG5;CCN3;CTSZ;BMP7;TRIM13;SOX4;RRAS2;SLC25A24;CCN1;PARP16;BECN1;TXNDC12;HSPA1B;NOA1;LRP1;APC;VPS35
prerank,regulation of mitochondrial fission (GO:0090140),-0.4131414174447601,-1.2108748538090146,0.18571428571428572,0.4672196623526915,1.0,7/24,12.94%,RALBP1;LRRK2;KDR;MIEF1;BNIP3;STAT2;MIEF2
prerank,bile acid biosynthetic process (GO:0006699),0.3853780799295488,1.2107461780398,0.20484581497797358,0.6022145058534606,1.0,6/24,16.99%,AKR1D1;CYP46A1;OSBPL6;CYP27A1;OSBPL9;ACOX2
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4080577245051382,-1.2106445265107866,0.20593692022263452,0.467254901839943,1.0,12/22,30.14%,MED1;PTPRK;STXBP4;NOTCH2;PRKD1;FGF7;KLF9;CRNN;ZFP36L1;FGF10;SNAI2;SRSF6
prerank,regulation of blood coagulation (GO:0030193),-0.3985954276476804,-1.209971536186582,0.19929453262786595,0.4684355429083049,1.0,12/27,26.84%,ST3GAL4;CAV1;CD34;THBS1;ENPP4;EDN1;TFPI;SERPINE2;SERPINE1;HPSE;DMTN;F2R
prerank,regulation of lamellipodium assembly (GO:0010591),-0.36667133060131457,-1.208995585852318,0.1821561338289963,0.4702339053877523,1.0,10/34,19.29%,WASF2;RAC1;PIK3R1;SLIT2;PLCE1;OCLN;ABI3;NCKAP1;CAPZB;EPHA2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4793027168437422,-1.208832166255051,0.22346368715083798,0.4701894932840062,1.0,3/13,8.44%,NRP2;PLXND1;PLXNA4
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3995628401499469,-1.2086658104912575,0.18825561312607944,0.47015203604296574,1.0,10/23,26.17%,JAK1;IRGM;PARP14;JAK2;SUMO1;NLRC5;IFNGR2;PPARG;PTPN2;PARP9
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3366054480675557,-1.208505280328821,0.15734265734265734,0.47006313133479105,1.0,16/55,24.66%,SLC7A1;IL15;IL6ST;TFRC;NCK1;NCK2;ICOSLG;IGF1;VCAM1;ANXA1;RPS3;CCL19;PTPRC;IGF2;CD276;HMGB1
prerank,negative regulation of chemotaxis (GO:0050922),-0.37915494691019197,-1.2082822974551626,0.19343065693430658,0.47011277979468974,1.0,13/31,18.35%,SEMA6A;SEMA3C;SEMA7A;THBS1;SLIT2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;DUSP3;SEMA5B;SEMA4A;SEMA3E
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5098449488870234,-1.2081775034792896,0.2335216572504708,0.46996007788433247,1.0,3/10,9.84%,PRKCE;IRS1;AKT1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.39502618679782325,-1.2078568565231949,0.22340425531914893,0.4702597603976211,1.0,6/24,8.56%,DAB2IP;PTPN1;PRKD2;NEDD4;TMEM204;GRB10
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3373630702471997,-1.2076045059101457,0.16407599309153714,0.4704140404428346,1.0,20/52,24.70%,PPP1R13B;YWHAE;HPS4;YWHAZ;NMT1;GSK3A;UBE2J2;CASP8;UBE2D3;TP53;MAPK8;BBC3;UBE2L3;BAP1;NPEPPS;PPP3CC;HUWE1;FZD5;TFDP1;SAE1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3711738582326585,-1.2073533303125508,0.20373831775700935,0.4705292960173195,1.0,7/32,9.39%,RREB1;WASF2;RAC1;CORO1C;PIK3R1;PLCE1;OCLN
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.36738706957186995,-1.20720382541238,0.18327402135231316,0.47041775859379603,1.0,14/37,24.54%,EIF3H;TLK2;FHIT;RYBP;HFE;SGTA;N4BP1;RPL5;GIPC1;USP7;OGT;RPS7;TRIM39;TAF9
prerank,epidermal cell differentiation (GO:0009913),-0.36161599851921233,-1.2071260732519296,0.17625899280575538,0.4701482932106825,1.0,15/41,22.98%,BCR;ADAM9;HDAC1;MED1;ERCC2;WNT16;TXNIP;ERCC3;JAG1;ASAH1;ANXA1;CTNNB1;EPHA2;USH2A;PIP5K1A
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4301244609788623,1.2070674329961089,0.24074074074074073,0.6104839028282277,1.0,7/16,20.61%,CHGA;KLK6;GPER1;PRMT5;MRAP2;C3;GRP
prerank,bone development (GO:0060348),-0.3596363363760849,-1.2066874528498979,0.1857638888888889,0.4706965185270263,1.0,12/39,13.32%,AKAP13;LRP5;PLS3;DYM;SH3PXD2B;LRP6;SLC10A7;TGM2;TP53;RPL13;NOTUM;MYOC
prerank,regulation of protein acetylation (GO:1901983),-0.48231689638722824,-1.2061411162255777,0.23132969034608378,0.47146293111443976,1.0,7/12,34.57%,GSK3B;DDX3X;KAT5;RAPGEF3;CEP295;FAM161A;PARK7
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4431731878857319,-1.205912775291897,0.20825852782764812,0.4715631221792586,1.0,7/17,18.37%,ABHD2;NR3C1;MED1;BMP4;UBE2L3;BMP7;TFPI
prerank,protein tetramerization (GO:0051262),0.31514044865918783,1.2054970257429234,0.1415525114155251,0.6130596107548559,1.0,14/67,15.30%,HCN1;GRIN2B;MS4A1;SYCP1;RYR3;AQP4;GNMT;HOMER1;ACACA;ALDH1A2;GLS;GOLGA2;CBY1;TDO2
prerank,primary miRNA processing (GO:0031053),-0.51911609487745,-1.2052328716414338,0.24738675958188153,0.4726855987328189,1.0,7/10,36.30%,SMAD1;SMAD2;PUS10;DROSHA;MRPL44;DGCR8;SMAD3
prerank,carbohydrate derivative transport (GO:1901264),-0.4301290104099009,-1.2050857843765705,0.21234119782214156,0.47260784593473665,1.0,5/18,9.30%,PLTP;LBP;SLC10A7;SCARB1;MFSD2A
prerank,cellular response to interleukin-1 (GO:0071347),-0.2849622529187702,-1.2046108117442182,0.1103202846975089,0.4732600716914956,1.0,44/143,24.76%,DAB2IP;IL1R1;PELI1;TAB3;NOD1;RPS6KA5;PSMA2;CCL25;NFKB1;RBX1;NFKBIA;PLCB1;PSME2;PSMB4;MAP3K3;IRAK1;FBXW11;CD40;MAP3K8;PSMC2;RC3H1;PSMB2;USP10;PSMB1;PELI2;TAB2;IRAK2;PSMA8;IKBKG;CCL19;IKBKB;HYAL2;NOD2;PSME1;PSMD4;PSMA7;RELA;HAS2;MAPK11;PSMD5;GBP3;ADAMTS7;PTGIS;MAP3K7
prerank,adenine nucleotide transport (GO:0051503),-0.444879137397787,-1.2044220163802113,0.2291296625222025,0.473280302535081,1.0,4/17,7.79%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,positive regulation of heart rate (GO:0010460),-0.4516464160684729,-1.2038879923288506,0.2205607476635514,0.47403130035867536,1.0,8/17,17.16%,ADRA1B;TRPM4;KCNQ1;EDN1;ADM;EDN3;TPM1;SCN3B
prerank,protein export from nucleus (GO:0006611),-0.3934153720731497,-1.2038687581203042,0.2062043795620438,0.47364002856129855,1.0,9/27,19.14%,NUP42;SMURF1;CSE1L;XPO7;CHP1;TPR;XPO4;NUP214;DUSP16
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.40008233226016093,-1.2037278132747689,0.22344322344322345,0.47354260640110685,1.0,5/22,12.95%,PTPRJ;EZR;DGKZ;CEACAM1;DUSP3
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.30303898976558125,-1.2033454079369899,0.15254237288135594,0.4739714435178191,1.0,31/87,26.54%,RBFOX2;SPRED2;TBX1;CEP57;CBL;DSTYK;SHOC2;FGF1;HNRNPM;MAPK1;POLR2G;FGF7;HNRNPF;FGF2;TIAL1;GRB2;HNRNPA1;FLRT2;HYAL2;FGFR4;DLL4;PTPN11;KIF16B;FRS2;POLR2C;EGR3;POLR2L;POLR2H;ZFP36L1;FLRT3;FGF10
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.39798315525172806,1.2030636851936254,0.20501138952164008,0.6182426391546477,1.0,9/23,16.53%,HSD17B12;FAR1;ACSBG1;HACD1;ACSL3;ACSL6;TECR;ACOT7;HACD2
prerank,negative regulation of cilium assembly (GO:1902018),-0.4981183368037377,-1.2024926561346672,0.24642857142857144,0.4755014126122686,1.0,5/12,8.80%,LIMK2;MAP4;CDK10;TBC1D30;YAP1
prerank,negative regulation of protein binding (GO:0032091),-0.32328418673710574,-1.2021436072481348,0.17102966841186737,0.4758479177080897,1.0,17/71,15.77%,CAV1;DAB2;GSK3B;LRRK2;PRKCD;ROCK1;ATP2A3;NES;AKT1;ZFPM1;HFE;ACTB;ITGA4;MAPK8;CTSZ;MITD1;PEX14
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.4699385969181789,-1.2014209337115747,0.2490974729241877,0.47708140600790205,1.0,4/14,8.04%,THBS1;IL34;PTK2;MAPK1
prerank,organelle transport along microtubule (GO:0072384),0.3681974670429497,1.2011390355117058,0.19002375296912113,0.6218543053926846,1.0,15/31,20.86%,BICD1;CLN3;MAP1S;MAPT;DYNC1I1;TMEM201;RAB6A;COPG2;HTT;BORCS5;TRAK2;BICDL1;RHOT1;HAP1;UBB
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.4690401692504791,-1.2010236531574703,0.25316455696202533,0.4775246890438974,1.0,8/13,28.11%,PRPF3;PRPF6;PRPF31;SRSF12;CD2BP2;SRSF10;AAR2;LSM2
prerank,regulation of blood circulation (GO:1903522),-0.36964471596026216,-1.2006305467275467,0.2,0.47796719027559637,1.0,9/34,18.24%,ACE;KCNQ1;ECE1;TBX2;AGTR1;S100A1;TPM1;KCNMB2;PLN
prerank,negative regulation of type I interferon production (GO:0032480),-0.3563386562877587,-1.2003313611541055,0.19310344827586207,0.4782060888201566,1.0,15/40,22.72%,IFIH1;TRIM25;RNF125;TAX1BP1;PPM1B;UBA7;IKBKE;TRAF3IP1;TNFAIP3;ILRUN;GPATCH3;NLRC5;MAVS;RNF216;YY1
prerank,cellular protein localization (GO:0034613),-0.2619891681081241,-1.2001182430352593,0.0782312925170068,0.47830014064367965,1.0,90/285,23.82%,TBC1D4;SEC31A;FERMT2;ESAM;ARF3;SH3PXD2B;ID1;ARCN1;LRRK2;RAB1A;SMURF1;EGFR;TLK1;RIC3;SYNRG;NIPBL;TBC1D1;RAB5B;CNTNAP1;STX3;TBC1D2B;COX18;CEP250;TBC1D8B;PTPRK;WDR11;CNTLN;SNX9;ITSN1;USP6NL;SEC13;RAB5A;TBC1D30;ARHGEF2;STX8;TBC1D14;SCFD1;OCLN;FGF7;FLNA;CROCC;TBC1D22B;AXIN2;WIPI1;COPA;FBLN5;RAB3GAP2;EHD1;TBC1D22A;VPS26A;ARL4A;SLU7;ABHD17A;WNT11;VPS45;RAB23;RAB24;RAB32;SNX8;ANGPT1;HERC2;SIL1;AP4M1;HDAC6;CTNNB1;TMED5;FAM91A1;HEY2;RAP2A;STX12;TBC1D8;VPS26C;AP3B1;TBC1D17;TBC1D25;WDR45B;ARL5C;VCL;REEP1;KIF13A;CTSA;SNX13;TBC1D12;EVI5;SAR1A;ARL4C;COPZ1;NPHP1;MYO7A;RAB19
prerank,response to ATP (GO:0033198),0.42132435930040746,1.1997622406646737,0.2071269487750557,0.6240719963243532,1.0,5/18,14.11%,DGKQ;RYR3;CIB2;P2RX3;TAF1
prerank,response to UV (GO:0009411),-0.3005858480228535,-1.1993881937145943,0.12478632478632479,0.4795383524586995,1.0,35/95,26.71%,CREBBP;DCUN1D3;MAP4K3;EGFR;UBE4B;NEDD4;PRKCD;PTPRK;ERCC2;RPL26;AKT1;TP53;NSMCE3;CAT;REV1;MAPK8;ATF4;ERCC3;COPS9;GPX1;N4BP1;ERCC8;RUVBL2;WRN;SDE2;CCND1;USP1;CDC25A;RELA;YY1;INO80;ERCC6;EIF2AK4;DTL;RHBDD1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4644727002522773,-1.198780031675863,0.24408014571949,0.4804860435534662,1.0,6/13,18.45%,RAMP1;ALG10B;PLCB1;CHP1;IGF1;CCL19
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3782735855617154,-1.1987705407225644,0.19963031423290203,0.48009211036259314,1.0,7/29,12.85%,VTI1A;COG5;COG1;TRAPPC3;COPG1;COPA;COPE
prerank,myelination (GO:0042552),0.3319858853474562,1.1985629313877109,0.20238095238095238,0.6256657432662287,1.0,18/46,18.23%,MYRF;SCN8A;EPB41L3;PLP1;BCAS1;SCN2A;ACSBG1;NFASC;GPC1;KLK6;MBP;SLC8A3;TPPP;GAL3ST1;AMIGO1;B4GALT6;LGI4;CXCR4
prerank,proteasomal protein catabolic process (GO:0010498),-0.2708283490244922,-1.1983296377196284,0.09326424870466321,0.4806471741870264,1.0,71/201,27.45%,WWP1;PELI1;NEDD4L;ZNRF1;SMURF2;UBE2K;RNF139;PSMA2;FBXL17;SMURF1;DDI2;RBX1;UBE4B;CUL3;NEDD4;PSME2;SPSB1;PSMB4;GSK3A;UBE2D3;AREL1;TNFAIP1;RMND5A;SPOPL;ARMC8;KAT5;ATXN3;FEM1C;FBXW11;APPBP2;PSMC2;FEM1B;ERCC8;PSMB2;PSMB1;AGAP3;TRIM13;CTNNB1;KCTD10;UBXN11;PSMA8;SPOP;DNAJB12;RAD23A;SIAH1;PSME1;TRIM3;RNF4;UCHL1;TBL1X;WWP2;PSMD4;HUWE1;MDM2;PSMA7;RNF216;HACE1;NFE2L2;PSMD5;ARRB1;MAEA;FBXL22;ZFAND2A;PSMB10;RNF122;UBXN2A;RHBDD1;PSMA3;KIF14;RNF34;PPP2R5C
prerank,actin cytoskeleton reorganization (GO:0031532),-0.31699179006466394,-1.1981520350151467,0.15630885122410546,0.48061383070128383,1.0,21/63,18.65%,GAB1;PARVB;MYH9;PARVA;PTPN1;RICTOR;EZR;CDC42BPA;S1PR1;BCAR1;FGF7;FLNA;PHACTR1;RHOA;NEDD9;GRB2;ANXA1;CDC42BPB;RAP2A;TRPV4;MKLN1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.28497140614608296,-1.19805928145498,0.12,0.48044021939212644,1.0,47/128,28.79%,FBXL7;MNAT1;FBXL12;FBXL17;PPP1R12B;YWHAE;FBXL3;CEP57;DNM2;PLCB1;CEP250;CEP78;NES;HAUS8;TPD52L1;CCNY;PPP1R12A;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;FBXW11;CEP41;ALMS1;PLK4;PCM1;CETN2;CNTRL;CEP152;CDK14;ODF2;CDC25A;HSP90AA1;PCNT;CEP131;AKAP9;AJUBA;KHDRBS1;FBXL22;PLK3;DYNLL1;ARPP19;CDKN2B;CCNH;HAUS1;BORA
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4970728607627732,-1.1980250717150651,0.25444839857651247,0.48007441030493475,1.0,3/10,22.00%,KLF4;PTPRC;MAPK7
prerank,negative regulation of anoikis (GO:2000811),-0.4645439922389481,-1.1979011253847642,0.25,0.4799271443550709,1.0,5/14,12.19%,ITGB1;CAV1;MCL1;PTK2;NOTCH1
prerank,transition metal ion homeostasis (GO:0055076),-0.3846802660627362,-1.197867344898259,0.19529837251356238,0.479573530157723,1.0,7/28,14.16%,XIAP;SLC40A1;BDH2;PICALM;HFE;HMOX2;ABCB7
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.34621124570247647,-1.197678273229764,0.17105263157894737,0.479595649843176,1.0,15/46,21.66%,FOXP1;ELN;THBS1;IL6R;BMP4;AKT1;EDN1;TNFAIP3;IGFBP5;IGF1;CTNNB1;PRKDC;TCF7L2;PPARG;PDGFRB
prerank,"transcription, DNA-templated (GO:0006351)",-0.26796665472439035,-1.1976333210258157,0.10616438356164383,0.4792939481296475,1.0,68/207,27.24%,RREB1;MNAT1;MEF2A;CBFB;MLLT3;DEK;THRB;NFIX;IVNS1ABP;NFKB1;FOXO3;IWS1;EAF1;POLR2G;GTF2E1;GTF2E2;ERCC2;TAF11;TP53;PWP1;TAF1B;NFIC;BRF1;CDC73;RTF1;TCEA1;DRG1;TAF5L;TAF1C;MLLT1;ATF4;ERCC3;MRPL12;PIR;CREBL2;TAF7;TAF3;NELFB;HSF2BP;NCOA6;RNPS1;ELOC;TAF4B;PTMA;UBTF;SNAPC3;TAF13;TCEA2;MED20;GTF3C4;SUPT4H1;POLR2C;CCNK;GMEB2;TAF9;TFDP1;TAF15;POLR2L;ERCC6;MLF1;POLR2H;TRIP11;LEO1;RSF1;MMS19;POLR3GL;TRIP13;GTF2H3
prerank,negative regulation of lipid storage (GO:0010888),-0.4205173024661665,-1.1976206396677314,0.23869801084990958,0.47890635743465737,1.0,8/19,28.28%,PPARA;NFKBIA;PPARD;PPARG;ITGB3;PNPLA2;PTPN2;TREM2
prerank,negative regulation of nervous system development (GO:0051961),0.4089550705022167,1.1975519573804116,0.21779859484777517,0.6268094610582858,1.0,3/17,9.89%,ROBO2;SORL1;SLIT1
prerank,negative regulation of cell motility (GO:2000146),-0.29754273742535403,-1.1974901187640945,0.1512455516014235,0.47875189358931197,1.0,37/108,21.11%,CLDN5;ENG;ACVRL1;CRK;MITF;ARID2;PTPRJ;SCAI;LDLRAD4;AFDN;TCAF1;STK24;FOXO3;SLIT2;PTPRK;EPHA4;DACH1;CDH1;ZMYND8;SMAD7;FRMD5;LIMCH1;TPM1;DUSP3;WNT11;JAG1;IGFBP5;MIF;FUZ;ADARB1;RAP2A;CITED2;DUSP22;RAP2C;PTEN;NF1;VCL
prerank,response to cadmium ion (GO:0046686),-0.3880310608572682,-1.1972352327610591,0.23049645390070922,0.478921742507895,1.0,14/26,25.53%,EGFR;JUN;MAPK1;AKT1;MAPK8;SUMO1;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B
prerank,positive regulation of developmental process (GO:0051094),-0.27745148645734924,-1.1972169855967167,0.11512027491408934,0.47854543034270536,1.0,34/164,14.44%,DAB2IP;RREB1;SLC6A6;ZBTB16;SHANK3;INSR;BMPR2;SMURF2;CORO1C;DVL3;ZDHHC6;RALBP1;BMP5;SHLD1;KDR;TFRC;TRPM4;FZD4;KMT5B;MIEF1;PLCB1;BMP4;BNIP3;RBM19;LMNA;PSEN1;EDN3;RPS6KA1;PA2G4;LLPH;MIEF2;AGO2;B4GALT5;RPS6KA3
prerank,regulation of anoikis (GO:2000209),-0.42893285824743727,-1.196975589790788,0.22711267605633803,0.4786489216497013,1.0,5/19,6.61%,ITGB1;CAV1;MCL1;SIK1;PTK2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.40558842271190004,-1.1966138751266404,0.2184873949579832,0.4790070437833436,1.0,18/24,45.32%,IL6ST;FLT4;ATF4;ARNT;BRCA1;HPSE;EIF2AK3;CYP1B1;TGFB1;SULF1;IL1A;HIF1A;RORA;GATA4;ISL1;CCBE1;NODAL;IL6
prerank,heart looping (GO:0001947),-0.3542717872752629,-1.1965346957724494,0.1894353369763206,0.4787727072400458,1.0,10/39,14.01%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;MEF2C;TBX2;NOTCH1;ZIC3
prerank,acyl-CoA biosynthetic process (GO:0071616),0.430968405897604,1.195970121801695,0.24093816631130063,0.6294601049259785,1.0,7/16,22.56%,ACLY;ACACA;ACSS1;SCD5;SCD;ACAT1;HSD17B8
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.30538968360458635,-1.1959422092707468,0.16295025728987994,0.4796421437964712,1.0,32/93,24.99%,DAB2IP;MFHAS1;TRAF5;APP;MAP3K5;MID1;PLCB1;TGFB2;RASSF2;FLT4;ARL6IP5;SH3RF1;WNT16;TAOK3;TPD52L1;SEMA4C;TNFRSF19;MTURN;SASH1;CCL19;EDAR;NOD2;DUSP22;KLHDC10;SH3RF2;PTK2B;LTBR;GADD45A;RIPK1;FZD7;HMGB1;BMP2
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.3398659878060842,-1.1959333489678123,0.1903114186851211,0.4792448318460032,1.0,20/50,24.96%,NXN;CAV1;DTX3L;IVNS1ABP;ABL1;AKT1;SMAD7;SPOPL;CHP1;TNFAIP3;N4BP1;SENP2;RPS3;SOX4;OGT;SH3RF2;ARRB1;HSPA1B;PINX1;ADGRB1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4627547448234479,1.1957551163428428,0.24503311258278146,0.6282705461275334,1.0,6/13,21.60%,CPSF1;TUT1;CSTF2T;CPSF2;CSTF2;NCBP2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.36431274595800733,-1.1954902159139207,0.18397085610200364,0.4798606265421658,1.0,13/36,28.80%,MECOM;FOXO1;DLG1;EZR;TAOK3;DUSP3;IGBP1;ZMYND11;SH3RF2;GPS2;AIDA;TREM2;DUSP1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.32502882868097904,-1.1954519033889488,0.1651031894934334,0.47952641592020817,1.0,23/60,26.34%,KLF4;NEK7;ATM;PRKD2;TCP1;MAPK1;HMBOX1;RGCC;FGF2;HGF;PNKP;PARN;PTGES3;HNRNPA1;SMOC2;CTNNB1;FGFR4;PDGFRB;RFC4;HSP90AA1;CCT5;CCT2;NAF1
prerank,fluid transport (GO:0042044),0.4626822676311903,1.1953528283862236,0.22939866369710468,0.6276407312308702,1.0,2/12,4.58%,PDPN;AQP4
prerank,nitric oxide mediated signal transduction (GO:0007263),0.431805478562506,1.1953014645170483,0.2296983758700696,0.626052455565769,1.0,2/16,2.78%,KCNC2;DDAH2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.46229501189125355,1.1951644084394404,0.21428571428571427,0.6246612336939692,1.0,2/13,3.86%,B3GALT1;B3GALT5
prerank,positive regulation of macrophage activation (GO:0043032),-0.4323180209000927,-1.1949953744039141,0.21964285714285714,0.4801452944893624,1.0,11/17,48.48%,THBS1;LBP;CEBPA;TREM2;TLR6;TNIP2;STAP1;TLR4;TAFA3;WNT5A;CCL3
prerank,negative regulation of leukocyte activation (GO:0002695),0.4364039374706063,1.19455187691411,0.22294372294372294,0.6246152076119982,1.0,6/15,19.45%,LRFN5;GRN;GPER1;HAVCR2;FCGR2B;CD84
prerank,microvillus assembly (GO:0030033),-0.4601624571268471,-1.1944858704730692,0.25650557620817843,0.480880422815775,1.0,8/14,19.61%,RAPGEF2;RAP1A;EZR;FXYD5;RAP1B;MAP4K4;RAP2A;RAP2C
prerank,autophagy of nucleus (GO:0044804),-0.438575272415029,-1.1944704179235646,0.22752293577981653,0.4805056648636293,1.0,10/16,34.25%,ATG7;WIPI1;ULK2;ATG5;WDR45B;ATG2A;ATG2B;ATG3;ATG9A;WIPI2
prerank,mRNA 3'-end processing (GO:0031124),-0.3131143582786432,-1.1943431192168006,0.16390423572744015,0.4803767269826365,1.0,21/78,20.23%,SRSF11;TENT4B;APP;SARNP;THOC2;RPRD2;UPF3B;THOC7;DDX39B;CPSF7;DHX38;CDC73;SLU7;LSM11;TENT2;THOC3;THOC1;FIP1L1;SRRM1;RNPS1;SRSF3
prerank,anterograde axonal transport (GO:0008089),0.34873244595006925,1.1941730060759757,0.2013129102844639,0.6238843844366675,1.0,13/37,19.50%,DLG2;RAB27B;AP3S2;KIF5A;KIF3A;AP3M2;KIF1C;SNAPIN;NEFL;TRAK2;MAP1A;HAP1;MAPK8IP3
prerank,mRNA processing (GO:0006397),-0.2607321162700807,-1.1940957667343266,0.07692307692307693,0.4805432802268128,1.0,97/287,28.50%,MNAT1;SRSF11;PRPF3;METTL14;SMU1;SARNP;PSPC1;CWF19L2;RSRC1;HNRNPA0;THOC2;RBM5;RPRD2;NOVA2;HNRNPR;UPF3B;FUS;THOC7;PRPF6;SF3B6;SPEN;ERN1;RBM19;HNRNPM;POLR2G;PHF5A;CELF1;DDX39B;SF3B1;ERCC2;PUF60;PRPF31;CPSF7;SNIP1;HNRNPA3;HNRNPUL1;EFTUD2;DHX38;DBR1;HNRNPF;SON;SFPQ;SLU7;CTNNBL1;SNRPE;ERCC3;SF3A1;HNRNPA1;SYNCRIP;THOC3;SRSF12;THOC1;CWC25;RBM4B;ZMAT5;BUD13;CD2BP2;FIP1L1;TFIP11;SRRM1;NONO;RNPS1;SRSF3;SRSF10;TRA2B;LSM3;RBM6;CWC22;PPIH;CMTR2;ALKBH5;RBM15;PCBP1;SUPT4H1;POLR2C;GEMIN7;USP39;POLDIP3;RNPC3;PDCD7;SF3B5;GCFC2;DHX9;POLR2L;PRPF40B;POLR2H;PRPF18;HNRNPL;HNRNPD;GTF2H3;PABPC1;HNRNPU;SCAF11;TXNL4A;LSM2;CCNH;CWC27
prerank,visual perception (GO:0007601),0.2970512429802663,1.194003980874672,0.14840182648401826,0.6225904133384862,1.0,11/84,8.06%,COL2A1;EML2;COL1A1;CABP4;GRM8;RP2;FSCN2;OAT;EFEMP1;PAX2;TRPM1
prerank,cell projection organization (GO:0030030),-0.3831966301097035,-1.1939498418439831,0.1989247311827957,0.4804724420669496,1.0,6/30,6.53%,ITGB1;PARVB;RAC1;RHOJ;PARVA;RHOQ
prerank,myotube differentiation (GO:0014902),0.41798776633717943,1.1939020099944746,0.2441860465116279,0.6211246683966662,1.0,4/17,10.42%,ADAM12;ADGRB3;ADAMTS15;PLD3
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.437043409854665,-1.193646691268255,0.25280898876404495,0.4807194139809187,1.0,6/16,21.16%,JCAD;THBS1;AGTR1;FGF2;GATA2;DLL4
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5099197133878057,-1.1935684312750665,0.2504638218923933,0.4804860205493894,1.0,3/10,8.35%,DAB2IP;ANXA2;EPHA4
prerank,regulation of wound healing (GO:0061041),-0.3494383995934444,-1.1934400806465801,0.19047619047619047,0.48037290972207497,1.0,11/42,17.00%,ITGB1;CAV1;PRKCE;CRK;PTK2;OCLN;MYLK;ARFGEF1;FGF2;TNFAIP3;ANXA1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.44185659587323356,-1.192962397785788,0.2335216572504708,0.48105925169191005,1.0,7/16,14.51%,CDK13;RSRC1;HNRNPM;PUF60;SFPQ;SLU7;SCNM1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2941876986360118,-1.1927335580472713,0.1577981651376147,0.4811699673633983,1.0,36/104,26.57%,DAB2IP;MNAT1;RB1;LRP5;DDX3X;CDK12;CDKN1B;ABL1;PPEF2;LRP6;CCND3;IRGM;AKT1;RPTOR;RHOA;ACTB;MTCP1;KSR1;CDK5RAP3;CCND1;PPP2CA;CNPPD1;BLM;CDKN2C;CDC25A;GADD45A;PARP16;SYAP1;RALB;CCNG1;TRIB3;CCNK;CCNE2;CAB39;CDKN3;CCNJ
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.4925771633686899,-1.1921519541554337,0.24736842105263157,0.4820696902567201,1.0,5/11,19.06%,TGFB2;BMP4;JAG1;HEY2;SOX4
prerank,positive regulation of protein kinase activity (GO:0045860),-0.27890516985072245,-1.1917731088940133,0.12166666666666667,0.4824997591067317,1.0,50/148,23.45%,DAB2IP;RAPGEF2;INSR;IQGAP1;PTPN1;PAK2;DDX3X;ACE;TGFBR2;IL6R;GAS6;MRNIP;STK3;IL34;TGFB2;PTK2;IRGM;PRKCD;RASSF2;RAP1A;SNX9;EPHA4;MMD;CLSPN;TAOK3;RPTOR;RHOA;MTCP1;NEDD9;MAP4K4;MARK2;NAB2;TAB2;NOX4;ALS2;CACUL1;CCL19;CENPE;PPP2CA;PTPRC;ITGB3;NRK;MAP2K3;PTK2B;CCN1;HSP90AA1;FCGR1A;PARP16;SYAP1;RALB
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4477103414231838,-1.1916654840483831,0.22183098591549297,0.48190803155970396,1.0,7/16,20.17%,ACVRL1;CORO1C;THBS1;FAM107A;BCAS3;DUSP22;PTEN
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4477103414231838,-1.1916654840483831,0.22183098591549297,0.48190803155970396,1.0,7/16,20.17%,ACVRL1;CORO1C;THBS1;FAM107A;BCAS3;DUSP22;PTEN
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.43986252858372343,-1.1913197724480602,0.23601398601398602,0.48231222221902553,1.0,6/16,21.30%,LRRK2;SEC16B;UBAC2;BCAP31;VAPA;BCAP29
prerank,regulation of axonogenesis (GO:0050770),0.3259393694835254,1.1910673324783723,0.19298245614035087,0.6271494542589755,1.0,21/51,19.75%,LRRC4C;ROBO2;ROBO1;EFNB3;PAK3;NTRK2;PAK1;SLITRK1;RTN4;MAG;CDH2;OMG;PLXNA2;PLXNA1;BRSK2;AMIGO1;PLXNA3;LINGO1;MAP6;RTN4R;RUFY3
prerank,relaxation of cardiac muscle (GO:0055119),0.4587635568872725,1.1907954023985978,0.2539325842696629,0.6261752776675087,1.0,5/13,11.92%,ATP1A2;ATP1B1;CHGA;GSN;SLC8A1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.3198529739734625,-1.1902034352720936,0.19463087248322147,0.4843187915182371,1.0,19/63,18.47%,DAB2IP;MCL1;TAB3;TLK2;MTOR;RASIP1;ROCK1;TBC1D14;DAPL1;GSK3A;MFSD2A;AKT1;PTPN3;TIMP3;HGF;DAP;TAB2;CDK5RAP3;WASHC1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3143223262201687,-1.190077424544812,0.1811965811965812,0.4841708421360742,1.0,27/73,24.96%,CAV1;APP;PRKD2;EGFR;TFRC;GAS6;IRGM;NGF;PRKD1;RAF1;HAX1;AKT1;FNIP2;BRAF;RPTOR;MTCP1;MIF;MAD2L2;CREBL2;HDAC6;TXN;CAPRIN2;NOS1;HSP90AA1;AKAP9;SH2D3C;RAPGEF3
prerank,negative regulation of axonogenesis (GO:0050771),0.37100741240635626,1.1897697783257317,0.2068230277185501,0.6272102050226077,1.0,12/27,21.41%,DCC;EFNB3;MAP2;RTN4;PTPRS;MAG;OMG;TRIM46;LINGO1;RTN4R;RUFY3;NGFR
prerank,skeletal muscle tissue development (GO:0007519),-0.36797783070329154,-1.1896843040791025,0.21708185053380782,0.48466068781141486,1.0,13/32,30.33%,CAV1;SVIL;SIX1;MEF2C;CFLAR;SKI;SIX4;MYL6;FOXL2;KLHL41;MSC;CAV2;MYORG
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4284840942774319,-1.1895142703410873,0.2495511669658887,0.4846152675729171,1.0,9/18,28.04%,DAB2IP;MSN;VGLL4;EZR;CDK5RAP3;AMER1;HSP90AA1;VPS35;RDX
prerank,telomere maintenance via recombination (GO:0000722),-0.4846208287420311,-1.1895123106012184,0.24953445065176907,0.484208543327532,1.0,8/11,42.06%,SMC5;NSMCE2;TEP1;RAD51D;RAD50;ERCC4;SMC6;ERCC1
prerank,dendrite morphogenesis (GO:0048813),0.3539916097053434,1.1893919033488025,0.18984547461368653,0.6265074953594885,1.0,11/35,12.36%,CTNNA2;CTNND2;DOCK10;EPHB1;SHANK1;DCDC2;PAK3;MAP2;MINK1;CELSR2;DLG4
prerank,regulation of cardiac conduction (GO:1903779),0.3225392515209777,1.1884305616406419,0.17249417249417248,0.6274592457106455,1.0,12/54,12.90%,ATP1A2;RYR3;ATP2B4;ATP2B2;ATP1B1;NPPC;SLC8A2;RYR2;SLC8A3;SLC8A1;CASQ1;FXYD4
prerank,liver development (GO:0001889),-0.3684154641813143,-1.1876048466670153,0.22851919561243145,0.4880621132560211,1.0,13/32,24.41%,PKD2;LSR;TGFBR3;PRKCSH;ZIC3;ANXA1;ARID5B;CDK5RAP3;CEBPG;CITED2;NF1;CEBPA;E2F7
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3552429136177787,-1.1870834823091798,0.19748653500897667,0.48881946636096985,1.0,14/40,23.11%,RNF139;SMURF1;GNA12;PTK2;HFE;FOXF2;SGTA;RPL5;CDK5RAP3;RAD23A;PTEN;PTK2B;RPS7;TRIM39
prerank,DNA repair (GO:0006281),-0.2595730311450513,-1.1870363174771315,0.06589785831960461,0.4885275028098638,1.0,102/284,29.66%,MNAT1;PDS5B;SETD2;ATM;UIMC1;DTX3L;PARP4;KMT5B;ABL1;TRRAP;XRCC4;FTO;ASCC1;MRE11;INIP;NABP1;ERCC2;RBBP8;TENT4A;TP53;DOT1L;NSMCE3;ENDOV;PDS5A;POLD3;RAD18;INTS3;OGG1;RPA3;DNA2;KAT5;ATXN3;RPA1;BABAM2;PNKP;XPC;MAPK8;RNF168;ERCC3;VCPIP1;FANCM;BTG2;UBE2V2;ERCC8;MAD2L2;HERC2;SUMO1;POLE2;RFWD3;FANCD2;FANCC;FANCG;HPF1;BRCC3;WRN;CETN2;RAD23A;RPA2;BAP1;PRKDC;RAD54L;PIAS4;TIMELESS;USP1;NSMCE4A;HUWE1;LIG4;FANCL;BRCA1;RAD51AP2;BAZ1B;ERCC6L2;TRIM28;CHRNA4;DCLRE1B;BLM;RFC4;CHEK1;PWWP3A;GADD45A;ALKBH5;MSH3;LIG1;FANCI;INO80;DCLRE1A;APBB1;ERCC6;PARP9;ASCC2;MMS19;TRIP13;GTF2H3;POLL;EXO1;XRCC2;APLF;HINFP;RAD51AP1;MDC1;TDP1;CHD1L
prerank,cardiac muscle tissue development (GO:0048738),-0.33674104423342666,-1.186964905797423,0.19298245614035087,0.48827366142436296,1.0,15/50,12.19%,AKAP13;BMPR2;BMP5;SIK1;RBP4;BMP4;SMAD1;TBX2;MAML1;NOTCH2;ADAMTS9;SMAD4;KDM6B;ZFPM1;NOTCH1
prerank,regulation of membrane repolarization (GO:0060306),-0.46847614442218016,-1.1868430655251396,0.24295774647887325,0.4881362617651247,1.0,5/13,6.70%,CAV1;NEDD4L;KCNJ2;YWHAE;KCNQ1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.37702259651348385,-1.1867561518372893,0.2067137809187279,0.48790679128786596,1.0,11/29,26.55%,CAV1;THBS1;PAK2;TNFSF10;WWOX;HYAL2;G0S2;LTBR;RIPK1;TNFSF12;TNFRSF12A
prerank,xenobiotic transport (GO:0042908),-0.4382549568590401,-1.1865621194614342,0.2257495590828924,0.48791577667620417,1.0,3/16,2.43%,ABCG2;SLC47A1;SLC7A5
prerank,negative regulation of blood coagulation (GO:0030195),0.3421524794606005,1.1863538395338156,0.189010989010989,0.6316039537407583,1.0,9/38,16.65%,VTN;CPB2;C1QTNF1;F8;PDGFA;SERPING1;APOE;PDGFRA;KLKB1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.376244665257808,-1.1862113673898358,0.21621621621621623,0.4883061934467713,1.0,12/28,25.92%,SHANK3;GSK3B;APP;ABL1;EPHA4;FAM107A;LGMN;ADCY1;CALB1;PTN;CALB2;EIF2AK4
prerank,AMP metabolic process (GO:0046033),0.4482623070435249,1.1862086994680157,0.24651162790697675,0.6303419174941407,1.0,4/13,10.48%,AK9;AK3;ADSS2;ADSS1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.37280506423833787,-1.1859700663665143,0.21973929236499068,0.4884550731080097,1.0,13/30,28.41%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH
prerank,lamellipodium organization (GO:0097581),-0.37583059442957956,-1.1856707549732082,0.2058287795992714,0.4887342028951731,1.0,4/29,1.85%,ABLIM1;ITGB1;PARVB;RAC1
prerank,regulation of protein catabolic process (GO:0042176),-0.29857029398542007,-1.185495978519348,0.15437392795883362,0.48872963744321535,1.0,36/99,26.50%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;EGFR;CDKN1B;NEDD4;NKD1;PLK2;GSK3A;FLNA;AREL1;SNX12;AZIN1;TNFAIP3;MAD2L2;OAZ2;GPC3;WWP2;HUWE1;MDM2;CTSA;HACE1;SEC22B;FZR1;GFAP;ADGRB1;TNFSF12;DTL;APC
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3099903409983119,-1.1854339487245362,0.15063520871143377,0.488053664185261,1.0,24/78,22.22%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;SEC24A;DNM2;AP2S1;SEC24D;SEC13;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF15;KIF26A;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3099903409983119,-1.1854339487245362,0.15063520871143377,0.488053664185261,1.0,24/78,22.22%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;SEC24A;DNM2;AP2S1;SEC24D;SEC13;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF15;KIF26A;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,regulation of mRNA catabolic process (GO:0061013),-0.28726875069561664,-1.1852976053045505,0.13242784380305603,0.4879675917144321,1.0,44/121,27.32%,ZC3HAV1;PSMA2;PRKCD;XRN1;SAMD4A;PUM1;PSME2;MAPKAPK2;YWHAZ;EXOSC2;PSMB4;EXOSC1;AKT1;EXOSC3;SERBP1;PARN;PSMC2;RC3H1;ZC3H14;PSMB2;PSMB1;EXOSC8;MOV10;PSMA8;NUP214;TNFSF13;PSME1;EXOSC5;DCP1A;PSMD4;PSMA7;RBM24;PSMD5;CARHSP1;EXOSC7;FXR1;IGF2BP2;CNOT8;ZFP36L1;PSMB10;HNRNPD;PSMA3;CNOT1;PABPC1
prerank,cellular component assembly (GO:0022607),-0.2605354562334521,-1.185290080256593,0.0839041095890411,0.48757595179595725,1.0,62/253,19.04%,SPTBN1;SLC2A1;PARD3;LIMA1;MNAT1;CREBBP;FERMT2;EPS8;PARVB;BAIAP2L1;CD2AP;RAC1;RHOJ;LIMS2;PARVA;LIMS1;PLS3;RANBP9;TEAD1;MITF;HES1;GAS6;TOGARAM1;FAS;KPNA3;RHOQ;EZR;SNX9;WASL;YAP1;YWHAZ;AFG3L2;PICALM;SHROOM1;FAM107A;DET1;OCLN;TP53;FLNA;SHROOM2;ILK;HFE;RHOA;ACTB;LCP1;NEDD9;RHOG;CD40;NCKAP1;HAS1;VCPIP1;PEX14;TUBGCP4;TLCD1;TFAP4;CALD1;FANCC;IKBKG;VAMP3;WASF1;MDN1;MAGI1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4552221734259103,1.1852770803936081,0.2590909090909091,0.631339289257863,1.0,5/13,15.64%,INSIG1;CD81;SORL1;BRSK2;SAR1B
prerank,N-glycan processing (GO:0006491),-0.428816953921792,-1.1850958106233858,0.25,0.4875872749768718,1.0,8/18,13.38%,ST8SIA4;MAN2A1;MAN1C1;MGAT4B;FUT8;MAN1A2;PRKCSH;MAN1B1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.38356657452356907,-1.184166853745926,0.22365988909426987,0.48929791803073386,1.0,11/27,21.38%,SLC47A1;SLC7A1;SLC7A5;SLC38A5;ARL6IP5;SLC36A4;PRAF2;SLC1A1;SLC7A2;SLC1A4;SLC3A2
prerank,protein localization to cell periphery (GO:1990778),0.27719318667025844,1.184105124228305,0.11778846153846154,0.6329149783858866,1.0,29/133,11.34%,KCNIP4;ABCA12;DPP10;MAP7;ANK3;DPP6;ANK1;RAB15;EPB41L3;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CACNB3;WNK3;CD81;MYO5A;ARL3;ZFYVE27;SPTBN4;TESC;C2CD5;RAB3A;LIN7C;TSPAN32;PPIL2;NKD2
prerank,cell cycle G2/M phase transition (GO:0044839),-0.2804954180281718,-1.1840894585571886,0.1356521739130435,0.48905808973245246,1.0,47/129,28.79%,FBXL7;MNAT1;FBXL12;FBXL17;PPP1R12B;YWHAE;FBXL3;CEP57;DNM2;PLCB1;CEP250;CEP78;NES;HAUS8;TPD52L1;CCNY;PPP1R12A;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;FBXW11;CEP41;ALMS1;PLK4;PCM1;CETN2;CNTRL;CEP152;CDK14;ODF2;CDC25A;HSP90AA1;PCNT;CEP131;AKAP9;AJUBA;KHDRBS1;FBXL22;PLK3;DYNLL1;ARPP19;CDKN2B;CCNH;HAUS1;BORA
prerank,response to X-ray (GO:0010165),-0.44763554047783694,-1.1838076491703282,0.24280575539568344,0.48922633184646314,1.0,7/14,21.31%,ATM;NIPBL;XRCC4;ANXA1;BRCC3;LIG4;BLM
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2757725607435323,-1.183675424180985,0.13095238095238096,0.4891015248692032,1.0,41/151,22.06%,TEK;RAPGEF2;FERMT2;ROR1;BMPER;MFHAS1;PDGFD;SEMA7A;GCNT2;APP;CCL25;KDR;ICAM1;PRKD2;EGFR;SLC30A10;GAS6;DSTYK;RAP1A;NOTCH2;FLT4;HTR2A;BRAF;NOTCH1;FGF2;ACKR3;P2RY6;MIF;ABCA7;TNFAIP8L3;MTURN;ANGPT1;CCL19;NOD2;PTPRC;FGFR4;PTPN11;P2RY1;ROR2;PDGFRB;PTK2B
prerank,negative regulation of cell adhesion (GO:0007162),-0.3151209969704506,-1.1836081498869075,0.1829059829059829,0.488845501861756,1.0,29/72,27.14%,SEMA6A;ACVRL1;PODXL;ACER2;CBLL1;GCNT2;FZD4;PTK2;ARHGDIA;PLXND1;PLXNA4;CDH1;ADAM10;RASA1;NOTCH1;RHOA;JAG1;ANGPT1;PTPRC;TGFBI;SERPINE1;FZD7;CYP1B1;SEMA5A;PLXNB1;SIPA1;DMTN;RND1;SNAI2
prerank,positive regulation of DNA replication (GO:0045740),-0.43968849277121824,-1.1835948566244998,0.2297551789077213,0.48845753160224353,1.0,4/16,13.51%,STN1;EGFR;DNA2;CTC1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2921051218927158,-1.1834745903143769,0.15136054421768708,0.4882913514124524,1.0,35/110,23.63%,DAB2IP;RB1;TRABD2B;MPP7;GSK3B;DDX3X;TFRC;IRGM;SPIDR;CDH5;RAF1;TAL1;HJURP;FNIP2;ICE1;RHOC;SLF2;TRAF3IP1;HCFC1;IAPP;BCL2L11;NCLN;SUMO1;HDAC6;RPS3;TFIP11;PTPN11;WARS1;PREB;HSP90AA1;SAR1A;BIK;RALB;GFAP;AJUBA
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.4138132994725277,-1.1830301555238614,0.24816176470588236,0.4888655072630211,1.0,11/21,40.63%,LRRK2;NCK1;BCL2L11;HERPUD1;TXNDC12;EIF2AK3;DDIT3;PMAIP1;PARK7;CREB3L1;TMBIM6
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.34814314162563587,1.1828997174207334,0.20240963855421687,0.6346616015727626,1.0,8/38,8.20%,CTNNA3;SCN1B;KCNA5;KCNJ3;CACNA2D1;PKP2;CACNA1D;SCN5A
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3760912072735839,-1.1827656652783423,0.22262773722627738,0.48908271936987685,1.0,7/30,17.07%,FOXP1;DAB2;HDAC1;ZBTB7A;PIAS2;H3-3A;HDAC6
prerank,mitotic spindle assembly (GO:0090307),-0.34585265772990426,-1.1827249219810212,0.19400352733686066,0.4887739451563487,1.0,14/42,22.30%,STAG1;CCDC61;TOGARAM1;WRAP73;FLNA;KIF23;RHOA;ARHGEF10;STAG2;KIF11;RAB11A;KIF3B;PRC1;MISP
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.308170912674347,-1.1825919474273814,0.1621129326047359,0.4886850394553804,1.0,24/79,22.22%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;SEC24A;DNM2;AP2S1;SEC24D;SEC13;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF15;KIF26A;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,lamellipodium assembly (GO:0030032),-0.38619049138796835,-1.182468755244181,0.22242647058823528,0.4885615081601496,1.0,4/26,1.85%,ABLIM1;ITGB1;PARVB;RAC1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.41556260970800835,-1.1822175294416728,0.2293103448275862,0.48870560586851547,1.0,12/20,34.66%,PUM1;ZC3H7B;SNIP1;DICER1;AGO2;DROSHA;TERT;ZC3H7A;TSN;PUM2;TARBP2;MRPL44
prerank,regulation of mitotic nuclear division (GO:0007088),-0.3281860918893299,-1.1822172607998644,0.17272727272727273,0.48830138286945135,1.0,32/55,41.41%,INSR;LRP5;CDK13;CUL9;BMP4;CUL7;EDN1;RGCC;EDN3;CCDC8;BMP7;IGF1;IGF2;PDGFRB;CHEK1;TOM1L2;BORA;DUSP1;CAV2;BTC;OBSL1;AURKA;PHIP;IL1A;DRD3;FBXO5;TOM1L1;AURKAIP1;CCNB1;CD28;PDXP;CDC25C
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.47994030672155685,-1.1822079154008773,0.2641843971631206,0.4879156969122215,1.0,1/12,0.40%,IL1R1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.4554093766688722,-1.1818373563635856,0.2621184919210054,0.4883435368344044,1.0,7/14,29.20%,ARID2;MRNIP;FUS;TIMELESS;ERCC6;MMS19;RAD51AP1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.37169395154548357,-1.1815451146388822,0.2198952879581152,0.4885398076935874,1.0,14/29,34.60%,BIRC3;CASP8;UBE2D3;IKBKE;CD40;IKBKG;IKBKB;RIPK1;IRF7;CD300LF;TICAM1;TLR6;CD14;TBK1
prerank,protein neddylation (GO:0045116),-0.4661393748255003,-1.1807550533792799,0.2449725776965265,0.48987129389177964,1.0,5/13,20.63%,DCUN1D3;RBX1;UBE2M;DCUN1D2;DCUN1D5
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.3800426311998766,-1.1805205132284757,0.2326454033771107,0.4900073146270173,1.0,11/28,20.08%,ESAM;NAA80;HAX1;FCHSD2;RASA1;ARHGAP28;GBA2;DBNL;ARHGAP35;FCHSD1;CXCL12
prerank,nuclear migration (GO:0007097),-0.45603069289985443,-1.1804371623694427,0.2427007299270073,0.48977045547505094,1.0,5/13,17.98%,SYNE2;DCTN1;PAFAH1B1;FBXW11;PCM1
prerank,sphingosine metabolic process (GO:0006670),0.4222078909607254,1.180393150100223,0.23582766439909297,0.6400874467595674,1.0,7/17,11.24%,PLPP2;SPHK1;SGPP1;ACER1;ABCA2;SPHK2;NAAA
prerank,melanosome localization (GO:0032400),0.3994471677784207,1.180300878682612,0.22195704057279236,0.6386639295085405,1.0,9/21,16.60%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,endodermal cell fate commitment (GO:0001711),-0.5031173531566618,-1.179679209513068,0.2537313432835821,0.49108718545446384,1.0,3/10,12.44%,SOX17;CDC73;RTF1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.2526749315364242,-1.1791462510248913,0.07868852459016394,0.49188235363745786,1.0,103/314,27.45%,FBXL7;WWP1;PELI1;RB1;ECPAS;NEDD4L;ZNRF1;SMURF2;FBXL12;UBE2K;TRIM25;PSMA2;FBXL17;SMURF1;FBXL3;RBX1;UBE4B;CUL3;NEDD4;LTN1;PSME2;CUL2;ANKZF1;SPSB1;PSMB4;GSK3A;UBE2J2;UBE2D3;FEM1A;UBR2;AREL1;TNFAIP1;RMND5A;CDC16;SPOPL;ARMC8;ANAPC16;KAT5;ATXN3;FEM1C;SGTA;MAN1B1;UBE4A;FBXW11;ERLIN2;APPBP2;DNAJC10;PSMC2;FEM1B;ERCC8;PSMB2;PSMB1;AGAP3;TRIM13;CTNNB1;KCTD10;UBXN11;PSMA8;SPOP;DNAJB12;DMAC2;RAD23A;UBR1;SIAH1;PSME1;TRIM3;DNAJB9;RNF4;BUB1B;UCHL1;TBL1X;WWP2;HERPUD1;ECRG4;PSMD4;HUWE1;MDM2;BUB3;PSMA7;RNF216;HACE1;NFE2L2;FZR1;PSMD5;ARRB1;NEMF;MAEA;FBXL22;ZFAND2A;FBXO17;ANAPC7;FBXO38;PSMB10;TMUB1;RNF122;UBXN2A;RNF103-CHMP3;PSMA3;KIF14;USP19;RNF34;RNF103;PPP2R5C
prerank,positive regulation of filopodium assembly (GO:0051491),0.38353726276301753,1.1789753350337222,0.2290249433106576,0.6408576091939846,1.0,6/24,8.91%,NLGN1;TENM1;TENM2;FSCN1;GPM6A;PLPPR5
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3368602569520848,-1.1784958372030065,0.21256931608133087,0.4929633733756845,1.0,14/49,23.39%,SGMS1;CAV1;MCL1;DDX3X;TP53;BCAP31;BBC3;BCL2L11;GSDME;PPIF;SIAH1;HERPUD1;BECN1;EIF2AK3
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.34757094161637864,-1.1783485590787321,0.21180555555555555,0.4928855426035519,1.0,11/41,19.04%,TJP1;PODXL;GCNT2;JAK1;AFDN;DENND6A;SMAD7;FLOT1;BMP7;CITED2;MAGI1
prerank,potassium ion homeostasis (GO:0055075),0.39303674704691544,1.1783167399069536,0.25986078886310904,0.6410021167355324,1.0,6/23,8.71%,KCNMA1;ATP1A2;ATP12A;ATP1B1;SLC12A5;ATP4A
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.32639696231027443,-1.1780895008077557,0.2060931899641577,0.49304031611236493,1.0,14/57,17.30%,GSK3B;ZDHHC6;RALBP1;KDR;TNFSF10;MIEF1;BNIP3;GSK3A;TP53;MIEF2;BBC3;HIP1R;BCL2L11;PPIF
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.3169397087358164,-1.1770847718070674,0.17606837606837608,0.49491250468362963,1.0,23/69,24.95%,THBS1;IFIH1;APP;PTPRJ;FRMD8;LBP;ARHGEF2;PLCG2;PSEN1;JAK2;LPL;MIF;MAVS;CCL19;NOD2;PTPRC;PTPN11;ARFGEF2;RIPK1;FZD5;HMGB1;DDT;DHX9
prerank,myelin maintenance (GO:0043217),0.4856451139701897,1.1761713016138233,0.2814645308924485,0.6455572266952315,1.0,2/10,2.76%,MYRF;EPB41L3
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4019505229405692,1.1755431523841455,0.2119047619047619,0.6456453012842521,1.0,5/21,8.20%,SCN1B;KCNA5;CACNA2D1;CACNA1D;SCN5A
prerank,sodium ion homeostasis (GO:0055078),0.40615895631825033,1.175511342530796,0.2409090909090909,0.6440170113033319,1.0,5/21,11.92%,ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,lipid translocation (GO:0034204),-0.4119046318508465,-1.175013462127575,0.20959147424511546,0.49910259115583705,1.0,6/21,16.71%,ATP10A;ATP8B1;RFT1;ATP10B;ABCA7;ATP9B
prerank,cell junction maintenance (GO:0034331),0.4292095880370654,1.1748358446549927,0.23094170403587444,0.6442033611426033,1.0,7/14,24.93%,CD177;CBLN1;CSF1R;NLGN2;PARD6A;CBLN2;CLDN1
prerank,T cell mediated immunity (GO:0002456),-0.4542471590737873,-1.174637918584944,0.2616487455197133,0.49949732720307066,1.0,6/13,32.75%,CD55;JAG1;CTSH;GNL1;EMP2;MYO1G
prerank,energy reserve metabolic process (GO:0006112),-0.4149904905466275,-1.1745521731916635,0.2482638888888889,0.499284589980193,1.0,5/19,13.72%,GBE1;GSK3B;GFPT2;PPP1R3C;PHKB
prerank,protein homooligomerization (GO:0051260),0.27912238116913274,1.1744824959414601,0.13544018058690746,0.6434476984570523,1.0,23/114,15.30%,KCNC2;MPP2;GLRA3;HCN1;SYCP1;RYR3;C9;ADCY8;ATL1;AQP4;GNMT;SLC1A2;ACACA;CARD11;ALDH1A2;P2RX3;GLS;SIGMAR1;GOLGA2;RNF112;ASIC1;CBY1;TDO2
prerank,skeletal system development (GO:0001501),-0.27400720142731394,-1.1735622159148862,0.15097402597402598,0.5011227266081073,1.0,43/148,21.04%,TLL1;ZBTB16;AKAP13;EXT1;CDH11;TEAD4;PLS3;DYM;BMP5;ANKRD11;SH3PXD2B;BMP6;KIAA1217;TGFB2;ALPL;RBP4;CREB3L2;SLC10A7;TGM2;PCSK5;ADAMTS4;ETS2;PKDCC;RPL13;COMP;WWOX;NOTUM;WNT11;MYOC;RPS6KA3;EBP;TRPS1;BMP7;IGF1;TNFRSF11B;ANKH;CMKLR1;HYAL2;SOX4;COL13A1;HAPLN3;IGF2;HAPLN1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4545897939851741,-1.1729421995422429,0.26344086021505375,0.5021165377651808,1.0,6/14,10.15%,LIMS2;LIMS1;LOXL3;PHACTR4;PRKD1;FLNA
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4889817414344869,-1.1727185608626667,0.26062846580406657,0.5022442471909372,1.0,10/11,45.43%,TP53;ATF4;ATF6;DDIT3;CEBPB;ATF3;CREB3L1;ATF6B;CREB3L3;MBTPS2
prerank,RNA metabolic process (GO:0016070),-0.27947480537835917,-1.1726947710552214,0.14821124361158433,0.5018973957957962,1.0,45/127,26.53%,RBPMS;RBFOX2;RBMS1;METTL14;DDX3X;HNRNPA0;RBM5;HNRNPR;FTO;RBMS2;HNRNPM;POLR2G;RNASE3;DDX39B;NOL9;HNRNPA3;WTAP;DICER1;HNRNPUL1;RBM39;HNRNPF;XRN2;APOBEC1;TENT2;PARN;AGO2;HNRNPA1;SYNCRIP;THOC1;ADARB1;WDR74;TFIP11;RNASEH2C;DROSHA;RBM3;RBM6;PCBP1;POLR2C;DHX9;POLR2L;EXOSC7;POLR2H;ATXN1;HNRNPL;HNRNPD
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4998874455789114,-1.1724943204029223,0.25757575757575757,0.5019619491138179,1.0,5/10,28.45%,SLC44A1;SMOX;ALDH7A1;CHDH;DMGDH
prerank,organic substance transport (GO:0071702),-0.2827967108536568,-1.1720977781685462,0.1510791366906475,0.5024699923840035,1.0,22/120,9.94%,ABCG2;SLC47A1;PLTP;RUFY1;SLCO2A1;CALCRL;MYH9;RAMP1;RAB7A;SPNS2;SCAMP2;SLC19A2;SLC22A5;ABCB9;ABCD3;TAP2;ARRDC1;SLCO2B1;ARL6IP5;MFSD2A;RAMP2;ABCA9
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.4918734715756676,-1.1714721117555265,0.2844364937388193,0.5034731370230935,1.0,4/10,14.78%,MLLT3;ACE;TP53;LMBR1L
prerank,cellular response to organic cyclic compound (GO:0071407),-0.27861546885000604,-1.1711861886902468,0.1301989150090416,0.503722075731287,1.0,36/141,15.81%,CTNNA1;RAPGEF2;GNB1;PKD2;ESR1;NRIP1;LRRK2;NR3C1;DIAPH1;TIPARP;EGFR;MSN;PDE3A;LARP1;PDE2A;MED1;KCNQ1;SPIDR;RAP1A;MEF2C;EZR;TGM2;RAP1B;CDH1;ARL6IP5;RAPGEF1;NCOA4;ACTB;KAT5;PDE12;P2RY6;IGFBP5;ROCK2;RUVBL2;ADCY1;UBE2L3
prerank,cellular lipid catabolic process (GO:0044242),0.37495708800473776,1.1710065580286364,0.23076923076923078,0.6518197315942067,1.0,4/27,7.61%,ENPP2;NUDT19;LPIN1;SMPDL3B
prerank,metal ion homeostasis (GO:0055065),-0.34546668371469247,-1.1709704881582792,0.2093425605536332,0.5037942233046909,1.0,8/40,11.02%,SLC12A7;CAV1;FAM20A;CNNM2;TMTC2;SLC12A2;CNNM4;COX11
prerank,positive regulation of viral life cycle (GO:1903902),0.3895511298645686,1.1700640650567837,0.2536231884057971,0.6527376560207239,1.0,6/22,18.33%,LGALS1;TYRO3;DDB1;TSG101;P4HB;CHMP2A
prerank,vesicle transport along actin filament (GO:0030050),-0.4096779257198697,-1.1700158197796886,0.2539964476021314,0.5054411162019543,1.0,5/19,12.83%,MYO1D;FNBP1L;WASL;MYO1F;ACTN4
prerank,response to amyloid-beta (GO:1904645),0.336092220050453,1.1695564041634465,0.22510822510822512,0.6525893199201571,1.0,7/44,4.29%,GRM5;MMP12;CACNA1B;CDK5;CACNA2D1;GRIN2A;CACNA1A
prerank,regulation of microtubule nucleation (GO:0010968),0.476526462867543,1.1693728262450809,0.2692307692307692,0.6514560855894744,1.0,3/10,7.33%,EML2;ARHGEF7;PAK1
prerank,MAPK cascade (GO:0000165),-0.2507465418371247,-1.16902627742477,0.11351351351351352,0.5073026371385889,1.0,66/295,17.04%,SPTBN1;TEK;DAB2IP;KITLG;RAPGEF2;SPTAN1;SHANK3;MAP3K20;MEF2A;RASAL2;BRAP;IL17RD;JAK1;RANBP9;PSMA2;LRRK2;MAP3K5;KDR;YWHAE;EGFR;NFKB1;RASGRF2;RBX1;PIK3R1;IRS1;DLG1;SHOC2;CUL3;PTK2;FGF1;MEF2C;PSME2;MAPKAPK2;MAPK1;RAF1;PSMB4;FGF7;PDE6D;MAP3K3;TAOK3;RASA4;PTPN3;PEBP1;BRAF;JAK2;RASA1;FGF2;ABHD17A;FBXW11;MAP3K8;HGF;KSR1;MAPK8;ABHD17C;PIK3CB;PSMC2;GRB2;MAP4K4;PSMB2;MAPK12;PSMB1;ANGPT1;IGF1;FYN;MARK3;CTSH
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.45241080881917206,-1.1686601854698326,0.2681564245810056,0.5077020221088747,1.0,6/14,27.64%,NOL9;RPL7L1;BOP1;PES1;ZNHIT3;WDR12
prerank,negative regulation of cell activation (GO:0050866),0.43917181964673546,1.1684480967999598,0.26124197002141325,0.652396649558868,1.0,7/14,15.32%,C1QTNF1;NR1D1;PDGFA;GPER1;LDLR;APOE;PDGFRA
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2709141355095399,-1.1682866563303766,0.14726027397260275,0.5081244092441376,1.0,58/172,25.93%,RUFY1;MTMR3;ARF3;PLA2G4A;PIP4K2A;LPCAT1;PLD1;PIK3R1;BMX;PIP4K2B;PI4KB;SLC44A1;PIP5K1B;PIK3C2A;MTMR6;RAB5A;PLD2;STARD7;PLCG2;MFSD2A;PIK3CD;DGKA;AGPAT4;DGKZ;INPP4A;PIK3R6;MTMR12;FGF2;ACP6;AGPAT3;PTPN13;AGK;PLEKHA4;PLSCR1;PIK3CB;AGPAT1;PI4K2B;CEPT1;PIK3R3;PTDSS1;PCTP;PLA2G12A;LCLAT1;PTEN;LPIN2;DDHD2;LPCAT3;INPP5D;LCAT;MTMR4;GPD1;PIP5K1A;DGKH;CHAT;INPP5J;PIK3CA;DGKE;INPP5E
prerank,import into cell (GO:0098657),-0.3455240209439064,-1.1681322812926622,0.21908127208480566,0.508041690606252,1.0,8/41,7.79%,SLC47A1;SLC6A6;SLC12A7;LRRC8C;SLC7A1;SLC7A5;SLC5A6;LRRC8D
prerank,DNA metabolic process (GO:0006259),-0.25561506920119786,-1.1680742095670005,0.09390444810543658,0.5077712542110661,1.0,90/270,27.65%,SP100;MNAT1;PDS5B;STN1;ATM;NT5E;PARP4;DMC1;TOP3A;KMT5B;SAMHD1;TRRAP;TOP3B;MRE11;INIP;UHRF2;NABP1;RBBP8;MCM4;DOT1L;AXIN2;ORC5;NSMCE3;ENDOV;PDS5A;POLD3;RAD18;INTS3;OGG1;RPA3;DNA2;KAT5;RPA1;CTC1;PNKP;XPC;PTGES3;ERCC3;BTG2;UBE2V2;TOP1MT;TERF2;SRPK2;ORC2;DNMT1;SUMO1;POLE2;FANCC;FANCG;PRIM2;WRN;ORC4;RPA2;USP7;SMARCAD1;PRKDC;RAD54L;TCF7L2;TIMELESS;NSMCE4A;LIG4;FANCL;BRCA1;TRIM28;CHRNA4;DCLRE1B;TERT;BLM;RFC4;CHEK1;PWWP3A;GADD45A;MCM3;TOP1;NTHL1;RFC1;MSH3;SMARCB1;LIG1;HMGB1;INO80;POLA2;MCM7;RAN;MMS19;MCM5;GTF2H3;MCM10;POLL;EXO1
prerank,cell-matrix adhesion (GO:0007160),-0.294823938280121,-1.1680742065582823,0.16666666666666666,0.5073617612641216,1.0,33/95,23.08%,SORBS1;ITGB1;THSD1;BCR;FERMT2;CD34;RAC1;ITGBL1;ITGA3;ITGA1;ITGB4;ADAM9;ITGB5;PPFIA1;PTPRK;ADAMTS9;BCAM;FBLN5;ILK;ACTN1;MSLN;ITGA4;ITGA2;VCAM1;MKLN1;COL13A1;LYVE1;FERMT3;ITGB3;VCL;ITGA7;PIP5K1A;HPSE
prerank,cellular response to interleukin-4 (GO:0071353),-0.48877606884565844,-1.1676591744109572,0.29313543599257885,0.5079398640189622,1.0,2/10,6.72%,LEF1;STAT6
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3237340192709369,1.1675734356999456,0.20665083135391923,0.6533560345789277,1.0,13/51,13.12%,CNTNAP2;EPB41L3;SHTN1;NBL1;TNIK;MAP1S;GPM6A;PAK1;NYAP2;MINK1;SRGAP2;SGK1;BDNF
prerank,negative regulation of ion transport (GO:0043271),0.3762912250722279,1.1672994546457978,0.25874125874125875,0.6524943210057591,1.0,6/24,9.30%,GPM6B;STC1;SYT11;WNK2;WNK3;ADRA2A
prerank,RNA splicing (GO:0008380),-0.2926487711003374,-1.1671914928249791,0.18213058419243985,0.508564141242824,1.0,27/95,21.25%,MBNL1;SRSF11;PRPF3;SMU1;CDK12;IVNS1ABP;RSRC1;PPIG;FUS;PRPF6;DDX39B;SF3B1;DBR1;SFPQ;SLU7;YJU2;SCNM1;SYNCRIP;SRPK2;USB1;ZMAT5;PPP2CA;SRRM1;NONO;RNPS1;SRSF10;TRA2B
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.40927982723200884,1.1664436036357348,0.2627118644067797,0.6531878263557857,1.0,4/18,5.12%,NLGN1;RIMS2;RIMS1;SYN1
prerank,membrane repolarization during action potential (GO:0086011),-0.4604316216239076,-1.1663272085661869,0.28415300546448086,0.5101082997658958,1.0,7/13,28.18%,KCNJ2;YWHAE;KCNQ1;KCNE4;KCNH2;KCND3;ATP1A1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.30108680801493504,1.1662035170460654,0.18867924528301888,0.6522755868309303,1.0,16/75,13.07%,SLC24A2;ATP1A2;KCNJ3;ATP12A;ATP2B4;CACNA2D1;SLC9A7;ATP1B1;SLC9A9;SLC8A2;SLC12A5;ATP4A;KCNJ6;SLC8A3;SLC8A1;SLC12A4
prerank,protein localization to Golgi apparatus (GO:0034067),-0.37456439776347183,-1.1661932692771124,0.26238532110091745,0.5100162062540374,1.0,10/27,21.42%,VPS13A;VPS13C;GAK;CSNK1D;VPS13D;RIPOR1;GBP5;GOLPH3;ARL5C;IFT20
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.33868721791795386,-1.1661648397759259,0.19593345656192238,0.509672956258482,1.0,9/43,8.09%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;HES1;MEF2C;TBX2
prerank,regulation of cell morphogenesis (GO:0022604),-0.3726176410119854,-1.166164164839321,0.22992700729927007,0.5092669711705521,1.0,11/30,18.40%,FERMT2;PDZD8;ZMYM6;MACF1;MFSD2A;ZMYM4;FMNL2;MOV10;CAPZB;CFL1;WTIP
prerank,positive regulation of DNA recombination (GO:0045911),-0.3801684793220556,-1.1656052286762806,0.2356115107913669,0.5101120643777666,1.0,9/27,15.99%,ARID2;SHLD1;TFRC;KMT5B;MRNIP;FUS;ERCC2;PRDM9;MAD2L2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.47224895049634935,-1.1654234109175363,0.2776769509981851,0.5101119826530653,1.0,5/12,17.86%,PTPN14;NEDD4;BMP4;TPR;NUP214
prerank,positive regulation of protein transport (GO:0051222),-0.31245602950817664,-1.164766749305053,0.20353982300884957,0.5111525945487503,1.0,27/67,25.30%,UNC13B;CD2AP;GOLPH3L;ADAM9;IER3IP1;BMP6;TGFB2;EZR;MYO18A;CNST;MYOM1;BCAS3;ICE1;CHP1;TPR;IGF1;RIPOR1;GOLPH3;PCM1;OAZ2;ARHGEF5;VAMP2;PCNT;CEP131;SYTL4;APBB1;PLK3
prerank,canonical glycolysis (GO:0061621),0.3745840787844258,1.1647530155065409,0.240990990990991,0.653038873453872,1.0,6/24,18.82%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3745840787844258,1.1647530155065409,0.240990990990991,0.653038873453872,1.0,6/24,18.82%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,response to amino acid starvation (GO:1990928),-0.3031997446056375,-1.164751825854512,0.1917562724014337,0.5107772491960527,1.0,21/72,19.30%,SESN1;MAP3K5;MTOR;LARP1;FAS;SEC13;MAPK1;MIOS;PRKD1;DAPL1;RPTOR;ATP6V1E1;LARS1;KPTN;MAPK8;ATF4;DAP;CASTOR1;GCN1;RNF152;ITFG2
prerank,negative regulation of protein modification process (GO:0031400),-0.3023013204627508,-1.1646908539595917,0.19572953736654805,0.5105011202387217,1.0,17/79,14.35%,DAB2IP;MFHAS1;LYN;CORO1C;GSK3B;LRRK2;NIBAN1;CDYL;LRP6;SLIT2;OCLN;PRKAA1;PTPN13;CHP1;PNKP;TRAF3IP1;DNAJC10
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.2937992411428442,-1.1646629621773483,0.17918088737201365,0.5101726081252284,1.0,45/95,33.67%,SMC5;NIPBL;SAMHD1;ZFYVE26;SPIDR;MMS22L;MRE11;NABP1;MCM9;RBBP8;MCM4;RAD54B;NSMCE2;SFPQ;RPA3;RPA1;FANCM;PALB2;RFWD3;WRN;RPA2;RAD54L;BRCA1;RAD51AP2;BLM;YY1;MCM3;MORF4L1;INO80;MCM7;MCM5;POLL;XRCC2;AP5Z1;KDM4D;RAD51AP1;SWI5;RAD51D;MCM2;HUS1B;RMI1;MEIOB;RAD50;GINS2;FAN1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3491505310311681,-1.1644789922314003,0.22302158273381295,0.5102059747393562,1.0,14/38,21.87%,DAB2IP;MGA;RYBP;SUZ12;MAX;RBBP8;EHMT1;YAF2;PHC1;FOXO4;RNF2;BRCA1;PHC3;CHEK1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.42881651412478095,-1.1644546838752245,0.2759259259259259,0.5098751792391232,1.0,5/17,17.30%,CBFA2T3;PPARA;HDAC4;PDE12;PPIF
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.31192878704073845,1.164283962156643,0.2043956043956044,0.6527516430782594,1.0,14/59,16.99%,AKR1D1;CYP46A1;ELOVL4;ACLY;OSBPL6;ACACA;CYP27A1;OXSM;ALDH1A2;LIPC;OSBPL9;NDUFAB1;ALOX5;ACOX2
prerank,defense response to symbiont (GO:0140546),-0.29423872203476825,-1.1641763436585235,0.18327402135231316,0.5101519511373057,1.0,41/92,31.08%,IRF2;IFIH1;ATG7;TRIM56;SETD2;ABCC9;SAMHD1;DDIT4;BNIP3;IRF1;SERINC3;FLNA;STAT2;IFITM3;CD40;PLSCR1;PDE12;CGAS;MOV10;NLRC5;MAVS;ZMYND11;SERINC5;MAP3K14;PTPRC;EXOSC5;ABCE1;IFNAR2;RELA;IRF7;NCBP3;IFITM2;AGBL5;OASL;BST2;RSAD2;IFNLR1;SHFL;LILRB1;RTP4;PMAIP1
prerank,regulation of centriole replication (GO:0046599),-0.4252391692188934,-1.1640293587557258,0.2807971014492754,0.5100910812223819,1.0,6/17,25.55%,KAT2B;PLK2;ALMS1;PLK4;BRCA1;CEP295
prerank,DNA catabolic process (GO:0006308),0.4571513543033772,1.1639705944584657,0.27601809954751133,0.6520174768327154,1.0,6/11,23.77%,MUS81;REXO4;DNASE1L1;FBH1;ISG20;DNASE1L2
prerank,glycoprotein metabolic process (GO:0009100),-0.33054753397009595,-1.1637114053131357,0.22905027932960895,0.5103733118537516,1.0,22/53,27.55%,ST3GAL4;ST8SIA4;MAN2A1;MAN1C1;ST6GALNAC3;MGAT4B;FUT8;MAN1A2;ST3GAL2;ADAMTS9;PRKCSH;MAN1B1;B4GALT5;GAL3ST2;GOLPH3;LARGE1;ENGASE;HPSE;FBXO17;TNIP1;ST8SIA6;MANBA
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.368546590715043,-1.1636533156375986,0.2346368715083799,0.5101010624919496,1.0,15/31,36.49%,DCUN1D3;RAB1A;MAGEC2;UBE2L3;DCUN1D2;PTEN;DCUN1D5;FZR1;TRIB3;RPS2;PLK1;BMI1;TOPORS;CDC20;UBE2C
prerank,nitrogen compound transport (GO:0071705),-0.2721561791019462,-1.1635683111530617,0.16695957820738136,0.5098807659677869,1.0,29/141,13.74%,ABCG2;SLC6A6;CERT1;RUFY1;CALCRL;MYH9;SLC7A1;SLC7A5;RALBP1;RAMP1;RAB7A;SLC12A2;SCAMP2;SLC19A2;SLC38A5;SLC22A5;SLC44A1;SLC1A5;LRRC8D;ARRDC1;ARL6IP5;RAMP2;SLC52A1;SEC14L1;EDN1;TXNIP;SLC52A3;CHMP2B;SLC7A7
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.3477188220162965,-1.1633843020468932,0.2469775474956822,0.5099404232649095,1.0,14/38,19.61%,CAV1;PTPN1;APP;ACE;GAS6;IL34;SH3BP5L;EPHA4;NCK2;NEDD9;NOX4;HYAL2;PTPRC;RAP2C
prerank,regulation of vacuole organization (GO:0044088),-0.39350078331021343,-1.1629609858812449,0.2593320235756385,0.5105052949267844,1.0,4/20,8.79%,ANXA2;MTMR3;RAB5A;TBC1D14
prerank,endocytic recycling (GO:0032456),-0.3282281775879899,-1.162584320964071,0.22182468694096602,0.5109997330804383,1.0,14/50,18.79%,EPS15;RAB7A;EHD2;RAB11FIP3;ANKRD50;SNX12;EHD1;VPS26A;VPS52;EHD4;ANKRD27;VPS35L;WASHC1;VPS26C
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3983850579012249,-1.1621735726642703,0.24567474048442905,0.511543738456571,1.0,6/22,12.11%,ADAM9;TNFRSF1B;SNX9;ROCK1;PTPN3;TIMP3
prerank,phospholipid metabolic process (GO:0006644),0.30164100405106314,1.161762705051185,0.1951219512195122,0.6566773044775185,1.0,14/71,12.26%,ENPP2;IDI2;FADS1;PIP4P1;PLPPR4;PLPPR1;PLPP2;SMPD3;PLA2G3;PLA2G4E;PLPPR5;ABCA2;GNPAT;FDFT1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2821852956237725,-1.161499318866487,0.17457627118644067,0.5127087189505929,1.0,29/119,16.18%,RUFY1;MTMR3;ARF3;EFR3B;PIP4K2A;PIK3R1;BMX;PIP4K2B;PI4KB;PIP5K1B;PIK3C2A;MTMR6;RAB5A;PLCG2;ITPKB;PIK3CD;TTC7A;SOCS2;INPP4A;PIK3R6;MTMR12;PIGV;FGF2;PTPN13;PLEKHA4;PIK3CB;PIGG;PI4K2B;PIK3R3
prerank,lipid biosynthetic process (GO:0008610),0.2939196723934374,1.1607676900278254,0.17865429234338748,0.6578057429667156,1.0,18/77,15.88%,IDI2;FADS1;ACSS2;LSS;ELOVL4;CYP51A1;ACLY;ACACA;OXSM;ACSL6;GNPAT;LIPC;FDFT1;OLAH;SCD5;NDUFAB1;CLN8;ALOX5
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2764815963876364,-1.1607604456238843,0.16179001721170397,0.5139945177830016,1.0,26/138,11.47%,PTPRG;FLT1;TEK;IGF1R;TIE1;ROR1;INSR;ABI1;LYN;BMPR2;KDR;MERTK;EGFR;IL6ST;YES1;PTK2;NGF;EPHA4;FLT4;LIFR;ACVR2A;BCAR1;MPZL1;FRK;RAPGEF1;JAK2
prerank,intracellular protein transport (GO:0006886),-0.25103985153869407,-1.160730646638932,0.11879432624113476,0.5136598467856875,1.0,86/304,23.09%,TBC1D4;SEC31A;RASSF9;KIF13B;TRAK1;NUP42;ARF3;RAB7A;ARCN1;RAB1A;SMURF1;CSE1L;TLK1;SYNRG;TBC1D1;RAB5B;XPO7;STX3;TBC1D2B;COX18;HPS4;TBC1D8B;WDR11;SNX9;USP6NL;SEC13;RAB5A;TBC1D30;ARHGEF2;STX8;TBC1D14;SCFD1;SRPRA;AKT1;FUT10;PPP1R10;TBC1D22B;COPA;GABARAP;RAB3GAP2;EHD1;TBC1D22A;VPS26A;NUP153;ARL4A;SLU7;CHP1;VPS45;RAB23;VPS36;RAB24;RAB32;TPR;SNX8;HERC2;SIL1;AP4M1;HDAC6;LAMP2;TMED5;XPO4;GIPC1;FAM91A1;NUP214;NXT1;IPO8;STX12;TBC1D8;VPS26C;AP3B1;TBC1D17;AP4B1;TBC1D25;ARL5C;KIF13A;CTSA;TECPR2;SNX13;PREB;NUP188;TBC1D12;EVI5;SAR1A;ARL4C;HOMER3;COPZ1
prerank,covalent chromatin modification (GO:0016569),-0.45163896624981026,-1.1597632328195124,0.25830258302583026,0.5154076359665891,1.0,3/14,7.41%,CHD1;HDAC1;SETD5
prerank,telomere capping (GO:0016233),-0.4371387377723188,-1.15959334564403,0.2722222222222222,0.5153873306881417,1.0,8/16,25.05%,STN1;MRE11;CTC1;TERF2;TFIP11;PRKDC;DCLRE1B;DCLRE1A
prerank,protein destabilization (GO:0031648),-0.35994574792531786,-1.1595530338430016,0.2537313432835821,0.5150814183366114,1.0,11/32,18.31%,CREBBP;RNF139;SOX17;FBXL3;CUL3;IRGM;CDC73;FBXW11;SENP2;CTSH;RAD23A
prerank,pre-miRNA processing (GO:0031054),-0.45001807974318586,-1.159474800693729,0.28415300546448086,0.5148420836481178,1.0,5/14,21.02%,TUT7;DICER1;TUT4;AGO2;DROSHA
prerank,defense response to virus (GO:0051607),-0.29056237198477136,-1.1592701703575066,0.19389587073608616,0.5149023244856662,1.0,45/100,31.08%,IRF2;IFIH1;ATG7;TRIM56;SETD2;ABCC9;CLPB;SAMHD1;DDIT4;BNIP3;IRF1;SERINC3;FLNA;STAT2;IFITM3;CD40;PLSCR1;PDE12;CGAS;MOV10;NLRC5;MAVS;ZMYND11;SERINC5;MAP3K14;PTPRC;ZDHHC1;EXOSC5;ABCE1;IFNAR2;RELA;AKAP1;IRF7;NCBP3;IFITM2;AGBL5;CXCL10;OASL;BST2;RSAD2;IFNLR1;SHFL;LILRB1;RTP4;PMAIP1
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.3842428630069494,-1.1592606602559017,0.2702205882352941,0.5145105254824208,1.0,12/24,30.85%,DTX3L;SIN3A;CGAS;MAVS;ZDHHC1;HSP90AA1;EIF2AK4;TRIM44;PARP9;TRIM6;TOMM70;LILRB1
prerank,cellular response to interleukin-15 (GO:0071350),-0.4610339986072115,-1.1589375062234908,0.29945553539019965,0.514491480699175,1.0,7/13,31.42%,JAK1;IL15;PLCB1;GRB2;IL15RA;IL2RG;STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4610339986072115,-1.1589375062234908,0.29945553539019965,0.514491480699175,1.0,7/13,31.42%,JAK1;IL15;PLCB1;GRB2;IL15RA;IL2RG;STAT3
prerank,protein stabilization (GO:0050821),-0.2699608258379467,-1.1585190841507578,0.14956521739130435,0.5150326150287959,1.0,59/168,27.57%,HIP1;USP9X;PARVA;DVL3;SOX17;NAA16;PIK3R1;STK3;HPS4;IRGM;PRKCD;RASSF2;TCP1;AAK1;STXBP4;EPHA4;CTNND1;USP2;USP13;NAA15;FLNA;PER3;SMAD7;FLOT1;CHP1;TBRG1;PTGES3;HCFC1;HIP1R;RPL5;CREBL2;IGF1;NCLN;SUMO1;LAMP2;TMEM88;STX12;SOX4;USP7;COA8;TBL1X;PTEN;CREB1;RPS7;HSP90AA1;GLMP;TRIM39;MSX1;PLPP3;CRTAP;HSPA1B;TAF9;CCT5;PEX6;TRIM44;CCT2;USP19;BAG4;BAG5
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3824578922778611,1.1585118139606057,0.25517241379310346,0.6625067239655628,1.0,5/22,9.55%,RELL2;GADD45B;SPHK1;VEGFA;MINK1
prerank,mitotic metaphase plate congression (GO:0007080),-0.3301449649252517,-1.158195602937191,0.20955882352941177,0.5153586011880869,1.0,28/51,39.59%,MAD1L1;CUL3;CHMP4B;CHMP4A;CHMP2B;CHMP5;RAB11A;CENPE;PDCD6IP;RRS1;BECN1;EML4;PINX1;CHMP3;KIF14;SPDL1;CDCA8;CHMP6;CHMP1A;NUDC;BOD1;NUF2;PSRC1;MIS12;CHMP1B;RMDN1;KIF2C;CCNB1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.32526402068476146,-1.1571842547507338,0.22077922077922077,0.5173712392004871,1.0,19/54,23.61%,PAK1IP1;RPF1;RRP15;NOP2;RPL3;RPL26;NIP7;RPL10;RPL7A;RPL5;NLE1;WDR74;MDN1;RPL35A;BOP1;PES1;RRS1;EBNA1BP2;NOP16
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.41300080933127054,-1.156973989163396,0.273224043715847,0.517458031430835,1.0,8/21,21.08%,NT5C2;NT5E;PDE2A;PDE9A;NT5C1A;HPRT1;HINT1;AMPD3
prerank,protein dephosphorylation (GO:0006470),-0.27831555572822275,-1.1565732372686741,0.168141592920354,0.5179931651512439,1.0,38/135,20.31%,PTPRG;PTPRB;PTPRM;PPP2R5A;PTPN14;PPM1H;EYA4;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;NCK1;PPEF2;PPM1L;ILKAP;PTPRK;MTMR6;PPM1F;PPP2R2D;PPM1B;PPP1R12A;UBLCP1;PTPN3;DUSP3;PTPN13;CTTNBP2NL;FBXW11;PPP2CB;UBASH3B;TNS2;PPM1D;DUSP16;DUSP22;PPP2CA;PTPRC;PTEN;PPP3CC
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.40080397028406994,-1.1563570577639248,0.26714801444043323,0.518072380483644,1.0,8/20,24.52%,DCUN1D3;ZMIZ1;DCUN1D2;EPAS1;WASHC1;DCUN1D5;HSP90AA1;HSPA1B
prerank,brain development (GO:0007420),0.2665294385679384,1.1562501157137564,0.18243243243243243,0.6673584110627508,1.0,19/136,7.58%,CNTNAP2;ROBO2;CTNNA2;CNTN4;GRIN2B;DSCAML1;ADGRL3;GRIN2A;POMK;MEIS1;NDRG4;MEIS3;MDGA1;PITPNM1;SMG9;PAX2;MAP1S;PROX1;BBS4
prerank,protein polyubiquitination (GO:0000209),-0.25017735400725133,-1.1560777503234438,0.1266891891891892,0.518314300142471,1.0,93/297,26.36%,FBXL7;WWP1;PELI1;UBR5;CBFB;NEDD4L;ZNRF1;SMURF2;TRAF5;FBXL12;UBE2K;TRIM56;PSMA2;FBXL17;DTX3L;SMURF1;RNF125;FBXL3;RNF213;RBX1;LMO7;UBE4B;CUL3;NEDD4;PSME2;RNF115;RNF144B;SPSB1;PSMB4;HECTD1;TRIP12;UBE2J2;ZNRF2;UBE2D3;TPP2;UBR2;FBXW8;AREL1;TRIM14;RMND5A;CDC16;HERC6;UBE2E2;UBE4A;FBXW11;RNF168;PSMC2;RC3H1;RNF167;MYLIP;TNFAIP3;UBE2V2;ERCC8;PSMB2;UBE2L3;PSMB1;PELI2;MIB2;CTNNB1;PSMA8;SPOP;SASH1;KLHL3;SIAH1;RNF152;AKTIP;PSME1;TRIM3;NPEPPS;RNF4;WWP2;PSMD4;HUWE1;BRCA1;UBE2R2;MDM2;PSMA7;RNF216;HACE1;FZR1;PSMD5;THOP1;TRIM68;RNF146;FBXO32;FBXL22;FBXO17;ANAPC7;FBXO40;DTL;FBXO38;PSMB10;ARIH2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.48590974706583817,-1.1559737440983067,0.2982142857142857,0.5181530582263386,1.0,10/10,51.45%,SMAD7;RC3H1;NFKBID;IL4;FOXP3;MALT1;RC3H2;TBX21;NFKBIZ;ZC3H12A
prerank,cellular response to calcium ion (GO:0071277),0.303369610131319,1.1558980286472027,0.20909090909090908,0.6666067446491691,1.0,15/67,12.14%,NLGN1;SYT1;SYT5;RYR3;ADCY8;SYT12;SYT11;HPCA;CPNE9;DPEP1;SCN5A;ACER1;CPNE1;SYT4;GPLD1
prerank,C-terminal protein amino acid modification (GO:0018410),0.4510009205198976,1.1558179590957252,0.3006535947712418,0.6651930338023009,1.0,3/11,12.14%,AGBL4;AGBL1;GPLD1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.34264148192894833,-1.1553938719642998,0.2323943661971831,0.5191062955775275,1.0,9/40,14.91%,FLT1;EDNRA;ESR1;PLCG1;EGFR;HTR2A;FGF2;P2RY6;LPAR2
prerank,cellular response to insulin stimulus (GO:0032869),-0.2780121415611236,-1.1551700740662214,0.17625899280575538,0.5192042078877807,1.0,43/124,26.80%,IGF1R;TBC1D4;SORBS1;FOXO1;GAB1;INSR;GSK3B;KAT2B;PIK3R1;IRS1;RHOQ;PIK3C2A;GRB10;GSK3A;ZNF106;NAMPT;GRB14;BCAR1;AKT1;SLC27A4;RAB8B;INSIG2;CEACAM1;ATP6V1E1;GRB2;DENND4C;FOXO4;PIK3R3;ATP6V0A1;PRKDC;PPARG;LPIN2;IGF2;VAMP2;ATP6V1H;SYAP1;TRIB3;SH2B2;PTPN2;ZFP36L1;APC;HDAC5;ATP6V0E2
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.39384282488035516,-1.1550187596945023,0.24107142857142858,0.5191831962349709,1.0,7/22,14.14%,SP100;LRRK2;MDFIC;GDI1;CHP1;UFM1;RAB23
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.3292132185182411,-1.154445622952978,0.22953736654804271,0.5200948380751684,1.0,15/50,22.72%,CREBBP;FBXL17;TTC23;SMO;HERC4;WDR11;GLI3;GLIS2;MOSMO;FUZ;ZIC1;KIF7;GPC3;TUBD1;TULP3
prerank,lymphocyte differentiation (GO:0030098),-0.31231104426759815,-1.153854869836045,0.2074468085106383,0.5210900505719258,1.0,19/68,19.36%,PBX1;ITGB1;PTPRJ;JAG2;ZBTB7A;PLCG2;TPD52;PIK3CD;HDAC4;ITGA4;NHEJ1;LMBR1L;TCF3;VCAM1;CEBPG;CLCF1;SOX4;PTPRC;DNAJB9
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.31725444415761234,1.153656173877563,0.22972972972972974,0.6697391142564646,1.0,13/52,11.30%,RBFOX1;KHDRBS2;CELF5;KHDRBS3;SRRM4;CELF4;CELF2;CELF6;FXR2;DDX17;RBFOX3;ZC3H10;RBM8A
prerank,sensory perception of pain (GO:0019233),0.38706411660250795,1.1535720565845942,0.2774327122153209,0.6683148802893603,1.0,3/21,4.61%,OPRM1;MME;KCNA2
prerank,osteoclast differentiation (GO:0030316),-0.3940717075735256,-1.1535078458859,0.25565217391304346,0.5214843308609717,1.0,2/22,2.79%,FOXP1;ANXA2
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.4621201366526697,-1.1534656308327504,0.2931654676258993,0.5211715281509434,1.0,4/13,9.93%,ATG7;ATG10;UBA2;UBA7
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.28265555581632457,-1.1533615712691487,0.1742957746478873,0.5210080853524501,1.0,41/109,26.42%,RUFY1;MTMR3;ARF3;PLA2G4A;PLCG1;PIP4K2A;PLCB3;PIK3R1;BMX;PLCB1;PIP4K2B;PI4KB;PIP5K1B;PIK3C2A;MTMR6;RAB5A;PLCG2;PIK3CD;INPP4A;PIK3R6;MTMR12;FGF2;PTPN13;PLEKHA4;PIK3CB;PI4K2B;PIK3R3;PIP4P2;PLA2G12A;LCLAT1;PTEN;PIGW;INPP5D;PDGFRB;MTMR4;PIP5K1A;INPP5J;PIK3CA;PLA2G4F;INPP5E;TPTE
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3696199579548468,-1.153266052488184,0.22743055555555555,0.5208498215728777,1.0,9/29,18.94%,MNAT1;RBX1;ERCC2;RPA3;RPA1;XPC;ERCC3;CETN2;RPA2
prerank,cellular response to lectin (GO:1990858),-0.2856522886849919,-1.1532502505189315,0.1857638888888889,0.5200717179632113,1.0,27/104,20.36%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PSMB4;PLCG2;FBXW11;ICAM2;PSMC2;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;KRAS;NRAS;PSMD4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2856522886849919,-1.1532502505189315,0.1857638888888889,0.5200717179632113,1.0,27/104,20.36%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PSMB4;PLCG2;FBXW11;ICAM2;PSMC2;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;KRAS;NRAS;PSMD4
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4482594184371698,-1.1530559118327954,0.2848605577689243,0.5201366754020587,1.0,2/13,6.02%,ENTPD1;ENTPD6
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3562259127490003,1.152921607402815,0.23690205011389523,0.6684645757427568,1.0,9/27,19.07%,HPCA;CALM2;CACNB3;CACNB4;ADRA2A;HRC;SELENON;CACNB1;PDE4D
prerank,neuromuscular junction development (GO:0007528),-0.3798917214953896,-1.1524326490271006,0.2547008547008547,0.5211856168889494,1.0,7/24,11.74%,UNC13B;PPFIBP1;LRRK2;NEDD4;AGRN;PDZRN3;DCTN1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.2948789078213202,-1.1517667733285002,0.1975736568457539,0.5222986909143784,1.0,29/86,22.06%,GHR;PECAM1;APP;PAK2;IL15;PTPRJ;EGFR;BMP6;IL6R;ABL1;PRKCD;ARHGEF2;PLCG2;HAX1;CSPG4;FGF7;TP53;JAK2;HGF;MIF;ANGPT1;IGF1;FYN;PTPRC;RAP2C;ITGB3;IGF2;PTPN11;PTK2B
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3028031859410514,-1.1515966412509657,0.2181500872600349,0.5222499920388178,1.0,23/71,20.25%,SGMS1;CERT1;ACER2;DEGS2;SGMS2;A4GALT;PRKD3;PRKD2;SPNS2;ELOVL5;CERS4;PPM1L;PRKD1;ACER3;AGK;SPTLC1;ASAH1;CERS5;SMPD2;VAPA;LARGE1;DEGS1;ELOVL7
prerank,response to copper ion (GO:0046688),-0.4116100680499222,-1.1505716077208994,0.24551971326164876,0.5241306932534958,1.0,13/20,35.95%,MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B;ATP7B;ATP5F1D;AQP1;IL1A;MT3
prerank,cellular response to superoxide (GO:0071451),-0.49273581125757204,-1.150516567302996,0.31021194605009633,0.5238515506003962,1.0,3/10,18.06%,NOS3;CCS;SOD1
prerank,regulation of cell aging (GO:0090342),-0.4775298588726213,-1.1502496543839542,0.30071174377224197,0.5240434202569381,1.0,4/11,15.37%,NEK6;LMNA;MIF;NUAK1
prerank,response to calcium ion (GO:0051592),0.2805581255939518,1.1500488877860282,0.19310344827586207,0.6750178233863712,1.0,19/102,9.77%,NLGN1;SYT1;SYT5;KCNMA1;RYR3;SLC25A13;ADCY8;SYT12;SYT11;HPCA;CALM2;HOMER1;RYR2;CPNE9;DPEP1;SCN5A;ACER1;PPP3CA;CPNE1
prerank,ion transport (GO:0006811),0.27509419456238965,1.1498722165724116,0.19523809523809524,0.6738399309077898,1.0,23/111,14.48%,TRPM3;SLC24A4;SLC24A2;GABRB1;SLC5A12;GLRA1;SLC9A7;KCNN2;SLC9A9;SLC4A2;SLC8A2;SLC1A2;SLC36A2;SLC12A5;PANX2;VDAC2;SLC17A6;KCNN3;SLC8A3;SLC8A1;SLC12A4;SLC1A3;SLC26A8
prerank,extracellular transport (GO:0006858),0.4472509856522179,1.1498701221077714,0.28365384615384615,0.6721923632428681,1.0,6/12,16.82%,ADCY10;TSG101;ROPN1L;SPAG17;CABYR;DNAAF2
prerank,regulation of cell motility (GO:2000145),-0.27736833058510224,-1.1497109804946277,0.1781305114638448,0.5249105101646455,1.0,34/121,17.05%,RAC1;NTN1;TMSB4X;SPOCK2;CRK;DIAPH1;EGFR;ABL1;LMO4;ROBO4;MACF1;FGF1;PRAG1;PLXND1;ROCK1;PLXNA4;RAF1;LDB1;FGF7;AKT1;FLNA;LMNA;FRMD5;ABI3;RHOA;FGF2;CEACAM1;CDK6;PKN2;TBCCD1;ROCK2;CAVIN1;SLK;TMSB10
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.28417284328692993,-1.149597914246543,0.18244406196213425,0.5247496093890647,1.0,27/105,20.36%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PSMB4;PLCG2;FBXW11;ICAM2;PSMC2;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;KRAS;NRAS;PSMD4
prerank,androgen receptor signaling pathway (GO:0030521),-0.4516689872548435,-1.149041785266024,0.2956204379562044,0.5256128742314771,1.0,5/11,29.32%,ZMIZ1;KDM3A;PMEPA1;PLPP1;RNF14
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.3705911006362978,1.1486632103320613,0.2773892773892774,0.6740160512171155,1.0,5/25,9.33%,ANK3;ATP1B1;WNK2;WNK3;STAC
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.44264901006853563,-1.148654221346671,0.2921146953405018,0.5261500262647253,1.0,4/14,9.84%,PPARA;IRS1;MFSD2A;AKT1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.35768526781910265,-1.1484109165305558,0.25996533795493937,0.5262867714120648,1.0,14/30,34.60%,BIRC3;CASP8;UBE2D3;IKBKE;CD40;IKBKG;IKBKB;RIPK1;IRF7;CD300LF;TICAM1;TLR6;CD14;TBK1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.46475034750410044,1.1471869488457445,0.30620985010706636,0.6765541617290938,1.0,4/10,14.60%,DGKQ;GNMT;SIRT7;SELENOS
prerank,synaptic vesicle localization (GO:0097479),0.4428419746279851,1.147057330674269,0.2986111111111111,0.6752896168466394,1.0,4/13,10.15%,NLGN1;CDK5;SYNDIG1;KIF5A
prerank,positive regulation of lipid storage (GO:0010884),-0.39912427569122194,-1.1466156556835003,0.25996204933586337,0.5299398724923241,1.0,6/21,15.72%,NFKB1;SCARB1;EHD1;IKBKE;LPL;PLIN2
prerank,platelet degranulation (GO:0002576),-0.2838717797659651,-1.1460933972929923,0.19444444444444445,0.5306865635999036,1.0,34/118,23.75%,ABCC4;VWF;PECAM1;PHACTR2;LYN;THBS1;TMSB4X;APP;PROS1;SRGN;GAS6;FAM3C;TGFB2;APOOL;VEGFC;FLNA;TIMP3;ACTN1;ACTN4;HGF;F5;IGF1;LAMP2;SOD1;NHLRC2;FERMT3;ITGB3;IGF2;VCL;LHFPL2;SERPINE1;SYTL4;TLN1;ITIH3
prerank,amino acid import across plasma membrane (GO:0089718),-0.3822583963091344,-1.1458361711635734,0.26752767527675275,0.5308788407095876,1.0,5/24,7.64%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC1A5
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.47330715736060436,-1.1454461215728091,0.3093145869947276,0.5310032907848562,1.0,8/11,45.95%,TCP1;CCT5;CCT2;LARP7;CCT3;CCT7;DKC1;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.47330715736060436,-1.1454461215728091,0.3093145869947276,0.5310032907848562,1.0,8/11,45.95%,TCP1;CCT5;CCT2;LARP7;CCT3;CCT7;DKC1;CCT6A
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3671734386741786,1.1449005887543229,0.2727272727272727,0.6798903402634444,1.0,6/25,18.82%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,electron transport chain (GO:0022900),-0.4289120043344014,-1.1443206531657366,0.2773972602739726,0.5331758997688193,1.0,5/15,19.79%,ENOX2;PDIA5;UQCRFS1;ETFRF1;POR
prerank,mRNA stabilization (GO:0048255),-0.3409007064858253,-1.1443205712880553,0.23277467411545624,0.5327695156988735,1.0,16/40,30.72%,HNRNPA0;LARP1;FUS;MAPKAPK2;AXIN2;SYNCRIP;ANGEL2;RBM24;THRAP3;TAF15;DHX9;PABPC1;HNRNPU;TENT5C;MAPK14;BOLL
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.39391059752372837,-1.1434250525038006,0.28909090909090907,0.5341093192119399,1.0,13/20,48.74%,GSTT1;GSTM2;ESD;HPGDS;GSTO2;GSTK1;MGST2;GSTM5;GSTA4;GSTM4;GSTP1;AKR1A1;GSTA2
prerank,glutathione derivative metabolic process (GO:1901685),-0.39391059752372837,-1.1434250525038006,0.28909090909090907,0.5341093192119399,1.0,13/20,48.74%,GSTT1;GSTM2;ESD;HPGDS;GSTO2;GSTK1;MGST2;GSTM5;GSTA4;GSTM4;GSTP1;AKR1A1;GSTA2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.37545998588401985,-1.1427103506487999,0.2608695652173913,0.5353589696223693,1.0,11/26,25.25%,ITGB1;NEDD4L;YWHAE;DLG1;NEDD4;CASQ2;WWP2;VAMP2;FHL1;AKAP9;CAB39
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.35494642450936925,-1.1425295149178907,0.258364312267658,0.5353648351900314,1.0,15/33,24.02%,NET1;MAP3K5;ABL1;PRKCD;ANKZF1;TNFAIP3;ANXA1;HDAC6;PPIF;RPS3;MAPK7;NFE2L2;RELA;RIPK1;CYP1B1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3196656507074514,1.1421974912226462,0.22972972972972974,0.6860274745217828,1.0,9/44,13.40%,AKR1D1;CYP46A1;INSIG1;SC5D;OSBPL6;SQLE;CYP27A1;ALOX12;OSBPL9
prerank,negative regulation of hydrolase activity (GO:0051346),-0.3278711292678556,-1.1417212999652704,0.2490974729241877,0.5368868631019794,1.0,11/49,13.15%,DAB2IP;SH3BP4;F11R;LRCH1;LRRK2;ZCCHC9;GPATCH2;RASA4;BCAS3;ARFGEF1;CHP1
prerank,gliogenesis (GO:0042063),-0.42662544458162066,-1.1413279428268959,0.3029197080291971,0.5374290551913605,1.0,6/15,18.34%,NFIB;METTL14;TGFB2;CDK6;ANXA1;NDUFS2
prerank,negative regulation of heart contraction (GO:0045822),0.4602204687361392,1.1408124628691723,0.3063457330415755,0.6884753880234408,1.0,3/11,12.08%,ATP1A2;SPTBN4;SRI
prerank,keratan sulfate catabolic process (GO:0042340),0.4643805461678743,1.1407647079206689,0.3028322440087146,0.6869724373372755,1.0,5/11,21.58%,FMOD;PRELP;HEXB;OGN;ACAN
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3004211686505405,-1.139898425864786,0.22887323943661972,0.5403646575583038,1.0,18/76,14.72%,TEK;BAIAP2L1;PRKCE;NCK1;ABL1;SNX9;NES;HAX1;EDN1;NCK2;CFL2;FCHSD2;BCAS3;SYNPO2;LMOD1;CDC42EP3;SORBS3;NCKAP1
prerank,regulation of stem cell differentiation (GO:2000736),-0.29314685083660447,-1.139883768681609,0.21015761821366025,0.5399890135713722,1.0,32/89,28.41%,CBFB;TCF12;PSMA2;LMO2;HES1;ABL1;PSME2;YAP1;LDB1;PSMB4;TAL1;NOTCH1;PSMC2;JAG1;TCF3;PSMB2;PSMB1;PSMA8;NELFB;PSME1;GATA2;PRKDC;PSMD4;PSMA7;PTN;RBM24;PSMD5;SP7;PSMB10;PSMA3;HNRNPU;LMO1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.40742711854019525,-1.139765058635664,0.27240773286467485,0.5398613753364664,1.0,7/19,12.27%,TGFBR3;VGLL4;RBP4;MEF2C;TBX2;NOTCH1;FGF2
prerank,regulation of macrophage migration (GO:1905521),-0.48343598475130084,-1.13926895008327,0.3285198555956679,0.5405834306803913,1.0,2/10,3.25%,CD200;MTUS1
prerank,spermatid development (GO:0007286),0.34121345601754666,1.1388581984951214,0.2549019607843137,0.6910090765322336,1.0,13/32,23.58%,DDX25;CCDC63;ZMYND15;BBS4;RNF8;MKKS;YTHDC2;NME5;SYCP3;IQCG;ACRBP;CIB1;TDRD5
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.28192717880589774,-1.1387442347560262,0.23738317757009345,0.5414072572751626,1.0,21/102,12.66%,TBC1D4;SORBS1;FOXO1;INSR;CAV1;PRKACB;KAT2B;ADCY9;SLC30A10;NFKB1;PIK3R1;IRS1;RHOQ;PRKCD;ADCY4;GSK3A;AKT1;CYSLTR2;RAB8B;INSIG2;CEACAM1
prerank,negative regulation of kinase activity (GO:0033673),-0.3055027915644607,-1.1386989417715456,0.24736842105263157,0.5411097699854168,1.0,18/62,21.49%,RB1;PPP2R5A;CEP85;PAK2;CDKN1B;RTRAF;LRP6;PPM1F;PRKRIP1;AKT1;CEACAM1;CHP1;TAF7;UBASH3B;PTPRC;AKT1S1;NF1;WARS1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.2988811214048845,-1.1386280782988014,0.22586206896551725,0.5408607259053898,1.0,22/69,25.92%,INTS8;SP1;RPRD2;POLR2G;NABP1;GTF2E1;GTF2E2;TAF11;ICE1;INTS3;SNAPC1;TAF8;INTS9;PHAX;INTS7;SNAPC3;TAF13;POLR2C;CCNK;TAF9;POLR2L;POLR2H
prerank,toxin transport (GO:1901998),0.46493628377802315,1.138385846087081,0.3116883116883117,0.6907072596595196,1.0,4/10,12.78%,SLC22A1;SLC29A4;ANTXR1;ANTXRL
prerank,cellular response to glucose starvation (GO:0042149),-0.33303744670455526,-1.1380849651025675,0.24784853700516352,0.541739069931068,1.0,19/41,34.07%,SESN1;MTMR3;SIK1;FOXO3;TP53;PRKAA1;KPTN;ATF4;HNRNPA1;NUAK1;ITFG2;BECN1;EIF2AK3;PMAIP1;CPEB4;NIM1K;TBL2;NUAK2;SZT2
prerank,innate immune response in mucosa (GO:0002227),-0.48076319588275906,-1.1380254626430695,0.3079777365491651,0.5414765088580424,1.0,9/10,51.95%,RNASE3;DEFA6;RPL39;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.38419312359155294,-1.1377944446426218,0.2839285714285714,0.5416596806994133,1.0,8/22,17.05%,KANK3;TMSB4X;SLIT2;PRKCD;KANK4;ARFGEF1;HIP1R;TMSB10
prerank,cellular response to estrogen stimulus (GO:0071391),-0.44076032459199765,-1.1375180779002378,0.28545780969479356,0.5418808566633992,1.0,11/14,43.67%,NCOA4;BCAS3;RARA;WBP2;PELP1;TRIM24;AR;CRHBP;SERPINB9;SFR1;OCSTAMP
prerank,regulation of intracellular protein transport (GO:0033157),-0.35125851256161844,-1.1374259796907193,0.25985663082437277,0.5416694637944961,1.0,15/32,25.30%,PTPN14;PTPN1;BMP4;BCAS3;ICE1;LCP1;TPR;RIPOR1;PCM1;OAZ2;NDEL1;VAMP2;PCNT;CEP131;PLK3
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4482388636281448,-1.13682893370141,0.3005366726296959,0.5426213007073459,1.0,3/13,8.99%,SEMA7A;TGFB2;PLCG2
prerank,ncRNA catabolic process (GO:0034661),-0.3661655013967257,-1.1358367068131385,0.26811594202898553,0.54456856036572,1.0,10/28,25.27%,TENT4B;XRN1;EXOSC2;EXOSC3;TUT4;PARN;EXOSC8;EXOSC5;DIS3L2;EXOSC7
prerank,mammary gland epithelium development (GO:0061180),0.4308778378717897,1.1356078710675857,0.2841648590021692,0.6970925200667698,1.0,2/14,1.29%,ERBB4;WNT7B
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.38376302905318316,-1.135477577408727,0.2894736842105263,0.54498343970785,1.0,6/23,19.32%,CAV1;CBL;SH3BP5L;HYAL2;DUSP22;PTPRC
prerank,spindle assembly (GO:0051225),-0.30420415902103926,-1.1340009498261745,0.25,0.548029101661202,1.0,21/67,22.30%,NEK7;NEK6;STAG1;CCDC61;TOGARAM1;WRAP73;HAUS8;FLNA;RHOA;CSNK1D;ARHGEF10;HAUS6;STAG2;KIF11;TUBGCP4;RAB11A;TUBGCP5;RPS3;KIF3B;STARD9;MISP
prerank,regulation of T cell migration (GO:2000404),-0.40825363548715093,-1.1339108969368545,0.30103806228373703,0.547822469338696,1.0,3/18,3.19%,CD200;APP;LRCH1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.39499009955871955,-1.1338559632896146,0.2937956204379562,0.5467158391626327,1.0,9/20,27.15%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.39499009955871955,-1.1338559632896146,0.2937956204379562,0.5467158391626327,1.0,9/20,27.15%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.39499009955871955,-1.1338559632896146,0.2937956204379562,0.5467158391626327,1.0,9/20,27.15%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.40593399754589393,-1.1338121822212661,0.3171171171171171,0.5464234189384988,1.0,6/18,16.22%,NCK1;PIK3R1;ERN1;USP13;ATXN3;BCL2L11
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4087866900640197,1.1337111425316408,0.29504504504504503,0.7008421478727359,1.0,3/16,6.86%,CLDN18;CLDN14;CLDN11
prerank,response to UV-B (GO:0010224),0.44202442022704835,1.1333077858901033,0.30957683741648107,0.7003499413282509,1.0,3/12,9.73%,MME;STK11;IL12A
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2947251568298091,-1.133242842056711,0.25678119349005424,0.5473245022344112,1.0,28/80,29.94%,VTI1A;ERC1;RAB7A;TMEM87B;HEATR5A;VPS54;TBC1D14;BET1L;SNX12;DCTN1;VPS26A;ANKFY1;VPS52;TBC1D23;SNX8;WASHC1;VAMP3;TBC1D17;CLN5;SPAG9;EVI5;RAB9B;RAB6B;VPS35;RBSN;PHETA2;GOSR2;STX5
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.27682053411397733,-1.1325020723737431,0.21561969439728354,0.5487221677492187,1.0,33/121,16.83%,GHR;PECAM1;LYN;PTPN1;PAK2;IL15;PTPRJ;ACE;IL6ST;BMP6;IL6R;HES1;GAS6;ABL1;IL34;PARP14;EPHA4;ARHGEF2;PLCG2;HAX1;CSPG4;FGF7;TP53;JAK2;NEDD9;STAP2;CD40;HGF;MIF;TNFRSF1A;ANGPT1;IGF1;NOX4
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.39217506513785405,-1.132114094009171,0.29345794392523367,0.5492164648107779,1.0,12/22,44.17%,GSK3B;ROCK1;ROCK2;IKBKB;CRY2;BOD1L1;PPP1R1B;BOD1;FKBP1B;MASTL;STYXL1;TNF
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3202095645026032,-1.1319650707653586,0.26405451448040884,0.5491721193737595,1.0,17/51,15.35%,FERMT2;RAC1;PXN;ABL1;ARHGEF15;PPM1F;RGCC;RHOA;LIMCH1;SYNPO2;TPM1;WNT11;MYOC;RHOC;ARHGEF10;SORBS3;ROCK2
prerank,midbody abscission (GO:0061952),-0.40475872563029436,-1.1318611293827656,0.2849264705882353,0.5490067117778358,1.0,11/17,36.37%,CHMP4B;CHMP4A;CHMP2B;MITD1;CHMP5;PDCD6IP;CHMP3;CHMP6;CHMP1A;KIF20A;CHMP1B
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.47104601241681787,-1.1317685026833535,0.3090909090909091,0.5488320940403002,1.0,5/11,24.29%,ZMIZ1;ARID1B;ELOF1;CHEK1;SERTAD2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.4037410314081326,1.1317463148403377,0.28978622327790976,0.7033148974443438,1.0,3/17,6.22%,ANK3;AKAP6;RNF207
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3348847505265638,-1.131649991290041,0.2569444444444444,0.5487002566043572,1.0,15/41,21.16%,ENG;TGFBR3;TGFBR2;TGFB2;BMP4;MEF2C;GSK3A;SMAD7;NOTCH1;TPM1;JAG1;HEY1;HEY2;SOX4;DLL4
prerank,regulation of protein secretion (GO:0050708),0.26879089577461984,1.1311702534406138,0.1943127962085308,0.7034003430455985,1.0,31/119,18.05%,KCNC2;STXBP5L;SNAP25;GIP;GCK;KCNA5;CACNA1A;EXOC1;MTNR1B;CYP51A1;ANG;CACNA1D;ADRA2C;CACNA1E;GIPR;ADRA2A;IL12A;FRMD4A;EIPR1;ATP13A2;LLGL1;CCL5;PPID;PPIA;APOE;ALOX5;SLC8B1;ADAM8;GLP1R;ABCC8;KCNG2
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.42420598791219893,-1.1303955908500753,0.3089887640449438,0.5511944519774796,1.0,10/16,41.60%,MCM4;RPA1;WRN;BLM;MCM7;MCM2;MCMDC2;HMGA1;TWNK;RECQL4
prerank,sensory organ development (GO:0007423),-0.3229436343957528,-1.1302267523537917,0.24734982332155478,0.5511931484407719,1.0,17/51,23.57%,PBX1;SH3PXD2B;SMOC1;PBX3;TGFB2;RBP4;ECE1;SIPA1L3;SHROOM2;FOXC1;FREM2;HIPK1;SIX4;PBX2;CHRDL1;ATF6;MYO7A
prerank,histone methylation (GO:0016571),-0.36777740643711737,-1.1293593311388337,0.28596802841918295,0.5528031026352,1.0,8/26,18.01%,CREBBP;NSD1;NSD3;SUV39H1;EHMT1;SMYD1;N6AMT1;CARM1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.41645599795298516,1.1291970579922848,0.32119914346895073,0.7073590751992104,1.0,4/14,9.70%,AK7;AK3;AK5;NME2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.41103975107757873,-1.1290984043209442,0.31194295900178254,0.5530182363445314,1.0,12/17,48.63%,CD55;BACH2;JAG1;GNL1;STAT3;MYO1G;IL18;TLR4;BTN3A3;EBI3;SLA2;IL12B
prerank,calcium ion homeostasis (GO:0055074),0.2766167797721141,1.1287274925125337,0.2052505966587112,0.7070189481247734,1.0,16/95,12.59%,SLC24A4;SLC24A2;HTR2C;STC1;ATP2B4;ATP2B2;ATP1B1;SLC8A2;RYR2;TMCO1;CCL13;ATP13A2;CIB2;SLC8A3;SLC8A1;CCL5
prerank,RNA transport (GO:0050658),-0.30259392417010633,-1.1283374342634136,0.2560296846011132,0.5543834551864953,1.0,21/71,20.23%,SRSF11;RAE1;SARNP;RTRAF;TGFBR2;THOC2;UPF3B;THOC7;DDX39B;DHX38;NUP153;SLU7;FLOT1;HNRNPA1;TPR;THOC3;THOC1;NUP214;SRRM1;RNPS1;SRSF3
prerank,Golgi to plasma membrane transport (GO:0006893),-0.32173762777020887,-1.1280176294950706,0.27854671280276816,0.5547683117309119,1.0,15/47,22.58%,SPTBN1;EXOC6;STXBP6;EXOC4;GOLPH3L;MACF1;RABEP1;EXOC2;GOLGA4;EXOC8;GOLPH3;VPS35L;KIF13A;VAMP2;ARFGEF2
prerank,regulation of myotube differentiation (GO:0010830),-0.3749912011544218,-1.1279710240088607,0.31625441696113077,0.5544645055499975,1.0,11/24,26.59%,SIK1;HDAC1;MAML1;NOTCH1;HDAC4;SMYD1;CCN3;PIEZO1;RBM24;DMPK;HDAC5
prerank,regulation of cytoplasmic transport (GO:1903649),-0.4605605787810612,-1.1278038988559032,0.29775280898876405,0.5544410668661424,1.0,3/11,8.04%,DNAJC13;LRRK2;MAPK1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.38316894819963454,-1.1273710335882854,0.2830508474576271,0.5546334677074467,1.0,8/23,14.96%,PPP1R13B;YWHAE;YWHAZ;NMT1;CASP8;TP53;MAPK8;BBC3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.38316894819963454,-1.1273710335882854,0.2830508474576271,0.5546334677074467,1.0,8/23,14.96%,PPP1R13B;YWHAE;YWHAZ;NMT1;CASP8;TP53;MAPK8;BBC3
prerank,regulation of chemotaxis (GO:0050920),-0.3576235065468886,-1.1270879503842959,0.29525483304042177,0.5548667622873851,1.0,11/30,30.81%,ADGRA2;THBS1;STX3;PPM1F;DUSP3;CCL19;ZSWIM6;PDGFRB;PTPN2;TREM2;TGFB1
prerank,sensory perception of sound (GO:0007605),0.2834120343939225,1.127061772675251,0.24434389140271492,0.7102960414291578,1.0,13/88,9.74%,PCDH15;COL2A1;SLC26A5;LHFPL3;EML2;COL1A1;ATP2B2;COL11A2;DCDC2;TMC1;CACNA1D;GRM7;SPTBN4
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.42889130330123365,-1.126840291237317,0.3284671532846715,0.55505569506264,1.0,7/15,28.28%,PPARA;LPL;PLIN2;PPARG;PNPLA2;PLIN3;TREM2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.3010655720304654,-1.1268277576096664,0.25704225352112675,0.5546753416203414,1.0,21/70,21.85%,CBFB;TCF12;PSMA2;LMO2;ABL1;PSME2;YAP1;LDB1;PSMB4;TAL1;PSMC2;TCF3;FOXC1;PSMB2;PSMB1;PSMA8;PSME1;GATA2;PRKDC;PSMD4;PSMA7
prerank,polyol biosynthetic process (GO:0046173),0.40406105089300337,1.1268211747520744,0.29954954954954954,0.7093440174910527,1.0,5/16,10.42%,ITPKA;ISYNA1;CYP27A1;IP6K2;IPPK
prerank,regulation of multicellular organismal development (GO:2000026),-0.368384655217571,-1.1263366189292348,0.28888888888888886,0.5554177641971889,1.0,5/25,10.19%,INSR;SOX17;NIPBL;TRIP12;EHMT1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.41217236988751205,1.1257435486866674,0.309255079006772,0.7108633109602148,1.0,4/15,4.83%,KCNA5;KCNJ3;KCNN2;ATP1B1
prerank,vesicle organization (GO:0016050),-0.3250801994932441,-1.1256171361212397,0.27486437613019893,0.5567366127215828,1.0,15/46,18.82%,DNAJC13;CAV1;CD34;EPS15;FNBP1L;SRGN;ALS2CL;WASL;CHMP2B;EXOC8;PI4K2B;ALS2;ZFYVE16;WASHC4;AKTIP
prerank,barbed-end actin filament capping (GO:0051016),-0.39537424953884037,-1.1253138050962364,0.28703703703703703,0.5565971311775221,1.0,3/18,2.67%,EPS8;ADD3;SVIL
prerank,actin filament capping (GO:0051693),-0.39537424953884037,-1.1253138050962364,0.28703703703703703,0.5565971311775221,1.0,3/18,2.67%,EPS8;ADD3;SVIL
prerank,regulation of histone acetylation (GO:0035065),-0.3484640399505166,-1.1249860786702692,0.2720970537261698,0.5569667221385445,1.0,16/33,30.97%,RPS6KA5;IWS1;SETD5;RUVBL2;TAF7;BRCA1;CHEK1;NOS1;MYOCD;ARRB1;RAPGEF3;HDAC5;GLYR1;SET;SPI1;RPS6KA4
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.34436727972480025,-1.124905246692511,0.2833333333333333,0.556739448378587,1.0,6/36,11.78%,SHANK3;ITGB1;HDAC1;EDN1;JAK2;HFE
prerank,nucleic acid-templated transcription (GO:0097659),-0.32392427001124025,-1.1245835424690385,0.284452296819788,0.557113049389907,1.0,16/42,26.98%,MEF2A;THRB;POLR2G;PWP1;TAF1B;DRG1;CREBL2;RNPS1;TERT;PTMA;MED20;POLR2C;POLR2L;MLF1;POLR2H;MMS19
prerank,neurogenesis (GO:0022008),-0.3301877929656529,-1.1241155708551542,0.284452296819788,0.5578098801414848,1.0,15/43,19.71%,TRAK1;METTL14;THOC2;SIX1;TGFB2;BTBD3;CDK6;BTBD1;FAT4;SIX4;ANXA1;NDUFS2;DAGLB;CLN5;RITA1
prerank,positive regulation of DNA binding (GO:0043388),-0.35486447141969385,-1.1240427146171286,0.28896672504378285,0.557573191328616,1.0,14/31,30.81%,RB1;HES1;NGF;FOXC1;IGF1;SKI;CEBPG;TXN;PPARG;HMGB1;PINX1;TRIM6;PLAUR;TGFB1
prerank,positive regulation of immune effector process (GO:0002699),-0.3654801221766489,-1.1239451064782826,0.27256637168141595,0.557379583796726,1.0,5/27,11.08%,ANKRD17;PTPRJ;LBP;MYO18A;DDX60
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.34908180439789094,-1.123778343461149,0.28597122302158273,0.5573663596625443,1.0,13/33,28.93%,LYN;ACER2;ADAM9;TGFB2;PTK2;EPHA2;FERMT3;PTPN11;SERPINE1;CYP1B1;ADA;SNAI2;FOXC2
prerank,cellular response to cAMP (GO:0071320),-0.3578693106564111,-1.123330252160906,0.291970802919708,0.5579663495089382,1.0,14/30,26.06%,RAPGEF2;PKD2;PDE2A;KCNQ1;RAP1A;EZR;RAP1B;RAPGEF1;IGFBP5;SLC5A5;AKAP9;RAPGEF3;DMTN;ZFP36L1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.44975194741602276,-1.1231392011296215,0.3005464480874317,0.5580287310737105,1.0,3/11,11.47%,JAK1;IL6ST;JAK2
prerank,DNA replication (GO:0006260),-0.2788091661739641,-1.122980822640848,0.22758620689655173,0.5580039471276819,1.0,48/105,33.70%,MCMBP;RBMS1;ATM;TOP3A;BAZ1A;MRE11;MCM9;RBBP8;CLSPN;MCM4;ORC5;RPA3;DNA2;KAT5;REV1;RPA1;PNKP;TBRG1;TOP1MT;ORC2;POLE2;PTMS;WRN;ORC4;RPA2;TIMELESS;BRCA1;BLM;RFC4;CHEK1;MCM3;TOP1;RFC1;POLA2;MCM7;MCM5;MCM10;POLL;EXO1;SET;ING5;MCM2;RMI1;RAD50;GRWD1;ORC3;CDC6;PIF1
prerank,membrane fusion (GO:0061025),-0.3441141971719152,-1.1228940951791386,0.2965009208103131,0.5577986971572931,1.0,12/33,22.30%,MYOF;DNM3;DYSF;DNM2;RABEP1;CHP1;VAPA;VAMP3;HUWE1;RABIF;VAMP2;HACE1
prerank,icosanoid metabolic process (GO:0006690),-0.33163772862596635,-1.1228932808154615,0.2572463768115942,0.5573939503561359,1.0,17/40,32.41%,PLA2G4A;PON2;GGT5;MAPKAPK2;PTGS1;EPHX1;MGLL;GPX1;DAGLB;PTGR1;PNPLA8;CYP1B1;PTGIS;GPX4;TBXAS1;ALOX5AP;ALOXE3
prerank,phagosome acidification (GO:0090383),0.3502517016958763,1.1211989836067826,0.2766439909297052,0.722719051776089,1.0,10/26,19.06%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V1G2;RAB39A;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,regulation of transmembrane transport (GO:0034762),-0.3529513229973862,-1.1210407111153857,0.2826475849731664,0.5614255381223134,1.0,13/31,26.89%,SLC2A1;NEDD4L;KCNJ2;NEDD4;OCLN;ACTB;CTTNBP2NL;KCNJ8;WWP2;PIM1;TRIB3;ACE2;KCNJ13
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.2790384298865166,-1.1209912169029426,0.23426573426573427,0.561116650640422,1.0,21/95,10.57%,ST3GAL6;ST3GAL4;ST3GAL1;EXT1;GCNT2;CSGALNACT1;B3GNT2;GPC6;CHST15;NDST1;B4GALT4;SLC10A7;DSE;HS3ST3B1;AGRN;HSPG2;ST3GAL2;CHST11;CSPG4;HS3ST1;BGN
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.43440285816479407,1.120838455043892,0.3186046511627907,0.7220343478193608,1.0,6/12,24.40%,GMNN;WRNIP1;NUGGC;KAT7;WDR18;TIPIN
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3837545103182075,1.1207769798920648,0.31567328918322296,0.7205057218429778,1.0,6/21,8.12%,ABCA12;CTSK;SULT2B1;MAFG;SGPP1;MAFF
prerank,protein N-linked glycosylation (GO:0006487),-0.29979023892224005,-1.1207432669016832,0.2532347504621072,0.5613038435967637,1.0,18/66,16.93%,ST3GAL1;ALG14;ST6GAL1;ALG10B;MAN1C1;DAD1;MGAT4B;GFPT2;FUT8;SLC39A8;ALG12;ALG8;OST4;ALG11;DOLPP1;ALG13;UGGT1;MGAT2
prerank,metanephros development (GO:0001656),0.35852892810380127,1.1206090916698623,0.29933481152993346,0.7193045672291771,1.0,5/26,6.07%,ROBO2;WNT7B;OSR1;WT1;PAX2
prerank,regulated exocytosis (GO:0045055),0.2557594543157235,1.1204106370375255,0.19901719901719903,0.7182079158541902,1.0,31/173,13.30%,ABCA12;SYT1;PCLO;SYT5;BLK;RIMS2;SNAP25;RIMS1;CDK5;F8;SYT12;SYT11;CLEC3B;PLEK;CD63;RAB27B;ECM1;LY6G6F;PF4;STXBP2;TIMP1;VEGFA;PDGFA;RAB3A;VTI1B;CHID1;SYT4;SERPING1;SYNGR1;CDC37L1;CLU
prerank,positive regulation of interferon-beta production (GO:0032728),-0.3448365868060298,-1.1203826224291367,0.2852173913043478,0.5617416294523288,1.0,18/33,36.11%,IFIH1;TRIM56;DDX3X;IRF1;FLOT1;POLR3F;MAVS;PTPN11;HSP90AA1;DHX9;IRF7;RIOK3;TOMM70;IRF5;POLR3A;TBK1;TLR2;TLR8
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.41348147976407906,1.1203295082585896,0.30201342281879195,0.7167974632495561,1.0,5/14,9.21%,PPP2R2B;PPP5C;PPP2R2C;PPP3CA;PPTC7
prerank,tRNA metabolic process (GO:0006399),-0.40564020786561916,-1.1199232644817652,0.3242753623188406,0.5624313066943882,1.0,8/17,36.94%,FARS2;DARS2;TRPT1;RPP30;SSB;DTD2;SARS1;THG1L
prerank,positive regulation of translational initiation (GO:0045948),-0.40245602444565187,-1.119831090937855,0.32397003745318353,0.562247836141046,1.0,5/18,12.82%,DDX3X;MTOR;LARP1;POLR2G;CDC123
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.4259078257858708,-1.1196221706311664,0.32085561497326204,0.5622993059353354,1.0,5/15,15.57%,PRKCH;MED1;BMP4;FOXC1;TRIM16
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.37170427694952995,-1.1194741331246274,0.3003472222222222,0.5622477029581308,1.0,6/23,15.68%,CBFA2T3;SIK1;PPARA;GSK3A;HDAC4;C1QTNF3
prerank,positive regulation of dendrite development (GO:1900006),-0.4801323530190228,-1.1194242810803954,0.32342657342657344,0.5619397837186797,1.0,2/10,3.14%,DAB2IP;BMP5
prerank,epithelial cell migration (GO:0010631),-0.3308516949974495,-1.1189114480055615,0.2804878048780488,0.5627305959849104,1.0,11/37,15.17%,NOS3;ADGRA2;PLEKHG5;PXN;ABL1;PLXND1;ROCK1;STARD13;RHOA;PKN2;PKN3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3548551801879048,-1.1186123059247195,0.2923076923076923,0.5630293310488885,1.0,10/29,16.38%,LYN;SHOC2;NGF;TGM2;NOTCH2;RAPGEF1;JAK2;NOTCH1;GRB2;IGF1
prerank,keratinocyte differentiation (GO:0030216),-0.35871927024877825,-1.1184390473112509,0.298372513562387,0.5630507086283328,1.0,9/29,19.29%,BCR;ADAM9;MED1;WNT16;TXNIP;JAG1;ASAH1;ANXA1;EPHA2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.40938764118418314,-1.1182632889321833,0.3003533568904594,0.563073888034847,1.0,5/18,12.94%,RALBP1;KDR;MIEF1;BNIP3;MIEF2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2871280929393783,-1.1181494979133144,0.25569176882662,0.5629432039324379,1.0,23/86,14.72%,RB1;CLIP1;BAIAP2L1;RAC1;PRKCE;APP;NCK1;TOGARAM1;SNX9;OCLN;EDN1;NCK2;CFL2;PSEN1;FCHSD2;DCTN1;SYNPO2;LMOD1;SLAIN2;DRG1;CDC42EP3;GPX1;NCKAP1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.4534976316101945,-1.1180646189689976,0.3502722323049002,0.5627459130975753,1.0,6/12,30.70%,JAM2;APP;RHOA;CXCL12;CXCL10;TNFRSF14
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3965466377481177,-1.1179450086874247,0.3216168717047452,0.5626165670172424,1.0,12/19,31.66%,ADK;POLD3;AMPD2;HPRT1;AMPD3;TERT;ADA;PNP;POLL;GMPR2;APRT;DCK
prerank,integrated stress response signaling (GO:0140467),0.41552450853112,1.1178942918593768,0.3146853146853147,0.7223305333787383,1.0,4/14,15.10%,OMA1;IMPACT;CCL2;EIF2AK1
prerank,zinc ion transmembrane transport (GO:0071577),-0.3803631291633508,-1.117260622149595,0.3003731343283582,0.5637528565698245,1.0,7/22,20.72%,SLC39A10;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,macrophage differentiation (GO:0030225),-0.4480085823279455,-1.1164746892173552,0.33629893238434166,0.5652563772993939,1.0,3/13,9.60%,IL15;BMP4;CASP8
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.36751354272410697,-1.1160963098021486,0.3148148148148148,0.5657386221762816,1.0,5/24,9.39%,WASF2;RAC1;PIK3R1;PLCE1;OCLN
prerank,negative regulation of inflammatory response (GO:0050728),-0.2549471663053657,-1.116056747769731,0.21391304347826087,0.565434275391798,1.0,37/182,16.68%,TEK;GNB1;RB1;CALCRL;KLF4;MYH9;MFHAS1;LYN;CD200;PRKACB;ADCY9;RAMP1;PLCG1;YES1;PPARA;TNFRSF1B;GGT5;OTULIN;PRKCD;CDH5;PLK2;RHBDF2;ADCY4;PPARD;PLCG2;RAMP2;FEM1A;ADM;CYSLTR2;TNFAIP3;IAPP;CCN3;C1QTNF3;ADCY1;TNFRSF1A;IGF1;FYN
prerank,regulation of protein localization (GO:0032880),-0.31204254426546263,-1.1157892448797795,0.2965779467680608,0.5656469380123784,1.0,21/58,28.79%,DVL3;TRIM25;AFDN;DLG1;AAK1;DNAJB6;PPM1F;MMD;PICALM;TRIM14;MAPK8;TPR;DZIP1L;SUMO1;ITGB3;HSP90AA1;TRIM68;TMEM231;TRIM67;TRIM6;BORA
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3901259738363154,-1.1155188971935122,0.3100917431192661,0.5659066376008822,1.0,3/19,6.73%,PPARA;IRS1;PRKCD
prerank,negative regulation of bone remodeling (GO:0046851),0.4503912917820747,1.1152761774474422,0.32987551867219916,0.7285228016879571,1.0,2/11,3.45%,CARTPT;CALCA
prerank,sterol metabolic process (GO:0016125),0.29669030892314596,1.1151729270536679,0.2669902912621359,0.7271556678091711,1.0,13/60,9.92%,CYP46A1;INSIG1;PIP4P1;SULT2B1;CYP26B1;CYP51A1;SC5D;SQLE;NSDHL;TSKU;CYP27A1;CYP11B1;OSBPL5
prerank,macromolecule catabolic process (GO:0009057),-0.3684756637318337,-1.1151535174027984,0.2838827838827839,0.5663697520732188,1.0,15/26,36.35%,SMURF1;MTOR;NEDD4;USE1;LGMN;SIAH1;CLN5;SNX25;KIF16B;BECN1;PPT1;TGFB1;CLPX;CLN6;TRIM24
prerank,regulation of synapse maturation (GO:0090128),0.4591483548682171,1.1149459359671594,0.3382978723404255,0.7261619122846307,1.0,3/10,6.81%,NRXN1;ANAPC2;CAMK2B
prerank,negative regulation of nuclear division (GO:0051784),-0.4531505991355067,-1.1144759011714584,0.3430127041742287,0.5675704021928867,1.0,7/11,38.89%,BMP4;BMP7;CHEK1;TOM1L2;FBXO5;TOM1L1;AURKAIP1
prerank,alanine transport (GO:0032328),-0.4738380081170721,-1.114385931406679,0.338768115942029,0.5673630392865916,1.0,3/10,20.54%,SLC6A6;SLC36A4;SLC1A4
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4353599967341174,-1.114274591528735,0.31956912028725315,0.56723949116822,1.0,4/13,14.14%,GNAI3;LRRK2;RHOQ;RAB23
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.2995846877390309,-1.1141913282100138,0.24955436720142601,0.567040824586412,1.0,29/68,32.11%,SLC2A1;PANK2;SLC25A32;SLC5A6;SLC19A2;MTHFD1;PDXK;RFK;AOX1;SLC52A1;SLC52A3;LMBRD1;MTHFD1L;PCCA;PCCB;GSTO2;CUBN;ALDH1L1;MTRR;PNPO;MTR;SHMT1;SLC19A3;SLC2A3;VNN1;HLCS;SLC25A19;SLC23A1;SLC23A2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.4475798599769094,-1.1136067713742046,0.3267504488330341,0.56801819580376,1.0,3/12,16.33%,GCNT2;FLOT1;BMP7
prerank,protein modification process (GO:0036211),-0.29428066201050473,-1.113594454801362,0.2667910447761194,0.567639894753624,1.0,22/76,21.35%,ST3GAL6;ST3GAL1;PLOD2;ST8SIA4;PARP4;YES1;CSNK1G3;ABL1;PHKA2;UBE2D3;UBA7;ERO1A;STK38;MSRA;UBE2M;UBE2L3;PLAT;BAP1;PRKDC;WWP2;UBL4A;LOX
prerank,negative regulation of autophagy (GO:0010507),-0.31054312611863544,-1.1132442229812385,0.2792642140468227,0.5680768375550652,1.0,13/54,16.41%,MCL1;TAB3;TLK2;ATG7;LRRK2;MTOR;RASIP1;TBC1D14;DAPL1;AKT1;HGF;DAP;TAB2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.45450002907155074,-1.1130486587206245,0.33691756272401435,0.5681368517355653,1.0,3/11,17.00%,SMAD7;RC3H1;ANXA1
prerank,positive regulation of macrophage migration (GO:1905523),-0.3996297033494021,-1.1130017224264077,0.32854578096947934,0.5678189330980606,1.0,4/19,8.04%,THBS1;IL34;PTK2;MAPK1
prerank,regulation of phospholipase activity (GO:0010517),0.44514520388764633,1.1127764547726917,0.33695652173913043,0.731004456621109,1.0,6/10,24.83%,FGFR2;RASGRP1;FGFR3;ANGPTL3;PDPK1;SNCA
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.44780817707138243,-1.1126436216095845,0.32269503546099293,0.5682457847614276,1.0,5/12,17.12%,RB1;CTCF;WAPL;AXIN2;CTNNB1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.35379758863888044,-1.1124461078543926,0.30755395683453235,0.568320896447161,1.0,10/29,25.37%,RPS21;RPS14;NOL10;UTP3;RPS16;DCAF13;UTP4;RRS1;RPS8;WDR46
prerank,snRNA transcription (GO:0009301),-0.2905291915175582,-1.1124093522918417,0.2629757785467128,0.5680062297585207,1.0,22/70,25.92%,INTS8;SP1;RPRD2;POLR2G;NABP1;GTF2E1;GTF2E2;TAF11;ICE1;INTS3;SNAPC1;TAF8;INTS9;PHAX;INTS7;SNAPC3;TAF13;POLR2C;CCNK;TAF9;POLR2L;POLR2H
prerank,signal transduction in response to DNA damage (GO:0042770),-0.31787162885090275,-1.1123489425399922,0.2852112676056338,0.5677379794109443,1.0,17/49,25.60%,MAP3K20;ACER2;ATM;ABL1;CLSPN;TP53;DOT1L;NDRG1;GRB2;USP10;MAD2L2;ATRX;CHEK1;GADD45A;INTS7;E2F7;ERCC6
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4708287984671953,-1.1123387641339797,0.3171171171171171,0.5673593179416129,1.0,4/10,17.32%,SP100;TP53;KAT5;TFAP4
prerank,regulation of cell growth (GO:0001558),-0.2504414585040658,-1.1123022826835212,0.18088737201365188,0.567036098724555,1.0,67/204,25.55%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;NET1;DDX3X;MTOR;PTPRJ;SOX17;EGFR;TFRC;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;PLCE1;RASGRP2;EXOSC2;SMAD4;MFSD2A;FAM107A;BCAR1;ADAM10;AKT1;SOCS2;TP53;AGTR1;RPTOR;ARHGEF11;DCBLD2;LTBP4;RPS6KA1;CEACAM1;WNT11;ST7L;RPS6KA3;H3-3A;CCN3;N6AMT1;RERG;MAD2L2;NPR1;KIF26A;OSGIN2;HYAL2;BAP1;BRAT1;PPP2CA;CDK11B;BCL6;DCUN1D5;CDKN2C;CAPRIN2;FHL1;MTPN;MSX1;SERTAD2;HSPA1B;GNG4;INO80;APBB1;SIPA1;SERTAD3
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.45538153654940566,-1.1121895468229537,0.3285198555956679,0.5669040235657841,1.0,10/11,50.73%,SMAD7;HFE;CEACAM1;PTPRC;LILRB1;AHR;KLRD1;FOXP3;XCL1;KLRC1
prerank,regulation of postsynapse organization (GO:0099175),0.35542736861618923,1.1121608194110497,0.29464285714285715,0.7312150690773647,1.0,7/28,10.54%,IL1RAPL1;PPFIA2;CDK5;CDKL5;HOMER1;TANC2;ABI2
prerank,prostanoid biosynthetic process (GO:0046457),-0.41803433776435506,-1.111823384593249,0.31992687385740404,0.5673383984825422,1.0,10/15,30.65%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;DAGLB;PNPLA8;PTGIS;PRXL2B;TBXAS1
prerank,regulation of endopeptidase activity (GO:0052548),0.29346465593641935,1.1098276078545226,0.26851851851851855,0.7365634674122259,1.0,11/59,12.71%,VTN;SPOCK3;SPOCK1;PRELID1;SERPIND1;TIMP1;A2ML1;ATP13A2;SERPINA2;SERPING1;FETUB
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3389116504726261,-1.1098108606098456,0.2931654676258993,0.5716020677096303,1.0,13/32,28.41%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.35120751952686025,-1.1090270795579957,0.3089983022071307,0.5730709934561982,1.0,11/29,27.03%,CBFB;ESR1;STRN3;YAP1;UFM1;CARM1;WBP2;BRCA1;SRARP;CNOT2;CNOT1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.364634798863803,-1.1083926002746696,0.30178571428571427,0.5741109090893026,1.0,12/24,27.94%,MTHFD1;TXN2;MSRA;NOX4;CDO1;CTH;ADO;GCLC;MTRR;MPST;AHCY;MTR
prerank,cellular response to interferon-gamma (GO:0071346),-0.28302996959393745,-1.1079079925022344,0.2641843971631206,0.5748813661914074,1.0,25/88,23.92%,SP100;DAPK1;IRF2;TRIM25;JAK1;CCL25;ICAM1;MID1;CAMK2G;PRKCD;GBP6;IRF1;JAK2;GBP4;PDE12;SYNCRIP;VCAM1;GBP5;CCL19;IFNGR2;FCGR1A;CASP1;RPL13A;GBP3;TRIM68
prerank,regulation of chemokine production (GO:0032642),-0.3369705638015437,-1.1077522066761198,0.30347349177330896,0.5748303081860295,1.0,24/36,48.17%,FOXP1;APP;IL6R;LPL;ACKR1;IL7;ADAM17;LGALS9;SNAI2;HMOX1;TREM2;TSLP;CD74;TLR2;HIF1A;IL18;SIGIRR;TLR4;TNF;IL6;TLR3;AGER;F2RL1;WNT5A
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2868831372814001,-1.10700816729107,0.2591240875912409,0.5761218754198871,1.0,32/82,22.47%,ANKS1A;RAC1;LYN;ARHGEF28;CRK;MMP2;YES1;AP2B1;AP2A2;PSEN2;CHN1;PTK2;AP2S1;WASL;ITSN1;ROCK1;EPHA4;NCK2;PSEN1;RASA1;RHOA;ACTB;ROCK2;ARPC4;FYN;APH1A;EPHA2;AP2M1;PTPN11;VAV2;EPHB6;EPHB3
prerank,toll-like receptor signaling pathway (GO:0002224),-0.28319214551970706,-1.1068006387413218,0.25573192239858905,0.576193444907396,1.0,34/84,36.11%,TAB3;BIRC3;NMI;LBP;MAPKAPK2;PLCG2;CASP8;UBE2D3;IRAK1;S100A1;RPS6KA3;LGMN;TAB2;IRAK2;IKBKG;IKBKB;ITGAM;RIPK1;HMGB1;MAP3K7;TNIP1;LGALS9;PIK3AP1;TICAM1;TLR6;RFTN1;TNIP2;SCARA3;TLR1;TLR5;CD14;S100A9;TLR2;TLR8
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3837768948684358,-1.1061297859532504,0.3303411131059246,0.5774187807242666,1.0,7/20,15.61%,THBS1;PRKD2;DSTYK;FGF2;SPRY4;FGFBP3;SMOC2
prerank,regulation of programmed cell death (GO:0043067),-0.25639063991207106,-1.1060404597071822,0.23024054982817868,0.5772053172523267,1.0,30/161,13.04%,MECOM;HIP1;PPP1R13B;CREBBP;DAPK1;ACER2;ATM;LRRK2;BIRC3;RARG;ABL1;ZBTB7A;FAS;STEAP3;BNIP3;TGM2;RAF1;HAX1;BCAR1;AKT1;TP53;CRADD;PERP;JAK2;ACER3;TM7SF3;ACTN1;ACTN4;NDRG1;RTKN
prerank,glycolipid metabolic process (GO:0006664),-0.32168546896809114,-1.1059385292367498,0.3083941605839416,0.5770385645848596,1.0,14/47,21.99%,ESYT2;ST3GAL6;ST3GAL4;ST6GALNAC3;ST3GAL2;ARSA;ASAH1;SMPD2;GBA2;GBGT1;GLTP;PIGW;CTSA;GLA
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.42084283041792436,1.1057536775507266,0.31627906976744186,0.7470787282334487,1.0,4/13,8.20%,KCNA5;KCNJ3;KCNN2;SCN5A
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.4643104350138556,-1.1056552673390438,0.3327556325823224,0.5773144268585231,1.0,6/10,35.09%,TNFRSF1B;NOTCH1;TNFRSF1A;EMILIN1;TGFB1;FAP
prerank,negative regulation of protein processing (GO:0010955),-0.4504378547826213,-1.1046834828709775,0.322463768115942,0.5791656719185024,1.0,6/12,22.81%,THBS1;LRRK2;SNX12;CTSZ;SERPINE2;SERPINE1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.33457103340888333,-1.1046708024396779,0.30386740331491713,0.5787975009394072,1.0,23/35,40.85%,RAE1;CHMP4B;DCTN1;DRG1;CHMP2B;TPR;CHMP5;TACC3;PDCD6IP;HSPA1B;CHMP3;HNRNPU;CCSAP;BORA;CHMP1A;MAP9;PARP3;PLK1;PSRC1;CHMP1B;TPX2;CEP97;CLTC
prerank,ethanol metabolic process (GO:0006067),0.42484483183752375,1.1039923714700945,0.3288590604026846,0.7506681977128622,1.0,2/12,7.59%,ACSS2;ACSS1
prerank,cellular response to leucine starvation (GO:1990253),-0.4694491939358172,-1.103627494820721,0.3392857142857143,0.5806869483628572,1.0,4/10,16.82%,SESN1;MTOR;LARS1;GCN1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4427413260187665,1.1033796746438995,0.3310502283105023,0.7508769394831255,1.0,2/11,0.95%,ANK3;BLK
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.37910129840181667,-1.1033359477147788,0.3242753623188406,0.5809888379587611,1.0,5/21,11.89%,MITF;MED1;JUN;MED13;MED17
prerank,negative regulation of protein transport (GO:0051224),-0.36493780313588714,-1.103293761979077,0.3177737881508079,0.5806921560346903,1.0,12/25,30.35%,RHBDF2;PPM1F;DPH3;SNX12;PKDCC;CSK;WWP2;NDFIP2;SERGEF;HMGCR;RSAD2;RHBDF1
prerank,cellular response to amino acid starvation (GO:0034198),-0.2891935430852183,-1.103289260091748,0.2604735883424408,0.5802981908365916,1.0,26/71,27.17%,SESN1;MAP3K5;MTOR;FAS;SEC13;MAPK1;MIOS;PRKD1;DAPL1;RPTOR;ATP6V1E1;LARS1;KPTN;MAPK8;ATF4;DAP;CASTOR1;GCN1;RNF152;ITFG2;ATP6V1H;EIF2AK3;RHEB;EIF2AK4;ATP6V0E2;WDR24
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3638782762118346,-1.10298525528269,0.28368794326241137,0.5806165829827342,1.0,15/26,36.91%,RB1;NEK6;CUL3;CDC16;NSMCE2;CENPE;ANAPC7;DUSP1;ANAPC11;ANAPC5;PLK1;CDC6;ESPL1;UBE2C;FBXO5
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3972890482129311,1.102146055678487,0.35201793721973096,0.7528616551242439,1.0,4/16,10.48%,ATIC;PAICS;ADSS2;ADSS1
prerank,cell junction organization (GO:0034330),-0.29051932826243076,-1.1014522975560888,0.2841918294849023,0.5837877578355758,1.0,18/71,12.61%,TJP1;APBB2;FERMT2;PPFIBP1;LIMS2;LIMS1;APP;TGFB2;PPFIA1;TJP2;AGRN;OCLN;FLNA;ILK;PSEN1;RAB8B;RHOA;ACTB
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.2928108843183179,-1.1012677842516267,0.28862478777589134,0.5838267477741425,1.0,23/73,24.95%,THBS1;IFIH1;APP;PTPRJ;FRMD8;LBP;ARHGEF2;PLCG2;PSEN1;JAK2;LPL;MIF;MAVS;CCL19;NOD2;PTPRC;PTPN11;ARFGEF2;RIPK1;FZD5;HMGB1;DDT;DHX9
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.28738685632497546,-1.1011081283260438,0.28489483747609945,0.58381165654321,1.0,25/72,26.54%,RBFOX2;SPRED2;CEP57;CBL;SHOC2;FGF1;HNRNPM;MAPK1;POLR2G;FGF7;HNRNPF;FGF2;TIAL1;GRB2;HNRNPA1;FLRT2;FGFR4;PTPN11;KIF16B;FRS2;POLR2C;POLR2L;POLR2H;FLRT3;FGF10
prerank,positive regulation of response to wounding (GO:1903036),-0.35642231807276714,-1.1009780403774378,0.31894934333958724,0.5837151598776175,1.0,7/24,11.88%,ITGB1;PRKCE;SCARF1;PTK2;OCLN;MYLK;ARFGEF1
prerank,negative regulation of coagulation (GO:0050819),0.4073185700730324,1.1009255234919892,0.3429844097995546,0.7550501803097707,1.0,2/14,2.07%,VTN;HS3ST5
prerank,platelet aggregation (GO:0070527),-0.3429532401522451,-1.1008453864938716,0.31382978723404253,0.58361968187607,1.0,14/33,27.59%,MYH9;FLNA;ILK;ACTN1;ACTB;PIK3CB;CLIC1;UBASH3B;FERMT3;ITGB3;VCL;TLN1;MYL9;RAP2B
prerank,protein localization to vacuole (GO:0072665),0.4129249804859827,1.1008261605973226,0.34080717488789236,0.7536482600200592,1.0,5/13,11.96%,MFSD1;CD81;RTN4;ATP13A2;RNF128
prerank,determination of heart left/right asymmetry (GO:0061371),-0.321875042487564,-1.1000202578022433,0.291970802919708,0.5851691625640696,1.0,8/42,8.09%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;MEF2C;TBX2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.42803628175627434,-1.0995396109109588,0.3088512241054614,0.5859101057776949,1.0,4/13,15.78%,SHANK3;APP;LGMN;ADCY1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3652130736865058,-1.0994370307490884,0.3351449275362319,0.5857479899664483,1.0,6/25,15.35%,HIP1;AFAP1L2;CBL;AKT1;ARAP1;HIP1R
prerank,visual system development (GO:0150063),-0.33183654141360147,-1.0993419939637892,0.3118279569892473,0.5855534649635803,1.0,14/37,23.20%,PBX1;SH3PXD2B;SMOC1;PBX3;TGFB2;RBP4;SIPA1L3;FOXC1;FREM2;HIPK1;PBX2;ITGAM;CHRDL1;ATF6
prerank,negative regulation of receptor internalization (GO:0002091),0.4289929592964926,1.0989949425090157,0.3561643835616438,0.7575475181284809,1.0,4/12,12.36%,ANKRD13B;WDR54;MTMR2;DLG4
prerank,autophagy of mitochondrion (GO:0000422),-0.32627411645511406,-1.0989808820634148,0.32212389380530976,0.5860052683389907,1.0,16/38,27.26%,ATG7;MAP1LC3B;AMBRA1;BNIP3;WIPI1;GABARAP;FUNDC1;ULK2;MARK2;ATG5;WDR45B;BECN1;ATG2A;FUNDC2;ATG2B;ATG3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4140715427696553,1.098770594745036,0.3115124153498871,0.7565791998265958,1.0,2/13,4.15%,BPNT2;SULT2B1
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4460357989860013,-1.0987210532087537,0.3492647058823529,0.5862186354889437,1.0,6/11,24.95%,SETD2;IWS1;NUP153;TPR;KHDRBS1;DHX9
prerank,response to interleukin-4 (GO:0070670),-0.460690583313099,-1.0986706175190402,0.3672316384180791,0.5859388121536105,1.0,1/10,0.16%,LEF1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4449456334779496,-1.0984362029181851,0.3464419475655431,0.5861211455048615,1.0,3/12,8.54%,PRKD2;NIPBL;PRKD1
prerank,embryonic axis specification (GO:0000578),-0.41930328929125815,-1.0983652824200816,0.3530405405405405,0.5858848450232857,1.0,9/15,34.00%,SMAD2;TASOR;SMAD6;TBX3;FZD5;RIPPLY2;PTCH1;WNT7A;HOXD8
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.3789381153991778,-1.0982264396654204,0.3157894736842105,0.5857920413843997,1.0,11/21,38.32%,RAB1A;RPL5;MAD2L2;PTEN;RPS7;FZR1;PLK1;CDC20;UBE2C;FBXO5;BAG2
prerank,macrophage migration (GO:1905517),0.4236120694013541,1.0980979484068012,0.3377777777777778,0.7569871946125624,1.0,4/13,18.23%,CXCL17;CCL5;CCL2;EDNRB
prerank,regulation of interleukin-12 production (GO:0032655),-0.3191203145249085,-1.0977714519939936,0.29609929078014185,0.5864436895379316,1.0,9/47,18.45%,FOXP1;THBS1;MAST2;PLCB1;PLCG2;CD40;IL16;CMKLR1;CCL19
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3361906421544034,1.097598157173299,0.296551724137931,0.756784145027223,1.0,16/33,25.82%,DDAH2;OAT;PYCR2;RIMKLA;GLS2;GLS;GLUD1;ART4;NIT2;RIMKLB;DDAH1;MTHFS;ALDH4A1;SIRT4;GCLM;FPGS
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.44750585344668314,-1.0975849235941448,0.3482142857142857,0.586479567320397,1.0,5/12,31.57%,RAB27A;PLCG2;ADGRB1;SLC5A3;TLR6
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.43714218722638587,-1.0973397212515918,0.3414179104477612,0.586644245614669,1.0,4/13,19.36%,PTPN1;NCK1;ABCA7;DNAJB9
prerank,modulation by symbiont of host process (GO:0044003),0.4570319156235049,1.0971831536174865,0.3403755868544601,0.7563662539244246,1.0,6/10,29.71%,HGS;UBB;MRC1;PGK1;RPS27A;UBC
prerank,positive regulation of cell cycle process (GO:0090068),-0.27552905718824455,-1.0971238904183276,0.2796296296296296,0.586714096995916,1.0,27/91,27.05%,MAP3K20;INSR;LRP5;PRKCE;SVIL;PKP4;CUL3;CDC14A;EDN1;RGCC;EDN3;KIF23;RHOA;PLSCR1;PKN2;TPR;IGF1;GIPC1;PLK4;ATRX;IGF2;PDGFRB;E2F7;INO80;CEP295;KIF14;USP19
prerank,cellular response to nitrogen compound (GO:1901699),-0.38074354384976206,-1.0967233769117484,0.32656826568265684,0.5872512751696345,1.0,9/20,21.31%,DDI2;SPIDR;RTF2;NSMCE3;PDE12;ROCK2;ATRX;TIMELESS;BLM
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3954455732236748,-1.0965738850330273,0.33088235294117646,0.5872200199673856,1.0,6/19,15.96%,TENT4B;STN1;XRN1;CTC1;HNRNPA1;TERF2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.31264365356548174,-1.0964537459628696,0.2972972972972973,0.5870961509372415,1.0,16/48,25.53%,PLA2G4A;LPCAT1;PLD1;PLD2;DGKA;AGPAT4;DGKZ;ACP6;AGPAT3;AGPAT1;PLA2G12A;LCLAT1;DDHD2;GPD1;DGKH;DGKE
prerank,protein targeting to membrane (GO:0006612),-0.28362559778972474,-1.0963180919295261,0.2774774774774775,0.5870327249579983,1.0,35/83,36.63%,PARD3;ZDHHC6;ZDHHC3;AQP11;ABCD3;SRPRA;CHMP4B;CHMP4A;RAB8B;SGTA;PEX14;SRP14;SIL1;ZDHHC1;ZDHHC4;PEX3;ZDHHC12;RAB3IP;SEC61A1;ATG3;VPS37B;PEX11B;PEX19;RTP4;GOLGA7B;ZDHHC9;SEC63;PEX26;ZDHHC22;SRP19;NCF1;VPS37C;ICMT;YIF1B;RABGEF1
prerank,respiratory electron transport chain (GO:0022904),0.41100718015573773,1.0962159605912882,0.35280898876404493,0.757660704755924,1.0,3/14,11.52%,SLC25A13;SDHA;NDUFA5
prerank,response to tumor necrosis factor (GO:0034612),-0.2778373758861484,-1.096161348190101,0.27008547008547007,0.586988590299558,1.0,30/91,26.06%,DAB2IP;CCL25;MAP4K3;ADAM9;GGT5;GCH1;ARHGEF2;CASP8;ADAM10;AKT1;JAK2;CD40;ZFAND6;ASAH1;GSDME;IGBP1;RPS3;CCL19;IKBKB;HYAL2;BRCA1;NFE2L2;RELA;RIPK1;HAS2;GBP3;ADAMTS7;DHX9;ERBIN;ZFP36L1
prerank,acute inflammatory response (GO:0002526),-0.3753577545622347,-1.096008546909236,0.3416815742397138,0.5869200911647594,1.0,13/23,37.60%,IL6R;LBP;ANO6;PLSCR1;CTNNBIP1;F3;IL22;AHSG;VNN1;CEBPB;HPR;HP;CRP
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.36089475165385715,-1.0958061479880927,0.3257042253521127,0.587014698348744,1.0,10/25,27.75%,PRPF3;PRPF6;SF3B1;DBR1;SLU7;SRRM1;SRSF10;TRA2B;SCAF11;TXNL4A
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3753535884358862,-1.0957673160541415,0.336996336996337,0.5867119419762583,1.0,12/21,36.91%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13;PLK1;CDC20;FBXO5
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4656723326252875,-1.095730030201142,0.35495495495495494,0.5859997997429527,1.0,3/10,3.58%,NFAT5;NFATC1;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),-0.4656723326252875,-1.095730030201142,0.35495495495495494,0.5859997997429527,1.0,3/10,3.58%,NFAT5;NFATC1;NFATC4
prerank,neutrophil mediated immunity (GO:0002446),-0.22912978378660012,-1.095226328744506,0.18810289389067525,0.586791119272133,1.0,102/432,21.99%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;CTSC;ADGRE5;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;RAB7A;KMT2E;DDX3X;DIAPH1;ANXA3;PTPRJ;ACE;LPCAT1;PLD1;IDH1;AP2A2;NFKB1;TNFRSF1B;RAB5B;MOSPD2;ENPP4;PRKCD;CD55;RAP1A;CD93;HRNR;MAPK1;RAP1B;ROCK1;PDXK;OSTF1;RAB27A;TSPAN14;RNASE3;NBEAL2;IGF2R;RAB4B;STOM;ADAM10;FRK;PGLYRP1;STK10;PSEN1;EEF2;ALDOC;ANO6;ARMC8;RHOA;HMOX2;PA2G4;CEACAM1;CAT;UBR4;PRCP;RHOG;ARSA;LRG1;RAB24;PSMC2;MIF;CTSZ;TOM1;ASAH1;PSMB1;SRP14;CTSH;LAMP2;DBNL;DSN1;VAPA;PLEKHO2;ATP6V0A1;VPS35L;SCAMP1;NAPRT;PTPRC;FRMPD3;KCNAB2;B4GALT1;RAP2C;NRAS;DEGS1;ORMDL3;HUWE1;GYG1;CAP1;CD53;AMPD3;VCL;CTSA;VAMP2;NDUFC2;ITGAM;GLA
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.40054798521205204,1.0948849450367901,0.3244444444444444,0.7599899952081396,1.0,2/15,8.37%,MAGI2;ACVR1B
prerank,regulation of phagocytosis (GO:0050764),-0.3043996571800888,-1.0948117059557234,0.29695885509839,0.5873537460572282,1.0,14/53,19.32%,IL15;MERTK;DYSF;GAS6;TGM2;RAB27A;SCARB1;PLSCR1;ABCA7;PIP4P2;LMAN2;TULP1;GATA2;PTPRC
prerank,regulation of viral transcription (GO:0046782),-0.3256954359354292,-1.0944858206109729,0.31866197183098594,0.5877402376492215,1.0,20/39,33.95%,UBP1;POLR2G;MDFIC;TRIM14;IFITM3;TRIM13;NELFB;SUPT4H1;POLR2C;DHX9;POLR2L;POLR2H;RSF1;LARP7;TRIM32;TRIM62;NELFA;NELFCD;POLR2E;TARBP2
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.3253426209244913,-1.0942971829709869,0.30343511450381677,0.5877921906831797,1.0,13/40,20.28%,MCL1;ABL1;PRKCD;IER3;WDR76;KMT5A;FEM1B;UBE2V2;RFWD3;ARMT1;RPA2;USP1;NSMCE4A
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.36116694397459953,1.0942912620250038,0.3452914798206278,0.7601499210643208,1.0,8/21,19.12%,TOX;PROX1;INSM1;VEGFA;FZD9;FZD3;DISP3;CX3CL1
prerank,B cell differentiation (GO:0030183),-0.3173706482759998,-1.0940601486080501,0.29391304347826086,0.5879715175359032,1.0,18/46,26.59%,ITGB1;PTPRJ;ZBTB7A;PLCG2;TPD52;HDAC4;ITGA4;NHEJ1;TCF3;VCAM1;CEBPG;CLCF1;PTPRC;DNAJB9;GPS2;PTPN2;ADAM17;HDAC5
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3702345868977876,-1.0938892718268405,0.3285198555956679,0.5879625956546217,1.0,9/24,19.32%,ITPR1;PKD2;ITPR2;PLCG2;HTR2A;ERO1A;FGF2;CCL19;PTPRC
prerank,regulation of T cell activation (GO:0050863),0.3136290533776585,1.0936571681228606,0.32096069868995636,0.7603597134123093,1.0,8/42,15.73%,TNFSF18;PAG1;PRELID1;VTCN1;CCL5;CCL2;CD47;SIRPA
prerank,negative regulation of translational initiation (GO:0045947),-0.42679306907641523,-1.093077217383529,0.3503521126760563,0.5895268264194362,1.0,9/13,36.89%,EIF3E;LARP1;AGO2;TPR;EIF2AK4;PAIP2B;EIF4EBP1;EIF4EBP3;PAIP2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3701743461213686,-1.0922692259713591,0.3404634581105169,0.5911140198100218,1.0,7/22,10.76%,LYN;RANBP9;SP1;EPHA4;GSK3A;PICALM;SLC2A13
prerank,regulation of plasminogen activation (GO:0010755),0.4310190918166214,1.092158241110945,0.33569739952718675,0.763312158591645,1.0,3/12,7.09%,MELTF;CLEC3B;PLGRKT
prerank,negative regulation of complement activation (GO:0045916),-0.4596699396367748,-1.0915824447192606,0.3745583038869258,0.5923497516129596,1.0,2/10,7.02%,CR1L;CD55
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.3836707937564459,-1.0914733012612041,0.33089579524680074,0.5922221002123909,1.0,3/19,3.89%,IFIH1;SETD2;DDX3X
prerank,peptidyl-glutamic acid modification (GO:0018200),0.3530524929677665,1.091267942898084,0.3463302752293578,0.764345577277986,1.0,5/24,11.50%,AGBL4;TTLL8;TPGS1;TTLL10;TTLL5
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3931942268312484,-1.090327113070871,0.34901960784313724,0.5945528328098496,1.0,6/16,21.78%,CHMP4B;CHMP4A;VTA1;VPS36;CHMP5;TMEM50B
prerank,axonal transport of mitochondrion (GO:0019896),0.440009413990163,1.0901847226209942,0.3627906976744186,0.7658926531052089,1.0,7/11,25.16%,SYBU;MAPT;NEFL;TRAK2;HAP1;SPAST;ACTR10
prerank,mRNA catabolic process (GO:0006402),-0.31519989428717843,-1.0897750379039606,0.31523642732049034,0.595542980541341,1.0,15/44,29.29%,TUT7;XRN1;ERN1;XRN2;TUT4;PDE12;RC3H1;NUDT12;DIS3L2;METTL16;THRAP3;HSPA1B;DXO;LSM2;NBDY
prerank,organophosphate catabolic process (GO:0046434),0.4415949181804397,1.0893866244272052,0.352549889135255,0.7666509553954355,1.0,1/11,1.48%,ENPP2
prerank,dopaminergic neuron differentiation (GO:0071542),0.3643430442186838,1.088856636860502,0.3295711060948081,0.76666708478061,1.0,3/19,9.25%,PHOX2A;LMX1B;VEGFA
prerank,organelle assembly (GO:0070925),-0.22931664809018232,-1.088794934175841,0.1847457627118644,0.5974173351208187,1.0,94/384,21.53%,ABCC4;ABLIM1;PGM5;EXOC6;ASAP1;NEK7;CD34;PARVA;ATG7;FNBP1L;RAB7A;SH3PXD2B;EXOC4;DDX3X;RAB1A;NEK6;MAP1LC3B;EHD2;PTPDC1;LIMD1;CCDC61;SSX2IP;TMOD3;AMBRA1;CEP250;HPS4;IRGM;E2F4;IFT140;CDC14A;OGFOD1;WDR11;RAB11FIP3;EXOC2;PDE6D;HAUS8;CHMP4B;CHMP4A;FLNA;WIPI1;POGZ;GABARAP;PRRC2C;EHD1;WDR35;GALNT11;RAB8B;NOTCH1;IFT52;LMOD1;CSNK1D;VTA1;CHMP2B;CFAP44;ULK2;HAUS6;RAB23;ZFYVE1;TRAF3IP1;VPS36;CEP41;RC3H1;RAB32;EXOC8;ATG5;FUZ;TUBGCP4;DZIP1L;NUDCD3;EHD4;CHMP5;RAB11A;TUBGCP5;HDAC6;DBNL;CFAP298;EDC3;PLK4;PCM1;STX12;RPS3;TMEM17;CENPE;KIF3B;IFT43;EMC6;GORASP2;WDR45B;PDCD6IP;KIF27;ATG16L2;IFT20;STARD9;LSM3
prerank,acylglycerol catabolic process (GO:0046464),-0.33952877170474893,-1.088661948542867,0.3270223752151463,0.5973279571682586,1.0,12/30,42.18%,ABHD2;MGLL;LPL;LIPE;PNPLA2;FABP3;LIPH;ABHD12;FABP4;LYPLA2;FABP12;DAGLA
prerank,cellular response to metal ion (GO:0071248),0.2573721822108528,1.0886452245473532,0.2632794457274827,0.7656606735810081,1.0,23/123,12.36%,NLGN1;SYT1;SYT5;DLG2;ANK3;RYR3;ADCY8;SYT12;SYT11;GLRA1;HPCA;HSF1;CPNE9;DPEP1;SCN5A;ACER1;ADCY7;CPNE1;CYP11B1;ATP13A2;SYT4;GPLD1;DLG4
prerank,negative regulation of cell development (GO:0010721),-0.3564442315321202,-1.0885210054903265,0.3281519861830743,0.5972576444549376,1.0,13/25,38.83%,GSK3B;GSK3A;NOTCH1;IGF1;PCM1;FBN1;RFLNB;RFLNA;LILRB1;WNT7A;CCL11;PAX6;APPL2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.41000605649588817,-1.0883670453566971,0.3686200378071834,0.5972347553759566,1.0,5/14,14.98%,PRKG1;SLIT2;MEF2C;TPM1;IGFBP5
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3258789476424149,-1.0882544689425366,0.32065217391304346,0.5970889263796162,1.0,15/41,26.43%,PLA2G4A;ELOVL5;PTGS1;GSTM2;EPHX1;MGLL;GPX1;ACOX1;ACSL1;DAGLB;DEGS1;PTGR1;PNPLA8;CYP1B1;GPX4
prerank,macrophage chemotaxis (GO:0048246),0.4525042033524783,1.0879678006549587,0.3431818181818182,0.7660573848303698,1.0,4/10,18.23%,CXCL17;CCL5;CCL2;EDNRB
prerank,ether lipid metabolic process (GO:0046485),0.4058492906800805,1.0878563036120306,0.3493150684931507,0.7646747060360326,1.0,6/14,12.69%,FAR1;PLA2G7;PLA2G6;GNPAT;DHRS7B;PEDS1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.35408029542513036,-1.087788649602441,0.3350877192982456,0.5977992121411748,1.0,9/26,27.81%,SLC30A10;PPARA;RAB27A;PLCG2;ABCB7;COA8;ADGRB1;SLC5A3;SLC25A33
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.33394802227988296,-1.0874960457522262,0.33807829181494664,0.598082586375225,1.0,12/35,18.65%,HIP1;RAC1;LDLRAP1;CBL;AAK1;PICALM;HFE;FLOT1;PIK3CB;HIP1R;CCL19;MKLN1
prerank,cardiac muscle cell differentiation (GO:0055007),0.3654223705051255,1.0870979288258436,0.32456140350877194,0.7654076146761963,1.0,8/21,14.86%,NRG1;WT1;CXADR;ALPK3;IRX3;VEGFA;SLC8A1;CBY1
prerank,sphingolipid metabolic process (GO:0006665),-0.2696001366540926,-1.0868361988033524,0.296229802513465,0.5992443702658721,1.0,34/108,21.99%,SGMS1;ESYT2;CERT1;ACER2;DEGS2;SGMS2;PRKD3;PRKD2;SPNS2;ST6GALNAC3;ELOVL5;CERS4;PPM1L;PRKD1;ACER3;PDXDC1;ARSA;AGK;ORMDL1;SPTLC1;ASAH1;CERS5;SMPD2;GBA2;VAPA;SERINC1;GLTP;PPP2CA;DEGS1;ORMDL3;ELOVL7;TEX2;CTSA;GLA
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3664844409306947,-1.0868058409544352,0.33989266547406083,0.5989286290136996,1.0,11/25,20.17%,ACVRL1;CORO1C;THBS1;ACE;ROCK1;FAM107A;BCAS3;ROCK2;IKBKB;DUSP22;PTEN
prerank,regulation of macrophage activation (GO:0043030),-0.3386385572725361,-1.086706405897658,0.33084112149532713,0.598773579542753,1.0,7/30,15.33%,MFHAS1;CD200;THBS1;LBP;MYO18A;GPR137B;MIF
prerank,macroautophagy (GO:0016236),-0.2643426319007656,-1.086656279078337,0.28136200716845877,0.598515963493373,1.0,51/118,36.25%,LIX1L;MTMR3;ATG7;ATG10;MAP1LC3B;PIP4K2A;AMBRA1;PIP4K2B;TECPR1;CHMP4B;CHMP4A;TOMM40;PRKAA1;WIPI1;GABARAP;FUNDC1;VTA1;CHMP2B;ZFYVE1;VPS36;ILRUN;ATG5;TOMM5;LAMP2;HDAC10;KLHL3;PRKAB1;PLEKHM1;BECN1;STAM2;VPS39;TOMM20;CHMP3;DYNLL1;ATG3;VPS37B;TOMM70;LIX1;CHMP6;ARL8B;VAMP8;TCIRG1;YOD1;WIPI2;TOMM6;GABARAPL2;VPS37C;VCP;MTMR14;CSNK2A1;CSNK2A2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.3761738817381236,-1.0858692985757028,0.33579335793357934,0.599926814631179,1.0,5/22,7.85%,PDGFD;DDX3X;ACE;RASSF2;MRE11
prerank,regulation of cell division (GO:0051302),-0.2895683988810996,-1.0858230546332857,0.3231597845601436,0.5996431102361578,1.0,22/72,25.30%,MLLT3;SETD2;AHCTF1;ZFYVE26;FGF1;RAB11FIP3;PLK2;BIRC6;TAL1;KLHL13;TXNIP;RAB11A;PLK4;CETN2;CDK2AP2;PRC1;BLM;KIF13A;BECN1;KIF18B;TLE6;PLK3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.31130804889333674,-1.0857972246711594,0.295668549905838,0.5993042293942297,1.0,14/51,17.12%,NEK7;TENT4B;STN1;ATM;XRN1;TCP1;MAPK1;HMBOX1;CTC1;PNKP;PARN;HNRNPA1;TERF2;CTNNB1
prerank,negative regulation of ossification (GO:0030279),-0.3671020579088383,-1.0854783558835683,0.36787564766839376,0.599620090973531,1.0,6/23,15.62%,SRGN;TRPM4;MEF2C;NOTCH1;BCOR;SMAD6
prerank,CENP-A containing chromatin organization (GO:0061641),0.33811943959909463,1.085402314001757,0.34615384615384615,0.767211008729355,1.0,10/29,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.33811943959909463,1.085402314001757,0.34615384615384615,0.767211008729355,1.0,10/29,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,regulation of muscle contraction (GO:0006937),0.35274765656934265,1.0849715375367943,0.31662870159453305,0.7668878511173277,1.0,6/26,12.61%,CHRM2;ATP1A2;TNNC1;NMUR2;SRI;MYL2
prerank,polyamine metabolic process (GO:0006595),-0.428722681246824,-1.0849327254145982,0.3617391304347826,0.6005210896904771,1.0,5/13,23.09%,SMOX;HDAC6;HDAC10;OAZ2;SRM
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.3321050822695375,-1.0849140873220569,0.31746031746031744,0.6001712126518448,1.0,9/33,18.43%,PRKD2;PTPRJ;EZR;DGKZ;CEACAM1;DUSP3;RC3H1;RPS3;IKBKG
prerank,eye morphogenesis (GO:0048592),-0.3900348736617855,-1.0842141649131845,0.35384615384615387,0.6014320702165497,1.0,7/19,10.69%,COL5A1;NIPBL;RARG;COL5A2;NKD1;SHROOM2;AGTPBP1
prerank,regulation of proteolysis (GO:0030162),-0.30800228552878717,-1.0841892003577052,0.3117338003502627,0.6010794960827085,1.0,16/48,22.35%,CAV1;RNF139;DNAJC1;ASPH;CASP8;AKT1;PERP;SPOPL;LTBP4;FBXW11;PLAT;HDAC6;SPOP;FGFR4;OGT;SERPINE2
prerank,regulation of cellular respiration (GO:0043457),-0.3912488961012657,-1.083985237388586,0.3400735294117647,0.6011726250139716,1.0,3/17,3.95%,CBFA2T3;PRDM16;IFNAR1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.3848372875610581,1.0833520758234523,0.37264150943396224,0.7701409482786175,1.0,9/17,22.38%,ATP1A2;PKP2;ATP1B1;RYR2;SLC8A1;GJC3;GJA1;ATP1B2;ATP1A3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.3950076444309307,-1.0833300745121537,0.34888059701492535,0.6022592852918439,1.0,6/17,11.05%,PKD2;EGFR;CCND3;AKT1;CCNY;RGCC
prerank,cellular response to organic substance (GO:0071310),-0.2618488764949081,-1.08331024176776,0.2872531418312388,0.6019094157328853,1.0,21/116,10.10%,LEF1;GHR;ACVRL1;NFAT5;PTPN14;KLF4;BMPR2;RAMP1;LRRK2;PTPN9;LDLRAP1;TIPARP;EMD;PTPN12;TGFBR2;SLIT2;ARL6IP5;ACVR2A;HAX1;RAMP2;SOCS2
prerank,aminoglycan metabolic process (GO:0006022),0.4549295663715838,1.0829064829155008,0.3553191489361702,0.7698241244309711,1.0,4/10,17.73%,B4GALT7;CHST9;B3GAT1;GAL3ST3
prerank,neuron apoptotic process (GO:0051402),0.3700112477330621,1.0826384980688453,0.331002331002331,0.769013520934579,1.0,4/19,5.95%,CDK5;BCL2;SCN2A;NAE1
prerank,insulin secretion (GO:0030073),0.37631424066869373,1.0826225065452184,0.33737864077669905,0.767433149890628,1.0,2/19,1.46%,RIMS2;PTPRN2
prerank,mitochondrial fission (GO:0000266),-0.4113315185016976,-1.0824951058554226,0.3548387096774194,0.6034078854158,1.0,3/16,6.07%,DNM3;MIEF1;DNM2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.24017556607814433,-1.0823036080324262,0.2652027027027027,0.6034652501763711,1.0,76/241,28.11%,SRSF11;PRPF3;METTL14;SMU1;PSPC1;CWF19L2;RSRC1;HNRNPA0;RBM5;NOVA2;HNRNPR;UPF3B;FUS;PRPF6;SF3B6;SPEN;RBM19;HNRNPM;POLR2G;PHF5A;DDX39B;SF3B1;PUF60;PRPF31;CPSF7;SNIP1;HNRNPA3;HNRNPUL1;EFTUD2;DHX38;DBR1;HNRNPF;SFPQ;SLU7;CTNNBL1;SNRPE;SF3A1;HNRNPA1;SYNCRIP;SRSF12;CWC25;RBM4B;ZMAT5;BUD13;CD2BP2;FIP1L1;TFIP11;SRRM1;NONO;RNPS1;SRSF3;SRSF10;TRA2B;LSM3;RBM6;CWC22;PPIH;RBM15;PCBP1;POLR2C;GEMIN7;USP39;RNPC3;PDCD7;SF3B5;GCFC2;DHX9;POLR2L;PRPF40B;POLR2H;HNRNPL;HNRNPD;PABPC1;HNRNPU;TXNL4A;LSM2
prerank,positive regulation of protein secretion (GO:0050714),-0.28870955142317417,-1.0822798527383208,0.3041958041958042,0.6031186701611458,1.0,11/69,7.78%,UNC13B;MYRIP;CD2AP;GOLPH3L;ADAM9;IER3IP1;BMP6;TGFB2;RBP4;EZR;MYO18A
prerank,positive regulation of phosphatase activity (GO:0010922),0.36213547930565854,1.0818520744401023,0.34101382488479265,0.768097614942202,1.0,3/21,5.75%,MAGI2;PLEK;CALM2
prerank,cardiac muscle cell development (GO:0055013),0.3649249556235759,1.0814137540381883,0.34375,0.7677613992340581,1.0,8/20,15.32%,FHOD3;CXADR;ALPK3;VEGFA;MYLK3;SLC8A1;MYL2;PDGFRA
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3654533214026314,-1.0814127164052887,0.33505154639175255,0.6047820682468269,1.0,6/22,14.55%,ESR1;MED1;TP53;MED13;MED17;PSMC2
prerank,positive regulation of potassium ion transport (GO:0043268),0.31402913516081776,1.0814052934801617,0.30434782608695654,0.7661534803367901,1.0,9/38,12.02%,KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;KCNJ6;ADRA2A;KCNN3;GABBR1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.27600294730656333,-1.0813857602785868,0.3193430656934307,0.6044511720475331,1.0,20/91,11.99%,HIP1;RUFY1;DNAJC13;PTPN1;STON1;RNF139;LRRK2;PLD1;RAB5B;ABL1;AP2S1;MAPK1;RAB5A;SCFD1;SCARB1;PICALM;RAB4B;BET1L;SNX12;RAB8B
prerank,innate immune response (GO:0045087),-0.24213525364571317,-1.081173632760583,0.27627118644067794,0.604560189058048,1.0,77/217,32.08%,SP100;ANKHD1;MFHAS1;LYN;ANKRD17;IFIH1;TRIM25;APP;TRIM56;SETD2;DDX3X;RNASE7;YES1;CLPB;OTULIN;GCH1;PTK2;IRGM;LBP;RNASE3;PLCG2;ALPK1;PIK3CD;SERINC3;FRK;PGLYRP1;TRIM14;IFITM3;IRAK1;CD40;NCF2;TRIM59;TRIM13;SRPK2;FYN;NRROS;NLRC5;MAVS;IKBKG;SERINC5;IKBKB;DEFA6;NOD2;TKFC;ZDHHC1;PPARG;KYNU;TRIM28;PTK2B;RELA;TRIM39;AKAP1;TRIM68;HMGB1;IRF7;LCN2;IFITM2;RPL39;FCER1G;TRIM6;TIFA;CXCL10;TREM2;BST2;TRIM35;RNF187;IFNLR1;MASP2;SHFL;SRMS;TRIM32;MFAP4;TRIM62;VNN1;CORO1A;JCHAIN;IRF5
prerank,early endosome to late endosome transport (GO:0045022),-0.37248812818592253,-1.0810397433029655,0.34954954954954953,0.6044566636393696,1.0,7/20,23.00%,RAB7A;RAB5A;STX8;ANKRD27;AKTIP;KIF16B;BECN1
prerank,negative regulation by host of viral process (GO:0044793),-0.4608903331104618,-1.08089987745752,0.37037037037037035,0.604394712345405,1.0,9/10,51.95%,VAPA;CCNK;EIF2AK4;CRP;CCL8;PTX3;PSMC3;ZC3H12A;LTF
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.42547628594793907,-1.0807714446443608,0.3689839572192513,0.6043235474975284,1.0,6/13,29.25%,ZMIZ1;ARID1B;ELOF1;CHEK1;SERTAD2;SPI1
prerank,organophosphate biosynthetic process (GO:0090407),0.3207074570754331,1.0807552505618805,0.31322505800464034,0.7664939861911738,1.0,8/37,11.41%,ITPKA;FADS1;TKT;TPI1;GK;IP6K2;IPPK;GNPAT
prerank,membrane raft organization (GO:0031579),-0.4047405186622397,-1.0806795512330123,0.38519924098671726,0.6041367780594519,1.0,10/15,35.55%,ANXA2;NAXE;FLOT1;ABCA7;PPT1;EMP2;RFTN1;MYADM;NPC1;S100A10
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.38678000223726505,-1.0805910938212049,0.3738656987295826,0.6039679796205534,1.0,5/18,19.59%,COX16;COX18;SCO1;COX17;COA8
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4060067978950108,-1.0805800471105864,0.3576388888888889,0.6035944591155734,1.0,10/15,38.32%,DTX3L;ABL1;SMAD7;RPL5;MAD2L2;RPS7;BAG5;PARK7;FBXO5;BAG2
prerank,negative regulation of defense response (GO:0031348),-0.28108539765083035,-1.0804214548433986,0.3153153153153153,0.6035762693092548,1.0,18/77,15.91%,TEK;RB1;KLF4;MFHAS1;PPARA;OTULIN;NMI;PRKCD;CDH5;PPARD;PPM1B;FEM1A;TRAF3IP1;TNFAIP3;ILRUN;CCN3;C1QTNF3;TNFRSF1A
prerank,sterol transport (GO:0015918),-0.3878854465990868,-1.0794908758256467,0.3406193078324226,0.6053420565150682,1.0,5/19,21.53%,CAV1;LDLRAP1;STARD3;OSBPL2;LCAT
prerank,regulation of pseudopodium assembly (GO:0031272),-0.4650559247978987,-1.0789537518577483,0.3961267605633803,0.605896460677591,1.0,9/10,50.29%,CDC42EP3;WASHC1;CDC42EP1;APC;CDC42EP5;CDC42EP4;CDC42EP2;F2RL1;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.4650559247978987,-1.0789537518577483,0.3961267605633803,0.605896460677591,1.0,9/10,50.29%,CDC42EP3;WASHC1;CDC42EP1;APC;CDC42EP5;CDC42EP4;CDC42EP2;F2RL1;CDC42
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3954422750957373,1.0788519088741146,0.35,0.7707012585423644,1.0,14/14,60.49%,POU4F1;IL23A;TYROBP;ATP6AP1;IFNG;POU4F2;CSF1;TRAF6;IL12B;IL23R;TNF;OCSTAMP;TNFSF11;CCR1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.41547710248065184,-1.078808732320325,0.3690909090909091,0.6058541009620735,1.0,7/13,24.02%,NOS3;GCH1;AKT1;CYB5B;NQO1;NOS1;CYP1B1
prerank,phagosome maturation (GO:0090382),0.3185916581932722,1.0781618015127543,0.30660377358490565,0.7712264705366038,1.0,12/35,19.06%,MREG;ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V1G2;RAB39A;RAB34;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,protein processing (GO:0016485),0.2593080278897854,1.0780109580635884,0.284688995215311,0.7700620897734948,1.0,24/102,16.86%,OMA1;MYRF;C1RL;MME;MMP16;CLN3;CPE;TYSND1;METAP2;BACE1;KLK1;KLK6;SPCS3;ADAM19;CPN1;PCSK2;AEBP1;HTRA2;SPCS1;PCSK6;ECE2;EEF1AKMT4-ECE2;KLKB1;CASP4
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.373509116221592,-1.0779044614609925,0.35125448028673834,0.6075481940234874,1.0,7/22,20.84%,RNF139;MAN1C1;MAN1A2;MAN1B1;TRIM13;UGGT1;EDEM2
prerank,neuron projection fasciculation (GO:0106030),0.4527768326235533,1.0776360368650486,0.35572139303482586,0.7695269953460228,1.0,3/10,8.64%,CNTN4;NRCAM;RTN4
prerank,nucleoside catabolic process (GO:0009164),-0.4462649618238296,-1.0774695387315525,0.3649906890130354,0.6081780805983901,1.0,7/11,36.67%,NT5E;NT5C1A;NT5C;UPB1;UPP1;DERA;DPYS
prerank,negative regulation of cell projection organization (GO:0031345),0.2956714138486412,1.0773271513488076,0.32547169811320753,0.7688818382291679,1.0,12/48,15.52%,DCC;GRIN2B;SPOCK1;ITM2C;TSKU;PTPRS;STMN2;MAG;PAQR3;DENND5A;APOE;PTPRO
prerank,negative chemotaxis (GO:0050919),-0.33751939192547736,-1.0772674629359245,0.33955223880597013,0.6082660145590479,1.0,13/33,21.05%,SEMA6A;SEMA3C;NTN1;SEMA7A;SLIT2;RHOA;SEMA3G;SEMA6B;SEMA4C;SEMA4A;SEMA3E;ITGB3;SEMA4G
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.38970495771378433,-1.0772259677326714,0.3466204506065858,0.6079597868295782,1.0,4/17,12.66%,KLF7;CAV1;APOLD1;CEACAM1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3566737854396926,-1.0771560651420398,0.3438077634011091,0.6077276927399398,1.0,9/24,29.13%,ZBTB16;ACVRL1;PKDCC;TRPS1;PTPN11;ADAMTS7;SNAI2;TGFBR1;WNT9A
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.3486540022194578,-1.0768313428131875,0.34014869888475835,0.6081046150522982,1.0,11/27,35.99%,TAB3;IRAK1;TAB2;IRAK2;MAP3K7;TNIP1;TLR6;TLR1;TLR5;CD14;TLR2
prerank,muscle cell development (GO:0055001),-0.3377505344276042,-1.0766578047904238,0.36036036036036034,0.6080953040419376,1.0,8/30,10.09%,ENG;MYOF;HES1;DYSF;MYH11;RAMP2;CHRNB1;NEBL
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4055966691275042,-1.0762091192783474,0.3723021582733813,0.608790913764073,1.0,5/15,7.19%,TBX1;TGFBR2;NIPBL;SIX1;MTHFD1
prerank,nitric oxide metabolic process (GO:0046209),-0.4064178967707712,-1.0761274715631877,0.35507246376811596,0.6085664043390322,1.0,7/14,24.02%,NOS3;GCH1;AKT1;CYB5B;NQO1;NOS1;CYP1B1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.4590838550554599,-1.0755937531323883,0.3801801801801802,0.6094378308308607,1.0,2/10,1.62%,ENG;CAV1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.4570827186042399,-1.0755542238205322,0.3766891891891892,0.6091322407508888,1.0,8/10,30.85%,RAPGEF2;LYN;GAS6;CCL19;CXCL12;LGALS9;AXL;LILRB1
prerank,microtubule anchoring (GO:0034453),0.423011406044854,1.075512844083731,0.3393665158371041,0.7728120843663936,1.0,4/12,17.24%,BICD1;BCCIP;CLASP2;CAMSAP3
prerank,regulation of receptor binding (GO:1900120),-0.4567906578508221,-1.0753396350344882,0.3896797153024911,0.6092432159939168,1.0,3/10,11.78%,ATP2A3;GREM2;HFE
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3583458084079365,-1.075259234463767,0.33793103448275863,0.6090123310583535,1.0,11/24,28.80%,LYN;MOSPD2;SLIT2;ANO6;CCN3;LGMN;CXCL12;SERPINE1;HMGB1;CXCL10;DUSP1
prerank,response to fatty acid (GO:0070542),-0.38178553982152785,-1.0745509818214594,0.3595505617977528,0.6103017997100536,1.0,4/17,12.71%,FOXO1;IRS1;FOXO3;LPL
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.351497603292845,-1.0745166285172605,0.3532423208191126,0.6099847911441637,1.0,11/27,22.03%,UTRN;NEDD4L;SLMAP;DLG1;FXYD5;PTPN3;FXYD6;SCN3B;SCN4B;SNTA1;NOS1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.38261316198353734,-1.0744581795810506,0.3634686346863469,0.6097222652328972,1.0,8/19,26.27%,GFPT2;GNPDA2;GNPNAT1;UAP1;NANS;SLC35D1;UAP1L1;PMM2
prerank,negative regulation of macroautophagy (GO:0016242),-0.34597674372605697,-1.074151217412521,0.34306569343065696,0.6100353224480805,1.0,6/26,10.04%,LRRK2;MTOR;SCFD1;AKT1;CHMP4B;CHMP4A
prerank,positive regulation of protein polymerization (GO:0032273),-0.28443121635662416,-1.0737541063033478,0.3339191564147627,0.6106486944774033,1.0,23/65,23.71%,CLIP1;BAIAP2L1;RAC1;PRKCE;NCK1;TOGARAM1;SNX9;OCLN;NCK2;FCHSD2;DCTN1;LMOD1;SLAIN2;DRG1;CDC42EP3;NCKAP1;RPS3;FCHSD1;CDC42EP1;PTK2B;HSP90AA1;AKAP9;ARL2
prerank,regulation of cell differentiation (GO:0045595),-0.252486037633546,-1.073744911194332,0.31951640759930916,0.6102700231974463,1.0,38/148,20.89%,SLC6A6;CREBBP;CBFB;KLF4;ZFHX3;SPOCK2;TBX1;SIK1;SMOC1;NREP;SIX1;PTK2;SUZ12;NGF;ROCK1;RAF1;NOTCH4;MOSMO;SMAD7;EDN3;LTBP4;RPS6KA1;PA2G4;CDK6;ATF4;RPS6KA3;TAF8;NR1D2;TRPS1;MCRIP1;CDK5RAP3;HEY1;HEY2;UQCC2;PPP2CA;BCL6;NF1;IGF2
prerank,negative regulation of phosphatase activity (GO:0010923),-0.35412557524008365,-1.0734898509138966,0.3670212765957447,0.6104651305402155,1.0,11/25,35.33%,GSK3B;TGFB2;ZCCHC9;GPATCH2;CHP1;SH3RF2;CRY2;BOD1L1;PPP1R1B;BOD1;FKBP1B
prerank,actin crosslink formation (GO:0051764),-0.43982094934544563,-1.0734416198426162,0.35977859778597787,0.610189052422651,1.0,4/12,12.71%,EPS8;BAIAP2L1;FLNA;LCP1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.3845479585512682,-1.0728328561418286,0.39201451905626133,0.6112763216094789,1.0,4/19,8.04%,THBS1;IL34;PTK2;MAPK1
prerank,positive regulation of intracellular transport (GO:0032388),0.31364746833678403,1.0724853730614512,0.3554083885209713,0.7802636342587768,1.0,9/38,11.79%,ABCA12;TENM1;PGAP1;STK11;ZFAND1;SORL1;PLA2G4E;EIPR1;PRR5L
prerank,regulation of cytoplasmic translation (GO:2000765),0.39889989279632054,1.0723375725314546,0.37303370786516854,0.779087139028999,1.0,4/14,17.26%,CPEB1;PKM;CPEB3;DHX36
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.40495768636509605,-1.072180130157558,0.35359116022099446,0.6124441495024634,1.0,5/15,15.65%,EGFR;PTPN12;RHBDF2;CEACAM1;LGMN
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.3194558395923111,-1.072086219280567,0.3402777777777778,0.6122641384939478,1.0,11/42,21.87%,SETD2;ARID2;SHLD1;MRNIP;FUS;SPIDR;CGAS;MAD2L2;RPA2;TIMELESS;CHEK1
prerank,regulation of platelet activation (GO:0010543),0.36466983441528017,1.0716296196886907,0.36027713625866054,0.779681088363368,1.0,7/21,15.32%,BLK;C1QTNF1;PLEK;PDGFA;TXK;APOE;PDGFRA
prerank,brain morphogenesis (GO:0048854),0.4206827583519387,1.0715455710927675,0.3401360544217687,0.7783385317652501,1.0,6/12,16.60%,CTNNA2;PAX2;BBS4;SLC6A4;MKKS;BBS2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4181829408574057,1.0713872769252861,0.3761467889908257,0.7771841033689535,1.0,3/11,8.52%,PTPRT;SOCS3;HGS
prerank,regulation of cytokine production (GO:0001817),-0.2565035018392699,-1.07077174873308,0.2885572139303483,0.6149919096908538,1.0,26/126,20.24%,FOXP1;AFAP1L2;LYN;IFIH1;TRIM56;RPS6KA5;IL15;SRGN;TNFRSF1B;MAST2;MAPKAPK2;CASP8;PIK3CD;RGCC;FLOT1;ASB1;ICOSLG;AGPAT1;N4BP1;MIF;C1QTNF3;ANXA1;SOD1;LURAP1;PTPRC;BCL6
prerank,neutrophil degranulation (GO:0043312),-0.22471845940215784,-1.0706396271173884,0.2358642972536349,0.6148674994658859,1.0,100/425,21.99%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;CTSC;ADGRE5;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;RAB7A;DDX3X;DIAPH1;ANXA3;PTPRJ;LPCAT1;PLD1;IDH1;AP2A2;NFKB1;TNFRSF1B;RAB5B;MOSPD2;ENPP4;PRKCD;CD55;RAP1A;CD93;HRNR;MAPK1;RAP1B;ROCK1;PDXK;OSTF1;RAB27A;TSPAN14;RNASE3;NBEAL2;IGF2R;RAB4B;STOM;ADAM10;FRK;PGLYRP1;STK10;PSEN1;EEF2;ALDOC;ANO6;ARMC8;RHOA;HMOX2;PA2G4;CEACAM1;CAT;UBR4;PRCP;RHOG;ARSA;LRG1;RAB24;PSMC2;MIF;CTSZ;TOM1;ASAH1;PSMB1;SRP14;CTSH;LAMP2;DBNL;DSN1;VAPA;PLEKHO2;ATP6V0A1;VPS35L;SCAMP1;NAPRT;PTPRC;FRMPD3;KCNAB2;B4GALT1;RAP2C;NRAS;DEGS1;ORMDL3;HUWE1;GYG1;CAP1;CD53;AMPD3;VCL;CTSA;VAMP2;NDUFC2;ITGAM;GLA
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3293604297594198,1.070465726072642,0.3362255965292842,0.7782615123815979,1.0,6/32,10.68%,RIMS2;RIMS1;SYT11;SYN1;GPER1;MCTP2
prerank,positive regulation of RNA splicing (GO:0033120),-0.3445409410709234,-1.06994660532932,0.3527204502814259,0.6161117236066638,1.0,9/29,24.13%,DYRK1A;PIK3R1;NUP98;ERN1;ZPR1;RBM20;RBM3;TRA2B;THRAP3
prerank,defense response to bacterium (GO:0042742),-0.2635290507002172,-1.0697497480602463,0.3181019332161687,0.6161864799186829,1.0,38/105,33.07%,ANKRD17;NOD1;RAB1A;ANXA3;RNASE7;IL6R;IRGM;PRKCD;LBP;GBP6;RNASE3;PGLYRP1;STAB1;GBP4;MAVS;DEFA6;NOD2;DROSHA;SERPINE1;RPL30;ADGRB1;LCN2;ADAM17;RPL39;LYZL4;FCER1G;TREM2;SELP;MPEG1;NLRC4;TNFRSF14;TLR6;JCHAIN;CEBPB;FGR;LPO;NOS2;AQP1
prerank,C4-dicarboxylate transport (GO:0015740),0.4050184921005704,1.0693634267364103,0.3640256959314775,0.780037619201425,1.0,3/14,6.54%,SLC25A13;LRRC8E;SLC1A2
prerank,cellular response to drug (GO:0035690),-0.35358747131432716,-1.0688155773449277,0.38543516873889877,0.6179627069764575,1.0,7/25,10.11%,ACER2;TFRC;GAS6;KCNQ1;MEF2C;PPM1F;TP53
prerank,mitotic spindle organization (GO:0007052),-0.24956246462790016,-1.0687680398681576,0.2901023890784983,0.6176693675186472,1.0,74/153,39.98%,CLIP1;MAD1L1;MAP4;NEK6;RANBP2;STAG1;CCDC61;AHCTF1;TOGARAM1;NUP98;PLK2;SEC13;WRAP73;FLNA;KIF23;RHOA;PAFAH1B1;ARHGEF10;MECP2;STAG2;KIF11;RAB11A;RPS27;DSN1;CENPL;CENPE;NDEL1;KIF3B;BUB1B;CENPO;PRC1;BUB3;TTK;MISP;PCNT;CENPI;CENPH;EML4;CENPN;RAN;DYNLL1;SPC25;SPDL1;TUBG2;CDCA8;STMN1;BIRC5;EFHC2;WDR62;NUDC;CEP192;MAP9;PLK1;NUF2;CKAP5;AURKA;MIS12;SPC24;TNKS;CDC20;NUP43;VCP;LSM14A;RMDN1;TPX2;TUBG1;SPICE1;KIF2C;NSL1;DYNC1LI1;SMC3;CCNB1;CENPT;CENPM
prerank,cranial nerve development (GO:0021545),0.4264358897105651,1.0685975030052643,0.375,0.7808103815498731,1.0,2/11,8.54%,PAX2;POU4F1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.2690657051911701,1.0685362891227297,0.31947483588621445,0.7794242429093616,1.0,12/85,9.74%,PCDH15;COL2A1;SLC26A5;LHFPL3;EML2;COL1A1;ATP2B2;COL11A2;DCDC2;CACNA1D;GRM7;SPTBN4
prerank,cellular response to oxygen levels (GO:0071453),0.4550901866909583,1.0683516780738185,0.3925438596491228,0.7783730898371941,1.0,4/10,19.06%,CCDC115;ATP6V0A2;ATP6V0D1;ATP6V1A
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.36135210923336597,1.0682939377797873,0.3400447427293065,0.7769761852432867,1.0,4/21,6.31%,HS6ST3;HS3ST5;HS6ST2;GPC1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.34673553061377127,1.067584552693748,0.3642241379310345,0.7775288946896394,1.0,4/25,3.86%,B3GALT1;NDST4;FUT9;B3GALT5
prerank,organic cation transport (GO:0015695),-0.3802987054441348,-1.0675135415434456,0.37681159420289856,0.6203500884054206,1.0,5/19,10.06%,SLC47A1;RALBP1;SLC22A5;SLC44A1;SEC14L1
prerank,cell proliferation in forebrain (GO:0021846),-0.4522054045504563,-1.0673383405988857,0.4050179211469534,0.620332178984924,1.0,6/10,33.22%,NUMB;PCM1;AKNA;KIF14;NUMBL;WNT7A
prerank,androgen metabolic process (GO:0008209),0.3715165027269906,1.0672239088296478,0.34684684684684686,0.7770148941472587,1.0,3/18,13.06%,AKR1D1;HSD17B7;SPP1
prerank,response to peptide (GO:1901652),0.31953572210770237,1.0671343245077067,0.32991803278688525,0.7757022561800788,1.0,5/33,4.32%,MMP12;CACNA1B;GNAI1;CACNA1A;INAVA
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4320122415080187,-1.0671138352622478,0.36823104693140796,0.6204566143909167,1.0,6/12,25.35%,LIMA1;CFL2;PLEKHH2;MTPN;SEMA5A;PIK3CA
prerank,regulation of heart contraction (GO:0008016),0.26612120453690014,1.0670454313936535,0.32524271844660196,0.7744015478436447,1.0,17/90,12.90%,ATP1A2;RYR3;ATP2B4;ATP2B2;ATP1B1;CELF2;CALM2;NPPC;RNF207;SLC8A2;RYR2;SLC8A3;SLC8A1;SRI;HRC;CASQ1;FXYD4
prerank,regulation of phosphatase activity (GO:0010921),-0.3578479787980727,-1.0668407017340815,0.3670886075949367,0.6207535376430889,1.0,8/24,24.99%,PPP1R2;ZCCHC9;GPATCH2;PPP6R3;CHP1;CDK5RAP3;SH3RF2;BMP2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4415318084788849,-1.0666780713397128,0.4006734006734007,0.6207033596838012,1.0,3/11,10.97%,P3H2;OGFOD1;P4HA1
prerank,cristae formation (GO:0042407),-0.3474952221315373,-1.0665853079836238,0.35528596187175043,0.6205202323211777,1.0,11/27,24.75%,CHCHD3;APOOL;AFG3L2;SAMM50;DMAC2L;ATP5F1E;UQCC3;ATP5F1C;ATP5MF;ATP5PO;IMMT
prerank,dephosphorylation (GO:0016311),-0.24886445673039878,-1.066570835352183,0.30849220103986136,0.6201543595995319,1.0,29/147,13.71%,PTPRG;PTPRB;PTPRM;PPP2R5A;PTPN14;PPM1H;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;PPEF2;ALPL;PPM1L;ILKAP;PTPRK;MTMR6;PPM1F;PPM1B;PPP1R12A;UBLCP1;PTPN3;DUSP23;ACP6;DUSP3;PTPN13;CTTNBP2NL;FBXW11;PNKP
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.30148070985621744,-1.0662038644160303,0.3563636363636364,0.6206155352827429,1.0,22/48,37.76%,NUP42;PRDM16;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188;NOA1;NUP88;NUP35;NOS2;NUP43;HIF1A;GCGR;PGAM1;JMJD8;PRKAG2
prerank,translational termination (GO:0006415),-0.26576087708648183,-1.06619518115285,0.32894736842105265,0.6202394192944248,1.0,34/95,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;GSPT1;MRPS24;MRPL46;MRPS27;MRPL12;N6AMT1;MRPL58;MRPL24;MTRF1L;MRPL57;MRPS14;ABCE1;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;MRPS28;MRPS35;MRPL43;MRPL48;MRPL11;TRMT112;MRPS31
prerank,histone H4 acetylation (GO:0043967),-0.30552186171787216,-1.0659029517897356,0.3411978221415608,0.6205402490044074,1.0,16/47,25.06%,LEF1;KANSL3;EP400;PHF20;TRRAP;ZZZ3;HCFC1;TADA3;TRIM16;RUVBL2;JADE2;OGT;WDR5;MORF4L1;BEND3;APBB1
prerank,cellular component disassembly (GO:0022411),-0.2970914597855427,-1.065477868242371,0.3559322033898305,0.62111895891581,1.0,12/53,15.16%,TLL1;BSG;SH3PXD2B;HTRA1;MMP2;CAPN2;ADAM10;ADAMTS4;ADAMTS5;LCP1;FLOT1;EXOC8
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3254394173997778,-1.065337861554228,0.36727272727272725,0.6210761330044554,1.0,10/33,18.69%,SH3BP4;SESN1;MTOR;CAPN2;UBR2;RPTOR;LARS1;CASTOR1;FYN;UBR1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.22375388043579356,-1.0650876831564078,0.25162337662337664,0.6212785765799975,1.0,100/428,21.99%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;CTSC;ADGRE5;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;RAB7A;DDX3X;DIAPH1;ANXA3;PTPRJ;LPCAT1;PLD1;IDH1;AP2A2;NFKB1;TNFRSF1B;RAB5B;MOSPD2;ENPP4;PRKCD;CD55;RAP1A;CD93;HRNR;MAPK1;RAP1B;ROCK1;PDXK;OSTF1;RAB27A;TSPAN14;RNASE3;NBEAL2;IGF2R;RAB4B;STOM;ADAM10;FRK;PGLYRP1;STK10;PSEN1;EEF2;ALDOC;ANO6;ARMC8;RHOA;HMOX2;PA2G4;CEACAM1;CAT;UBR4;PRCP;RHOG;ARSA;LRG1;RAB24;PSMC2;MIF;CTSZ;TOM1;ASAH1;PSMB1;SRP14;CTSH;LAMP2;DBNL;DSN1;VAPA;PLEKHO2;ATP6V0A1;VPS35L;SCAMP1;NAPRT;PTPRC;FRMPD3;KCNAB2;B4GALT1;RAP2C;NRAS;DEGS1;ORMDL3;HUWE1;GYG1;CAP1;CD53;AMPD3;VCL;CTSA;VAMP2;NDUFC2;ITGAM;GLA
prerank,cellular protein-containing complex assembly (GO:0034622),-0.24915677080401272,-1.0647324319405767,0.321880650994575,0.6217764621643559,1.0,53/159,26.83%,HIP1;FCHO2;STXBP6;EPS15;EIF4H;NCK1;PXN;AHCTF1;AP2S1;NUP98;PSMG2;TCP1;PIK3C2A;SNX9;SMAD1;SMAD2;PICALM;SMAD4;CHMP4B;CHMP4A;SAMM50;VBP1;NCK2;POGZ;NUP153;RPL38;PTGES3;TTC12;HIP1R;TPR;ANGPT1;CASQ2;DNAJB12;CENPE;VAMP3;PFDN6;ADRM1;TCF4;AP2M1;PSMD4;HIGD2A;VAMP2;HSP90AA1;NDUFAF1;ARL2;HIGD1B;DHX9;DRC1;PSMG1;CCT2;GPX4;IMMP2L;CHMP3
prerank,positive regulation of insulin secretion (GO:0032024),0.3164519113118919,1.0644801998580729,0.37644341801385683,0.7805823848764862,1.0,10/36,15.32%,BLK;GCK;ADCY8;TRH;GPER1;PLA2G6;GPLD1;NLGN2;GLUD1;MCU
prerank,exit from mitosis (GO:0010458),-0.4247937425320625,-1.063771352319496,0.39811320754716983,0.6236108607563373,1.0,3/12,10.03%,EPS8;PPP2R2D;CHMP4B
prerank,cellular response to alcohol (GO:0097306),-0.3065630854953793,-1.0636772585301135,0.3516483516483517,0.6234425434246996,1.0,14/42,21.31%,CTNNA1;GNB1;SMO;LARP1;LRP6;SPIDR;CDH1;PTGFR;KLF9;ADCY1;CTNNB1;GOLPH3;BRCA1;BLM
prerank,glycosaminoglycan metabolic process (GO:0030203),0.29093542601141437,1.0635469348020303,0.32505643340857787,0.7818455698518907,1.0,10/54,8.46%,GPC5;HS3ST6;HS3ST5;HPSE2;HS6ST2;GPC1;GALNT5;B4GALT7;HS3ST2;CHST9
prerank,oligosaccharide biosynthetic process (GO:0009312),0.35875291504637313,1.063495672304273,0.3553191489361702,0.7804297142017104,1.0,5/20,8.28%,B3GALT1;B3GALT4;FUT9;B3GALT5;ST6GALNAC5
prerank,regulation of viral genome replication (GO:0045069),-0.29310145003021165,-1.0634368681807735,0.33807829181494664,0.6235932185616224,1.0,24/56,29.19%,IFIH1;ZC3HAV1;DDX3X;LARP1;PPARA;IFITM3;PLSCR1;PKN2;PDE12;N4BP1;SRPK2;ADARB1;MAVS;RAD23A;STAU1;PPIH;IFITM2;TNIP1;PABPC1;TRIM6;OASL;BST2;RSAD2;PPIE
prerank,GTP metabolic process (GO:0046039),-0.39855290596911536,-1.063291095117282,0.37050359712230213,0.6235448983952981,1.0,4/15,14.14%,GNAI3;LRRK2;RHOQ;RAB23
prerank,peptide hormone secretion (GO:0030072),-0.3532644682056907,-1.0632727263493684,0.3741379310344828,0.6231945564206263,1.0,7/26,17.00%,RAB1A;CAMK2G;EDN1;EDN3;LTBP4;SNX19;ANXA1
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.4154109864387547,-1.0631346559371386,0.3783303730017762,0.6231449257049364,1.0,7/13,27.52%,LSG1;ABCE1;RRS1;RPS15;NUP88;RAN;NMD3
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4508925718384238,-1.0628178554859076,0.4,0.6234718702823872,1.0,4/10,18.14%,MSN;EZR;RHOA;RAP2A
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.42827007800786465,-1.062336005443672,0.3877551020408163,0.6242031121139555,1.0,2/12,1.62%,GJD3;CAV1
prerank,regulation of lipid storage (GO:0010883),-0.36116310064055335,-1.062074202120604,0.3727598566308244,0.6244250066862932,1.0,9/22,28.14%,NFKB1;NFKBIA;FTO;IKBKE;LPL;ITGB3;PTPN2;HILPDA;ALKBH7
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3617376820422487,-1.0616952588083357,0.35334476843910806,0.6249177070211622,1.0,5/21,10.69%,PDZD8;MCUB;TGM2;AFG3L2;BCAP31
prerank,regulation of sensory perception of pain (GO:0051930),-0.44257557317651014,-1.0611455631768971,0.38137082601054484,0.6258534648330155,1.0,5/11,26.84%,MGLL;CCN3;ACP3;SPX;F2R
prerank,DNA methylation (GO:0006306),-0.3587892801507042,-1.0607557846585602,0.36936936936936937,0.6263592176607914,1.0,9/23,24.04%,KMT2E;METTL4;EHMT1;N6AMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,chromatin remodeling at centromere (GO:0031055),0.3243872142196511,1.0607543386885554,0.37044967880085655,0.7872225479996517,1.0,10/31,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,heart process (GO:0003015),0.4021429626441323,1.060506458621785,0.3986784140969163,0.7863893583339959,1.0,1/14,0.03%,SGCZ
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.44994663240556676,-1.0604921261384692,0.4050632911392405,0.6262094773790905,1.0,5/10,20.03%,AP2B1;AP2A2;AP2S1;MYLIP;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.44994663240556676,-1.0604921261384692,0.4050632911392405,0.6262094773790905,1.0,5/10,20.03%,AP2B1;AP2A2;AP2S1;MYLIP;AP2M1
prerank,hyaluronan metabolic process (GO:0030212),-0.35433529281924997,-1.0604125830659614,0.3432574430823117,0.6259858827002537,1.0,11/23,32.00%,CEMIP2;FGF2;CHP1;HAS1;HYAL2;LYVE1;HAS2;HEXA;HYAL3;TGFB1;CEMIP
prerank,response to steroid hormone (GO:0048545),-0.338340010156727,-1.0601194234235771,0.3594306049822064,0.6263099591196456,1.0,7/31,8.80%,ABHD2;CAV1;THBS1;NR3C1;TGFB2;MED1;YAP1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2967859915667966,-1.0600977051694316,0.33512544802867383,0.6259710358459453,1.0,17/56,15.74%,SPTBN1;STAMBP;SNX9;BIN3;ROCK1;CHMP4B;CECR2;CUL7;KIF23;RASA1;DCTN3;RHOA;SON;RTKN;RHOC;ROCK2;MITD1
prerank,photoreceptor cell development (GO:0042461),0.3920754477325073,1.0597029541636684,0.3922902494331066,0.7872747273428393,1.0,4/14,9.43%,AHI1;ARL3;VEGFA;DCX
prerank,mismatch repair (GO:0006298),-0.34621080408042987,-1.0594182422069827,0.39929947460595444,0.6272241668306944,1.0,11/27,27.65%,SETD2;ABL1;MCM9;POLD3;RPA3;RPA1;XPC;RPA2;MSH3;LIG1;EXO1
prerank,wound healing (GO:0042060),-0.29007333945632857,-1.0587968752810526,0.37302977232924694,0.6283522352306962,1.0,16/62,13.27%,MYOF;MYH9;DYSF;TGFB2;MACF1;AHNAK2;FGF1;RAF1;DST;SCARB1;CFLAR;FUT10;DCBLD2;FGF2;TPM1;PRCP
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.36032850456073595,1.0586446209542282,0.3777292576419214,0.7888216943492232,1.0,3/20,5.98%,GCK;CDA;BCKDK
prerank,positive regulation of growth (GO:0045927),-0.28147372709703944,-1.0583685630626838,0.34229390681003585,0.6290312672160445,1.0,16/64,15.48%,INSR;DDX3X;EGFR;PLCB1;TGFB2;PPM1F;EXOSC2;MFSD2A;ADAM10;AKT1;RPTOR;RPS6KA1;ZPR1;RPS6KA3;H3-3A;N6AMT1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.28386799801115664,-1.0583196389213252,0.3379073756432247,0.6287567633820407,1.0,28/68,36.91%,IFIH1;APP;IL6R;LBP;ARHGEF2;PLCG2;LPL;IL17RA;IL16;MAVS;HYAL2;NOD2;PTPN11;HMGB1;DHX9;F2R;LGALS9;STAT3;TLR6;TLR1;NOS2;RAB7B;IL1A;TSLP;CD74;TLR2;TLR8;SYK
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3942530928530217,-1.0577710139750829,0.3628158844765343,0.6296296041291628,1.0,4/15,9.10%,STOX2;RICTOR;TGFB2;CELF1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.3944600368141863,-1.0576907343409194,0.38120567375886527,0.6294162464557717,1.0,8/17,34.35%,RB1;CTCF;BUB3;TTK;MTBP;SPDL1;BOD1;MIS12
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.3636933459538229,-1.0576523899013393,0.3875,0.6291050150039488,1.0,7/23,25.30%,PLK2;NABP1;INTS3;CDK5RAP3;BUB1B;CHEK1;PLK3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3738777770480717,-1.0574872114687417,0.3772893772893773,0.6290980693213024,1.0,12/19,40.16%,ZMIZ1;GAS6;PPP2R3C;PRKDC;IL7;AXL;MMP14;SYK;ZAP70;MDK;GATA3;IL4
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.4064184339221365,-1.0573352467574286,0.4051094890510949,0.629083901453736,1.0,6/14,17.15%,DYRK1A;PSEN2;ADAM10;PSEN1;ABCA7;APH1A
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.27701926979378205,-1.0571916304347904,0.32167832167832167,0.6290247872377109,1.0,25/72,29.19%,MNAT1;RBX1;POLR2G;ERCC2;POLD3;TCEA1;RPA3;RPA1;ERCC3;ERCC8;RPA2;USP7;COPS7A;RFC4;RFC1;COPS8;POLR2C;COPS4;LIG1;POLR2L;ERCC6;POLR2H;GTF2H3;CCNH;PPIE
prerank,cellular response to organonitrogen compound (GO:0071417),-0.26572718463999145,-1.0562710072118284,0.36095764272559855,0.630909223929693,1.0,24/99,15.21%,CTNNA1;RAPGEF2;PKD2;SH3BP4;DIAPH1;MTOR;PDE3A;LARP1;PDE2A;SLIT2;KCNQ1;RAP1A;MEF2C;EZR;RAP1B;CDH1;CAPN2;RAPGEF1;RPTOR;ACTB;LARS1;P2RY6;IGFBP5;HTR1B
prerank,male meiosis I (GO:0007141),-0.3826047723013987,-1.056220961699886,0.381294964028777,0.6306228918425171,1.0,7/16,30.92%,ZSCAN21;FOXJ3;HSF2BP;TDRD9;DDX4;MYBL1;FOXJ2
prerank,protein targeting to peroxisome (GO:0006625),-0.3356591282386908,-1.055816229365624,0.3683274021352313,0.6311543638772412,1.0,13/29,33.89%,PEX1;ABCD3;PEX7;RAB8B;ZFAND6;PEX14;PEX3;PEX6;PEX11B;HACL1;PEX19;LONP2;PEX26
prerank,monoacylglycerol metabolic process (GO:0046462),-0.41596457743070003,-1.0556956514902056,0.3925925925925926,0.6310396328450669,1.0,3/13,16.55%,PLA2G4A;MGLL;DGAT2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3804627593399932,1.0556385015912404,0.3763440860215054,0.7964710633864207,1.0,4/14,10.48%,ATIC;PAICS;ADSS2;ADSS1
prerank,extracellular matrix disassembly (GO:0022617),-0.2963865187266925,-1.05536205369793,0.36860068259385664,0.631452513952624,1.0,12/53,15.16%,TLL1;BSG;SH3PXD2B;HTRA1;MMP2;CAPN2;ADAM10;ADAMTS4;ADAMTS5;LCP1;FLOT1;EXOC8
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.2687810147808621,-1.0553115935467503,0.35443037974683544,0.6311657606030329,1.0,26/88,22.58%,CLINT1;VPS13A;EXOC6;STXBP6;EPS15;APP;EXOC4;SCAMP2;DNM2;RABEP1;PUM1;SCFD1;EXOC2;VPS13C;AP1G1;ACBD3;EXOC8;CORO7;AP4M1;VPS35L;SCAMP1;AP4B1;RABIF;VAMP2;KIF16B;ARFGEF2
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.4140067566525495,-1.055242699749914,0.38727272727272727,0.6309273317290275,1.0,2/13,5.04%,OGDH;IDH1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3072477799061268,1.0552425015718019,0.37389380530973454,0.7961337383308499,1.0,8/41,13.12%,GRM5;DOCK3;NTRK2;ADRA2A;LILRA5;CSF1R;DLG4;BDNF
prerank,response to amino acid (GO:0043200),0.3295934211377422,1.055235609756991,0.34844868735083534,0.794585813149309,1.0,5/31,10.51%,GLRA3;RRAGA;GLRA1;CPEB1;CPEB3
prerank,positive regulation of ossification (GO:0045778),-0.3134909357449167,-1.0550665375568002,0.3634782608695652,0.630951240922474,1.0,10/39,12.16%,ZBTB16;BMPR2;BMP6;TGFB2;BMP4;MEF2C;ACVR2A;ADGRV1;ANO6;PKDCC
prerank,striated muscle cell development (GO:0055002),-0.40641927764014985,-1.0546966077166655,0.40148698884758366,0.6314373916503241,1.0,3/14,12.75%,PGM5;TMOD3;LMOD1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3358897577203819,-1.054497082960599,0.3591549295774648,0.6315223888175918,1.0,7/29,12.81%,ENG;TGFBR3;S1PR1;SMAD7;ZFPM1;NOTCH1;TPM1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3532552217156308,1.0543477439378033,0.3874458874458874,0.7957560744576571,1.0,3/21,5.71%,PAG1;SAMSN1;VTCN1
prerank,positive regulation of viral process (GO:0048524),-0.2868223049353095,-1.053960239031305,0.36917562724014336,0.6324174330699269,1.0,28/60,33.95%,RAB7A;DDX3X;LARP1;PPARA;POLR2G;MDFIC;PKN2;PDE12;TBC1D20;SRPK2;ADARB1;RAD23A;NELFB;STAU1;PPIH;SUPT4H1;POLR2C;DHX9;POLR2L;POLR2H;RSF1;PABPC1;AXL;PPIE;NELFA;NELFCD;POLR2E;TARBP2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.3605786383198164,1.0538252053604427,0.3849462365591398,0.7956576350171923,1.0,6/20,17.17%,FAR1;ACLY;ACACA;ACSL3;SCD5;SCD
prerank,positive regulation of myelination (GO:0031643),0.42316158825201833,1.0532678206971566,0.3877551020408163,0.7957842685995399,1.0,2/11,1.02%,TENM4;MYRF
prerank,protein localization to cell surface (GO:0034394),-0.3407868839465691,-1.053104682436355,0.41025641025641024,0.6340636252707352,1.0,9/26,17.12%,SMURF1;RIC3;PTPRK;FGF7;FLNA;FBLN5;WNT11;ANGPT1;CTNNB1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.29549545849638287,-1.0527371601366653,0.3765112262521589,0.6346405842575232,1.0,20/54,29.10%,UBE2K;BIRC3;TAX1BP1;GAS6;OTULIN;CASP8;CFLAR;TNFAIP3;TNFRSF1A;HIPK1;IKBKG;IKBKB;RIPK1;CASP1;HSPA1B;GPS2;PTPN2;ADAM17;NLRP2B;RNF31
prerank,regulation of viral life cycle (GO:1903900),0.35727831488264555,1.0526996644041566,0.3733031674208145,0.7959013832919791,1.0,5/21,14.05%,HS3ST5;TYRO3;TRIM27;TSG101;PPIA
prerank,cell-cell junction maintenance (GO:0045217),-0.43933952430991213,-1.0525622360625144,0.3874538745387454,0.6346565087033785,1.0,2/11,1.30%,TJP1;FERMT2
prerank,metal ion transport (GO:0030001),0.26646252563489636,1.0524875128523712,0.3462414578587699,0.7949967706012889,1.0,21/86,12.59%,RYR3;CACNA1B;ATP2B2;CACNA2D1;TUSC3;CACNA1A;CACNB3;CACNG8;CACNA1D;SLC8A2;SELENOK;RYR2;CACNG3;CACNA1E;NIPA1;SLC39A2;NMUR2;NIPAL1;SLC8A3;SLC8A1;CCL5
prerank,mitochondrion organization (GO:0007005),-0.24747760553616158,-1.0524843858487318,0.3401015228426396,0.6344640182729525,1.0,66/165,34.86%,MEF2A;NOS3;ALAS1;DNM3;TRAK1;LRRK2;MIEF1;DNM2;CHCHD3;SIRT5;BNIP3;PYROXD2;AKT3;AFG3L2;HAX1;VPS13C;SAMM50;TOMM40;AGTPBP1;BCAP31;MTX1;GABPB1;MIEF2;SIRT3;AFG1L;HCFC1;RAB32;TIMM17B;VPS13D;TOMM5;FANCG;NRF1;DNAJC19;WASF1;HIGD2A;TERT;ATPAF1;GABPA;BIK;HIGD1B;TIMM50;TMEM11;STOML2;TIMM10;IMMP2L;TOMM20;RAB38;MTFR1;SLC25A33;RHOT2;CAV2;YME1L1;HIGD1A;TOMM70;PID1;MTM1;ATP5F1D;SPG7;TIMM10B;AIFM1;TIMM13;PARK7;ATP2A1;IFIT2;WDR81;NUBPL
prerank,regulation of establishment of planar polarity (GO:0090175),-0.2705374917630362,-1.0524782602258842,0.35456110154905335,0.6340881457519788,1.0,27/88,23.89%,RAC1;SMURF2;FZD6;DVL3;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;AP2S1;PSME2;PSMB4;RHOA;WNT11;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;AP2M1;PSMD4;ROR2;PSMA7;FZD7;PSMD5;FZD5
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.26959366443980687,-1.0524260101868161,0.36316695352839934,0.63381839890578,1.0,23/80,18.72%,WASF2;EPS8;RAC1;FNBP1L;EPS8L2;PIK3R1;PALM;RHOQ;WASL;PLCE1;AGRN;OCLN;CROCC;ARAP1;BCAS3;CDC42EP3;FAM98A;NCKAP1;FUZ;ARHGAP35;CCL19;WASHC1;NDEL1
prerank,regulation of isotype switching (GO:0045191),-0.4110258691458052,-1.0523418526818755,0.3930530164533821,0.6336410825086101,1.0,3/14,5.29%,SHLD1;TFRC;KMT5B
prerank,mesenchymal to epithelial transition (GO:0060231),0.43249471388503835,1.0521134691582599,0.4060475161987041,0.7945385800711194,1.0,2/10,6.07%,WT1;PAX2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.42288341650131334,-1.051824529054394,0.40693430656934304,0.6345200238039475,1.0,6/12,24.23%,ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3
prerank,peptidyl-lysine methylation (GO:0018022),-0.34846887635048834,-1.0517116658939312,0.3704379562043796,0.6343884805057313,1.0,8/26,16.06%,SETD2;SUV39H1;SETD3;EHMT1;KMT5A;SMYD1;N6AMT1;ANTKMT
prerank,negative regulation of microtubule polymerization (GO:0031115),0.42072588453472326,1.051649100091839,0.38095238095238093,0.794414012098778,1.0,6/12,18.37%,EML2;ARHGEF7;MAP2;STMN2;MAPRE1;TUBB4A
prerank,type I interferon signaling pathway (GO:0060337),-0.30747503625736416,-1.0512212521517679,0.37433155080213903,0.6347301307876416,1.0,10/41,14.93%,SP100;IRF2;JAK1;IFNAR1;SAMHD1;IRF1;STAT2;IFITM3;IRAK1;IFI35
prerank,cellular response to type I interferon (GO:0071357),-0.30747503625736416,-1.0512212521517679,0.37433155080213903,0.6347301307876416,1.0,10/41,14.93%,SP100;IRF2;JAK1;IFNAR1;SAMHD1;IRF1;STAT2;IFITM3;IRAK1;IFI35
prerank,protein localization to chromosome (GO:0034502),-0.328726142535573,-1.0511435085760765,0.37608318890814557,0.6345195582214197,1.0,12/34,19.63%,RB1;ESR1;CTCF;MRNIP;XRCC4;MCM9;WAPL;RPA1;SLF2;TERF2;RPA2;ATRX
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4138118022612508,-1.0510379725751127,0.4088495575221239,0.6343867605374097,1.0,5/12,21.29%,SORBS1;IRS1;GKAP1;IGF2;PTPN11
prerank,acute-phase response (GO:0006953),-0.4216143696209984,-1.050826978964181,0.4091743119266055,0.634473084554543,1.0,10/12,45.32%,IL6R;LBP;PLSCR1;IL22;AHSG;CEBPB;CRP;SIGIRR;ITIH4;IL6
prerank,regulation of neuron projection arborization (GO:0150011),0.38911534073653525,1.0504939502630968,0.4004474272930649,0.796343538115895,1.0,6/15,15.83%,GRIP1;NTNG2;NTNG1;DLG4;MYO9A;DVL2
prerank,negative regulation of catalytic activity (GO:0043086),-0.35248062250400436,-1.0502634799125137,0.3968804159445407,0.6355096306634884,1.0,14/24,36.42%,NES;TP53;PPP1R12A;NOTCH1;APBA3;HDAC6;PLN;NOS1;PARP9;NOSIP;PHPT1;HP;MT3;ATP5IF1
prerank,negative regulation of cell communication (GO:0010648),0.35286490562263045,1.0499986001156258,0.35944700460829493,0.7963958905951658,1.0,3/21,3.44%,OPRM1;IGFBP3;GLRA1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4063356738848557,-1.0495704252773421,0.39705882352941174,0.6367327851848988,1.0,3/14,5.29%,SHLD1;TFRC;KMT5B
prerank,anion transmembrane transport (GO:0098656),-0.28357559534636745,-1.0491271800132824,0.3464991023339318,0.637361104610375,1.0,20/67,21.38%,LRRC8C;SLC7A1;SLC7A5;SLC13A4;SLC16A12;SLC5A6;SLC38A5;SLC39A8;LRRC8D;ARL6IP5;SLC13A3;SLC35A3;SLC25A11;SLC36A4;SLC35B4;PRAF2;SLC25A1;SLC1A1;SLC7A2;SLC3A2
prerank,mesonephros development (GO:0001823),-0.4378836729371813,-1.0489931663280072,0.39963503649635035,0.6372931906644753,1.0,3/11,7.18%,ZBTB16;FGF1;BMP4
prerank,regulation of protein modification process (GO:0031399),-0.29673316361590896,-1.0487517833182187,0.3870967741935484,0.637502739833266,1.0,11/50,11.30%,LYN;CORO1C;ATG7;KAT2B;SPRED2;ATG10;PTK2;CDH5;ASPSCR1;STAT2;FNIP2
prerank,GPI anchor biosynthetic process (GO:0006506),0.327937244473534,1.0480141328751413,0.38235294117647056,0.8010347925856719,1.0,6/30,11.22%,PGAP1;DPM1;PIGP;MPPE1;PIGB;PGAP3
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.34774961787278935,-1.0478958067594746,0.3945945945945946,0.6391413791592598,1.0,7/26,12.27%,ITPR1;PKD2;ITPR2;PLCG2;HTR2A;ERO1A;FGF2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.36729426449368346,1.0469474909573142,0.4066193853427896,0.8027254238664298,1.0,4/18,7.38%,TENM4;OPALIN;PTPRZ1;SOX1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.36861597717482064,1.0465126972772363,0.3844444444444444,0.8024834511692416,1.0,3/18,5.19%,CHRM2;OPRM1;CHRM3
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3818380519099838,-1.0456064013984852,0.3908918406072106,0.6442141771871948,1.0,11/18,30.65%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;HPGDS;DAGLB;PNPLA8;PTGIS;PRXL2B;TBXAS1
prerank,regulation of filopodium assembly (GO:0051489),-0.318878222055613,-1.0451947113724314,0.38155515370705245,0.6448477252424544,1.0,11/38,11.65%,MYO10;FNBP1L;PIK3R1;PALM;RHOQ;PRKCD;WASL;AGRN;RAB5A;ARAP1;BCAS3
prerank,fatty acid transmembrane transport (GO:1902001),-0.37265481048091637,-1.045108871228626,0.4091710758377425,0.6446566989780362,1.0,4/19,10.86%,SLC2A1;ABCD3;ACACB;CPT1A
prerank,oxoacid metabolic process (GO:0043436),0.329764630809014,1.0450535009238355,0.3876146788990826,0.805267764188707,1.0,4/27,5.76%,BPNT2;SULT2B1;GNMT;HAO1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3170051208245373,-1.0449985644117508,0.41238938053097346,0.6445672478405717,1.0,17/34,30.26%,PTPRB;PTPN1;PTPN9;PTPRJ;PTPN12;DUSP3;PTPN13;UBASH3B;TNS2;DUSP16;DUSP22;PTPN11;PTPRQ;PTPN2;PTPN18;DUSP1;DUSP6
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.4309890497289223,-1.0442508220124502,0.41788321167883213,0.6459554462447213,1.0,5/11,19.59%,SLC30A10;PPARA;ABCB7;FYN;COA8
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.29674000436854914,-1.0441433788426218,0.3856893542757417,0.6458111664897102,1.0,21/47,31.57%,THBS1;TGFBR2;PRKCD;RAB27A;PLCG2;DHRS4;TP53;AGTR1;GRB2;SOD1;PDGFRB;ITGAM;GADD45A;RIPK1;ACE2;ADGRB1;SLC5A3;MAPK14;PID1;TGFB1;TLR6
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.25766515035420373,-1.0438855409731354,0.37285223367697595,0.6460230559372,1.0,38/109,27.30%,RAC1;TAB3;LYN;NFATC1;PSMA2;PAK2;PLCG1;NFKB1;PIK3R1;PSME2;JUN;MAPK1;PSMB4;PLCG2;FBXW11;MAPK8;PIK3CB;PSMC2;GRB2;GAB2;PSMB2;PSMB1;MAP2K4;TAB2;PSMA8;IKBKG;IKBKB;PSME1;PSMD4;VAV2;PSMA7;RELA;PSMD5;MAP3K7;PIK3CA;PSMB10;PSMA3;FCER1G
prerank,Fc receptor signaling pathway (GO:0038093),-0.2585580291803721,-1.0436111240212311,0.3712784588441331,0.6462393861083502,1.0,38/110,27.30%,RAC1;TAB3;LYN;NFATC1;PSMA2;PAK2;PLCG1;NFKB1;PIK3R1;PSME2;JUN;MAPK1;PSMB4;PLCG2;FBXW11;MAPK8;PIK3CB;PSMC2;GRB2;GAB2;PSMB2;PSMB1;MAP2K4;TAB2;PSMA8;IKBKG;IKBKB;PSME1;PSMD4;VAV2;PSMA7;RELA;PSMD5;MAP3K7;PIK3CA;PSMB10;PSMA3;FCER1G
prerank,regulation of protein transport (GO:0051223),-0.3409230206393822,-1.0435710724926865,0.42077464788732394,0.6459377836566907,1.0,11/27,22.24%,PTPN1;DNAJC1;RHBDF2;PPM1F;SCFD1;SNX12;LCP1;CHP1;NDEL1;WWP2;NDFIP2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.42017781782489205,1.0432933826122983,0.3978494623655914,0.8089918209907945,1.0,2/11,4.84%,CD177;CAMK4
prerank,histone H2B ubiquitination (GO:0033523),-0.4409700612202133,-1.0431260409022811,0.41788321167883213,0.6466148951510962,1.0,3/10,12.39%,DTX3L;RNF40;CDC73
prerank,regulation of TOR signaling (GO:0032006),-0.277553333813463,-1.0430890366370276,0.38545454545454544,0.6463095217695662,1.0,18/67,20.40%,SH3BP4;RICTOR;GNA12;GAS6;DDIT4;SEC13;MIOS;GSK3A;UBR2;PRKAA1;TTI1;RPTOR;LARS1;GOLPH3;UBR1;ITFG2;TMEM127;AKT1S1
prerank,phospholipid transport (GO:0015914),-0.29366337531398723,-1.0429496827382383,0.40545454545454546,0.64628046813699,1.0,14/52,20.94%,ATP10A;PITPNC1;ATP8B1;PLTP;SCARB1;MFSD2A;ATP10B;ABCA7;TNFAIP8L3;ATP9B;PCTP;PRELID2;OSBPL2;ATP11C
prerank,response to interleukin-6 (GO:0070741),-0.4369862927787417,-1.042264501375251,0.41530054644808745,0.6475318893139201,1.0,6/10,31.27%,ST3GAL6;NFKB1;RELA;PTGIS;PID1;SBNO2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3509492279939976,-1.0421313128272867,0.3833922261484099,0.6474583988415813,1.0,6/23,8.04%,GNB1;LRRK2;ABL1;KCNQ1;TGM2;MAPK1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.34436461657054074,-1.041965866290059,0.3985890652557319,0.6474833129841235,1.0,10/24,21.05%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3625344062789658,-1.0416718484534941,0.3931947069943289,0.6478279125060398,1.0,6/20,11.05%,PKD2;EGFR;CCND3;AKT1;CCNY;RGCC
prerank,negative regulation of secretion by cell (GO:1903531),0.3014103434222228,1.0413942036769062,0.3883720930232558,0.8132200296198023,1.0,8/38,11.31%,IL1RAPL1;SYT11;CHGA;CYP51A1;TRH;GRM7;IL12A;SYT4
prerank,regulation of protein dephosphorylation (GO:0035304),-0.3124833899883457,-1.0408307460356812,0.3822463768115942,0.6495093979300067,1.0,6/37,7.57%,PPP2R5A;MFHAS1;PPP1R2;PRKCD;SPPL3;CDH5
prerank,rRNA catabolic process (GO:0016075),-0.3877487008815117,-1.0406945547512765,0.4111310592459605,0.6494208573860734,1.0,7/16,25.27%,XRN1;EXOSC2;EXOSC3;EXOSC8;EXOSC5;PELO;EXOSC7
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3484159176816314,-1.0406390261934555,0.40337711069418386,0.6491557367550007,1.0,14/23,51.45%,GAS6;CEACAM1;TNFAIP3;IGF1;NLRP2B;CARD16;NLRP3;CD33;GIT1;NLRP12;GSTP1;APOA1;FFAR4;ZC3H12A
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4205365090201227,-1.0406170954910703,0.4040219378427788,0.6488123738236836,1.0,3/11,9.84%,NOS3;GCH1;AKT1
prerank,inner dynein arm assembly (GO:0036159),0.41983211465886155,1.0405389223134895,0.39869281045751637,0.8142213649811368,1.0,2/10,8.25%,DNAAF5;DNAAF1
prerank,DNA strand elongation (GO:0022616),-0.38019753068372153,-1.0404286725946807,0.41379310344827586,0.6488791266253275,1.0,10/18,26.13%,MRE11;MCM4;POLD3;GINS3;GINS1;DCLRE1B;TERT;RFC4;MCM3;MCM7
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3883236764388448,-1.0400657146190087,0.3954305799648506,0.6493024118699606,1.0,3/15,9.30%,SIK1;SCARB1;MFSD2A
prerank,skin development (GO:0043588),-0.2809073760513705,-1.0399278488875257,0.3758620689655172,0.6492437735362142,1.0,12/65,11.42%,ITGA6;BCR;ITGA3;LSR;COL5A1;ITGB4;ADAM9;MED1;COL5A2;HRNR;WNT16;TXNIP
prerank,cellular response to estradiol stimulus (GO:0071392),-0.37539600574829407,-1.039887261619112,0.39492753623188404,0.6489485301866346,1.0,5/18,15.76%,ESR1;NRIP1;EGFR;KAT5;RUVBL2
prerank,T cell activation (GO:0042110),-0.2752681593617479,-1.038992244863691,0.38045375218150085,0.650756069651702,1.0,35/69,41.00%,KIF13B;MSN;JAG2;NCK1;CTPS1;CASP8;PIK3CD;NCK2;LCP1;NHEJ1;ICOSLG;LMBR1L;CCL19;SOX4;PTPRC;DLL4;CD276;ADA;PTPN2;EIF2AK4;LFNG;PPP3CB;LAT;CD74;ZAP70;MDK;TNFRSF4;GATA3;GPR89A;GPR89B;CRTAM;LCK;IL4;CD28;CD44
prerank,amino acid transport (GO:0006865),0.2858657945944483,1.0389087202562353,0.39545454545454545,0.8177158538402094,1.0,9/49,9.62%,SLC7A11;SLC7A4;PDPN;SLC6A15;SLC7A8;SLC36A2;SLC7A14;SLC25A45;SLC7A6
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3203237258479517,-1.038898084638565,0.4,0.650587371618028,1.0,5/33,9.60%,LEF1;IL34;ACIN1;HAX1;CASP8
prerank,protein insertion into ER membrane (GO:0045048),-0.3075656583517117,-1.038478667557279,0.38104089219330856,0.6511632417846931,1.0,12/37,21.65%,APP;EMD;UBE2J2;SGTA;TRAM2;VAPA;EMC9;EMC2;EMC6;WDR83OS;UBL4A;VAMP2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.41274261990393646,1.0381398477240762,0.4166666666666667,0.8184526574145684,1.0,2/11,5.71%,GMNN;DONSON
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.22362222070442075,-1.0380103625163861,0.3493975903614458,0.6518599445828387,1.0,59/291,16.45%,DAB2IP;RAPGEF2;GNB1;FOXO1;PKD2;DAPK1;ESR1;LYN;NRIP1;SH3BP4;ATM;TBX1;MTOR;EGFR;PDE3A;ADAM9;FZD4;NFKB1;TNFRSF1B;PXN;IRS1;PDE2A;PDCD4;SLIT2;KCNQ1;IRGM;PRKCD;LBP;RAP1A;PTPRK;MEF2C;EZR;JUN;TGM2;MAPK1;RAP1B;PRKD1;CAPN2;AKT1;NFKBIL1;RAPGEF1;RPTOR;RHOA;IRAK1;CDC73;ACTB;LPL;TPM1;KAT5;WNT11;LARS1;MAPK8;P2RY6;TNFAIP3;IGFBP5;ROCK2;RUVBL2;AGAP3;CHMP5
prerank,regulation of protein autophosphorylation (GO:0031952),-0.31371137825769707,-1.0378981174771589,0.39469026548672564,0.651723375340491,1.0,6/36,7.85%,ENG;PPP2R5A;PDGFD;DDX3X;RASSF2;MRE11
prerank,post-translational protein modification (GO:0043687),-0.2206383911391096,-1.0378466512187365,0.3404605263157895,0.6514508962615935,1.0,109/332,30.55%,FBXL7;IGFBP7;ZBTB16;KLHL5;DCAF10;DCUN1D3;PTP4A2;FBXL12;APP;PSMA2;IGFBP4;RAB1A;CUL9;FBXL3;RAB2A;RBX1;GAS6;LMO7;CUL3;DCAF5;BMP4;PSME2;PDIA6;CUL2;WSB2;RAB5A;SPSB1;PSMB4;ADAM10;FEM1A;SOCS2;CUL7;FBXW8;KLHL13;ITIH2;LRRC41;PRKCSH;ANO8;CCDC8;NOTUM;FEM1C;MSLN;ASB1;FBXW11;KLHL25;BTBD1;PSMC2;HIF3A;IGFBP5;SERPINC1;FEM1B;UBE2M;ATG5;ERCC8;PSMB2;PSMB1;F5;DCAF13;RAB11A;PSMA8;KLHL3;EPAS1;PSME1;GPC3;ELOC;PSMD4;COPS7A;MFGE8;LAMB1;FN3KRP;PSMA7;KEAP1;CCN1;ASB7;CHRDL1;KTN1;WDR5;COPS8;PSMD5;RBBP5;FBN1;COPS4;FBXO32;PNPLA2;FBXL22;FBXO17;UBXN7;FBXO40;DTL;RABGGTB;PSMB10;RHBDD1;PSMA3;RAB38;TMEM132A;DNAJC3;ASB4;SCG3;KLHL41;NEURL2;FBXO31;DSCC1;ASB5;SUMF1;MBTPS1;OBSL1;LTBP1;AHSG;COPS5
prerank,transcription by RNA polymerase I (GO:0006360),-0.31692404073711955,-1.0377753963452856,0.4040590405904059,0.6512506083101515,1.0,13/34,28.41%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH
prerank,negative regulation of axon extension (GO:0030517),-0.3255340944817745,-1.0377705945695848,0.3900184842883549,0.6508652308869866,1.0,10/30,18.35%,SEMA6A;SEMA3C;SEMA7A;DIP2B;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,protein complex oligomerization (GO:0051259),0.26215910775107176,1.0375020824072128,0.3690205011389522,0.8188398816295354,1.0,7/85,4.27%,KCNC2;MPP2;GLRA3;MS4A1;C9;ADCY8;ATL1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.3700730589776223,-1.0372484864751563,0.41467889908256883,0.6517351881999262,1.0,4/18,13.15%,MFHAS1;ZCCHC9;GPATCH2;CHP1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.401182013279619,-1.0367908494962559,0.44014732965009207,0.6524274665867097,1.0,2/14,5.18%,DYRK1A;NIPBL
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2866441068276383,-1.036444658520766,0.39399624765478425,0.6528360165616863,1.0,35/61,40.60%,MNAT1;RB1;CDKN1B;CRLF3;CUL3;MAX;PLK2;CUL2;LATS2;CDK6;GSPT1;CACUL1;CCND1;CDKN2C;CDC25A;CCNE2;E2F3;KHDRBS1;PLK3;CDKN3;CCNH;HINFP;CDC34;CUL5;CDK4;CCNE1;EIF4EBP1;NASP;CCNA2;PPP6C;TRIM71;CDKN1A;ACVR1;USP37;CDKN2D
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.33778132660921184,-1.0362703872007757,0.38204225352112675,0.6528357868577352,1.0,13/25,33.18%,MTHFD1;ADK;AMPD2;HPRT1;AMPD3;PRPS2;ADA;PNP;GMPR2;APRT;SHMT1;DCK;GART
prerank,cellular response to copper ion (GO:0071280),-0.38496141325978395,-1.0362533903978535,0.41532976827094475,0.6524814115721047,1.0,10/16,35.95%,MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B;AQP1;MT3
prerank,protein autoubiquitination (GO:0051865),-0.281548759445402,-1.0362436069492638,0.3989169675090253,0.6521143849712592,1.0,20/61,24.35%,CNOT4;DTX3L;RNF213;CUL3;RNF115;UHRF2;SH3RF1;UBE2D3;RAD18;OBI1;ERCC8;TRIM13;RNF10;RNF4;WWP2;BRCA1;MDM2;SH3RF2;TRIM68;RNF146
prerank,prostaglandin metabolic process (GO:0006693),-0.3378605612167177,-1.0361122220188153,0.37924528301886795,0.6520184730574877,1.0,11/26,24.19%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;ACOX1;HPGDS;DAGLB;PTGR1;PNPLA8;PTGIS
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3909641477853631,-1.0360587650637243,0.42911153119092627,0.6517712851602316,1.0,4/15,12.39%,CUL3;STXBP4;PLCG2;CDC73
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.4396666391970552,-1.0360232599776509,0.41535776614310643,0.6514537377120855,1.0,6/10,26.59%,SMAD4;BRCA1;CHEK1;SMARCB1;RAPGEF3;HDAC5
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.382304684696968,1.0360090727260465,0.40589569160997735,0.821805811848604,1.0,6/15,15.14%,APOM;PLA2G3;LIPC;ABCA5;APOE;APOC1
prerank,carbohydrate biosynthetic process (GO:0016051),0.34592159853461024,1.0359619537456282,0.40987124463519314,0.8204093086096773,1.0,5/21,8.28%,B3GALT1;B3GALT4;FUT9;B3GALT5;ST6GALNAC5
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.3950704528863811,-1.035712235775181,0.4116541353383459,0.6518220038941747,1.0,2/14,6.02%,ENTPD1;ENTPD6
prerank,muscle cell differentiation (GO:0042692),-0.32236920073288977,-1.0355827809821927,0.3975694444444444,0.6517249655253973,1.0,8/32,12.80%,MRTFB;TBX1;SYNE1;MEF2C;TMEM204;CHRNB1;NEBL;SEMA4C
prerank,kidney development (GO:0001822),0.2728289633057458,1.0355101761752477,0.3972911963882618,0.8203213485234928,1.0,11/65,9.25%,ROBO2;MME;LHX1;OSR1;WT1;PAX2;HNF1B;VANGL2;PROX1;ARL3;VEGFA
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3623518172853716,-1.0349083786153315,0.3981981981981982,0.6525939201313374,1.0,5/20,12.25%,DLD;ACAD8;BCKDHA;ACADSB;SLC25A44
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3623518172853716,-1.0349083786153315,0.3981981981981982,0.6525939201313374,1.0,5/20,12.25%,DLD;ACAD8;BCKDHA;ACADSB;SLC25A44
prerank,cellular response to heat (GO:0034605),-0.31844711191087344,-1.0345274381117235,0.41360294117647056,0.6531214122747178,1.0,11/35,18.49%,THBS1;YWHAE;ANO1;CLPB;FGF1;SLU7;ATXN3;TCIM;TPR;SUMO1;TRPV4
prerank,inflammatory response (GO:0006954),-0.23408690297707663,-1.0344978098351338,0.3416666666666667,0.6527996073561617,1.0,91/195,41.27%,AFAP1L2;RAC1;MFHAS1;ADGRE5;NOD1;THBS1;F11R;NFATC4;CCL25;PARP4;LOXL3;HNRNPA0;NFKB1;GGT5;MAPKAPK2;HSPG2;PXK;PIK3CD;PTGFR;ADM;AGTR1;MGLL;HDAC4;CD40;ADCY1;TNFRSF1A;NOX4;ANXA1;NRROS;AOC3;IL10RB;CMKLR1;IKBKG;CCL19;IKBKB;LY75;CDO1;RELA;ACKR1;HMGB1;PTGDR;BMP2;HDAC5;F2R;LGALS9;IL22;CXCL10;IL2RA;HYAL3;NLRC4;TGFB1;STAT3;TLR6;VNN1;CEBPB;TLR1;C5AR2;NOS2;TLR5;LAT;CD14;IL1A;NLRP3;PTGER1;S100A9;TBK1;CCRL2;SIGLEC1;HPR;HP;PROK2;CXCL5;TLR2;CCL11;ITCH;CXCL1;CRP;PTGER4;TNFRSF4;CCL4;IL18;PTGER2;CRHBP;CCR1;IL4;PPBP;ABCF1;CD44;CCL8;TUSC2;CRH
prerank,mitotic nuclear membrane organization (GO:0101024),-0.2927163437276523,-1.0342891012859152,0.3853564547206166,0.6525156287690178,1.0,13/51,19.24%,EMD;AHCTF1;NUP98;SEC13;REEP3;CHMP4B;CHMP4A;LMNA;CHMP2B;CC2D1B;LBR;SUMO1;PPP2CA
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.2927163437276523,-1.0342891012859152,0.3853564547206166,0.6525156287690178,1.0,13/51,19.24%,EMD;AHCTF1;NUP98;SEC13;REEP3;CHMP4B;CHMP4A;LMNA;CHMP2B;CC2D1B;LBR;SUMO1;PPP2CA
prerank,iron ion homeostasis (GO:0055072),-0.2842203335807114,-1.033705498018038,0.3707052441229656,0.653469668563886,1.0,13/58,18.25%,ABCG2;SLC40A1;TFRC;BMP6;SCARA5;BDH2;PICALM;SMAD4;HFE;HMOX2;ABCB7;SOD1;FLVCR1
prerank,stem cell development (GO:0048864),0.37793434416072036,1.033596357963151,0.4174107142857143,0.8244764597775096,1.0,3/16,11.60%,NRG1;NOLC1;CDH2
prerank,amino acid transmembrane transport (GO:0003333),-0.29895110894245713,-1.033525873972612,0.38528896672504376,0.6535202092359712,1.0,7/45,7.79%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC38A11;SLC38A5;LRRC8D
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2670705843604238,1.033092608768832,0.3977272727272727,0.8244617461104284,1.0,19/69,17.26%,BCL2;TYRO3;CLN3;PTPRZ1;NTRK2;VSTM2L;GRN;PLA2G3;POU4F1;MAG;FZD9;NRBP2;CCL2;BDNF;FGF20;APOE;ADAM8;MSH2;RETREG1
prerank,regulation of lipase activity (GO:0060191),-0.4052690603993636,-1.0327727270917564,0.4184027777777778,0.6549150155384587,1.0,4/13,13.34%,PCSK5;RHOA;LPL;RHOC
prerank,JNK cascade (GO:0007254),-0.3052411648081169,-1.032677258959762,0.424408014571949,0.6547320674060252,1.0,15/40,24.79%,TAB3;NOD1;MAP3K5;MAP4K3;IRAK1;MAPK8;TNFRSF19;MAP2K4;TAB2;IRAK2;IKBKG;NOD2;SH2D3C;MAP3K7;GPS2
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3796706562261291,-1.0326284854008407,0.4261992619926199,0.6544708483346887,1.0,6/16,23.01%,SMAD4;BCOR;DNMT1;CTNNB1;BRCA1;WDR5
prerank,catecholamine biosynthetic process (GO:0042423),-0.41146728531563226,-1.0325656844809004,0.41901408450704225,0.6542274585365018,1.0,2/11,6.59%,TGFB2;GCH1
prerank,hyaluronan catabolic process (GO:0030214),-0.3696538973005393,-1.0324449305376553,0.40657439446366783,0.6541099462356099,1.0,9/18,32.00%,CEMIP2;FGF2;CHP1;HYAL2;LYVE1;HEXA;HYAL3;TGFB1;CEMIP
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4134928826913788,-1.0323544738188914,0.4363957597173145,0.6539218318934306,1.0,5/12,18.80%,STARD3;FDX1;FDXR;STARD3NL;STAR
prerank,regulation of cellular localization (GO:0060341),0.28872505193115167,1.0323531499727312,0.38105263157894737,0.8251414347631175,1.0,7/46,7.80%,ABCA12;BLK;NR1D1;EPHA5;MAP2;GSN;STXBP2
prerank,regulation of immune response (GO:0050776),-0.24593551223315638,-1.032286489326698,0.36252189141856395,0.6536936508529181,1.0,25/135,18.01%,FOXP1;ITGB1;XIAP;CD34;LYN;CD200;IL15;ICAM1;CLEC2D;BIRC3;SAMHD1;TGFB2;IRF1;CASP8;PVR;CSK;ITGA4;CD40;PLSCR1;ICAM2;N4BP1;GPR108;VCAM1;ZMPSTE24;ERAP1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.29253790726844087,-1.0322501507106632,0.39267015706806285,0.6533966038718908,1.0,22/52,28.11%,PAN3;TUT7;CNOT4;SAMD4A;EXOSC2;EXOSC1;EXOSC3;TUT4;PARN;PDE12;RC3H1;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;NT5C3B;CNOT2;EXOSC7;CNOT8;CNOT1;LSM2
prerank,respiratory system development (GO:0060541),0.3090742158358713,1.0322245050567136,0.39954853273137697,0.8239741650072973,1.0,7/32,9.25%,WNT7B;PDPN;WT1;PROX1;FGFR2;DNAAF1;VEGFA
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.38424270941442973,-1.0317408521431082,0.4207436399217221,0.6541933191051602,1.0,3/15,6.02%,ENTPD1;CMPK1;ENTPD6
prerank,neuron remodeling (GO:0016322),-0.441829379274732,-1.0314664837036502,0.4421052631578947,0.6544442237496307,1.0,3/10,5.32%,ANKS1A;APP;SCARF1
prerank,carbohydrate homeostasis (GO:0033500),-0.274694150570584,-1.031419892136011,0.36767317939609234,0.6541753215831455,1.0,9/67,10.64%,KLF7;IGF1R;INSR;TENT4B;ADIPOR2;IRS1;RBP4;HECTD4;PRKAA1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.34734547144698735,-1.0313187036965608,0.410958904109589,0.6540189170019375,1.0,10/23,34.01%,COX18;SAMM50;AGK;BCL2L11;HSP90AA1;TIMM10;TOMM70;PMAIP1;TIMM10B;TIMM13
prerank,cellular response to radiation (GO:0071478),-0.304664788932621,-1.0305609646635523,0.4045936395759717,0.6554042149435971,1.0,23/40,40.43%,NET1;SPIDR;TP53;NSMCE3;GRB2;LIG4;BLM;GADD45A;INTS7;INO80;KDM4D;RAD51AP1;GPR52;SWI5;MAPK14;EEF1D;RRH;OPN1MW;OPN1MW3;GPR88;RAD1;CDKN1A;SIRT1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2825780623154726,-1.0304356877827157,0.39267015706806285,0.655310100301542,1.0,18/61,21.85%,CAV1;PSMA2;PANK2;PPARA;SIRT5;PSME2;PSMB4;AZIN1;PSMC2;PSMB2;PSMB1;PSMA8;OAZ2;PSME1;NQO1;PSMD4;FGFR4;PSMA7
prerank,neural tube closure (GO:0001843),-0.3195008203373023,-1.03032246333802,0.4230769230769231,0.6551843204099412,1.0,10/34,18.67%,DVL3;LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI;MTHFD1L
prerank,glycogen catabolic process (GO:0005980),0.37651841634702343,1.029975955747222,0.3982102908277405,0.8294882050275063,1.0,7/15,18.43%,AGL;PHKG1;PYGM;PYGB;PGM2;PGM2L1;PYGL
prerank,apoptotic cell clearance (GO:0043277),-0.3264479333895037,-1.0287362821278117,0.4098939929328622,0.6585679857213201,1.0,14/30,28.28%,RAC1;RHOBTB1;THBS1;GAS6;TGM2;SCARB1;RHOG;RARA;ANXA1;ITGB3;HMGB1;ADGRB1;LRP1;TREM2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.23776226200401374,1.028212479931187,0.3832923832923833,0.8333643772997584,1.0,34/140,19.46%,HTR2C;C1QTNF1;ADCY8;CACNA2D1;CALCA;CACNA1A;PTGER3;CACNB3;GRM1;RYR2;TRPM1;C3AR1;CCR6;GPR65;GPER1;ADRA1D;ADRA1A;CIB2;TACR1;NMUR2;P2RX3;SLC8A1;DLG4;BDKRB2;P2RX5;TAC4;PDGFRA;LPAR4;GLP1R;CCKBR;CXCR4;F2RL2;CD24;PTGIR
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.24051819442852496,1.0280386243290944,0.3907766990291262,0.8323135656880183,1.0,25/142,12.48%,ATP1A2;HCRTR1;C1QTNF1;ATP2B4;ATP2B2;ADCY8;CALCA;CLN3;CACNA1A;PTGER3;SLC8A2;RYR2;C3AR1;CCR6;GPER1;TMEM178A;ADRA1D;ADRA1A;CIB2;TACR1;NMUR2;SLC8A1;HRC;DLG4;FZD9
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.41871904206360905,1.0278674622268205,0.42436974789915966,0.8312642300888196,1.0,2/10,9.30%,ATP1A2;ADRA2A
prerank,chondrocyte differentiation (GO:0002062),-0.3159036814795462,-1.0271927385231192,0.42857142857142855,0.661922691891701,1.0,15/32,33.22%,NFIB;BMPR2;BMP4;CREB3L2;MEF2C;SNX19;CCN3;EIF2AK3;BMP2;WNT2B;WNT5B;RUNX1;TGFB1;SULF1;WNT7A
prerank,regulation of cilium assembly (GO:1902017),-0.27692012523546916,-1.0268879701527545,0.4010600706713781,0.662244095225138,1.0,19/62,19.31%,LIMK2;TBC1D1;TBC1D2B;IFT140;CDK10;USP6NL;TBC1D30;TBC1D14;YAP1;CROCC;TBC1D22B;TBC1D22A;DYNC2LI1;ATG5;TBC1D20;FUZ;ARHGAP35;TBC1D8;TBC1D17
prerank,signal transduction by p53 class mediator (GO:0072331),-0.32543446994399833,-1.0265558667247616,0.40850277264325324,0.6626292754526049,1.0,8/30,19.63%,PPP1R13B;ACER2;FHIT;TP53;NDRG1;USP10;HINT1;ATRX
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.24080696199811447,-1.0265300491767515,0.3944153577661431,0.6622890618785625,1.0,53/152,26.87%,XIAP;RSPO3;UBR5;ADGRA2;CAV1;SMURF2;PSMA2;LRRK2;DDX3X;EGFR;CSNK1G3;TRPM4;NFKB1;LRRK1;MACF1;PSME2;PSMB4;PPM1B;AXIN2;ILK;CDC73;CSNK1G1;DKK2;CSNK1D;PLEKHA4;PSMC2;TNFAIP3;LYPD6;USP34;PSMB2;PSMB1;DAAM2;SKI;PSMA8;PSME1;SOX4;TBL1X;GPC3;PSMD4;TERT;CAPRIN2;PSMA7;AMER1;RSPO2;SFRP4;PSMD5;RNF146;SEMA5A;BMP2;WNT5B;PSMB10;FGF10;PSMA3
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.388298336790202,-1.0263800414158168,0.4363327674023769,0.6618682818338957,1.0,7/15,27.32%,TNRC6B;AGO2;TOB1;ZFP36L1;NANOS1;CNOT1;PABPC1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.388298336790202,-1.0263800414158168,0.4363327674023769,0.6618682818338957,1.0,7/15,27.32%,TNRC6B;AGO2;TOB1;ZFP36L1;NANOS1;CNOT1;PABPC1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3100604144589215,-1.0263552243829366,0.4232209737827715,0.6615411713761331,1.0,12/36,24.54%,EIF3H;TLK2;FHIT;RYBP;AQP11;HFE;N4BP1;GIPC1;USP7;OGT;TRIM39;TAF9
prerank,early endosome to Golgi transport (GO:0034498),0.41626516480935316,1.0261266941809453,0.42795698924731185,0.8350370681253958,1.0,4/11,14.68%,LMAN1;RAB6A;SURF4;TMED9
prerank,aorta development (GO:0035904),-0.3921339645430133,-1.0257347452682952,0.4306569343065693,0.662629282152053,1.0,6/14,9.23%,PKD2;TBX1;PDE2A;TBX2;HECTD1;ADAMTS9
prerank,microtubule anchoring at centrosome (GO:0034454),0.411211435076398,1.0256551128375606,0.42731277533039647,0.8349442727910069,1.0,6/10,19.04%,NINL;BBS4;KIF3A;CEP19;HOOK3;CCDC120
prerank,cardiac conduction system development (GO:0003161),-0.3407305264607655,-1.0254995921476864,0.3961267605633803,0.6628007682825989,1.0,11/24,30.26%,BMP4;SMAD1;MAML1;NOTCH2;SMAD4;HEY1;HEY2;MSX1;GJA5;MSC;HCN4
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.31636908930731544,-1.02541278471582,0.40414507772020725,0.6625939557772468,1.0,18/33,37.97%,ETS1;FOXO3;MED1;ABCB10;ACVR2A;TAL1;MTURN;ARNT;PRKDC;MAPK11;HSPA1B;MAPK14;STAT3;RAB7B;SCIN;HOXA5;HIF1A;FES
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3091700871108903,-1.0253785255887864,0.41454545454545455,0.6622919803883348,1.0,17/39,29.20%,MYH9;TJP2;FLNA;ILK;ACTN1;ACTB;PIK3CB;CLIC1;UBASH3B;FERMT3;ITGB3;VCL;TLN1;PLPP3;MYL9;RAP2B;MEGF11
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3386184608425291,-1.0251196321730147,0.41869158878504675,0.6621295548019879,1.0,4/23,3.33%,CREBBP;DAB2;THBS1;RNF111
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3386184608425291,-1.0251196321730147,0.41869158878504675,0.6621295548019879,1.0,4/23,3.33%,CREBBP;DAB2;THBS1;RNF111
prerank,negative regulation of bone mineralization (GO:0030502),-0.4008489931140254,-1.0249018369573286,0.44601769911504424,0.6622355879445968,1.0,7/13,30.46%,SRGN;TRPM4;BCOR;PTK2B;RFLNB;RFLNA;AHSG
prerank,negative regulation of reproductive process (GO:2000242),0.35827369267590436,1.0248252315552344,0.4046511627906977,0.8359467452361752,1.0,6/17,22.57%,SPINK13;NPPC;TIMP1;ACVR1C;GJA1;WDR77
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.41304020589993923,1.0248174339137486,0.44543429844098,0.8344238152819514,1.0,3/11,12.41%,ST18;GSN;HTRA2
prerank,negative regulation of transposition (GO:0010529),-0.381123679988736,-1.0245094310766667,0.4220665499124343,0.6628323970326504,1.0,7/16,30.80%,TUT7;UBR2;TUT4;MOV10;TDRD9;DDX4;MYBL1
prerank,regulation of inclusion body assembly (GO:0090083),-0.4156963860302124,-1.0242590041324977,0.4379432624113475,0.6630262763874311,1.0,2/11,8.03%,SNCAIP;DNAJB6
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3982533487947747,-1.0241324852605236,0.436077057793345,0.6629100134096527,1.0,9/13,46.26%,TRIM13;TRIM28;CHMP3;TRIM35;TRIM32;TRIM5;TRIM21;PML;MID2
prerank,regulation of centrosome cycle (GO:0046605),-0.3488540156340356,-1.0240294426133854,0.43320610687022904,0.6627699465894301,1.0,14/21,42.30%,CHMP4B;CHMP2B;CHMP5;PDCD6IP;CEP131;ATF5;CHMP3;CHMP1A;AURKA;PKHD1;CHMP1B;MARK4;SIRT1;NAT10
prerank,camera-type eye development (GO:0043010),0.3338022135538231,1.0229925626007121,0.42892156862745096,0.8384896296403384,1.0,6/25,9.25%,TENM3;EFEMP1;WT1;PAX2;TSKU;VEGFA
prerank,relaxation of muscle (GO:0090075),0.3911552367724701,1.0228882053472574,0.43340857787810383,0.8372452985702993,1.0,4/13,11.92%,ATP1A2;ATP1B1;GSN;SLC8A1
prerank,regulation of cilium movement (GO:0003352),0.42576732721615124,1.0225511833868444,0.41983122362869196,0.8367196314001407,1.0,3/10,9.18%,ODAD2;DNAAF1;CFAP43
prerank,regulation of adaptive immune response (GO:0002819),0.3652624420334113,1.0220989712523945,0.40757238307349664,0.8365486548107688,1.0,4/18,8.27%,SASH3;SAMSN1;TRIM27;ADCY7
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2639848504587805,-1.0215651154900278,0.40808823529411764,0.6682430630715681,1.0,18/79,18.59%,ST3GAL6;ST3GAL4;BMPR2;ST8SIA4;GCNT2;CSGALNACT1;ALG10B;DAD1;B3GNT2;ST3GAL2;CHST11;FUT10;B4GALT5;GAL3ST2;IGF1;GOLPH3;ST6GALNAC2;LARGE1
prerank,cellular response to ketone (GO:1901655),-0.30924121224293544,-1.020943469348023,0.426497277676951,0.6693494550470368,1.0,10/35,17.78%,GNB1;NR3C1;MSN;LARP1;PTGFR;NCOA4;KLF9;ROCK2;ADCY1;GOLPH3
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3765054076712475,-1.0206591420350646,0.41560798548094374,0.6696061527495263,1.0,5/16,19.59%,SLC30A10;PPARA;CEACAM1;ABCB7;COA8
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4087575392710704,-1.0201929797227545,0.4438687392055268,0.6699754223275965,1.0,6/11,29.59%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.4087575392710704,-1.0201929797227545,0.4438687392055268,0.6699754223275965,1.0,6/11,29.59%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.31314001168948513,-1.0201156050936464,0.42170818505338076,0.6697787751772567,1.0,7/34,14.34%,FOXO1;FERMT2;ASXL1;YAP1;ANKRD26;ZFPM1;TRIO
prerank,mitotic nuclear division (GO:0140014),-0.270511447211248,-1.0200164159053293,0.4258289703315881,0.6696158868697811,1.0,35/71,39.50%,EPS8;STAG1;CCDC61;TOGARAM1;PPP2R2D;WRAP73;SMC4;CHMP4B;FLNA;RHOA;ARHGEF10;STAG2;KIF11;RAB11A;DSN1;NDEL1;KIF3B;MISP;KIF18B;INO80;RAN;TUBG2;CDCA8;CEP192;MAP9;PLK1;MIS12;ESPL1;UBE2C;LSM14A;TPX2;TUBG1;SPICE1;NSL1;SMC3
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.40949851936675247,1.019052898423634,0.418013856812933,0.8442319582593307,1.0,3/10,6.03%,HECW1;OSR1;HECW2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3817202763194616,1.018779065683482,0.4427645788336933,0.8434905444100612,1.0,5/15,13.30%,PSMD10;PRELID1;TRIAP1;GHITM;CLU
prerank,positive regulation of cellular component movement (GO:0051272),-0.33883377480095433,-1.0181503929735036,0.43010752688172044,0.6736164729978482,1.0,4/24,3.35%,ETS1;LYN;NTN1;SPOCK2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.26904856736728655,-1.0181303996531246,0.42830188679245285,0.6732572923475277,1.0,32/78,28.41%,MNAT1;PKD2;EGFR;CDKN1B;CCND3;LATS2;AKT1;CCNY;RGCC;ACTB;TFAP4;CDK5RAP3;CCND1;CNPPD1;PTEN;NR2F2;BLM;CDKN2C;CDC25A;GADD45A;MYOCD;CEBPA;CCNYL1;CCNG1;CCNK;CCNE2;ADAM17;CDKN3;APC;CCNJ;CDKN2B;CCNH
prerank,regulation of cell communication (GO:0010646),-0.31242040465446974,-1.0180657648911908,0.40559440559440557,0.6730004281906794,1.0,9/35,17.80%,GRK5;IGFBP7;PTPN1;CRK;SOCS2;MGLL;NCLN;ANXA1;CASQ2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.33074432848428753,1.017951607228695,0.43018018018018017,0.8445599915578521,1.0,4/23,10.34%,NRG1;AKAP6;PROX1;MYLK3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.34528824333219793,-1.0175319942502121,0.44074074074074077,0.6738194695056374,1.0,14/24,38.67%,TENT4B;STN1;XRN1;CTC1;HNRNPA1;TERF2;PINX1;HNRNPU;TNKS2;PIF1;TNKS;DCP2;SLX4;ERCC4
prerank,protein homotetramerization (GO:0051289),0.2830108843613738,1.0173585015672038,0.4111111111111111,0.8448592211544893,1.0,11/49,15.30%,HCN1;SYCP1;RYR3;AQP4;GNMT;ACACA;ALDH1A2;GLS;GOLGA2;CBY1;TDO2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3337297276296458,1.01734662353313,0.43383947939262474,0.843358206628178,1.0,5/22,15.14%,PDE3B;BSCL2;ADRA2A;GPER1;APOC1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3806789186072047,1.0165042596590514,0.44110854503464203,0.8444244405753356,1.0,3/14,12.34%,LPIN1;ETNK1;CHKA
prerank,double-strand break repair via break-induced replication (GO:0000727),0.3947374920986018,1.0163900374540211,0.4223744292237443,0.8432576639222801,1.0,4/12,14.66%,GINS4;CDC45;MUS81;CDC7
prerank,cholesterol efflux (GO:0033344),0.3412075551489446,1.0162775161182467,0.41855203619909503,0.8420165478651375,1.0,8/20,22.89%,APOM;TSKU;ABCA5;APOE;APOC1;SOAT2;SOAT1;ABCG1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.29806366667566814,-1.0162759074422933,0.4336917562724014,0.6764242295726443,1.0,11/41,22.54%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188
prerank,Golgi ribbon formation (GO:0090161),-0.39865907043224624,-1.0162628411313297,0.4608540925266904,0.67605830881812,1.0,8/13,34.06%,VTI1A;MYO18A;TMED5;GOLPH3;TRIP11;FHDC1;STX6;VAMP4
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2976298859300112,-1.0157729365949313,0.4290909090909091,0.6768592918390921,1.0,11/41,22.54%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4172605063789346,-1.0143189028151118,0.43478260869565216,0.6799382803750255,1.0,5/11,20.96%,STX18;ATL2;VCPIP1;MOSPD3;LPCAT3
prerank,ganglioside biosynthetic process (GO:0001574),-0.38855045885692724,-1.0141966472543702,0.4622467771639042,0.6798177607189433,1.0,5/15,14.37%,ST3GAL1;ST8SIA4;ST6GALNAC3;ST3GAL2;B4GALT5
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3432407895662728,1.014196038327413,0.43400447427293065,0.8468691180773433,1.0,5/20,10.48%,ATIC;PAICS;AK3;ADSS2;ADSS1
prerank,regulation of gluconeogenesis (GO:0006111),0.3182769131515932,1.0137710677257703,0.4353448275862069,0.8466223826961317,1.0,7/27,17.19%,DGKQ;GCK;GNMT;DDB1;SIRT7;SELENOS;PGP
prerank,positive regulation of calcium ion import (GO:0090280),0.4068766072603762,1.0132719413043112,0.4392935982339956,0.8465494131926738,1.0,3/12,12.96%,STC1;SPHK2;CCL2
prerank,L-amino acid transport (GO:0015807),-0.3254203782904086,-1.0132136557380218,0.4384057971014493,0.6817395935757722,1.0,10/28,21.38%,SLC7A1;SLC7A5;SLC38A5;ARL6IP5;SLC36A4;PRAF2;SLC1A1;SLC7A2;SLC1A4;SLC3A2
prerank,nuclear membrane reassembly (GO:0031468),-0.2820555520941128,-1.0132015546571425,0.4185606060606061,0.6813679423276157,1.0,20/54,31.36%,EMD;AHCTF1;NUP98;SEC13;REEP3;CHMP4B;CHMP4A;LMNA;CHMP2B;CC2D1B;LBR;SUMO1;PPP2CA;NUP188;RAN;UBXN2A;CHMP3;UBE2I;CHMP6;NUP35
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3794304246618656,-1.0131481836309264,0.4446494464944649,0.6810906876410491,1.0,5/16,12.27%,PKD2;SIX1;FGF1;BMP4;FGF2
prerank,regulation of telomerase activity (GO:0051972),-0.29183438152880326,-1.0130483769237162,0.4387947269303202,0.6809350243394773,1.0,11/45,14.30%,KLF4;NEK7;ATM;PARP4;TCP1;MAPK1;TP53;HMBOX1;PNKP;PARN;PTGES3
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3649872364077675,-1.0126659510802278,0.45964912280701753,0.6814668262923783,1.0,4/18,7.39%,CTSC;MSN;VGLL4;EZR
prerank,L-serine metabolic process (GO:0006563),-0.41631576094167183,-1.0126606942364396,0.4329710144927536,0.6810814250215486,1.0,5/10,29.63%,SRR;SERINC3;SERINC5;PSAT1;SHMT1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.3758579610938364,-1.0125708363529364,0.4400749063670412,0.6809216091831969,1.0,6/16,19.55%,DTX3L;SHLD1;KMT5B;PNKP;MAD2L2;PRKDC
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.30859356057636256,-1.0125250003888242,0.4329710144927536,0.6806476306818249,1.0,17/34,34.14%,DAB2IP;MFHAS1;LYN;NFKBIL1;OTUD4;TNFAIP3;GPR108;GPS2;CD300LF;NLRP2B;TREM2;CACTIN;TICAM1;TLR6;RAB7B;CD14;LRRC14
prerank,intermediate filament organization (GO:0045109),0.36244386094645675,1.0122382487062898,0.4279379157427938,0.8482224361658087,1.0,5/17,16.91%,PKP2;BFSP2;TCHH;NEFL;VIM
prerank,intracellular protein transmembrane transport (GO:0065002),-0.30144807415360475,-1.0120162096710137,0.41831238779174146,0.6814887701240684,1.0,20/42,37.62%,PEX1;PEX7;TOMM40;TIMM17B;PEX14;DNAJC19;TOMM40L;TIMM50;PEX6;TOMM20;SEC61A1;TOMM70;SEC63;AIFM1;PEX26;DNLZ;TIMM23;PAM16;AKT2;ZFAND2B
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4056701957611116,-1.0118702824941974,0.44954128440366975,0.6814550016172302,1.0,4/12,20.64%,PPARA;NFKBIA;PPARG;ITGB3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.35627305147624566,-1.011808236164757,0.4264705882352941,0.6812091752146286,1.0,10/20,28.16%,BMP5;SIK1;ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3;BMP2;PRMT3
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.33127347783085076,1.011776641174705,0.4360730593607306,0.8480288696476805,1.0,8/26,14.47%,ABCA12;NR1D1;ADCY8;EPHA5;ADRA2A;PLA2G6;GPLD1;BRSK2
prerank,response to cholesterol (GO:0070723),-0.36726231181803964,-1.011474776057946,0.43278084714548803,0.6816356211815456,1.0,4/17,7.68%,SMO;TGFBR2;LRP6;SMAD2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.26259847888990046,-1.0112824491483101,0.45161290322580644,0.681715108123881,1.0,21/80,19.16%,ARF3;STX18;ARCN1;RAB1A;GOLPH3L;COPG1;SCFD1;KDELR3;COPA;KIF23;COPE;ERGIC2;KIF11;USE1;KIF15;ATP9B;KIF26A;LMAN2;GOLPH3;CENPE;KIF3B
prerank,peptidyl-proline modification (GO:0018208),-0.3331265653374605,-1.0111968303718435,0.44601769911504424,0.6815276361561997,1.0,7/25,17.30%,P3H2;NKTR;PPIG;OGFOD1;FKBP5;FKBP10;PPIF
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3866650350478683,-1.009843418669669,0.44482758620689655,0.6844307230529729,1.0,5/15,20.29%,KDR;VEGFC;IL16;CXCL12;F3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.26628408391441094,-1.0098068960555335,0.443859649122807,0.6841273454390538,1.0,22/74,23.68%,CREBBP;PSMA2;LIMD1;RBX1;PSME2;CUL2;PSMB4;NOTCH1;PSMC2;HIF3A;PSMB2;PSMB1;ARNT;PSMA8;EPAS1;CITED2;PSME1;ELOC;PSMD4;PSMA7;NFE2L2;PSMD5
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.2910482277293388,-1.009570896842449,0.41788321167883213,0.6843020856662594,1.0,15/46,26.25%,ZNF423;RB1;ID1;IL15;LAMA4;NOVA2;ADAMTS5;NOTCH1;ATF4;PCTP;ALDH1A1;ACVR2B;RHEB;ACOT11;ADAM17
prerank,peptidyl-arginine modification (GO:0018195),0.3732507506193825,1.0095045409298178,0.4151376146788991,0.8533794266276813,1.0,4/15,15.91%,PADI1;PADI2;PRMT5;ART4
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.2949923429298865,1.009371759333599,0.44724770642201833,0.8522650554772738,1.0,8/40,10.12%,MAGI2;VTN;BICD1;CD63;ATAD1;AHI1;VEGFA;SGIP1
prerank,myotube cell development (GO:0014904),-0.42468191934915256,-1.00908740359365,0.45518453427065025,0.6850634043088716,1.0,6/10,36.45%,SIX1;IGF1;SKI;CAV2;MYORG;ACTA1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3404638134836135,1.0087012824860764,0.4158878504672897,0.8528315817713555,1.0,6/20,16.04%,SLC25A23;PHB2;PMPCB;SLC8A3;MCU;SLC8B1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.25937000937185317,-1.008247806709777,0.44308231173380036,0.6866221391958912,1.0,36/86,33.06%,CREBBP;KLF2;PSMA2;LIMD1;RBX1;PSME2;CUL2;PSMB4;TP53;ATF4;PSMC2;HIF3A;PSMB2;PSMB1;GCN1;ARNT;PSMA8;EPAS1;PSME1;ELOC;PSMD4;PSMA7;CHEK1;MAPK7;NFE2L2;PSMD5;INO80;PSMB10;PSMA3;HMOX1;HIGD1A;DDIT3;STOX1;PSMD13;PSMB6;ATF3
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.431115057544431,-1.0081039517641457,0.47866419294990725,0.6865599661505668,1.0,6/10,36.67%,NT5E;NT5C1A;NT5C;UPB1;UPP1;DPYS
prerank,sister chromatid segregation (GO:0000819),-0.31649851784968064,-1.0080003565888556,0.4520547945205479,0.6864356269987276,1.0,15/31,39.08%,RB1;WRAP73;SMC4;DSN1;KIF18B;INO80;RAN;TUBG2;CDCA8;PLK1;MIS12;ESPL1;TOP2A;TUBG1;NSL1
prerank,ceramide biosynthetic process (GO:0046513),-0.29970691307299263,-1.007569015473014,0.42702702702702705,0.6870271184808436,1.0,11/40,16.85%,SGMS1;ST8SIA4;DEGS2;SGMS2;ST6GALNAC3;CERS4;AGK;SPTLC1;ASAH1;CERS5;SMPD2
prerank,phospholipid biosynthetic process (GO:0008654),0.2965364302930437,1.0075656099351078,0.4421768707482993,0.8547396687942287,1.0,10/36,13.87%,IDI2;FADS1;CLN3;HDHD5;FAR1;CPNE1;SPHK2;GNPAT;NUS1;IDI1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.25054655931744907,-1.0072604191835293,0.4237588652482269,0.6873941316845534,1.0,38/101,34.17%,DAB2IP;LYN;PRKCE;ADAM9;NFKB1;TNFRSF1B;PDCD4;IRGM;LBP;MEF2C;NFKBIL1;RHOA;IRAK1;MTDH;CDC73;MAPK8;TNFAIP3;CHMP5;DEFA6;NOD2;RELA;SERPINE1;CASP1;SHPK;HMGB1;CXCL10;AXL;CACTIN;MAPK14;TGFB1;LILRB1;SBNO2;TICAM1;TNIP2;CD14;IL1A;CARD16;NLRP3
prerank,maturation of LSU-rRNA (GO:0000470),-0.3312565230773741,-1.0069860232023553,0.44234404536862004,0.6876839737326118,1.0,8/26,22.79%,RPF1;RRP15;NOP2;RPL7A;RPL7L1;BOP1;PES1;ZNHIT3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.38799648385556146,-1.0067582316007955,0.44385026737967914,0.6878544071009758,1.0,5/13,21.29%,SORBS1;IRS1;GKAP1;IGF2;PTPN11
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3873588875745625,-1.0064402858730244,0.44567219152854515,0.6882298047272609,1.0,6/14,26.17%,JAK1;JAK2;SUMO1;IFNGR2;PTPN2;PARP9
prerank,regulation of protein kinase A signaling (GO:0010738),-0.3545995367638286,-1.0057940966395735,0.44901960784313727,0.689359268630053,1.0,5/20,15.33%,LRRK2;ADGRV1;TCIM;IAPP;MIF
prerank,diol biosynthetic process (GO:0034312),0.3649434332320139,1.0057689664931957,0.4377880184331797,0.8587644052655145,1.0,5/15,9.92%,QDPR;SPHK1;ACER1;ABCA2;SPHK2
prerank,regulation of bone mineralization (GO:0030500),-0.2778814129936573,-1.0055108557971575,0.4584837545126354,0.6896801362201589,1.0,21/55,24.99%,BMPR2;SGMS2;SRGN;TRPM4;BMP6;BMP4;MEF2C;ACVR2A;S1PR1;ADGRV1;ANO6;PKDCC;NOTUM;BCOR;BMP7;ANKH;PTK2B;CCN1;PTN;ACVR2B;BMP2
prerank,cellular response to amyloid-beta (GO:1904646),0.2999389552640138,1.0047760640520704,0.43237250554323725,0.8602244407326027,1.0,5/35,4.29%,GRM5;CDK5;CACNA2D1;GRIN2A;CACNA1A
prerank,vitamin transport (GO:0051180),0.31433112786394407,1.004775355970456,0.4434782608695652,0.8586965109977315,1.0,8/29,12.09%,CBLIF;PDPN;SLC46A1;SLC19A1;SLC2A10;GC;SLC2A8;SLC35F3
prerank,cellular response to osmotic stress (GO:0071470),-0.3434630953649041,-1.0047337877184503,0.47684391080617494,0.691173357839177,1.0,6/21,9.43%,PKD2;RCSD1;DDX3X;LRRC8D;ARHGEF2;MYLK
prerank,iron ion transport (GO:0006826),-0.28746815790371727,-1.00445914987474,0.46440677966101696,0.6914483844190233,1.0,11/47,14.16%,SLC40A1;TFRC;DNM2;STEAP3;SCARA5;ARHGAP1;HFE;ATP6V1E1;MCOLN1;REP15;ABCB7
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2782504862761836,-1.0043593814057654,0.42987249544626593,0.6913168626995185,1.0,13/56,18.97%,TAB3;NOD1;LBP;MAPKAPK2;PLCG2;ALPK1;IRAK1;S100A1;RPS6KA3;LGMN;TAB2;IRAK2;NOD2
prerank,amyloid-beta metabolic process (GO:0050435),-0.3741757667539706,-1.004014852534335,0.4519774011299435,0.6917348297933662,1.0,6/16,17.15%,DYRK1A;ACE;PSEN2;PSEN1;ABCA7;APH1A
prerank,sodium ion import across plasma membrane (GO:0098719),-0.36472318971882023,-1.003600481469104,0.43920145190562615,0.692393016983352,1.0,4/17,11.32%,SLC9A2;SLC12A2;TRPM4;SLC9A5
prerank,positive regulation of TOR signaling (GO:0032008),0.29157830405005125,1.0034677644267815,0.46436285097192226,0.8610563672223264,1.0,7/40,8.51%,GPR137C;PIP4P1;RRAGA;HDAC3;FLCN;KLHL22;SEH1L
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.4233312171028889,-1.0027573388185285,0.4678260869565217,0.6940512127275947,1.0,4/10,19.26%,RNF125;SEC14L1;GPATCH3;TKFC
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.42872763712285,-1.0024859265818769,0.4657039711191336,0.6942744183558287,1.0,5/10,30.28%,ATF4;HERPUD1;NFE2L2;EIF2AK3;DDIT3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4248430451111994,-1.0020396653447958,0.47294938917975565,0.6949554368498535,1.0,5/10,29.45%,PODXL;FERMT3;PIEZO1;ADA;WNK1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3309529102506271,1.0019978614309144,0.44988344988344986,0.8640975179109459,1.0,5/26,6.42%,ATP2B4;AKAP6;EFHB;CAMTA1;FHL2
prerank,organophosphate ester transport (GO:0015748),-0.33196833255619695,-1.0017989867555346,0.4444444444444444,0.6951503020520263,1.0,8/24,23.46%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;PCTP;PRELID2;OSBPL2;PITPNA
prerank,mitotic chromosome condensation (GO:0007076),-0.3239913790624911,-1.0010315149800628,0.45663716814159294,0.696671173987232,1.0,14/26,36.25%,RB1;SMC4;TENT4A;KMT5A;NCAPD2;MCPH1;NCAPH;NCAPH2;SET;TTN;CHMP1A;PLK1;CSNK2A1;CSNK2A2
prerank,monocyte chemotaxis (GO:0002548),-0.31023136625641995,-1.0009732124523782,0.45225225225225224,0.6964111783393572,1.0,3/32,5.33%,FLT1;CCL25;IL6R
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2897298709215871,-1.000644034769434,0.47007042253521125,0.6967874015970689,1.0,16/42,33.07%,RNASE7;IL6R;IRGM;LBP;RNASE3;DEFA6;DROSHA;SERPINE1;RPL30;ADGRB1;TREM2;SELP;MPEG1;TNFRSF14;NOS2;AQP1
prerank,negative regulation of ATPase activity (GO:0032780),-0.37149000795788906,-1.0001962317033342,0.4473684210526316,0.6974418878578427,1.0,4/16,18.24%,PXK;TP53;PPIF;PLN
prerank,vesicle transport along microtubule (GO:0047496),0.3251965888262666,1.0001703809479128,0.42757009345794394,0.8681733153952961,1.0,11/23,19.74%,CLN3;KIFAP3;KIF5A;KIF3A;DYNC1I1;KIF1C;HTT;TRAK2;BICDL1;HAP1;FYCO1
prerank,neural crest cell development (GO:0014032),-0.28912589788682647,-0.999712944839136,0.4413919413919414,0.6982099364774903,1.0,13/44,18.35%,SEMA6A;SEMA3C;CORO1C;SEMA7A;TBX1;PHACTR4;KLHL12;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,transcription by RNA polymerase III (GO:0006383),-0.32967806103133385,-0.9994150466566231,0.45753899480069327,0.6985483429607795,1.0,16/27,41.25%,IVNS1ABP;BRF1;ICE1;SNAPC1;SNAPC3;GTF3C4;POLR2L;POLR3GL;POLR3K;RO60;GTF3C3;GTF3C6;ELL;GTF3A;SNAPC5;POLR3G
prerank,ether lipid biosynthetic process (GO:0008611),0.4122360620132445,0.9984193969027152,0.44772727272727275,0.8722023421809459,1.0,6/10,17.56%,FAR1;GNPAT;DHRS7B;PEDS1;CHPT1;LPCAT2
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.40971240608863746,-0.9983205078092953,0.4729241877256318,0.7008028049145026,1.0,3/11,7.39%,DAB2;MSN;EZR
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.40088667434309866,0.9980845188254152,0.45394736842105265,0.8717246551055536,1.0,4/11,13.72%,DDX11;NOP53;IPPK;SIRT7
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.34718957023753455,0.9978166764225798,0.47465437788018433,0.8710284505030522,1.0,4/18,6.65%,MELTF;PDPN;DDR2;FSCN1
prerank,proteasome assembly (GO:0043248),-0.40954957220158816,-0.9977524434714645,0.46691176470588236,0.7017944165351704,1.0,7/11,32.21%,PSMG2;ADRM1;PSMD4;PSMD5;PSMG1;OTUD6B;PSMD13
prerank,regulation of neuron migration (GO:2001222),-0.32249578485949065,-0.9975528057679894,0.4663023679417122,0.7018934557964716,1.0,6/26,11.61%,DAB2IP;RAPGEF2;SEMA6A;NIPBL;ARHGEF2;PHACTR1
prerank,regulation of interleukin-4 production (GO:0032673),-0.34425616687717275,-0.9973195533844355,0.4740740740740741,0.7020681307389429,1.0,2/21,2.43%,LEF1;SLC7A5
prerank,ncRNA 3'-end processing (GO:0043628),-0.3776736767858911,-0.9972244415760338,0.4691358024691358,0.7018900382031603,1.0,8/14,30.25%,INTS8;INTS7;ELAC2;TOE1;TRNT1;INTS5;INTS12;SSB
prerank,mitochondrial translational termination (GO:0070126),-0.25247810386235303,-0.9971588448516276,0.474671669793621,0.7016552206732476,1.0,30/88,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MTRF1L;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;MRPS28;MRPS35;MRPL43;MRPL48;MRPL11;MRPS31
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.37445640228052235,-0.9971275348123955,0.4254937163375224,0.7013335267682379,1.0,3/15,8.91%,PPARA;ELOVL5;PPARD
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3909573546821342,0.9969336942155103,0.4606741573033708,0.8723325453097698,1.0,3/12,11.87%,LPIN1;VRK1;PRKCB
prerank,respiratory tube development (GO:0030323),-0.3159705940536519,-0.9967047844711988,0.46181172291296624,0.7019558243316978,1.0,9/28,14.01%,ITGA3;LOXL3;RBP4;FGF1;BMP4;PCSK5;FGF7;FGF2;ZIC3
prerank,protein O-linked glycosylation (GO:0006493),-0.24866643228035204,-0.9964525792070749,0.4606164383561644,0.7021421992919145,1.0,14/96,6.30%,EOGT;ST3GAL4;ST3GAL1;PLOD1;TMTC1;PLOD2;ST6GAL1;TRAK1;TMTC2;GALNT10;GXYLT2;B3GNT2;TET2;C1GALT1
prerank,positive chemotaxis (GO:0050918),-0.36160395749173685,-0.9964375385800208,0.48695652173913045,0.7017826706147737,1.0,8/17,32.78%,PTPRJ;FGF7;ANGPT1;SEMA5A;FGF10;MET;CORO1A;TSC2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.31913246141999324,-0.996389937199871,0.4782608695652174,0.7014860626277986,1.0,9/27,23.28%,DYRK1A;ATM;SPRED2;YJU2;KMT5A;MIF;HIC1;MDM2;MSX1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.40346635789191865,-0.9963819786581346,0.47058823529411764,0.7007108257896278,1.0,3/11,19.09%,NOTCH4;AGO2;TNRC6A
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.40346635789191865,-0.9963819786581346,0.47058823529411764,0.7007108257896278,1.0,3/11,19.09%,NOTCH4;AGO2;TNRC6A
prerank,response to growth factor (GO:0070848),-0.2931927730621967,-0.9956707747839602,0.4665461121157324,0.7020049518370336,1.0,12/41,22.03%,ACVRL1;KLF4;BMPR2;EMD;TGFBR2;ACVR2A;AKT1;HDAC6;CTNNB1;EPHA2;MAPK7;NOS1
prerank,regulation of leukocyte migration (GO:0002685),0.36778399251431265,0.9954607954933842,0.4602803738317757,0.8752220441760196,1.0,4/16,9.25%,TNFSF18;HOXA7;CD81;VEGFA
prerank,melanosome organization (GO:0032438),-0.3211692889140421,-0.9952124632715247,0.4551971326164875,0.7027154663558848,1.0,7/26,21.54%,HPS4;BLOC1S5;SHROOM2;AP1G1;RAB32;AP3B1;KIF13A
prerank,regulation of protein metabolic process (GO:0051246),-0.29189487531771013,-0.9951271326480498,0.4679715302491103,0.7025230656090551,1.0,14/44,22.89%,KLF4;NEDD4L;KLF2;APP;ACE;SPOPL;LTBP4;MAPK8;ROCK2;ABCA7;SPOP;MDM2;MAPK7;MTPN
prerank,mesoderm development (GO:0007498),-0.3577646404088574,-0.9950369564184438,0.4592198581560284,0.7023444879856752,1.0,4/18,11.47%,TIE1;TBX1;BMX;JAK2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3760235408753496,-0.9949108863113516,0.4597495527728086,0.7022555771326904,1.0,5/15,19.64%,APP;VBP1;PSEN1;IAPP;PFDN6
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.31890442350625087,-0.9946860279762154,0.4472168905950096,0.7023978158519844,1.0,12/30,29.10%,HPS4;GSK3A;UBE2J2;UBE2D3;UBE2L3;BAP1;NPEPPS;HUWE1;FZD5;SAE1;ARIH2;RNF31
prerank,ceramide metabolic process (GO:0006672),-0.2824557777461311,-0.9943766413346616,0.48807339449541287,0.7027264892060603,1.0,16/49,20.08%,SGMS1;ACER2;DEGS2;SGMS2;ST6GALNAC3;CERS4;ACER3;AGK;ORMDL1;SPTLC1;ASAH1;CERS5;SMPD2;PPP2CA;DEGS1;ORMDL3
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.283369695920084,-0.9942675094885551,0.45601436265709155,0.7025846391168157,1.0,12/47,16.68%,RAPGEF2;CAV1;CD34;SIK1;NFKB1;ACADL;CEACAM1;ERLIN2;ACADVL;ROCK2;C1QTNF3;FYN
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.3514876485275339,0.9941094576224693,0.46284501061571126,0.8778571682757292,1.0,4/19,6.12%,HS6ST3;HS3ST5;NDST4;HS6ST2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3345204655746414,0.9940716801548585,0.45045045045045046,0.8764476264000173,1.0,6/23,12.61%,PKP2;PROX1;FGFR2;IRX3;TNNC1;MYL2
prerank,detection of mechanical stimulus (GO:0050982),-0.34899300873524536,-0.9936106041789905,0.4655493482309125,0.703757641013598,1.0,9/19,31.64%,PIEZO2;PKD2;PTK2;CTNNB1;PKD2L1;PIEZO1;TTN;JUP;LHFPL5
prerank,regulation of interferon-beta production (GO:0032648),-0.28113656725202735,-0.9935432103826879,0.4702886247877759,0.7035268704407346,1.0,23/46,36.11%,IFIH1;TRIM56;DDX3X;IRF1;PPM1B;FLOT1;POLR3F;MAVS;PTPN11;RNF216;HSP90AA1;YY1;DHX9;IRF7;RIOK3;CACTIN;TOMM70;LILRB1;IRF5;POLR3A;TBK1;TLR2;TLR8
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.23756577126984188,0.9930964073191068,0.4439461883408072,0.8780497533008964,1.0,20/110,10.78%,ADGRB3;ADGRL3;ADCY8;CALCA;GNAL;GPR101;ADGRG4;CNR1;PTGER3;ADRA2C;PF4;ADCY7;ADRB3;ADRA2A;GPR65;TSHR;GPER1;LGR5;ADRA1D;ADRA1A
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.21944955706484037,-0.9921998083441557,0.4826989619377163,0.7064263970549638,1.0,82/264,27.75%,SRSF11;CDK13;PRPF3;METTL14;SMU1;PSPC1;CWF19L2;RSRC1;HNRNPA0;RBM5;NOVA2;HNRNPR;UPF3B;FUS;PRPF6;SF3B6;SPEN;RBM19;HNRNPM;POLR2G;PHF5A;DDX39B;SF3B1;PUF60;PRPF31;CPSF7;SNIP1;HNRNPA3;HNRNPUL1;EFTUD2;DHX38;DBR1;HNRNPF;SFPQ;SLU7;CTNNBL1;SNRPE;SCNM1;SF3A1;TGS1;HNRNPA1;SYNCRIP;SRSF12;SRPK2;CWC25;RBM4B;ZMAT5;BUD13;CD2BP2;FIP1L1;TFIP11;SRRM1;NONO;RNPS1;SRSF3;STRAP;SRSF10;TRA2B;LSM3;RBM6;CWC22;PPIH;COIL;RBM15;PCBP1;POLR2C;GEMIN7;USP39;RNPC3;PDCD7;SF3B5;GCFC2;DHX9;POLR2L;PRPF40B;POLR2H;HNRNPL;HNRNPD;PABPC1;HNRNPU;SCAF11;TXNL4A
prerank,response to cAMP (GO:0051591),-0.30039842911675085,-0.9921537594206674,0.4749536178107607,0.7061309395593056,1.0,8/37,11.03%,RAPGEF2;PKD2;PDE2A;KCNQ1;RAP1A;EZR;RAP1B;RAPGEF1
prerank,fibrinolysis (GO:0042730),0.37798321280418495,0.9920070242273559,0.43559718969555034,0.879858502292192,1.0,1/13,1.24%,CPB2
prerank,negative regulation of signaling (GO:0023057),0.3231288523476547,0.9918969536179688,0.45,0.878669208958892,1.0,3/25,3.44%,OPRM1;IGFBP3;GLRA1
prerank,translational elongation (GO:0006414),-0.2445248573423473,-0.9918701996811593,0.4585537918871252,0.706401552816793,1.0,35/101,27.22%,DAP3;LTN1;PTCD3;MRPL32;MRPL47;EEF2;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;NEMF;MRPS28;MRPS35;MRPL43;MRPL48;TUFM;EEF1B2;MRPL11;MRPS31;EEF1G
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.3552071795906558,-0.9918001743873917,0.49016100178890876,0.7061669702552535,1.0,9/18,26.59%,HDAC1;GSK3A;NOTCH1;HDAC4;CCN3;FRS2;FZD7;BMP2;HDAC5
prerank,DNA recombination (GO:0006310),-0.29716001444478074,-0.9916163971212649,0.4681238615664845,0.7062116448996346,1.0,18/37,35.33%,DMC1;MRE11;RAD54B;RPA1;HDAC10;WRN;RAD54L;LIG4;BLM;MSH3;HMGB1;EXO1;XRCC2;RAD51D;TSN;RAD50;ENDOG;RAD52
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.26810986988069185,-0.9916046054886877,0.46258503401360546,0.7058479701569068,1.0,21/65,26.87%,FBXL7;PSMA2;RBX1;PSME2;NABP1;PSMB4;INTS3;PSMC2;PSMB2;PSMB1;PSMA8;CDK5RAP3;PSME1;PSMD4;PSMA7;CHEK1;FHL1;PSMD5;PINX1;PSMB10;PSMA3
prerank,catecholamine metabolic process (GO:0006584),-0.38062675598763623,-0.9915084857240122,0.4762773722627737,0.7056951359044027,1.0,1/14,1.18%,SNCAIP
prerank,negative regulation of double-strand break repair (GO:2000780),-0.30971317021820877,-0.9913702862208303,0.47653429602888087,0.7056227621085794,1.0,8/30,19.48%,UBR5;RNF169;SHLD1;TRIP12;OGG1;CGAS;MAD2L2;TFIP11
prerank,leukotriene biosynthetic process (GO:0019370),-0.3806747658714919,-0.991173223480962,0.4857142857142857,0.705683973859374,1.0,2/14,5.88%,PLA2G4A;GGT5
prerank,tricarboxylic acid metabolic process (GO:0072350),0.39371822473981277,0.9911631259125966,0.452914798206278,0.8794099082667098,1.0,7/12,24.08%,ACLY;ACO1;IDH3A;GLUD1;ACO2;SIRT4;IDH2
prerank,oligodendrocyte development (GO:0014003),0.3601516337218335,0.9911391789268204,0.4469525959367946,0.8779701513916804,1.0,5/15,16.50%,MYRF;PLP1;TPPP;EIF2B1;B4GALT6
prerank,peptidyl-threonine modification (GO:0018210),-0.2628471693277583,-0.99091683272919,0.4596622889305816,0.7058679014915354,1.0,21/66,19.55%,DYRK1A;GSK3B;LRRK2;PRKD2;TGFBR2;PRKCD;CDK10;CDC42BPA;MAPK1;ROCK1;PRKD1;GSK3A;AKT1;GALNT11;MAPK8;MARK2;ROCK2;HIPK1;CDC42BPB;GALNT1;PRKDC
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.38763604988510525,-0.9908413329741798,0.4689265536723164,0.7056593592668977,1.0,5/13,22.46%,NOS3;GCH1;AKT1;MTHFD1L;HSP90AA1
prerank,negative regulation of transferase activity (GO:0051348),-0.3220273215214595,-0.9903913466362024,0.4636363636363636,0.7062989465747792,1.0,7/28,11.55%,GSK3B;DTX3L;CDKN1B;ABL1;GSK3A;TP53;SMAD7
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.2980046752922211,-0.9903901686310254,0.4748603351955307,0.7059082994637425,1.0,15/38,29.10%,LRRK2;HPS4;GSK3A;HAX1;UBE2J2;UBE2D3;UBE2L3;BAP1;NPEPPS;HUWE1;FZD5;SAE1;ARIH2;BAG4;RNF31
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.32912412630916343,-0.9903022016259253,0.4936936936936937,0.705713538026663,1.0,8/24,24.65%,POLD3;RPA3;RPA1;RPA2;LIG4;RFC4;RFC1;LIG1
prerank,ureteric bud morphogenesis (GO:0060675),-0.3711033009329334,-0.9901591930889719,0.4652014652014652,0.705659129925663,1.0,5/16,13.26%,PKD2;SIX1;BMP4;FGF2;WNT11
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2295442374205217,-0.9900381817743503,0.46286701208981,0.7055503150992031,1.0,47/171,21.85%,TTC28;AFAP1L2;RB1;NEK7;BTG3;IQGAP1;CDK13;APP;PSMA2;SIK1;NEK6;CUL9;CDKN1B;RNF40;CDK10;PSME2;PSMB4;USP2;ERCC2;TAL1;CUL7;PTPN3;CDC16;ANAPC16;DUSP3;CCDC8;XPC;PKN2;ERCC3;PSMC2;FOXC1;BTG2;PSMB2;SMOC2;LGMN;PSMB1;TFAP4;PSMA8;CDK5RAP3;PSME1;BUB1B;CDK11B;ANGEL2;PSMD4;MDM2;BUB3;PSMA7
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.33127862065968805,-0.9898183945650899,0.48440366972477067,0.705716633988592,1.0,7/24,20.39%,ABCG2;ALAS1;ABCB10;SUCLA2;FLVCR1;COX10;RSAD1
prerank,positive regulation of T cell activation (GO:0050870),-0.26743393710503494,-0.9895724664022364,0.4955595026642984,0.7059180971227138,1.0,12/62,19.32%,ZMIZ1;SLC7A1;IL15;IL6ST;TFRC;NCK1;NCK2;VCAM1;ANXA1;CCL19;NOD2;PTPRC
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3566292437542486,-0.9891174034695794,0.46415770609318996,0.7066030756851619,1.0,3/18,11.38%,SLC2A1;OCLN;BRAF
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.33824198748459366,0.9889311543907773,0.4608501118568233,0.8832254396306184,1.0,3/19,6.49%,BPNT2;SULT2B1;SLC35B2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3262792641309835,-0.9874723869169534,0.47957371225577267,0.7101415356636057,1.0,6/26,13.89%,ADIPOR2;ELOVL5;ACADL;CEACAM1;ERLIN2;ACADVL
prerank,phospholipid catabolic process (GO:0009395),-0.3280248612380342,-0.9873809885108619,0.4422735346358792,0.7099853905832205,1.0,4/24,13.54%,GPCPD1;PLA2G4A;GDPD1;GDPD3
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3012210595151271,-0.987273667867692,0.4783362218370884,0.7098611442504125,1.0,5/36,6.54%,SPTBN1;RAB7A;GOLPH3L;AFDN;MACF1
prerank,protein targeting to mitochondrion (GO:0006626),-0.2799610513340928,-0.9871529256522843,0.48928571428571427,0.709736330963089,1.0,22/52,36.31%,SAMM50;TOMM40;BCAP31;AGK;IMMP1L;TIMM17B;TOMM5;DNAJC19;TOMM40L;HSP90AA1;TIMM50;TIMM10;PMPCA;IMMP2L;TOMM20;TOMM70;TIMM10B;AIFM1;TIMM13;DNLZ;TIMM23;PAM16
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.24960732905114397,-0.9867044526797535,0.4752136752136752,0.7103905380647623,1.0,21/88,16.80%,DAB2IP;TRABD2B;MPP7;GSK3B;RAB7A;STX18;TFRC;SPIDR;CDH5;TAL1;RGCC;FNIP2;ICE1;SYNPO2;FLOT1;RHOC;SLF2;TPR;BCL2L11;BMP7;SUMO1
prerank,protein targeting (GO:0006605),-0.24047479621818998,-0.9863476282602149,0.4966216216216216,0.7108673563168176,1.0,58/118,39.54%,PARD3;RASSF9;PEX1;KIF13B;TRAK1;ZDHHC6;ZDHHC3;HPS4;AQP11;SRPRA;FUT10;TOMM40;BCAP31;GABARAP;ZFAND6;TIMM17B;TOMM5;SRP14;AP4M1;LAMP2;GIPC1;DNAJC19;ZDHHC1;AP4B1;ZDHHC4;HOMER3;PEX6;ZFAND2A;ZDHHC12;RAB3IP;TIMM10;TOMM20;SEC61A1;ATG3;VPS37B;TOMM70;HACL1;PEX19;RTP4;GOLGA7B;LONP2;ZDHHC9;SEC63;TIMM10B;ZDHHC22;TIMM13;NCF1;VPS37C;TIMM23;ICMT;YIF1B;RABGEF1;ZFAND2B;CDC37;TAOK2;AIP;LTBP2;RTP3
prerank,regulation of response to oxidative stress (GO:1902882),0.39641462699668717,0.9859933459696572,0.47558386411889597,0.8906024524999957,1.0,6/11,27.55%,ALOX5;SELENON;ACOX2;GGT7;AIFM2;PINK1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3180032632465256,-0.9855986087674445,0.4607142857142857,0.7122405514826434,1.0,14/26,35.99%,BIRC3;IRF1;NFKBIL1;OTUD4;FLOT1;GPR108;GPS2;IRF7;NLRP2B;TREM2;CACTIN;TLR5;LRRC14;TLR2
prerank,histone H2A ubiquitination (GO:0033522),-0.3578922678607078,-0.9847327436075903,0.46964285714285714,0.7139145466501453,1.0,6/17,19.04%,DTX3L;RYBP;UBR2;RNF168;BCOR;RNF2
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.31450823692009955,-0.984632567661615,0.483695652173913,0.7137744878370116,1.0,12/28,24.52%,CLIP1;RAC1;TOGARAM1;OCLN;DCTN1;SLAIN2;DRG1;MECP2;RPS3;AKAP9;ARL2;HSPA1B
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.31372816110368484,-0.9845141537746878,0.5045045045045045,0.713648629481606,1.0,8/31,14.78%,PARD3B;PARD3;MSN;DLG1;EZR;RHOA;MTCL1;MARK2
prerank,negative regulation of response to external stimulus (GO:0032102),-0.24211199391979812,-0.9844134396902575,0.45390070921985815,0.7135004491938605,1.0,24/105,15.91%,TEK;RB1;KLF4;MFHAS1;CRK;PPARA;OTULIN;NMI;PRKCD;CDH5;EPHA4;PPARD;PPM1B;FEM1A;NFKBIL1;FGF2;DUSP3;RTN4RL1;TRAF3IP1;TNFAIP3;ILRUN;CCN3;C1QTNF3;TNFRSF1A
prerank,response to muscle stretch (GO:0035994),0.36416868243765704,0.9842243786316812,0.46255506607929514,0.8944754670296581,1.0,4/15,11.92%,GSN;RYR2;CDH2;SLC8A1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.32938090548945237,0.9841192164874606,0.44880174291938996,0.8932755736134996,1.0,7/22,18.98%,CYP24A1;GC;CBR1;ALDH1A2;LRAT;CYP1A1;RBP1
prerank,cellular response to peptide (GO:1901653),-0.2739291639939473,-0.9840827751777942,0.45636363636363636,0.7139311817315389,1.0,16/56,16.68%,IGF1R;CAV1;NOD1;GSK3B;APP;ICAM1;EPHA4;ARHGEF2;TP53;PSEN1;ITGA4;LGMN;IGF1;CHMP5;VCAM1;FYN
prerank,glucose homeostasis (GO:0042593),-0.2534583015027504,-0.9840348367887464,0.5167548500881834,0.7136280598441506,1.0,10/83,8.47%,KLF7;IGF1R;FOXO1;INSR;ADIPOR2;PIK3R1;IRS1;RBP4;LRRC8D;HECTD4
prerank,histone H4 deacetylation (GO:0070933),-0.4122143923595828,-0.9837870572525883,0.4956063268892794,0.7138031775819748,1.0,4/10,19.54%,RCOR1;HDAC1;HDAC4;SMARCAD1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.31650213054935733,-0.9835059167234698,0.4855072463768116,0.7141090689350849,1.0,12/28,24.03%,EGFR;NOTCH3;ZBTB7A;ARRDC1;AKT1;TCIM;HEY1;GATA2;RITA1;WWP2;DLL4;ARRB1
prerank,positive regulation of response to stimulus (GO:0048584),-0.29258894537339886,-0.9833469153903287,0.4946236559139785,0.7140877375793284,1.0,13/40,25.38%,IFIH1;IL15;TGFB2;PRKCD;YPEL3;ILK;ABI3;CGAS;MAVS;NSMCE4A;TAF9;DHX9;FXR1
prerank,glucose import (GO:0046323),-0.3909490859487855,-0.982965282183541,0.5044091710758377,0.7145988138904633,1.0,3/13,11.66%,SLC2A1;RAB4B;SLC27A4
prerank,cellular respiration (GO:0045333),0.2873003907724191,0.9829309508298516,0.45253863134657835,0.8954463263921952,1.0,17/41,27.03%,SLC25A13;UQCR10;NR4A3;UQCRH;SDHA;NDUFA5;NDUFS8;LYRM7;NDUFS7;MDH2;UQCRB;ME3;MTLN;PPARGC1A;OXA1L;MTFR1L;NDUFS1
prerank,melanocyte differentiation (GO:0030318),-0.4031541274725977,-0.9827976226711271,0.4866412213740458,0.7146688320052387,1.0,3/11,9.66%,MITF;MEF2C;USP13
prerank,apoptotic mitochondrial changes (GO:0008637),0.2972737073763483,0.9825451979855957,0.46756152125279643,0.8951553428747031,1.0,3/32,3.75%,ERBB4;BCL2;GGCT
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.30855397448118277,-0.9821087063967677,0.47900763358778625,0.7159826660931911,1.0,9/32,17.12%,NEK7;ATM;TCP1;MAPK1;HMBOX1;PNKP;PARN;HNRNPA1;CTNNB1
prerank,regulation of embryonic development (GO:0045995),-0.29662766249856953,-0.9813536296465929,0.5072992700729927,0.7173823612616318,1.0,7/34,10.19%,INSR;SOX17;NIPBL;PLCB1;RBM19;TRIP12;EHMT1
prerank,primary alcohol metabolic process (GO:0034308),-0.3267229360474666,-0.9810135453321792,0.4855072463768116,0.7177781214009519,1.0,9/25,26.70%,RBP4;RDH10;NAPEPLD;GDPD1;GDPD3;IGF1;RETSAT;CYP1B1;GDE1
prerank,fatty acid beta-oxidation (GO:0006635),-0.2777183323584699,-0.9808985609849961,0.5063291139240507,0.7176627556628377,1.0,10/51,17.47%,HADHB;ABCD3;BDH2;PPARD;ACADL;ACAD11;CRAT;ACADVL;ACOX1;ACOX3
prerank,regulation of interleukin-6 production (GO:0032675),-0.24765103203949748,-0.980840604374869,0.49225473321858865,0.7173969031315373,1.0,36/96,36.11%,AFAP1L2;CD200;IFIH1;APP;IL6R;GAS6;LBP;MAPKAPK2;ARHGEF2;PLCG2;LPL;IL17RA;TNFAIP3;C1QTNF3;IL16;MAVS;HYAL2;NOD2;PTPN11;ARRB1;HMGB1;DHX9;F2R;LGALS9;TREM2;STAT3;TLR6;TLR1;C5AR2;NOS2;RAB7B;IL1A;TSLP;CD74;TLR2;TLR8
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3177611701972624,0.9805091667294771,0.4988066825775656,0.8999606793000748,1.0,8/25,16.74%,RIT2;PLEK;SLC8A2;MAPT;P2RX3;P2RX5;HTT;CDH13
prerank,amide biosynthetic process (GO:0043604),-0.2807637535856956,-0.9802379480467301,0.4808743169398907,0.718447789218957,1.0,11/47,16.85%,SGMS1;DEGS2;SGMS2;CERS4;PAM;PCSK5;AGK;SPTLC1;ASAH1;CERS5;SMPD2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.26453954920622347,-0.980018141140602,0.4973637961335677,0.7185816004479899,1.0,15/63,19.32%,SLC7A1;IL15;IL6ST;TFRC;CD38;NCK1;MEF2C;NCK2;CD40;MIF;VCAM1;ANXA1;CCL19;CLCF1;PTPRC
prerank,glucan catabolic process (GO:0009251),0.3617596267193417,0.9799807910435484,0.4722222222222222,0.9000861247847173,1.0,7/15,18.43%,AGL;PHKG1;PYGM;PYGB;PGM2;PGM2L1;PYGL
prerank,histone exchange (GO:0043486),0.2879625869288178,0.9799149846158116,0.4646924829157175,0.8987349124015772,1.0,12/37,20.27%,SMARCA5;CENPS;ACTR6;MIS18BP1;OIP5;RUVBL1;RNF8;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,engulfment of apoptotic cell (GO:0043652),-0.37342161663886125,-0.9786850706768095,0.5097690941385435,0.7213647694228316,1.0,3/15,2.75%,RAC1;RHOBTB1;THBS1
prerank,regulation of myoblast differentiation (GO:0045661),-0.3057896192430414,-0.9786296638561831,0.49119718309859156,0.7210898201164434,1.0,16/32,31.54%,BOC;PLCB1;BMP4;MEF2C;NOTCH1;SMYD1;TBX3;RBM24;EID2B;ZFP36L1;LRRC8A;KLHL41;MAPK14;TGFB1;XKR8;SOSTDC1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3445622127691047,-0.9785726828052558,0.49514563106796117,0.720827688261559,1.0,7/21,27.01%,KDR;MAPK1;IGF1;CTSH;ZFP36L1;FGF10;LGALS9
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3006205127886317,-0.9780171477103263,0.4882943143812709,0.7217820886493754,1.0,7/35,12.19%,GHR;CAV1;CRLF3;HES1;DOT1L;JAK2;NOTCH1
prerank,histone deubiquitination (GO:0016578),-0.3470596852014326,-0.9780045943847421,0.47504621072088726,0.7214198400460903,1.0,7/18,23.18%,UIMC1;TRRAP;USP15;BRCC3;USP7;ATXN7;USP16
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.343072620634181,0.9779982997625091,0.47555555555555556,0.9029986950506187,1.0,2/17,5.75%,MAGI2;CALM2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3050935551893303,0.9779114859640472,0.4840182648401826,0.9017217448028189,1.0,5/26,5.58%,PFN2;SHANK1;PLEK;LIMK1;PFN1
prerank,positive regulation of transmembrane transport (GO:0034764),0.3731033639927722,0.9777785559250369,0.48394004282655245,0.9006303510912511,1.0,4/13,10.51%,CA2;NR4A3;C2CD5;AZIN2
prerank,response to chemokine (GO:1990868),-0.3838696909006106,-0.9773367789692353,0.47130434782608693,0.722592948999327,1.0,7/13,29.45%,LRCH1;SLC12A2;RHOA;FOXC1;CXCL12;DUSP1;WNK1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.27688576380941626,0.9773133375368732,0.4858490566037736,0.9005549217752051,1.0,7/44,7.85%,TENM1;PFN2;SPIRE1;PFN1;BAIAP2L2;GSN;CARMIL1
prerank,in utero embryonic development (GO:0001701),0.31160979133893335,0.9771455568954308,0.518348623853211,0.899535670472197,1.0,7/25,11.42%,WNT7B;FLCN;FGFR2;LMX1B;VEGFA;ZNF568;ARNT2
prerank,lytic vacuole organization (GO:0080171),0.2967115509942255,0.9770007675684985,0.47404063205417607,0.8984623342336828,1.0,14/32,23.83%,CLN3;CLVS2;CLVS1;HPS1;GRN;GNPTAB;HOOK1;SNAPIN;TPP1;HOOK3;ACP2;LAMTOR1;GAA;NAGPA
prerank,amyloid fibril formation (GO:1990000),-0.2767210309290673,-0.976926395856134,0.4900181488203267,0.7231326714121941,1.0,17/51,23.21%,SNCAIP;USP9X;APP;HSPG2;TSPAN14;ADAM10;TSPAN5;H3-3A;IAPP;APH1A;SIAH1;TGFBI;MFGE8;MDM2;CALB1;TSPAN33;RIPK1
prerank,actin nucleation (GO:0045010),0.3265965345386098,0.9766642036341733,0.49195402298850577,0.8979491995338479,1.0,7/21,19.43%,SPIRE1;TRIM27;ARPC5L;ARPC5;SPIRE2;WHAMM;ARPC1A
prerank,inositol phosphate catabolic process (GO:0071545),-0.38077625798578646,-0.9765095561603422,0.4938488576449912,0.7237473947639183,1.0,6/12,29.59%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.24377294159882382,-0.9764802654884986,0.5042735042735043,0.7234174406728394,1.0,30/98,24.59%,INSR;KLF4;SLCO1C1;THBS1;ANXA2;IFNAR1;RAB1A;TGFBR2;PPARA;NFKBIA;ECE1;PPARD;DHRS4;ACACB;AKT1;TP53;AGTR1;STARD4;GRB2;AGPAT1;ANGPT1;IL10RB;VAMP3;PPARG;PDGFRB;GADD45A;RIPK1;SFRP4;ARRB1;ACE2
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.34484582233223215,-0.9763973735810666,0.5053003533568905,0.7232305476355572,1.0,8/20,18.83%,DLG1;RHOQ;ROCK1;LCP1;NCKAP1;ROCK2;FMNL2;IKBKB
prerank,response to alcohol (GO:0097305),0.30299346490648116,0.9761337885298735,0.5,0.8979989542494459,1.0,5/27,9.89%,GRIN2B;GLRA1;GRIN2A;ABCA2;SLIT3
prerank,positive regulation of viral transcription (GO:0050434),-0.3211710534139844,-0.9760582135516814,0.5207207207207207,0.7236545101101165,1.0,12/25,33.73%,POLR2G;MDFIC;NELFB;SUPT4H1;POLR2C;DHX9;POLR2L;POLR2H;RSF1;NELFA;NELFCD;POLR2E
prerank,acylglycerol metabolic process (GO:0006639),0.28549623005746183,0.9756277433542373,0.47276688453159044,0.8980441394642739,1.0,9/37,16.52%,DGKK;DGKI;DGKQ;GK;PGS1;APOE;APOC1;ABHD6;SEL1L
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3364973162772494,-0.9755922245638528,0.48841354723707664,0.7243658718395674,1.0,10/20,34.93%,SP100;SYNE1;TAF8;SUN1;TAF3;ARL2;HNRNPU;MORC3;PARK7;TOPORS
prerank,defense response to fungus (GO:0050832),-0.35471231744345233,-0.975205762787439,0.4895470383275261,0.7248814297772509,1.0,12/17,53.00%,RNASE7;PLCG2;S100A9;GAPDH;CARD9;CLEC4D;BCL10;HRG;S100A8;CLEC6A;LTF;CLEC4E
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.30184758754252783,-0.9751323605846755,0.49433962264150944,0.7246512917171182,1.0,5/33,11.25%,HIP1;AFAP1L2;CBL;AKT1;ARAP1
prerank,protein localization to lysosome (GO:0061462),0.3056741708928663,0.9748347255852449,0.4976635514018692,0.8989879843838726,1.0,8/28,11.96%,MFSD1;GGA3;CD81;SORL1;HGS;RTN4;ATP13A2;RNF128
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.310834458958256,0.9745557655115386,0.4967032967032967,0.8983161508293198,1.0,9/25,24.83%,NPSR1;AKAP6;GPER1;CASQ1;CX3CL1;TRPC1;PDPK1;CAPN3;SNCA
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.25250814458909615,-0.9744803711634701,0.5,0.7257664788025845,1.0,19/77,20.26%,ITGA6;RB1;MCL1;THBS1;DDX3X;BMP4;BIRC6;CAAP1;SH3RF1;CFLAR;AKT1;MAZ;HGF;GPX1;IGF1;PPIF;ZMYND11;TCF7L2;HERPUD1
prerank,regulation of amyloid-beta formation (GO:1902003),0.29073967174411675,0.9743815254982628,0.5192307692307693,0.8973508774379308,1.0,9/34,14.63%,LRRTM3;GGA3;NTRK2;SORL1;RTN4;ABCA2;CLU;GSAP;APOE
prerank,negative regulation of platelet activation (GO:0010544),-0.36296679112684277,-0.9742367342001907,0.48028673835125446,0.7259835346370435,1.0,4/16,12.66%,PRKG1;NOS3;PRKCD;CEACAM1
prerank,positive regulation of telomerase activity (GO:0051973),-0.2979222684037894,-0.9741233597153649,0.5112781954887218,0.7258808408194628,1.0,9/33,17.12%,KLF4;NEK7;TCP1;MAPK1;HMBOX1;PNKP;PARN;PTGES3;CTNNB1
prerank,cellular response to hormone stimulus (GO:0032870),0.2539891547964287,0.9739368426037943,0.5066079295154186,0.8971967681776454,1.0,11/69,9.96%,ROBO2;NCOA2;ATP1A2;GCK;AKR1C1;WT1;NR4A3;ADRA2A;CYP11B1;SLIT3;GPER1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.36819901100940305,-0.9738723805540029,0.49740034662045063,0.7260927711698396,1.0,3/15,7.56%,ADAM9;TNFRSF1B;SNX9
prerank,B cell activation (GO:0042113),-0.25983387946601083,-0.9735165048164068,0.4940374787052811,0.7265574622042313,1.0,19/68,19.36%,ITGB1;PTPRJ;ZBTB7A;MEF2C;PLCG2;TPD52;CTPS1;CASP8;PIK3CD;HDAC4;ITGA4;CD40;NHEJ1;TCF3;VCAM1;CEBPG;CLCF1;PTPRC;DNAJB9
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2327235095472832,-0.973474566114224,0.5275862068965518,0.726260333773587,1.0,41/129,24.42%,XIAP;UBR5;ADGRA2;CAV1;SMURF2;PSMA2;LRRK2;DDX3X;EGFR;CSNK1G3;TRPM4;NFKB1;LRRK1;PSME2;PSMB4;PPM1B;AXIN2;ILK;CSNK1G1;DKK2;CSNK1D;PLEKHA4;PSMC2;LYPD6;USP34;PSMB2;PSMB1;DAAM2;PSMA8;PSME1;SOX4;TBL1X;GPC3;PSMD4;CAPRIN2;PSMA7;AMER1;SFRP4;PSMD5;RNF146;SEMA5A
prerank,phosphate ion transport (GO:0006817),0.3526704822246329,0.9733748909975503,0.4772234273318872,0.8974153657462078,1.0,2/16,4.64%,SLC34A1;SLC25A3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.36889477241763624,0.9731920492821223,0.49448123620309054,0.8964749233110069,1.0,6/14,21.60%,CPSF1;TUT1;CSTF2T;CPSF2;CSTF2;NCBP2
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3930014660826675,0.9731627785351292,0.4827586206896552,0.8950785240937847,1.0,3/11,10.42%,ITPKA;IP6K2;IPPK
prerank,secretory granule organization (GO:0033363),-0.4140006887480923,-0.9729911842692311,0.519927536231884,0.7270301696301846,1.0,7/10,45.11%,SRGN;F2R;BLOC1S2;BLOC1S1;F2RL3;BLOC1S3;DTNBP1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.330831023948007,-0.9728323825808113,0.5086505190311419,0.7270152805022889,1.0,7/25,11.85%,LIMK2;SLIT2;PRKCD;CDK10;TBC1D30;YAP1;ABI3
prerank,cGMP metabolic process (GO:0046068),-0.3950736077190349,-0.9724024777218312,0.5167548500881834,0.7276524948761712,1.0,5/12,24.28%,PDE2A;PDE9A;NPR1;GUCY1A1;GUCY2C
prerank,negative regulation of cell cycle (GO:0045786),-0.25878413358227026,-0.9722667839477815,0.5283018867924528,0.7275685370436342,1.0,31/73,30.85%,PPP1R13B;RB1;BTG3;CDKN1B;PDCD4;BMP4;PTPRK;LATS2;PTPN3;CDK6;NUDT6;RNF167;FOXC1;BTG2;BMP7;TFAP4;ANGEL2;PTEN;NR2F2;MYOCD;CEBPA;BMP2;SIPA1;NUPR2;APC;NLRP2B;DUSP1;TRIM35;TGFB1;CHMP1A;LILRB1
prerank,cAMP-mediated signaling (GO:0019933),-0.32161611554403974,-0.9718791093397177,0.506398537477148,0.7280803966186358,1.0,5/24,6.05%,RAPGEF2;ADGRG6;PDE7B;PDE3A;PDE2A
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.29682563971603537,0.9718681881161023,0.4928909952606635,0.8974206117073539,1.0,8/31,13.76%,NRG1;PKP2;PROX1;RYR2;FGFR2;TNNC1;MYL2;ZFPM2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3804642286404515,0.9715826848223087,0.5113636363636364,0.8968404617508656,1.0,2/11,6.48%,BCL2;TRIAP1
prerank,positive regulation of heart contraction (GO:0045823),-0.3499672468537822,-0.9714952911137079,0.4954128440366973,0.7285793420795244,1.0,7/19,11.69%,TRPM4;TGFB2;KCNQ1;GSK3A;EDN1;ADM;EDN3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.38004292146681873,0.9711049347453576,0.49324324324324326,0.8967655761333057,1.0,3/12,9.25%,LHX1;PAX2;VEGFA
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3911259701358791,0.970977202418656,0.47890295358649787,0.8957053488368409,1.0,3/11,6.16%,ENPP2;PDPN;ARHGEF7
prerank,cytoplasmic microtubule organization (GO:0031122),-0.2735235610170808,-0.9709666885137554,0.5123674911660777,0.7294380938173737,1.0,16/54,19.18%,CLIP1;LIMK2;DLG1;EZR;DST;DCTN1;RHOA;SLAIN2;CHP1;TUBGCP4;RAB11A;SLK;TUBGCP5;PCM1;TRPV4;CLIP2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3209580166146827,0.9708162194996646,0.48764044943820223,0.8947198172962167,1.0,4/22,10.42%,RASL11A;DDX11;DHX33;IPPK
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3731103052819666,0.9706764005269696,0.48847926267281105,0.8936858195926175,1.0,4/12,15.38%,CDA;DPYSL5;DPYD;DPYSL2
prerank,cellular response to inorganic substance (GO:0071241),0.3282834163378904,0.9704682959438237,0.49783549783549785,0.89283587490963,1.0,4/21,8.04%,KCNC2;DDX11;ADCY10;DPEP1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4054459052886028,-0.970235656866176,0.4929078014184397,0.7307966997945305,1.0,6/10,27.31%,CSGALNACT1;DSE;PXYLP1;XYLT2;CSGALNACT2;XYLT1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.30916504775663506,-0.9701591859225076,0.5220458553791887,0.7305768895918134,1.0,9/31,19.36%,SHLD1;TFRC;KMT5B;RBP4;MAD2L2;CLCF1;VAMP3;PTPRC;DNAJB9
prerank,negative regulation of protein polymerization (GO:0032272),-0.30873798001661495,-0.9701102609273787,0.5116696588868941,0.7303024953239716,1.0,8/27,15.35%,KANK3;DYRK1A;SLIT2;PRKCD;CDH5;KANK4;ARFGEF1;HIP1R
prerank,epithelium development (GO:0060429),-0.2378243511133834,-0.9695645784215599,0.4973544973544973,0.7311755916923827,1.0,17/107,11.52%,PKD2;CD34;TBX1;KDR;SOX17;SMO;LOXL3;MEOX2;SIX1;MTHFD1;TBX2;BDH2;ANXA4;MFSD2A;CPT1A;JAK2;ALDOC
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.2787472908590669,-0.9693669956877295,0.5087108013937283,0.7312406944574538,1.0,12/49,16.38%,GHR;LYN;IL15;IL6ST;IL6R;HES1;PARP14;JAK2;STAP2;CD40;TNFRSF1A;IGF1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.4100337990364521,-0.968504635951181,0.5052816901408451,0.732825921290323,1.0,3/10,13.32%,LRRK2;KDR;MYOC
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.21859093881077987,-0.9682374539109484,0.5311942959001783,0.7330815274012764,1.0,37/198,14.94%,PTPRB;PLCB4;LIMK2;PAK2;PANK2;PLA2G4A;LRRK2;INPP1;MTOR;PLCG1;PIP4K2A;INPP5A;LIMD1;GFPT2;PLCB3;ACYP2;PLCB1;ALPL;PIP4K2B;MINPP1;PLCE1;PLCG2;ITPKB;PIK3CD;AKT1;INPP4A;PFKFB3;ALDOC;DUSP23;ACP6;LPL;DUSP3;PNKP;AGK;PIK3CB;GK5;AGPAT1
prerank,glycoprotein catabolic process (GO:0006516),0.33935502125580086,0.9679600215325209,0.4945054945054945,0.8987578497018955,1.0,2/17,5.88%,MMP12;FBXO2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.34005606666719196,-0.9676290662895761,0.5099818511796733,0.7341788328808719,1.0,8/20,26.50%,CDKN1B;LATS2;TFAP4;PTEN;NR2F2;MYOCD;CEBPA;APC
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.33971208946125797,-0.9670257612795847,0.5091911764705882,0.7352619817134683,1.0,4/21,5.78%,PLTP;CAV1;RXRA;NFKBIA
prerank,positive regulation of immune system process (GO:0002684),-0.3553157485474455,-0.966101187758153,0.5,0.7371147211774686,1.0,5/16,17.00%,IL15;TGFB2;PIK3CD;PIK3CB;ANXA1
prerank,nuclear body organization (GO:0030575),-0.3846292492343633,-0.9655006918323351,0.5027322404371585,0.7381453233833069,1.0,4/12,16.58%,ETS1;SERBP1;ZPR1;SRPK2
prerank,snRNA 3'-end processing (GO:0034472),-0.3457576945538054,-0.9653832707867714,0.5293072824156305,0.7380243627611619,1.0,11/19,29.96%,INTS8;EXOSC2;EXOSC3;EXOSC8;USB1;EXOSC5;INTS7;EXOSC7;TOE1;INTS5;INTS12
prerank,tRNA aminoacylation (GO:0043039),-0.28958521617224176,-0.9653596333319789,0.518783542039356,0.7376888311679375,1.0,10/37,21.49%,YARS1;WARS2;FARS2;LARS1;AIMP2;HARS2;DARS2;FARSA;IARS2;WARS1
prerank,negative regulation of viral genome replication (GO:0045071),-0.28504742339005196,-0.965240143033351,0.5132275132275133,0.737584594009661,1.0,16/40,30.71%,RESF1;IFIH1;ZC3HAV1;TASOR;IFITM3;PLSCR1;N4BP1;SRPK2;MAVS;IFITM2;TNIP1;TRIM6;OASL;BST2;RSAD2;SHFL
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3979569224077085,-0.9652039627625727,0.539568345323741,0.7372728063035784,1.0,7/12,35.02%,TIPARP;PARP11;PARP16;PARP6;TNKS2;PARP3;TNKS
prerank,protein oxidation (GO:0018158),-0.3984383526275654,-0.9650673806724624,0.49727767695099817,0.7372076915082986,1.0,5/11,35.05%,LOXL3;LOXL1;LOX;SUMF1;LOXL4
prerank,L-glutamate transmembrane transport (GO:0015813),0.40501250017935564,0.9647048315853738,0.5011185682326622,0.9072468695667333,1.0,3/10,13.81%,SLC25A13;SLC1A2;SLC1A3
prerank,positive regulation of lipid localization (GO:1905954),-0.39698599292110937,-0.9644901249212529,0.48987108655616945,0.7381369983424447,1.0,5/11,27.15%,NFKB1;IKBKE;LPL;LRP1;HILPDA
prerank,regulation of oxidoreductase activity (GO:0051341),-0.3839266355504395,-0.9644783983501664,0.49907578558225507,0.737762876679503,1.0,6/13,35.95%,ABL1;HDAC6;NOD2;SZT2;HP;MT3
prerank,nerve growth factor signaling pathway (GO:0038180),0.39666175553588334,0.964413943340821,0.5141509433962265,0.9066507703345418,1.0,2/10,4.53%,MAGI2;KIDINS220
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.33211131532849614,-0.9642468531219162,0.5210237659963437,0.7379163727529463,1.0,9/22,23.28%,ATM;SPRED2;RPL37;EIF5A;HIC1;CDK5RAP3;RPS7;RPS15;MSX1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.3751765671059252,-0.9639980981359773,0.48633879781420764,0.7381029779777964,1.0,4/13,16.35%,ATM;SPRED2;RPL26;HIC1
prerank,T cell migration (GO:0072678),-0.38556811097476296,-0.9633819278250428,0.5103448275862069,0.7391363761887035,1.0,4/13,9.65%,SLC12A2;MSN;S1PR1;PIK3CD
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4105216185983331,-0.962972345203005,0.5054347826086957,0.7396728219168693,1.0,3/10,8.34%,SHANK3;APP;RAB5A
prerank,secondary alcohol metabolic process (GO:1902652),0.27530795715365985,0.9626606379521827,0.5141509433962265,0.9105373502685967,1.0,12/42,15.42%,PIP4P1;SULT2B1;SQLE;NSDHL;TSKU;CYP27A1;CYP11B1;OSBPL5;IDH3A;ABCA5;APOE;CLN8
prerank,negative regulation of JNK cascade (GO:0046329),-0.2981928646476317,-0.9622259208114549,0.5338078291814946,0.7410059720662051,1.0,8/31,24.93%,MECOM;PDCD4;TAOK3;DUSP3;ZMYND11;SH3RF2;GPS2;AIDA
prerank,peptide metabolic process (GO:0006518),-0.250036026177379,-0.9619636601392264,0.5239786856127886,0.7412305116907244,1.0,20/75,19.51%,CPQ;GSTT1;ACE;PSEN2;GSTT2;SPPL3;ABCB9;PCSK5;ENPEP;GSTM2;PSEN1;CPXM2;GPX1;HPGDS;ERAP1;SOD1;DNPEP;CPXM1;NPEPPS;CLN5
prerank,maturation of 5.8S rRNA (GO:0000460),-0.34809561872698497,-0.9618987041345771,0.5092592592592593,0.7409739760058285,1.0,5/17,20.70%,RPF1;RRP15;NOL9;PRKDC;PES1
prerank,activation of protein kinase activity (GO:0032147),-0.23955392257077443,-0.9609093888170553,0.5372881355932203,0.7428945389965593,1.0,25/106,16.38%,GHR;INSR;PRKACB;ADCY9;PAK2;MTOR;TGFBR2;RICTOR;GAS6;STK3;ABL1;TGFB2;PRKCD;FGF1;ADCY4;CLSPN;AKT1;TAOK3;JAK2;IRAK1;MAP4K4;MARK2;ADCY1;ANGPT1;IGF1
prerank,protein-DNA complex assembly (GO:0065004),-0.2372946271468647,-0.9604421416884692,0.5513245033112583,0.7436210418738828,1.0,38/116,27.24%,MNAT1;KAT6B;PSMA2;DMC1;RBX1;BRD2;PSME2;PSMB4;ERCC2;SPTY2D1;MCM4;ORC5;RPA3;RPA1;XPC;ERCC3;PSMC2;H3-3A;PSMB2;PSMB1;ORC2;PSMA8;CETN2;ORC4;RPA2;PSME1;ATRX;TCF4;PSMD4;PSMA7;MCM3;PSMD5;MCM7;PSMB10;RSF1;PSMA3;MCM5;GTF2H3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.22818819000220147,-0.9603859517539266,0.5167548500881834,0.7433474167595814,1.0,47/145,26.92%,FBXL7;PSMA2;YWHAE;CEP57;RBX1;CEP250;PSME2;CEP78;PSMB4;HAUS8;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;MECP2;CEP41;PSMC2;PSMB2;PSMB1;ALMS1;RAB11A;PSMA8;PLK4;PCM1;CETN2;CNTRL;CEP152;PSME1;CCND1;PSMD4;ODF2;PSMA7;CDC25A;HSP90AA1;FHL1;PCNT;CEP131;AKAP9;PSMD5;PINX1;BRD4;DTL;PSMB10;PSMA3;KIF14;DYNLL1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3981122692676641,-0.9601250112122818,0.5072727272727273,0.7435843074011407,1.0,5/10,25.17%,SETD5;DIP2B;PRKAA1;MYOCD;DIP2A
prerank,epidermis development (GO:0008544),0.26188235465470655,0.9598264048295133,0.5221445221445221,0.9173722594407009,1.0,10/56,14.33%,OVOL3;ZNF750;POU2F3;SCEL;FGFR2;ACER1;LAMB3;CERS3;GATA6;COL7A1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.4112561339547276,-0.9597037177887736,0.5152671755725191,0.74422553246263,1.0,8/10,50.61%,DNMT1;ATRX;BRCA1;DNMT3B;MYB;SIRT1;RIF1;PRDM12
prerank,regulation of establishment of cell polarity (GO:2000114),-0.36147440616484955,-0.9593211423609614,0.5322862129144852,0.7447297112107183,1.0,6/16,15.35%,CDH5;RAP1B;ROCK1;BCAS3;ARFGEF1;ROCK2
prerank,regulation of smooth muscle contraction (GO:0006940),0.3291227030047661,0.9593126695542966,0.504524886877828,0.9173909168309409,1.0,4/20,11.23%,CHRM2;CHRM3;SPHK1;NMUR2
prerank,potassium ion import across plasma membrane (GO:1990573),0.2803688926961284,0.959248791877638,0.5070754716981132,0.9161326419661295,1.0,7/41,8.79%,ATP1A2;KCNJ3;ATP12A;ATP1B1;SLC12A5;ATP4A;KCNJ6
prerank,intestinal absorption (GO:0050892),-0.3752069960382356,-0.9588374572431687,0.4882032667876588,0.7454546628968115,1.0,3/13,7.60%,F11R;KCNQ1;TJP2
prerank,regulation of interferon-alpha production (GO:0032647),-0.3218805347473417,-0.958720389814006,0.5018939393939394,0.7453230812178053,1.0,3/23,3.89%,IFIH1;SETD2;DDX3X
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.293367554994939,0.958188326981544,0.5197368421052632,0.9178473246003374,1.0,6/31,10.54%,NLGN1;PPFIA2;CDK5;CAMK2B;TANC2;ABI2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.3492406108800892,-0.9579858247101303,0.5171171171171172,0.7466892759091887,1.0,6/16,24.23%,ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2427330026850025,0.9576353894895286,0.5439429928741093,0.9179541421460744,1.0,20/84,16.07%,RBFOX1;KHDRBS2;CELF5;KHDRBS3;SRRM4;CELF4;CELF2;QKI;CELF6;SRPK1;FXR2;DDX17;RBFOX3;ZC3H10;RBM8A;TIA1;NOVA1;U2AF2;SF3B4;HNRNPK
prerank,renal absorption (GO:0070293),-0.3975830191472639,-0.9575996306531968,0.5270758122743683,0.7472139855316433,1.0,5/10,23.34%,KCNQ1;WNK4;KLHL3;HYAL2;HAS2
prerank,anterior/posterior axis specification (GO:0009948),-0.35860154143976336,-0.9574081563912507,0.5221088435374149,0.7472829953013532,1.0,8/15,34.00%,TASOR;SKI;TBX3;FZD5;RIPPLY2;DDIT3;SHH;HOXD8
prerank,ruffle organization (GO:0031529),-0.35514125873999447,-0.9569050465649618,0.5095320623916811,0.7480901408204391,1.0,2/16,1.85%,LIMA1;RAC1
prerank,mitochondrial gene expression (GO:0140053),-0.2812992798884594,-0.9564015476116291,0.527831094049904,0.7489011407170626,1.0,20/42,29.86%,FOXO3;PTCD3;MRPL47;MRPS18A;MRPL2;MRPS24;MRPL12;MRPL57;NDUFA7;MRPS14;IARS2;MRPS21;GFM2;FASTKD5;MRPS2;NOA1;MRPS28;SLC25A33;GATB;MRPS17
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.4069579317202987,-0.9561550665167742,0.5325131810193322,0.7487125739929387,1.0,2/10,17.54%,CEP250;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.4069579317202987,-0.9561550665167742,0.5325131810193322,0.7487125739929387,1.0,2/10,17.54%,CEP250;TULP1
prerank,positive regulation of calcium ion transport (GO:0051928),0.2842408816561291,0.955879259927399,0.5,0.9216801338561728,1.0,9/36,14.36%,STC1;WNK3;CACNA1D;SPHK2;LILRA5;P2RX3;CCL5;CCL2;P2RX5
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3009445292310427,-0.9552953183033039,0.51985559566787,0.750327776237129,1.0,14/29,41.40%,LARP1;FUS;AXIN2;RBM24;THRAP3;TAF15;PABPC1;HNRNPU;TENT5C;TENT5B;VIP;TENT5D;DND1;NOCT
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.22949048001590353,-0.9547056442816788,0.5869947275922671,0.7513177674336853,1.0,50/125,35.67%,CLIP1;MAD1L1;SETD2;MAP4;NEK6;RANBP2;AHCTF1;NUP98;PLK2;SEC13;PAFAH1B1;MECP2;KIF11;RPS27;DSN1;CENPL;CENPE;NDEL1;KIF3B;BUB1B;CENPO;TACC3;BUB3;TTK;PCNT;CENPI;CENPH;EML4;CENPN;RAN;DYNLL1;SPC25;SPDL1;TUBG2;CDCA8;STMN1;BIRC5;EFHC2;WDR62;NUDC;PLK1;NUF2;CKAP5;AURKA;MIS12;SPC24;ESPL1;TNKS;CDC20;NUP43
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3297419977170699,-0.9545635198840716,0.5102040816326531,0.7512656255602173,1.0,10/23,26.84%,GHR;CRLF3;HES1;JAK2;NOTCH1;IL10RB;PTK2B;OCIAD2;CYP1B1;F2R
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.36345099468771513,-0.9539257311432492,0.5340699815837937,0.7523774416130838,1.0,9/15,36.49%,NEK6;CDC16;TPR;CENPE;TACC3;ANAPC7;PLK1;CDC6;UBE2C
prerank,positive regulation of cell aging (GO:0090343),-0.3918966793859527,-0.9537478376521654,0.5376532399299475,0.7523991772250685,1.0,4/11,15.17%,YPEL3;LMNA;ABI3;CGAS
prerank,dendritic spine organization (GO:0097061),-0.30874326859284085,-0.9537137606837254,0.5575221238938053,0.7520739620869784,1.0,4/26,2.92%,IGF1R;SHANK3;INSR;ITGA3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3379881542290715,-0.9529519539129211,0.5374280230326296,0.7535055749464462,1.0,4/20,9.16%,MCL1;GSK3B;FAS;GSK3A
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4058781972578181,-0.9527916524159687,0.5339285714285714,0.7534972450428751,1.0,3/10,14.55%,ESR1;TP53;PSMC2
prerank,dicarboxylic acid transport (GO:0006835),0.3018536120472907,0.9525499236007219,0.5426695842450766,0.9303736449218268,1.0,8/28,14.48%,PDPN;SLC25A13;SLC46A1;SLC1A2;SLC19A1;SLC1A3;SLC13A5;SLC26A8
prerank,mitochondrial membrane organization (GO:0007006),0.2856139845550263,0.9525099388701379,0.5259593679458239,0.929000204138681,1.0,8/32,12.02%,BCL2;HSPA9;MFN1;SLC25A4;MTX3;CHCHD6;DNAJC11;GHITM
prerank,regulation of fibroblast proliferation (GO:0048145),-0.278285875222004,-0.9523440885933122,0.5284403669724771,0.75416028717297,1.0,12/45,20.79%,DAB2IP;EMD;GAS6;TP53;CDC73;CDK6;MIF;IGF1;SKI;CTNNB1;LIG4;NF1
prerank,autonomic nervous system development (GO:0048483),0.3394861382405152,0.9514202186314216,0.5282167042889391,0.9307868174769136,1.0,1/17,0.37%,PHOX2A
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.32633656531537647,-0.950838804345841,0.5176056338028169,0.7569505115405682,1.0,7/21,27.14%,EYA4;MCL1;AKT1;TERT;MAPK7;HSPA1B;SNAI2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.32633656531537647,-0.950838804345841,0.5176056338028169,0.7569505115405682,1.0,7/21,27.14%,EYA4;MCL1;AKT1;TERT;MAPK7;HSPA1B;SNAI2
prerank,regulation of protein localization to membrane (GO:1905475),0.2965842527533981,0.9506766392023485,0.5460674157303371,0.9314943810923684,1.0,5/28,6.96%,GPC5;CDK5;CLN3;GPC1;GSN
prerank,negative regulation of endocytosis (GO:0045806),-0.31816316702380004,-0.9505978396240556,0.517948717948718,0.7571440195795895,1.0,4/24,9.18%,CAV1;RAC1;PRKD1;PICALM
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.288454100352081,0.9503700546125572,0.5192743764172335,0.9308814265991052,1.0,4/32,5.75%,MAGI2;PPP1R7;CAMTA1;CALM2
prerank,skeletal system morphogenesis (GO:0048705),0.26697626776771405,0.9497621060643014,0.5495495495495496,0.9311747582795264,1.0,14/42,19.98%,DSCAML1;HOXD3;CYP26B1;MEGF8;FGFR2;RAB33B;HOXA4;HOXA9;PDGFRA;HOXD4;FBN2;HHIP;FGFR3;DYNC2I1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.38919474927674585,0.9497309018649164,0.5023923444976076,0.9297858830663829,1.0,2/10,14.87%,RCC2;RACGAP1
prerank,negative regulation of developmental growth (GO:0048640),0.2916564715060065,0.9494944684552352,0.5226244343891403,0.9290020480573279,1.0,10/30,19.83%,DCC;MAP2;RTN4;PTPRS;MAG;TRIM46;SLC6A4;BBS2;RTN4R;FGFR3
prerank,regulation of T cell proliferation (GO:0042129),-0.256448564643313,-0.9494716585111529,0.542314335060449,0.7594332673387618,1.0,13/61,23.62%,SLC7A1;IL15;IL6ST;TFRC;TNFRSF1B;NCK1;NCK2;VCAM1;ANXA1;CCL19;PTPRC;TNFSF8;CD276
prerank,actin filament network formation (GO:0051639),0.38002777458468495,0.9493354347005379,0.5203619909502263,0.9279881407409917,1.0,6/11,20.84%,SPIRE1;FHOD3;CARMIL1;SPIRE2;FHOD1;PLS1
prerank,embryonic eye morphogenesis (GO:0048048),-0.3963955684248254,-0.9491850668287644,0.5352112676056338,0.7597406503180217,1.0,3/11,8.09%,RARG;LRP6;TBX2
prerank,bone morphogenesis (GO:0060349),-0.3663699271205216,-0.9488822466893996,0.5379188712522046,0.7600743745219567,1.0,3/14,6.37%,LRP5;BMPR2;LRP6
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3126054596635853,-0.9484869138696927,0.5373665480427047,0.7606096187667919,1.0,11/26,24.02%,NOS3;ACER2;GCH1;AKT1;ACER3;SPTLC1;ASAH1;CYB5B;NQO1;NOS1;CYP1B1
prerank,positive regulation of viral genome replication (GO:0045070),-0.30334128175008557,-0.9482720041882198,0.5361010830324909,0.7606708563698008,1.0,9/29,18.77%,DDX3X;LARP1;PPARA;PKN2;PDE12;SRPK2;ADARB1;RAD23A;STAU1
prerank,positive regulation of dendritic spine development (GO:0060999),0.31620060959012963,0.9476192375326259,0.5268065268065268,0.9315193206808613,1.0,6/20,17.26%,NLGN1;SHANK1;CAMK2B;CPEB3;APOE;DHX36
prerank,positive regulation of T cell differentiation (GO:0045582),-0.2885456221193766,-0.9474444741566573,0.5529622980251346,0.762245466208179,1.0,16/36,40.16%,LEF1;ZMIZ1;GLI3;VSIR;SOX4;BCL6;NKAP;IL7;PNP;SHH;VNN1;ZAP70;MDK;GATA3;TESPA1;IL4
prerank,positive regulation of histone acetylation (GO:0035066),-0.3200804615623829,-0.9471793844973873,0.5571428571428572,0.7624640996909219,1.0,12/23,36.27%,RPS6KA5;SMAD4;RUVBL2;WBP2;BRCA1;NOS1;ARRB1;SMARCB1;GLYR1;RPS6KA4;MUC1;LIF
prerank,B cell homeostasis (GO:0001782),-0.39432993331363403,-0.9470555249852254,0.5299625468164794,0.7623686984773241,1.0,4/10,14.90%,LYN;MEF2C;PPP2R3C;TNFAIP3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.29932849748387086,-0.9470248227688222,0.5398550724637681,0.7620434812953902,1.0,13/29,29.39%,UBE2K;PTPN1;SAMHD1;STAT2;USP18;NLRC5;MAVS;ABCE1;PTPN11;IFNAR2;PTPN2;TRIM6;CACTIN
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3210209860738658,-0.947011418216648,0.5225225225225225,0.7616767623712675,1.0,3/23,6.37%,RAC1;MOSPD2;SLIT2
prerank,positive regulation of integrin activation (GO:0033625),-0.39236279738336893,-0.9466486214456581,0.5577981651376147,0.7621607572299448,1.0,3/11,8.05%,FERMT2;RASIP1;RAP1B
prerank,zymogen activation (GO:0031638),0.27396814723124896,0.9464465035101289,0.5454545454545454,0.9334414658492599,1.0,5/39,10.27%,OMA1;C1RL;GRIN2A;KLK1;RIPK2
prerank,mRNA metabolic process (GO:0016071),-0.24043848915781293,-0.9464200227926873,0.5658362989323843,0.7622813365882057,1.0,26/90,28.11%,SRSF11;PRPF3;HNRNPA0;HNRNPR;ERN1;CELF1;TP53;SON;SFPQ;LSM11;SNRPE;SF3A1;LSM10;NUDT12;NONO;LSM3;DIS3L2;METTL16;ALKBH5;SUPT4H1;USP39;HSPA1B;PRPF18;DXO;SCAF11;LSM2
prerank,fatty acid transport (GO:0015908),-0.34593169126369905,-0.9457558654706847,0.5563258232235702,0.7634156858691149,1.0,8/17,31.15%,PPARD;MFSD2A;SLC27A4;ACSL1;PPARG;SLC27A3;FABP3;SLC27A6
prerank,transepithelial transport (GO:0070633),-0.35010074777109734,-0.9457061031855326,0.5307262569832403,0.7631298735787441,1.0,2/15,4.55%,ABCG2;SLC12A2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.322791443832565,-0.9448957677044719,0.5286506469500925,0.7646216307040274,1.0,5/22,22.00%,KLF4;GCNT2;FLOT1;BMP7;MAPK7
prerank,protein prenylation (GO:0018342),-0.397075171386003,-0.9447517099682369,0.5557553956834532,0.7645625798446147,1.0,6/10,39.13%,PTAR1;PGGT1B;RABGGTB;RCE1;RABGGTA;CHML
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3050720259424429,0.9446409580811176,0.5205183585313174,0.9373898153479651,1.0,10/24,26.49%,MAPT;STMN2;TPPP3;TPPP;HDGFL3;STMN4;STMN3;NCKAP5;KIF18A;FGF13
prerank,mitochondrial translational elongation (GO:0070125),-0.23824362082527134,-0.9444017761136184,0.5716878402903811,0.7650170931167867,1.0,30/88,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;MRPS28;MRPS35;MRPL43;MRPL48;TUFM;MRPL11;MRPS31
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.2844801319470128,0.9442267466360188,0.5350467289719626,0.9371504348368552,1.0,5/35,5.39%,HTR2C;RIMS2;DGKQ;AKAP6;EPHA5
prerank,inner mitochondrial membrane organization (GO:0007007),-0.27224317193704006,-0.9437783839833396,0.5794066317626527,0.7660392643788788,1.0,22/47,34.01%,CHCHD3;APOOL;AFG3L2;SAMM50;MTX1;DMAC2L;AGK;ATP5F1E;UQCC3;ATP5F1C;ATP5MF;ATP5PO;TMEM11;IMMT;TIMM10;TOMM70;ATP5F1D;SPG7;MICOS10;TIMM10B;ATP5MC2;TIMM13
prerank,regulation of chromosome segregation (GO:0051983),-0.35393672886332694,-0.9434859062287494,0.5174708818635607,0.7663596681552933,1.0,13/16,48.28%,SMC5;PUM1;RAD18;PUM2;CDC6;CSNK2A1;CSNK2A2;IHO1;KIF2C;SMC6;AURKB;RMI2;HORMAD1
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.25190838662839055,-0.9434183292525667,0.5537918871252204,0.7661273946845925,1.0,24/66,36.11%,FOXP1;APP;CASP8;JAK2;LPL;PANX1;TNFAIP3;TRIM16;IGF1;GBP5;CCL19;NOD2;CASP1;FZD5;F2R;LGALS9;NLRP2B;NLRC4;STAT3;TLR6;CARD16;NLRP3;CD33;TLR8
prerank,intracellular cholesterol transport (GO:0032367),-0.3610192380191731,-0.94317611567216,0.5370705244122965,0.766324593781294,1.0,5/15,20.55%,LDLRAP1;LRP6;STARD4;STAR;OSBPL2
prerank,regulation of mast cell degranulation (GO:0043304),0.3547889562936032,0.9424264917340481,0.5191387559808612,0.9409107936382051,1.0,3/14,9.92%,BLK;STXBP2;SPHK2
prerank,positive regulation of reproductive process (GO:2000243),0.28927964913778975,0.9420241377865428,0.5452538631346578,0.9406759195633859,1.0,5/31,10.94%,CFAP69;GLRA1;ACVR1B;VEGFA;TACR1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.32579164070574684,-0.9419540549836134,0.5343642611683849,0.7688019340467575,1.0,3/22,5.58%,SLC7A5;TRPM4;TNFRSF1B
prerank,regulation of cell-cell adhesion (GO:0022407),-0.2795380899153823,-0.9417809297322941,0.5445026178010471,0.7688128335085911,1.0,12/39,22.47%,PTPRG;PODXL;AFDN;PTK2;CDH1;SMAD7;CEACAM1;JAG1;CITED2;MAGI1;FERMT3;EPHB3
prerank,cardiolipin metabolic process (GO:0032048),-0.36875266804455975,-0.9415053203360864,0.5324427480916031,0.7690195423712374,1.0,2/13,3.63%,HADHB;PLA2G4A
prerank,B cell proliferation (GO:0042100),0.33891809799250006,0.9412043914121908,0.5563380281690141,0.9416691647871662,1.0,2/17,3.49%,MS4A1;BCL2
prerank,lipoprotein catabolic process (GO:0042159),-0.38261567006771513,-0.9412014639600835,0.5497287522603979,0.7693341109515479,1.0,8/11,39.94%,ABHD17A;NOTUM;ABHD17C;LYPLA1;ABHD10;PPT1;ABHD17B;LYPLA2
prerank,heme biosynthetic process (GO:0006783),-0.31671103163761816,-0.9410920764267796,0.5310834813499112,0.7691741285506813,1.0,3/22,8.14%,ABCG2;ALAS1;ABCB10
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.24294471996161615,-0.9408370426120518,0.565365025466893,0.769356630445416,1.0,27/85,23.89%,RAC1;SMURF2;FZD6;DVL3;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;AP2S1;PSME2;PSMB4;RHOA;WNT11;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;AP2M1;PSMD4;ROR2;PSMA7;FZD7;PSMD5;FZD5
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.3125086518914879,0.9407572717730357,0.5370370370370371,0.9415223998286697,1.0,7/23,12.19%,PIP4P1;MTMR2;MTMR10;MTMR11;MTMR7;OCRL;INPP5F
prerank,glycogen metabolic process (GO:0005977),-0.30909648717054483,-0.9404485469914681,0.5444234404536862,0.7698666098818266,1.0,6/27,13.72%,GBE1;GSK3B;PHKA2;PPP1R3C;GYS1;PHKB
prerank,negative regulation of neuron death (GO:1901215),0.23172665702213532,0.9402395258776088,0.5976190476190476,0.9416012661682719,1.0,21/93,13.40%,CDK5;BCL2;TYRO3;CLN3;CHGA;PTPRZ1;NTRK2;VSTM2L;GRN;PLA2G3;SORL1;POU4F1;KIR3DL2;MAG;ATP13A2;HTRA2;FZD9;NRBP2;CCL2;BDNF;FGF20
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.2789064854402535,-0.9402079042190413,0.5701598579040853,0.7700183142682084,1.0,16/45,21.97%,BTG3;CDKN1B;BMP4;PLK2;NABP1;RGCC;PTPN3;FOXC1;BTG2;BMP7;CTNNB1;BUB1B;ANGEL2;BCL6;CHEK1;TOM1L2
prerank,substantia nigra development (GO:0021762),0.2788816969904032,0.9401310525632592,0.5318181818181819,0.9404521078944457,1.0,8/37,13.72%,PLP1;CALM2;MAOB;CNP;PADI2;CCDC14;MBP;GLUD1
prerank,regulation of organelle organization (GO:0033043),-0.240993959513352,-0.9401163983491262,0.5875,0.7698234729067686,1.0,13/80,9.73%,TJP1;F11R;PAK2;STX18;DIAPH1;MSN;PDE2A;PTK2;EZR;ARMH3;USP6NL;MAPK1;CAPN2
prerank,digestive tract development (GO:0048565),-0.2946254554109683,-0.9398518195912102,0.539543057996485,0.7700321970723035,1.0,8/32,14.01%,CLMP;SMO;NIPBL;TGFB2;GLI3;PCSK5;PKDCC;ZIC3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.32950305290768717,-0.9395380086370545,0.5197132616487455,0.7703667740516403,1.0,4/18,8.54%,CD200;RPS6KA5;PRKD2;PRKD1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21158055533351763,0.9389276763354542,0.6188118811881188,0.9425731074665867,1.0,29/163,14.61%,PDE4B;BLK;MS4A1;BLNK;PSMC5;PAG1;NFATC2;BCL2;CD3G;PSMD10;GRAP2;VTCN1;PAK3;PAK1;PIK3R2;PSMD14;VAV3;RIPK2;MOG;CARD11;PSMB7;RBCK1;PRKCB;PSMA4;TXK;PSMD1;PSMF1;EIF2B1;PSMB8
prerank,phosphate ion homeostasis (GO:0055062),0.3842085607180303,0.9387789415449816,0.5262008733624454,0.9415344954805689,1.0,1/10,1.56%,SLC34A1
prerank,histone monoubiquitination (GO:0010390),-0.31421941024198574,-0.9383449175023619,0.5622775800711743,0.7727262459033192,1.0,7/24,19.04%,DTX3L;RYBP;RNF40;CDC73;RNF168;BCOR;RNF2
prerank,regulation of cell projection organization (GO:0031344),0.3568030369111494,0.9375378710942562,0.5269320843091335,0.9436431145234914,1.0,3/13,7.70%,NTNG2;NTNG1;ERMN
prerank,actin polymerization or depolymerization (GO:0008154),-0.26672751558952684,-0.9373877479798394,0.536283185840708,0.774567068242819,1.0,15/50,20.38%,ABI1;RAC1;SVIL;MICAL2;DIAPH1;WASL;FAM107A;CFL2;JAK2;PREX1;CORO7;CFL1;PSTPIP1;WASF1;DSTN
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3500573277345797,-0.9370543921992657,0.5459272097053726,0.7749145244445651,1.0,4/16,15.40%,ESR1;RBFOX2;NCOA4;TADA3
prerank,negative regulation of transport (GO:0051051),-0.2661917809094528,-0.9363392917396526,0.566420664206642,0.7761986340450346,1.0,15/51,22.24%,RAB7A;DYSF;PPM1F;PRKD1;ARL6IP5;PXK;SNX12;CTTNBP2NL;PLSCR1;ABCA7;PIP4P2;WWP2;PTEN;ITGB3;NDFIP2
prerank,cellular defense response (GO:0006968),-0.2763244353215489,-0.9362605990947097,0.5645161290322581,0.7759901789838687,1.0,9/40,23.00%,ITGB1;ZNF148;LBP;CCR9;NCF2;RAB23;PTK2B;RELA;BECN1
prerank,negative regulation of immune effector process (GO:0002698),0.35584787663806267,0.9359806796688056,0.5337552742616034,0.9467235312496497,1.0,4/13,15.25%,GRN;ENPP3;HAVCR2;CD47
prerank,cellular response to acid chemical (GO:0071229),-0.29913081780581435,-0.9357490756166297,0.5401069518716578,0.7767742791404693,1.0,6/27,13.63%,SH3BP4;KLF2;MTOR;CAPN2;RPTOR;LARS1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.302550237029832,0.9356713437151477,0.5241228070175439,0.9461681662550587,1.0,6/24,15.33%,SLC25A13;ADRB3;NR4A3;LYRM7;MRAP2;GFPT1
prerank,primary neural tube formation (GO:0014020),-0.296380198355635,-0.9356128513459675,0.5350877192982456,0.7767168722227006,1.0,9/30,18.67%,LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI;MTHFD1L
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2400741167765223,-0.9352641134143078,0.580267558528428,0.7771447219752553,1.0,29/88,27.03%,DAB2IP;DAPK1;RNF139;DDX3X;GIGYF2;LARP1;NFKB1;DNAJC1;SAMD4A;AKT1;EDN1;IGFBP5;SYNCRIP;BTG2;PLAT;HDAC6;CDK5RAP3;RPS3;CAPRIN1;TOB1;SERPINE2;RPL13A;MRPL13;EIF2AK3;FXR1;IGF2BP2;CNOT8;NANOS1;CNOT1
prerank,regulation of fibrinolysis (GO:0051917),-0.37237383399196144,-0.9352570868946523,0.5413669064748201,0.7767623598286673,1.0,9/13,49.66%,THBS1;SERPINE1;USF1;FAP;APOH;PLG;F11;HRG;F2
prerank,cellular response to light stimulus (GO:0071482),-0.2480290993440558,-0.9351883461213423,0.5761245674740484,0.7765136500805123,1.0,13/66,15.76%,GNB1;CREBBP;NEDD4;PRKCD;PTPRK;RPL26;TP53;NSMCE3;SAG;ATF4;COPS9;N4BP1;RUVBL2
prerank,cellular amide metabolic process (GO:0043603),0.22650257049819938,0.9351160152347922,0.6043956043956044,0.946406782333563,1.0,24/102,16.64%,ABCA12;MME;PLPP2;SLC46A1;SMPD3;CPE;SLC19A1;PLA2G4E;OXSM;ALDH1L2;ABCA2;CPN1;AEBP1;ACSL6;MCCC2;NAAA;ACOT2;ACOT7;ACBD6;AASDHPPT;NSMAF;CLN8;MIPEP;ASAH2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.403609868772988,-0.9348048968972639,0.5674676524953789,0.7770388799705307,1.0,5/10,21.21%,MECP2;KDM1B;PCGF3;IGF2;PCGF5
prerank,regulation of supramolecular fiber organization (GO:1902903),0.31316750957682166,0.934615687268885,0.55125284738041,0.9463227632114365,1.0,9/22,17.71%,MAP2;MAP1S;MAPT;MAP1B;AEBP1;MAPRE3;APOE;CAMSAP3;MAP1A
prerank,negative regulation of cellular component organization (GO:0051129),0.23749738886203703,0.9344929885272137,0.632183908045977,0.9452342519496124,1.0,15/74,13.93%,TMEFF2;SYT11;APOM;IMPACT;MTMR2;HSF1;CARMIL1;SORL1;XRCC5;VEGFA;PRKCZ;NOP53;RUBCN;CLU;LRSAM1
prerank,cognition (GO:0050890),-0.2726755382051658,-0.9333356019085552,0.5724508050089445,0.780085074871886,1.0,8/42,9.33%,SHROOM4;ST3GAL4;SOBP;APP;NIPBL;SETD5;MFSD2A;FAM107A
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.28116943872002537,-0.9332546926932219,0.5936952714535902,0.7798957010477495,1.0,16/39,24.02%,UTRN;NEDD4L;YWHAE;TCAF1;NEDD4;TRPC6;FXYD5;PTPN3;FXYD6;SCN3B;PPIF;SCN4B;WWP2;FHL1;RIPK1;AHCYL1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.33350967331494374,-0.9328745574845215,0.5746691871455577,0.7803505928139863,1.0,11/17,41.00%,DYRK1A;YJU2;MIF;MDM2;SNAI2;RNF34;ARMC10;CD74;SIRT1;PTTG1IP;CD44
prerank,apoptotic DNA fragmentation (GO:0006309),-0.34781071956046294,-0.9328207261977417,0.5659655831739961,0.7800661492035157,1.0,6/16,24.66%,CECR2;DICER1;KPNA1;EXOG;FOXL2;HMGB1
prerank,cilium organization (GO:0044782),-0.21043866465670386,-0.9325726520401569,0.6512027491408935,0.7802391579609539,1.0,44/209,19.26%,ABCC4;ABLIM1;EXOC6;ASAP1;PKD2;PARVA;FNBP1L;EXOC4;RAB1A;EHD2;PTPDC1;SSX2IP;CEP250;IFT140;CDC14A;WDR11;RAB11FIP3;CEP78;EXOC2;PDE6D;FLNA;EHD1;WDR35;GALNT11;RAB8B;NOTCH1;IFT52;CFAP44;RAB23;TRAF3IP1;CEP41;EXOC8;FUZ;DZIP1L;NUDCD3;EHD4;RAB11A;HDAC6;CFAP298;PLK4;PCM1;TMEM17;KIF3B;IFT43
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.2892598296961419,-0.9319753300059828,0.5578747628083491,0.7811898071655822,1.0,9/35,17.12%,NEK7;ATM;TCP1;MAPK1;HMBOX1;PNKP;PARN;HNRNPA1;CTNNB1
prerank,lung epithelium development (GO:0060428),0.38189730928010457,0.9318914789383937,0.5327510917030568,0.9513729596137993,1.0,3/10,14.58%,WNT7B;FOXJ1;RCN3
prerank,regulation of platelet aggregation (GO:0090330),0.33468288417793,0.9313048025331151,0.5454545454545454,0.9516010745583595,1.0,3/17,1.83%,BLK;C1QTNF1;PDPN
prerank,regulation of microtubule polymerization (GO:0031113),-0.2762795016131975,-0.9311575935107946,0.5570093457943925,0.7826918096116898,1.0,10/40,13.02%,DYRK1A;CLIP1;RAC1;ABL1;TOGARAM1;CDH5;OCLN;DCTN1;SLAIN2;DRG1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.38772895128317936,-0.9310452029580301,0.5557553956834532,0.7825582538205,1.0,4/10,23.42%,SLC2A1;SLC27A4;ACSL1;SPX
prerank,positive regulation of organelle assembly (GO:1902117),-0.2697083233485602,-0.9309691697336414,0.5690909090909091,0.7823318994578486,1.0,11/44,17.96%,ASAP1;RAB3GAP1;STX18;PIP4K2A;PIP4K2B;CROCC;RAB3GAP2;LCP1;FUZ;ARHGAP35;PLK4
prerank,nuclear pore organization (GO:0006999),-0.3564757969469323,-0.9307321751413115,0.5748613678373382,0.7824714806224506,1.0,4/14,15.77%,AHCTF1;NUP98;NUP153;TPR
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.291656498059838,-0.9307029982985607,0.5768535262206148,0.7817450683247856,1.0,10/31,28.41%,MNAT1;POLR2G;ERCC2;ERCC3;CMTR2;POLR2C;POLR2L;POLR2H;GTF2H3;CCNH
prerank,7-methylguanosine RNA capping (GO:0009452),-0.291656498059838,-0.9307029982985607,0.5768535262206148,0.7817450683247856,1.0,10/31,28.41%,MNAT1;POLR2G;ERCC2;ERCC3;CMTR2;POLR2C;POLR2L;POLR2H;GTF2H3;CCNH
prerank,centromere complex assembly (GO:0034508),0.27613198429841296,0.9305788438682422,0.593607305936073,0.9522392309193594,1.0,11/36,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;DLGAP5;RBBP7;ITGB3BP;CENPA
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.3549031352577028,-0.9303340727957601,0.5424610051993067,0.7822304229591973,1.0,3/15,11.78%,TGFB2;SMAD7;HFE
prerank,regulation of mRNA processing (GO:0050684),0.2855765624585581,0.9303032831338737,0.5452436194895591,0.9515876537548711,1.0,8/32,16.07%,KHDRBS2;KHDRBS3;QKI;SRPK1;PTCD2;SAFB;TIA1;HNRNPK
prerank,intestinal lipid absorption (GO:0098856),-0.37756395742336424,-0.930165594606042,0.5587188612099644,0.7822167867936632,1.0,1/11,0.85%,LIMA1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.38755229115203,-0.9301366958440375,0.5545454545454546,0.7818779141524378,1.0,4/11,15.43%,RIN3;SLIT2;MIF;CCN3
prerank,connective tissue development (GO:0061448),-0.28856117735249665,-0.9299342408398,0.5806451612903226,0.7819382953879513,1.0,5/35,9.54%,ZBTB16;LRP5;SH3PXD2B;CREB3L2;NAMPT
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2918804241241396,-0.9297748932087608,0.5423423423423424,0.7819015277189532,1.0,11/31,26.71%,DAB2IP;PTPN1;ERN1;TM7SF3;ATXN3;HDAC6;DNAJB12;HSPA14;HSPA13;HSPA1B;RHBDD1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.38009228276875073,-0.9296984173045951,0.5609318996415771,0.7816836597330012,1.0,3/11,6.70%,KCNJ2;YWHAE;KCNQ1
prerank,establishment of spindle orientation (GO:0051294),-0.30368102046162326,-0.9296774407763079,0.5732368896925859,0.781337988144564,1.0,7/28,22.30%,ITGB1;MAP4;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,regulation of cell cycle process (GO:0010564),-0.23422851609108322,-0.9296352572605828,0.6140035906642729,0.7810521240435481,1.0,38/104,33.27%,DCUN1D3;CDK13;MAD1L1;SETD2;CEP85;CUL9;AHCTF1;ZFYVE26;CEP250;RAB11FIP3;PLK2;BIRC6;CUL7;KLHL13;CCDC8;KIF11;RAB11A;CTNNB1;PLK4;CETN2;PRC1;KIF13A;CHEK1;BECN1;ATF5;PLK3;APC;USP19;CDKN2B;BORA;CAV2;OBSL1;MAP9;PLK1;SND1;KIF20A;E4F1;AURKA
prerank,negative regulation of metabolic process (GO:0009892),-0.2560332715051459,-0.9295261650650343,0.562610229276896,0.7809189909134663,1.0,9/54,14.04%,ZNF423;RB1;ID1;IL15;LAMA4;NOVA2;ADAMTS5;NOTCH1;ATF4
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3050835588965727,-0.9292570472400216,0.5821428571428572,0.7811410767313738,1.0,11/27,28.28%,PLTP;CAV1;RXRA;NFKBIA;ABCA7;EEPD1;PPARG;LPCAT3;GPS2;LRP1;TREM2
prerank,response to insulin (GO:0032868),-0.24026129935690993,-0.9291794332200367,0.6038461538461538,0.7809151133385188,1.0,13/80,12.66%,TBC1D4;SORBS1;FOXO1;INSR;KAT2B;PIK3R1;IRS1;RHOQ;GSK3A;AKT1;RAB8B;INSIG2;CEACAM1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2709769032753219,0.9270125801662645,0.6038543897216274,0.9593561275568785,1.0,11/38,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;HIRA;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,negative regulation of hormone secretion (GO:0046888),-0.3972770847430063,-0.9267669366832889,0.5703422053231939,0.7860057193812664,1.0,5/10,36.27%,RAB11FIP3;RAB11FIP1;RAB11FIP5;IL11;LIF
prerank,O-glycan processing (GO:0016266),0.2582488874607681,0.9261854619091352,0.5981735159817352,0.9603129902872853,1.0,12/54,17.25%,MUC20;GALNT15;GALNT13;GALNT12;GALNT5;GALNT14;POFUT1;C1GALT1C1;MUC16;GALNT3;GALNT2;GALNT6
prerank,cellular polysaccharide catabolic process (GO:0044247),0.33781275552867773,0.9261003030448545,0.5617715617715617,0.9591044052387541,1.0,7/16,18.43%,AGL;PHKG1;PYGM;PYGB;PGM2;PGM2L1;PYGL
prerank,positive regulation of endocytosis (GO:0045807),-0.2669070413545293,-0.9253537293122306,0.5927927927927928,0.7889290921547178,1.0,10/45,13.06%,HIP1;DAB2;NEDD4L;CBLL1;LDLRAP1;CBL;HFE;ANO6;ANKFY1;FLOT1
prerank,regulation of telomere capping (GO:1904353),-0.31034120200124177,-0.9253309799870849,0.569060773480663,0.7885790430242335,1.0,13/23,38.35%,NEK7;ATM;MAPK1;PNKP;TERF2;USP7;SMG6;HNRNPD;TNKS2;RAD50;TNKS;MAPKAPK5;MAPK15
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.2627174240561548,-0.9251010510368742,0.5867620751341681,0.7887026681161509,1.0,18/49,28.28%,GSK3B;DDX3X;LDLRAD4;RAF1;TRAF3IP1;IAPP;SMAD6;HDAC6;ANKRD27;PMEPA1;TFIP11;RPL13A;HMGB1;AIDA;KIF14;NLRP2B;RIOK3;TREM2
prerank,lymphocyte mediated immunity (GO:0002449),-0.36551752996733855,-0.9249786160658138,0.5447761194029851,0.788584156981861,1.0,7/12,45.63%,CD55;JAG1;GNL1;MYO1G;BTN3A3;KLRD1;SLA2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.35691842690243203,-0.9247610239439676,0.5586080586080586,0.7886844948686614,1.0,7/14,36.67%,NT5E;NT5C1A;NT5C;UPB1;UPP1;CAD;DPYS
prerank,negative regulation of histone acetylation (GO:0035067),-0.38738744490529187,-0.9246562344308474,0.5821428571428572,0.788508243135069,1.0,5/11,29.25%,SIN3A;TAF7;BRCA1;SET;SPI1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3553699068620279,0.9245535132101281,0.5422993492407809,0.9621438400726858,1.0,4/13,16.41%,TOX;CAMK4;FOXJ1;ADAM8
prerank,cardiac cell development (GO:0055006),0.367052200414892,0.9243152387682246,0.5472972972972973,0.9613371355140096,1.0,4/11,11.92%,CXADR;ALPK3;VEGFA;SLC8A1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.36983361189141223,-0.9241193769474904,0.554945054945055,0.7893398773796955,1.0,3/12,4.94%,PKD2;ABCC9;TRPM4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3920064523759654,-0.9239818910015434,0.5533807829181495,0.7892701021536311,1.0,7/10,47.14%,AKT1;TREM2;TICAM1;TLR6;MIA3;TLR4;MYD88
prerank,negative regulation of protein depolymerization (GO:1901880),0.2922122630115181,0.9236416617363826,0.5416666666666666,0.9618588214185528,1.0,6/24,17.24%,NAV3;APC2;STMN2;HDGFL3;CLASP2;CAMSAP3
prerank,histone H3-K36 demethylation (GO:0070544),-0.3927991759154038,-0.9233033286688943,0.5482695810564663,0.790391990188989,1.0,3/10,14.06%,KDM2A;RIOX2;KDM7A
prerank,sympathetic nervous system development (GO:0048485),-0.3539519705399269,-0.9231980698350869,0.5473098330241187,0.7902325585068068,1.0,4/15,20.79%,NRP2;CTNNB1;SOX4;NF1
prerank,glycolytic process (GO:0006096),0.2945657707248935,0.9231901339807086,0.56,0.9617109802654066,1.0,5/28,15.03%,GCK;TPI1;PKM;ENO2;HK1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.3924902780641152,-0.9230247825939715,0.5597826086956522,0.7902394036097724,1.0,5/10,38.33%,HDAC6;AOC3;HP;MT3;ETFBKMT
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.22558744859644406,-0.9223813312853889,0.6512455516014235,0.791347567761184,1.0,17/117,11.72%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;PLK2;RHBDF2;ADCY4;PLCG2;RAMP2;ADM;CYSLTR2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.3802884384749949,-0.9212467770847084,0.5587188612099644,0.7935861414547544,1.0,2/11,3.17%,LYN;ATM
prerank,cellular iron ion homeostasis (GO:0006879),-0.2553382432233604,-0.9212164707698285,0.6036697247706422,0.7932505918148458,1.0,11/55,18.25%,ABCG2;SLC40A1;TFRC;BMP6;SCARA5;SMAD4;HFE;HMOX2;ABCB7;SOD1;FLVCR1
prerank,proteoglycan biosynthetic process (GO:0030166),-0.2858813827645026,-0.9211537941107731,0.5765765765765766,0.792997310585467,1.0,6/31,12.14%,EXT1;BMPR2;CSGALNACT1;HS3ST3B1;CHST11;EXTL3
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3071765809871121,-0.9209010975280686,0.5867620751341681,0.7931933966346416,1.0,7/24,24.01%,ACVRL1;BMPR2;DACH1;TERF2;RPS3;BLM;MSH3
prerank,regulation of ATP metabolic process (GO:1903578),-0.2540126496995237,-0.9207129512777577,0.6117021276595744,0.7932319833468,1.0,24/54,39.21%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;UQCC2;OGT;NUP188;BEND3;NUP88;SLC25A33;NUP35;NUP43;HIF1A;ATP5IF1;PGAM1;JMJD8;PRKAG2;COX7A1;NUP50
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2198977337404153,0.9206615715063544,0.6490384615384616,0.9677490944551105,1.0,15/107,12.59%,SLC24A4;SLC24A2;HTR2C;STC1;ATP2B4;ATP2B2;ATP1B1;SLC8A2;RYR2;TMCO1;CCL13;ATP13A2;SLC8A3;SLC8A1;CCL5
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.22665099841399902,-0.920452663104128,0.6703096539162113,0.7934009114268138,1.0,17/116,11.72%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;PLK2;RHBDF2;ADCY4;PLCG2;RAMP2;ADM;CYSLTR2
prerank,cellular response to zinc ion (GO:0071294),-0.3537838969777182,-0.9201889161104494,0.5952380952380952,0.7936252451864247,1.0,9/15,25.53%,HVCN1;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B
prerank,metanephric mesenchyme development (GO:0072075),0.36988597938168377,0.920098088807339,0.5448577680525164,0.9679197718713632,1.0,3/10,6.07%,OSR1;WT1;PAX2
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2969542146866452,-0.9195032812956281,0.584070796460177,0.7947617369009758,1.0,10/29,27.81%,JAM2;GAS6;MOSPD2;ANO6;LGMN;CXCL12;SERPINE1;HMGB1;LGALS9;CXCL10
prerank,regulation of lymphocyte activation (GO:0051249),0.3512503889166565,0.9192157542142234,0.540045766590389,0.9689096575862558,1.0,2/12,12.59%,PAG1;CCL5
prerank,multivesicular body organization (GO:0036257),-0.2841570020065055,-0.9190879789026905,0.5875912408759124,0.7952940304001416,1.0,14/31,30.85%,RAB27A;CHMP4B;CHMP4A;VTA1;CHMP2B;VPS36;CHMP5;RAB11A;PDCD6IP;STAM2;CHMP3;VPS37B;CHMP6;CHMP1A
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.272955543635484,-0.9185586244072549,0.6079136690647482,0.796077097503114,1.0,9/40,14.12%,SLC7A5;SLC38A11;SLC5A6;SLC38A5;SLC16A1;SLC13A3;SLC25A11;SLC7A7;SLC36A4
prerank,tube closure (GO:0060606),-0.29027761312090394,-0.918256535211496,0.5716814159292035,0.7963761420130012,1.0,9/31,18.67%,LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI;MTHFD1L
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.29083118901351057,0.9182535519426692,0.5736263736263736,0.9702433690088514,1.0,10/30,17.77%,UBE2J1;TUSC3;DPM1;MCFD2;UGGT2;LMAN1;RPN2;OSTC;RPN1;MGAT1
prerank,regulation of calcium ion import (GO:0090279),0.3144767317300265,0.9179683018651557,0.5726141078838174,0.9695932494887861,1.0,6/21,12.96%,STC1;WNK3;TRIM27;PLPP4;SPHK2;CCL2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.2578650126860585,0.9178545303953655,0.5933014354066986,0.9684886695535603,1.0,9/48,15.02%,PDE4B;TRIM27;IL12A;IL12RB1;RASGRP1;CD226;TXK;SLAMF6;IL23A
prerank,regulation of interleukin-2 production (GO:0032663),-0.26522965944382254,-0.9177858142171514,0.5818505338078291,0.7970476472278322,1.0,14/43,24.76%,SPTBN1;CD34;PRKD2;EZR;PLCG2;KAT5;TNFAIP3;ANXA1;RPS3;PTPRC;HDAC7;HOMER3;STOML2;MAP3K7
prerank,response to organonitrogen compound (GO:0010243),0.27249129443216635,0.9177492841195596,0.5838926174496645,0.9673736015946851,1.0,3/38,4.32%,GLRA3;GLRA1;INAVA
prerank,nucleus organization (GO:0006997),-0.26072889440270103,-0.9175693667395387,0.611214953271028,0.7971542059319613,1.0,16/47,31.36%,SYNE1;NUP98;REEP3;CHMP4B;CHMP4A;CHMP2B;TPR;SUN1;CHMP5;PDCD6IP;ATXN7;DMPK;CHMP3;CHMP6;CHMP1A;NUP35
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.29852766654937946,-0.917495597022555,0.5884543761638734,0.7969296471127129,1.0,4/27,12.29%,NFAT5;ETS1;RHOA;IRAK1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3036988877152697,-0.91729668997117,0.6046511627906976,0.7970393394389214,1.0,8/24,21.91%,MCL1;FOXO3;TGFB2;ATF4;SRPK2;CTNNB1;NF1;ITGAM
prerank,arachidonic acid metabolic process (GO:0019369),-0.27950085644116884,-0.9168140779576377,0.5661764705882353,0.7977225244230524,1.0,12/35,26.43%,PLA2G4A;PTGS1;EPHX1;MGLL;PTGES3;GPX1;HPGDS;DAGLB;PNPLA8;CYP1B1;PTGIS;GPX4
prerank,negative regulation of histone modification (GO:0031057),0.3492670476159728,0.9165775661392399,0.5889423076923077,0.9693122795782491,1.0,4/14,15.44%,PRMT6;SPHK2;THAP7;TWIST1
prerank,positive regulation of peptidase activity (GO:0010952),-0.3168880133209776,-0.916508100952415,0.5960502692998204,0.7980497233795268,1.0,6/20,19.01%,PSME2;MAPK12;VSIR;CTSH;APH1A;PSME1
prerank,cilium-dependent cell motility (GO:0060285),0.2997094744146588,0.9164338440265004,0.5594989561586639,0.9682622627952917,1.0,2/22,4.01%,TEKT1;CFAP54
prerank,phosphatidylcholine metabolic process (GO:0046470),0.23796938123216402,0.9156414581551878,0.6494623655913978,0.9689613917824053,1.0,15/70,17.56%,ENPP2;PCYT1B;LPIN1;PLA2G7;PLA2G3;PLA2G4E;PLA2G6;LIPC;MBOAT7;GPLD1;CHKA;CHPT1;SLC44A2;MBOAT2;LPCAT2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.31368464671708,-0.9156013353578208,0.5740072202166066,0.7997793102539484,1.0,8/23,30.85%,GAS6;VSIR;RARA;HMGB1;LGALS9;AXL;DDIT3;LILRB1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.37134611838581266,-0.9155803634159623,0.592391304347826,0.7994346269830642,1.0,5/12,15.57%,LAMA3;LAMA5;ACTB;TRAF3IP1;FUZ
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.27239859965202634,-0.9155764851040159,0.603415559772296,0.799041419389806,1.0,10/41,16.92%,CD34;GAS6;LBP;NFKBIL1;DICER1;TNFAIP3;ILRUN;VSIR;IGF1;RARA
prerank,triglyceride biosynthetic process (GO:0019432),0.3226319721111346,0.9154483459109071,0.5752808988764045,0.968033683355878,1.0,3/18,12.65%,LPIN1;GK;MOGAT1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.35871342333248113,-0.9154480648911504,0.5867620751341681,0.7989759218849384,1.0,5/13,12.27%,TGFBR3;MEF2C;TBX2;NOTCH1;FGF2
prerank,protein K48-linked deubiquitination (GO:0071108),0.30121795994053807,0.9154046317351168,0.5766590389016019,0.9667112409659703,1.0,11/23,24.59%,OTUD7A;USP25;OTUD7B;USP50;USP5;USP33;USP20;OTUB2;USP8;OTUB1;OTUD5
prerank,organonitrogen compound catabolic process (GO:1901565),-0.2506954200413607,-0.9153064228565729,0.6222627737226277,0.7989016133915792,1.0,18/57,22.25%,CPQ;PLA2G4A;MTOR;ACE;GNPDA2;TXN2;ENPEP;PDXDC1;GGACT;USE1;SMPD2;ERAP1;SIAH1;NPEPPS;CLN5;CTH;ADO;PNPLA8
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2969010470886445,-0.9150297270767096,0.5849731663685152,0.7991043079521871,1.0,11/26,23.71%,CLIP1;RAC1;TOGARAM1;OCLN;DCTN1;SLAIN2;DRG1;RPS3;TRPV4;AKAP9;ARL2
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.36879783632669705,-0.914632152311726,0.5860113421550095,0.7996184281250122,1.0,2/12,5.85%,PPARA;IRS1
prerank,polarized epithelial cell differentiation (GO:0030859),-0.3597502607265216,-0.913983430951432,0.5796064400715564,0.8007043353318262,1.0,4/13,18.14%,MSN;EZR;RHOA;RAP2A
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3377401879291898,-0.9138874216524112,0.5958188153310104,0.8005337682016842,1.0,8/16,33.12%,DMAC2L;ATP5F1E;ATP5F1C;ATP5MF;ATP5PO;STOML2;ATP5F1D;ATP5MC2
prerank,regulation of chromatin binding (GO:0035561),-0.3956658748911195,-0.913830203353165,0.5845070422535211,0.800257752501052,1.0,4/10,10.43%,BTAF1;DTX3L;WAPL;HMBOX1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.32660122191366264,0.913719562516164,0.562929061784897,0.970065729951559,1.0,4/17,8.20%,PKP2;GPD1L;RYR2;SCN5A
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3318183934430091,-0.9137015522263899,0.5886654478976234,0.8001615360907453,1.0,6/18,25.25%,CAV1;NEDD4L;SLC43A1;PPIF;KCNH2;CAB39
prerank,glucose transmembrane transport (GO:1904659),-0.3263133681527574,-0.9136000050348156,0.566003616636528,0.7999984427816946,1.0,4/18,13.25%,SLC2A1;PPARD;RAB4B;SLC2A9
prerank,SNARE complex assembly (GO:0035493),-0.38958155941002026,-0.9135246120185434,0.5804195804195804,0.7997742557123261,1.0,5/10,34.06%,STXBP6;VAMP3;VAMP2;VAMP8;VAMP4
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2435556572173514,-0.9128841237631853,0.6167557932263814,0.8008442283374293,1.0,17/69,17.81%,FERMT2;GSK3B;LIMK2;DTX3L;TFRC;RIC3;STX3;CEP250;YAP1;AKT1;CROCC;PRKAA1;GPR137B;TRAPPC12;ABCA7;FYN;CDK5RAP3
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.22192363594420358,-0.9127695017711358,0.6545454545454545,0.8007201533878876,1.0,48/117,35.11%,BSG;DLD;PANK2;SLC5A6;PPARA;GGT5;ACSF2;SLC16A1;PPARD;SCPEP1;THEM4;CPT1A;ACADSB;ABAT;SLC27A4;PDHB;LPL;IGF1;HOGA1;GBA2;MTHFD1L;PCCA;PPARG;PCCB;KYNU;GAMT;PTGR1;PNPLA8;ACOT6;ACSF3;CKMT1A;ACOT11;GLO1;SGPL1;ALKBH7;ME2;HACL1;HAGH;LDHA;VNN1;HLCS;NPC1;FASN;ADH1A;ME1;CYP4B1;ECHDC3;ALDH8A1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.2909520986426234,0.9127530672477085,0.5986394557823129,0.9713583509697946,1.0,3/24,6.48%,TMEM161A;BCL2;TRIAP1
prerank,regulation of cholesterol transport (GO:0032374),0.312441284043779,0.9126525374709962,0.5655021834061136,0.9702006143848227,1.0,9/20,27.51%,OSBPL6;ABCA2;NUS1;ABCA5;APOC1;LAMTOR1;NR1H2;ARV1;TTC39B
prerank,mitotic cytokinesis (GO:0000281),-0.2608620751752934,-0.9126360014395622,0.6101398601398601,0.8006340352473974,1.0,13/47,15.74%,SPTBN1;STAMBP;SNX9;ROCK1;CHMP4B;CUL7;KIF23;RASA1;SON;RTKN;RHOC;ROCK2;MITD1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.2983565110440941,-0.9124734582011347,0.5868794326241135,0.8005996830002123,1.0,5/25,11.33%,RIN3;RAC1;APP;PICALM;PSEN1
prerank,negative regulation of immune system process (GO:0002683),0.33216429517515833,0.9121864297925224,0.5859030837004405,0.9700322271284134,1.0,6/16,17.74%,FCRLB;HOXA7;GPER1;COL3A1;SOX9;FCGR2B
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23605800556503848,-0.9121241672776649,0.6348920863309353,0.8010195503456735,1.0,14/75,15.35%,GRK5;RGS3;RGS5;GIT2;ZDHHC3;RGS12;PLCB1;PLCE1;ROCK1;NMT1;EDN1;MGLL;SAG;ROCK2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2928858139855699,-0.9119092466157369,0.583804143126177,0.801112225818152,1.0,13/28,32.37%,DTX3L;SHLD1;KMT5B;MRNIP;PNKP;MAD2L2;TFIP11;PRKDC;ERCC6;PARP9;KDM4D;CYREN;PARP3
prerank,transferrin transport (GO:0033572),-0.28286352997444786,-0.9117645000749984,0.5986277873070326,0.8010751706931377,1.0,8/33,13.99%,TFRC;DNM2;STEAP3;ARHGAP1;HFE;ATP6V1E1;MCOLN1;REP15
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.38989857983943366,-0.91111101359953,0.5892255892255892,0.8021464568131651,1.0,5/10,32.72%,LYN;CD40;BTLA;LILRB1;FGR
prerank,cellular response to purine-containing compound (GO:0071415),0.37348269003445406,0.9105968482487773,0.5629139072847682,0.97307523088748,1.0,3/10,11.92%,RYR3;RYR2;SLC8A1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.32866881938486747,0.9101206589971652,0.5870535714285714,0.97304185405822,1.0,9/15,21.98%,SCN1A;TMC1;TMC2;KIT;WHRN;MKKS;COL11A1;PDZD7;KCNK4
prerank,regulation of autophagosome maturation (GO:1901096),0.34095409613748334,0.9100609863664039,0.5846153846153846,0.9717751041603816,1.0,6/13,23.94%,CLN3;RUBCN;FYCO1;CLEC16A;SMCR8;UBQLN4
prerank,regulation of interleukin-13 production (GO:0032656),-0.3564823865795269,-0.9098390472748128,0.5870307167235495,0.8046853102440412,1.0,1/13,0.16%,LEF1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.38853004515593736,-0.9096010745790051,0.5769230769230769,0.8047998699406889,1.0,7/10,34.66%,DICER1;AGO2;DROSHA;TERT;TSN;TARBP2;MRPL44
prerank,negative regulation of receptor binding (GO:1900121),-0.39023942988007143,-0.9095727992724242,0.575,0.8044621047351708,1.0,2/10,11.78%,ATP2A3;HFE
prerank,heterochromatin assembly (GO:0031507),-0.32854350614908934,-0.9092787805929711,0.5934819897084048,0.8047135136023491,1.0,4/20,14.82%,ZNFX1;HDAC1;SUV39H1;H3-3A
prerank,leukotriene metabolic process (GO:0006691),-0.3195239370070579,-0.9090615972195446,0.6070763500931099,0.8047958897734356,1.0,3/19,7.48%,PLA2G4A;GGT5;MAPKAPK2
prerank,positive regulation of ruffle assembly (GO:1900029),0.3477493093116961,0.9090170467403601,0.5625,0.9732617815575613,1.0,2/13,5.58%,NLGN1;PFN1
prerank,protein kinase B signaling (GO:0043491),-0.3032812240695294,-0.9087231485092726,0.5953654188948306,0.805179213242017,1.0,10/23,26.06%,KDR;GAS6;AKT1;THEM4;PIK3R3;IGF1;EPHA2;PTEN;PLK3;ZFP36L1
prerank,zinc ion transport (GO:0006829),-0.3136753904450824,-0.9081724287103478,0.6082089552238806,0.8060228816312709,1.0,6/21,20.72%,SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,cellular response to unfolded protein (GO:0034620),-0.29861560722896185,-0.9080450980540078,0.5909090909090909,0.8058908460612071,1.0,5/26,12.34%,DAB2IP;PTPN1;ERN1;ABCB10;TM7SF3
prerank,response to retinoic acid (GO:0032526),-0.24719913801361582,-0.9079163109014468,0.6300884955752213,0.8057664551085396,1.0,9/59,6.79%,LYN;ACER2;ASXL1;RXRA;ATM;TBX1;FZD4;RARG;RBP4
prerank,RNA biosynthetic process (GO:0032774),0.2781843453157177,0.9077848515728933,0.5746606334841629,0.9753073131064379,1.0,5/31,10.43%,TBPL1;SMARCA5;TAF5;POLA1;PRMT5
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.38752057606292256,-0.9071149845224497,0.5767857142857142,0.8071280927757041,1.0,2/10,7.02%,TGFBR2;CD55
prerank,negative regulation of cyclase activity (GO:0031280),0.3441348806913779,0.907021148567736,0.5856832971800434,0.9760020729593238,1.0,2/14,4.62%,GNAI2;GABBR2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.3300213546415442,0.9068331463735773,0.5827956989247312,0.975082299593671,1.0,3/17,12.59%,VTN;NR4A3;CCL5
prerank,regulation of pH (GO:0006885),0.3605289722339833,0.9068116553236131,0.5735607675906184,0.9737323932824281,1.0,1/11,3.49%,SLC9A7
prerank,nucleotide metabolic process (GO:0009117),0.29865168287902455,0.9067897051397751,0.6084070796460177,0.9723729937311054,1.0,7/23,17.00%,AK7;AK5;ENPP3;NME2;RNASEH2B;GUK1;AK1
prerank,lipid droplet organization (GO:0034389),0.3048458235547951,0.9060857156049195,0.5759637188208617,0.9729442654039014,1.0,6/22,17.76%,BSCL2;SQLE;PPID;PPIA;AUP1;CDS1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.31741045011543634,-0.9055904248932934,0.6088560885608856,0.810150611108597,1.0,3/19,5.88%,PARD3B;PARD3;DLG1
prerank,embryonic organ morphogenesis (GO:0048562),0.2598841701969952,0.9052879955835745,0.6326086956521739,0.9737733875355084,1.0,8/42,10.01%,DSCAML1;EFEMP1;HOXD3;MEGF8;RYR2;FGFR2;MFAP2;HOXA4
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.30012701540444364,-0.9049575953408299,0.6069469835466179,0.8111548387356096,1.0,9/26,19.01%,LYN;PSME2;EPHA4;PICALM;ROCK2;VSIR;FYN;APH1A;PSME1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2692707760329949,-0.9049394505396066,0.6237113402061856,0.8107999858367799,1.0,9/39,13.47%,MYO1D;TRAK1;FNBP1L;RAB1A;WASL;MYO1F;ACTN4;PAFAH1B1;FBXW11
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.29048634163637044,0.9049315633146983,0.5945378151260504,0.9733665472826877,1.0,6/24,11.98%,PDE3B;GNAI1;PEX5L;PDE11A;RNF157;PRKAR1B
prerank,response to nitric oxide (GO:0071731),0.3440769064266029,0.9047587258575537,0.5714285714285714,0.972402307321272,1.0,2/13,8.04%,KCNC2;DPEP1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3273908524150573,-0.9045662672948318,0.5992970123022847,0.8112706819057465,1.0,7/17,30.81%,BMP4;RGCC;VSIR;F2R;LARP6;RUNX1;TGFB1
prerank,phagosome-lysosome fusion (GO:0090385),0.37647239813815275,0.9044270402017307,0.6036446469248291,0.9719195056809423,1.0,4/10,15.85%,CLN3;RAB39A;RAB34;RAB20
prerank,positive regulation of cation channel activity (GO:2001259),0.2630932341323244,0.904282528257548,0.6365740740740741,0.9709220819622651,1.0,7/40,12.96%,ANK3;STAC2;AKAP6;CALM2;STAC;CASQ1;CCL2
prerank,mesenchymal cell development (GO:0014031),0.3192549236152964,0.9037744004356764,0.5933333333333334,0.9709771145379364,1.0,3/18,11.60%,NRG1;NOLC1;CDH2
prerank,positive regulation of proteolysis (GO:0045862),-0.2544967495140802,-0.9035291292081753,0.6348920863309353,0.8132088141717864,1.0,12/55,21.11%,CTSC;ADAM9;TNFRSF1B;SNX9;ASPH;CASP8;PERP;FBXW11;MAPK12;CTSH;FGFR4;OGT
prerank,dicarboxylic acid catabolic process (GO:0043649),0.34122265198161006,0.9032623618338619,0.5720720720720721,0.9709484479070053,1.0,5/13,22.04%,ASPA;GLUD1;GAD1;DDO;MTHFS
prerank,ceramide transport (GO:0035627),-0.36024597428046334,-0.9032062890589977,0.6083032490974729,0.813536827552637,1.0,2/12,1.27%,CERT1;PLTP
prerank,protein localization to cilium (GO:0061512),-0.27848001680730383,-0.9030835744254689,0.6196428571428572,0.8134253925248567,1.0,9/32,22.72%,ZNF423;RABEP1;IFT140;EHD1;WDR35;CSNK1D;TULP1;IFT20;TULP3
prerank,fat cell differentiation (GO:0045444),-0.24872275489018617,-0.9030805341955113,0.6293577981651376,0.8130347594855589,1.0,24/57,35.18%,FOXO1;KLF4;PRDM16;TMEM120A;ZBTB7A;MED1;CTBP2;SMAD6;C1QTNF3;SENP2;ERAP1;TCF7L2;PPARG;CEBPA;ATF5;WNT5B;SDF4;STEAP4;PID1;TRIM32;ALOXE3;IL11;NR4A2;ADIG
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.34552421165080727,-0.9028940734326165,0.6029411764705882,0.8130607722591672,1.0,4/15,10.57%,CSGALNACT1;DSE;CSPG4;BGN
prerank,carbohydrate transport (GO:0008643),-0.366402380023241,-0.9025742400536899,0.5825602968460112,0.8133944440357322,1.0,6/11,33.07%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1
prerank,diol metabolic process (GO:0034311),0.31463452314856594,0.9021441477639193,0.5916114790286976,0.9726119467701518,1.0,6/19,11.24%,PLPP2;SPHK1;SGPP1;PRKG2;SPHK2;NAAA
prerank,regulation of neurotransmitter transport (GO:0051588),0.33420896427579827,0.9020521607591916,0.5981735159817352,0.9714346983670332,1.0,3/16,10.68%,RIMS1;SYN1;MCTP2
prerank,peptidyl-asparagine modification (GO:0018196),0.28202641294607306,0.902019463333193,0.6025917926565875,0.9701077180030813,1.0,10/31,17.77%,UBE2J1;TUSC3;DPM1;MCFD2;UGGT2;LMAN1;RPN2;OSTC;RPN1;MGAT1
prerank,activation of protein kinase B activity (GO:0032148),0.27971790664913593,0.9016013695285289,0.6359338061465721,0.9698652686677993,1.0,5/29,9.30%,NRG1;CCDC88A;ANG;ADRA2C;ADRA2A
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.26564288357112037,0.9010300201854091,0.6261061946902655,0.9700014575217469,1.0,10/35,17.32%,FAR1;ACLY;ACACA;HMGCLL1;ALOX12;HMGCL;SCD5;ALOX5;SCD;GGT7
prerank,mitotic cytokinetic process (GO:1902410),-0.30932022166792283,-0.90097906682456,0.6067415730337079,0.8166269496141235,1.0,11/20,32.65%,CHMP4B;CHMP4A;RHOA;CHMP2B;MITD1;CHMP5;PDCD6IP;CHMP3;CHMP6;CHMP1A;KIF20A
prerank,fatty acid elongation (GO:0030497),0.34686568204398477,0.9004040010421491,0.6046511627906976,0.9702803096717451,1.0,5/13,19.34%,HACD1;ELOVL4;TECR;HACD2;HACD3
prerank,T cell receptor signaling pathway (GO:0050852),-0.21561240824695996,-0.9002441409986098,0.7021996615905245,0.8178695002496219,1.0,43/138,25.35%,PSMA2;PAK2;PLCG1;PRKD2;PTPRJ;NFKB1;NCK1;PIK3R1;SPPL3;PSME2;PSMB4;PLCG2;THEMIS;BCAR1;PIK3CD;EIF2B2;CSK;FBXW11;PIK3CB;ICOSLG;PSMC2;RC3H1;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;PTPRC;PSMD4;INPP5D;PSMA7;RELA;FYB2;CD276;PSMD5;CD247;STOML2;MAP3K7;KHDRBS1;PIK3CA
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3060146301152677,-0.900169231426181,0.5992844364937389,0.8176418384997548,1.0,8/22,26.50%,CDKN1B;LATS2;TFAP4;PTEN;NR2F2;MYOCD;CEBPA;APC
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2808803713563013,-0.9001169384163521,0.6148409893992933,0.8173683990136308,1.0,14/31,28.11%,POLR2G;EXOSC2;EXOSC1;EXOSC3;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;DIS3L2;NT5C3B;EXOSC7;CNOT8;LSM2
prerank,modified amino acid transport (GO:0072337),-0.3407281706076742,-0.900069996501811,0.5863247863247864,0.8170772083587523,1.0,3/15,5.22%,SLC16A12;SLC25A32;SLC5A6
prerank,bicarbonate transport (GO:0015701),-0.29793114070743204,-0.8999312826799858,0.6087751371115173,0.81698068081103,1.0,4/25,7.50%,SLC26A7;SLC4A10;CA4;SLC39A8
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.30293561890183357,-0.8999304286957458,0.6111111111111112,0.8165825798665473,1.0,7/24,15.57%,PRKCH;CBFB;MED1;ROCK1;FOXC1;ROCK2;TRIM16
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.30094424689814897,-0.8994779770914363,0.6131907308377896,0.8172172336653082,1.0,12/23,32.44%,UBE2K;APP;IRGM;MAPK1;RPTOR;BMP7;CAB39;TRIM6;STOX1;TGFB1;CEMIP;PLK1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.32627361325705173,-0.8993410729651844,0.5909090909090909,0.8171182985968997,1.0,5/17,15.78%,PRKACB;ADCY9;ADCY4;CYSLTR2;ADCY1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3507507765607325,0.8992939006142691,0.5874439461883408,0.9719022724279404,1.0,2/13,4.62%,GNAI2;GABBR2
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.22450777206816996,-0.8991715191102748,0.6816546762589928,0.8170975557367992,1.0,40/95,37.54%,DAB2IP;ADAM9;NFKB1;TNFRSF1B;PDCD4;IRGM;LBP;MEF2C;NFKBIL1;RHOA;IRAK1;CDC73;MAPK8;TNFAIP3;CHMP5;DEFA6;NOD2;RELA;SERPINE1;CASP1;FZD5;SHPK;HMGB1;CXCL10;AXL;CACTIN;MAPK14;LILRB1;SBNO2;TICAM1;TNIP2;CD14;IL1A;CARD16;NLRP3;CXCL5;TLR2;CD274;CTR9;CXCL1
prerank,selective autophagy (GO:0061912),-0.2501745385071946,-0.8989463373508074,0.620817843866171,0.8172063098124055,1.0,16/56,26.92%,ATM;RAB7A;MAP1LC3B;AMBRA1;WDFY3;UFM1;ULK2;ATG5;LGALS8;HDAC6;KLHL3;PCNT;BECN1;ATG2A;ATG2B;DYNLL1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.2775188093468827,-0.8988932898653759,0.627208480565371,0.8169273361214865,1.0,8/32,20.96%,PLA2G4A;MBOAT1;PLSCR1;PTDSS1;PLA2G12A;SERINC1;SERINC5;LPCAT3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.25145046691106726,-0.8988051680633911,0.6413793103448275,0.8167216644861223,1.0,18/55,26.87%,FBXL7;PSMA2;RBX1;PSME2;PSMB4;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;PSMD4;PSMA7;FHL1;PSMD5;ATF5;PINX1;PSMB10;PSMA3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.35842434557193587,0.8986596526337052,0.5958429561200924,0.9722226531002948,1.0,5/12,24.80%,CDA;UCK2;UCK1;TK1;TK2
prerank,regulation of DNA replication (GO:0006275),-0.2540536083487507,-0.8986279843687015,0.6459854014598541,0.8167061037126362,1.0,10/49,13.51%,ACVRL1;ANKRD17;STN1;EGFR;WAPL;ORC5;PDS5A;OBI1;DNA2;CTC1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.36769706437498856,-0.8977309909266941,0.6231884057971014,0.8183333843539808,1.0,6/11,29.00%,ITGB5;CCN3;VCL;KIFC3;THBS4;JUP
prerank,positive regulation of DNA repair (GO:0045739),-0.2610928290141544,-0.8977048702832804,0.6554934823091247,0.8180000211637506,1.0,20/46,26.54%,EYA4;UIMC1;EGFR;SPIDR;BABAM2;RNF168;SLF2;ERCC8;HDAC10;CEBPG;BRCC3;RPS3;TIMELESS;BRCA1;TRIM28;FAM168A;HMGB1;DHX9;ERCC6;FGF10
prerank,microtubule nucleation (GO:0007020),-0.31996357718365404,-0.8966939178675937,0.6187943262411347,0.8198381994454659,1.0,9/19,30.18%,RANBP9;SLAIN2;CSNK1D;TUBGCP4;TUBGCP5;NDEL1;AKAP9;TUBG2;TUBGCP3
prerank,positive regulation of cyclase activity (GO:0031281),-0.3469381184245154,-0.8960903100770486,0.6242990654205608,0.820760839963013,1.0,7/14,35.15%,NOS3;MAPK8;NF1;NOS1;MAPK14;NOS2;STIM1
prerank,protein maturation (GO:0051604),0.21685125417656487,0.8958918764392921,0.7048780487804878,0.9782678714705995,1.0,22/95,15.49%,MME;MMP16;DNAJB11;TSPAN15;CLN3;CPE;TYSND1;METAP2;SORL1;BACE1;ADAM19;TESC;CPN1;PCSK2;AEBP1;TSPAN32;PCSK6;NAA40;NFU1;NDUFAB1;ECE2;EEF1AKMT4-ECE2
prerank,anterior/posterior pattern specification (GO:0009952),-0.2510288764778849,-0.895863080979621,0.6471600688468159,0.820868628669527,1.0,12/53,18.38%,LRP5;BMPR2;TBX1;HES1;HOXB6;SMAD2;PCSK5;HOXC6;SKI;HEY1;HEY2;HOXB9
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.327861595060779,-0.8957352325335454,0.6285714285714286,0.8207678337782196,1.0,7/16,16.38%,TGFBR3;MEF2C;TBX2;EDN1;NOTCH1;FGF2;IGF1
prerank,lung development (GO:0030324),-0.271899583430043,-0.8953753420636985,0.6192170818505338,0.8211369118442778,1.0,9/33,14.01%,ITGA3;LOXL3;RBP4;FGF1;BMP4;FGF7;FGF2;WNT11;ZIC3
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2995640162562388,0.8949564746091744,0.6318082788671024,0.9793324919642192,1.0,3/20,7.35%,CHRM2;CHRM3;LY6G6D
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2626571732337961,-0.8948014222415209,0.6407407407407407,0.8220491244224708,1.0,10/43,16.92%,CD34;GAS6;LBP;NFKBIL1;DICER1;TNFAIP3;ILRUN;VSIR;IGF1;RARA
prerank,negative regulation of RNA splicing (GO:0033119),-0.32122286497135516,-0.8947202143652468,0.6238698010849909,0.8218087095752378,1.0,8/19,30.51%,SRSF12;SFSWAP;RNPS1;PTBP3;SRSF10;RPS26;SRSF6;RPS13
prerank,replicative senescence (GO:0090399),-0.3619169898780439,-0.8944621663558937,0.5945945945945946,0.8219846782867098,1.0,6/12,22.81%,ATM;WNT16;TP53;TERT;CHEK1;SERPINE1
prerank,regulation of ion transmembrane transport (GO:0034765),-0.28201989473863154,-0.894417855479673,0.620253164556962,0.821695302447969,1.0,12/33,24.02%,NEDD4L;KCNJ2;YWHAE;NEDD4;KCNQ1;ANO6;KCNJ8;CASQ2;WWP2;KCNH2;AKAP9;AHCYL1
prerank,cardiocyte differentiation (GO:0035051),-0.3753949680199477,-0.894074639979818,0.613013698630137,0.822045819326964,1.0,4/10,10.26%,AKAP13;SIK1;TGFB2;KDM6B
prerank,chordate embryonic development (GO:0043009),0.23818598004268757,0.893851306565429,0.6601941747572816,0.9808883991486292,1.0,12/55,11.42%,WNT7B;COL1A1;UCMA;FLCN;PROX1;DEAF1;FGFR2;LMX1B;VEGFA;ZNF568;ALDH1A2;ARNT2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3515148860377235,0.8938101669728956,0.5816831683168316,0.9795780230778369,1.0,2/12,6.82%,FADS1;FADS2
prerank,camera-type eye morphogenesis (GO:0048593),-0.38748855141055627,-0.89334924278989,0.6137931034482759,0.8232965550171604,1.0,5/10,20.79%,LRP6;TBX2;SHROOM2;SKI;NF1
prerank,chromosome organization (GO:0051276),-0.2258708829052817,-0.8931903370847816,0.7040280210157618,0.8232816097188884,1.0,36/99,30.82%,RAE1;HDAC1;RBX1;ABL1;ZBTB7A;SUV39H1;LDB1;EHMT1;DOT1L;AXIN2;HMG20A;HMGN3;XPC;H3-3A;TCF7L1;RFWD3;HDAC10;CETN2;HMGN2;TCF7L2;LIG4;COPS7A;PWWP3A;CENPH;COPS8;SUPT4H1;SETD7;MSH3;COPS4;HDAC5;CDCA8;PHF19;CDAN1;BRWD1;COPS5;BAHD1
prerank,neurotrophin signaling pathway (GO:0038179),-0.31123790247310706,-0.8930115897811651,0.6285211267605634,0.8232783471614903,1.0,7/21,14.62%,RAPGEF2;DDIT4;RAP1A;NGF;BCAR1;RAPGEF1;GRB2
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.36586731602727746,-0.8928845920070394,0.6183206106870229,0.8231707374896623,1.0,3/11,13.25%,NEDD4L;PICALM;TAX1BP3
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.3304723229689385,-0.8923114841809892,0.6268115942028986,0.8240418103537981,1.0,7/16,42.75%,PDE12;PPIF;UQCC2;SLC25A33;VCP;COX7A1;ABCD1
prerank,regulation of lipid metabolic process (GO:0019216),-0.22990711243894843,-0.8922973976166304,0.6869565217391305,0.8236726990161318,1.0,25/88,20.44%,CREBBP;CAV1;RXRA;PANK2;SP1;PPARA;MED1;NFYC;GGPS1;PPARD;ACACB;HELZ2;SIN3A;C1QTNF2;SMARCD3;NR1D2;TGS1;DHCR7;ABCA7;TNFAIP8L3;CARM1;NCOA6;TBL1X;PPARG;FGFR4
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3518140969424782,-0.8922526835812119,0.6162162162162163,0.8233762700878434,1.0,3/13,11.47%,JAK1;IL6ST;JAK2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.2995912220096538,0.8918460734374858,0.5921052631578947,0.9834185626938118,1.0,3/22,6.43%,GNAI2;GABBR2;CACNA1D
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.31231833079711546,-0.8910627588053731,0.6120218579234973,0.8255576524922168,1.0,4/20,6.52%,NEDD4L;PRKCE;YWHAE;NEDD4
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.3624677427670432,-0.8909787252971382,0.6222627737226277,0.8253334708083819,1.0,6/12,36.49%,RAB1A;PTEN;FZR1;PLK1;CDC20;UBE2C
prerank,error-free translesion synthesis (GO:0070987),-0.3037590796266337,-0.8904180685774897,0.6319702602230484,0.8262124239047351,1.0,7/22,24.17%,RPA3;REV1;RPA1;RPA2;RFC4;RFC1;RCHY1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2996565319334276,-0.8901972594666976,0.5985533453887885,0.8262946338613534,1.0,6/23,16.90%,SMO;SIX1;BMP4;PIK3CD;FGF2;SIX4
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.24511346203174816,-0.8899247832049673,0.6722972972972973,0.8264782678295276,1.0,14/57,19.24%,GHR;LYN;IL15;IL6ST;IL6R;HES1;PARP14;JAK2;STAP2;CD40;TNFRSF1A;IGF1;CLCF1;PPP2CA
prerank,maturation of SSU-rRNA (GO:0030490),-0.2767920604324394,-0.8898156009082837,0.6485507246376812,0.8263268039418232,1.0,15/34,42.30%,RPS14;NOL10;UTP3;RPS16;DCAF13;UTP4;RPS8;WDR46;RIOK3;SRFBP1;RRP36;DHX37;TSR2;RPS28;NAT10
prerank,axon extension (GO:0048675),-0.29739131142640296,-0.8892189336494626,0.6219739292364991,0.8272231393208814,1.0,6/23,16.15%,NRP2;USP9X;SLIT2;SPG11;ULK2;SEMA5B
prerank,cellular response to UV (GO:0034644),0.2259833731052918,0.8887569005262888,0.6674641148325359,0.990303856233989,1.0,14/76,14.11%,MME;TMEM161A;CERS1;RHNO1;USP28;STK11;IMPACT;TRIAP1;DDB1;TIMP1;BMF;ATR;PPID;TAF1
prerank,non-motile cilium assembly (GO:1905515),-0.27832032051820577,-0.8885658747262105,0.6238698010849909,0.8282138651164216,1.0,9/30,18.62%,TOGARAM1;CEP250;DCTN1;CSNK1D;FUZ;RPGRIP1;TBC1D32;PCM1;TMEM17
prerank,"base-excision repair, AP site formation (GO:0006285)",0.31279877375680043,0.8884768118396584,0.6054421768707483,0.9896621314977293,1.0,7/17,24.12%,TERF1;UNG;ACD;ERCC5;TERF2IP;NEIL2;TDG
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.34938270280353745,-0.8884211855656322,0.6247787610619469,0.8281551609052854,1.0,7/13,30.31%,GREM2;NRROS;DAND5;CHRDL1;FBN1;BMP2;LTBP1
prerank,tRNA methylation (GO:0030488),0.266556061161591,0.8877580299924446,0.6244239631336406,0.9901847974339164,1.0,12/34,25.66%,GTPBP3;TRMT13;TRMT10A;PRORP;FTSJ1;NSUN6;METTL2B;METTL2A;TRMT5;THUMPD3;TRMT1L;THUMPD2
prerank,negative regulation of insulin secretion (GO:0046676),-0.3186398291014655,-0.8876109120566933,0.6513761467889908,0.8294580282584894,1.0,2/17,5.85%,KLF7;IRS1
prerank,central nervous system neuron development (GO:0021954),-0.3324802592404037,-0.887386960150218,0.6208791208791209,0.8295792567092923,1.0,7/15,22.46%,RAPGEF2;LHX6;B4GALT5;GBA2;ARHGAP35;PTEN;HSP90AA1
prerank,replication fork processing (GO:0031297),-0.26767166677069193,-0.8870714945030005,0.651685393258427,0.8298447999383566,1.0,11/38,21.31%,SAMHD1;MMS22L;MRE11;ZGRF1;DNA2;FANCM;THOC1;RFWD3;WRN;ATRX;BLM
prerank,regulation of microtubule-based process (GO:0032886),0.26460502712660433,0.8869888925767615,0.6483253588516746,0.9908041983466053,1.0,11/36,18.69%,TRIM36;BICD1;PHLDB1;PHLDB2;CYLD;MAPT;TPPP;CLASP2;CAMSAP3;MAP6;MAP6D1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.2704632876883643,0.8866520675694514,0.6643990929705216,0.9903282465067841,1.0,11/32,23.18%,NPSR1;AKAP6;CALM2;GPER1;CASQ1;HTT;CX3CL1;HAP1;TRPC1;PDPK1;CAPN3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3385603397559604,0.8862160168245823,0.612691466083151,0.9900319505926941,1.0,3/13,15.02%,IL12A;IL12RB1;IL23A
prerank,lysosome organization (GO:0007040),0.25956493383231755,0.8861203013229926,0.6547085201793722,0.9889172072801012,1.0,15/36,24.38%,CLN3;CLVS2;CLVS1;HPS1;GRN;GNPTAB;HOOK1;SNAPIN;TPP1;HOOK3;ACP2;LAMTOR1;GAA;NAGPA;VPS33A
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3671976051529825,-0.8860620973860502,0.632768361581921,0.8316389836291574,1.0,5/11,34.01%,AGK;TIMM10;TOMM70;TIMM10B;TIMM13
prerank,histone H4-K5 acetylation (GO:0043981),-0.3341919431913919,-0.8854845516345979,0.6052173913043478,0.8321174365707199,1.0,6/15,23.01%,KANSL3;PHF20;HCFC1;JADE2;OGT;WDR5
prerank,histone H4-K8 acetylation (GO:0043982),-0.3341919431913919,-0.8854845516345979,0.6052173913043478,0.8321174365707199,1.0,6/15,23.01%,KANSL3;PHF20;HCFC1;JADE2;OGT;WDR5
prerank,determination of bilateral symmetry (GO:0009855),-0.2964669528780559,-0.8852937294301884,0.6166365280289331,0.8321410001960861,1.0,8/24,21.58%,PKD2;TBX1;GALNT11;NOTCH1;ZIC3;CITED2;KIF3B;CFAP53
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.36334303751300867,-0.8851712713382582,0.6,0.831621107239081,1.0,3/11,17.80%,PKD2;GSTM2;CASQ2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.36334303751300867,-0.8851712713382582,0.6,0.831621107239081,1.0,3/11,17.80%,PKD2;GSTM2;CASQ2
prerank,negative regulation of proteolysis (GO:0045861),-0.27137870835848704,-0.8849450406649351,0.6291739894551845,0.8317268699044953,1.0,10/34,17.07%,LRRK2;DNAJC1;ROCK1;EPHA4;AKT1;SNX12;PTPN3;TIMP3;PLAT;HDAC6
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.34880763648775936,0.8847438480832368,0.6167800453514739,0.991212628406825,1.0,2/11,7.33%,MUC20;PAK1
prerank,negative regulation of wound healing (GO:0061045),-0.2823138715351673,-0.8845723808144563,0.6345811051693404,0.8321360746976659,1.0,9/28,22.81%,CD34;CRK;SLC12A2;EDN1;FGF2;TFPI;PTEN;SERPINE2;SERPINE1
prerank,regulation of cellular protein localization (GO:1903827),-0.25673933141350663,-0.8843108733797349,0.6823956442831216,0.8322900344778165,1.0,17/45,23.85%,DVL3;PTPN1;SETD2;GPC6;SPIDR;PPM1F;PRKAA1;HFE;LCP1;VCPIP1;CTNNB1;NDEL1;KCNAB2;GPC3;HSP90AA1;RALB;RAB11FIP5
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3206491654493372,-0.8842898560507857,0.6260869565217392,0.8319337748776457,1.0,2/17,5.85%,RAC1;MOSPD2
prerank,protein import into peroxisome matrix (GO:0016558),-0.3626150199200934,-0.8836950922367504,0.6279491833030852,0.8328309077007556,1.0,3/12,15.77%,PEX1;PEX7;PEX14
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.3098473774681027,-0.8836291512681724,0.6507633587786259,0.832585009005293,1.0,11/19,51.45%,TNFAIP3;IGF1;NLRP2B;CARD16;NLRP3;CD33;GIT1;GSTP1;APOA1;FFAR4;ZC3H12A
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2692064222508252,0.8834863358164656,0.6751054852320675,0.993155681136826,1.0,16/33,29.41%,MED18;CPSF1;CSTF2T;SNRPD3;CLP1;CPSF2;SCAF8;CSTF2;NCBP2;SETX;CPSF4;CSTF3;PCF11;SNRPF;TTF2;PABPN1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.3711352633558816,-0.8828960589013196,0.6103202846975089,0.8338007556184286,1.0,3/10,21.93%,TUT7;TUT4;DIS3L2
prerank,regulation of primary metabolic process (GO:0080090),-0.21770454038411022,-0.8828755157803239,0.7611408199643493,0.8334426391789251,1.0,37/126,20.44%,CREBBP;RXRA;PSMA2;SP1;PPARA;MED1;NFYC;PSME2;GGPS1;PSMB4;PPARD;ACACB;HELZ2;SIN3A;AZIN1;C1QTNF2;SMARCD3;PSMC2;NR1D2;TGS1;DHCR7;ROCK2;PSMB2;ABCA7;PSMB1;TNFAIP8L3;PSMA8;CARM1;OAZ2;PSME1;NCOA6;PRKAB1;TBL1X;PPARG;NQO1;PSMD4;FGFR4
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3494794216641705,0.8827999076980919,0.6120092378752887,0.9935663501574489,1.0,3/12,7.41%,CTNNA3;PKP2;RYR2
prerank,acidic amino acid transport (GO:0015800),-0.3217416685142444,-0.8826848518823627,0.6116322701688556,0.8334376160780679,1.0,6/17,20.00%,SLC6A6;LRRC8D;ARL6IP5;GIPC1;PRAF2;SLC1A1
prerank,megakaryocyte differentiation (GO:0030219),-0.3651442198558641,-0.8824368443768851,0.6236559139784946,0.8335311763692477,1.0,3/11,11.57%,MED1;TAL1;ZFPM1
prerank,base conversion or substitution editing (GO:0016553),0.35233816395500067,0.8822967300564292,0.6042154566744731,0.9935382457982084,1.0,2/11,14.01%,ADARB2;NUDT16
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.27189382015250074,-0.881892275039095,0.6588868940754039,0.8343004668040409,1.0,11/35,27.42%,POLD3;OGG1;RPA3;RPA1;PNKP;RPA2;RFC4;NTHL1;RFC1;LIG1;POLL
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2771932404307316,-0.8815032509307376,0.6460176991150443,0.8346998587962344,1.0,6/31,13.71%,NEK7;ATM;MRE11;MAPK1;PPP1R10;PNKP
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.35516223255902524,-0.8814301683288691,0.6274509803921569,0.8344448312576015,1.0,3/12,2.83%,PODXL;IQGAP1;PROM1
prerank,regulation of protein polymerization (GO:0032271),0.26419425577500966,0.8813823931894688,0.6658823529411765,0.9945454928901717,1.0,8/35,12.81%,PFN2;PFN1;PAK3;MAP2;MAPT;TPPP3;MAPRE3;TPPP
prerank,negative regulation of hemostasis (GO:1900047),0.3437297266621431,0.880400291226887,0.6522727272727272,0.9957118664218765,1.0,1/12,0.27%,VTN
prerank,regulation of double-strand break repair (GO:2000779),-0.26401183052064436,-0.8799470890468366,0.651705565529623,0.837198530987991,1.0,7/39,9.15%,UBR5;SETD2;DEK;RNF169;MRNIP;SPIDR;TRIP12
prerank,modulation by host of viral genome replication (GO:0044827),-0.3430477164979603,-0.8798668248601026,0.6226765799256505,0.8369576436400764,1.0,7/13,41.09%,TBC1D20;VAPA;CCNK;EIF2AK4;IFI27;FBXL2;CCL8
prerank,regulation of protein kinase C signaling (GO:0090036),0.322172244153474,0.8795007167733584,0.6224256292906178,0.9966182641356651,1.0,4/14,10.78%,GPD1L;VEGFA;SPHK2;ADRA1A
prerank,negative regulation of protein catabolic process (GO:0042177),-0.25882481919966505,-0.87921495528483,0.6678765880217786,0.8379852119583134,1.0,10/40,17.81%,DAB2IP;EGFR;ROCK1;FLNA;SNX12;PTPN3;TIMP3;AZIN1;MAD2L2;CDK5RAP3
prerank,acetyl-CoA metabolic process (GO:0006084),0.3203662213489037,0.8791054416824677,0.6034858387799564,0.9962238692833137,1.0,7/15,21.28%,ACLY;ACACA;ACSS1;TDO2;HMGCS1;ACAT1;MVK
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3249904017457678,-0.8790177672611615,0.644927536231884,0.8380118101672769,1.0,7/17,27.81%,MOSPD2;ANO6;LGMN;CXCL12;SERPINE1;HMGB1;CXCL10
prerank,regulation of p38MAPK cascade (GO:1900744),0.2600242392963163,0.8789427689265195,0.6758620689655173,0.9952738995347312,1.0,8/35,12.19%,RELL2;GADD45B;SPHK1;CYLD;VEGFA;MINK1;PHLPP1;RASGRP1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.2813835785186162,0.8789310540976812,0.6435185185185185,0.9939162373390155,1.0,4/25,7.41%,CTNNA3;PKP2;CXADR;RYR2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.2395186007904247,-0.8789205491236951,0.6878306878306878,0.837819078683001,1.0,25/55,37.07%,RAC1;THBS1;TGFBR2;SIRT5;AATF;DHRS4;TP53;AGTR1;GRB2;BRCA1;PDGFRB;GADD45A;RIPK1;CYP1B1;ACE2;SLC25A33;MAPK14;PID1;PDK3;BST1;TFAP2A;RAC2;MT3;PARL;FOXM1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.36272480610148206,-0.8789097702706178,0.6208791208791209,0.8374494830257024,1.0,2/11,7.35%,TGFB2;MEF2C
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.2706078575065879,-0.8788953960591093,0.6536312849162011,0.837078431454829,1.0,13/33,27.86%,CDKN1B;PSME2;STXBP4;PLCG2;CDC73;TCIM;PSME1;PTEN;TRIM39;INO80;CRNN;KIF14;MN1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.331689889510046,-0.8787960626201206,0.6187050359712231,0.836906870416347,1.0,3/15,7.18%,SMO;SIX1;BMP4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3496393103212897,0.8786660487610004,0.6297117516629712,0.9918863041205868,1.0,2/12,6.42%,ATP2B4;FHL2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3496393103212897,0.8786660487610004,0.6297117516629712,0.9918863041205868,1.0,2/12,6.42%,ATP2B4;FHL2
prerank,positive regulation of hormone secretion (GO:0046887),-0.31822370944379963,-0.8783711720832932,0.6419294990723562,0.8374011609918586,1.0,4/17,15.68%,EDN1;EDN3;HFE;C1QTNF3
prerank,actin filament depolymerization (GO:0030042),-0.3653655130208481,-0.8782158264261697,0.6236559139784946,0.8373371995511303,1.0,4/11,20.38%,MICAL2;CFL2;CFL1;DSTN
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.33398904557750553,-0.8782074424643761,0.6311030741410488,0.8369596927809025,1.0,7/14,29.13%,PTPN11;ADAMTS7;RFLNB;SNAI2;RFLNA;TGFBR1;WNT9A
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2964287635810516,-0.8776328238291004,0.6341030195381883,0.8377619120281862,1.0,6/23,22.30%,ITGB1;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,response to UV-A (GO:0070141),0.33084106359692667,0.8770675147431276,0.6128318584070797,0.9945699511059928,1.0,4/14,13.12%,MME;CERS1;TIMP1;PPID
prerank,mitochondrial translation (GO:0032543),-0.2170111560639456,-0.8764207166048152,0.731203007518797,0.8399162480603606,1.0,34/104,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MTRF1L;MRPL57;NDUFA7;MRPS14;IARS2;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;NOA1;MRPS28;MRPS35;MRPL43;MRPL48;TUFM;MRPL11;MRPS31
prerank,positive regulation of lymphocyte activation (GO:0051251),0.27824381999340764,0.8759756881155122,0.6510638297872341,0.99595323916293,1.0,7/28,19.15%,IL12A;CCL2;XRCC6;IL23A;CD47;SIRPA;PRKCQ
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.27880096957032235,-0.875718611774677,0.6500857632933105,0.8409862831146767,1.0,7/26,27.14%,EYA4;MCL1;AKT1;TERT;MAPK7;HSPA1B;SNAI2
prerank,neuron maturation (GO:0042551),0.3005122751749793,0.8754901171824647,0.6592920353982301,0.9958075218840129,1.0,8/18,20.83%,ADGRB3;SRRM4;ACTL6B;B4GALT6;LGI4;C3;CX3CL1;MTCH1
prerank,mRNA methylation (GO:0080009),-0.3329707969592971,-0.8749978287673309,0.6265938069216758,0.8421518519106294,1.0,3/15,10.78%,CBLL1;METTL14;WTAP
prerank,translesion synthesis (GO:0019985),-0.26094274319117217,-0.8749110344268983,0.682261208576998,0.8419395882831109,1.0,13/42,25.94%,TRIM25;POLD3;RPA3;REV1;RPA1;USP10;MAD2L2;POLE2;RPA2;RFC4;RFC1;RCHY1;DTL
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.36991249181406455,-0.8745268632950371,0.6286701208981001,0.8423278021800147,1.0,3/10,12.66%,PRKG1;PRKCD;CEACAM1
prerank,neural crest cell differentiation (GO:0014033),-0.31103162205185964,-0.8740863100369364,0.6307977736549165,0.8428066677239205,1.0,4/18,7.81%,FBXL17;LRP6;MEF2C;KLHL12
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.24097547245409762,0.8736057776473599,0.6888361045130641,0.9991839154323293,1.0,11/48,19.69%,NPSR1;AKAP6;CALM2;GPER1;SRI;HRC;CASQ1;SELENON;PDE4D;CX3CL1;TRPC1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.30656111693297594,0.8733753996020627,0.6301969365426696,0.9984394551708674,1.0,4/17,17.61%,SULT2B1;AHI1;FOXJ1;SOX9
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.24221172029950888,0.8733004021843505,0.6889400921658986,0.9972624179854277,1.0,10/48,14.40%,ADCY8;ADCY10;AK5;NPPC;SLC35B2;ADCY7;ADSS2;ADSS1;ACOT7;ADCY3
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.26640769120100677,0.8730899021704389,0.6568181818181819,0.9964255806913905,1.0,10/32,23.18%,NPSR1;AKAP6;GPER1;P2RX3;CASQ1;P2RX5;CX3CL1;TRPC1;PDPK1;CAPN3
prerank,cilium assembly (GO:0060271),0.1834290353101089,0.8729656615757025,0.8620689655172413,0.9953693823099712,1.0,60/296,16.60%,DNAAF3;CFAP74;YWHAG;TEKT1;KIF17;RP2;BBOF1;B9D1;CFAP54;EXOC7;EXOC1;DYNC2H1;DCDC2;VANGL2;NINL;GSN;TTC8;BBS7;MAK;NPHP4;BBS4;PLA2G3;AHI1;DNAAF1;ARL3;RPGRIP1L;CFAP43;KIFAP3;DCX;KIF3A;SNX10;HAUS5;DYNC2I2;BBS5;CEP70;OCRL;DYNLRB2;IQCB1;CEP135;ARL6;BBS1;RPGR;CEP162;MKS1;FOXJ1;CEP72;CFAP70;CEP19;MAPRE1;GAS8;CFAP410;KIF3C;IFT172;ATP6V0D1;IFT22;MKKS;IFT81;TMEM138;WDR90;BBS2
prerank,protein localization to nucleus (GO:0034504),-0.21742009497816417,-0.8720585252821929,0.7374784110535406,0.846636171193818,1.0,33/102,26.64%,YWHAE;CSE1L;SIX1;ZBTB7A;TOR1B;BMP4;SEC13;AKT1;PPP1R10;LMNA;NUP153;TBRG1;TAF8;ABCA7;TPR;BMP7;SIX4;TAF3;NUP214;NXT1;IPO8;WRN;RRS1;MDM2;NUP188;MSX1;ARL2;E2F3;PINX1;NOL8;RANBP6;NUP88;RAN
prerank,protein alkylation (GO:0008213),0.2928572120638434,0.871962845660187,0.6226851851851852,0.9965627056319865,1.0,9/22,25.30%,METTL21A;EEF1AKMT2;SNRPD3;PCMT1;PRMT2;VCPKMT;PRMT8;EEF1AKMT1;FAM98B
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.3516672454969949,0.8718559892502815,0.6335403726708074,0.9954528219049122,1.0,1/10,0.27%,VTN
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.2777782118949814,-0.8718433285342116,0.6529080675422139,0.8466997782520158,1.0,19/30,41.00%,DYRK1A;DDX39B;ACKR3;YJU2;MIF;THOC1;RPS3;CXCL12;MDM2;SNAI2;TRIM32;CD74;FBXO5;DDIAS;SIRT1;PTTG1IP;CDKN2D;SFRP2;CD44
prerank,membrane repolarization (GO:0086009),0.32038511403407977,0.8717341796267466,0.6581395348837209,0.9943557931209994,1.0,2/15,4.83%,ATP1A2;ATP1B1
prerank,negative regulation of innate immune response (GO:0045824),0.2624927782066151,0.8711170925577689,0.6688741721854304,0.9945558562148176,1.0,8/34,15.63%,TYRO3;TTLL12;GRN;SUSD4;SERPING1;OAS3;CNOT7;LYAR
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3158308307660951,0.8710607754656041,0.6457831325301204,0.9933409225423955,1.0,3/17,8.20%,SCN1B;CACNA2D1;SCN5A
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.2872568312954409,-0.8709784264045233,0.6678507992895204,0.8480836052422904,1.0,6/25,17.30%,TNFSF10;BNIP3;TP53;BBC3;BCL2L11;PPIF
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2665291311129939,0.870961622827409,0.6584269662921348,0.9922316433705064,1.0,6/32,10.53%,CDK5;CDC45;TYMS;NPAT;POLA1;TFDP2
prerank,regulation of centrosome duplication (GO:0010824),-0.2738990045813442,-0.8709429971571646,0.6525911708253359,0.8477645600613838,1.0,15/29,42.30%,PLK2;CHMP4B;CHMP2B;CHMP5;ALMS1;PDCD6IP;CEP131;CEP295;CHMP3;CHMP1A;PKHD1;CHMP1B;SPICE1;SIRT1;NAT10
prerank,global genome nucleotide-excision repair (GO:0070911),-0.28762708604832765,-0.8696380376943798,0.6678260869565218,0.8501257108876477,1.0,6/26,18.21%,RNF111;RBX1;ERCC2;XPC;ERCC3;CETN2
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.31048933294817804,-0.8695640018268124,0.647912885662432,0.84987109159942,1.0,6/18,15.35%,SP1;EPHA4;GSK3A;PICALM;SLC2A13;ROCK2
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3149584011184752,-0.8692303267511204,0.6477064220183486,0.850175344525325,1.0,4/18,12.61%,SPTBN1;LDLRAP1;STX8;ACTB
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3616624893023404,-0.8691285111977256,0.6390423572744015,0.8499996854714527,1.0,6/10,41.65%,EMC9;EMC2;EMC6;EMC3;MMGT1;EMC8
prerank,regulation of protein localization to cell surface (GO:2000008),-0.26346547048444385,-0.8688537466544513,0.6761904761904762,0.8501730095278455,1.0,9/33,19.39%,NEDD4L;RIC3;STX3;PICALM;HFE;TAX1BP3;ABCA7;CTNNB1;KCNAB2
prerank,regulation of mitochondrial fusion (GO:0010635),-0.35866041307611135,-0.8688528912419344,0.6368515205724508,0.8497752114191474,1.0,3/11,7.28%,ZDHHC6;TFRC;BNIP3
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.3713044951707912,-0.86875201714607,0.6372180451127819,0.8495904552136181,1.0,5/10,28.47%,RUVBL2;ZNHIT3;TAF9;NAF1;NUFIP1
prerank,peroxisomal membrane transport (GO:0015919),-0.2827993549150043,-0.8686158340328278,0.6631016042780749,0.8494820874654178,1.0,9/27,30.08%,PEX1;ABCD3;PEX7;RAB8B;PEX14;PEX3;PEX6;PEX11B;PEX19
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.344244805302831,-0.8682534073084578,0.6236559139784946,0.8498255435450419,1.0,4/12,22.06%,DIAPH1;UBASH3B;CASQ2;PTK2B
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.30665553822545444,-0.8680098945623355,0.6643109540636042,0.8499259688000302,1.0,2/19,5.85%,RAC1;MOSPD2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.31799837552588894,-0.8677517117471729,0.6557659208261618,0.8501089493066122,1.0,8/16,46.16%,CEBPG;VAMP2;ARL8B;CORO1A;RAET1E;TUBB4B;SLAMF7;KLRK1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.30722794605621795,0.8671787999294772,0.6386946386946387,1.0,1.0,3/16,11.65%,RASGRF1;ARHGAP24;AUTS2
prerank,negative regulation of catabolic process (GO:0009895),0.24092340780441765,0.8653684777005509,0.6940639269406392,1.0,1.0,10/47,15.72%,PDE3B;FMN2;BSCL2;CYP51A1;SF3B3;ADRA2A;AZIN2;CST3;APOC1;ZDHHC7
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3188083778638753,-0.8649951352240847,0.6577060931899642,0.8554379787826565,1.0,5/17,16.18%,KDR;SLIT2;AKT1;FGF2;PIK3R3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.32283758296407483,-0.8647060915226918,0.6621880998080614,0.8556289066265534,1.0,4/15,33.41%,SMOX;SRM;DDC;AANAT
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3191494323908238,-0.8643703562120244,0.6347992351816444,0.8559146586697342,1.0,5/15,20.74%,DDX3X;MKNK2;HNRNPA1;PPIF;GSTO2
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.2703274191265612,-0.8642140093582287,0.696113074204947,0.8558529533353256,1.0,12/33,24.82%,STN1;MRE11;PPP6R3;RPA1;CTC1;PTGES3;TERF2;DCLRE1B;TERT;HSP90AA1;RFC1;PINX1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.32753883777086146,-0.8637843562237477,0.6530249110320284,0.8563287552273304,1.0,2/15,1.37%,RB1;TIE1
prerank,retinol metabolic process (GO:0042572),-0.3311777231062848,-0.8637745146980859,0.650709219858156,0.8559479153472921,1.0,6/14,33.86%,RBP4;RDH10;RETSAT;CYP1B1;RDH12;ADH1A
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.23135212052078877,-0.8631336584145949,0.7392055267702936,0.8568179402500771,1.0,22/72,26.87%,PSMA2;BIRC3;PSME2;PSMB4;AKT1;DICER1;IRAK1;FBXW11;PSMC2;PSMB2;PSMB1;PSMA8;MAP3K14;PSME1;PSMD4;PSMA7;RELA;COPS8;PSMD5;MAP3K7;PSMB10;PSMA3
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3549865059938492,0.8629814808799131,0.6089743589743589,1.0,1.0,10/10,64.52%,CBARP;CALM1;CALM3;GNB5;DRD4;FMR1;DRD2;GPR35;CRHR1;DRD3
prerank,phasic smooth muscle contraction (GO:0014821),0.3499515878169588,0.8626595094503101,0.625,1.0,1.0,4/10,22.64%,PTGER3;HTR1D;EDNRB;TIFAB
prerank,thyroid hormone generation (GO:0006590),-0.35958028167881373,-0.8625877769530462,0.6492805755395683,0.8575171408737581,1.0,1/10,0.41%,CPQ
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3076292277479077,-0.8623793128376082,0.6594911937377691,0.8575501623459546,1.0,3/18,9.23%,BPGM;SAMHD1;ADAMTS9
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.25947030273043103,0.8622336419230581,0.6827133479212254,1.0,1.0,6/33,9.96%,IGFBP3;TAFA5;NDRG4;ANG;IL12A;GPER1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.3496308998892417,0.8621475880517007,0.6503496503496503,1.0,1.0,3/11,19.15%,IL12RB1;IL23A;PRKCQ
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.22011090321726282,-0.8618262210587845,0.7508532423208191,0.8582128616400401,1.0,24/82,24.26%,YWHAE;CEP57;CEP250;CEP78;HAUS8;TP53;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;CEP41;ALMS1;PLK4;PCM1;CETN2;CNTRL;CEP152;ODF2;HSP90AA1;PCNT;CEP131;AKAP9;ATF5
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3519885709892651,0.8616126087917048,0.6221198156682027,1.0,1.0,3/10,8.60%,TERF1;MAPT;CORO2B
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.27205563608582106,0.8615685685533401,0.6467991169977925,1.0,1.0,4/26,12.08%,ATP1A2;CALM2;ADRA2A;SRI
prerank,piRNA metabolic process (GO:0034587),0.2991710625470989,0.8607080887153743,0.6532438478747203,1.0,1.0,19/19,70.12%,TDRKH;PIWIL2;EXD1;TEX15;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;PIWIL4;TDRD12;MYBL1;DDX4;TDRD9
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.34334219736658117,0.860518572740228,0.6516587677725119,1.0,1.0,2/11,6.22%,AKAP6;RNF207
prerank,TOR signaling (GO:0031929),0.2678604764484946,0.8600272341312973,0.6695842450765864,1.0,1.0,6/26,11.79%,CCDC88A;FLCN;RHEBL1;RPS6KB1;CARD11;PRR5L
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.36962971687292884,-0.8599634626211847,0.6685288640595903,0.8611228187859564,1.0,1/10,1.54%,KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.36962971687292884,-0.8599634626211847,0.6685288640595903,0.8611228187859564,1.0,1/10,1.54%,KLF4
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2256476476318084,-0.859915783073211,0.7293497363796133,0.8608290499119263,1.0,12/72,11.88%,SHANK3;LIMA1;KANK3;DYRK1A;SLIT2;PRKCD;CDH5;KANK4;ARHGEF2;SMAD4;VBP1;ARFGEF1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3091744025809442,0.8598170721219112,0.6659192825112108,1.0,1.0,6/15,21.88%,ATL1;RTN4;ZFYVE27;RTN3;REEP4;ARL6IP1
prerank,negative regulation of viral transcription (GO:0032897),-0.34219431031330505,-0.8598038332257628,0.6554770318021201,0.8606513373633381,1.0,7/13,31.52%,UBP1;TRIM14;IFITM3;TRIM13;LARP7;TRIM32;TRIM62
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.29995046589906876,-0.8592508663424379,0.6720720720720721,0.8614013986351877,1.0,9/20,27.89%,SMAD1;SMAD4;NOTCH1;ATF4;SMAD9;NFE2L2;RELA;BMP2;CARF
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.36058603694907443,-0.8590581130542168,0.6313868613138686,0.8614012306767289,1.0,1/10,0.53%,RAPGEF2
prerank,cAMP biosynthetic process (GO:0006171),0.3586938213588074,0.8586873070820069,0.6244343891402715,1.0,1.0,4/10,14.40%,ADCY8;ADCY10;ADCY7;ADCY3
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.30846030768992283,-0.8586521995617447,0.6552346570397112,0.8618187190246789,1.0,2/20,7.02%,IL1R1;CD55
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.2870106227855605,-0.8581963704497563,0.689908256880734,0.8623832293544531,1.0,9/25,27.28%,SPTBN1;PRKD2;PLCG2;ANXA1;RPS3;PTPRC;STOML2;MAP3K7;PNP
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3032787419309375,0.8580661907671927,0.6824324324324325,1.0,1.0,3/18,11.68%,CARTPT;TMEM178A;TCTA
prerank,protein heterotetramerization (GO:0051290),0.3230049531919535,0.8577646117210705,0.648068669527897,1.0,1.0,1/13,0.90%,GRIN2B
prerank,glucan biosynthetic process (GO:0009250),-0.3457046723941731,-0.8573428587429848,0.6690647482014388,0.863276812426384,1.0,4/12,20.65%,GBE1;PPP1R3C;GYS1;GYG1
prerank,glycogen biosynthetic process (GO:0005978),-0.3457046723941731,-0.8573428587429848,0.6690647482014388,0.863276812426384,1.0,4/12,20.65%,GBE1;PPP1R3C;GYS1;GYG1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.2827004948178693,-0.8571656969529136,0.6975881261595547,0.8632445692878348,1.0,7/24,13.34%,ACVRL1;COL5A1;FLNA;RHOA;CEACAM1;LCP1;RHOC
prerank,eye photoreceptor cell development (GO:0042462),0.3123083437280155,0.8570236847887804,0.6307692307692307,1.0,1.0,3/15,9.25%,BBS4;RPGRIP1L;VEGFA
prerank,histone H3 deacetylation (GO:0070932),-0.3242136272668036,-0.8569969755984495,0.6405109489051095,0.8631982309122168,1.0,5/15,19.54%,HDAC1;HDAC4;SFPQ;ELK4;SMARCAD1
prerank,cytoplasmic translational initiation (GO:0002183),-0.31428807234227896,-0.8567758457361364,0.6897163120567376,0.8632178219446185,1.0,5/17,31.00%,EIF4H;EIF3A;EIF3I;EIF4A2;DHX29
prerank,response to zinc ion (GO:0010043),-0.2831291983244766,-0.8567554708899406,0.7229129662522202,0.8628534303895777,1.0,11/25,25.53%,PAM;SLC30A5;HVCN1;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B
prerank,regulation of stem cell proliferation (GO:0072091),-0.3087026384760062,-0.8563331944275907,0.673721340388007,0.8632939766177682,1.0,6/17,27.56%,ACE;YAP1;PTPRC;TERT;ZFP36L1;HNRNPU
prerank,protein catabolic process (GO:0030163),-0.23422064294803163,-0.8562401164574052,0.7467889908256881,0.8630937871603442,1.0,27/59,38.37%,DAB2IP;MTOR;DDI2;DENND3;ADAMTS9;CEACAM1;MAGEC2;USE1;LAMP2;PSMA8;SIAH1;CLN5;HSP90AA1;RIPK1;FBXO17;MANBA;ATE1;PPT1;PMAIP1;CLPX;UBE2G2;VCP;CLN6;TRIM24;RNF5;DDI1;HSPA8
prerank,response to organic cyclic compound (GO:0014070),-0.23772099341485664,-0.8559983651388241,0.7102473498233216,0.863183265405106,1.0,22/52,31.88%,ESR1;LRRK2;TIPARP;STRN3;GGT5;ALPL;ARL6IP5;SOCS2;IGFBP5;ANXA1;CTNNB1;SLC1A1;FGFR4;KYNU;PAQR7;CYP1B1;GLDC;TGFB1;PMAIP1;STAT3;HLCS;CHRNB2
prerank,positive regulation of B cell activation (GO:0050871),-0.240450493049158,-0.8559028877602468,0.7168141592920354,0.8629909416987135,1.0,12/50,19.32%,SHLD1;TFRC;CD38;KMT5B;MEF2C;PPP2R3C;CD40;MIF;MAD2L2;CLCF1;NOD2;PTPRC
prerank,regulation of steroid biosynthetic process (GO:0050810),0.33275064437065094,0.8552737288803549,0.6536796536796536,1.0,1.0,2/11,5.11%,DGKQ;EGR1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.2956632528046996,-0.8551723002162017,0.6841186736474695,0.8640694676894086,1.0,9/22,26.87%,PSMA2;PSMB4;PSMB2;PSMB1;PSMA8;PSMA7;NFE2L2;PSMB10;PSMA3
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3021473444208709,-0.8548699246895696,0.6696588868940754,0.8642727153071991,1.0,5/19,22.34%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.34426674825742826,-0.8545709833130427,0.6666666666666666,0.8644968753421042,1.0,3/12,21.21%,ESR1;PPARG;TERT
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.22855987228162256,-0.8545127247854613,0.7345890410958904,0.8642152541501578,1.0,20/67,23.68%,PSMA2;ITGB5;PSME2;TAP2;PSMB4;PDIA3;NCF2;PSMC2;PSMB2;PSMB1;PSMA8;IKBKG;VAMP3;IKBKB;PSME1;PSMD4;PSMA7;SEC22B;FCGR1A;PSMD5
prerank,regulation of integrin activation (GO:0033623),-0.32791600358114803,-0.8543140027011464,0.6462093862815884,0.8642255032778398,1.0,3/15,8.05%,FERMT2;RASIP1;RAP1B
prerank,RNA catabolic process (GO:0006401),-0.24441607832690765,-0.8542079794203213,0.7248677248677249,0.864061325126685,1.0,14/46,28.11%,ERN1;RNASE3;XRN2;DNA2;ZPR1;NUDT12;RNASEH2C;DIS3L2;METTL16;HSPA1B;EXOSC7;HNRNPD;DXO;LSM2
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.34742549323093586,-0.8541169498575902,0.6759259259259259,0.8638423056108118,1.0,5/12,25.33%,MTHFD1;AMPD2;HPRT1;PRPS2;ADA
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.304028341790194,0.8540030178971102,0.6608695652173913,1.0,1.0,2/17,3.34%,GET1;CAMLG
prerank,mitochondrial fusion (GO:0008053),-0.3106832623648997,-0.8539566157414743,0.6563071297989032,0.863753888209992,1.0,4/18,12.94%,MIEF1;CHCHD3;AFG3L2;MIEF2
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.2806733328835405,-0.8535693429540815,0.6794425087108014,0.8641214525997292,1.0,12/25,44.17%,PPARA;CBL;HFE;PPARG;ACE2;CHMP6;RAMP3;SNX6;CRHBP;SLC6A9;VPS25;TNF
prerank,regulation of ruffle assembly (GO:1900027),0.2818661759507175,0.8535380231498836,0.6972477064220184,1.0,1.0,3/23,5.58%,NLGN1;PFN2;PFN1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.24685642001050792,0.8531589331146494,0.705607476635514,1.0,1.0,7/39,15.32%,BLK;GCK;TRH;GPER1;NLGN2;GLUD1;MCU
prerank,cellular response to decreased oxygen levels (GO:0036294),0.22506786467158765,0.8529241273661886,0.7578692493946732,1.0,1.0,12/65,16.41%,KCND2;FMN2;SCN2A;CPEB1;VEGFA;NOP53;SLC8A3;GATA6;HIPK2;TWIST1;P4HB;ADAM8
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3141679752125927,-0.8527526024947406,0.6730434782608695,0.865310675961689,1.0,9/17,24.99%,HES1;TNFRSF1B;IL34;DICER1;NOTCH1;CLCF1;SERPINE2;PTN;BMP2
prerank,B cell activation involved in immune response (GO:0002312),0.3281959613589732,0.8527009264870623,0.6544622425629291,1.0,1.0,5/13,17.74%,BATF;RNF8;GPR183;MSH2;FCGR2B
prerank,nuclear membrane disassembly (GO:0051081),0.3244130106089481,0.852109904556723,0.6666666666666666,1.0,1.0,6/14,23.84%,LPIN1;VRK1;PRKCB;AKAP8L;CDK1;CTDNEP1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3305516242642878,-0.852071319102272,0.6790352504638218,0.8662815774699932,1.0,7/14,45.34%,LRRK2;HERPUD1;TXNDC12;PARK7;CREB3L1;TMBIM6;BCL2L1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.258156503264548,0.8511993178308441,0.7117516629711752,1.0,1.0,2/32,1.40%,GRM5;DDX25
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.323740777466485,0.8509144793448603,0.6349206349206349,1.0,1.0,4/14,15.61%,ATP2B4;PKIB;PRKAR1B;HTT
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.33330868789847007,0.8508628008411049,0.6634146341463415,1.0,1.0,5/12,20.99%,ACSL3;APOC1;P4HB;SOAT2;SOAT1
prerank,cellular response to alkaloid (GO:0071312),-0.3041514301063139,-0.8502117921782582,0.7021276595744681,0.8696697870906257,1.0,6/17,21.31%,SPIDR;TGM2;GSTM2;HTR1B;CASQ2;BLM
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.30880880024174584,-0.849839709619569,0.6858736059479554,0.8700502989663295,1.0,11/18,45.95%,TCP1;PARN;RUVBL2;CCT5;CCT2;NAF1;CCT3;DCP2;CCT7;DKC1;CCT6A
prerank,cell cycle checkpoint signaling (GO:0000075),-0.34614529732272753,-0.8498370751430762,0.6799307958477508,0.8696566246477266,1.0,3/12,19.75%,PLK2;NABP1;BUB1B
prerank,sulfur amino acid catabolic process (GO:0000098),-0.3573686986726874,-0.8492399047718211,0.6761061946902654,0.8704232436494269,1.0,8/10,41.18%,TXN2;CTH;ADO;MTRR;MPST;BLMH;CBS;TST
prerank,aminoglycan catabolic process (GO:0006026),0.2677751839944809,0.8491018683355727,0.6909090909090909,1.0,1.0,3/28,6.31%,GPC5;HPSE2;GPC1
prerank,digestive tract morphogenesis (GO:0048546),-0.3244904400027128,-0.849033979247092,0.6802973977695167,0.8704335104124391,1.0,6/14,26.96%,SOX17;NIPBL;EPHB3;FOXF1;RBPMS2;STRA6
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3030119987967337,-0.8488800915296556,0.6829268292682927,0.8703383629900278,1.0,9/18,37.74%,RNF139;MAN1B1;TRIM13;UGGT1;EDEM2;RNF103;RNF185;OS9;RNF5
prerank,positive regulation of actin nucleation (GO:0051127),-0.3465081773458593,-0.848775724086477,0.649155722326454,0.870126304508617,1.0,4/11,18.92%,WASF2;FCHSD2;NCKAP1;WASF1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2154552341376021,-0.8482566787508249,0.7858407079646018,0.8707126889519375,1.0,25/88,26.91%,FBXL7;FBXL12;PSMA2;FBXL17;FBXL3;RBX1;PSME2;CUL2;PSMB4;FBXW11;PSMC2;PSMB2;PSMB1;PSMA8;DMAC2;PSME1;PSMD4;PSMA7;PSMD5;FBXL22;FBXO17;FBXO38;PSMB10;PSMA3;KIF14
prerank,regulation of cholesterol efflux (GO:0010874),-0.2695620722269957,-0.8482013055209392,0.6838235294117647,0.8704244704439426,1.0,8/30,20.11%,PLTP;CAV1;RXRA;NFKBIA;NAXE;ABCA7;EEPD1;PPARG
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.28801539552105393,0.8481681393799875,0.6575342465753424,1.0,1.0,4/18,15.63%,RASL11A;DHX33;SIRT7;LYAR
prerank,linoleic acid metabolic process (GO:0043651),0.3057261842137204,0.8480998330540873,0.665893271461717,1.0,1.0,4/17,15.88%,FADS1;FADS2;ALOX12;ALOX5
prerank,postreplication repair (GO:0006301),-0.24746059615517135,-0.8479669873067032,0.7051282051282052,0.8704829596116007,1.0,12/45,23.23%,TRIM25;POLD3;RAD18;RPA3;REV1;RPA1;UBE2V2;USP10;RPA2;BRCA1;RFC4;RFC1
prerank,import into nucleus (GO:0051170),0.22035925897942035,0.8477257511314036,0.7674943566591422,1.0,1.0,6/73,4.18%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;DDX20
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2635570107254388,0.8476945998353949,0.7213114754098361,1.0,1.0,6/29,13.86%,ACLY;OXSM;ACSL6;ACOT2;ACOT7;ACBD6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2635570107254388,0.8476945998353949,0.7213114754098361,1.0,1.0,6/29,13.86%,ACLY;OXSM;ACSL6;ACOT2;ACOT7;ACBD6
prerank,response to interferon-gamma (GO:0034341),-0.22659375944067298,-0.8476187670143738,0.7769784172661871,0.8707563715207255,1.0,21/67,30.71%,SP100;DAPK1;CCL25;GCH1;GBP6;IFITM3;GBP4;CD40;PDE12;SYNCRIP;GBP5;CCL19;KYNU;CASP1;RPL13A;GBP3;IFITM2;LGALS9;BST2;SLC26A6;SHFL
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3083881686634666,-0.8476003957376856,0.6629834254143646,0.8703953532098282,1.0,7/17,35.88%,PLA2G4A;PLA2G12A;LCLAT1;PLA2G4F;PLA2G5;LPGAT1;PLBD1
prerank,regulation of receptor recycling (GO:0001919),-0.3092537289871068,-0.8474019776433325,0.6830122591943958,0.8703957269476073,1.0,4/16,22.11%,ANXA2;ECE1;VAMP3;KIF16B
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.22575295812777466,-0.8473781707358989,0.7426470588235294,0.8700415849973033,1.0,21/71,24.07%,USP9X;CTSC;FBXL17;DDI2;CASP8;CAPN2;CHMP4B;ATXN3;ZER1;TNFAIP3;CTSZ;LGMN;ZYG11B;CTSH;HDAC6;PSMA8;PDCD6IP;MDM2;CTSF;CTSO;ADAMTS7
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.33505662359935695,0.84735147408296,0.6567505720823799,1.0,1.0,2/12,5.75%,MELTF;RCC2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.33505662359935695,0.84735147408296,0.6567505720823799,1.0,1.0,2/12,5.75%,MELTF;RCC2
prerank,regulation of metal ion transport (GO:0010959),0.30585693190006386,0.8473449762752849,0.696551724137931,1.0,1.0,4/16,12.08%,CACNA2D1;BCL2;CAMK2B;SRI
prerank,carnitine metabolic process (GO:0009437),-0.33729947864542215,-0.8470690519627929,0.6923076923076923,0.8702474244674524,1.0,7/12,32.48%,ACADL;CPT1A;CRAT;TMLHE;BBOX1;SHMT1;CPT2
prerank,transport along microtubule (GO:0010970),-0.3383761354775471,-0.8466751800296959,0.6912280701754386,0.8706327810052896,1.0,3/13,13.33%,APP;COPG1;SPG11
prerank,base-excision repair (GO:0006284),-0.24546281668648906,-0.8465874267226605,0.740072202166065,0.8703966390648641,1.0,15/48,27.42%,POLD3;OGG1;RPA3;DNA2;RPA1;PNKP;WRN;RPA2;HUWE1;RFC4;NTHL1;RFC1;LIG1;ERCC6;POLL
prerank,negative regulation of T cell activation (GO:0050868),0.25602699865125167,0.8465730601777638,0.7103448275862069,1.0,1.0,5/35,13.29%,PAG1;VTCN1;SDC4;HAVCR2;CD86
prerank,regulation of macroautophagy (GO:0016241),-0.20960463261963316,-0.846425716393927,0.8071428571428572,0.8703165074801421,1.0,24/105,19.78%,GNAI3;SESN1;LRRK2;EXOC4;KDR;MTOR;LARP1;NEDD4;BNIP3;ERN1;AKT1;PRKAA1;RPTOR;VPS26A;ATP6V1E1;MAPK8;EXOC8;TRIM13;HDAC6;ATP6V0A1;IKBKG;PRKAB1;TBC1D25;UCHL1
prerank,calcium-mediated signaling (GO:0019722),-0.21538447969331986,-0.8461255278565695,0.7898423817863398,0.8705027433162265,1.0,16/93,11.79%,LRRK2;KDR;PLCG1;PTPRJ;EGFR;TRPM4;IRGM;STIMATE;PLCE1;CCR9;PLCG2;EDN1;PRKAA1;BCAP31;PTGFR;AGTR1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.3014016528811567,-0.8457938299639943,0.6774193548387096,0.8707628753128072,1.0,2/18,6.78%,THBS1;LBP
prerank,ERBB2 signaling pathway (GO:0038128),0.2620606587778468,0.8455205552736805,0.6995614035087719,1.0,1.0,2/31,0.56%,NRG1;ERBB4
prerank,regulation of viral entry into host cell (GO:0046596),0.2620818616484273,0.845173182926934,0.6938775510204082,1.0,1.0,4/30,7.21%,HS3ST5;LGALS1;GSN;TRIM27
prerank,lipid homeostasis (GO:0055088),-0.2300013484883115,-0.8447462711455809,0.7363636363636363,0.8723593942302357,1.0,18/57,28.28%,ZBTB20;DDX3X;PRKAA1;ORMDL1;NR1D2;ACOX1;TLCD1;DGAT2;ACOX3;ORMDL3;PPARG;PNPLA8;CEBPA;PNPLA2;TLCD3B;USF2;FABP3;TREM2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.343159478537913,0.8447307339512328,0.6727272727272727,1.0,1.0,3/10,14.63%,APOM;ZDHHC8;APOE
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.19313058007601172,-0.8446958416342442,0.8752136752136752,0.8720657711013771,1.0,54/184,26.92%,PSMA2;NEK6;YWHAE;CEP57;CUL3;CEP250;CDC14A;PSME2;CEP78;PSMB4;ERCC2;HAUS8;RGCC;CDC16;DCTN1;DCTN3;ANAPC16;CSNK1D;PAFAH1B1;HAUS6;XPC;CEP41;ERCC3;PSMC2;PSMB2;PSMB1;ALMS1;TFAP4;PSMA8;PLK4;PCM1;CETN2;CNTRL;CEP152;CENPE;PSME1;BUB1B;PSMD4;BUB3;ODF2;PSMA7;HSP90AA1;PCNT;CEP131;AKAP9;FZR1;PSMD5;INO80;ANAPC7;ZFP36L1;PSMB10;PSMA3;KIF14;DYNLL1
prerank,regulation of feeding behavior (GO:0060259),0.3435079158778002,0.84433986673276,0.6438053097345132,1.0,1.0,4/11,23.48%,NR4A3;SGIP1;CFAP20;AGRP
prerank,positive regulation of B cell proliferation (GO:0030890),0.26417753915867864,0.8443397939901809,0.7038724373576309,1.0,1.0,5/29,10.26%,NFATC2;BCL2;SASH3;CD81;VAV3
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3041425559878208,0.8438826422715832,0.6673728813559322,1.0,1.0,5/15,19.43%,TRIM27;ARPC5L;ARPC5;WHAMM;ARPC1A
prerank,ERAD pathway (GO:0036503),-0.21776865644386223,-0.8435519765377406,0.7822141560798548,0.873914500884503,1.0,24/83,27.19%,ECPAS;TRIM25;RNF139;UBE4B;ANKZF1;UBE2J2;USP13;ATXN3;SGTA;MAN1B1;UBE4A;ERLIN2;DNAJC10;TRIM13;UGGT1;DNAJB12;DNAJB9;HERPUD1;FBXO17;TMUB1;RHBDD1;RNF103-CHMP3;USP19;RNF103
prerank,regulation of mRNA polyadenylation (GO:1900363),0.29618440255991296,0.8435286269039961,0.6617021276595745,1.0,1.0,4/17,13.57%,HSF1;CPEB1;CPEB3;CCNT1
prerank,embryonic heart tube development (GO:0035050),-0.3228787472944228,-0.8433660649092102,0.6784386617100372,0.8739098090763301,1.0,3/14,8.09%,SOX17;HES1;TBX2
prerank,nucleoside salvage (GO:0043174),0.3458781775852972,0.8429817797455574,0.6528735632183909,1.0,1.0,5/10,24.80%,CDA;UCK2;UCK1;TK1;TK2
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.3417573773101048,-0.8429739980198422,0.6797153024911032,0.8742994340657825,1.0,8/12,52.74%,TREM2;IL18;STAP1;TNF;TAFA3;IL6;CCL3;IL1B
prerank,tRNA processing (GO:0008033),0.22363246423401367,0.8424924200552464,0.7822222222222223,1.0,1.0,17/61,22.06%,QTRT2;TRMT10B;CPSF1;PTCD1;TRMT6;DDX1;TRMT10A;CLP1;FTSJ1;AARS2;ANKRD16;QTRT1;TRIT1;CSTF2;NSUN6;ADAT2;THUMPD1
prerank,magnesium ion transport (GO:0015693),0.3204855339418673,0.8424708780063672,0.6978723404255319,0.999667299249522,1.0,4/12,16.15%,TUSC3;NIPA1;NIPAL1;NIPAL2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3202535315388904,-0.8421551362594283,0.7170818505338078,0.8755237148102112,1.0,4/15,14.62%,DDIT4;NGF;BCAR1;GRB2
prerank,synaptic vesicle transport (GO:0048489),-0.3488531675555566,-0.8410789380469089,0.7051509769094139,0.8771218055575362,1.0,4/11,13.33%,DNM2;RAB27A;TMEM230;SPG11
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.262083292422303,0.8409112007848609,0.7334851936218679,1.0,1.0,11/30,21.68%,ACSBG1;HACD1;ELOVL4;ACSL6;TECR;ACOT2;HACD2;ACOX2;HACD3;PEX2;ABCD4
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.30597982454534634,-0.8408045449140649,0.6759581881533101,0.8772661450980831,1.0,4/17,18.16%,BMP6;CD55;NFKBIL1;SASH1
prerank,aerobic respiration (GO:0009060),0.2874953268900153,0.8401157440743706,0.688034188034188,1.0,1.0,9/20,26.14%,UQCR10;UQCRH;NDUFS8;NDUFS7;MDH2;UQCRB;ME3;OXA1L;MTFR1L
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.344642707751153,0.8398121640854711,0.6767895878524945,1.0,1.0,2/10,7.85%,PLEK;CARMIL1
prerank,regulation of cholesterol esterification (GO:0010872),0.3448310184325638,0.8397109001876908,0.632183908045977,1.0,1.0,5/10,22.89%,ABCA2;APOE;APOC1;LAMTOR1;ABCG1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.279670972208361,-0.8391771478139531,0.6895238095238095,0.8800185881059892,1.0,13/25,38.62%,CHMP4B;CHMP4A;VTA1;CHMP2B;CHMP5;TMEM50B;CHMP3;CHMP6;CHMP1A;LEPROTL1;VCP;CHMP1B;RILP
prerank,pinocytosis (GO:0006907),0.3458356306062552,0.8388230890145031,0.6775599128540305,1.0,1.0,5/10,21.22%,CARMIL1;RAB34;SNX33;SNX5;MAPKAPK3
prerank,nuclear membrane organization (GO:0071763),-0.2921895583072054,-0.8384016805894275,0.7119266055045872,0.8810998166706857,1.0,4/19,11.74%,EMD;TOR1B;CHMP4B;DCTN1
prerank,DNA replication checkpoint signaling (GO:0000076),0.30041544699446604,0.8381975195375142,0.6908665105386417,1.0,1.0,4/16,15.81%,CDC45;NAE1;RAD9B;ORC1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.27159863140154805,-0.8381147773342524,0.7171171171171171,0.8812697956668376,1.0,4/27,7.57%,PPP2R5A;PRKCD;SPPL3;CDH5
prerank,organelle fusion (GO:0048284),-0.2930056918145093,-0.8379604127464446,0.6844036697247706,0.8811455425171982,1.0,4/22,12.94%,MIEF1;CHCHD3;AFG3L2;MIEF2
prerank,glycolipid biosynthetic process (GO:0009247),0.24525546533608406,0.837245841330687,0.7348837209302326,1.0,1.0,10/38,16.87%,DPM1;ST8SIA5;ST6GALNAC5;PIGP;MPPE1;PIGB;PGAP3;ST8SIA3;B4GALT6;PIGQ
prerank,skeletal muscle contraction (GO:0003009),0.2873215665295989,0.8369954901850306,0.6945701357466063,1.0,1.0,4/19,13.30%,STAC2;STAC;TNNC1;TNNI2
prerank,isotype switching (GO:0045190),0.35138464212885373,0.8366164714287192,0.6712962962962963,1.0,1.0,4/10,17.15%,CCR6;BATF;RNF8;MSH2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.22237759485307293,-0.8365528189142062,0.789198606271777,0.8834028764997981,1.0,23/70,27.30%,PSMA2;ITGB5;PSME2;TAP2;PSMB4;PDIA3;NCF2;PSMC2;PSMB2;PSMB1;PSMA8;IKBKG;VAMP3;IKBKB;PSME1;PSMD4;PSMA7;SEC22B;FCGR1A;PSMD5;PSMB10;PSMA3;FCER1G
prerank,ganglioside metabolic process (GO:0001573),0.2858219923741008,0.8363414454977859,0.6817204301075269,1.0,1.0,6/20,17.68%,B3GALT4;ST6GALNAC5;ABCA2;HEXB;ST8SIA3;ST8SIA2
prerank,regulation of trophoblast cell migration (GO:1901163),0.3154482094027828,0.8355895644566023,0.7006802721088435,1.0,1.0,5/14,19.14%,ACVR1B;TIMP1;VEGFA;ACVR1C;GJA1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.34524233785242076,-0.8354882379790625,0.6940298507462687,0.8850463956767249,1.0,2/11,14.71%,CAT;GPX1
prerank,sphingoid biosynthetic process (GO:0046520),0.3331103521121136,0.8354427534721173,0.664367816091954,0.9987862309095044,1.0,4/11,9.92%,SPHK1;ACER1;ABCA2;SPHK2
prerank,sphingosine biosynthetic process (GO:0046512),0.3331103521121136,0.8354427534721173,0.664367816091954,0.9987862309095044,1.0,4/11,9.92%,SPHK1;ACER1;ABCA2;SPHK2
prerank,regulation of myelination (GO:0031641),0.26545461379372265,0.8349925550152615,0.7099056603773585,0.9985157814840064,1.0,3/25,5.85%,TENM4;MYRF;PTPRZ1
prerank,chromosome condensation (GO:0030261),-0.25334016574605767,-0.8348171574052686,0.7289377289377289,0.8859033680477513,1.0,17/36,36.25%,RB1;ACIN1;SMC4;TENT4A;KMT5A;NCAPD2;MCPH1;NCAPH;NCAPH2;SET;TTN;CHMP1A;PLK1;AIFM1;TOP2A;CSNK2A1;CSNK2A2
prerank,morphogenesis of an epithelium (GO:0002009),-0.27366359464454526,-0.8346659407190492,0.6978021978021978,0.8857979269489666,1.0,8/25,21.11%,LAMA3;LRP6;LAMA5;ACTB;TRAF3IP1;ARHGAP12;TIMELESS;VCL
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.32002601768990097,-0.8344765269924389,0.6792114695340502,0.8857712459967889,1.0,4/14,18.76%,RPUSD4;MRPS27;MPV17L2;UQCC2
prerank,estrogen metabolic process (GO:0008210),0.31173072174566874,0.8343814673715791,0.6628959276018099,0.9986151003996333,1.0,5/15,24.55%,HSD17B7;HSD17B14;CYP1A1;HSD17B8;HSD17B2
prerank,antibacterial humoral response (GO:0019731),0.3024931661134196,0.8343768025592124,0.6959459459459459,0.9973800472184384,1.0,3/16,10.06%,RNASE6;ANG;PLA2G6
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.24851790867508225,-0.834209616100079,0.7645985401459854,0.8858685596313223,1.0,14/38,29.39%,DAB2IP;ESR1;PPM1B;CASP8;TRIM59;TNFAIP3;USP10;ZMYND11;TRIM39;RIPK1;TNIP1;RIOK3;TREM2;CACTIN
prerank,intracellular lipid transport (GO:0032365),-0.29080048292231564,-0.8340546738621268,0.7125,0.8857472139118184,1.0,4/21,10.86%,CERT1;ABCD3;ACACB;CPT1A
prerank,negative regulation of cartilage development (GO:0061037),-0.322241710423495,-0.8337769440952909,0.6785714285714286,0.885863946912474,1.0,6/13,29.13%,WNT11;PTPN11;ADAMTS7;SNAI2;TGFBR1;WNT9A
prerank,glucose metabolic process (GO:0006006),0.22403044697332558,0.8337723986482729,0.7760180995475113,0.9974346190266223,1.0,4/58,5.09%,OMA1;SLC25A13;DCXR;TPI1
prerank,regulation of Golgi organization (GO:1903358),-0.30697870513877423,-0.8336731881470144,0.6938405797101449,0.8856727869275851,1.0,4/17,8.04%,STX18;ARMH3;USP6NL;MAPK1
prerank,ribosomal small subunit assembly (GO:0000028),0.30636492867259735,0.8326135659802506,0.7167381974248928,0.9987117456338032,1.0,5/16,16.89%,RRP7A;ERAL1;XRCC5;ABT1;PWP2
prerank,histone ubiquitination (GO:0016574),-0.2852721396204367,-0.8309775714791823,0.724907063197026,0.8903818420083002,1.0,6/21,20.37%,DTX3L;RNF40;UBR2;CDC73;PHC1;HUWE1
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.22439136563318987,-0.830941192121386,0.7823741007194245,0.8900490944983231,1.0,17/68,22.12%,GNAI3;NT5C2;LRRK2;RHOQ;ACSF2;TPST2;SULT1A1;PDE9A;THEM4;AMPD2;RAB23;HPRT1;HINT1;ACOT9;EPHA2;AMPD3;BPNT1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3536653318506905,-0.8306119779373492,0.6946983546617916,0.8902901790099995,1.0,8/10,51.26%,ANO6;TREM2;RAB31;APPL2;STAP1;F2RL1;NCKAP1L;CD300A
prerank,protein K63-linked deubiquitination (GO:0070536),0.25699676459080606,0.8302917423727467,0.7381489841986456,1.0,1.0,6/31,10.37%,OTUD7A;USP25;CYLD;OTUD7B;PSMD14;USP50
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.31782439412399355,0.8292845255425094,0.6984126984126984,1.0,1.0,2/12,6.48%,BCL2;TRIAP1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3126402804565316,0.829208563877778,0.6680761099365751,1.0,1.0,4/14,13.15%,NR1D1;SYT11;GRN;LDLR
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3479520256613443,-0.829108885880034,0.6861313868613139,0.8926994203034895,1.0,4/10,24.98%,ATRX;STOML2;E2F7;INO80
prerank,cyclooxygenase pathway (GO:0019371),0.33805086784361005,0.8290843787272049,0.6903765690376569,1.0,1.0,2/10,10.64%,PTGDS;CBR1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.263970776703109,-0.8289939233516361,0.759493670886076,0.89250733219955,1.0,20/31,48.63%,PLCB1;PLCG2;CD40;IL16;CCL19;MAPK11;HMGB1;LGALS9;MAPK14;IRF5;TLR2;SYK;MDK;ISL1;TLR4;SCIMP;TLR3;IL23R;AGER;IL12B
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.27808997526982937,0.8289662323444199,0.7311111111111112,1.0,1.0,4/21,8.27%,ADCY8;ADCY10;NPPC;ADCY7
prerank,regulation of DNA recombination (GO:0000018),-0.2645411790689645,-0.8282775873076138,0.7255244755244755,0.8934117762177329,1.0,10/32,24.01%,SETD2;SPIDR;MRE11;KPNA1;THOC1;RPA2;SMARCAD1;BLM;CHEK1;MSH3
prerank,multivesicular body assembly (GO:0036258),-0.2568055650956555,-0.8277208770787673,0.7536231884057971,0.8940251571471716,1.0,13/30,30.85%,CHMP4B;CHMP4A;VTA1;CHMP2B;VPS36;CHMP5;RAB11A;PDCD6IP;STAM2;CHMP3;VPS37B;CHMP6;CHMP1A
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3278147871131012,0.827515781443318,0.6891891891891891,1.0,1.0,3/12,12.14%,ADCY8;PLA2G6;GPLD1
prerank,fatty acid metabolic process (GO:0006631),0.19873208886154672,0.8271926699732389,0.8693586698337292,1.0,1.0,23/115,16.99%,NUDT19;LPIN1;ACSBG1;ELOVL4;ACLY;ACACA;ACSL3;CPT1B;OXSM;CPT1C;ACSL6;ALOX12;NAAA;GNPAT;LIPC;AASDH;ACOT2;ACOT7;NDUFAB1;MECR;ALOX5;CYP1A1;ACOX2
prerank,endosome organization (GO:0007032),0.23982480047937743,0.8271516030556458,0.7466666666666667,1.0,1.0,9/41,12.09%,TMEM9;RNF26;DNM1;LAPTM4B;ANXA8;ANXA8L1;USP50;SNX10;PHETA1
prerank,response to metal ion (GO:0010038),0.21936680713511886,0.8271270235221709,0.8167053364269141,0.9992711151911474,1.0,10/67,10.02%,KCNMA1;SLC34A1;SLC25A13;BCL2;PPP5C;CALM2;HOMER1;MAPT;PPP3CA;HAAO
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.24189371338621196,0.8268185845980386,0.7529411764705882,0.9986731075934292,1.0,10/37,16.40%,KIF17;DYNC2H1;KIFAP3;KIF3A;DYNC2I2;DYNLRB2;KIF3C;IFT172;IFT22;IFT81
prerank,regulation of B cell proliferation (GO:0030888),0.23662742498905684,0.8258255572985302,0.7672209026128266,0.9995218255090894,1.0,5/44,6.52%,BLK;NFATC2;BCL2;SASH3;CD81
prerank,regulation of water loss via skin (GO:0033561),0.3101901864976599,0.8252216825927196,0.6914414414414415,0.9983521665988433,1.0,1/15,0.47%,ABCA12
prerank,establishment of skin barrier (GO:0061436),0.3101901864976599,0.8252216825927196,0.6914414414414415,0.9983521665988433,1.0,1/15,0.47%,ABCA12
prerank,interstrand cross-link repair (GO:0036297),-0.2321086769858525,-0.8249667901836123,0.7751371115173674,0.8987402174382827,1.0,17/53,25.05%,MCM9;RPA3;RPA1;RNF168;FANCM;RFWD3;FANCD2;FANCC;FANCG;RPA2;USP1;FANCL;RAD51AP2;ERCC6L2;DCLRE1B;FANCI;DCLRE1A
prerank,activation of phospholipase C activity (GO:0007202),0.25605632379022003,0.824838768812145,0.7367205542725174,0.9979055148293503,1.0,7/29,13.29%,PHB2;ANG;NTRK2;ADRA1A;TXK;BDNF;CD86
prerank,retinoic acid metabolic process (GO:0042573),0.30883897805614446,0.824511280109533,0.7033707865168539,0.9973667059835506,1.0,4/14,22.31%,CYP26B1;ALDH1A2;BCO2;CYP26C1
prerank,response to glucagon (GO:0033762),-0.2904563932727028,-0.8244956691680155,0.7161410018552876,0.899203948675831,1.0,5/19,15.78%,PRKACB;ADCY9;ADCY4;CYSLTR2;ADCY1
prerank,diterpenoid metabolic process (GO:0016101),0.2220228957512681,0.8244951191608855,0.7844036697247706,0.9961836757168343,1.0,8/55,14.63%,GPC5;AKR1C1;APOM;GPC1;SDC4;LRAT;AKR1B10;APOE
prerank,aromatic amino acid family catabolic process (GO:0009074),0.306011586227405,0.8243677295418377,0.7120181405895691,0.9952192569558032,1.0,3/15,15.30%,QDPR;HAAO;TDO2
prerank,tRNA modification (GO:0006400),0.2167329787446745,0.8242483756297374,0.826879271070615,0.9942323638499085,1.0,19/62,23.09%,QTRT2;TRMT6;GTPBP3;TRMT13;TRMT10A;PUS1;FTSJ1;AARS2;ANKRD16;QTRT1;TRIT1;NSUN6;TPRKB;METTL2B;METTL2A;ADAT2;THUMPD1;TRMT5;THUMPD3
prerank,positive regulation of cilium assembly (GO:0045724),0.2837899880895764,0.8240502080715887,0.6986301369863014,0.9934694704554587,1.0,6/18,20.52%,CCDC88A;BBS4;CEP135;HTT;HAP1;SEPTIN9
prerank,positive regulation of neutrophil migration (GO:1902624),-0.29559744360977835,-0.8240063150345731,0.7103448275862069,0.899686663891292,1.0,2/18,5.85%,RAC1;MOSPD2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3178591118270079,-0.8239463347575743,0.6994633273703041,0.8994081201760697,1.0,5/13,17.95%,TGFBR2;GSK3A;SMAD4;NOTCH1;HEY2
prerank,negative regulation of lyase activity (GO:0051350),0.30369808395986514,0.8236474468585357,0.7095343680709535,0.9930352261400314,1.0,2/16,4.62%,GNAI2;GABBR2
prerank,phagolysosome assembly (GO:0001845),0.3294144703418489,0.8234692785673029,0.7061503416856492,0.9921942465439887,1.0,4/12,15.85%,CLN3;RAB39A;RAB34;RAB20
prerank,response to axon injury (GO:0048678),-0.2952060512280985,-0.8233932837223071,0.700374531835206,0.900025989870584,1.0,6/18,28.28%,NREP;RTN4RL1;SOD1;FLRT3;MTR;TREM2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.31474084173066486,0.8227256942180387,0.7246049661399548,0.9924839439479711,1.0,5/13,19.34%,HACD1;ELOVL4;TECR;HACD2;HACD3
prerank,peptide cross-linking (GO:0018149),-0.27634364963488434,-0.8225369722016103,0.7218181818181818,0.9011874871529588,1.0,18/25,49.30%,THBS1;TGM2;ABCA7;ANXA1;CD247;EVPL;FCGR3A;KRT10;TGM7;TGM4;DSP;TGM1;SPRR1A;LORICRIN;TGM6;TGM5;NDNF;EPB42
prerank,proteolysis (GO:0006508),0.17680866688786714,0.8223346462302158,0.9359605911330049,0.9920620297278561,1.0,46/252,17.46%,CPB2;TMPRSS11D;MMP12;MME;TRHDE;MMP16;CELA3A;MMP24;MMP25;PAPPA2;CLN3;CTSK;CPA2;CPE;FBXO2;TYSND1;METAP2;PRSS57;USP25;BACE1;SPCS3;TMPRSS7;ADAM19;CPN1;CPNE1;PCSK2;AEBP1;UFSP2;HTRA2;SPCS1;PCSK6;CPA4;CPA3;CLPP;ATG4D;ECE2;EEF1AKMT4-ECE2;MIPEP;TPP1;LONP1;ATG4B;KLKB1;CASP4;PSMB5;PGPEP1;NAPSA
prerank,regulation of peptidase activity (GO:0052547),0.28126735956822646,0.8219990137379167,0.7076566125290024,0.9915616258140998,1.0,6/19,14.61%,ECM1;A2ML1;ATP13A2;CST3;RCN3;PSMB8
prerank,glycosphingolipid metabolic process (GO:0006687),-0.24434125546754326,-0.8216814146339608,0.7657992565055762,0.9023268701135666,1.0,11/42,21.99%,ESYT2;A4GALT;ST6GALNAC3;ARSA;ASAH1;SMPD2;GBA2;LARGE1;GLTP;CTSA;GLA
prerank,neuron projection extension (GO:1990138),0.24852179308214503,0.8216602802947167,0.7297297297297297,0.9910417853060904,1.0,7/32,11.65%,SH3GL2;TMEM108;CDK5;IMPACT;CPNE1;MAP1B;AUTS2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.31516801751514817,-0.8215181281820444,0.7086330935251799,0.9022053430457975,1.0,8/14,42.75%,CRAT;ACOX1;ACOX3;ECI2;EHHADH;ACOXL;SCP2;ABCD1
prerank,lipid oxidation (GO:0034440),0.3180531874677246,0.8212786259983329,0.7109004739336493,0.9905930037674004,1.0,3/12,15.88%,PLA2G7;ALOX12;ALOX5
prerank,regulation of axon regeneration (GO:0048679),-0.33007140415776914,-0.821174246537268,0.7190388170055453,0.9024037355584337,1.0,4/12,13.05%,SCARF1;STK24;EPHA4;RTN4RL1
prerank,regulation of neutrophil migration (GO:1902622),-0.343023789194869,-0.820673514351424,0.7127468581687613,0.9028818021468425,1.0,2/10,13.44%,RAC1;RHOG
prerank,peptidyl-amino acid modification (GO:0018193),0.33784115634758743,0.8201978536906257,0.6928251121076233,0.9916172960988477,1.0,3/10,19.08%,METAP2;METAP1;FKBP7
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.30017146503959496,-0.8197517020499702,0.7251356238698011,0.904121297847997,1.0,9/16,36.67%,NT5E;TET2;NT5C1A;CRMP1;NT5C;UPB1;UPP1;DPYSL4;DPYS
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.34332505892048026,-0.8196198774918365,0.7119565217391305,0.9039679299287571,1.0,6/10,45.84%,RC3H1;LGALS9;CD274;CRTAM;PDCD1LG2;FOXP3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.29829498889874434,-0.8196056553637614,0.6946428571428571,0.9035806657891788,1.0,2/17,4.87%,PLA2G4A;LPCAT1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.3180580486434538,-0.8194317171043939,0.7063197026022305,0.9034895650728796,1.0,4/13,19.32%,HES1;DOT1L;JAK2;PTPRC
prerank,cardiac myofibril assembly (GO:0055003),0.2966781159769232,0.8192246015996777,0.6986607142857143,0.992405687139028,1.0,5/15,15.32%,FHOD3;PROX1;MYLK3;MYL2;PDGFRA
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.2909961790729129,-0.8190822934250405,0.7228464419475655,0.903714662563485,1.0,7/18,22.95%,CD34;EZR;KAT5;TNFAIP3;PTPRC;HDAC7;HOMER3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.29651113674958485,0.8186395951827592,0.7149425287356321,0.9923710201177116,1.0,7/15,25.40%,NYNRIN;ZC3H12B;ZC3H12C;NUDT16;RNASEH1;LACTB2;POP7
prerank,positive regulation of metabolic process (GO:0009893),-0.2032905591344814,-0.8183260635883869,0.8513986013986014,0.9046560360375108,1.0,15/103,11.47%,IGF1R;INSR;CAV1;ADIPOR2;PRDM16;STAT6;UCP2;GRB10;ACADL;ACACB;EHMT1;KDM6B;IL4R;KDM3A;JAK2
prerank,regulation of catabolic process (GO:0009894),-0.2982042294713063,-0.8183256341984365,0.7285714285714285,0.9042532789307468,1.0,2/18,2.03%,ITGB1;NEDD4L
prerank,regulation of actin nucleation (GO:0051125),0.3191262318749611,0.8180233298190854,0.6876355748373102,0.9924137961808992,1.0,12/12,68.11%,GSN;WHAMM;CORO1B;PICK1;ARFIP2;WASHC5;ARFIP1;ARF1;ARPIN;VIL1;SCIN;CORO1A
prerank,establishment of protein localization to organelle (GO:0072594),0.21317337040905274,0.8178893579711789,0.8253968253968254,0.9914725020316004,1.0,17/72,22.11%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;RYR2;RANBP17;RPAIN;LRSAM1;HK1;HIKESHI;POM121;NUP107;FAM53B;FAM53C;PRICKLE1;NUP93
prerank,DNA alkylation (GO:0006305),-0.2891684763796844,-0.817746686339431,0.7243243243243244,0.9044731158646129,1.0,7/19,24.04%,KMT2E;EHMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,DNA methylation or demethylation (GO:0044728),-0.2891684763796844,-0.817746686339431,0.7243243243243244,0.9044731158646129,1.0,7/19,24.04%,KMT2E;EHMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,positive regulation of rRNA processing (GO:2000234),0.34144735325070485,0.8175130821329796,0.701123595505618,0.9910618729467745,1.0,3/10,13.72%,BUD23;DIMT1;SIRT7
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.23120707685412975,-0.8173450209530844,0.783001808318264,0.9047810825028217,1.0,23/50,33.59%,MNAT1;CDKN1B;CCND3;ACTB;CDK5RAP3;CCND1;CNPPD1;BLM;CDKN2C;CDC25A;GADD45A;CCNG1;CCNK;CCNE2;CDKN3;CCNJ;CDKN2B;CCNH;CCND2;STOX1;CDK5R1;CCNE1;CDC6
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.34172329443534283,-0.8165542391479473,0.7158469945355191,0.905801393437546,1.0,4/10,14.75%,MTOR;ADAM9;FGF7;MAP4K4
prerank,actin filament polymerization (GO:0030041),-0.26135521081035473,-0.8159433217460744,0.7535460992907801,0.9064711522452087,1.0,9/29,18.92%,RAC1;DIAPH1;WASL;FAM107A;JAK2;PREX1;CORO7;PSTPIP1;WASF1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2966808210310964,0.8158105712999631,0.7325842696629213,0.9933186150240589,1.0,2/15,6.48%,BCL2;TRIAP1
prerank,positive regulation of lyase activity (GO:0051349),-0.31616918575362407,-0.8156523478526618,0.7231638418079096,0.9065742338945153,1.0,8/14,41.71%,NOS3;NF1;NOS1;NOS2;PARK7;STIM1;FXN;CACNA1C
prerank,epithelial cell differentiation (GO:0030855),-0.20625731668432068,-0.8155917119875213,0.8366247755834829,0.9062934091871168,1.0,15/88,14.85%,DAB2;TBX1;KDR;HDAC1;SIX1;E2F4;BMP4;BDH2;ANXA4;AKT1;KDM6B;CPT1A;ALDOC;ACADVL;JAG1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.31686763612113444,-0.8151111795631689,0.7476280834914611,0.9067959428110545,1.0,9/13,41.00%,DYRK1A;YJU2;MIF;MDM2;SNAI2;CD74;SIRT1;PTTG1IP;CD44
prerank,cellular response to lipid (GO:0071396),-0.1836643241688525,-0.8145260052765669,0.927461139896373,0.9074476922465959,1.0,34/191,16.45%,DAB2IP;ESR1;LYN;NRIP1;ATM;TBX1;NR3C1;EGFR;MSN;ADAM9;FZD4;NFKB1;TNFRSF1B;IRS1;PDCD4;MED1;IRGM;LBP;MEF2C;NFKBIL1;NCOA4;RHOA;IRAK1;CDC73;LPL;KAT5;WNT11;MAPK8;TNFAIP3;ROCK2;RUVBL2;ADCY1;UBE2L3;CHMP5
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.31277595544217185,-0.8144950697822898,0.7132486388384754,0.9071092735614087,1.0,6/15,20.71%,RTRAF;ERN1;TSEN15;TSEN34;TRPT1;RTCB
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.32174147672502346,-0.8141204892065984,0.7185741088180112,0.9073585514474444,1.0,5/13,27.03%,ZC3HAV1;RC3H1;MOV10;CNOT8;CNOT1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.23907773714174807,-0.8140802327578411,0.7956989247311828,0.90701934441948,1.0,10/40,17.30%,TNFSF10;BNIP3;AKT1;TP53;HGF;GPX1;BBC3;BCL2L11;IGF1;PPIF
prerank,detection of visible light (GO:0009584),-0.30363896080250397,-0.8138537386643675,0.7401433691756273,0.9070288426104076,1.0,11/16,54.27%,CEP250;TULP1;GNA11;PDE6B;RP1;GNAQ;RHO;GNAT1;REEP6;GNAT2;CACNA1F
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.3327306253166469,0.8138445382502818,0.7058823529411765,0.9959006904690291,1.0,1/10,0.75%,ANK3
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3002068616029028,-0.8130032643863525,0.7186963979416809,0.9081039327237329,1.0,9/16,34.42%,BOC;PLCB1;MEF2C;SMYD1;RBM24;LRRC8A;MAPK14;XKR8;HIF1AN
prerank,vasodilation (GO:0042311),0.31380354826886453,0.812931998914104,0.7303370786516854,0.9964953146584177,1.0,3/13,9.96%,KCNMA1;ADRB3;GPER1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.26742283484471063,-0.81276918135073,0.7655954631379962,0.908132093077883,1.0,3/25,2.50%,ITGB1;CD200;PARVA
prerank,lymphocyte chemotaxis (GO:0048247),-0.2536724131119037,-0.8117458810113215,0.7586837294332724,0.9095401724942129,1.0,5/34,9.65%,CCL25;SLC12A2;CYP7B1;GAS6;PIK3CD
prerank,mitochondrial protein processing (GO:0034982),0.32781276222850664,0.8115355760054767,0.6936936936936937,0.9980054768552642,1.0,3/11,15.79%,OMA1;PMPCB;MIPEP
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.23477621315447328,-0.8110951261307278,0.7848101265822784,0.9102525556330077,1.0,17/46,36.31%,AKT1;TOMM40;BCAP31;TIMM17B;TOMM5;DNAJC19;TOMM40L;TIMM50;TIMM10;TOMM20;TOMM70;TIMM10B;AIFM1;TIMM13;DNLZ;TIMM23;PAM16
prerank,endoderm development (GO:0007492),0.3068224788604864,0.8107261161573233,0.7097505668934241,0.9983519396473608,1.0,2/13,6.44%,LHX1;DUSP4
prerank,Golgi to lysosome transport (GO:0090160),-0.3359104151014594,-0.8103498826785258,0.7200736648250461,0.9111510634784019,1.0,4/11,16.96%,GAK;ANKFY1;AP1G1;AP4M1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.32973650293442935,0.8103258007458028,0.7251184834123223,0.9967652088339438,1.0,4/10,15.11%,SMPD3;SPHK2;PLA2G6;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.32973650293442935,0.8103258007458028,0.7251184834123223,0.9967652088339438,1.0,4/10,15.11%,SMPD3;SPHK2;PLA2G6;NSMAF
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.297857408418484,0.8096793398772004,0.6972477064220184,0.9968030313048709,1.0,5/15,15.11%,SMPD3;SPHK1;SPHK2;PLA2G6;NSMAF
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2409398684423173,-0.809677858924738,0.7789855072463768,0.9119655615273978,1.0,7/35,15.37%,PPP1R2;GSK3B;ITGA1;MTOR;PPP1R12A;PPP6R3;NUAK1
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.18726893046413107,-0.8092939558471564,0.895,0.912255539442247,1.0,47/170,26.53%,FOXP1;AFF1;PRDM5;MTMR3;APP;HMG20B;CTCF;NOVA2;KDM6A;HNRNPAB;PRDM2;CDH1;KDM6B;POGZ;HMG20A;PSEN1;TRIM14;PRDM6;EDN3;RASA1;FLOT1;CDK6;MARF1;ROCK2;ZNF462;PRDM9;IGF1;FUBP1;ZNF507;MKLN1;PTPRC;CAVIN4;PRDM1;TOB1;NKAP;KIF16B;MTMR4;TRIM39;RFXANK;PCBP1;TRIM68;UBAP2;IGF2BP2;CRNN;TRIM44;ZFP36L1;HNRNPD
prerank,DNA replication initiation (GO:0006270),0.23605889668264532,0.8092479398654345,0.8156028368794326,0.9964613560845008,1.0,9/37,16.00%,GMNN;MCM8;CDC45;POLA1;PURA;POLE4;CDC7;ORC1;CDK2
prerank,regulation of protein targeting to membrane (GO:0090313),-0.26298328388272213,-0.8091915659822453,0.7574692442882249,0.9120340511818068,1.0,7/28,16.68%,MIEF1;TCAF1;GDI1;MTCL1;MIEF2;CHP1;FYN
prerank,T cell differentiation in thymus (GO:0033077),-0.3137942839637173,-0.8089242565433401,0.7281021897810219,0.9120918345429135,1.0,6/14,31.26%,GLI3;PTPRC;LIG4;ZFP36L1;ADAM17;SHH
prerank,DNA damage checkpoint signaling (GO:0000077),-0.26358379211895183,-0.8084338675815458,0.7931034482758621,0.912541335749704,1.0,4/28,10.47%,MAP3K20;ATM;CLSPN;DOT1L
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.21384864285797583,-0.8071900114700805,0.8264758497316637,0.9143032408479531,1.0,20/69,27.19%,ECPAS;TRIM25;UBE4B;ANKZF1;UBE2J2;SGTA;MAN1B1;UBE4A;ERLIN2;DNAJC10;TRIM13;DNAJB12;DNAJB9;HERPUD1;EDEM2;FBXO17;TMUB1;RNF103-CHMP3;USP19;RNF103
prerank,basement membrane organization (GO:0071711),-0.3077049769816784,-0.8069271568537005,0.7266187050359713,0.9143745274916726,1.0,5/14,15.07%,NTN4;COL4A1;RAMP2;NID1;FLRT2
prerank,renal system development (GO:0072001),-0.22699124456679237,-0.8063429964760443,0.8036363636363636,0.9149423820499598,1.0,11/52,14.92%,SOX17;ACE;SIX1;C1GALT1;TGFB2;RBP4;BMP4;PCSK5;AGTR1;TRAF3IP1;FOXC1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.27662906273800913,-0.8057382792799239,0.7473309608540926,0.9155932186700145,1.0,8/23,22.06%,DIAPH1;PSEN2;NOS1AP;FYN;UBASH3B;CASQ2;NOS1;PTK2B
prerank,regulation of viral release from host cell (GO:1902186),-0.28051499274269276,-0.8056330802908572,0.7460035523978685,0.9153597426628882,1.0,10/21,33.32%,TRIM25;CHMP2B;TRIM13;TRIM28;CHMP3;VPS37B;TRIM35;TRIM32;TRIM62;TRIM5
prerank,defense response to protozoan (GO:0042832),-0.3300800419113544,-0.8053404460900224,0.7082601054481547,0.9154713035486524,1.0,3/12,13.55%,GBP6;GBP4;CD40
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.3397823206114654,-0.8053337726656331,0.7135325131810193,0.9150791758593451,1.0,3/10,18.61%,NCK1;JUN;CITED2
prerank,serine family amino acid catabolic process (GO:0009071),-0.33440645019769066,-0.805074953735405,0.7344028520499108,0.9151124601689427,1.0,6/10,40.11%,DLD;GLDC;SHMT1;GCSH;DAO;CBS
prerank,acyl-CoA metabolic process (GO:0006637),-0.24756804400347118,-0.8049653630642465,0.7750439367311072,0.9148868736804481,1.0,8/35,18.87%,OGDH;ACSF2;SUCLG2;ACACB;THEM4;HMGCS2;SUCLA2;ACOT9
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.33827023784003507,-0.8049567104105743,0.7284644194756554,0.9145011077084502,1.0,7/11,47.26%,H3-3A;ATRX;ASF1B;ASF1A;NASP;HAT1;CABIN1
prerank,negative regulation of viral process (GO:0048525),-0.2212347578731492,-0.8046150483782082,0.8188277087033747,0.9146870894509549,1.0,23/57,31.52%,IFIH1;ZC3HAV1;UBP1;TRIM14;IFITM3;PLSCR1;N4BP1;TRIM13;SRPK2;MAVS;TRIM28;IFITM2;TNIP1;CHMP3;TRIM6;OASL;BST2;TRIM35;RSAD2;LARP7;SHFL;TRIM32;TRIM62
prerank,glycerolipid metabolic process (GO:0046486),0.32575105573623936,0.8044105667896276,0.7212389380530974,1.0,1.0,3/11,17.19%,DGKQ;GAL3ST1;PGP
prerank,regulation of neuroblast proliferation (GO:1902692),0.2967081793583516,0.8041488364873312,0.7385321100917431,1.0,1.0,3/15,12.49%,TAFA1;VEGFA;FZD3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.27329833726805186,-0.8030258096073101,0.7724014336917563,0.9169509628673072,1.0,14/24,36.28%,KLF2;TP53;NOTCH1;ATF4;GCN1;MAPK7;NFE2L2;ATF6;DDIT3;CEBPB;ATF3;MUC1;MT3;HIF1A
prerank,metallo-sulfur cluster assembly (GO:0031163),0.26934258283398793,0.8029776996878719,0.7540229885057471,1.0,1.0,9/22,23.76%,HSPA9;ISCA2;NFU1;CIAO3;NUBP2;NUBP1;NFS1;CIAPIN1;LYRM4
prerank,histone H2A acetylation (GO:0043968),0.2888117499844769,0.8028191495512166,0.7372881355932204,1.0,1.0,4/16,14.00%,MEAF6;SPHK2;RUVBL1;NAA40
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.2951716013959501,-0.8023703237354897,0.7333333333333333,0.9176552712457341,1.0,8/16,40.38%,TGFB2;FOXC1;PTN;RBM24;SP7;TCF15;LTBP3;GATA4
prerank,nucleocytoplasmic transport (GO:0006913),-0.23579787582730657,-0.8019002823475442,0.7996357012750456,0.9180214764732119,1.0,12/40,26.21%,RSRC1;NUP98;BACH2;SNRPE;HNRNPA1;LSG1;NXT1;PHAX;RITA1;GEMIN7;NEMF;ATXN1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.26039291087623245,0.8016808347112909,0.7839643652561247,1.0,1.0,6/24,19.07%,AKAP6;CALM2;SRI;HRC;SELENON;PDE4D
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.2685111006649835,0.8012736834876206,0.776255707762557,1.0,1.0,3/21,12.21%,GRIN2B;USP50;PCID2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2667613700736871,-0.8012006316160271,0.7663551401869159,0.9187955109614654,1.0,10/24,30.94%,SUZ12;TASOR;H3-3A;DNMT1;PPHLN1;PPM1D;AEBP2;PHF19;SPI1;DNMT3B
prerank,glycerophospholipid catabolic process (GO:0046475),0.2510980329671224,0.8009208597919444,0.75054704595186,1.0,1.0,6/27,12.19%,ENPP2;PLA2G7;PLA2G4E;PLA2G6;LIPC;INPP5F
prerank,negative regulation of telomere maintenance (GO:0032205),-0.30125156337322456,-0.8008739466364501,0.7509090909090909,0.91896805658509,1.0,10/15,42.06%,ATM;TERF2;SMG6;PINX1;TNKS2;RAD50;TNKS;SLX4;ERCC4;ERCC1
prerank,DNA-dependent DNA replication (GO:0006261),0.18886101770376976,0.8003473755867206,0.9200968523002422,1.0,1.0,25/128,17.14%,GMNN;GINS4;WRNIP1;PSMC5;MCM8;PSMD10;CDC45;POLD4;PSMD14;POLA1;PSMB7;RPAIN;PSMA4;PURA;SIRT7;POLE4;PSMD1;PSMF1;PSMB8;CDC7;ORC1;CDK2;PSMD7;PSMB5;PSMD2
prerank,positive regulation of bone mineralization (GO:0030501),-0.24320355197281507,-0.8002890763606564,0.7968476357267951,0.9195621711978452,1.0,8/35,12.16%,BMPR2;BMP6;BMP4;MEF2C;ACVR2A;ADGRV1;ANO6;PKDCC
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3085439776526363,-0.7996377325283084,0.7439446366782007,0.9202526574827773,1.0,5/13,28.90%,RPS21;NOL9;RRS1;RCL1;UTP20
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.24008986703516294,-0.7994804953748808,0.8112874779541446,0.9201031769904491,1.0,11/39,23.23%,RBX1;ERCC2;POLD3;OGG1;RPA3;RPA1;ERCC3;RPA2;RFC4;NTHL1;RFC1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3276659506781279,-0.7994236103242748,0.7226277372262774,0.9198024965711931,1.0,7/12,31.42%,PROM1;NKD1;AGTPBP1;TULP1;MYO7A;SDK2;STAT3
prerank,ribosome assembly (GO:0042255),-0.23358115209288866,-0.7991426157516075,0.825136612021858,0.919907490300789,1.0,15/47,24.41%,DDX3X;RPS14;RPSA;NOP2;RPL3;RPL10;RPL5;NLE1;MPV17L2;RPS27;MDN1;BOP1;RRS1;RPS15;MRPS2
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.2504956994383058,-0.7990632263195496,0.7633851468048359,0.9196305050569256,1.0,3/30,6.54%,SPTBN1;GOLPH3L;MACF1
prerank,protein targeting to lysosome (GO:0006622),-0.28187412652480764,-0.7988779672512746,0.7526501766784452,0.9195137843362098,1.0,7/20,20.42%,RAB7A;NEDD4;NCOA4;AP4M1;LAMP2;ZFYVE16;M6PR
prerank,membrane lipid catabolic process (GO:0046466),0.338500638969789,0.7986488130233144,0.7236842105263158,1.0,1.0,3/10,15.25%,ENPP2;SMPDL3B;FUCA1
prerank,response to hexose (GO:0009746),-0.2681410409660596,-0.798209069239512,0.8014184397163121,0.9202385830363994,1.0,10/25,33.43%,THBS1;EIF2B2;LPL;TCF7L2;VAMP2;PFKL;SELENOT;MAFA;EIF2B4;EIF2B5
prerank,negative regulation of response to wounding (GO:1903035),-0.2827855154023868,-0.7980586431214407,0.7485928705440901,0.9200939413576582,1.0,4/19,13.05%,CRK;EPHA4;FGF2;RTN4RL1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.24180272703564193,-0.7978913772583311,0.7948243992606284,0.9199427670159877,1.0,7/39,6.92%,DTX3L;ARID2;SHLD1;KMT5B;MRNIP;FUS;SPIDR
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2783956587248818,-0.7978692712313853,0.7583774250440917,0.9191750987034583,1.0,6/21,18.94%,RBX1;ERCC2;RPA3;RPA1;ERCC3;RPA2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2783956587248818,-0.7978692712313853,0.7583774250440917,0.9191750987034583,1.0,6/21,18.94%,RBX1;ERCC2;RPA3;RPA1;ERCC3;RPA2
prerank,striated muscle cell differentiation (GO:0051146),-0.29463574970671613,-0.7978425920509763,0.7575757575757576,0.918816704439541,1.0,4/16,10.26%,AKAP13;SIK1;MEF2C;KDM6B
prerank,negative regulation of neuron differentiation (GO:0045665),-0.27207225440027505,-0.7978131821301416,0.7564766839378239,0.918462499943694,1.0,7/22,25.92%,GSK3B;HES1;MED1;BMP7;HEY1;NEPRO;EIF2AK4
prerank,regulation of mast cell activation (GO:0033003),-0.34163955213254726,-0.7976813685474352,0.7383820998278829,0.9182907706764898,1.0,4/10,26.85%,LYN;PLSCR1;MILR1;CD300LF
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.19567288617439066,0.7975637120871807,0.8753056234718827,1.0,1.0,23/84,20.79%,PATL2;GGA3;TYMS;ENC1;SPHK1;NTRK2;SORL1;RTN4;FXR2;CPEB3;EIF4A3;CNOT7;CLU;EIF4E2;APOE;EIF2AK2;DHX36;IGF2BP3;RTN3;HAP1;SAMD4B;RTN1;RBM4
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.30864094865417113,-0.7972006429077407,0.7521663778162911,0.9186870383671673,1.0,2/14,7.02%,TGFBR2;CD55
prerank,lysosome localization (GO:0032418),0.23611184288002401,0.7971665115176606,0.7887323943661971,1.0,1.0,11/37,19.88%,PIP4P1;CHGA;FLCN;NR4A3;RAB3A;RAB34;KIT;SNAPIN;BORCS5;MAP6;VPS33B
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.25613778162018763,-0.7970879792495487,0.7688172043010753,0.9184755292127783,1.0,6/27,14.28%,KHNYN;XRN1;ERN1;DICER1;PARN;PDE12
prerank,glial cell development (GO:0021782),-0.26305793863231863,-0.7967353271596167,0.7678883071553229,0.9186899957558238,1.0,14/25,37.42%,APP;EIF2B2;CDK6;NRROS;SOX4;NF1;NSUN5;EIF2B4;EIF2B5;PRDM8;S100A9;MT3;TLR2;MDK
prerank,mitochondrial transport (GO:0006839),-0.22577410589386593,-0.7966439668923792,0.8359788359788359,0.9184289229160735,1.0,22/53,34.01%,COX18;BNIP3;ABCB10;STARD3;TOMM40;BCAP31;TMEM14C;TIMM17B;TOMM5;PPIF;FLVCR1;DNAJC19;SLC25A24;HSP90AA1;TIMM10;TOMM20;TOMM70;PMAIP1;SPG7;SLC25A5;TIMM10B;TIMM13
prerank,negative regulation of immune response (GO:0050777),-0.18711693705398938,-0.7960743073422394,0.9221238938053097,0.9189774833950953,1.0,25/154,15.78%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;NMI;PLK2;RHBDF2;ADCY4;PLCG2;PPM1B;RAMP2;ADM;CYSLTR2;TRAF3IP1;RC3H1;TNFAIP3;ILRUN;IAPP;ADCY1
prerank,gastrulation (GO:0007369),-0.3001131730985489,-0.7955282897339641,0.753731343283582,0.9195034772464158,1.0,4/15,13.60%,LRP5;SMAD2;TASOR;LMBRD1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.3371275604284784,-0.7949963852495152,0.7127468581687613,0.9199495241579787,1.0,2/10,4.84%,PTPRJ;PTPN12
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.2828103162806539,-0.7941511694209439,0.7544483985765125,0.9209458573085902,1.0,2/18,3.07%,ESR1;KAT2B
prerank,protein polymerization (GO:0051258),-0.22073576244498827,-0.7940442994724889,0.8339285714285715,0.9207130522364357,1.0,14/55,18.92%,RAC1;UBE2K;DIAPH1;WASL;FAM107A;CHMP4B;CHMP4A;JAK2;PREX1;CORO7;CASQ2;TRPV4;PSTPIP1;WASF1
prerank,response to iron ion (GO:0010039),0.3108561633081122,0.7939529816934523,0.747072599531616,1.0,1.0,2/12,8.01%,BCL2;ACO1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.30352587360363664,-0.7939192856554315,0.7541284403669725,0.9205184885835253,1.0,4/14,29.64%,DAGLB;NOS1;CHAT;SLC22A2
prerank,dendritic cell migration (GO:0036336),-0.297733781954575,-0.7927145843043342,0.7545126353790613,0.9221084245276208,1.0,2/16,4.94%,EPS8;TRPM4
prerank,negative regulation of chemokine production (GO:0032682),-0.30093071758132633,-0.7923475783841893,0.7381370826010545,0.9223248883293607,1.0,1/14,1.54%,KLF4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.2740626026118777,-0.7923163071957888,0.7545787545787546,0.9219790199880487,1.0,5/21,10.57%,CSGALNACT1;CHST15;CHST11;CSPG4;BGN
prerank,placenta development (GO:0001890),-0.3123443693050375,-0.7922977920965476,0.7535714285714286,0.9216064841019292,1.0,5/12,24.41%,PTK2;CUL7;SOD1;PPARG;E2F7
prerank,arachidonate transport (GO:1903963),-0.3337489981748933,-0.7922032238579242,0.7491039426523297,0.9209597054038331,1.0,5/10,35.49%,ACE;ANXA1;PNPLA8;PLA2G5;DRD3
prerank,arachidonic acid secretion (GO:0050482),-0.3337489981748933,-0.7922032238579242,0.7491039426523297,0.9209597054038331,1.0,5/10,35.49%,ACE;ANXA1;PNPLA8;PLA2G5;DRD3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.28757960708821023,-0.7921970977459709,0.7636363636363637,0.9205688559167776,1.0,8/17,31.63%,AKT1;SFPQ;SOD1;MAPK7;NFE2L2;BAG5;TREM2;VNN1
prerank,protein import into nucleus (GO:0006606),0.207338715389459,0.7919228167178455,0.874439461883408,1.0,1.0,5/66,3.44%,MMP12;SPRN;PHB2;NUP62CL;TNPO3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.2685137089559708,-0.7919137995465899,0.7915129151291513,0.9206321429897474,1.0,11/23,35.90%,HERC4;GLI3;GLIS2;MOSMO;KIF7;GPC3;TULP3;SUFU;PTCH1;MGRN1;VCP
prerank,regulation of membrane depolarization (GO:0003254),-0.2859647430706477,-0.7914879183445421,0.7734806629834254,0.9208974648615635,1.0,9/18,30.27%,NEDD4L;LRRK2;PTPN3;SMAD7;SCN3B;FHL1;GJA5;HCN4;RANGRF
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.29221904427860773,0.7912327504062758,0.7290322580645161,1.0,1.0,5/16,18.78%,IL12A;RASGRP1;CD226;SLAMF6;CADM1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.27194253935998386,-0.7912076679627854,0.7611940298507462,0.9209539684516321,1.0,8/20,32.03%,PLOD2;PLSCR1;PTDSS1;GAMT;GCLC;CNDP2;HAGH;MGST2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2741462513550826,-0.7910661979030146,0.7699115044247787,0.9207991806050849,1.0,5/22,10.11%,CDKN1B;BMP4;ROCK1;PRKRIP1;TP53
prerank,retinoid metabolic process (GO:0001523),0.20731629282265987,0.7906970900029245,0.8784119106699751,1.0,1.0,10/71,14.63%,GPC5;AKR1C1;APOM;CYP26B1;GPC1;ALDH1A2;SDC4;LRAT;AKR1B10;APOE
prerank,positive regulation of neuron death (GO:1901216),0.22041250576864288,0.7905683992632649,0.8275058275058275,1.0,1.0,6/46,8.61%,GRIN2B;CDK5;EGR1;GRN;MAPT;BACE1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.31060891664328205,0.7905585319488195,0.7465753424657534,1.0,1.0,3/12,13.45%,INSIG1;RER1;KDELR2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.20150028477341175,-0.7904938743358565,0.8966725043782837,0.9213103393272183,1.0,21/90,21.69%,IGF1R;CAV1;ADIPOR2;PRDM16;STAT6;UCP2;GRB10;ACADL;EHMT1;KDM6B;IL4R;KDM3A;JAK2;ALMS1;ACSL1;CMKLR1;EPAS1;PRKAB1;G0S2;OGT;DIO2
prerank,mitochondrion morphogenesis (GO:0070584),0.3203694363898026,0.790489025776532,0.7379912663755459,1.0,1.0,5/11,23.29%,SLIRP;MFF;FIS1;MYH14;DNM1L
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.28957116845608116,0.7904692433973516,0.7364705882352941,1.0,1.0,16/16,71.07%,BCKDK;SCARB2;PDK2;PDK1;MLYCD;PRKN;ADIPOQ;FOXK2;ADIPOR1;SIRT1;GNB3;RORA;PDK3;FOXK1;PDK4;RORC
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2275878120418644,0.7899593926690832,0.8140589569160998,1.0,1.0,5/38,11.70%,MAGI2;FLCN;GPER1;NOP53;PHLPP1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.3200041259234049,-0.7897774622070285,0.7513812154696132,0.9220293769276369,1.0,4/11,26.46%,CDC73;AHCYL1;ZFP36L1;LEO1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.25657274962657955,-0.7896601579652962,0.7941176470588235,0.9218222683685938,1.0,7/25,17.07%,FBXL17;CUL3;ATXN3;ZER1;ZYG11B;UGGT1;HDAC6
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3128447276570615,-0.7889327223847021,0.7513227513227513,0.922580450982825,1.0,4/12,15.43%,HDAC1;NOTCH1;HDAC4;CCN3
prerank,protein import (GO:0017038),0.1995158378803522,0.7887725669922865,0.8914549653579676,1.0,1.0,22/84,22.11%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;ATAD1;RANBP17;RPAIN;CLU;APOE;HIKESHI;POM121;SNX33;NUP107;GDAP1;FAM53B;FAM53C;FIS1;PEX2;ACBD5;PRICKLE1;NUP93
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.29018433687931733,0.7885056429188568,0.7543478260869565,1.0,1.0,7/16,19.31%,B3GALT4;ST8SIA5;ST6GALNAC5;ST8SIA3;B4GALT6;ST8SIA2;ST8SIA1
prerank,activation of protein kinase A activity (GO:0034199),-0.29506164471346197,-0.7884286547424671,0.7570093457943925,0.9229706074498375,1.0,3/16,8.02%,PRKACB;ADCY9;ADCY4
prerank,nuclear envelope organization (GO:0006998),-0.27504822540605783,-0.7876664709562543,0.7663043478260869,0.9237457032307499,1.0,4/20,15.89%,EMD;TOR1B;REEP3;SUN1
prerank,aerobic electron transport chain (GO:0019646),0.20649392573640843,0.7876632390535715,0.8852097130242825,1.0,1.0,15/68,17.30%,COX6A2;UQCR10;NDUFA1;UQCRH;SDHA;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;COX6A1;NDUFS7;NDUFB6;NDUFA11
prerank,regulation of osteoblast proliferation (GO:0033688),0.2813045630134366,0.7875882960120664,0.7927350427350427,1.0,1.0,4/17,15.10%,NELL1;FGFR2;ATRAID;EIF2AK2
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.2921892609128829,-0.7875577376165516,0.7486818980667839,0.9235053909615886,1.0,7/16,28.28%,HDAC1;ROCK1;ABCA7;MYOCD;LRP1;HMGCR;TREM2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.20174049878158534,-0.7874491709113407,0.8805704099821747,0.9232773148175304,1.0,29/83,29.98%,MNAT1;RB1;CDK17;CDKN1B;CRLF3;CUL3;MAX;PLK2;CUL2;LATS2;CDK6;GSPT1;CACUL1;CCND1;CDK14;CDKN2C;CDC25A;CDK18;CCNE2;E2F3;TFDP1;KHDRBS1;BRD4;PLK3;CDKN3;CDK16;CCNH;HINFP;CDC34
prerank,mononuclear cell differentiation (GO:1903131),-0.26675068865338813,-0.7873088099082707,0.7965517241379311,0.9231111960010364,1.0,4/24,7.18%,MYH9;LYN;GAS6;BMP4
prerank,regulation of nuclear division (GO:0051783),-0.27748433473603007,-0.7871943759776217,0.7738970588235294,0.9228856704280746,1.0,4/20,13.18%,CDK13;CUL9;CUL7;CCDC8
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.2774300820544968,-0.7868681497603814,0.7588785046728972,0.9230071062057061,1.0,7/19,19.32%,KDR;PTPRJ;STIMATE;BCAP31;PTGFR;VCAM1;PTPRC
prerank,positive regulation of cell killing (GO:0031343),-0.3090772550965078,-0.7867733840082547,0.7456140350877193,0.9227539802108891,1.0,3/13,23.43%,RAC1;MAPK8;FZD7
prerank,cAMP metabolic process (GO:0046058),0.30316815730319896,0.7865950878885378,0.7657657657657657,1.0,1.0,3/13,8.27%,ADCY8;ADCY10;ADCY7
prerank,cholesterol homeostasis (GO:0042632),0.20480419171690528,0.7863963363112545,0.87248322147651,1.0,1.0,21/64,23.55%,NR1D1;INSIG1;AKR1C1;APOM;TSKU;ABCA2;LIPC;ABCA5;LDLR;GRAMD1B;APOE;SOAT2;DISP3;CD24;SOAT1;ANGPTL3;LAMTOR1;ABCG1;CNBP;NR1H2;TMEM97
prerank,DNA duplex unwinding (GO:0032508),-0.22428660318948437,-0.7852102191363963,0.8344709897610921,0.9247441246466419,1.0,19/50,33.70%,RBX1;MRE11;MCM9;ERCC2;MCM4;RPA1;XPC;ERCC3;ANXA1;WRN;CETN2;BLM;DHX9;MCM7;GTF2H3;CHD1L;MCM2;RAD50;PIF1
prerank,positive regulation of histone modification (GO:0031058),-0.24189442092171165,-0.7851810467830493,0.8035714285714286,0.9243895740394088,1.0,10/33,30.97%,RPS6KA5;NIPBL;RUVBL2;BRCA1;SAP30BP;NOS1;ARRB1;GLYR1;APLNR;RPS6KA4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.2897534877346186,-0.7851758555690828,0.7835420393559929,0.9240064341849482,1.0,8/16,39.65%,BMP4;RGCC;F2R;LARP6;RUNX1;TGFB1;HDAC2;CREB3L1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.24081636203264606,-0.78472936113826,0.8077669902912621,0.9242867914742257,1.0,6/32,17.21%,PPP1R13B;FHIT;DDIT4;TP53;HIPK1;HINT1
prerank,second-messenger-mediated signaling (GO:0019932),0.19896917784148288,0.7841072854180252,0.8669724770642202,1.0,1.0,21/82,22.18%,PPP1R9A;KSR2;DDAH2;CHRM3;SPHK1;RYR2;CCR6;RCAN2;MCTP2;NMUR2;RCAN3;APOE;MCU;HRH1;EDNRB;CXCR4;PPP2R1A;SAMD14;DDAH1;BTK;PDPK1
prerank,positive regulation of T cell migration (GO:2000406),-0.2764355194351832,-0.784098602206142,0.7620689655172413,0.9248850061921726,1.0,8/20,30.70%,APP;ADAM10;RHOA;CXCL12;ADAM17;CXCL10;WNK1;TNFRSF14
prerank,cholesterol transport (GO:0030301),-0.22582023778285298,-0.7840412385074452,0.8457538994800693,0.924578369919324,1.0,11/45,21.53%,LIMA1;CAV1;LDLRAP1;SCARB1;STARD3;STARD4;ABCA7;STX12;STAR;OSBPL2;LCAT
prerank,chromatin assembly (GO:0031497),-0.23478717295916635,-0.7838324349334418,0.8149466192170819,0.9245163515034127,1.0,7/38,15.56%,KAT6B;CTCF;BRD2;SPTY2D1;TP53;H3-3A;PRDM9
prerank,acylglycerol biosynthetic process (GO:0046463),0.25823020042381584,0.7837675129543513,0.779510022271715,1.0,1.0,4/23,12.65%,LPIN1;ANG;GK;MOGAT1
prerank,mRNA splice site selection (GO:0006376),0.24329743548471972,0.7835557644782268,0.8022988505747126,1.0,1.0,4/30,6.47%,CELF5;CELF4;CELF2;CELF6
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2203601762095031,-0.7827557022639249,0.8318739054290718,0.9258083739987548,1.0,17/51,31.57%,APP;CASP8;JAK2;LPL;PANX1;TRIM16;IL16;GBP5;CCL19;NOD2;CASP1;FZD5;HMGB1;LGALS9;NLRC4;STAT3;TLR6
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.26542295423587037,0.7824071815298099,0.7930232558139535,1.0,1.0,3/20,7.48%,BCL2;SELENOK;TMCO1
prerank,regulation of keratinocyte migration (GO:0051547),-0.3099660658259498,-0.7819265593467737,0.7622504537205081,0.9267050685418469,1.0,5/12,20.17%,MTOR;ADAM9;FGF7;MAP4K4;PTEN
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.26463182545668096,-0.7818424455327728,0.7773654916512059,0.9264302465301665,1.0,13/24,39.62%,CTSC;PSME2;EPHA4;GPX1;PSME1;PTK2B;RHBDF1;ATP5IF1;DNAAF4;UBE3A;NUDT15;PSME3;EFNA1
prerank,regulation of interferon-gamma production (GO:0032649),0.20035546026255763,0.7818191185750164,0.8772727272727273,1.0,1.0,12/71,15.73%,PDE4B;TRIM27;IL12A;IL12RB1;RASGRP1;CD226;HAVCR2;TXK;SLAMF6;IL23A;CD47;SIRPA
prerank,establishment of protein localization to extracellular region (GO:0035592),0.22715555828105627,0.781814131038687,0.8267543859649122,1.0,1.0,8/39,16.52%,RAB15;PDIA4;RAB3C;TANGO2;RAB3A;RCN3;COPG2;SEL1L
prerank,prostanoid metabolic process (GO:0006692),-0.3080088930821241,-0.781198568689225,0.7625231910946196,0.9270379648188469,1.0,4/13,21.13%,PTGS1;ACOX1;HPGDS;PTGR1
prerank,pseudouridine synthesis (GO:0001522),-0.30957169442560856,-0.7808898353866923,0.7676056338028169,0.9271064490178557,1.0,5/13,29.47%,PUS10;TRUB1;PUSL1;RPUSD2;GAR1
prerank,rRNA modification (GO:0000154),0.265893881713059,0.7806601671157801,0.7702702702702703,1.0,1.0,7/21,22.42%,MTERF4;BUD23;TFB1M;DIMT1;TSR3;THUMPD1;NOP10
prerank,cartilage development (GO:0051216),-0.222584272260614,-0.7803466544365908,0.857397504456328,0.9275391122208604,1.0,19/49,33.22%,ZBTB16;NFIB;BMP4;CREB3L2;MEF2C;FGF2;SNX19;CCN3;TRPV4;HYAL2;BMP2;WNT2B;WNT5B;TRIP11;HYAL3;RUNX1;TGFB1;SULF1;WNT7A
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.23745089627693275,0.7801188375580614,0.8107476635514018,1.0,1.0,5/34,13.29%,PHB2;INAVA;SASH3;SPHK2;CD86
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2298793288916813,0.7798266631450057,0.8438177874186551,1.0,1.0,10/38,17.30%,NDUFA1;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;NDUFS7;NDUFB6;NDUFA11
prerank,modulation by symbiont of entry into host (GO:0052372),-0.29368114795701594,-0.7792255729575175,0.76007326007326,0.9288623492689602,1.0,4/16,11.39%,CAV1;TRIM25;EXOC2;TRIM14
prerank,negative regulation of cellular metabolic process (GO:0031324),0.22866613859725582,0.779063212231196,0.8468468468468469,1.0,1.0,9/37,18.23%,ANKRD13B;WDR54;PAX2;MTMR2;ABCA2;DLG4;APOE;OPTN;EDNRB
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.2796094239825664,0.778868613303665,0.7313432835820896,1.0,1.0,5/17,18.78%,IL12A;RASGRP1;CD226;SLAMF6;CADM1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.30643515036563096,-0.7787924462479148,0.7796296296296297,0.9290937620495779,1.0,6/13,31.54%,BMP4;NOTCH1;TBX3;EID2B;TGFB1;SOSTDC1
prerank,natural killer cell activation (GO:0030101),-0.25980534421798546,-0.7778237956700957,0.8160291438979964,0.9301544420468881,1.0,3/23,9.65%,PBX1;CASP8;PIK3CD
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3038206763048704,-0.7776454343079526,0.7974683544303798,0.9300518369572863,1.0,7/13,33.46%,RNF168;NELFB;SUPT4H1;HNRNPU;LARP7;NELFA;NELFCD
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.2681725571630622,-0.7773028712884432,0.7836456558773425,0.9301659880161358,1.0,3/22,5.40%,GHR;CRLF3;HES1
prerank,sterol homeostasis (GO:0055092),0.20147941600393865,0.7771359148798043,0.8822222222222222,1.0,1.0,21/65,23.55%,NR1D1;INSIG1;AKR1C1;APOM;TSKU;ABCA2;LIPC;ABCA5;LDLR;GRAMD1B;APOE;SOAT2;DISP3;CD24;SOAT1;ANGPTL3;LAMTOR1;ABCG1;CNBP;NR1H2;TMEM97
prerank,response to acidic pH (GO:0010447),-0.30774676314126015,-0.7769490100291863,0.779385171790235,0.9302724617058745,1.0,5/13,23.85%,CHP1;LGMN;PKD2L1;GPR4;RAB11FIP5
prerank,regulation of phosphate metabolic process (GO:0019220),-0.28460961925613854,-0.7766206642564703,0.7527075812274369,0.9303452897052009,1.0,10/16,42.55%,PSEN1;IGBP1;IKBKB;SMG6;MCM7;SMG7;PGAM1;GNB3;IL4;SRPX2
prerank,neutrophil migration (GO:1990266),-0.21295140601686882,-0.7763790550001536,0.8483754512635379,0.9303293349189823,1.0,7/58,11.69%,PECAM1;BSG;CCL25;TGFB2;PIK3CD;EDN1;EDN3
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.25456742651292996,-0.7759629702914395,0.8007662835249042,0.9305513239927106,1.0,6/26,15.01%,NMI;PPM1B;NFKBIL1;TRAF3IP1;TNFAIP3;ILRUN
prerank,ncRNA transcription (GO:0098781),0.2972159144996245,0.7758631424424398,0.7697674418604651,1.0,1.0,6/13,24.10%,ANG;SIRT7;RPAP2;USPL1;NIFK;SPIN1
prerank,axonal transport (GO:0098930),0.2282463193845144,0.7757898769307653,0.8543046357615894,1.0,1.0,8/36,16.69%,TMEM108;SYBU;AP3S2;MAPT;KIF3A;AP3M2;SNAPIN;NEFL
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.310228818901947,0.7743416901649118,0.7264957264957265,1.0,1.0,3/11,15.70%,STK26;LANCL1;P4HB
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.27124111715414495,-0.7738504029844792,0.7902350813743219,0.9332870868654789,1.0,7/21,31.44%,PLA2G4A;MBOAT1;PLA2G12A;LPCAT3;PLA2G4F;OSBPL10;PLA2G5
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.27380757031072234,0.7730614118969207,0.7556053811659192,1.0,1.0,2/18,5.71%,PAG1;VTCN1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.28554150109041954,0.7728921476183339,0.7855477855477856,1.0,1.0,2/14,6.31%,SHISA2;GPC1
prerank,regulation of steroid metabolic process (GO:0019218),-0.2611537116767989,-0.7727733560687409,0.8185053380782918,0.9344887997360182,1.0,6/23,19.85%,PANK2;ACADL;ACADVL;ASAH1;STAR;FMO5
prerank,regulation of T cell differentiation (GO:0045580),-0.24013564421178915,-0.7724971403473537,0.8283185840707965,0.9344856942658908,1.0,3/33,5.93%,CBFB;ZMIZ1;ABL1
prerank,tyrosine metabolic process (GO:0006570),0.2999623399447653,0.7722255491899782,0.7307692307692307,1.0,1.0,11/11,70.02%,THAP4;GSTZ1;FAH;IL4I1;TAT;PAH;TH;IYD;DCT;HGD;TYR
prerank,chondroitin sulfate metabolic process (GO:0030204),0.23751753819918614,0.7720563196642815,0.8189845474613686,1.0,1.0,8/30,13.61%,DSEL;CHSY3;NCAN;CHST9;HEXB;CHST12;CHSY1;UGDH
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.323825371844402,0.7720416019163759,0.7406542056074766,1.0,1.0,2/10,8.44%,ATP5MC1;VPS9D1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.30415416777168824,-0.771891799170029,0.7783783783783784,0.9349641220961787,1.0,2/12,11.64%,LY6E;IFITM3
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3204910576256954,0.7717985312786765,0.7549234135667396,1.0,1.0,3/10,10.59%,PDE3B;PDE11A;RNF157
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.24141244915952648,0.7713853277567172,0.8329411764705882,1.0,1.0,9/31,23.02%,PYCR2;LSS;CYP51A1;FDFT1;ALOX5;NOXRED1;NFS1;LIAS;PRLR
prerank,intraciliary retrograde transport (GO:0035721),-0.31092253934167985,-0.7711156504498652,0.7843137254901961,0.9357054704952101,1.0,4/12,19.26%,IFT140;WDR35;DYNC2LI1;IFT43
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.32899272630520116,-0.7703886422192553,0.7654545454545455,0.936323752040861,1.0,7/10,45.95%,TCP1;CCT5;CCT2;CCT3;CCT7;DKC1;CCT6A
prerank,female gamete generation (GO:0007292),-0.24955318601381757,-0.7703459473974604,0.8342440801457195,0.9359850642787089,1.0,6/29,15.56%,USP9X;DMC1;MCM9;PARN;MARF1;PRDM9
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.29381562010113194,-0.7702939741881728,0.7811934900542495,0.935671453750268,1.0,11/15,48.63%,CD55;GLI3;NKAP;PNP;SHH;HSPH1;SYK;EBI3;IHH;IL23R;IL12B
prerank,response to purine-containing compound (GO:0014074),0.2694314041448282,0.7693642090529367,0.7816593886462883,1.0,1.0,2/17,7.41%,DGKQ;RYR2
prerank,programmed necrotic cell death (GO:0097300),-0.27652761584742147,-0.7689427940107816,0.7974683544303798,0.9372569888554872,1.0,14/18,49.60%,TRPM7;PPIF;RIPK1;ALKBH7;IPMK;TICAM1;CD14;MLKL;TLR4;TICAM2;TLR3;ITPK1;RIPK3;LY96
prerank,extracellular matrix assembly (GO:0085029),0.253112665849455,0.7687623344559054,0.7973856209150327,1.0,1.0,4/23,8.36%,GPM6B;NTNG2;NTNG1;LAMB3
prerank,regulation of glucose metabolic process (GO:0010906),0.22843369587989135,0.7686438293620205,0.8429203539823009,1.0,1.0,6/34,14.60%,DGKQ;GNMT;BCKDK;GPLD1;SIRT7;SELENOS
prerank,glutamate metabolic process (GO:0006536),0.26249852295115256,0.7678652962580546,0.804932735426009,1.0,1.0,9/19,27.42%,OAT;GLS2;GLS;GLUD1;GAD1;MTHFS;GCLM;FPGS;ALDH5A1
prerank,pre-replicative complex assembly (GO:0036388),0.20384998146903807,0.7675469488033595,0.912718204488778,1.0,1.0,14/64,17.14%,GMNN;PSMC5;MCM8;PSMD10;PSMD14;PSMB7;PSMA4;PSMD1;PSMF1;PSMB8;ORC1;PSMD7;PSMB5;PSMD2
prerank,protein localization to microtubule organizing center (GO:1905508),0.28597101556868815,0.7672837784777067,0.7640449438202247,1.0,1.0,3/15,10.63%,BBS4;SNX10;CCDC14
prerank,monocyte differentiation (GO:0030224),-0.32726778196803746,-0.7672167294639646,0.7768014059753954,0.9393559504174591,1.0,5/10,25.52%,MYH9;BMP4;PIR;PPARG;MT1G
prerank,peptidyl-methionine modification (GO:0018206),-0.3095730538044724,-0.767188913610484,0.7822141560798548,0.9389960999050596,1.0,2/12,10.04%,NAA16;NAA15
prerank,negative regulation of neurogenesis (GO:0050768),-0.23735290204274945,-0.7667730532717928,0.8384879725085911,0.9392224420840124,1.0,9/34,22.67%,RAPGEF2;ARHGDIA;GDI1;NOTCH1;RHOA;PCM1;PTEN;NF1;PTN
prerank,establishment of vesicle localization (GO:0051650),-0.27742675183034754,-0.7667557572477108,0.7787769784172662,0.9388511212151254,1.0,7/18,18.43%,LIMK2;DNM2;RAB27A;TMEM230;SPG11;RAB11A;IKBKG
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.3086659310302608,0.766659767542727,0.7733644859813084,1.0,1.0,3/12,14.60%,TMEFF2;PF4;SELENOS
prerank,protein localization to condensed chromosome (GO:1903083),-0.31249973492258915,-0.7666567720082651,0.7817164179104478,0.9386016007433834,1.0,8/12,47.06%,BUB3;TTK;MTBP;SPDL1;MIS12;AURKB;CHAMP1;KNL1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3244699373569096,0.7663355958734772,0.7520491803278688,1.0,1.0,3/10,18.89%,ADRA2A;TGFA;HBEGF
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2511995205529988,-0.7652503092137187,0.8035714285714286,0.9401582365826431,1.0,14/26,40.43%,LRRK2;AKT1;ATF4;FYN;TXN;MAPK7;NFE2L2;BAG5;PYCR1;VNN1;PARK7;PDE8A;GATA4;SIRT1
prerank,fatty acid oxidation (GO:0019395),-0.20961852825051047,-0.7651736563641799,0.872072072072072,0.9398697038832097,1.0,9/57,15.50%,HADHB;ADIPOR2;ABCD3;BDH2;PPARD;ACADL;ACAD11;ACADVL;ACOX1
prerank,apoptotic nuclear changes (GO:0030262),0.24685252257602788,0.7651345503209315,0.8056155507559395,1.0,1.0,6/24,15.23%,BLCAP;H1-0;GPER1;HMGB2;ACVR1C;DEDD2
prerank,steroid hormone biosynthetic process (GO:0120178),-0.2474801381120305,-0.7642127688463164,0.8185053380782918,0.9408473547675401,1.0,7/29,18.80%,MED1;STARD3;FDX1;FDXR;STARD3NL;DHCR7;STAR
prerank,oligosaccharide metabolic process (GO:0009311),-0.22150619771918717,-0.7640756024202128,0.858195211786372,0.9406500042172321,1.0,6/46,9.03%,ST3GAL6;ST3GAL4;ST8SIA4;ST6GALNAC3;FUT8;ST3GAL2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.3079702651761056,-0.7639909182236244,0.7795992714025501,0.9403659205245434,1.0,3/12,13.13%,NFIB;EPHA4;PAFAH1B1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.20812023199837354,-0.7637930331963791,0.8943533697632058,0.9402595556555133,1.0,22/64,32.80%,PLA2G4A;ELOVL5;ACADL;GSTM2;EPHX1;CPT1A;ACAD9;SLC27A4;MGLL;GPX1;ACOX1;ACSL1;DAGLB;PNPLA8;CYP1B1;SLC27A3;GPX4;HACL1;ELOVL2;ALOXE3;CPT2;ELOVL6
prerank,ear morphogenesis (GO:0042471),-0.2656140920080523,-0.7637684962201609,0.8223443223443223,0.93988476183629,1.0,3/20,5.59%,TBX1;NIPBL;SIX1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2758047603425681,-0.7631985963913148,0.8072916666666666,0.9402871060365624,1.0,5/19,15.59%,MTOR;RPTOR;ICE1;POLR3F;NAB2
prerank,activation of adenylate cyclase activity (GO:0007190),0.23150333967987782,0.7628844513691306,0.8381374722838137,1.0,1.0,8/35,14.40%,ADCY8;GIPR;ADCY7;ADRB3;TSHR;LGR5;ACR;ADCY3
prerank,negative regulation of protein metabolic process (GO:0051248),-0.21494303372319992,-0.7628757690004282,0.8684684684684685,0.9403346012039644,1.0,12/48,20.64%,EGFR;NFKB1;ROCK1;FLNA;VBP1;EDN1;SNX12;AZIN1;IAPP;MAD2L2;PFDN6;ITGB3
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.2951654225192233,-0.7619809818474507,0.795774647887324,0.941202118432275,1.0,8/14,46.44%,IRAK1;COPS8;MAP3K7;TLR6;ZFP91;CARD14;MALT1;TLR3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.24571316313594072,-0.7616928923864146,0.7914438502673797,0.9412299264128425,1.0,11/27,27.31%,CSGALNACT1;CHST15;CHST11;CSPG4;BGN;CHST7;CHPF2;PXYLP1;XYLT2;CSGALNACT2;XYLT1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.3225501238438163,-0.7612038028807033,0.8065693430656934,0.9414930398740925,1.0,2/10,9.16%,GRB10;GSK3A
prerank,neutrophil chemotaxis (GO:0030593),0.20748564931836183,0.7606689738160111,0.8855291576673866,1.0,1.0,8/53,14.71%,PDE4B;CXADR;PF4;CCL13;CCL5;CCL2;PPIA;CCL7
prerank,negative regulation of interferon-beta production (GO:0032688),0.3078553463458314,0.7605610616400402,0.7831858407079646,1.0,1.0,3/10,15.73%,REL;PTPRS;SIRPA
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.248019504979554,0.7599201938905724,0.8201284796573876,1.0,1.0,2/23,6.18%,PPEF1;METAP2
prerank,epiboly involved in wound healing (GO:0090505),-0.2744498424605267,-0.7596864527741592,0.8062730627306273,0.9432181001180169,1.0,7/16,22.42%,FLNA;RHOA;CEACAM1;LCP1;RHOC;ARHGAP35;CCN1
prerank,ribosomal large subunit assembly (GO:0000027),-0.2593999071323002,-0.7591377672488049,0.8159392789373814,0.9435661937202297,1.0,8/24,20.94%,NOP2;RPL3;RPL10;RPL5;NLE1;MDN1;BOP1;RRS1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.3045893368379694,-0.7589986695345963,0.8090737240075614,0.9433525880880747,1.0,5/13,27.47%,KCNK5;KCNQ1;KCNE4;KCNH2;KCND3
prerank,retina homeostasis (GO:0001895),-0.2578668777308109,-0.7589912988417356,0.8214285714285714,0.94296669911984,1.0,10/23,33.71%,POTEF;ACTB;TULP1;SOD1;CCDC66;POC1B;PRDX1;JCHAIN;CRB2;ACTG1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.1986895330870799,0.7587514891743119,0.918141592920354,1.0,1.0,15/69,17.30%,COX6A2;UQCR10;NDUFA1;UQCRH;SDHA;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;COX6A1;NDUFS7;NDUFB6;NDUFA11
prerank,ESCRT complex disassembly (GO:1904896),-0.3200020948090586,-0.7583013615357962,0.7836879432624113,0.9431065636812341,1.0,3/10,16.45%,VTA1;CHMP2B;CHMP5
prerank,ESCRT III complex disassembly (GO:1904903),-0.3200020948090586,-0.7583013615357962,0.7836879432624113,0.9431065636812341,1.0,3/10,16.45%,VTA1;CHMP2B;CHMP5
prerank,histone H2A monoubiquitination (GO:0035518),-0.27591379450958753,-0.7582366989348268,0.823321554770318,0.9427852554925497,1.0,6/17,21.21%,RYBP;RNF168;BCOR;PCGF3;RNF2;PCGF5
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.2234909110815873,-0.7568960570283567,0.8442477876106195,0.9442003444642653,1.0,8/40,12.16%,BMPR2;BMP6;BMP4;MEF2C;ACVR2A;ADGRV1;ANO6;PKDCC
prerank,regulation of mitochondrion organization (GO:0010821),0.21111552857695934,0.7565526674692046,0.8883826879271071,1.0,1.0,16/47,23.29%,OMA1;PRMT6;FLCN;MAPT;ATP13A2;INF2;HTRA2;SIRT7;RHOT1;MFF;VDAC1;FIS1;PISD;SQSTM1;USP36;DNM1L
prerank,positive regulation of cell development (GO:0010720),-0.23778226458185742,-0.7565404566423076,0.8523131672597865,0.9442928497822195,1.0,4/31,7.84%,PDE3A;SPEN;BMP4;TGM2
prerank,cobalamin metabolic process (GO:0009235),0.2723897394685984,0.7565081484450611,0.7557603686635944,1.0,1.0,3/17,13.47%,CBLIF;MMAB;MMAA
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.2776063843362052,-0.7563646474163771,0.7767527675276753,0.9441253694859253,1.0,2/16,6.13%,PPARA;PDCD4
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.2704821566685416,-0.7561742562109145,0.8067542213883677,0.9439766625489451,1.0,5/17,28.06%,FERMT2;PTPRC;TERT;HNRNPU;N4BP2L2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.31176211262605646,0.7560401690271922,0.7842227378190255,1.0,1.0,4/10,17.07%,EGR1;SORL1;CLU;HSP90AB1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.23831100667934685,0.7554953744090277,0.8288888888888889,1.0,1.0,4/27,9.59%,DDR2;SPHK1;S100A6;PDGFA
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.30494076043345664,-0.7542629258570271,0.7982142857142858,0.9461323023544287,1.0,9/12,46.50%,MAD1L1;CENPE;BOD1;NUF2;MIS12;RMDN1;KIF2C;CDT1;CHAMP1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.23465219488866682,-0.7541579275246394,0.833941605839416,0.9458871329662282,1.0,10/32,24.21%,LPCAT1;SLC44A1;STARD7;MFSD2A;CEPT1;PCTP;LPIN2;LPCAT3;LCAT;CHAT
prerank,sarcomere organization (GO:0045214),0.23918193435478863,0.7535189275208598,0.839907192575406,1.0,1.0,4/27,12.82%,FHOD3;MYPN;MYLK3;CASQ1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.23177250836923718,-0.7533712294547795,0.8688524590163934,0.9465077892135471,1.0,13/38,28.11%,PRPF3;PRPF6;PRPF31;SNRPE;TGS1;SRSF12;CD2BP2;STRAP;SRSF10;COIL;GEMIN7;AAR2;LSM2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.3002832275162195,-0.7531981760325751,0.8104693140794224,0.9463535518954247,1.0,3/12,13.36%,CHMP4B;CHMP4A;SGTA
prerank,inorganic anion transport (GO:0015698),0.20619070562311312,0.7531491303611382,0.9002320185614849,1.0,1.0,10/53,16.03%,SLC34A1;CLCNKA;GLRA1;ANO4;CLCN2;ENPP3;SLC26A8;RACGAP1;SLC4A11;SLC13A1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.30485195931109654,-0.7530055354506857,0.8044692737430168,0.9461999746943459,1.0,1/12,2.01%,ESR1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2775747192046149,0.7528137887821854,0.7937219730941704,1.0,1.0,2/14,7.07%,PELI3;TRAIP
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.26980489864272905,-0.7523569550219248,0.811284046692607,0.9467151076068152,1.0,5/17,18.92%,WASF2;FCHSD2;NCKAP1;GMFB;WASF1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.2993607994096653,-0.751628515740032,0.7837370242214533,0.9472770535366242,1.0,4/13,18.06%,BMP5;NFKB1;ERLIN2;SOD1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.2728132931891107,-0.7515699204664732,0.8154121863799283,0.946972593185453,1.0,8/18,26.13%,MCM4;POLD3;GINS3;GINS1;RFC4;MCM3;LIG1;MCM7
prerank,positive regulation of cellular senescence (GO:2000774),-0.31882578775382686,-0.7515353176466276,0.8074204946996466,0.9466243654192392,1.0,3/10,15.17%,YPEL3;ABI3;CGAS
prerank,mucosal immune response (GO:0002385),-0.2873462568549972,-0.7513369057612929,0.7912885662431942,0.9464943223062736,1.0,13/15,54.27%,RNASE3;DEFA6;RPL39;IFNLR1;NOS2;RAB17;IL4;CAMP;BPIFB1;DEFB1;FFAR2;LTF;PIGR
prerank,regulation of phospholipid metabolic process (GO:1903725),0.31044896255243726,0.7498817373607878,0.7264770240700219,1.0,1.0,2/10,6.82%,PHB2;MTMR2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2866910685433451,-0.7485980699265,0.8324022346368715,0.9496494586723178,1.0,5/15,26.34%,TCP1;RUVBL2;CCT5;CCT2;NAF1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.30064352330336336,-0.747499816473511,0.8062730627306273,0.9506942311151239,1.0,4/12,21.42%,PTPRJ;CBL;F3;IFT20
prerank,sulfur compound catabolic process (GO:0044273),0.21737969442462404,0.747475184215266,0.8807947019867549,1.0,1.0,6/38,10.66%,GADL1;DPEP1;NCAN;FMOD;PRELP;HEXB
prerank,cellular macromolecule catabolic process (GO:0044265),-0.21020394872972498,-0.7471842559474132,0.8974820143884892,0.9507098555004849,1.0,12/49,27.55%,DAB2IP;DENND3;RNASE3;ADAMTS9;XRN2;MAGEC2;RNASEH2C;RIPK1;EXOSC7;FBXO17;HNRNPD;MANBA
prerank,determination of left/right symmetry (GO:0007368),0.2227277607302135,0.7466580746779546,0.8878923766816144,1.0,1.0,10/36,16.21%,ODAD2;MEGF8;BBS7;DNAAF1;PKD1L1;ENKUR;LEFTY1;ARL6;FOXJ1;MKKS
prerank,nuclear transport (GO:0051169),-0.268227693218564,-0.7459515707033251,0.8406593406593407,0.9518718744955431,1.0,2/16,6.96%,RSRC1;NUP98
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.31559609167806435,-0.7457730707111123,0.7858407079646018,0.9517044724198359,1.0,4/10,33.53%,LRP6;CTNNB1;FZD1;WNT3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.24837207497024114,-0.7457235262836538,0.8461538461538461,0.9513711557064736,1.0,11/25,36.25%,EPHA4;HFE;SGTA;RPL5;RPS7;TRIM39;PRKCG;OPHN1;GABARAPL2;CSNK2A1;CSNK2A2
prerank,regulation of aerobic respiration (GO:1903715),-0.27957600865699106,-0.7454417522041876,0.8096947935368043,0.9513484125511522,1.0,1/15,1.76%,CBFA2T3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3047613407683285,-0.7450084570228288,0.8138297872340425,0.9515312337545635,1.0,2/11,9.30%,SCARB1;MFSD2A
prerank,negative regulation of locomotion (GO:0040013),-0.297396707197749,-0.7448715945886054,0.8107606679035251,0.9512982293338805,1.0,3/12,12.95%,CRK;FRMD5;DUSP3
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3122683407869259,-0.7439464847451104,0.8191489361702128,0.9520701182800995,1.0,4/10,25.05%,TERF2;TFIP11;DCLRE1B;DCLRE1A
prerank,chemical homeostasis (GO:0048878),-0.2020529845040158,-0.7438857487058932,0.9211009174311927,0.9517547566876432,1.0,18/61,24.91%,ZBTB20;NEDD4L;SLC4A10;TENT4B;DDX3X;AQP11;WNK4;NR1D2;ACOX1;TLCD1;ACOX3;KLHL3;PPARG;SLC66A1;PNPLA8;CEBPA;PNPLA2;TLCD3B
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.2774489383563432,0.7437973567702327,0.8202247191011236,1.0,1.0,6/14,22.89%,XRCC5;ATR;ACD;TPP1;TERF2IP;BRCA2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2365895888601894,-0.7435628078424262,0.8436944937833037,0.9517614425934952,1.0,12/29,28.11%,EXOSC2;EXOSC1;EXOSC3;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;NT5C3B;EXOSC7;CNOT8;LSM2
prerank,genitalia development (GO:0048806),-0.29851055984020997,-0.7431814863291367,0.8081180811808119,0.9518313988542824,1.0,6/12,31.26%,FOXF2;DNAJC19;PTPN11;TBX3;STRA6;SHH
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3006300523474136,0.743158525076472,0.771889400921659,1.0,1.0,1/11,1.95%,GCK
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.28011787782058617,-0.7428846904983987,0.8074766355140187,0.951814855908547,1.0,3/15,16.62%,GGT5;GGACT;HOGA1
prerank,regulation of defense response to virus (GO:0050688),-0.28682649093549983,-0.7426370664385127,0.8246628131021194,0.9517477478888924,1.0,8/14,29.57%,PPM1B;TRAF3IP1;TNFAIP3;ILRUN;ZMPSTE24;RNF216;DHX9;IFNLR1
prerank,neuron projection regeneration (GO:0031102),-0.31288020013094386,-0.7421335064703865,0.8081705150976909,0.9519940487006193,1.0,4/10,27.94%,NREP;RTN4RL1;PTN;MTR
prerank,cellular amino acid catabolic process (GO:0009063),0.1835161937819555,0.7420970796983465,0.9432624113475178,1.0,1.0,24/87,21.70%,OTC;QDPR;BCKDK;ASPA;HMGCLL1;HAAO;AMT;MCCC2;SDSL;HMGCL;GLS2;GLS;GLUD1;CARNS1;TDO2;SARDH;GAD1;DDO;BCAT2;DLST;SLC25A21;ACAT1;DDAH1;GSTZ1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.28732362165300357,-0.7420859889044183,0.7927272727272727,0.9516758167936649,1.0,5/13,30.12%,ITGB1;LPL;PPARG;FCER1G;CD9
prerank,cell part morphogenesis (GO:0032990),0.28483796935606065,0.7418824555968045,0.8063063063063063,1.0,1.0,5/13,23.29%,SLIRP;MFF;FIS1;MYH14;DNM1L
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2005939505440399,0.7416401124767609,0.9243119266055045,1.0,1.0,13/53,18.51%,PSMC5;PSMD10;BCKDK;PSMD14;PSMB7;PSMA4;PSMD1;PSMF1;PSMB8;PSMD7;PSMB5;PSMD2;PSMB3
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2667898758560339,-0.7414245271248555,0.8475836431226765,0.9521055902706761,1.0,6/18,24.21%,ERC1;CHRNB1;FCHSD2;STAC3;FCHSD1;CHAT
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.2640172665778608,-0.7410336998386018,0.8357400722021661,0.9522094200122515,1.0,7/19,30.81%,BMP4;RGCC;EMILIN1;F2R;LARP6;RUNX1;TGFB1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.22479248690382836,-0.7405243239174267,0.8641114982578397,0.952417792791505,1.0,10/37,23.23%,RBX1;ERCC2;POLD3;RPA3;RPA1;ERCC3;RPA2;RFC4;NTHL1;RFC1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.20176300834241903,0.7401650552796193,0.9305555555555556,1.0,1.0,8/55,11.97%,GPC5;HPSE2;GPC1;NCAN;FMOD;PRELP;HEXB;SDC4
prerank,regulation of rRNA processing (GO:2000232),-0.28258233432877367,-0.7392532633505849,0.8320754716981132,0.9535683153039033,1.0,2/16,5.91%,KAT2B;WDR75
prerank,ganglion development (GO:0061548),-0.30859680915110876,-0.7388018085459716,0.8100558659217877,0.953758093126489,1.0,1/11,0.76%,NRP2
prerank,immunoglobulin mediated immune response (GO:0016064),0.30586754956851403,0.7386260284875361,0.7956521739130434,1.0,1.0,2/10,17.74%,CD81;FCGR2B
prerank,glutathione biosynthetic process (GO:0006750),0.2982063420048251,0.7382718494797612,0.7799564270152506,1.0,1.0,1/11,3.75%,GGCT
prerank,lymphocyte proliferation (GO:0046651),-0.2550060453233624,-0.7382418329668895,0.8601769911504424,0.9540590401085867,1.0,7/22,21.96%,MSN;MEF2C;CTPS1;CD40;LMBR1L;PTPRC;ELF4
prerank,positive regulation of type 2 immune response (GO:0002830),0.2766184963518282,0.7379174238865223,0.8211009174311926,1.0,1.0,3/14,13.29%,CD81;PRKCZ;CD86
prerank,protein localization to centrosome (GO:0071539),0.2632657755135623,0.7378576888036084,0.8106904231625836,1.0,1.0,5/17,18.80%,BBS4;SNX10;CCDC14;GOLGB1;HOOK3
prerank,tRNA wobble base modification (GO:0002097),-0.2858225022788502,-0.7376140293089254,0.827027027027027,0.9544557963538322,1.0,8/14,40.13%,DPH3;TRMT9B;MOCS3;KTI12;CTU2;ALKBH1;ELP4;ELP3
prerank,positive regulation of chemokine production (GO:0032722),-0.2140887572015962,-0.737141479118601,0.9071428571428571,0.9545909302375515,1.0,17/44,38.51%,APP;DDX3X;IL6R;LPL;IL17RA;MAVS;HMGB1;IL7;ADAM17;LGALS9;HMOX1;TSLP;CD74;TLR2;HIF1A;SYK;IL18
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.20101338581375985,-0.7368434343639518,0.9225225225225225,0.9545686109511446,1.0,27/62,40.78%,MCL1;LRRK2;DDX3X;ARHGEF2;AKT1;ACKR3;PPIF;CXCL12;HERPUD1;MDM2;MAPK7;NFE2L2;TXNDC12;SNAI2;BAG5;PLAUR;TRIM32;VNN1;ARMC10;PARK7;DDIAS;CREB3L1;SIRT1;PTTG1IP;CDKN2D;TMBIM6;SFRP2
prerank,regulation of intracellular transport (GO:0032386),0.22127652243135357,0.7363599826372542,0.8997668997668997,1.0,1.0,12/38,20.79%,ATP9A;MAP2;PLA2G3;NEFH;ATP13A2;INPP5F;MLC1;NUMA1;AAAS;HAP1;REEP5;RBM4
prerank,negative regulation of defense response to virus (GO:0050687),0.30399693864149546,0.736065997512138,0.7943107221006565,1.0,1.0,3/10,14.02%,RNF26;TSPAN6;PCBP2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.20588187599002533,0.7360371609039718,0.9264367816091954,1.0,1.0,8/48,13.26%,ROBO1;TTLL12;PELI3;TRAIP;PADI2;SLIT3;OAS3;CNOT7
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.2544090779780596,-0.7358567960737479,0.850909090909091,0.9553389854546418,1.0,14/21,43.00%,MECP2;RAB11A;CCND1;CDC25A;BRD4;DTL;STOX1;CDK4;DYRK3;FBXO5;ATAD5;CCNB1;CDC25C;RAD51C
prerank,regulation of lymphocyte proliferation (GO:0050670),0.2711791249567359,0.7357519089700635,0.8127962085308057,1.0,1.0,2/16,9.73%,TNFSF18;IL12A
prerank,positive regulation of chromosome organization (GO:2001252),0.26214250350517865,0.7353017253632879,0.8078703703703703,1.0,1.0,4/15,17.26%,DDX11;GNL3;RAD21;DHX36
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2028756756853249,-0.7350034233902413,0.9347826086956522,0.9559431284180272,1.0,9/53,19.01%,DAB2IP;GNA12;PSME2;FOXF2;ECSCR;PSMC2;GPX1;RAD23A;PSME1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.2892000695128367,-0.7345313237342638,0.8388214904679376,0.9560947133050735,1.0,8/13,37.00%,LRRK2;HGF;TXN;NFE2L2;MET;PYCR1;PARK7;PDE8A
prerank,cellular response to fatty acid (GO:0071398),-0.292466081224574,-0.7343707533444583,0.8240740740740741,0.9559000680196722,1.0,6/12,32.40%,IRS1;LPL;DGAT2;PID1;PDK4;PDK3
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.2793137111602002,0.7339156393487081,0.8024948024948025,1.0,1.0,4/12,18.92%,DOCK10;GPR183;FCGR2B;POU2AF1
prerank,regulation of immunoglobulin production (GO:0002637),0.2459817662460213,0.7334666925530169,0.825503355704698,1.0,1.0,2/23,4.82%,PHB2;SASH3
prerank,regulation of cell cycle phase transition (GO:1901987),0.1785580570041766,0.7334459418812113,0.9773242630385488,1.0,1.0,19/91,17.14%,ANAPC2;PSMC5;ATP2B4;PSMD10;DDB1;PSMD14;NEK10;NEK11;PSMB7;PSMA4;CDC26;PSMD1;TAF1;PSMF1;PSMB8;CDC27;PSMD7;PSMB5;PSMD2
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.2528952234462494,-0.7331874866393326,0.8342151675485009,0.9569203786392784,1.0,4/22,20.24%,CBFB;IRF1;VSIR;BCL6
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.2949843387201472,-0.733111644871591,0.7992700729927007,0.9566240573297884,1.0,3/12,10.57%,DSE;CSPG4;BGN
prerank,regulation of protein sumoylation (GO:0033233),-0.2674649130506375,-0.7326969188601234,0.8633776091081594,0.9566835944197526,1.0,5/17,19.68%,ZMIZ1;UBA2;HDAC4;CTNNB1;PIAS4
prerank,meiosis I (GO:0007127),-0.24327813044091123,-0.7322134751672383,0.855098389982111,0.9568439729071894,1.0,9/23,32.33%,ZSCAN21;FOXJ3;BCL2L11;HSF2BP;TDRD9;DDX4;MYBL1;FOXJ2;MEIOB
prerank,regulation of dephosphorylation (GO:0035303),-0.27375307801574544,-0.731791406968657,0.8352059925093633,0.9569582366999756,1.0,5/15,24.30%,MTMR3;IGBP1;CDK5RAP3;MTMR4;SMG6
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.26037844179407543,-0.7314436399363858,0.8483685220729367,0.9569637643920202,1.0,4/19,18.06%,CAT;GPX1;ACOX1;SOD1
prerank,ncRNA metabolic process (GO:0034660),-0.22055723904436386,-0.7312594764251159,0.8984238178633975,0.9567599238051918,1.0,6/37,14.23%,TUT7;TENT4B;DICER1;TUT4;PARN;AGO2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.27194951829556646,-0.7311384246439337,0.8476357267950964,0.9565035396315812,1.0,4/16,16.38%,BMP5;IGFBP4;IGFBP5;IGF1
prerank,protein lipidation (GO:0006497),0.1951311011412905,0.730865129638761,0.9503386004514672,1.0,1.0,10/59,12.14%,DPM1;SELENOK;PIGP;ZDHHC8;ZDHHC13;MPPE1;ZDHHC20;PIGB;PGAP3;GPLD1
prerank,snRNA processing (GO:0016180),-0.2704116186726284,-0.7306608150275217,0.8535714285714285,0.9566777483046751,1.0,7/16,29.96%,INTS8;INTS3;INTS9;INTS7;TOE1;INTS5;INTS12
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.1993129976139367,0.7305159529649407,0.9315673289183223,1.0,1.0,12/56,17.30%,FOXRED1;NDUFA1;NDUFAF3;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;NDUFS7;NDUFB6;NDUFA11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.1993129976139367,0.7305159529649407,0.9315673289183223,1.0,1.0,12/56,17.30%,FOXRED1;NDUFA1;NDUFAF3;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;NDUFS7;NDUFB6;NDUFA11
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.28523996924158573,0.7305082278210214,0.8129175946547884,1.0,1.0,1/11,5.44%,GNAT3
prerank,regulation of spindle organization (GO:0090224),-0.26482454906580727,-0.7299539015550475,0.8481481481481481,0.9570922080595903,1.0,9/18,34.17%,RAE1;DCTN1;RNF4;TACC3;SENP6;BORA;MAP9;PARP3;PSRC1
prerank,tRNA wobble uridine modification (GO:0002098),-0.2820812550227267,-0.7298388321243799,0.8226691042047533,0.9568250567185129,1.0,8/14,40.13%,DPH3;TRMT9B;MOCS3;KTI12;TRMU;CTU2;ELP4;ELP3
prerank,myofibril assembly (GO:0030239),-0.21327009741928157,-0.7297302571755754,0.8854545454545455,0.956557082194949,1.0,6/42,12.81%,PGM5;TMOD3;CSRP2;CFLAR;LMOD1;TPM1
prerank,glycerophospholipid metabolic process (GO:0006650),0.18634487592863214,0.7294212464749348,0.9394618834080718,1.0,1.0,13/75,12.14%,CLN3;HDHD5;PLEK;FAR1;PLA2G7;PLA2G3;PIGP;PLA2G4E;CPNE1;PLA2G6;PIGB;CSF1R;GPLD1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.3010226864080132,0.728966291736518,0.8151898734177215,1.0,1.0,2/10,12.59%,OXSR1;CCL5
prerank,protein secretion (GO:0009306),-0.20058137877335655,-0.7287550618134713,0.918825561312608,0.957201806025444,1.0,9/56,12.56%,CAMK2G;TANGO6;STEAP3;MON1A;COPG1;PCSK5;TVP23A;RAB8B;SNX19
prerank,protein K11-linked ubiquitination (GO:0070979),-0.23384190033881216,-0.7287119817628462,0.8690909090909091,0.9568662176157422,1.0,15/27,36.49%,UBE2D3;CDC16;UBE2E2;UBE2L3;RNF4;FZR1;ANAPC7;ANAPC11;UBE2H;ANAPC10;ANAPC5;ANAPC13;UBE2A;UBE2T;UBE2C
prerank,tetrapyrrole metabolic process (GO:0033013),0.2599174384779266,0.7284786137782293,0.8097447795823666,1.0,1.0,3/18,13.47%,CBLIF;MMAB;MMAA
prerank,positive regulation of superoxide anion generation (GO:0032930),0.2776024719729949,0.7283873431252733,0.8183908045977012,1.0,1.0,2/13,8.42%,CD177;MAPT
prerank,negative regulation of interleukin-6 production (GO:0032715),0.23184516118620707,0.728011621547001,0.8662280701754386,1.0,1.0,6/27,19.12%,SYT11;PTPN6;FOXJ1;SELENOS;SIRPA;CX3CL1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.21147624343009008,-0.7266691568232454,0.9084380610412927,0.9589184764374037,1.0,9/47,14.24%,KLF4;APP;NFKB1;NFKBIA;FOXO3;AKT1;EDN1;AGTR1;RPL10
prerank,epithelial structure maintenance (GO:0010669),-0.3047227289169677,-0.7265187437368804,0.8308823529411765,0.9587010619726699,1.0,6/11,37.72%,RBP4;NOD2;STRAP;MUC13;PIWIL4;MUC6
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.20873472976437063,-0.7263842541833713,0.9022687609075044,0.9584682261922984,1.0,20/45,32.99%,GCNT2;APP;LARP1;FOXO3;PUM1;ZC3H7B;RPL10;RC3H1;RBM4B;RBM3;METTL16;MTPN;PARP9;NANOS1;TDRD7;ZC3H7A;METTL18;ATXN2;EIF2B4;PUM2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.2542919347904147,-0.7260827285183447,0.8578947368421053,0.9584128178780299,1.0,4/20,13.67%,ZBTB16;LDB1;CDC73;CDK6
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.25376051341243383,-0.7258657810976683,0.8180076628352491,0.9582831599316929,1.0,8/20,30.50%,PSMG2;PTGES3;PFDN6;HSP90AA1;NDUFAF1;PSMG1;CCT2;PSMG3
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3007629666968869,-0.7258598872794937,0.829443447037702,0.9578996542246931,1.0,1/11,3.07%,KAT2B
prerank,fatty acid catabolic process (GO:0009062),-0.19307058723824316,-0.7255922201587051,0.936247723132969,0.9578004205732017,1.0,13/67,20.49%,ABHD2;HADHB;ABCD3;BDH2;PPARD;ACADL;SLC27A4;ACAD11;ACADVL;ACOX1;PCCA;LPIN2;PCCB
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.289344179822483,0.7255047385811477,0.8251748251748252,1.0,1.0,1/11,3.10%,CACNA2D1
prerank,hexose transmembrane transport (GO:0008645),-0.2482977343933528,-0.7253598298039917,0.8506375227686703,0.9576639064592677,1.0,3/21,13.25%,SLC2A1;PPARD;SLC2A9
prerank,establishment of mitotic spindle localization (GO:0040001),-0.23106115065841962,-0.7241074545039867,0.8697916666666666,0.9586888667541497,1.0,6/28,22.30%,ITGB1;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.27334693373700736,-0.7240563521624053,0.8374125874125874,0.958350929282064,1.0,2/16,5.48%,TMSB4X;PPARA
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.19133926058769787,-0.7238787965356097,0.9408695652173913,0.9581594206300865,1.0,17/72,23.23%,RBX1;MRE11;ERCC2;DICER1;XRN2;POLD3;OGG1;RPA3;DNA2;RPA1;PDE12;ERCC3;EDC3;RPA2;DCP1A;RFC4;RFC1
prerank,natural killer cell mediated immunity (GO:0002228),-0.2716631644374999,-0.7234418824205905,0.8289703315881326,0.9582296899936344,1.0,9/15,53.23%,CEBPG;ARL8B;RAET1E;TUBB4B;SLAMF7;KLRD1;KLRK1;KIF5B;KLRC2
prerank,lipoxygenase pathway (GO:0019372),-0.27954531841259067,-0.7232956750090825,0.852670349907919,0.9580067976596817,1.0,5/14,32.41%,PON2;GPX1;GPX4;ALOX5AP;ALOXE3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.25504012994746117,-0.7229583797986456,0.8505535055350554,0.9579719906839348,1.0,3/18,6.39%,SARNP;THOC2;IWS1
prerank,triglyceride catabolic process (GO:0019433),-0.25211484233003734,-0.7228117299866366,0.8382608695652174,0.9577426579478747,1.0,6/19,40.17%,LPL;PNPLA2;FABP3;LIPH;FABP4;FABP12
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.25982408101447285,-0.722387055401669,0.8534923339011925,0.9578207408001242,1.0,8/17,33.12%,DMAC2L;ATP5F1E;ATP5F1C;ATP5MF;ATP5PO;STOML2;ATP5F1D;ATP5MC2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.1745384321649128,-0.7214645865824311,0.9849906191369606,0.9584447231450368,1.0,39/132,26.36%,EIF4H;RBM5;RPS14;PRPF6;RPSA;NOP2;CELF1;DDX39B;RPL3;SF3B1;PUF60;CPSF7;DICER1;CDC73;RPL38;SNRPE;RPL10;PTGES3;TGS1;RPL5;NLE1;SRPK2;RPS27;MDN1;PRKDC;BOP1;STRAP;RRS1;SRSF10;HSP90AA1;RPS15;COIL;EIF3A;GEMIN7;USP39;GCFC2;DHX9;NAF1;PRPF18
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.261832590106599,-0.7214565351835774,0.8436911487758946,0.9580666393901835,1.0,10/18,40.43%,AKT1;NONO;MAPK7;NFE2L2;BAG5;VNN1;PARK7;HIF1A;TRAP1;SIRT1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.30185706655804745,-0.7211687810933234,0.8183453237410072,0.95801379813269,1.0,5/10,44.43%,PDCD4;AIDA;DUSP19;HIPK3;GSTP1
prerank,cellular response to hypoxia (GO:0071456),-0.17579652794448297,-0.721053320778561,0.9796610169491525,0.957759094945121,1.0,38/126,28.31%,CREBBP;PSMA2;MTOR;LIMD1;RBX1;BNIP3;PSME2;SUV39H1;CUL2;PSMB4;TP53;RGCC;LMNA;NDRG1;PSMC2;HIF3A;PSMB2;PSMB1;BMP7;ARNT;PSMA8;EPAS1;PSME1;NPEPPS;ELOC;PSMD4;TERT;MDM2;PSMA7;PSMD5;PTGIS;PLK3;ZFP36L1;PSMB10;PSMA3;HILPDA;HMOX1;ANGPT4
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.24326399176673216,-0.7204566488361269,0.8852459016393442,0.95805948241899,1.0,6/24,16.68%,MIEF1;TCAF1;MTCL1;MIEF2;CHP1;FYN
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.2613903579781891,0.7200960619084801,0.8507462686567164,1.0,1.0,5/16,19.56%,CELF4;SF3B4;DAZAP1;PRDX6;RBMX
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.22737773432988925,-0.7193592688772635,0.8990990990990991,0.9588239916918119,1.0,7/30,19.32%,CAV1;PRKCD;PARP14;SH3BP5L;HYAL2;PPP2CA;PTPRC
prerank,granulocyte chemotaxis (GO:0071621),0.19456381257905267,0.7189914775666162,0.9451754385964912,1.0,1.0,8/55,14.71%,PDE4B;CXADR;PF4;CCL13;CCL5;CCL2;PPIA;CCL7
prerank,response to unfolded protein (GO:0006986),0.19983264675179552,0.718080729015285,0.9122807017543859,1.0,1.0,6/48,7.98%,PACRG;HSPA4L;DNAJB4;HSPA9;HSF1;HSPA1L
prerank,dermatan sulfate metabolic process (GO:0030205),-0.28304124117183393,-0.7175202369167861,0.8354661791590493,0.9604331992063472,1.0,3/13,10.57%,DSE;CSPG4;BGN
prerank,histone H4-K16 acetylation (GO:0043984),-0.255155729922371,-0.7168763741473856,0.8703374777975134,0.9607341996172171,1.0,6/19,23.01%,KANSL3;PHF20;HCFC1;JADE2;OGT;WDR5
prerank,icosanoid biosynthetic process (GO:0046456),0.291104303006224,0.7165403288298012,0.8280542986425339,1.0,1.0,1/10,2.26%,FADS1
prerank,protein methylation (GO:0006479),-0.21306809141505412,-0.716193083296811,0.9037433155080213,0.9610849435528347,1.0,8/40,18.01%,NSD1;NSD3;SETD3;EHMT1;GSPT1;FAM98A;N6AMT1;CARM1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.20900117745890856,0.7161423943874414,0.9215686274509803,1.0,1.0,12/40,24.40%,DDX11;CENPS;DONSON;TRAIP;ATR;ETAA1;PCNA;GEN1;CDK9;FBH1;RTEL1;TIPIN
prerank,negative regulation of B cell activation (GO:0050869),-0.2507318562961498,-0.7157767812389578,0.8683729433272395,0.9611469329300033,1.0,4/21,14.90%,LYN;ATM;RC3H1;TNFAIP3
prerank,regulation of mitochondrial translation (GO:0070129),-0.24660281928600455,-0.7155259577331962,0.8504347826086956,0.9610384345091609,1.0,10/21,40.77%,RPUSD4;MRPS27;MPV17L2;UQCC2;MTG2;TSFM;ALKBH1;NSUN3;RCC1L;TRMT10C
prerank,positive regulation of mRNA processing (GO:0050685),0.24662838223866512,0.7153388264685369,0.8644444444444445,1.0,1.0,8/21,21.60%,CELF4;SF3B4;DHX36;DAZAP1;PRDX6;RBMX;PAF1;NCBP2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2717535984861491,-0.7151854620553604,0.8812392426850258,0.9610092890684884,1.0,4/15,16.34%,RAB3GAP1;SRPRA;RAB3GAP2;SRP14
prerank,DNA geometric change (GO:0032392),-0.23857182411849354,-0.7151396437789336,0.8817005545286506,0.9606709523275482,1.0,8/24,24.95%,MRE11;MCM9;DNA2;ANXA1;WRN;BLM;HMGB1;DHX9
prerank,negative regulation of cell division (GO:0051782),-0.29470006628707046,-0.7150642267805181,0.8454198473282443,0.9603575752552889,1.0,3/11,24.41%,TXNIP;BLM;E2F7
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.2933837165660918,-0.7147207011547972,0.8454198473282443,0.9603369657178626,1.0,4/11,18.37%,UQCR11;UQCRFS1;UQCRC1;UQCC3
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2515949557581011,0.7146032614834209,0.8767123287671232,1.0,1.0,4/18,16.23%,MPV17L;TMEM14A;FZD9;SLC35F6
prerank,DNA packaging (GO:0006323),0.26615351615620575,0.7141401104594999,0.8302752293577982,1.0,1.0,2/16,6.57%,M1AP;H1-0
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2491293484689162,-0.713910151445699,0.8761220825852782,0.9608050698581351,1.0,9/20,35.33%,NKTR;PPIG;FKBP5;PPIF;PPIH;CWC27;PPIE;PPIC;FKBP1B
prerank,renal water homeostasis (GO:0003091),0.23854988100041544,0.7137013526383851,0.8850325379609545,1.0,1.0,5/23,14.40%,ADCY8;AQP4;ADCY7;PRKAR1B;ADCY3
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.22303102695730226,0.7135537997741892,0.8875,1.0,1.0,7/29,18.78%,IL12A;IL12RB1;RASGRP1;CD226;SLAMF6;IL23A;CADM1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.21104525487273537,0.7124999045535388,0.9243119266055045,1.0,1.0,4/36,5.71%,RHNO1;CDC45;USP28;DONSON
prerank,triglyceride homeostasis (GO:0070328),-0.23607120274432533,-0.7122162206975035,0.8816254416961131,0.962230275745852,1.0,15/26,48.36%,SCARB1;LPL;C1QTNF3;DGAT2;PNPLA8;RORA;IL18;SIRT1;APOC4;PLA2G12B;NR1H3;HNF4A;ACSM2A;ANGPTL8;APOA1
prerank,regulation of histone methylation (GO:0031060),-0.27638418124816555,-0.7113388738086913,0.8579439252336448,0.9627737434190351,1.0,1/13,1.14%,NSD1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.22990795523427912,0.7099425003817963,0.8772321428571429,1.0,1.0,4/26,11.68%,CARTPT;HOXA7;TMEM178A;TCTA
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2776256597182152,-0.7093472147803347,0.8416988416988417,0.9644274559951218,1.0,4/13,15.65%,ASPH;CASP8;PERP;LGMN
prerank,regulation of B cell differentiation (GO:0045577),-0.2566424628007611,-0.7090373906069832,0.8638059701492538,0.9643739503654906,1.0,5/17,36.91%,PPP2R3C;ZFP36L1;IKZF3;MMP14;SYK
prerank,lipoprotein localization (GO:0044872),-0.29181761804051354,-0.7085374500520619,0.829225352112676,0.9644666475574553,1.0,3/11,26.11%,ZDHHC3;PPARG;LRP1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.22613261475846588,-0.7080188138937221,0.8911439114391144,0.9646018186662241,1.0,11/30,27.87%,DNAJC7;GAK;ERO1A;PTGES3;UGGT1;DNAJB12;HSPA14;HSPA13;HSPA1B;CCT2;SDF2L1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.20634286449716763,-0.7078802816028755,0.9141323792486583,0.9643648583394144,1.0,15/45,31.57%,APP;CASP8;JAK2;LPL;PANX1;TRIM16;GBP5;CCL19;NOD2;CASP1;FZD5;LGALS9;NLRC4;STAT3;TLR6
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2492986945734188,0.7078647690322146,0.8863109048723898,1.0,1.0,3/18,12.14%,BLK;C3AR1;GPLD1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.26408329610827985,-0.7076142352886704,0.856637168141593,0.9642300209237122,1.0,2/16,6.99%,CAV1;PARP14
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.26188069152966875,0.7061517438970399,0.8567961165048543,1.0,1.0,3/14,14.71%,OXSR1;CCL5;CCL7
prerank,response to muramyl dipeptide (GO:0032495),-0.28868934223288073,-0.7056624428036123,0.8590225563909775,0.9657695815255328,1.0,5/12,25.08%,NOD1;ARHGEF2;CHMP5;NOD2;ERBIN
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.20222230508300698,-0.705457641160074,0.9428571428571428,0.9655872009144895,1.0,16/50,26.87%,PSMA2;PSME2;PSMB4;AZIN1;PSMC2;PSMB2;PSMB1;PSMA8;OAZ2;PSME1;NQO1;PSMD4;PSMA7;PSMD5;PSMB10;PSMA3
prerank,dendritic cell differentiation (GO:0097028),-0.2422959784528832,-0.7049231348316087,0.9017241379310345,0.9657446715572757,1.0,3/22,5.73%,LYN;TGFBR2;GAS6
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.24372255465312243,-0.7048816486851667,0.8873483535528596,0.9653952206491357,1.0,5/22,18.21%,RBX1;ERCC2;XPC;ERCC3;CETN2
prerank,regulation of exit from mitosis (GO:0007096),0.20711128524564446,0.704736599056027,0.9193899782135077,1.0,1.0,3/38,5.70%,ANAPC2;PHB2;ANLN
prerank,regulation of establishment of protein localization (GO:0070201),0.2689679764821076,0.7041800633150477,0.8657718120805369,1.0,1.0,3/13,12.84%,PTP4A3;CORO2B;CEP135
prerank,tRNA 5'-end processing (GO:0099116),0.2611125062782522,0.7038448079084503,0.8440366972477065,1.0,1.0,15/15,73.91%,RPP25L;PRORP;POP7;POP5;RPP21;POP1;HSD17B10;RPP38;RPP25;RPP14;TRMT10C;RPP40;SSB;POP4;RPP30
prerank,positive regulation of transporter activity (GO:0032411),-0.2786738561317885,-0.7037116622406839,0.8471454880294659,0.9661921429969051,1.0,2/13,7.87%,RXRA;TRPC6
prerank,defense response to Gram-positive bacterium (GO:0050830),0.2025714285641605,0.7036887050765109,0.917960088691796,1.0,1.0,6/40,11.75%,RNASE6;CHGA;ANG;IL12A;MBL2;HMGB2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.1993568774667197,0.7035030373177202,0.9267782426778243,1.0,1.0,5/42,10.09%,SYCP1;WRNIP1;POLD4;PCLAF;POLA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.2905404772508274,-0.7030838332346291,0.8566243194192378,0.9660310657982804,1.0,4/12,16.38%,SPPL3;STIMATE;LMCD1;IGF1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.2905404772508274,-0.7030838332346291,0.8566243194192378,0.9660310657982804,1.0,4/12,16.38%,SPPL3;STIMATE;LMCD1;IGF1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.21478252563704728,0.702710217907899,0.9116279069767442,1.0,1.0,4/31,13.29%,BLK;VTCN1;SDC4;CD86
prerank,cellular response to pH (GO:0071467),0.25336593118740786,0.7025947226380691,0.8665158371040724,1.0,1.0,4/17,15.20%,IMPACT;GPLD1;ASIC1;GPR68
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.23874391260548994,-0.7024122794795494,0.8978494623655914,0.9662579911277142,1.0,2/22,3.85%,SLC7A5;IL15
prerank,central nervous system neuron axonogenesis (GO:0021955),0.2764271611449813,0.7012029782498925,0.8590604026845637,1.0,1.0,4/12,17.07%,EPHB1;SPTBN4;B4GALT6;HSP90AB1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.27074925643472125,-0.7011418941034836,0.8549323017408124,0.9670844207466126,1.0,2/14,7.48%,HNRNPA0;MAPKAPK2
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.1830764076942359,-0.7009767889096628,0.9566037735849057,0.9668587338108843,1.0,23/68,32.20%,MNAT1;ERCC2;CPSF7;TAF1B;MAZ;LSM11;TAF1C;SNRPE;ERCC3;CAVIN1;LSM10;FIP1L1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH;POLR3K;MTERF2;POLR1H;SMN1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2496032720307296,-0.7008549414170103,0.8601398601398601,0.9665761120998888,1.0,16/18,49.09%,BNIP3;THEM4;PPIF;ALKBH7;PMAIP1;NAIF1;SPG7;SLC25A5;HEBP2;SLC25A31;BAK1;MUL1;BCL2L1;BAD;TMEM102;CAMK2A
prerank,regulation of biosynthetic process (GO:0009889),0.2781195079086115,0.7005352486134055,0.8397291196388262,1.0,1.0,11/11,72.21%,SPHK2;ALOX5;SNCA;PCK1;UCP1;PIKFYVE;CCN6;GSTP1;THRSP;MID1IP1;SLC25A33
prerank,spliceosomal complex assembly (GO:0000245),0.20028322987211666,0.7004022475690829,0.9192825112107623,1.0,1.0,8/46,13.60%,CELF5;CELF4;CELF2;CELF6;SRPK1;DDX1;SNRPD2;SNRPD1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.25755307231249763,0.7002727411880253,0.8476190476190476,1.0,1.0,1/14,4.83%,ATP1B1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.28309921407471894,-0.7002144983216526,0.864406779661017,0.9668274332950992,1.0,4/11,25.72%,NOVA2;RASA1;PCBP1;IGF2BP2
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.27249583172896474,-0.6996700253313123,0.8490230905861457,0.966944030983978,1.0,1/14,2.75%,THBS1
prerank,calcium import into the mitochondrion (GO:0036444),0.2803962522853954,0.6985764531563838,0.8306997742663657,1.0,1.0,1/10,1.91%,SLC25A23
prerank,RNA polyadenylation (GO:0043631),-0.22555981996540048,-0.6983543785709407,0.8972477064220183,0.9674646135349279,1.0,8/26,27.32%,TENT4B;APP;CDC73;TENT2;FIP1L1;AHCYL1;LEO1;PABPC1
prerank,mRNA polyadenylation (GO:0006378),-0.22555981996540048,-0.6983543785709407,0.8972477064220183,0.9674646135349279,1.0,8/26,27.32%,TENT4B;APP;CDC73;TENT2;FIP1L1;AHCYL1;LEO1;PABPC1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2511533771598952,-0.6978743937505536,0.8687050359712231,0.9675319578634067,1.0,5/18,17.15%,LDLRAP1;PSEN2;ADAM10;PSEN1;APH1A
prerank,positive regulation of interleukin-13 production (GO:0032736),0.2850092824124025,0.6978690726695489,0.8340909090909091,1.0,1.0,2/10,10.15%,SPHK2;PRKCZ
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.2838833299746784,0.6971245014999802,0.8442982456140351,1.0,1.0,4/10,21.75%,TSKU;WHRN;PLS1;PDZD7
prerank,cellular response to misfolded protein (GO:0071218),-0.23978060144330804,-0.6962820407129503,0.8853383458646616,0.9686380917747005,1.0,11/20,43.33%,CUL3;ATXN3;UGGT1;DNAJB12;KLHL15;RNF185;VCP;RNF5;POMT2;RNF126;DNAJB14
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.2716728944833361,0.6946514262180816,0.8730853391684902,1.0,1.0,2/13,11.60%,CHST2;EXTL2
prerank,glutathione metabolic process (GO:0006749),0.20401497925116913,0.6943025279809767,0.9217002237136466,1.0,1.0,4/38,8.04%,NAT8;GGCT;GLRX2;DPEP1
prerank,carbohydrate catabolic process (GO:0016052),0.2076257336083482,0.6936313602750637,0.9281045751633987,1.0,1.0,4/38,10.95%,GCK;TPI1;PKM;ENO2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.24329454628262198,-0.6935027692051167,0.8886792452830189,0.9708534726282861,1.0,7/19,32.19%,DDIT4;TP53;HIPK1;PHLDA3;TMEM109;CDIP1;RPS27L
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.24953029820517608,0.6933161529579297,0.8727272727272727,1.0,1.0,5/16,23.17%,DCPS;PSIP1;SNRPC;NCBP2;WBP11
prerank,regulation of lamellipodium organization (GO:1902743),0.26010192216247496,0.6932148164188959,0.860813704496788,1.0,1.0,2/14,7.85%,PDPN;CARMIL1
prerank,ketone body metabolic process (GO:1902224),-0.290848378668382,-0.6927000521681338,0.8550185873605948,0.9711893058070635,1.0,4/10,24.63%,BDH2;HMGCS2;OXCT1;ACSS3
prerank,regulation of protein localization to centrosome (GO:1904779),-0.290567499104506,-0.6919425942110512,0.852670349907919,0.9714572895545065,1.0,2/10,6.45%,GSK3B;CEP250
prerank,sphingolipid catabolic process (GO:0030149),0.2561061478899316,0.6918356009668438,0.8878923766816144,1.0,1.0,3/15,8.22%,ENPP2;SPHK1;ACER1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.293414975810133,-0.6904159990406034,0.8703703703703703,0.9724285361379568,1.0,1/10,5.52%,ELOVL5
prerank,mRNA modification (GO:0016556),-0.23605376106466225,-0.6898160023062554,0.8696428571428572,0.9725648187461405,1.0,13/22,44.40%,CBLL1;METTL14;WTAP;TRUB1;METTL16;RPUSD2;TRMT61A;PCIF1;PUS7;TRMT10C;VIRMA;DKC1;NSUN2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.26697189810024824,0.689516177694951,0.8747252747252747,1.0,1.0,6/13,27.39%,PCID2;CDK5RAP2;ANAPC15;GEN1;MAD2L1;NDC80
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.22959447316036172,0.6891530496124858,0.9070294784580499,1.0,1.0,3/23,7.87%,OTC;SLC9A7;SLC12A5
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.2670966278342252,-0.6870121314962777,0.8826714801444043,0.9746158662207081,1.0,4/14,21.18%,SRSF12;SFSWAP;RNPS1;SRSF10
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.17108392522357416,-0.6868575086862967,0.9828473413379074,0.974344806111048,1.0,24/94,23.44%,YWHAE;CEP57;CEP250;CEP78;HAUS8;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;CEP41;ALMS1;RAB11A;PLK4;PCM1;CETN2;CNTRL;CEP152;ODF2;HSP90AA1;PCNT;NPHP1;CEP131;AKAP9
prerank,negative regulation by host of viral transcription (GO:0043922),-0.278679676696516,-0.6852793240163948,0.8629629629629629,0.9753351582991417,1.0,3/12,17.32%,HDAC1;JUN;TFAP4
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.2628607680530595,-0.6851109653255867,0.8621323529411765,0.9751066082953731,1.0,4/14,18.14%,MSN;EZR;RHOA;RAP2A
prerank,regulation of histone modification (GO:0031056),-0.26245718354954695,-0.6843111011372738,0.8647619047619047,0.9754011665482102,1.0,4/13,22.61%,SETD5;HPF1;IGF2;MYOCD
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.28820410899712745,-0.6834936528776806,0.8648148148148148,0.9757192961372061,1.0,4/10,30.85%,CEACAM1;PTPRC;LGALS9;LILRB1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2584768912320245,-0.6832418072404757,0.8781362007168458,0.9755460537285263,1.0,4/15,17.56%,SAMHD1;STAT2;USP18;NLRC5
prerank,hexose metabolic process (GO:0019318),-0.20279390743203848,-0.6827807830748143,0.9385171790235082,0.9755662818693949,1.0,12/39,26.52%,CHST15;HECTD4;PPARD;GALK2;ALDOC;GALK1;BRAT1;FPGT;FUOM;GALM;PMM2;SLC37A4
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2721489619753722,-0.6826402522079486,0.8846153846153846,0.9752910453058866,1.0,2/12,9.84%,PPARA;AKT1
prerank,iron-sulfur cluster assembly (GO:0016226),0.2267333706086716,0.6821513521441956,0.9279069767441861,1.0,1.0,9/24,23.76%,HSPA9;ISCA2;NFU1;CIAO3;NUBP2;NUBP1;NFS1;CIAPIN1;LYRM4
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.19042798691407717,-0.6808295737698411,0.9698581560283688,0.9764082307368991,1.0,11/52,21.80%,DGLUCY;SLC25A32;OGDH;IDH1;MTHFD1;ALDH18A1;HOGA1;MTHFD1L;ALDH1L1;GCLC;MTRR
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.23957471888400564,-0.6807933473756121,0.8919925512104283,0.9760550308614278,1.0,7/21,31.26%,TTC23;SMO;KIF7;TUBD1;TEDC2;ARMC9;SHH
prerank,myeloid dendritic cell activation (GO:0001773),0.2644913783985706,0.6806680615367444,0.8725274725274725,1.0,1.0,2/12,11.01%,CAMK4;BATF
prerank,regulation of neuroinflammatory response (GO:0150077),-0.23898759120992186,-0.6795776954520402,0.9041591320072333,0.976685429663395,1.0,2/19,5.58%,CD200;TNFRSF1B
prerank,receptor recycling (GO:0001881),0.2780698227901675,0.6794969003743017,0.8804597701149425,1.0,1.0,3/10,18.61%,SORL1;PHETA1;NSG1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.17523501551061085,-0.677755517647344,0.9821109123434705,0.977804771100713,1.0,30/84,33.27%,RB1;PSMA2;CUL3;PSME2;PSMB4;CDC16;ANAPC16;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;BUB1B;ECRG4;PSMD4;BUB3;PSMA7;FZR1;PSMD5;ANAPC7;PSMB10;PSMA3;FBXO31;ANAPC11;ANAPC10;ANAPC5;PSMD13;PLK1;PSMB6;AURKA
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.26707734468900096,0.6776696840195715,0.8606194690265486,1.0,1.0,2/11,9.46%,ITM2C;ABCA2
prerank,regulation of protein processing (GO:0070613),0.2276341524176168,0.6773599618400301,0.9114832535885168,1.0,1.0,2/21,3.86%,TMEM59;CLN3
prerank,autophagosome maturation (GO:0097352),-0.2099945014495449,-0.6773591242289605,0.9307116104868914,0.9777139859745718,1.0,4/32,10.83%,LIX1L;MAP1LC3B;TECPR1;GABARAP
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.2602451659542927,0.6772849818007698,0.8619909502262444,1.0,1.0,2/13,9.92%,CD177;SPHK2
prerank,lipid catabolic process (GO:0016042),-0.24095190468928268,-0.6769072426043882,0.9055944055944056,0.9776752570641238,1.0,3/18,14.81%,ACADL;LPL;LIPE
prerank,chemokine-mediated signaling pathway (GO:0070098),0.19269620705205992,0.6767972836948893,0.9457013574660633,1.0,1.0,11/42,22.67%,OXSR1;PF4;CCL13;CCL5;THPO;CCL2;CCL7;CX3CL1;CCL14;CIB1;STK39
prerank,glycerol metabolic process (GO:0006071),0.2845099023632919,0.6760906338840773,0.8558558558558559,1.0,1.0,4/10,21.14%,TPI1;GK;PGP;ANGPTL3
prerank,positive regulation of establishment of protein localization (GO:1904951),0.23543452829820483,0.6753655454486481,0.9041095890410958,1.0,1.0,4/18,13.39%,PTP4A3;CORO2B;CEP135;WRAP53
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.2839168447818139,-0.6745727408192135,0.8896797153024911,0.9787971176926011,1.0,2/10,7.77%,FTO;ASCC1
prerank,DNA dealkylation (GO:0035510),-0.2839168447818139,-0.6745727408192135,0.8896797153024911,0.9787971176926011,1.0,2/10,7.77%,FTO;ASCC1
prerank,membrane lipid metabolic process (GO:0006643),-0.2337165695899093,-0.674017170239109,0.9027027027027027,0.9788648748364525,1.0,10/22,32.41%,ST3GAL6;B4GALT4;AGK;SPTLC1;SERINC1;TEX2;CYP1B1;CERKL;MGST2;ALOXE3
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.20442159364398785,-0.673948767615818,0.9432234432234432,0.9785264342622162,1.0,4/37,11.80%,ENTPD1;ENTPD6;RNASE3;XRN2
prerank,activin receptor signaling pathway (GO:0032924),-0.255625281294731,-0.6732049457955964,0.8684719535783365,0.9787206739431761,1.0,7/15,40.23%,SMAD2;ACVR2A;ACVR2B;TGFBR1;SMAD3;INHBB;ACVR1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.2807004506540287,0.6729564109857706,0.8646788990825688,1.0,1.0,4/10,20.35%,SORL1;DNAJB2;DNAJB1;DNAJA4
prerank,tRNA 5'-leader removal (GO:0001682),0.26107972379158817,0.6727468383979417,0.8876404494382022,1.0,1.0,13/13,73.91%,RPP25L;PRORP;POP7;POP5;RPP21;POP1;RPP38;RPP25;RPP14;RPP40;SSB;POP4;RPP30
prerank,homocysteine metabolic process (GO:0050667),-0.28097054957429,-0.6721416270647721,0.8772893772893773,0.9791770842735833,1.0,7/11,41.18%,NOX4;CTH;MTRR;MPST;BLMH;CBS;TST
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.2244605694059312,-0.6719616319218029,0.9200743494423792,0.978932032912639,1.0,2/24,4.87%,PLA2G4A;LPCAT1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.24276098557184073,-0.6714156548199358,0.8956043956043956,0.978966900949399,1.0,7/17,29.89%,FGF1;PRKAA1;ERLIN2;SOD1;LPCAT3;RAN;MBTPS1
prerank,cellular response to interleukin-2 (GO:0071352),-0.28165070781911217,-0.6713885485528727,0.8953900709219859,0.9782111114784409,1.0,4/11,29.51%,JAK1;PTK2B;IL2RA;IL2RG
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.28165070781911217,-0.6713885485528727,0.8953900709219859,0.9782111114784409,1.0,4/11,29.51%,JAK1;PTK2B;IL2RA;IL2RG
prerank,negative regulation of protein secretion (GO:0050709),-0.20162283325051195,-0.6712543940397743,0.9367088607594937,0.9779231109329846,1.0,15/38,32.22%,CD200;IRS1;RAB11FIP3;RHBDF2;DPH3;CCN3;RAB11FIP1;RAB11FIP5;SERGEF;F2R;HMGCR;MIDN;RSAD2;RHBDF1;KCNB1
prerank,ceramide catabolic process (GO:0046514),-0.2641246232456049,-0.670658214625843,0.8898916967509025,0.9780110647652653,1.0,5/14,27.88%,ACER2;ACER3;ASAH1;GLA;HEXA
prerank,microtubule bundle formation (GO:0001578),0.1895170755036394,0.6696581417753145,0.9578713968957872,1.0,1.0,10/42,18.60%,CFAP74;MAP1S;DCX;TPPP3;TPPP;FOXJ1;GAS8;NUMA1;AAAS;CDK5RAP2
prerank,vitamin D metabolic process (GO:0042359),0.2590060651215429,0.6696402996028464,0.8812785388127854,1.0,1.0,3/13,16.35%,CYP24A1;GC;CYP1A1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.25700999992369256,0.6689576263752609,0.8873239436619719,1.0,1.0,3/13,14.65%,ISCA2;CISD3;NFU1
prerank,positive regulation of telomere capping (GO:1904355),-0.24628769625288946,-0.6684030591723291,0.908256880733945,0.9793431786468112,1.0,3/17,13.71%,NEK7;MAPK1;PNKP
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.24541059712433597,-0.6670708921514179,0.9014336917562724,0.9799655410812771,1.0,9/16,38.67%,ATM;TERF2;SMG6;PINX1;NAF1;TNKS2;TNKS;SLX4;ERCC4
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.1709593329043458,-0.6669100289314825,0.9791271347248577,0.9796968697467286,1.0,27/87,28.33%,COX16;COX18;SAMM50;NDUFV3;ACAD9;SCO1;NDUFB2;NDUFB11;UQCRFS1;COX17;DMAC2;NDUFS2;UQCC3;NDUFA7;NDUFV1;UQCC2;COA8;TMEM126B;NDUFC2;NDUFV2;NDUFAF1;NDUFB3;IMMP2L;SDHAF4;NDUFB4;SLC25A33;NDUFS5
prerank,positive regulation of cellular respiration (GO:1901857),-0.27244160505785364,-0.6662058659347182,0.9005328596802842,0.9798291218939912,1.0,6/11,40.16%,IFNAR1;IL10RB;IFNLR1;PARK7;VCP;IL4
prerank,RNA interference (GO:0016246),-0.24107555156044208,-0.6661245652337823,0.9144385026737968,0.9795105842627381,1.0,9/17,34.66%,CELF1;DICER1;AGO2;DROSHA;TERT;DHX9;TSN;TARBP2;MRPL44
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2541728870588389,0.6661233864546301,0.891647855530474,1.0,1.0,3/12,17.75%,NAE1;ORC1;CHEK2
prerank,P-body assembly (GO:0033962),-0.2667261062547126,-0.6659195003468289,0.8800738007380073,0.9792684680661928,1.0,4/12,21.53%,LIMD1;RC3H1;EDC3;LSM3
prerank,regulation of coagulation (GO:0050818),-0.2836850717186266,-0.6659005377006151,0.8929824561403509,0.9788947996240963,1.0,1/11,1.62%,CAV1
prerank,development of primary male sexual characteristics (GO:0046546),-0.20755050338045403,-0.6655724405938555,0.9474605954465849,0.9787317305814439,1.0,9/34,25.40%,KITLG;TGFB2;MAMLD1;NCOA4;SIX4;LHFPL2;COL9A3;BIK;WNT2B
prerank,dendritic cell chemotaxis (GO:0002407),0.24660117054763014,0.6639016657676923,0.9157427937915743,1.0,1.0,6/14,25.08%,CCR6;CCL5;GPR183;CXCR4;TRPM2;CCR5
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.2661079616009165,-0.663139305067308,0.8822429906542056,0.980136948943846,1.0,6/12,33.46%,RNF168;NELFB;HNRNPU;LARP7;NELFA;NELFCD
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.28251746367460406,-0.6610711479373635,0.896551724137931,0.9812283538068576,1.0,7/10,37.00%,LRRK2;TXN;NFE2L2;RIPK1;PYCR1;PARK7;PDE8A
prerank,microtubule depolymerization (GO:0007019),0.23690820042697452,0.6606696361260277,0.8995633187772926,1.0,1.0,17/17,76.33%,STMN2;STMN4;STMN3;NCKAP5;KIF18A;KIF2A;KIF24;STMND1;KATNB1;KIF2C;CKAP5;KIF19;NCKAP5L;STMN1;CCSAP;KIF14;KIF18B
prerank,ovarian follicle development (GO:0001541),0.2560375676096853,0.6606640766806331,0.8818181818181818,1.0,1.0,3/13,13.55%,ANG;VEGFA;KIT
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.19570031084606687,-0.6590840098310962,0.9577981651376147,0.9822788894386449,1.0,18/40,36.42%,LRRK2;ABL1;ARL6IP5;AKT1;SOD1;STOML2;RNF122;SLC25A33;PID1;STOX1;PYCR1;PMAIP1;PIP5KL1;HEBP2;PARK7;VCP;AKT2;ATP5IF1
prerank,regulation of T cell chemotaxis (GO:0010819),0.2627869399084909,0.6588527723294566,0.9177057356608479,1.0,1.0,2/11,12.59%,OXSR1;CCL5
prerank,regulation of histone deacetylation (GO:0031063),0.25005090286470866,0.6587480069768714,0.8691796008869179,1.0,1.0,2/13,9.92%,PRMT6;SPHK2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.224715080052331,-0.6582378943568966,0.9289719626168225,0.9825046992198158,1.0,6/23,25.79%,PLA2G4A;MBOAT1;PLA2G12A;LPCAT3;PNPLA8;PLA2G4F
prerank,coenzyme A biosynthetic process (GO:0015937),-0.27054705154229663,-0.6575393622179678,0.9045936395759717,0.9818607821189712,1.0,1/11,3.56%,PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.27054705154229663,-0.6575393622179678,0.9045936395759717,0.9818607821189712,1.0,1/11,3.56%,PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.27054705154229663,-0.6575393622179678,0.9045936395759717,0.9818607821189712,1.0,1/11,3.56%,PANK2
prerank,protein trimerization (GO:0070206),-0.2515771397277087,-0.656716190884918,0.9051878354203936,0.9816626986744519,1.0,7/14,31.68%,SCARA5;SLC1A5;MIF;CLYBL;DISP1;STEAP4;ALOX5AP
prerank,protein homotrimerization (GO:0070207),-0.2515771397277087,-0.656716190884918,0.9051878354203936,0.9816626986744519,1.0,7/14,31.68%,SCARA5;SLC1A5;MIF;CLYBL;DISP1;STEAP4;ALOX5AP
prerank,regulation of mRNA metabolic process (GO:1903311),-0.26814408557679165,-0.6564907104995535,0.9139784946236559,0.9814468135560936,1.0,5/11,27.71%,IWS1;SRPK2;CDK11B;DHX9;SLTM
prerank,protein palmitoylation (GO:0018345),0.2046238904045508,0.6562482907580899,0.9460093896713615,1.0,1.0,6/30,15.72%,SELENOK;ZDHHC8;ZDHHC13;ZDHHC20;ZDHHC24;ZDHHC7
prerank,positive regulation of macrophage differentiation (GO:0045651),0.26630191681685167,0.6554964640837799,0.9100642398286938,1.0,1.0,2/11,7.79%,HSF1;PF4
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.20417565343692576,-0.6536077507039929,0.9446428571428571,0.9830603416685274,1.0,6/33,18.01%,CBFB;ESR1;UFM1;H3-3A;HDAC6;CARM1
prerank,positive regulation of histone methylation (GO:0031062),-0.217281501054719,-0.6531022035060257,0.9144981412639405,0.9830234920246947,1.0,8/24,30.94%,SMAD4;DNMT1;CTNNB1;BRCA1;OGT;WDR5;PHF19;DNMT3B
prerank,signal peptide processing (GO:0006465),-0.26478233395651973,-0.653084937609555,0.9071803852889667,0.9826518963875056,1.0,4/11,25.87%,SPPL3;PCSK5;CLN5;SEC11A
prerank,pancreas development (GO:0031016),0.24959950923688218,0.6528812078432358,0.9048723897911833,1.0,1.0,2/12,8.25%,PROX1;DNAAF1
prerank,stabilization of membrane potential (GO:0030322),0.2406344961276396,0.652651387172884,0.9084821428571429,1.0,1.0,5/16,23.51%,KCNK12;KCNK10;KCNK9;KCNK4;KCNN4
prerank,retinal metabolic process (GO:0042574),0.2506029409366679,0.6519957196286773,0.8909512761020881,1.0,1.0,1/12,2.73%,AKR1C1
prerank,B cell mediated immunity (GO:0019724),0.27308102679972385,0.6514894864288207,0.9075268817204301,1.0,1.0,10/10,72.71%,MSH2;FCGR2B;CD70;CD27;CD19;SLA2;CARD9;TLR8;CD74;FCER1G
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2386416779116674,0.6513266134136267,0.8940397350993378,1.0,1.0,2/16,11.48%,CENPS;MUS81
prerank,regulation of ERAD pathway (GO:1904292),0.2632454322927712,0.6507028387569518,0.896551724137931,1.0,1.0,2/11,7.01%,TMEM259;USP25
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.23410002619291223,-0.6503957865359189,0.9195612431444241,0.9840788040901609,1.0,12/18,43.00%,MECP2;RAB11A;CCND1;CDC25A;BRD4;DTL;STOX1;CDK4;FBXO5;CCNB1;CDC25C;RAD51C
prerank,mitotic DNA replication (GO:1902969),-0.27835692057454314,-0.6503793934247126,0.9149305555555556,0.9837040995707068,1.0,5/10,24.65%,MCM4;GINS3;GINS1;MCM3;LIG1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.25262490294898765,-0.6498490189217782,0.9157706093189965,0.9836715340625418,1.0,5/14,20.71%,RTRAF;TSEN15;TSEN34;TRPT1;RTCB
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.21768142308668043,-0.6490032681095536,0.9341864716636198,0.9838384504483804,1.0,9/25,27.87%,DNAJC7;GAK;ERO1A;PTGES3;DNAJB12;HSPA14;HSPA13;HSPA1B;SDF2L1
prerank,folic acid metabolic process (GO:0046655),0.22878762605673275,0.647605214886292,0.9507829977628636,1.0,1.0,3/18,9.28%,SLC46A1;SLC19A1;ALDH1L2
prerank,microtubule polymerization (GO:0046785),-0.20686764587679887,-0.6473150303911637,0.9533213644524237,0.9846113269249677,1.0,7/28,18.72%,RANBP9;SLAIN2;CSNK1D;TUBGCP4;TUBGCP5;TRPV4;NDEL1
prerank,protein depolymerization (GO:0051261),-0.20918168460793862,-0.6469172176714609,0.9600725952813067,0.9845183070032384,1.0,14/27,40.53%,MICAL2;CFL2;CFL1;DSTN;KIF18B;KIF14;MICAL1;STMN1;NCKAP5L;CKAP5;TWF2;KIF2C;VIL1;KATNB1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.21243315426549342,-0.646414456132761,0.9360146252285192,0.9844387737495265,1.0,3/26,10.77%,APP;CBL;NCK2
prerank,regulation of cellular metabolic process (GO:0031323),-0.18821955096729848,-0.6462046095351676,0.9671532846715328,0.9842008806094285,1.0,19/45,37.78%,PANK2;PPARA;ACACB;FLOT1;AGPAT1;MKLN1;KIF16B;CYP1B1;VPS35;RNF34;PID1;PDK4;PDK3;FASN;TBC1D16;PM20D2;PARL;FOXM1;GNB3
prerank,response to light stimulus (GO:0009416),-0.18186087353962427,-0.6445953387647283,0.9756521739130435,0.9848294380153428,1.0,21/55,34.18%,MAP4K3;UBE4B;ERCC2;REV1;MAPK8;ERCC3;ERCC8;USP1;ERCC6;DTL;CRY2;GPR52;TYR;TRIM32;USF1;FECH;UBE2A;RRH;AANAT;OPN1MW;OPN1MW3
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.22803466730775476,-0.644469081566949,0.9322638146167558,0.984528556476937,1.0,7/19,29.63%,SLC25A32;MTHFD1;MTHFD1L;ALDH1L1;MTRR;GGH;SHMT1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.22246556625303637,-0.6441517494005977,0.9373881932021467,0.9839458435268982,1.0,2/22,4.27%,ZDHHC6;ZDHHC3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.22246556625303637,-0.6441517494005977,0.9373881932021467,0.9839458435268982,1.0,2/22,4.27%,ZDHHC6;ZDHHC3
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2504544577120016,-0.6434149196270506,0.922509225092251,0.9840188848062137,1.0,3/13,15.49%,RIC3;STX3;ABCA7
prerank,t-circle formation (GO:0090656),-0.26989294009269404,-0.6430055928437906,0.9068100358422939,0.9831257308564992,1.0,4/10,27.65%,DNA2;WRN;BLM;EXO1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.26989294009269404,-0.6430055928437906,0.9068100358422939,0.9831257308564992,1.0,4/10,27.65%,DNA2;WRN;BLM;EXO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.26989294009269404,-0.6430055928437906,0.9068100358422939,0.9831257308564992,1.0,4/10,27.65%,DNA2;WRN;BLM;EXO1
prerank,alpha-amino acid catabolic process (GO:1901606),0.19673025845818354,0.642257433531525,0.960352422907489,1.0,1.0,8/29,23.60%,OTC;HAAO;TDO2;SARDH;DDO;ACAT1;GSTZ1;ALDH4A1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.23593059976637926,-0.6414033449140857,0.9233644859813084,0.9837106850785221,1.0,3/16,15.99%,SHLD1;CGAS;MAD2L2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2741462731121216,-0.6410007380345114,0.895117540687161,0.9835803585727119,1.0,1/10,5.38%,NFKB1
prerank,snRNA metabolic process (GO:0016073),-0.23335465502150932,-0.6396076621240896,0.9358288770053476,0.9840371010170604,1.0,6/17,29.96%,INTS8;INTS3;INTS9;INTS7;INTS5;INTS12
prerank,nucleosome assembly (GO:0006334),-0.20214729847523719,-0.6382705710999673,0.9550359712230215,0.9845018916113245,1.0,4/31,14.82%,KAT6B;BRD2;SPTY2D1;H3-3A
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.20995770526571714,0.6381770280479778,0.9424778761061947,1.0,1.0,8/22,23.70%,VPS37D;TSG101;UBAP1;MVB12B;VPS4B;UBAP1L;PTPN23;VPS28
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.27120004498383526,-0.6380641606753652,0.9121863799283154,0.9842256464306992,1.0,1/10,5.37%,GFPT2
prerank,negative regulation of viral life cycle (GO:1903901),-0.2346512631542469,-0.6379185637157451,0.9314079422382672,0.9839249197790304,1.0,2/15,11.64%,LY6E;IFITM3
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.21546714435282563,-0.6376360097383094,0.9568221070811744,0.9837152727226413,1.0,8/25,30.70%,SLC7A5;CD55;PLCG2;NOD2;FZD5;MAP3K7;TRIM6;TNFRSF14
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.23504540962439857,0.6370770251396228,0.9398663697104677,1.0,1.0,3/15,15.10%,DHX33;USP50;EIF2AK2
prerank,regulation of macrophage differentiation (GO:0045649),0.23247545096304234,0.6365542328660379,0.919661733615222,1.0,1.0,2/15,7.79%,HSF1;PF4
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2383885532084403,0.6363189593966528,0.9443207126948775,1.0,1.0,4/15,17.75%,NEK11;MUS81;RAD9B;CHEK2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.23304594538872317,-0.6357898978687803,0.9205776173285198,0.98442228709819,1.0,4/16,24.84%,SCARB1;MFSD2A;DAGLB;PNPLA2
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.26137311317499784,-0.6355506563843187,0.9126559714795008,0.9841810356238692,1.0,9/11,51.45%,TP53;PTGIS;FAP;DLC1;CIDEA;DFFA;BCL2L1;SIRT2;ZC3H12A
prerank,T cell activation involved in immune response (GO:0002286),-0.25773990519178314,-0.6353467379991672,0.9138576779026217,0.9839276423751395,1.0,7/12,37.42%,ICAM1;LCP1;EIF2AK4;FCER1G;LILRB1;CD74;MDK
prerank,regulation of tissue remodeling (GO:0034103),-0.2254073841145961,-0.634422252330814,0.9334532374100719,0.9840762107243773,1.0,3/18,12.66%,IL15;FLT4;CEACAM1
prerank,stress granule assembly (GO:0034063),0.2162357831929933,0.632850607758907,0.941834451901566,1.0,1.0,2/20,8.42%,BICD1;MAPT
prerank,pyruvate metabolic process (GO:0006090),-0.17674542088329065,-0.6324295926697611,0.9720767888307156,0.9848549198493481,1.0,6/52,12.06%,BSG;SRR;DLD;SLC16A1;ALDOC;PDHB
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.2063255660250015,0.6322357637210716,0.9336283185840708,1.0,1.0,6/23,16.96%,LMAN1;SURF4;SELENOS;TMED9;SEL1L;AUP1
prerank,necroptotic process (GO:0070266),-0.2345921655705635,-0.6321555967271054,0.9408602150537635,0.9846321000787789,1.0,12/16,49.60%,TRPM7;RIPK1;IPMK;TICAM1;CD14;MLKL;TLR4;TICAM2;TLR3;ITPK1;RIPK3;LY96
prerank,epithelial cell development (GO:0002064),0.21721879046259215,0.6317768935861908,0.9479638009049773,1.0,1.0,1/20,1.29%,WNT7B
prerank,protein O-linked mannosylation (GO:0035269),-0.22723939347565475,-0.6314424008198144,0.9436619718309859,0.9846364450180238,1.0,2/18,3.65%,TMTC1;TMTC2
prerank,regulation of neurogenesis (GO:0050767),-0.1752475977032445,-0.6307996747462968,0.986013986013986,0.9846033793717842,1.0,11/55,20.39%,HES1;SPEN;TGM2;YAP1;NOTCH1;NUMB;CTNNB1;HEY1;HEY2;PCM1;LIG4
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.26180119213925335,-0.6302985777193411,0.9365942028985508,0.9844906337060502,1.0,4/11,34.54%,LRP6;CTNNB1;FZD1;NR4A2
prerank,positive regulation of immune response (GO:0050778),-0.17034958386542834,-0.630207667394235,0.987719298245614,0.9841615745996,1.0,17/64,29.07%,IL15;IL6ST;NMI;TGFB2;AKIRIN2;PLSCR1;POLR3F;IFI35;GBP5;NOD2;PTPRC;ITGAM;DHX9;EIF2AK4;LGALS9;RIOK3;RSAD2
prerank,gonad development (GO:0008406),0.18426784565059046,0.6295591867555131,0.9709443099273608,1.0,1.0,11/41,20.74%,ADAM29;WT1;GATA6;KIT;WNT4;MKKS;MSH2;SOX9;NUP107;ADAM21;IRX5
prerank,male gonad development (GO:0008584),-0.19522814775628977,-0.6289952353803876,0.9706390328151986,0.9844187922743015,1.0,4/34,11.06%,KITLG;TGFB2;MAMLD1;NCOA4
prerank,positive regulation of protein sumoylation (GO:0033235),-0.26305643756796676,-0.6285013722291063,0.9115523465703971,0.984318043176449,1.0,4/10,24.70%,UBA2;HDAC4;PIAS4;SAE1
prerank,negative regulation of mRNA processing (GO:0050686),-0.24015658473349427,-0.6283570553952338,0.9396709323583181,0.984009573268938,1.0,4/15,21.18%,SRSF12;SFSWAP;RNPS1;SRSF10
prerank,proteoglycan metabolic process (GO:0006029),-0.20436607671170334,-0.6283336159440286,0.9475524475524476,0.9836429054145025,1.0,11/26,35.56%,BMPR2;CSGALNACT1;CHST11;IGF1;HPSE;CSGALNACT2;XYLT1;SULF1;CHST14;CHST13;CNMD
prerank,T cell proliferation (GO:0042098),0.24249748121910708,0.6282800376194416,0.9353348729792148,1.0,1.0,4/13,18.78%,TNFSF18;RASGRP1;DOCK8;CADM1
prerank,neural tube development (GO:0021915),-0.23727785422115577,-0.62797734915915,0.9205776173285198,0.9834586335618735,1.0,1/15,1.72%,PKD2
prerank,cellular response to sterol (GO:0036315),-0.24646621637975757,-0.627470416396221,0.9388888888888889,0.9833515408363901,1.0,3/13,12.41%,SMO;LRP6;INSIG2
prerank,reticulophagy (GO:0061709),-0.2545289245055985,-0.6273110201914885,0.9099264705882353,0.9830532388608973,1.0,4/12,26.64%,UFM1;ULK2;ATG2A;ATG2B
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.22655316318166352,-0.6267612786660827,0.922365988909427,0.9829640358888937,1.0,9/17,40.89%,SLC7A5;RARA;LGALS9;FCER1G;CEBPB;NLRP3;SYK;GATA3;CD28
prerank,phospholipid homeostasis (GO:0055091),0.25031492048735393,0.6261599469851695,0.9147121535181236,1.0,1.0,4/11,22.89%,RCN3;TLCD2;ANGPTL3;ABCG1
prerank,regulation of transport (GO:0051049),-0.19150003526155537,-0.6254851800993774,0.9673321234119783,0.9832498387989342,1.0,6/36,16.66%,LRRK2;SCFD1;ARL6IP5;ACTB;ICA1;RAB11A
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.19006849411388854,0.6245591150415766,0.9691629955947136,1.0,1.0,4/32,9.94%,RNASE6;ANG;PF4;CCL13
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.19514626004499538,0.6231733761532601,0.9664268585131894,1.0,1.0,12/29,23.85%,TERF1;ANKRD28;WRAP53;PPIA;CDK2;ACD;HSP90AB1;TERF2IP;TELO2;NOP10;SHQ1;RTEL1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.224087626002217,0.6226837594577207,0.924892703862661,1.0,1.0,14/15,64.25%,SELENOS;SEL1L;AUP1;NPLOC4;DERL2;SYVN1;UFD1;TMEM129;FAF2;DERL1;HSP90B1;SEC61B;VCP;OS9
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.20956921990315175,0.6207142748993862,0.9646799116997793,1.0,1.0,6/23,18.78%,IL12A;RASGRP1;CD226;SLAMF6;ARRB2;CADM1
prerank,RNA methylation (GO:0001510),0.16729424072417134,0.6203569194974052,1.0,1.0,1.0,17/60,23.09%,MTERF4;TRMT6;GTPBP3;TRMT13;TRMT10A;BUD23;ZC3H13;TFB1M;DIMT1;FTSJ1;METTL8;NSUN6;CMTR1;METTL2B;METTL2A;TRMT5;THUMPD3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.21885756056233704,-0.6175548421961038,0.9363636363636364,0.986986453943495,1.0,3/20,16.38%,RB1;FOXC1;IGF1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.21256028645116298,0.6136680054736365,0.9334719334719335,1.0,1.0,6/17,25.16%,SELENOS;SEL1L;AUP1;HM13;NPLOC4;DERL2
prerank,regulation of superoxide anion generation (GO:0032928),0.22669505149955985,0.613551006727728,0.9389140271493213,1.0,1.0,2/14,8.42%,CD177;MAPT
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.18622237256384322,-0.6131749733574625,0.9733096085409253,0.9887906298273018,1.0,12/39,32.46%,RPS14;RPSA;RPS16;RPS27;UTP4;RPS7;RPS15;RPS17;EMG1;RIOK3;RPS27L;SRFBP1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.23621768082182776,-0.6128966339147988,0.9342105263157895,0.9885564078082083,1.0,8/14,40.43%,IRS1;AKT1;PTPN2;ARPP19;PMAIP1;AKT2;NNMT;SIRT1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.2563728177111453,-0.6122632167188684,0.9411764705882353,0.9884828759736757,1.0,4/10,29.47%,RPUSD4;NAF1;RPUSD2;GAR1
prerank,cellular response to chemokine (GO:1990869),-0.17898384785352772,-0.6121264409156326,0.978021978021978,0.9881760659578759,1.0,13/46,30.62%,LRCH1;CCL25;SLC12A2;RHOA;ACKR3;FOXC1;CCL19;CXCL12;PTK2B;CXCL10;DUSP1;WNK1;GPR75
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.2482206315772025,0.6119058707579628,0.9184100418410042,1.0,1.0,5/10,28.05%,VEGFA;FZD3;CX3CL1;CX3CR1;KDM1A
prerank,UV-damage excision repair (GO:0070914),0.2384927328467305,0.6116159698023133,0.9380733944954128,1.0,1.0,2/12,10.09%,DDB1;POLA1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.24084880684084536,-0.6106643652254461,0.9439421338155516,0.9884939235344501,1.0,1/13,1.34%,NOS3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.19349363260953292,-0.6100798949708587,0.9660107334525939,0.9883921503613133,1.0,7/29,25.79%,PLA2G4A;LPCAT1;TMEM86B;PLA2G12A;LPCAT3;PNPLA8;PLA2G4F
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.2287943298327882,0.6097763213299672,0.9497716894977168,1.0,1.0,3/14,12.46%,CD81;CARD11;CD226
prerank,long-chain fatty acid transport (GO:0015909),-0.19393588539378465,-0.6097096666877134,0.9716312056737588,0.9881814958916479,1.0,18/30,42.75%,ABCD3;MFSD2A;ACACB;CPT1A;SLC27A4;ACSL1;PPARG;SPX;FABP3;SLC27A6;CPT2;MID1IP1;FABP4;PRKAG2;THRSP;SLC25A20;SLC27A2;ABCD1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.21526457283551445,0.6095473409795419,0.9586056644880174,1.0,1.0,3/16,15.02%,IL12A;IL12RB1;IL23A
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2313106612215685,-0.6092878685565498,0.9396709323583181,0.9880042157719923,1.0,5/14,30.41%,FOXO3;MRPL12;FASTKD5;SLC25A33;MTERF2
prerank,monosaccharide transmembrane transport (GO:0015749),0.21978274897381517,0.6055298360509936,0.9445676274944568,1.0,1.0,2/16,9.94%,SLC2A10;SLC2A8
prerank,response to sterol (GO:0036314),-0.2535010507378494,-0.6051904877386914,0.9266547406082289,0.9894758327872664,1.0,6/11,30.81%,TGFBR2;SMAD2;PMVK;TGFBR1;RORC;TGFB1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.20377295291054354,-0.6048069228839293,0.9709618874773139,0.9892708615208915,1.0,5/24,23.04%,LRRK2;AQP11;HERPUD1;LPCAT3;TXNDC12
prerank,regulation of chromosome organization (GO:0033044),-0.2048423334899886,-0.6041055541044911,0.9571428571428572,0.9891933784153332,1.0,9/22,33.70%,RB1;WAPL;TERF2;LIG4;SMG6;HNRNPD;SMG1;HDAC8;PIF1
prerank,triglyceride metabolic process (GO:0006641),0.16962027257705248,0.6034625304528605,0.9904761904761905,1.0,1.0,7/48,16.52%,LPIN1;GK;LIPC;MOGAT1;APOE;APOC1;SEL1L
prerank,positive regulation of protein depolymerization (GO:1901881),0.239974430388196,0.6013896999422077,0.945823927765237,1.0,1.0,2/11,9.80%,PLEK;STMN2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.25358138177542366,-0.5999199515772883,0.9496527777777778,0.990635049414139,1.0,5/10,29.45%,ACER2;SERPINE1;CYP1B1;SNAI2;WNK1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.23332079927424548,0.5995561721548971,0.9267782426778243,1.0,1.0,1/12,3.75%,GGCT
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.21270195911362,0.5993464226284281,0.9573991031390134,1.0,1.0,7/17,28.30%,LIPC;PCSK6;APOC1;ANGPTL3;NR1H2;SORT1;HDAC9
prerank,regulation of nervous system development (GO:0051960),0.17675122391344672,0.597152869977402,0.9791183294663574,1.0,1.0,2/37,5.85%,TENM4;PTPRZ1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.20242235085424892,-0.5969517532991153,0.9653979238754326,0.9914340864126372,1.0,6/23,24.47%,RBX1;XPC;CETN2;COPS7A;COPS8;COPS4
prerank,telomere maintenance via telomerase (GO:0007004),-0.19181303006367506,-0.5963142479646011,0.9759862778730704,0.9913193162599439,1.0,9/28,24.82%,MRE11;PPP6R3;RPA1;PTGES3;TERF2;TERT;HSP90AA1;RFC1;PINX1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.22324744457936777,0.5951414550187215,0.9586374695863747,1.0,1.0,3/14,19.45%,RASGRP1;IL23A;CD84
prerank,lipoprotein transport (GO:0042953),0.24850453712363896,0.5939859905923076,0.9454545454545454,1.0,1.0,4/10,26.23%,PRKCB;VMP1;UNC119;CD36
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.20764826689508936,-0.5927364083327815,0.963963963963964,0.9924024387870688,1.0,4/19,21.04%,RIC3;CHRNB1;NQO1;CHRNA4
prerank,regulation of microtubule-based movement (GO:0060632),0.23932588747152034,0.5925624926912547,0.9577777777777777,1.0,1.0,2/11,8.66%,MAP2;NEFH
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.21008716138403347,-0.5923328409488845,0.9555555555555556,0.9918039604115461,1.0,6/19,25.92%,POLR2G;TERF2;ATRX;POLR2C;POLR2L;POLR2H
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.21008716138403347,-0.5923328409488845,0.9555555555555556,0.9918039604115461,1.0,6/19,25.92%,POLR2G;TERF2;ATRX;POLR2C;POLR2L;POLR2H
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.19635443378940054,0.5916607025538849,0.9683257918552036,1.0,1.0,4/23,12.58%,H1-0;MUS81;HMGB2;REXO4
prerank,heterocycle biosynthetic process (GO:0018130),0.22126821483435907,0.5905810931644596,0.9544468546637744,1.0,1.0,5/14,22.45%,PYCR2;ALOX5;NOXRED1;NFS1;LIAS
prerank,epithelial cell morphogenesis (GO:0003382),0.20680107006957038,0.5905436934282743,0.9602510460251046,1.0,1.0,1/17,2.77%,STC1
prerank,organelle disassembly (GO:1903008),0.18205217167672288,0.5899560706600775,0.986046511627907,1.0,1.0,6/33,17.26%,VRK1;ZFAND1;UBA5;GOLGA2;UFL1;RETREG1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.23510316917411078,0.5898363192179596,0.9351851851851852,1.0,1.0,2/12,8.27%,TRH;SLC29A4
prerank,protein localization to kinetochore (GO:0034501),0.2166488794023481,0.5876898922093619,0.9393939393939394,1.0,1.0,14/14,78.35%,RCC2;CDK1;IK;ZWILCH;ZW10;KNL1;CHAMP1;AURKB;CENPT;MIS12;SPDL1;MTBP;TTK;BUB3
prerank,Golgi inheritance (GO:0048313),-0.2384941058978137,-0.5855225549778497,0.9597197898423818,0.9940154270061654,1.0,5/11,33.57%,YWHAZ;VCPIP1;PLK3;STX5;PDCD10
prerank,endocrine system development (GO:0035270),-0.20116973740300098,-0.5848889316957867,0.9588336192109777,0.993860493572144,1.0,6/21,28.59%,TBX1;SIX1;WNT11;NF1;STRA6;TGFBR1
prerank,inner ear morphogenesis (GO:0042472),-0.20099795119321828,-0.5846365856455626,0.9715370018975332,0.993564200354932,1.0,2/22,5.59%,TBX1;SIX1
prerank,regulation of telomere maintenance (GO:0032204),-0.19096000333282537,-0.5827427625303345,0.9757009345794393,0.9939033273674281,1.0,11/26,33.70%,MRE11;PPP1R10;TERF2;USP7;ATRX;SMG6;HNRNPD;SMG1;RAD50;HDAC8;PIF1
prerank,oogenesis (GO:0048477),0.21188498248245313,0.5804866499915177,0.9484029484029484,1.0,1.0,1/15,3.69%,FMN2
prerank,negative regulation of T cell proliferation (GO:0042130),0.18243944240202487,0.5798745961626129,0.9718614718614719,1.0,1.0,27/28,73.00%,VTCN1;SDC4;CD86;PRNP;IL4I1;TNFRSF21;PRKAR1A;SCRIB;PLA2G2F;DLG5;VSIG4;IL10;BTN2A2;PLA2G2D;CD80;GLMN;SPN;FOXP3;PDCD1LG2;CRTAM;ARG1;GPNMB;CD274;CEBPB;LILRB1;TNFRSF14;LGALS9
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.2255528886283101,0.5793888439541158,0.9474835886214442,1.0,1.0,1/13,2.30%,UBE2J1
prerank,regulation of DNA metabolic process (GO:0051052),0.16215858573758968,0.5787509655264448,0.9957627118644068,1.0,1.0,11/44,22.35%,WRNIP1;XRCC5;PDGFA;SMG5;SIRT7;UPF1;KAT7;WDR70;WDR18;TERF2IP;CDK9
prerank,protein mannosylation (GO:0035268),-0.19775652068722802,-0.5774669651677962,0.9539823008849557,0.9953731565279511,1.0,2/22,3.65%,TMTC1;TMTC2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.197269732388368,0.577279071033531,0.9747126436781609,1.0,1.0,10/19,29.22%,ATP13A2;HTRA2;HTT;VDAC1;FBXO7;USP36;DNM1L;SREBF1;PINK1;SREBF2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.2391926823716324,-0.5765362452280872,0.9626168224299065,0.9953053533749864,1.0,6/11,32.94%,CASP8;RIPK1;TICAM1;RFTN1;TNIP2;SCARA3
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.22900203525073293,0.5727880204897365,0.9548693586698337,1.0,1.0,3/11,16.74%,P2RX3;P2RX5;CDH13
prerank,rRNA methylation (GO:0031167),0.19005121701086458,0.5721666818922544,0.9773242630385488,1.0,1.0,4/22,13.07%,MTERF4;BUD23;TFB1M;DIMT1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2321057749022888,-0.5717002204956703,0.9508506616257089,0.9965439135900785,1.0,5/12,31.12%,SLC25A11;SLC20A2;SLC37A4;SLC20A1;SLC25A10
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.23025882045126173,-0.5716355598758659,0.9489981785063752,0.9961850495272446,1.0,3/12,20.87%,RBP4;NOD2;STRAP
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.22161993147612263,0.5703316937329973,0.9547511312217195,1.0,1.0,4/12,19.63%,LDLR;CLU;APOE;PFDN4
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.19789840407429668,-0.5698939598314487,0.9766187050359713,0.9963522717808212,1.0,9/22,30.26%,PPM1F;PPM1B;PPP2CB;PPM1D;DUSP16;PPP2CA;PPP1CA;DUSP1;DUSP6
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.22092067196981519,-0.5684453270507094,0.968476357267951,0.996410268072961,1.0,1/13,5.60%,CBL
prerank,glycine metabolic process (GO:0006544),-0.22446645633116818,-0.5681381156305754,0.9506398537477148,0.9961265086042062,1.0,1/12,3.50%,DLD
prerank,establishment of spindle localization (GO:0051293),-0.21564405237100762,-0.5674285848023848,0.9712230215827338,0.9959689386082466,1.0,6/14,39.72%,MAP4;CFL1;TLE6;ESPL1;NLRP5;ZBED3
prerank,muscle filament sliding (GO:0030049),-0.16604807368464697,-0.5649299005313974,0.9891107078039928,0.9959688519234654,1.0,13/38,36.59%,TPM3;TPM1;MYL6;TNNI1;TNNT3;ACTN2;TTN;TPM2;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,actin-myosin filament sliding (GO:0033275),-0.16604807368464697,-0.5649299005313974,0.9891107078039928,0.9959688519234654,1.0,13/38,36.59%,TPM3;TPM1;MYL6;TNNI1;TNNT3;ACTN2;TTN;TPM2;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2334559497852961,0.5648872329918561,0.958904109589041,1.0,1.0,3/10,19.57%,SOCS3;INPP5F;PPP2R1A
prerank,carnitine shuttle (GO:0006853),0.22223606279210936,0.5633578590214517,0.9610091743119266,1.0,1.0,2/11,9.04%,ACACA;CPT1B
prerank,carboxylic acid catabolic process (GO:0046395),0.2248904067715336,0.5633540634058876,0.956140350877193,1.0,1.0,3/12,20.47%,BCKDK;NPL;GNPDA1
prerank,chromatin assembly or disassembly (GO:0006333),0.23209039220694194,0.563299246089638,0.9458874458874459,1.0,1.0,1/11,5.61%,M1AP
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.2341176210115654,-0.563067796833057,0.9679144385026738,0.9961164162780479,1.0,4/11,24.39%,ADM;SAG;ARRB1;GRK3
prerank,lymphocyte migration (GO:0072676),-0.17808626903651692,-0.5615657653460333,0.9908424908424909,0.9961714672694476,1.0,3/32,9.20%,CCL25;MSN;S1PR1
prerank,regulation of interleukin-17 production (GO:0032660),-0.17835022930490957,-0.5615133756670422,0.9874551971326165,0.9958057518181211,1.0,2/31,3.85%,SLC7A5;IL15
prerank,cochlea morphogenesis (GO:0090103),-0.23709991575728,-0.5613884449942063,0.9668508287292817,0.9954601340859536,1.0,1/10,3.63%,TBX1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.1966055354111315,-0.5608642398797841,0.9848197343453511,0.9952346185330501,1.0,5/20,20.96%,LDLRAP1;ACADL;ACADVL;FMO5;LPCAT3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.21465967723324098,0.5603788813931736,0.9460093896713615,1.0,1.0,2/12,15.02%,RASGRP1;IL23A
prerank,protein polyglutamylation (GO:0018095),0.21874716710997066,0.5594333410883388,0.961864406779661,1.0,1.0,5/11,26.93%,TPGS1;TTLL5;CFAP20;TTLL11;TTLL2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.2317176684200899,-0.5592255029496311,0.9651567944250871,0.995299098563391,1.0,2/11,16.25%,JAK2;TAF7
prerank,regulation of small molecule metabolic process (GO:0062012),-0.18245172317774563,-0.5590159536992447,0.9801084990958409,0.9949926953914848,1.0,4/28,13.89%,PANK2;PPARA;ACADL;ACADVL
prerank,coenzyme A metabolic process (GO:0015936),0.20823839932170715,0.5587983815636123,0.9596412556053812,1.0,1.0,6/14,25.87%,ACLY;ACOT7;ACAT1;CROT;DCAKD;COASY
prerank,anterograde synaptic vesicle transport (GO:0048490),0.2017227892041914,0.5569303841317166,0.9721030042918455,1.0,1.0,3/15,15.41%,AP3S2;AP3M2;SNAPIN
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.2017227892041914,0.5569303841317166,0.9721030042918455,1.0,1.0,3/15,15.41%,AP3S2;AP3M2;SNAPIN
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.22930126701204276,-0.5567522837889027,0.9610619469026549,0.9952411170247527,1.0,5/11,37.65%,SLC19A2;SLC19A3;DCK;SLC25A19;THTPA
prerank,positive regulation of bone resorption (GO:0045780),0.22326136078332914,0.5566370263524156,0.9617977528089887,1.0,1.0,11/11,77.69%,SPP1;ADAM8;DEF8;ATP6AP1;PRKCA;TNFRSF11A;DCSTAMP;TNFSF11;SYK;MC4R;PLEKHM1
prerank,mitochondrial transcription (GO:0006390),-0.23155246048873335,-0.5550581563163163,0.9510357815442562,0.9952992488263608,1.0,4/10,30.41%,FOXO3;MRPL12;SLC25A33;MTERF2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.2009531213009106,-0.5536669070957102,0.9730700179533214,0.9952555696010362,1.0,5/17,29.29%,AFG1L;COX10;COX6C;COX5A;COX4I2
prerank,regulation of fatty acid oxidation (GO:0046320),-0.20807955745038267,-0.5531681827178567,0.9667250437828371,0.9950055740209804,1.0,3/16,13.89%,PPARA;ACADL;ACADVL
prerank,nucleotide biosynthetic process (GO:0009165),-0.1983990408865438,-0.5522961592092741,0.9724612736660929,0.9948733618093426,1.0,7/18,35.84%,MTHFD1;HPRT1;PRPS2;PNP;GART;ME1;NMNAT3
prerank,ATP transport (GO:0015867),0.2249262639000715,0.5483671575748794,0.977728285077951,1.0,1.0,2/10,15.25%,SLC25A4;CD47
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.21494155834091294,-0.5476912419300769,0.967032967032967,0.9956556296388481,1.0,2/14,8.99%,SEMA7A;PLCG2
prerank,regulation of transposition (GO:0010528),-0.21208931754928,-0.546665219062624,0.9676840215439856,0.9955401266144931,1.0,6/13,40.03%,UBR2;TDRD9;DDX4;MYBL1;PIWIL4;SPOCD1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.194151917667414,0.5465642461264079,0.9815668202764977,1.0,1.0,1/16,2.91%,TMEM161A
prerank,negative regulation of phagocytosis (GO:0050765),0.19245381872942735,0.5464781184205996,0.9868421052631579,1.0,1.0,4/17,17.74%,SYT11;CD47;SIRPA;FCGR2B
prerank,positive regulation of leukocyte migration (GO:0002687),-0.1767809484774735,-0.5446452870401731,0.9925925925925926,0.99564904109195,1.0,3/27,11.69%,ICAM1;IL6R;EDN3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.21532307791340477,-0.5444018958312578,0.9630996309963099,0.9953257440116358,1.0,4/13,32.09%,IRAK1;IRAK2;PIK3AP1;TNIP2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.23078277317438164,-0.5433411259967723,0.9614035087719298,0.9951902935141075,1.0,3/10,28.54%,TAF7;BRCA1;SET
prerank,tetrahydrofolate metabolic process (GO:0046653),0.22281440236945366,0.5432316294361131,0.9671052631578947,1.0,1.0,1/10,5.28%,TYMS
prerank,negative regulation of DNA recombination (GO:0045910),0.1537212682203159,0.5406830368496904,0.997737556561086,1.0,1.0,15/43,25.96%,SHLD3;TERF1;H1-0;POLR2D;FANCB;ACD;MSH2;TERF2IP;FBH1;RTEL1;UBQLN4;POLR2J;POLR2K;ZRANB3;POLQ
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.19252560332926763,-0.5386214535797358,0.975517890772128,0.9959305714387385,1.0,4/18,26.06%,ABL1;PRKDC;PRDM1;ZFP36L1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.20947174209641412,-0.5362619870359238,0.9698581560283688,0.9960660910745324,1.0,4/13,22.62%,SEC16B;BCAP31;EDEM2;SAR1A
prerank,negative regulation of cation channel activity (GO:2001258),-0.17724570633713582,-0.5351840349777233,0.9926062846580407,0.9959165803136935,1.0,2/26,10.36%,PKD2;GSTM2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.20936080594877696,-0.533767982860756,0.9648798521256932,0.995825779590834,1.0,2/13,10.57%,CSPG4;BGN
prerank,regulation of activated T cell proliferation (GO:0046006),-0.16896908641876934,-0.5304556311614789,0.9891500904159132,0.9961268277102809,1.0,19/30,49.57%,ICOSLG;RC3H1;IGF1;RPS3;IGF2;HMGB1;LGALS9;IL27RA;CD274;IL18;CRTAM;PDCD1LG2;TNFSF9;FOXP3;IL23R;AGER;IL12B;IL2;RIPK3
prerank,N-terminal protein amino acid modification (GO:0031365),-0.20595229612945662,-0.5302622427073423,0.9809688581314879,0.9957864464816663,1.0,2/14,10.04%,NAA16;NAA15
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2111779752908047,0.5272040469083827,0.9797752808988764,1.0,1.0,2/11,13.39%,TERF1;WRAP53
prerank,acylglycerol homeostasis (GO:0055090),-0.18765811295107993,-0.5260383579558567,0.9893992932862191,0.9962619152057456,1.0,12/20,48.36%,SCARB1;LPL;PNPLA8;RORA;IL18;APOC4;PLA2G12B;NR1H3;HNF4A;ACSM2A;ANGPTL8;APOA1
prerank,superoxide anion generation (GO:0042554),0.19952984589790757,0.5231767941859826,0.9862385321100917,1.0,1.0,2/13,11.55%,ALOX12;NOX3
prerank,hexose biosynthetic process (GO:0019319),-0.15304470691592398,-0.5231736431867992,0.9946140035906643,0.9964017990927,1.0,5/42,14.04%,CHST15;RBP4;SLC25A11;ALDOC;ATF4
prerank,protein deneddylation (GO:0000338),-0.22193342177367914,-0.5208432279837375,0.9820466786355476,0.9964533681089757,1.0,4/10,30.55%,COPS7A;COPS8;COPS4;COPS5
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.20452600599767667,-0.5192998157920056,0.9873417721518988,0.9963510691656784,1.0,7/14,39.88%,RARA;ANXA1;CCL19;NFKBID;NLRP3;IL18;MYB
prerank,maintenance of protein localization in organelle (GO:0072595),-0.17914130403049466,-0.5154995284131468,0.9948275862068966,0.9966301614345816,1.0,8/19,37.85%,AKT1;TAF8;TAF3;ARL2;HNRNPU;MORC3;TOPORS;ARL2BP
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.15669906988760365,-0.5151942317377444,0.9943609022556391,0.9963176545097723,1.0,18/37,45.32%,PPARA;PDCD4;IL17RA;GBP5;NOD2;TREM2;MAPK14;STAT3;TICAM1;TLR6;NOS2;HIF1A;APPL2;ABCD1;CARD9;TLR4;TNF;IL6
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.16901585738045077,0.513140853708753,0.9889135254988913,1.0,1.0,4/22,19.02%,IL12A;IL12RB1;IL23A;ZBTB1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.1975442438963601,0.5127056787295937,0.988479262672811,1.0,1.0,3/13,18.00%,BMF;VDAC2;RHOT1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.19999767991295828,-0.5074781638412585,0.9803921568627451,0.9971408053554978,1.0,5/13,32.76%,AQP11;LPCAT3;EIF2AK3;USP19;MANF
prerank,protein localization to phagophore assembly site (GO:0034497),-0.20867015061265792,-0.5072661853338984,0.9766187050359713,0.99679723914105,1.0,5/11,34.25%,WIPI1;WDR45B;ATG9A;PACS2;WIPI2
prerank,tryptophan catabolic process (GO:0006569),0.20499623399447653,0.5070220653714975,0.9845132743362832,1.0,1.0,11/11,79.51%,HAAO;TDO2;IL4I1;AFMID;ACMSD;IDO1;IDO2;AADAT;KYAT1;KYNU;KMO
prerank,intracellular sterol transport (GO:0032366),-0.20089547062569693,-0.5062501506275311,0.9818511796733213,0.9965787721462882,1.0,3/13,20.55%,STARD4;STAR;OSBPL2
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.17964733763072993,0.505914256019388,0.9890350877192983,1.0,1.0,3/18,15.69%,CHGA;ADRA2A;BMP8A
prerank,tryptophan metabolic process (GO:0006568),0.20499623399447653,0.5043838032492204,0.9913232104121475,1.0,1.0,11/11,79.51%,HAAO;TDO2;IL4I1;ACMSD;IDO1;ATP7A;IDO2;AADAT;KYAT1;KYNU;KMO
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.18113527774163624,0.5035213256064549,0.9888392857142857,1.0,1.0,7/16,29.33%,PIGP;PIGB;PIGQ;DPM2;PIGA;PIGM;PIGC
prerank,female gonad development (GO:0008585),-0.17783170557062677,-0.5026845827431348,0.9907235621521335,0.9967009032631633,1.0,8/19,33.43%,EIF2B2;SOD1;NR2F2;FOXL2;COL9A3;CEBPB;EIF2B4;EIF2B5
prerank,cGMP biosynthetic process (GO:0006182),-0.21822983949028202,-0.501867773271919,0.9784560143626571,0.9964372306844486,1.0,3/10,24.28%,NPR1;GUCY1A1;GUCY2C
prerank,DNA modification (GO:0006304),0.16112193457630297,0.49733380685618506,0.9977011494252873,1.0,1.0,2/22,6.89%,TERF1;UNG
prerank,kinetochore organization (GO:0051383),-0.19953342629898255,-0.49552606682049677,0.9927797833935018,0.9969300790959948,1.0,6/13,39.77%,POGZ;CENPE;CENPH;NUF2;MIS12;CENPT
prerank,rRNA transcription (GO:0009303),-0.1796533783078828,-0.4955194262199423,0.9948186528497409,0.9965557155664807,1.0,5/17,25.09%,TAF1B;BRF1;CAVIN1;GTF3C4;POLR1E
prerank,gluconeogenesis (GO:0006094),0.14467948016948806,0.49197831236445455,1.0,1.0,1.0,2/39,5.09%,SLC25A13;TPI1
prerank,RNA modification (GO:0009451),0.13318519356628458,0.4906406686259936,1.0,1.0,1.0,13/54,22.42%,QTRT2;TRMT6;TFB1M;TSR3;FTSJ1;AARS2;ANKRD16;QTRT1;TRIT1;NSUN6;ADAT2;THUMPD1;NOP10
prerank,indolalkylamine catabolic process (GO:0046218),0.20498336785288396,0.48900367332512434,0.9889624724061811,1.0,1.0,10/10,79.51%,HAAO;TDO2;IL4I1;ACMSD;IDO1;IDO2;AADAT;KYAT1;KYNU;KMO
prerank,microglial cell activation (GO:0001774),0.161646712549699,0.48607843948505863,0.9954648526077098,1.0,1.0,7/21,26.02%,GRN;MAPT;CLU;CX3CL1;SNCA;CX3CR1;TYROBP
prerank,positive regulation of protein maturation (GO:1903319),0.19062264624654787,0.4812883761687728,0.9976133651551312,1.0,1.0,11/11,80.95%,NKD2;ADAM8;ASTL;TNP2;ANGPTL8;TFR2;CCBE1;BAG2;NLRC4;RHBDD1;SOX4
prerank,protein import into peroxisome membrane (GO:0045046),-0.16417249114780275,-0.4757289836124873,0.9946524064171123,0.9984150015432085,1.0,7/22,33.89%,ABCD3;RAB8B;PEX14;PEX3;PEX11B;PEX19;PEX26
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.18830552892802574,-0.4738057425464565,0.9925233644859813,0.9982274399898553,1.0,2/13,13.29%,GAS6;AP1G1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.1721539888663193,-0.4737298940470145,0.996415770609319,0.9978601670129235,1.0,8/16,42.84%,RC3H1;MOV10;RBM24;ZFP36L1;ZC3H12D;TRIM71;DND1;PLEKHN1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.18787179773601703,0.4734084599567271,0.984375,1.0,1.0,3/11,21.50%,UGGT2;AUP1;TOR1A
prerank,positive regulation of interleukin-10 production (GO:0032733),0.14152363787316313,0.463895171967252,1.0,1.0,1.0,4/30,15.02%,INAVA;PRKCZ;LILRA5;IL23A
prerank,aggrephagy (GO:0035973),0.14805729161009235,0.4632335390913662,0.9931818181818182,1.0,1.0,7/27,21.97%,DYNC1I1;DYNC1LI2;VIM;UBB;DYNC1I2;ACBD5;SQSTM1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.1686948969572643,-0.46168551386262613,0.9966499162479062,0.9984893769505953,1.0,10/16,50.08%,VSIR;LILRB1;TRIB2;CD274;PDCD1LG2;FOXP3;IL23R;AGER;IL12B;DLL1
prerank,regulation of B cell activation (GO:0050864),0.14907651715039597,0.4576620826177262,0.9978260869565218,1.0,1.0,25/25,85.12%,SAMSN1;FOXJ1;FCGR2B;IL4I1;MZB1;IGLL1;TNFSF4;TLR9;ZFP36L2;SH3KBP1;LAPTM5;IL10;CD19;SLAMF8;IL6;CD22;IL4;AHR;THEMIS2;IKZF3;TNIP2;BANK1;ZFP36L1;NOD2;TNFAIP3
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.167866830373984,0.45523716757014987,0.9935205183585313,0.9998509988964494,1.0,2/15,11.60%,CHST2;EXTL2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.16147017181820328,-0.451105652564846,0.9948979591836735,0.9988316162716934,1.0,5/18,24.66%,ICOSLG;IGF1;RPS3;IGF2;HMGB1
prerank,regulation of interleukin-10 production (GO:0032653),-0.12732717202705193,-0.438174848794988,1.0,0.9991998080197252,1.0,25/44,50.08%,CD34;PLCG2;VSIR;NOD2;HMGB1;LGALS9;LILRB1;STAT3;TSLP;TRIB2;CD274;SYK;PDCD1LG2;IL4;CD28;TLR4;IL6;FOXP3;IRF4;IL23R;AGER;F2RL1;IL12B;XCL1;DLL1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.17889126748548728,0.43715889418787873,0.997737556561086,1.0,1.0,1/10,9.73%,IL12A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.1664914276611339,0.4349414187644659,0.995475113122172,0.9992062185404692,1.0,1/13,6.89%,UNG
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.1655239443289099,0.42412536109043225,0.9977628635346756,0.9987452684029309,1.0,2/12,13.39%,GNL3;WRAP53
prerank,regulation of stem cell population maintenance (GO:2000036),-0.14646233796815822,-0.40848612847901594,1.0,0.9999135516394393,1.0,4/18,27.03%,TAF5L;PTN;CNOT2;CNOT1
prerank,smoothened signaling pathway (GO:0007224),-0.12197608830830528,-0.3898345707118727,1.0,0.9999267933987256,1.0,5/32,20.33%,SMO;GLI3;HIPK1;TMEM17;PKD2L1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.15525578789424843,-0.37316664940636723,0.9981981981981982,0.9997681928178804,1.0,4/11,36.28%,ATF4;NONO;PARK7;HIF1A
